Citrus Sinensis ID: 004564
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 745 | 2.2.26 [Sep-21-2011] | |||||||
| Q9CAV6 | 700 | Serine/threonine-protein | yes | no | 0.801 | 0.852 | 0.657 | 0.0 | |
| Q0D598 | 704 | Probable serine/threonine | yes | no | 0.645 | 0.683 | 0.698 | 0.0 | |
| A2YMV6 | 704 | Probable serine/threonine | N/A | no | 0.645 | 0.683 | 0.698 | 0.0 | |
| Q2V338 | 492 | Probable serine/threonine | no | no | 0.632 | 0.957 | 0.680 | 0.0 | |
| Q8S8Y9 | 568 | Serine/threonine-protein | no | no | 0.634 | 0.832 | 0.626 | 0.0 | |
| Q65X23 | 621 | Probable serine/threonine | no | no | 0.563 | 0.676 | 0.577 | 1e-147 | |
| Q9STK6 | 516 | Probable serine/threonine | no | no | 0.506 | 0.730 | 0.597 | 1e-143 | |
| Q9SCU5 | 549 | Probable serine/threonine | no | no | 0.526 | 0.714 | 0.566 | 1e-134 | |
| Q8S8Y8 | 567 | Probable serine/threonine | no | no | 0.559 | 0.735 | 0.533 | 1e-132 | |
| Q8LST2 | 557 | Probable serine/threonine | no | no | 0.562 | 0.752 | 0.523 | 1e-131 |
| >sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 852 bits (2200), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/678 (65%), Positives = 516/678 (76%), Gaps = 81/678 (11%)
Query: 1 MNGLTHLEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF 60
MN L++LEPD SEFVEVDPTGRYGRYNE+LGKGASKTVYRAFDEYEGIEVAWNQVKLYDF
Sbjct: 1 MNNLSYLEPDYSEFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDF 60
Query: 61 LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK 120
LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTE+FTSGTLRQYRL+HK
Sbjct: 61 LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHK 120
Query: 121 RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180
RVNIRA+K WCRQILRGL YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK
Sbjct: 121 RVNIRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180
Query: 181 SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS 240
SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTF+YPYSECTHPAQIYKKV+S
Sbjct: 181 SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMS 240
Query: 241 GKKPDSLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELD 300
GKKPD+LY+VKDPEV+ F+EKCLATVSLR+SARELL+DPFL+IDD E +LRS+D D
Sbjct: 241 GKKPDALYKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRIDDGEFDLRSVDME---D 297
Query: 301 DMDPLIRQPH--IDFHH-------IDNSFSNG------------CANGYG--YDTPSEWG 337
+ PL RQPH D+++ ++ +SNG +NGY ++ + W
Sbjct: 298 SVGPLYRQPHHLPDYYNYPSNSSSLNRQYSNGNYPSNSSSLNRQYSNGYNSHHEYQNGWA 357
Query: 338 YSPVEV-ESNGIELFGYHDDD------HSSDVDISIKGKRRDDGGIFLRLRIADKEGRIR 390
Y+P E E++GIELF ++D S +VDI+IKGKRRDDGG+FLRLRIADKEGR+R
Sbjct: 358 YNPAETEETHGIELFESRNNDDQEEEKKSGNVDITIKGKRRDDGGLFLRLRIADKEGRVR 417
Query: 391 NIYFPFDVETDTALSVATEMVAELDITDQDVTKIADMIDGEIASLVPEWRPGPGIEE--- 447
NIYFPFD+ETDTALSVATEMVAELD+ D VTKIA+MIDGEI+SLVP WRPGP EE
Sbjct: 418 NIYFPFDIETDTALSVATEMVAELDMDDHGVTKIANMIDGEISSLVPSWRPGPEFEECLA 477
Query: 448 -TPRFANQGFCSNCASNRTSTGSLMEYFSNPYGTNLQLLQCCRNGCASMHGRFGEITFDV 506
C+NC SNRTS GS+M++ G N ++QCCRNGC HGRF EIT +
Sbjct: 478 AAAAANAASICNNCVSNRTSMGSVMDFLRTNPGAN--VIQCCRNGCGETHGRFEEIT--I 533
Query: 507 DESEHHVTDGAPNESSQSDCLHYQEIWG---QLESRELSSVDSGHSHSDEE------YEK 557
E+E + +E+W Q ESRELSS+DSGH+HS+EE YE
Sbjct: 534 RETE----------------VRLRELWKLQQQQESRELSSIDSGHNHSEEEEEEEVLYED 577
Query: 558 LDQSFATEDNKETKVESETALNARNSTRHLVNSHSYSEIPSVDCDQ-SDNHEKEIQQELR 616
+ F+ E A N H+ S S+S +PS CD+ S+ E ++QQELR
Sbjct: 578 PENMFSCE--------------AGNEINHISGSGSFSFMPSKYCDEPSEKTENQVQQELR 623
Query: 617 WLKAKYMMELSELREQQL 634
WLKAK +EL +++++QL
Sbjct: 624 WLKAKCQIELRDIQDEQL 641
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 721 bits (1862), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/501 (69%), Positives = 408/501 (81%), Gaps = 20/501 (3%)
Query: 10 DCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLER 69
D E+ EVDPTGRYGRYN++LGKGASKTVYRAFDEY+G+EVAWNQVKL+DFLQSPEDLER
Sbjct: 13 DLPEYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLER 72
Query: 70 LYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL 129
LYCEIHLLKTLKH+NIMKFYTSWVD + RNINF+TEMFTSGTLRQYR KH RVNI AVK
Sbjct: 73 LYCEIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKH 132
Query: 130 WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGT 189
WCRQIL GLLYLHSHDPP+IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA HCVGT
Sbjct: 133 WCRQILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVGT 192
Query: 190 PEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYR 249
PEFMAPEVYEE YNELVDIYSFGMC+LEMVTFEYPYSECTHP QIYKKV+SG KP++LY+
Sbjct: 193 PEFMAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYK 252
Query: 250 VKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDMDPLIRQP 309
VKDP VR+FVEKCLAT S RLSARELL DPFLQ+DD DYS + +RQP
Sbjct: 253 VKDPMVRQFVEKCLATASRRLSARELLKDPFLQVDDLVFCPGDGDYS-----LMNYLRQP 307
Query: 310 HIDFHHIDNS-FSNGCANGYGYDTPSE--WGYSPVEVESNGIELFGYHDDDHSSDVDISI 366
+++ + + S SNG + DTP+E W +++++GI+LF H+D+ +VDI+I
Sbjct: 308 YLEHAYSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLGNVDITI 367
Query: 367 KGKRRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDITDQDVTKIAD 426
KG++ +DG IFLRLRIAD +G +RNIYFPFD+E DTALSVATEMVAELDITD +VT+IA+
Sbjct: 368 KGRKSEDGSIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAE 427
Query: 427 MIDGEIASLVPEWRPGPGIEETPRFANQGFCSNCASNRTSTGSLMEYFSNPYGTNLQLLQ 486
MIDGE+++LVP+WRPGPGIEE+ + +C NC SN +S GSL Y S+ +
Sbjct: 428 MIDGEVSALVPDWRPGPGIEES---QDTTYCHNCGSNVSSCGSLYAYMSSA-------AR 477
Query: 487 CCRNGCASMHGRFGEITFDVD 507
C+ CA +HGRF EITF +
Sbjct: 478 GCQ--CAELHGRFEEITFQAN 496
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 721 bits (1861), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/501 (69%), Positives = 408/501 (81%), Gaps = 20/501 (3%)
Query: 10 DCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLER 69
D E+ EVDPTGRYGRYN++LGKGASKTVYRAFDEY+G+EVAWNQVKL+DFLQSPEDLER
Sbjct: 13 DLPEYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLER 72
Query: 70 LYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL 129
LYCEIHLLKTLKH+NIMKFYTSWVD + RNINF+TEMFTSGTLRQYR KH RVNI AVK
Sbjct: 73 LYCEIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKH 132
Query: 130 WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGT 189
WCRQIL GLLYLHSHDPP+IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA HCVGT
Sbjct: 133 WCRQILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVGT 192
Query: 190 PEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYR 249
PEFMAPEVYEE YNELVDIYSFGMC+LEMVTFEYPYSECTHP QIYKKV+SG KP++LY+
Sbjct: 193 PEFMAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYK 252
Query: 250 VKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDMDPLIRQP 309
VKDP VR+FVEKCLAT S RLSARELL DPFLQ+DD DYS + +RQP
Sbjct: 253 VKDPMVRQFVEKCLATASRRLSARELLKDPFLQVDDLVFCPGDGDYS-----LMNYLRQP 307
Query: 310 HIDFHHIDNS-FSNGCANGYGYDTPSE--WGYSPVEVESNGIELFGYHDDDHSSDVDISI 366
+++ + + S SNG + DTP+E W +++++GI+LF H+D+ +VDI+I
Sbjct: 308 YLEHAYSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLGNVDITI 367
Query: 367 KGKRRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDITDQDVTKIAD 426
KG++ +DG IFLRLRIAD +G +RNIYFPFD+E DTALSVATEMVAELDITD +VT+IA+
Sbjct: 368 KGRKSEDGSIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAE 427
Query: 427 MIDGEIASLVPEWRPGPGIEETPRFANQGFCSNCASNRTSTGSLMEYFSNPYGTNLQLLQ 486
MIDGE+++LVP+WRPGPGIEE+ + +C NC SN +S GSL Y S+ +
Sbjct: 428 MIDGEVSALVPDWRPGPGIEES---QDTTYCHNCGSNVSSCGSLYAYMSSA-------AR 477
Query: 487 CCRNGCASMHGRFGEITFDVD 507
C+ CA +HGRF EITF +
Sbjct: 478 GCQ--CAELHGRFEEITFQAN 496
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2V338|WNK9_ARATH Probable serine/threonine-protein kinase WNK9 OS=Arabidopsis thaliana GN=WNK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 681 bits (1756), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/517 (68%), Positives = 407/517 (78%), Gaps = 46/517 (8%)
Query: 1 MNGLTHLEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF 60
MN L+HLE D SE+VEVDPTGRYGRYNE+LGKG+SKTVYR FDEY+GIEVAWNQVKLYDF
Sbjct: 2 MNNLSHLESDYSEYVEVDPTGRYGRYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYDF 61
Query: 61 LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK 120
LQSP++LERLYCEIHLLKTLKHK+IMKFY SWVDT NRNINFVTEMFTSGTLRQYRLKHK
Sbjct: 62 LQSPQELERLYCEIHLLKTLKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHK 121
Query: 121 RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180
RVNIRAVK WCRQILRGL YLH+HDPPVIHRDLKCDNIF+NGNQGEVKIGDLGLAA L+
Sbjct: 122 RVNIRAVKNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQH 181
Query: 181 SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS 240
SHAAHCVGTPEFMAPEVY+E YN+LVDIYSFGMC+LEMVTF+YPYSEC+HPAQIYK+V+S
Sbjct: 182 SHAAHCVGTPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVIS 241
Query: 241 GKKPDSLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELD 300
GKKPD L +VKDPEVR F+EKCLATVSLRLSA ELL+D FL ID ES++R ++ + L
Sbjct: 242 GKKPDGLDKVKDPEVRGFIEKCLATVSLRLSACELLDDHFLCID--ESDMRRVESEKGLI 299
Query: 301 DM--DPLIRQPHIDFHHIDNSFSNGCANGYGYDTPSEWGYSPVE-VESNGIELFGYHDDD 357
D PL HI +SNG + Y ++W Y+ E VES+ I+L + +DD
Sbjct: 300 DEAGTPLRHSYHIP------HYSNGYYSLY---NQNQWDYNGDETVESHEIDLLEFQNDD 350
Query: 358 HS-------SDVDISIKGKRRDDG-GIFLRLRIADKEGRIRNIYFPFDVETDTALSVATE 409
VDISIKGKRRD+G G+FLRL+ +KEG +RNIYFPFD+ETDTA+SVA E
Sbjct: 351 DEEEEDKRFGSVDISIKGKRRDNGDGLFLRLKTVNKEGCVRNIYFPFDIETDTAISVARE 410
Query: 410 MVAELDITDQDVTKIADMIDGEIASLVPEWRPGPGIEETPRFANQGFCSNCASNRTSTGS 469
MV EL++ D+DVTKIA+MIDGEIASLVP W FCS+ SNR+S GS
Sbjct: 411 MVEELEMDDRDVTKIANMIDGEIASLVPNWSI--------------FCSS-ESNRSSVGS 455
Query: 470 LMEYFSNPYGTNLQLLQCCRNGCASMHGRFGEITFDV 506
+M++ +QC R+GC HGRF EITF++
Sbjct: 456 VMDF---------NEMQCGRDGCEEKHGRFEEITFEI 483
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y9|WNK2_ARATH Serine/threonine-protein kinase WNK2 OS=Arabidopsis thaliana GN=WNK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 635 bits (1639), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/512 (62%), Positives = 375/512 (73%), Gaps = 39/512 (7%)
Query: 1 MNGLTHLEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF 60
MNG DCS FVE+DP+GRYGRY+EILGKGASKTVYRAFDEYEGIEVAWNQVKL +F
Sbjct: 1 MNGEESFVEDCSVFVEIDPSGRYGRYDEILGKGASKTVYRAFDEYEGIEVAWNQVKLRNF 60
Query: 61 LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK 120
++PE+LE+ + EIHLLKTL H+NIMKFYTSWVDT N +INFVTE+FTSGTLRQYRL+H+
Sbjct: 61 TRNPEELEKFFREIHLLKTLNHQNIMKFYTSWVDTNNLSINFVTELFTSGTLRQYRLRHR 120
Query: 121 RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180
RVNIRAVK WC+QIL+GLLYLHS PP+IHRDLKCDNIF+NGNQGEVKIGDLGLAAILRK
Sbjct: 121 RVNIRAVKQWCKQILKGLLYLHSRSPPIIHRDLKCDNIFINGNQGEVKIGDLGLAAILRK 180
Query: 181 SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS 240
SHA CVGTPEFMAPEVY+E YNELVD+Y+FGMC+LEMVTF+YPYSECTHPAQIYKKV S
Sbjct: 181 SHAVRCVGTPEFMAPEVYDEEYNELVDVYAFGMCVLEMVTFDYPYSECTHPAQIYKKVTS 240
Query: 241 GKKPDSLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCES-NLRSLDYSREL 299
GKKP++ Y VKDPEVR FVEKCLA V+ RL+A ELL DPFLQ D+ + +R +DY
Sbjct: 241 GKKPEAFYLVKDPEVREFVEKCLANVTCRLTALELLQDPFLQDDNMDGFVMRPIDYYNGY 300
Query: 300 DDMDPLIRQPHID--FHHIDNSFSNGCANGYGYDTPSEWGYSPVEVESNGIELFGYHDDD 357
D+ +R P ID +H S C I+LF D+D
Sbjct: 301 DETGVFLRHPLIDDPLYHDQFESSQICE----------------------IDLFANDDED 338
Query: 358 HSSDVDISIKGKRRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDIT 417
H VDISIKGKR D GIFLRLRI+D EGRIRNIYFPF+ DTA SVA EMV+ELDIT
Sbjct: 339 H---VDISIKGKRNGDDGIFLRLRISDAEGRIRNIYFPFETAIDTAWSVAVEMVSELDIT 395
Query: 418 DQDVTKIADMIDGEIASLVPEWR----PGPGIEETPRFANQGFCSNCASNRTSTGSLMEY 473
+QDV KIA+MID EIA+LVP+W+ + GFC CASN G + E
Sbjct: 396 NQDVAKIAEMIDAEIAALVPDWKNDTESSQNVNNNKNNNTAGFCGECASN----GYIQET 451
Query: 474 FSN---PYGTNLQLLQCCRNGCASMHGRFGEI 502
S+ + + + C+S+HGRF ++
Sbjct: 452 VSSGEKSHHNHHEFDSSEDKSCSSVHGRFADM 483
|
Regulates flowering time by modulating the photoperiod pathway. Possesses kinase activity in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 521 bits (1343), Expect = e-147, Method: Compositional matrix adjust.
Identities = 260/450 (57%), Positives = 327/450 (72%), Gaps = 30/450 (6%)
Query: 13 EFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC 72
EF EVDPT RYGRY E+LGKGA KTVY+AFD+ EG+EVAWNQ+K+ D L++ +DLERL
Sbjct: 17 EFAEVDPTARYGRYTEVLGKGAFKTVYKAFDQLEGLEVAWNQIKVGDILRNNDDLERLRS 76
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCR 132
E+ LLKTLKHKNI+KFY SW+D N NINF+TE+FTSGTLRQYR+KHK+V++RA+K W R
Sbjct: 77 EVRLLKTLKHKNIIKFYNSWLDKKNNNINFITEVFTSGTLRQYRIKHKKVDVRALKKWSR 136
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-CVGTPE 191
QIL GL+YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA IL + +AH +GTPE
Sbjct: 137 QILSGLVYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLATILDNARSAHSIIGTPE 196
Query: 192 FMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK 251
FMAPE+Y+E YNELVDIY+FGMC+LE+VTFEYPY EC++ AQIYKKV G+KP SL +++
Sbjct: 197 FMAPELYDEEYNELVDIYAFGMCLLELVTFEYPYCECSNAAQIYKKVSDGEKPSSLAKIE 256
Query: 252 DPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDMDPLIRQPHI 311
DPEVR F+EKC+A S RLSA+ELL DPFL+ DD E L + +
Sbjct: 257 DPEVRFFIEKCIAKASQRLSAQELLMDPFLR-DDGEKIFYPLQSNTKAS----------- 304
Query: 312 DFHHIDNSFSNGCANGYGYDTPS------EWGYSPVEVESNGIELFGYHDDDHSSDVDIS 365
D + S+ + GY YD + E S E + + D ++ I+
Sbjct: 305 -----DGAGSSNSSMGYKYDRDASSMAIREHTGSFAEEHPSDRYIHSTMDPQAAAGRIIT 359
Query: 366 IKGKRRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDITDQDVTKIA 425
++ + +D IFL+LRIAD G +NI+FPFD+E DT++SVATEMV +LD+TDQDVT IA
Sbjct: 360 VESQMKDLNTIFLKLRIADSTGHAQNIHFPFDIEADTSISVATEMVVQLDLTDQDVTAIA 419
Query: 426 DMIDGEIASLVPEWRPGPGIEETPRFANQG 455
+MID EI + +P+W +EE+ NQG
Sbjct: 420 EMIDAEIRAHIPDW----ALEES--VENQG 443
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9STK6|WNK3_ARATH Probable serine/threonine-protein kinase WNK3 OS=Arabidopsis thaliana GN=WNK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 509 bits (1310), Expect = e-143, Method: Compositional matrix adjust.
Identities = 260/435 (59%), Positives = 315/435 (72%), Gaps = 58/435 (13%)
Query: 13 EFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC 72
EFVE+DPTGRYGRY E+LGKGA K VYRAFD+ EGIEVAWNQVKL D S EDL+RLY
Sbjct: 11 EFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSEDLDRLYS 70
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCR 132
E+HLLKTLKHK+I+KFYTSW+D + IN +TE+FTSG LRQYR KHK V++RA+K W R
Sbjct: 71 EVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLRALKKWSR 130
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV-GTPE 191
QIL GL+YLHSHDPPVIHRDLKCDNIF+NGNQGEVKIGDLGLAAIL ++ +AH V GTPE
Sbjct: 131 QILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAHSVIGTPE 190
Query: 192 FMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK 251
FMAPE+YEE YN LVDIY+FGMC+LE+VTFEYPYSECT+ AQIY+KV SG KP +L V
Sbjct: 191 FMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKPAALLNVT 250
Query: 252 DPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDC-ESNLRSLDYSRELDDMDPLIRQPH 310
DP+VR F+EKC+A VS RLSA+ELL+DPFL+ C + N ++ +E
Sbjct: 251 DPQVRAFIEKCIAKVSQRLSAKELLDDPFLK---CYKENTENVSSHKE------------ 295
Query: 311 IDFHHIDNSFSNGCANGYGYDTPSEWGYSPVEVESNGIELFGYHDDDHSSDVDI---SIK 367
NGY NGI D SD ++ +++
Sbjct: 296 ---------------NGYN---------------GNGIV-------DKLSDSEVGLLTVE 318
Query: 368 GKRRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDIT-DQDVTKIAD 426
G+R+D IFL+LRI D +G+IRNI+FPF++ETDT+ SVA EMV ELD+T DQD++ IA
Sbjct: 319 GQRKDLNTIFLKLRITDSKGQIRNIHFPFNIETDTSFSVAIEMVEELDLTDDQDISTIAK 378
Query: 427 MIDGEIASLVPEWRP 441
MID EI S +P+W P
Sbjct: 379 MIDTEIHSHIPDWTP 393
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SCU5|WNK5_ARATH Probable serine/threonine-protein kinase WNK5 OS=Arabidopsis thaliana GN=WNK5 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 479 bits (1234), Expect = e-134, Method: Compositional matrix adjust.
Identities = 246/434 (56%), Positives = 300/434 (69%), Gaps = 42/434 (9%)
Query: 10 DCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLER 69
D +VE DP+GRYGR+ E+LGKGA KTVY+AFD+ G+EVAWNQVKL + +SPE L+R
Sbjct: 11 DSIAYVETDPSGRYGRFREVLGKGAMKTVYKAFDQVLGMEVAWNQVKLNEVFRSPEPLQR 70
Query: 70 LYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL 129
LY E+HLLK L H++I+++ TSW+D R NF+TE+FTSGTLR+YR K+++V+IRA+K
Sbjct: 71 LYSEVHLLKNLNHESIIRYCTSWIDVNRRTFNFITELFTSGTLREYRRKYQKVDIRAIKS 130
Query: 130 WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV-G 188
W RQIL GL YLH HDPPVIHRDLKCDNIFVNG+ G+VKIGDLGLAAILR S AH V G
Sbjct: 131 WARQILNGLAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQNAHSVIG 190
Query: 189 TPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLY 248
TPEFMAPE+YEE YNELVDIYSFGMC+LEM+T EYPYSECT+PAQIYKKV SGK PDS +
Sbjct: 191 TPEFMAPELYEEDYNELVDIYSFGMCVLEMLTGEYPYSECTNPAQIYKKVTSGKLPDSFH 250
Query: 249 RVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDMDPLIRQ 308
++ E +RFV KCL TVS RL A+ELL DPFL D D+ PL R
Sbjct: 251 LIQHTEAQRFVGKCLETVSRRLPAKELLADPFLAATDER-------------DLAPLFRL 297
Query: 309 PHIDFHHIDNSFSNGCANGYGYD-TPSEWGYSPVEVESNGIELFGYHDDDHSSDVDISIK 367
P + N ANG + PS D + D+SI
Sbjct: 298 PQ------QLAIQNLAANGTVVEHLPST--------------------TDPTRTTDMSIT 331
Query: 368 GK-RRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDITDQDVTKIAD 426
GK +D IFL+++I D +G +RNI FPF++ +DT L VA EMV EL+ITD D +IA
Sbjct: 332 GKMNSEDHTIFLQVQILDGDGHMRNIQFPFNILSDTPLEVALEMVKELEITDWDPLEIAA 391
Query: 427 MIDGEIASLVPEWR 440
MI+ EI+ LVP WR
Sbjct: 392 MIENEISLLVPNWR 405
|
Regulates flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 473 bits (1218), Expect = e-132, Method: Compositional matrix adjust.
Identities = 237/444 (53%), Positives = 313/444 (70%), Gaps = 27/444 (6%)
Query: 8 EPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDL 67
EP E +EVDPT RY RY E++GKGA KTVY+AFDE +GIEVAWNQV++ D LQSP L
Sbjct: 12 EPPDPEVLEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCL 71
Query: 68 ERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAV 127
ERLY E+ LLK+LKH NI++FY SW+D N+ +N +TE+FTSG+LR YR KH++VN++AV
Sbjct: 72 ERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAV 131
Query: 128 KLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV 187
K W RQIL GL YLH +PP+IHRDLKCDNIF+NGN GEVKIGDLGLA ++ +++A +
Sbjct: 132 KNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVI 191
Query: 188 GTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSL 247
GTPEFMAPE+Y+E YNEL DIYSFGMC+LEMVTF+YPY EC + AQIYKKV SG KP SL
Sbjct: 192 GTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASL 251
Query: 248 YRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDMDPLIR 307
RVKDPEV++F+EKCL S RLSA+ELL DPFLQ++ N +PL
Sbjct: 252 SRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLNGLTMN-------------NPL-P 297
Query: 308 QPHIDFHHIDNSFSNGCANGYGYDT--PSEWGYSPVEVESNGIELFGYHDDDHSSDVDIS 365
P I + +F + C G T PS+ ++ +SN + + + D+ S +++
Sbjct: 298 LPDIVMPK-EGAFGDRCLMSEGPPTTRPSKTLSIDLDEDSN-LPIVTFSDNSGSRCIEVR 355
Query: 366 ---------IKGKRRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDI 416
+KG+ D+ + L LRI D+ GR+RNI+F F E DTA V++EMV +L++
Sbjct: 356 RAKRGNFFVLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQEGDTASKVSSEMVEQLEL 415
Query: 417 TDQDVTKIADMIDGEIASLVPEWR 440
TDQ+VT IA++ID + +++P W+
Sbjct: 416 TDQNVTFIAELIDILLVNMIPTWK 439
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LST2|WNK7_ARATH Probable serine/threonine-protein kinase WNK7 OS=Arabidopsis thaliana GN=WNK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 470 bits (1209), Expect = e-131, Method: Compositional matrix adjust.
Identities = 232/443 (52%), Positives = 307/443 (69%), Gaps = 24/443 (5%)
Query: 7 LEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPED 66
+EP E +E+DPT RY RY E++GKGASKTV++ FDE +GIEVAWNQV++ D LQSP+
Sbjct: 11 VEPPDPEVLEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRIDDLLQSPDC 70
Query: 67 LERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRA 126
LERLY E+ LLK+LKHKNI++FY SW+D N+ +N +TE+FTSG+LRQYR KH++VN++A
Sbjct: 71 LERLYSEVRLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNMKA 130
Query: 127 VKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC 186
VK W RQIL GL YLHS DPP+IHRD+KCDNIF+NGN GEVKIGDLGLA ++ +++A
Sbjct: 131 VKCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQANAKSV 190
Query: 187 VGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDS 246
+GTPEFMAPE+Y+E YNEL DIYSFGMC+LEMVTFEYPY EC + AQIYKKV SG KP S
Sbjct: 191 IGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIKPAS 250
Query: 247 LYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDMDPLI 306
L +VKDPEV +F+EKCL S RLSA ELL D FL ++ N +PL
Sbjct: 251 LSKVKDPEVMKFIEKCLLPASERLSAEELLLDSFLNVNGLVMN-------------NPL- 296
Query: 307 RQPHIDFHHIDNSFSNGCANGYGYDTPSEWGYSPVEVESNGIELFGYHDDDHSSDVDIS- 365
P I + SF C G S E N + + ++ ++ +++
Sbjct: 297 PLPDIVMPK-EGSFGERCLMSEGPPNARNRTMSMNLDEDNNLPIVISSNNSGTNCIEVRR 355
Query: 366 --------IKGKRRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDIT 417
+KG+ D+ + L LRI D+ GR+RNI+F F E DTA +V++EMV +L++T
Sbjct: 356 AKRGNFFVLKGEENDENSVSLILRIVDENGRVRNIHFLFFQEGDTASNVSSEMVEQLELT 415
Query: 418 DQDVTKIADMIDGEIASLVPEWR 440
D++V IA++ID + +L+P W+
Sbjct: 416 DKNVKFIAELIDVLLVNLIPNWK 438
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 745 | ||||||
| 255542364 | 775 | kinase, putative [Ricinus communis] gi|2 | 0.944 | 0.908 | 0.741 | 0.0 | |
| 224125588 | 730 | predicted protein [Populus trichocarpa] | 0.977 | 0.997 | 0.712 | 0.0 | |
| 356535149 | 708 | PREDICTED: serine/threonine-protein kina | 0.947 | 0.997 | 0.713 | 0.0 | |
| 359487822 | 743 | PREDICTED: serine/threonine-protein kina | 0.989 | 0.991 | 0.712 | 0.0 | |
| 351722259 | 698 | with no lysine kinase 1 [Glycine max] gi | 0.934 | 0.997 | 0.700 | 0.0 | |
| 307136062 | 734 | WNK kinase [Cucumis melo subsp. melo] | 0.977 | 0.991 | 0.687 | 0.0 | |
| 357441481 | 742 | With no lysine kinase [Medicago truncatu | 0.985 | 0.989 | 0.690 | 0.0 | |
| 449442903 | 732 | PREDICTED: serine/threonine-protein kina | 0.977 | 0.994 | 0.687 | 0.0 | |
| 357512227 | 726 | With no lysine kinase [Medicago truncatu | 0.963 | 0.988 | 0.683 | 0.0 | |
| 147815157 | 752 | hypothetical protein VITISV_035622 [Viti | 0.940 | 0.932 | 0.703 | 0.0 |
| >gi|255542364|ref|XP_002512245.1| kinase, putative [Ricinus communis] gi|223548206|gb|EEF49697.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1072 bits (2773), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/713 (74%), Positives = 592/713 (83%), Gaps = 9/713 (1%)
Query: 1 MNGLTHLEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF 60
MN ++LEPD SEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF
Sbjct: 2 MNCPSNLEPDYSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF 61
Query: 61 LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK 120
LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK
Sbjct: 62 LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK 121
Query: 121 RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180
RVNIRAVK WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK
Sbjct: 122 RVNIRAVKHWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181
Query: 181 SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS 240
SHAAHCVGTPEFMAPEVYEEAYNELVD+YSFGMCILEMVTFEYPYSECTHPAQIYKKV+S
Sbjct: 182 SHAAHCVGTPEFMAPEVYEEAYNELVDVYSFGMCILEMVTFEYPYSECTHPAQIYKKVIS 241
Query: 241 GKKPDSLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELD 300
G+KPD+LY+VKDPEVR+FVEKCLATVSLRLSARELLNDPFLQ+DDCESN++S+DY E D
Sbjct: 242 GRKPDALYKVKDPEVRQFVEKCLATVSLRLSARELLNDPFLQMDDCESNIKSIDYGEEFD 301
Query: 301 DMDPLIRQPHIDFHHIDNSFSNGCANGYGYDTPSEWGYSPVEVESNGIELFGYHDDDHSS 360
M PLIRQP+ +FH +SNG +NGYGY+ +E+ Y PVE E +GIELF +HDD+HS
Sbjct: 302 GMGPLIRQPYYEFHDDTYPYSNGYSNGYGYEAQNEFEYYPVEFEQSGIELFEHHDDEHSP 361
Query: 361 DVDISIKGKRRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDITDQD 420
++DISIKGKRRDDGGIFLRLRIADK+GRIRNIYFPFD+ETDTAL+VATEMVAELDITDQD
Sbjct: 362 NLDISIKGKRRDDGGIFLRLRIADKDGRIRNIYFPFDIETDTALTVATEMVAELDITDQD 421
Query: 421 VTKIADMIDGEIASLVPEWRPGPGIEETPRFANQGFCSNCASNRTSTGSLMEYFSNPYGT 480
VTKIA+MID EIASLVPEWR GPGIEETPRFAN C NCAS RTS GSLM++ SN
Sbjct: 422 VTKIAEMIDEEIASLVPEWRRGPGIEETPRFANLTLCHNCASARTSNGSLMDFISNN--- 478
Query: 481 NLQLLQCCRNGCASMHGRFGEITFD-VDESEHHVTDGAPNESSQSDCLHYQEIWGQLESR 539
CCRNGCASMHGRF EITF DESEHH+T+ APN S SDC+ YQ IW Q ESR
Sbjct: 479 -----PCCRNGCASMHGRFEEITFQAADESEHHLTEVAPNALSHSDCVDYQRIWAQHESR 533
Query: 540 ELSSVDSGHSHSDEEYEKLDQSFATEDNKETKVESETALNARNSTRHLVNSHSYSEIPSV 599
E++ + SG SHSDEEYEK DQS +T+D + K+E+ + +RNS +L S S+ +PSV
Sbjct: 534 EVTPMGSGRSHSDEEYEKFDQSISTKDENDVKMENGSQSGSRNSIPYLKGSGSFYRLPSV 593
Query: 600 DCDQSDNHEKEIQQELRWLKAKYMMELSELREQQLGVASNTSSYSNKENNTTNGRLSYPI 659
D D++E ++QQELRWLKAKY +ELS+LR+QQL AS +S+ N + NG S I
Sbjct: 594 CSDLQDSNENKMQQELRWLKAKYQIELSKLRDQQLDFASRSSTSINTDCKIRNGVSSSTI 653
Query: 660 SSPTQRDRNGFHLNLPMDKKHFSSNCSDRINKSCPSLDPPMARYCGAIKESLR 712
+ Q +RN L +K + N +NKSCP+LD + C A KES R
Sbjct: 654 MNSFQENRNEDLLKSFAHEKLYRPNLHTDVNKSCPNLDTRRDQNCEAKKESPR 706
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224125588|ref|XP_002319623.1| predicted protein [Populus trichocarpa] gi|222857999|gb|EEE95546.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1058 bits (2737), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 532/747 (71%), Positives = 599/747 (80%), Gaps = 19/747 (2%)
Query: 1 MNGLTHLEP-DCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD 59
MNGL+HLEP D SEFVEVDPTGRYGRYNEILG+GASK VYRAFDEYEGIEVAWNQVKLYD
Sbjct: 1 MNGLSHLEPPDYSEFVEVDPTGRYGRYNEILGRGASKIVYRAFDEYEGIEVAWNQVKLYD 60
Query: 60 FLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 119
FLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH
Sbjct: 61 FLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 120
Query: 120 KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179
KRVNIRAVK WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR
Sbjct: 121 KRVNIRAVKHWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
Query: 180 KSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVV 239
KSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHP QIYKKV+
Sbjct: 181 KSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPVQIYKKVI 240
Query: 240 SGKKPDSLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSREL 299
SGKKPD+LY+VKDPEVR FVEKCLATVSLRLSARELLNDPFLQID CES+LR LD+ E+
Sbjct: 241 SGKKPDALYKVKDPEVRHFVEKCLATVSLRLSARELLNDPFLQIDGCESDLRLLDHRIEV 300
Query: 300 DDMDPLIRQPHIDFHHIDNSFSNGCANGYGYDTPSEWGYSPVEVESNGIELFGYHDDDHS 359
D + PL+R P+++ H +NS+S+G NGY Y+ +EW Y VEVE +GIELF YH D+H
Sbjct: 301 DGLGPLMRPPYLEHHDNNNSYSSGYLNGYDYEAQNEWEYHQVEVELSGIELFEYH-DEHP 359
Query: 360 SDVDISIKGKRRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDITDQ 419
++VDISIKGKR DDGGIFLRLRIADKEGRIRNIYFPFD+E DTALSVATEMVAELDITDQ
Sbjct: 360 ANVDISIKGKRGDDGGIFLRLRIADKEGRIRNIYFPFDIENDTALSVATEMVAELDITDQ 419
Query: 420 DVTKIADMIDGEIASLVPEWRPGPGIEETPRFANQGFCSNCASNRTSTGSLMEYFSNPYG 479
DVTKIADMIDGEIASLVPEWRPGPGIEETP FANQ C NCAS TS GS M++ SN
Sbjct: 420 DVTKIADMIDGEIASLVPEWRPGPGIEETPCFANQTLCHNCASTCTSNGSFMDFLSNN-- 477
Query: 480 TNLQLLQCCRNGCASMHGRFGEITFDVDESEHHVTDGAPNESSQSDCLHYQEIWGQLESR 539
CC +GCASMHGRFGEI F+VDESEHH+T+GAPN +Q D LHY+EIWGQ ESR
Sbjct: 478 ------PCCSHGCASMHGRFGEIIFEVDESEHHLTEGAPNILNQPDYLHYKEIWGQQESR 531
Query: 540 ELSSVDSGHSHSDEEYEKLDQSFATEDNKETKVESETALNARNSTRHLVNSHSYSEIPSV 599
+L+ + SG S DEEYE DQS +D K+TK+E+ + S +H S S S + S+
Sbjct: 532 QLTPIGSGKSQLDEEYENFDQSIPEKDTKDTKMEN--GIPGGKSFQHFTGSGSLSRLTSL 589
Query: 600 DCDQSDNHEKEIQQELRWLKAKYMMELSELREQQLGVASNTSSYSNKENNTTNGRLSYPI 659
D +D++E EIQQ+LRWLKAK+ MEL +LR+++LG+A S+ N E T+N S +
Sbjct: 590 YNDLADSNENEIQQDLRWLKAKHQMELRKLRDERLGLAVKPSTSRNGEEKTSNVVSSTSM 649
Query: 660 SSPTQRDRNGFHLNLPMDKKHFSSNCSDRINKSCPSL-DPPMARYCGAIKESLRTEDTVT 718
+ Q NG L K + S ++ +L D + + R +D V
Sbjct: 650 LNSFQEGSNGDLL------KSLAKQISHSLHTHAGALSDTQRPWNHKVMNQPPRAKDMVN 703
Query: 719 ATCFPSGSLLPPSLHRTTSLPVDAIDL 745
A +G +LP SLHRTTSLPVDA+D+
Sbjct: 704 AKNLCTGPMLPHSLHRTTSLPVDAVDV 730
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356535149|ref|XP_003536111.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1057 bits (2734), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 533/747 (71%), Positives = 598/747 (80%), Gaps = 41/747 (5%)
Query: 1 MNGLTHLEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF 60
MNG+THLEPD SEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEY+GIEVAWNQVKLYDF
Sbjct: 1 MNGVTHLEPDESEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYQGIEVAWNQVKLYDF 60
Query: 61 LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK 120
LQSPEDLERLYCEIHLLKTLKH+NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK
Sbjct: 61 LQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK 120
Query: 121 RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180
RVNIRAVK WCRQIL GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK
Sbjct: 121 RVNIRAVKHWCRQILSGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180
Query: 181 SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS 240
SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKV+S
Sbjct: 181 SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVIS 240
Query: 241 GKKPDSLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELD 300
GKKPD+LYRVKDPEVR+FVEKCLATVSLRLSARELL+DPFLQIDD E +LR++D + ELD
Sbjct: 241 GKKPDALYRVKDPEVRQFVEKCLATVSLRLSARELLDDPFLQIDDYEYDLRTVD-NGELD 299
Query: 301 DMDPLIRQPHIDFHHIDNSFSNGCANGYGYDTPSEWGYSPVEVESNGIELFGYHDDDH-S 359
+ PL+RQP D H ++FSN NG+GY+ +WG P E+E +GIELF Y DDD S
Sbjct: 300 EFGPLMRQPFFDLHRSYSNFSNEYTNGFGYE--GDWGPHPAEIEPSGIELFEYRDDDEPS 357
Query: 360 SDVDISIKGKRRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDITDQ 419
DVDISIKGKR+DDGGIFLRLRIADKEGRIRNIYFPFD+E DTA+SVATEMVAELD+TDQ
Sbjct: 358 EDVDISIKGKRKDDGGIFLRLRIADKEGRIRNIYFPFDIEMDTAISVATEMVAELDMTDQ 417
Query: 420 DVTKIADMIDGEIASLVPEWRPGPGIEETPRFANQGFCSNCASNRTSTGSLMEYFS-NPY 478
DVT+IADMIDGEIASLVPEWRPGPGI+ETPRFANQG C NC SN TS+GS +++ S NP
Sbjct: 418 DVTRIADMIDGEIASLVPEWRPGPGIDETPRFANQGLCHNCVSNHTSSGSFLDFLSNNPD 477
Query: 479 GTNLQLLQCCRNGCASMHGRFGEITFDVDESEHHVTDGAPNESSQSDCLHYQEIWGQLES 538
NLQLL CCR+GCASMHGRFGEITF QS+ L YQE+W Q ES
Sbjct: 478 NKNLQLLDCCRHGCASMHGRFGEITF------------------QSEDLQYQELWNQHES 519
Query: 539 RELSSVDSGHSHSDEEYEKLDQSFATEDNKETKVESETALNARNSTRHLVNSHSYSEIPS 598
RELS V+S SHSDE+YE+LD+ +D + E + + NA NS R+L SH +S I S
Sbjct: 520 RELSPVESDQSHSDEQYEQLDKPILAKDKAQDVWEDKFSPNAANSLRNLSGSHDFSTIRS 579
Query: 599 VDCDQSDNHEKEIQQELRWLKAKYMMELSELREQQLGVASNTSSYSNKENNTTNGRLSYP 658
CD D++EKEIQ+ELRWL+AKY MEL + +++Q G S++ N E+ T NG LS
Sbjct: 580 TYCDLEDDYEKEIQKELRWLRAKYQMELRDHKDRQFGQCSHS---CNSEHRTENGFLSPS 636
Query: 659 ISSPTQRDRNGFHLNLPMDKKHFSSNCSDRINKSCPSLDPPMARYCGAIKESLRTEDTVT 718
++ + NG H +++S P+ D A+ C AIK E VT
Sbjct: 637 LTETLKGGNNGTH-------------SHPHVHESSPNSDTQRAQNCVAIKSP--GEGMVT 681
Query: 719 ATCFPSGSLLPPSLHRTTSLPVDAIDL 745
A F +GSLLP SLHRT SLPVDA+D+
Sbjct: 682 AKSFYTGSLLPHSLHRTVSLPVDAVDI 708
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487822|ref|XP_003633655.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1038 bits (2684), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/751 (71%), Positives = 600/751 (79%), Gaps = 14/751 (1%)
Query: 1 MNGLTHLEPD-CSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD 59
MNG+ + E D SEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD
Sbjct: 1 MNGVINPEADDYSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD 60
Query: 60 FLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 119
FLQSPEDLERLYCEIHLLKT+KH NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYR KH
Sbjct: 61 FLQSPEDLERLYCEIHLLKTMKHNNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRQKH 120
Query: 120 KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179
KRVNIRAVK WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR
Sbjct: 121 KRVNIRAVKHWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
Query: 180 KSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVV 239
KSHAAHCVGTPEFMAPEVYEE YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKV+
Sbjct: 181 KSHAAHCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVI 240
Query: 240 SGKKPDSLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSREL 299
SGKKPD+LY+VKDPEVR FVEKCLA+VSLRLSARELL DPFL+IDDCES+LR ++ RE
Sbjct: 241 SGKKPDALYKVKDPEVREFVEKCLASVSLRLSARELLQDPFLRIDDCESDLRPIECRREP 300
Query: 300 DDMDPLIRQPHIDFHHIDNSFSNGCANGYGYDTPSEWGYSPVEVESNGIELFGYHDDDHS 359
DDM PL+RQP +++HH +NSFSNG +N +D + WGY P+E+E GIELF YH+D+H
Sbjct: 301 DDMVPLLRQPFLEYHHSNNSFSNGYSNAVDFDAHNGWGYQPLEMEPTGIELFEYHEDEHP 360
Query: 360 SDVDISIKGKRRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDITDQ 419
++VDISIKGKRR+D GIFLRLRIADKE IRNIYFPFD+E DTALSVATEMVAELDITDQ
Sbjct: 361 ANVDISIKGKRREDDGIFLRLRIADKEDHIRNIYFPFDIEMDTALSVATEMVAELDITDQ 420
Query: 420 DVTKIADMIDGEIASLVPEWRPGPGIEETPRFANQGFCSNCASNRTSTGSLMEYFS-NPY 478
DVTKIADMIDGEIASLVPEW+PGPGIEETP FA C NC SN TS GSLM+ + NP
Sbjct: 421 DVTKIADMIDGEIASLVPEWKPGPGIEETPCFATLNLCHNCVSNHTSNGSLMDILANNPG 480
Query: 479 GTNLQLLQCCRNGCASMHGRFGEITFDVDESEHHVTDGAPNESSQSDCLHYQEIWGQLES 538
NLQ+ Q C NGCA+MHGRF EIT+ VD ++HH+ +G QS+ LH EIW + ES
Sbjct: 481 AKNLQIFQ-CSNGCAAMHGRFEEITYQVDGADHHIPEG------QSEELHCTEIWDKHES 533
Query: 539 RELSSVDSGHSHSDEEYEKLDQSFATEDNKETKVESETALNARNSTRHLVNSHSYSEIPS 598
RELSSV SG S SDEEYEK++ S +D + + + A N +NS HL N S S IPS
Sbjct: 534 RELSSVSSGESPSDEEYEKINHSI-IKDERGSGTGNVVASNVKNSISHLRNPSSSSAIPS 592
Query: 599 VDCDQSDNHEKEIQQELRWLKAKYMMELSELREQQLGVASNTSSYSNKENNTTNGRLSYP 658
+ C SD++E EIQQ LRWLKAK+ ME+ LR+ QLG AS SS N++ N L
Sbjct: 593 MSCALSDDYENEIQQVLRWLKAKHQMEMRGLRDLQLGFASKPSSLDNRQLKPDNEGLFST 652
Query: 659 ISSPTQRDRNGFHLNLPMDKKHFSSNCSDRINKSCPSLDPPMARYCGAIKESLRTED--- 715
+S+ +Q NG L KHF+SNC+ ++NK P L AR C A K S ED
Sbjct: 653 LSNTSQGHNNGLFLKSSAYDKHFTSNCATQVNKCSPDLVTHGARNCEANKGSRSAEDMVH 712
Query: 716 TVTATCF-PSGSLLPPSLHRTTSLPVDAIDL 745
VTA F +GSLLP +HRT SLPVDA+D+
Sbjct: 713 VVTAKSFYTAGSLLPCPIHRTMSLPVDAVDI 743
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351722259|ref|NP_001235958.1| with no lysine kinase 1 [Glycine max] gi|225348631|gb|ACN87277.1| with no lysine kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1037 bits (2681), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 523/747 (70%), Positives = 593/747 (79%), Gaps = 51/747 (6%)
Query: 1 MNGLTHLEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF 60
MNG+THLEPD SEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEY+GIEVAWNQVKLYDF
Sbjct: 1 MNGVTHLEPDESEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYQGIEVAWNQVKLYDF 60
Query: 61 LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK 120
LQSPEDLERLYCEIHLLKTLKH+NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK
Sbjct: 61 LQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK 120
Query: 121 RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180
RVNIRAVK WCRQIL GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK
Sbjct: 121 RVNIRAVKHWCRQILSGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180
Query: 181 SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS 240
SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKV+S
Sbjct: 181 SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVIS 240
Query: 241 GKKPDSLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELD 300
GKKPD+LYRVKDPEVR+FVEKCL TVSLRLSARELLNDPFLQIDD E +L++++ + ELD
Sbjct: 241 GKKPDALYRVKDPEVRQFVEKCLVTVSLRLSARELLNDPFLQIDDYEYDLKTVE-NGELD 299
Query: 301 DMDPLIRQPHIDFHHIDNSFSNGCANGYGYDTPSEWGYSPVEVESNGIELFGYHDDDH-S 359
+ L+RQP D H ++FSN +NG+GY+ +WG P E+E +GIELF YHDDD S
Sbjct: 300 EFGSLMRQPFFDLHRSYSNFSNEYSNGFGYE--GDWGPHPAEIEPSGIELFEYHDDDEPS 357
Query: 360 SDVDISIKGKRRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDITDQ 419
DVDISIKGKR+DDGGIFLRLRIADKEGRIRNIYFPFD+E DTA+SVATEMVAELD+TDQ
Sbjct: 358 EDVDISIKGKRKDDGGIFLRLRIADKEGRIRNIYFPFDIELDTAISVATEMVAELDMTDQ 417
Query: 420 DVTKIADMIDGEIASLVPEWRPGPGIEETPRFANQGFCSNCASNRTSTGSLMEYFS-NPY 478
DVT+IADMIDGEIASLVPEWRPGPGI+ETPR+AN+GFC NC SN TS+GS +++ S NP
Sbjct: 418 DVTRIADMIDGEIASLVPEWRPGPGIDETPRYANEGFCHNCVSNHTSSGSFLDFLSNNPG 477
Query: 479 GTNLQLLQCCRNGCASMHGRFGEITFDVDESEHHVTDGAPNESSQSDCLHYQEIWGQLES 538
NLQLL+CCR+GCASMHGRFGEITF QS+ L YQE+W Q ES
Sbjct: 478 NKNLQLLECCRHGCASMHGRFGEITF------------------QSEDLQYQELWNQHES 519
Query: 539 RELSSVDSGHSHSDEEYEKLDQSFATEDNKETKVESETALNARNSTRHLVNSHSYSEIPS 598
RELS V+S SHSDE+ E+LD+ +D + E + + NA NS R+L SH +S I S
Sbjct: 520 RELSPVESDQSHSDEQCEQLDKPIPAKDKAQDVWEKKFSPNAANSLRNLSGSHDFSTIRS 579
Query: 599 VDCDQSDNHEKEIQQELRWLKAKYMMELSELREQQLGVASNTSSYSNKENNTTNGRLSYP 658
CD D++EKEIQ+ELRWL+AKY MEL + ++ Q G S++ SN E+ T NG LS
Sbjct: 580 TYCDLEDDYEKEIQKELRWLRAKYQMELRDHKDGQFGQCSHS---SNSEHRTENGFLSPS 636
Query: 659 ISSPTQRDRNGFHLNLPMDKKHFSSNCSDRINKSCPSLDPPMARYCGAIKESLRTEDTVT 718
++ + NG + +++S P+ D A+ C AI+
Sbjct: 637 LTETLKGGNNG-------------TRSHPHVHESSPNSDTQRAQNCEAIESP-------- 675
Query: 719 ATCFPSGSLLPPSLHRTTSLPVDAIDL 745
GSLLP SLHRT SLPVDA+D+
Sbjct: 676 ----GEGSLLPHSLHRTVSLPVDAVDI 698
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|307136062|gb|ADN33913.1| WNK kinase [Cucumis melo subsp. melo] | Back alignment and taxonomy information |
|---|
Score = 1005 bits (2599), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/751 (68%), Positives = 591/751 (78%), Gaps = 23/751 (3%)
Query: 1 MNGLTHLEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF 60
M+G++ LE DCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF
Sbjct: 1 MDGVSDLELDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF 60
Query: 61 LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK 120
LQSPEDLERLYCEIHLLKTLKH+NIMKFYTSWVD ANRNINFVTEMFTSGTLRQYRLKHK
Sbjct: 61 LQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDIANRNINFVTEMFTSGTLRQYRLKHK 120
Query: 121 RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180
RVNIRAVK WCRQILRGL YLHSH+PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK
Sbjct: 121 RVNIRAVKHWCRQILRGLHYLHSHEPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180
Query: 181 SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS 240
SHA HCVGTPEFMAPEVY EAYNELVDIYSFGMCILEM+TFEYPYSECTHPAQIYKKV+S
Sbjct: 181 SHADHCVGTPEFMAPEVYAEAYNELVDIYSFGMCILEMITFEYPYSECTHPAQIYKKVIS 240
Query: 241 GKKPDSLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELD 300
GKKPD+LY+VKDPEVR+F++KCLATVS RLSA ELLNDPFL++D+ E +LR +DY R LD
Sbjct: 241 GKKPDALYKVKDPEVRQFIDKCLATVSYRLSAAELLNDPFLRVDNGEYDLRPVDYGRGLD 300
Query: 301 DMDPLIRQPHIDFHHIDNSFSNGCANGYGYDTPSEWGYSPVEVESNGIELFGYHDDDHSS 360
D+ PLIRQP+++ H D+SF G Y ++ SE GY P++ E+NGIELF Y + +HS
Sbjct: 301 DVCPLIRQPYLELHRSDSSFCTGYPYDYSFEASSESGYHPIDNETNGIELFEYCEGEHSE 360
Query: 361 DVDISIKGKRRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDITDQD 420
DVDISIKGK +DGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELD+TDQD
Sbjct: 361 DVDISIKGKMSEDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDMTDQD 420
Query: 421 VTKIADMIDGEIASLVPEWRPGPGIEETPRFANQGFCSNCASNRTSTGSLMEYFSNPYGT 480
VT+IADMIDGEIASLVPEWRPGPGIEETPRFANQ +C NCA + ++ S N G
Sbjct: 421 VTRIADMIDGEIASLVPEWRPGPGIEETPRFANQSYCHNCAPSTYNSASNGLMLRNRDGK 480
Query: 481 NLQLLQCCRNGCASMHGRFGEITFDVDESEHHVTDGAPNESSQSDCLHYQEIWGQLESRE 540
N ++ QCC + ASMHGRF EI + DES HH + APN SS L+Y EIWG ESRE
Sbjct: 481 NSEVAQCCGHRYASMHGRFEEIMYQADESGHHTAEEAPNVSSHPGGLNYPEIWGHHESRE 540
Query: 541 LSSVDSGHSHSDEEYEKLDQSFATEDNKETKVESETALNARNSTRHLVNSHSYSEIPSVD 600
LSS+ S SHSDE+YEK D+ D KE +ES+TA N R + R L+NS S+SE PS
Sbjct: 541 LSSMSSRQSHSDEDYEKTDRPLTDTDTKEMIMESKTAPNTRRTLRSLMNSLSFSETPS-- 598
Query: 601 CDQSDNHEKEIQQELRWLKAKYMMELSELREQQLGVASNTSSYSNK----ENNTTNGRLS 656
D +E ++QQE+RW+KAKY +EL++LR+QQL ++S +SS +K EN T G +
Sbjct: 599 --PPDINENDVQQEMRWIKAKYQLELNKLRDQQLNLSSKSSSSEDKQQKMENETPRGNHN 656
Query: 657 YPISSPTQRDRNGFHLNLPMDKKHFSSNCSDRINKSCPSLDPPM--ARYCGAIKESLRTE 714
+ S ++ D S++ IN SC S D P AR A++ S+ E
Sbjct: 657 QILDSSSR------------DTNRSSTDSHVYINNSCYSTDVPKQRARNRKAVESSI-VE 703
Query: 715 DTVTATCFPSGSLLPPSLHRTTSLPVDAIDL 745
TA +GSLLP SLHRT SLPVDA+ +
Sbjct: 704 KVATAKNACNGSLLPSSLHRTISLPVDAVHI 734
|
Source: Cucumis melo subsp. melo Species: Cucumis melo Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357441481|ref|XP_003591018.1| With no lysine kinase [Medicago truncatula] gi|355480066|gb|AES61269.1| With no lysine kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1001 bits (2589), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 520/753 (69%), Positives = 598/753 (79%), Gaps = 19/753 (2%)
Query: 1 MNGLTHLEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF 60
MNG+THLE D SEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEY+GIEVAWNQVKLYDF
Sbjct: 1 MNGVTHLEEDDSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYQGIEVAWNQVKLYDF 60
Query: 61 LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK 120
LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK
Sbjct: 61 LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK 120
Query: 121 RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180
RVNIRAVK WC QILRGLLYLHSHDPPVIHRDLKCDNIF+NGNQGEVKIGDLGLAAILRK
Sbjct: 121 RVNIRAVKHWCIQILRGLLYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILRK 180
Query: 181 SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS 240
SHAAHCVGTPEFMAPEVYEE+YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKV+S
Sbjct: 181 SHAAHCVGTPEFMAPEVYEESYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVIS 240
Query: 241 GKKPDSLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELD 300
GKKPD+LY+VKDPEVR+FV+KCLATVSLRLSA+ELL+DPFLQIDD E +LR +D S EL
Sbjct: 241 GKKPDALYKVKDPEVRQFVDKCLATVSLRLSAKELLDDPFLQIDDYEYDLRPVD-SGELG 299
Query: 301 DMDPLIRQPHIDFHHIDNSFSNGCANGYGYDTPSEWGYSPVEVESNGIELFGYHDDDHSS 360
D PLIRQP D H ++FSN +NG+GY+ + Y PV+ E GIELF +HDD+ S
Sbjct: 300 DFGPLIRQPLYDLHRSYSNFSNEYSNGFGYE--GDCYYHPVDNEPCGIELFEHHDDEEPS 357
Query: 361 D-VDISIKGKRRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDITDQ 419
+ VDISIKGK++DDG IFLRLRI+DKEGR+RNIYFPFD+E DTA+SVATEMVAELDITDQ
Sbjct: 358 EHVDISIKGKKKDDGSIFLRLRISDKEGRVRNIYFPFDIEMDTAISVATEMVAELDITDQ 417
Query: 420 DVTKIADMIDGEIASLVPEWRPGPGIEETPRFANQGFCSNCASNRTSTGSLMEYFSNPYG 479
DVT IADMIDGEIASLVPEW+ GPGI ETPRFANQGFC NC SN TS+GSLM++ S+ G
Sbjct: 418 DVTSIADMIDGEIASLVPEWQSGPGIVETPRFANQGFCRNCVSNHTSSGSLMDFLSHNQG 477
Query: 480 TNLQLLQCCRNGCASMHGRFGEITFDVDESEHHVTDGAPNESSQSDCLHYQEIWGQLESR 539
+ LQL +CC++GCAS HGRF EITF +E ++HV + N ++ +D L Y +W Q ESR
Sbjct: 478 S-LQLPECCKHGCASTHGRFEEITFQSEEYDNHVRENM-NIANIADGLQYLGLWNQHESR 535
Query: 540 ELSSVDS-GHSHSDEEYEKLDQSFATEDNKETKVESETALNARNSTRHLVNSHSYSEIPS 598
ELS V+S SHSDE+ E+LD+S + E ES+ NA S R+ + +S I S
Sbjct: 536 ELSPVESDDQSHSDEQNEQLDKSISAEGQGHNICESKFPPNAIISPRYSSGTRDFSNIRS 595
Query: 599 VDCD-QSDNHEKEIQQELRWLKAKYMMELSELREQQLGVASNTSSYSNKENNTTNGRLSY 657
+ C D +EKEIQ+ELRWLKA+Y+MEL L++QQLG+ +S N E+ ++ Y
Sbjct: 596 LYCGLDGDGYEKEIQKELRWLKARYLMELRGLKDQQLGITDKSSRGGNGEH-----KIDY 650
Query: 658 PISSPTQRDR-NGFH--LNLPMDKKHFSSNCSDR--INKSCPSLDPPMARYCGAIKESLR 712
I P+ + G + L ++SS+ S R ++KS P D MA C A+ S
Sbjct: 651 AIMLPSLTETFKGADSVIRLQSVINNWSSDLSSRPCVHKSSPDSDAKMAENCEAMG-SPG 709
Query: 713 TEDTVTATCFPSGSLLPPSLHRTTSLPVDAIDL 745
VTA F SGSL P SLHRT SLPVDA+D+
Sbjct: 710 EGMMVTAKSFYSGSLFPHSLHRTVSLPVDAVDI 742
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449442903|ref|XP_004139220.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Cucumis sativus] gi|449482944|ref|XP_004156450.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 991 bits (2563), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 515/749 (68%), Positives = 587/749 (78%), Gaps = 21/749 (2%)
Query: 1 MNGL-THLEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD 59
M+G+ + LE DCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD
Sbjct: 1 MDGVVSDLELDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD 60
Query: 60 FLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 119
FLQSPEDLERLYCEIHLLKTLKH+NIMKFYTSWVD ANRNINFVTEMFTSGTLRQYRLKH
Sbjct: 61 FLQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDIANRNINFVTEMFTSGTLRQYRLKH 120
Query: 120 KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179
KRVNIRAVK WCRQILRGL YLHSH+PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR
Sbjct: 121 KRVNIRAVKHWCRQILRGLHYLHSHEPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
Query: 180 KSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVV 239
KSHA HCVGTPEFMAPEVY EAYNELVDIYSFGMCILEM+TFEYPYSECTHPAQIYKKV+
Sbjct: 181 KSHADHCVGTPEFMAPEVYAEAYNELVDIYSFGMCILEMITFEYPYSECTHPAQIYKKVI 240
Query: 240 SGKKPDSLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSREL 299
SGKKPD+LY+VKDPEVR+F++KCLATVS RLSA ELLNDPFL+ D+ E +LR +DY R L
Sbjct: 241 SGKKPDALYKVKDPEVRQFIDKCLATVSYRLSAAELLNDPFLRTDNGEYDLRPVDYGRGL 300
Query: 300 DDMDPLIRQPHIDFHHIDNSFSNGCANGYGYDTPSEWGYSPVEVESNGIELFGYHDDDHS 359
DD+ PLIRQP+++ H D+SF G Y ++ SE GY P++ NGIELF Y + +HS
Sbjct: 301 DDVCPLIRQPYLELHRSDSSFCTGYPYDYSFEASSESGYHPID---NGIELFEYCEGEHS 357
Query: 360 SDVDISIKGKRRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDITDQ 419
DVDISIKGK +DGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELD+TDQ
Sbjct: 358 EDVDISIKGKMSEDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDMTDQ 417
Query: 420 DVTKIADMIDGEIASLVPEWRPGPGIEETPRFANQGFCSNCASNRTSTGSLMEYFSNPYG 479
DVT+IADMIDGEIASLVPEWRPGPGIEETPRFANQ +C NCA + ++ S N G
Sbjct: 418 DVTRIADMIDGEIASLVPEWRPGPGIEETPRFANQSYCHNCAPSTYNSASNGLMLRNHDG 477
Query: 480 TNLQLLQCCRNGCASMHGRFGEITFDVDESEHHVTDGAPNESSQSDCLHYQEIWGQLESR 539
N ++ QCC + ASMHGRF EI + DE EHH + APN SS D L Y EIWG ESR
Sbjct: 478 KNSEVAQCCGHRYASMHGRFEEIMYHADEPEHHTAEDAPNVSSHPDGLSYPEIWGHHESR 537
Query: 540 ELSSVDSGHSHSDEEYEKLDQSFATEDNKETKVESETALNARNSTRHLVNSHSYSEIPSV 599
ELSS+ S SHSDE+YEK D+ D KE +ES+TA N R + R L+NS S+SE PS
Sbjct: 538 ELSSMSSRQSHSDEDYEKTDRPITDTDTKEIIMESKTAPNTRRTLRSLMNSLSFSETPS- 596
Query: 600 DCDQSDNHEKEIQQELRWLKAKYMMELSELREQQLGVASNTSSYSNKENNTTNGRLSYPI 659
D +E ++QQE+RW+KAKY +ELS+LR+QQL ++S +SS +++ N P
Sbjct: 597 ---PPDINEIDVQQEMRWIKAKYQLELSKLRDQQLNLSSKSSSSEDRQQKMENAT---PR 650
Query: 660 SSPTQ-RDRNGFHLNLPMDKKHFSSNCSDRINKSCPSLDPPM--ARYCGAIKESLRTEDT 716
+ Q D +G +N H IN SC S D P +R A++ S+ +
Sbjct: 651 GNHNQILDSSGRDMNRSSTDSHVY------INNSCYSTDMPKQRSRNRKAVESSI-VDKV 703
Query: 717 VTATCFPSGSLLPPSLHRTTSLPVDAIDL 745
VTA +GSLLP SLHRT SLPVDA+ +
Sbjct: 704 VTAKNACNGSLLPSSLHRTISLPVDAVHI 732
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357512227|ref|XP_003626402.1| With no lysine kinase [Medicago truncatula] gi|355501417|gb|AES82620.1| With no lysine kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 988 bits (2555), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 515/753 (68%), Positives = 582/753 (77%), Gaps = 35/753 (4%)
Query: 1 MNGLTHLEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF 60
MN +T LE D S+FVEVDPTGRYGRY+EILGKGASKTVYRAFDEY+GIEVAWNQ+KLYDF
Sbjct: 1 MNCVTQLETDDSDFVEVDPTGRYGRYHEILGKGASKTVYRAFDEYQGIEVAWNQIKLYDF 60
Query: 61 LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK 120
LQ+PEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTE+FTSGTLRQYRLKHK
Sbjct: 61 LQNPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLKHK 120
Query: 121 RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180
RVNIRAVK WCRQIL+GL YLHSHDPPVIHRDLKCDNIF+NGNQGEVKIGDLGLAAILRK
Sbjct: 121 RVNIRAVKHWCRQILQGLHYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILRK 180
Query: 181 SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS 240
SHAAHCVGTPEFMAPEVYEE YNELVDIYSFGMC+LEMVTFEYPYSEC+HPAQIYKKV S
Sbjct: 181 SHAAHCVGTPEFMAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECSHPAQIYKKVSS 240
Query: 241 GKKPDSLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELD 300
GKKPD+LY+VKDPEVR FVEKCLAT SLRLSARELL+DPFL+IDD E +L S+D E
Sbjct: 241 GKKPDALYKVKDPEVREFVEKCLATASLRLSARELLDDPFLRIDDDEYDLGSVDVG-EFG 299
Query: 301 DMDPLIRQPHIDFHHIDNSFSNGC---ANGYGYDTPSEWGYSPVEVESNGIELFGYHDDD 357
D+ PL+ Q F ID S+SN +NG+GY+ +W P E+E +GIELF HDD+
Sbjct: 300 DLGPLVSQS---FFSIDRSYSNISTEYSNGFGYEV--DWYSQPTEIE-HGIELFECHDDE 353
Query: 358 HSSDVDISIKGKRRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDIT 417
S DVDISIKGKR+DDGGIFLRLRIADKE IRNIYFPFD+E DTALSVATEMVAELDIT
Sbjct: 354 PSKDVDISIKGKRKDDGGIFLRLRIADKEDHIRNIYFPFDIELDTALSVATEMVAELDIT 413
Query: 418 DQDVTKIADMIDGEIASLVPEWRPGPGIEETPRFANQGFCSNCASNRTS-TGSLMEYFSN 476
DQDVT IA MIDGEIASLVPEWRPGPGI+ET ++NQ FC NC SN T+ T SL+ N
Sbjct: 414 DQDVTSIAHMIDGEIASLVPEWRPGPGIDETINYSNQSFCDNCVSNHTTDTDSLLR---N 470
Query: 477 PYGTNLQLLQCCRNGCASMHGRFGEITFDV-DESEHHVTDGAPNESSQSDCLHYQEIWGQ 535
NL LLQCC +GCASMHGRF EITF D + HV++ APN SS+SD L YQE W Q
Sbjct: 471 QSAKNLHLLQCCMHGCASMHGRFEEITFQSEDYDDIHVSEDAPNISSKSDFLQYQESWNQ 530
Query: 536 LESRELSSVDSGHSHSDEEYEKLDQSFATEDNKETKVESETALNARNSTRHLVNSHSYSE 595
ESRELS V+S SHSDE+YE LD+SF ED +E E+ A NA NS + L +H S
Sbjct: 531 HESRELSPVESTRSHSDEQYELLDKSFLIEDKREGIRENSFAPNAGNSLKDLSGNHYLST 590
Query: 596 IPSVDCDQSDNHEKEIQQELRWLKAKYMMELSELREQQLGVASNTSSYSNK---ENNTTN 652
I S+ C +++EKEIQ ELRWLKAKY MEL EL+++QLGV + + +K E T N
Sbjct: 591 IGSLYCGVENDYEKEIQHELRWLKAKYQMELWELKDKQLGVEAKSPHIEHKTPPETETVN 650
Query: 653 GRLSYPISSPTQRDRNGFHLNLPMDKKHFSSNCSDRINKSCPSLDPPMARYCGAIKESLR 712
G NG H + + K S+ + R KS P+LD + CG I +
Sbjct: 651 GF------------DNGIHFH---NYKDCDSSYNSREQKSHPNLDTRRVQNCGVI--CSK 693
Query: 713 TEDTVTATCFPSGSLLPPSLHRTTSLPVDAIDL 745
ED TA F + LP +LHRT SLPVDA+D+
Sbjct: 694 EEDMATAKSFYTRLFLPDTLHRTISLPVDAVDV 726
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147815157|emb|CAN72330.1| hypothetical protein VITISV_035622 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 978 bits (2528), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/715 (70%), Positives = 564/715 (78%), Gaps = 14/715 (1%)
Query: 36 KTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT 95
K YRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKT+KH NIMKFYTSWVDT
Sbjct: 47 KKSYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTMKHNNIMKFYTSWVDT 106
Query: 96 ANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKC 155
ANRNINFVTEMFTSGTLRQYR KHKRVNIRAVK WCRQILRGLLYLHSHDPPVIHRDLKC
Sbjct: 107 ANRNINFVTEMFTSGTLRQYRQKHKRVNIRAVKHWCRQILRGLLYLHSHDPPVIHRDLKC 166
Query: 156 DNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCI 215
DNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEE YNELVDIYSFGMCI
Sbjct: 167 DNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEEYNELVDIYSFGMCI 226
Query: 216 LEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLATVSLRLSAREL 275
LEMVTFEYPYSECTHPAQIYKKV+SGKKPD+LY+VKDPEVR FVEKCLA+VSLRLSAREL
Sbjct: 227 LEMVTFEYPYSECTHPAQIYKKVISGKKPDALYKVKDPEVREFVEKCLASVSLRLSAREL 286
Query: 276 LNDPFLQIDDCESNLRSLDYSRELDDMDPLIRQPHIDFHHIDNSFSNGCANGYGYDTPSE 335
L DPFL+IDDCES+LR ++ RE DDM PL+RQP +++HH +NSFSNG +N +D +
Sbjct: 287 LQDPFLRIDDCESDLRPIECRREPDDMVPLLRQPFLEYHHSNNSFSNGYSNAVDFDAHNG 346
Query: 336 WGYSPVEVESNGIELFGYHDDDHSSDVDISIKGKRRDDGGIFLRLRIADKEGRIRNIYFP 395
WGY P+E+E GIELF YH+D+H ++VDISIKGKRR+D GIFLRLRIADKE IRNIYFP
Sbjct: 347 WGYQPLEMEPTGIELFEYHEDEHPANVDISIKGKRREDDGIFLRLRIADKEDHIRNIYFP 406
Query: 396 FDVETDTALSVATEMVAELDITDQDVTKIADMIDGEIASLVPEWRPGPGIEETPRFANQG 455
FD+E DTALSVATEMVAELDITDQDVTKIADMIDGEIASLVPEW+PGPGIEETP FA
Sbjct: 407 FDIEMDTALSVATEMVAELDITDQDVTKIADMIDGEIASLVPEWKPGPGIEETPCFATLN 466
Query: 456 FCSNCASNRTSTGSLMEYFS-NPYGTNLQLLQCCRNGCASMHGRFGEITFDVDESEHHVT 514
C NC SN TS GSLM+ + NP NLQ+ Q C NGCA+MHGRF EIT+ VD ++HH+
Sbjct: 467 LCHNCVSNHTSNGSLMDILANNPGAKNLQIFQ-CSNGCAAMHGRFEEITYQVDGADHHIP 525
Query: 515 DGAPNESSQSDCLHYQEIWGQLESRELSSVDSGHSHSDEEYEKLDQSFATEDNKETKVES 574
+G QS+ LH EIW + ESRELSSV SG S SDEEYEK++ S ++
Sbjct: 526 EG------QSEELHCTEIWYKHESRELSSVSSGESPSDEEYEKINHSIIKDERGSGT--G 577
Query: 575 ETALNARNSTRHLVNSHSYSEIPSVDCDQSDNHEKEIQQELRWLKAKYMMELSELREQQL 634
A N +NS HL N S S IPS+ C SD++E EIQQ LRWLKAK+ ME+ LR+ QL
Sbjct: 578 NVASNVKNSISHLRNPSSSSAIPSMSCALSDDYENEIQQVLRWLKAKHQMEMRGLRDLQL 637
Query: 635 GVASNTSSYSNKENNTTNGRLSYPISSPTQRDRNGFHLNLPMDKKHFSSNCSDRINKSCP 694
G AS SS N++ N L +S+ +Q NG L KHF+SNC+ ++NK P
Sbjct: 638 GFASKPSSLDNRQLKPDNEGLFSTLSNTSQGHNNGLFLKSSAYDKHFTSNCATQVNKCSP 697
Query: 695 SLDPPMARYCGAIKESLRTED---TVTATCF-PSGSLLPPSLHRTTSLPVDAIDL 745
L AR C A K S ED VTA F +GSLLP +HRT SLPVDA+D+
Sbjct: 698 DLVTHGARNCEANKGSRSAEDMVHVVTAKSFYTAGSLLPCPIHRTMSLPVDAVDI 752
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 745 | ||||||
| TAIR|locus:2114845 | 700 | WNK1 "with no lysine (K) kinas | 0.428 | 0.455 | 0.861 | 2.7e-239 | |
| TAIR|locus:2182039 | 492 | WNK9 [Arabidopsis thaliana (ta | 0.601 | 0.910 | 0.687 | 3.5e-178 | |
| TAIR|locus:504955638 | 516 | WNK3 "with no lysine (K) kinas | 0.362 | 0.523 | 0.745 | 2.9e-133 | |
| TAIR|locus:2098242 | 549 | WNK5 "with no lysine (K) kinas | 0.379 | 0.515 | 0.680 | 1.7e-127 | |
| TAIR|locus:2161278 | 571 | WNK4 "with no lysine (K) kinas | 0.367 | 0.479 | 0.683 | 1.7e-122 | |
| TAIR|locus:2028521 | 557 | WNK7 [Arabidopsis thaliana (ta | 0.624 | 0.834 | 0.497 | 1.5e-121 | |
| TAIR|locus:2093994 | 567 | WNK6 "with no lysine (K) kinas | 0.561 | 0.737 | 0.539 | 1.9e-121 | |
| TAIR|locus:2165790 | 563 | WNK8 "with no lysine (K) kinas | 0.366 | 0.484 | 0.659 | 1.6e-113 | |
| TAIR|locus:2019404 | 524 | WNK10 "with no lysine (K) kina | 0.548 | 0.780 | 0.514 | 8e-110 | |
| TAIR|locus:2176135 | 314 | AT5G55560 [Arabidopsis thalian | 0.373 | 0.885 | 0.619 | 9e-93 |
| TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1485 (527.8 bits), Expect = 2.7e-239, Sum P(4) = 2.7e-239
Identities = 279/324 (86%), Positives = 303/324 (93%)
Query: 1 MNGLTHLEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF 60
MN L++LEPD SEFVEVDPTGRYGRYNE+LGKGASKTVYRAFDEYEGIEVAWNQVKLYDF
Sbjct: 1 MNNLSYLEPDYSEFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDF 60
Query: 61 LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK 120
LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTE+FTSGTLRQYRL+HK
Sbjct: 61 LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHK 120
Query: 121 RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180
RVNIRA+K WCRQILRGL YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK
Sbjct: 121 RVNIRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180
Query: 181 SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS 240
SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTF+YPYSECTHPAQIYKKV+S
Sbjct: 181 SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMS 240
Query: 241 GKKPDSLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELD 300
GKKPD+LY+VKDPEV+ F+EKCLATVSLR+SARELL+DPFL+IDD E +LRS+D D
Sbjct: 241 GKKPDALYKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRIDDGEFDLRSVDME---D 297
Query: 301 DMDPLIRQPHI--DFHHIDNSFSN 322
+ PL RQPH D+++ ++ S+
Sbjct: 298 SVGPLYRQPHHLPDYYNYPSNSSS 321
|
|
| TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1647 (584.8 bits), Expect = 3.5e-178, Sum P(2) = 3.5e-178
Identities = 332/483 (68%), Positives = 385/483 (79%)
Query: 1 MNGLTHLEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF 60
MN L+HLE D SE+VEVDPTGRYGRYNE+LGKG+SKTVYR FDEY+GIEVAWNQVKLYDF
Sbjct: 2 MNNLSHLESDYSEYVEVDPTGRYGRYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYDF 61
Query: 61 LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK 120
LQSP++LERLYCEIHLLKTLKHK+IMKFY SWVDT NRNINFVTEMFTSGTLRQYRLKHK
Sbjct: 62 LQSPQELERLYCEIHLLKTLKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHK 121
Query: 121 RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180
RVNIRAVK WCRQILRGL YLH+HDPPVIHRDLKCDNIF+NGNQGEVKIGDLGLAA L+
Sbjct: 122 RVNIRAVKNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQH 181
Query: 181 SHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS 240
SHAAHCVGTPEFMAPEVY+E YN+LVDIYSFGMC+LEMVTF+YPYSEC+HPAQIYK+V+S
Sbjct: 182 SHAAHCVGTPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVIS 241
Query: 241 GKKPDSLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSREL- 299
GKKPD L +VKDPEVR F+EKCLATVSLRLSA ELL+D FL ID ES++R ++ + L
Sbjct: 242 GKKPDGLDKVKDPEVRGFIEKCLATVSLRLSACELLDDHFLCID--ESDMRRVESEKGLI 299
Query: 300 DDMDPLIRQPHIDFHHIDNSFSNGCANGYGYDTPSEWGYSPVE-VESNGIELFGYXXXXX 358
D+ +R + HI + +SNG Y ++W Y+ E VES+ I+L +
Sbjct: 300 DEAGTPLRHSY----HIPH-YSNGY---YSLYNQNQWDYNGDETVESHEIDLLEFQNDDD 351
Query: 359 XX-------XXXXXXKGKRRDDG-GIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEM 410
KGKRRD+G G+FLRL+ +KEG +RNIYFPFD+ETDTA+SVA EM
Sbjct: 352 EEEEDKRFGSVDISIKGKRRDNGDGLFLRLKTVNKEGCVRNIYFPFDIETDTAISVAREM 411
Query: 411 VAELDITDQDVTKIADMIDGEIASLVPEWRPGPGIEETPRFANQGFCSNCASNRTSTGSL 470
V EL++ D+DVTKIA+MIDGEIASLVP W I FCS+ SNR+S GS+
Sbjct: 412 VEELEMDDRDVTKIANMIDGEIASLVPNW----SI----------FCSS-ESNRSSVGSV 456
Query: 471 MEY 473
M++
Sbjct: 457 MDF 459
|
|
| TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1089 (388.4 bits), Expect = 2.9e-133, Sum P(2) = 2.9e-133
Identities = 202/271 (74%), Positives = 234/271 (86%)
Query: 13 EFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC 72
EFVE+DPTGRYGRY E+LGKGA K VYRAFD+ EGIEVAWNQVKL D S EDL+RLY
Sbjct: 11 EFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSEDLDRLYS 70
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCR 132
E+HLLKTLKHK+I+KFYTSW+D + IN +TE+FTSG LRQYR KHK V++RA+K W R
Sbjct: 71 EVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLRALKKWSR 130
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV-GTPE 191
QIL GL+YLHSHDPPVIHRDLKCDNIF+NGNQGEVKIGDLGLAAIL ++ +AH V GTPE
Sbjct: 131 QILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAHSVIGTPE 190
Query: 192 FMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK 251
FMAPE+YEE YN LVDIY+FGMC+LE+VTFEYPYSECT+ AQIY+KV SG KP +L V
Sbjct: 191 FMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKPAALLNVT 250
Query: 252 DPEVRRFVEKCLATVSLRLSARELLNDPFLQ 282
DP+VR F+EKC+A VS RLSA+ELL+DPFL+
Sbjct: 251 DPQVRAFIEKCIAKVSQRLSAKELLDDPFLK 281
|
|
| TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1034 (369.0 bits), Expect = 1.7e-127, Sum P(3) = 1.7e-127
Identities = 194/285 (68%), Positives = 231/285 (81%)
Query: 10 DCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLER 69
D +VE DP+GRYGR+ E+LGKGA KTVY+AFD+ G+EVAWNQVKL + +SPE L+R
Sbjct: 11 DSIAYVETDPSGRYGRFREVLGKGAMKTVYKAFDQVLGMEVAWNQVKLNEVFRSPEPLQR 70
Query: 70 LYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL 129
LY E+HLLK L H++I+++ TSW+D R NF+TE+FTSGTLR+YR K+++V+IRA+K
Sbjct: 71 LYSEVHLLKNLNHESIIRYCTSWIDVNRRTFNFITELFTSGTLREYRRKYQKVDIRAIKS 130
Query: 130 WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV-G 188
W RQIL GL YLH HDPPVIHRDLKCDNIFVNG+ G+VKIGDLGLAAILR S AH V G
Sbjct: 131 WARQILNGLAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQNAHSVIG 190
Query: 189 TPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLY 248
TPEFMAPE+YEE YNELVDIYSFGMC+LEM+T EYPYSECT+PAQIYKKV SGK PDS +
Sbjct: 191 TPEFMAPELYEEDYNELVDIYSFGMCVLEMLTGEYPYSECTNPAQIYKKVTSGKLPDSFH 250
Query: 249 RVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSL 293
++ E +RFV KCL TVS RL A+ELL DPFL D E +L L
Sbjct: 251 LIQHTEAQRFVGKCLETVSRRLPAKELLADPFLAATD-ERDLAPL 294
|
|
| TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1042 (371.9 bits), Expect = 1.7e-122, Sum P(2) = 1.7e-122
Identities = 188/275 (68%), Positives = 228/275 (82%)
Query: 12 SEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLY 71
+E+VE DPTGRYGR+ EILG+GA KTVY+A DE GIEVAW+QVKL + L+S DL+RLY
Sbjct: 7 AEYVETDPTGRYGRFAEILGRGAMKTVYKAIDEKLGIEVAWSQVKLKEVLRSSVDLQRLY 66
Query: 72 CEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWC 131
E+HLL TL HK+I++FYTSW+D N +NF+TE+FTSGTLRQY+ K+ R++IRA+K W
Sbjct: 67 SEVHLLSTLNHKSIIRFYTSWIDVHNHTLNFITELFTSGTLRQYKNKYLRIDIRAIKSWA 126
Query: 132 RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV-GTP 190
RQIL GL+YLH HDPPVIHRDLKCDNIFVNG+ G+VKIGDLGLA +LR H+AH + GTP
Sbjct: 127 RQILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLARMLRDCHSAHSIIGTP 186
Query: 191 EFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRV 250
EFMAPE+YEE YNEL+D+YSFGMC LEM+T E+PYSEC HPAQIYKKVV GK P + YRV
Sbjct: 187 EFMAPELYEENYNELIDVYSFGMCFLEMITSEFPYSECNHPAQIYKKVVGGKLPGAFYRV 246
Query: 251 KDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDD 285
D E +RF+ KCL + S R+SA+ELL DPFL D+
Sbjct: 247 GDIEAQRFIGKCLVSASKRVSAKELLQDPFLASDE 281
|
|
| TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1168 (416.2 bits), Expect = 1.5e-121, Sum P(2) = 1.5e-121
Identities = 237/476 (49%), Positives = 315/476 (66%)
Query: 7 LEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPED 66
+EP E +E+DPT RY RY E++GKGASKTV++ FDE +GIEVAWNQV++ D LQSP+
Sbjct: 11 VEPPDPEVLEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRIDDLLQSPDC 70
Query: 67 LERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRA 126
LERLY E+ LLK+LKHKNI++FY SW+D N+ +N +TE+FTSG+LRQYR KH++VN++A
Sbjct: 71 LERLYSEVRLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNMKA 130
Query: 127 VKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC 186
VK W RQIL GL YLHS DPP+IHRD+KCDNIF+NGN GEVKIGDLGLA ++ +++A
Sbjct: 131 VKCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQANAKSV 190
Query: 187 VGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDS 246
+GTPEFMAPE+Y+E YNEL DIYSFGMC+LEMVTFEYPY EC + AQIYKKV SG KP S
Sbjct: 191 IGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIKPAS 250
Query: 247 LYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDMDPLI 306
L +VKDPEV +F+EKCL S RLSA ELL D FL ++ N L L D+ +
Sbjct: 251 LSKVKDPEVMKFIEKCLLPASERLSAEELLLDSFLNVNGLVMN-NPLP----LPDI-VMP 304
Query: 307 RQPHIDFHHIDNSFSNGCANGYGYDTPSEWGYSPVEVESNGIELFGYXXXXXXXXXXXXX 366
++ + + N E P+ + SN
Sbjct: 305 KEGSFGERCLMSEGPPNARNRTMSMNLDEDNNLPIVISSNNSGTNCIEVRRAKRGNFFVL 364
Query: 367 KGKRRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDITDQDVTKIAD 426
KG+ D+ + L LRI D+ GR+RNI+F F E DTA +V++EMV +L++TD++V IA+
Sbjct: 365 KGEENDENSVSLILRIVDENGRVRNIHFLFFQEGDTASNVSSEMVEQLELTDKNVKFIAE 424
Query: 427 MIDGEIASLVPEWRPGPGIEET--PRFANQGFCSNCASNRTSTG--SLMEYFSNPY 478
+ID + +L+P W+ ++ P+ NQ N + +S S+ S+ Y
Sbjct: 425 LIDVLLVNLIPNWKTDVAVDHLIHPQ-QNQSSKDNHQNGASSQAGESISHSLSSDY 479
|
|
| TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1165 (415.2 bits), Expect = 1.9e-121, Sum P(2) = 1.9e-121
Identities = 239/443 (53%), Positives = 305/443 (68%)
Query: 8 EPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDL 67
EP E +EVDPT RY RY E++GKGA KTVY+AFDE +GIEVAWNQV++ D LQSP L
Sbjct: 12 EPPDPEVLEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCL 71
Query: 68 ERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAV 127
ERLY E+ LLK+LKH NI++FY SW+D N+ +N +TE+FTSG+LR YR KH++VN++AV
Sbjct: 72 ERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAV 131
Query: 128 KLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV 187
K W RQIL GL YLH +PP+IHRDLKCDNIF+NGN GEVKIGDLGLA ++ +++A +
Sbjct: 132 KNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVI 191
Query: 188 GTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSL 247
GTPEFMAPE+Y+E YNEL DIYSFGMC+LEMVTF+YPY EC + AQIYKKV SG KP SL
Sbjct: 192 GTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASL 251
Query: 248 YRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDMDPLIR 307
RVKDPEV++F+EKCL S RLSA+ELL DPFLQ L L + L PL
Sbjct: 252 SRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQ-------LNGLTMNNPL----PL-- 298
Query: 308 QPHIDFHHIDNSFSNGCANGYGYDT--PSEWGYSPVEVESN-GIELFGYXXXX------- 357
P I + +F + C G T PS+ ++ +SN I F
Sbjct: 299 -PDIVMPK-EGAFGDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVTFSDNSGSRCIEVRR 356
Query: 358 XXXXXXXXXKGKRRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDIT 417
KG+ D+ + L LRI D+ GR+RNI+F F E DTA V++EMV +L++T
Sbjct: 357 AKRGNFFVLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQEGDTASKVSSEMVEQLELT 416
Query: 418 DQDVTKIADMIDGEIASLVPEWR 440
DQ+VT IA++ID + +++P W+
Sbjct: 417 DQNVTFIAELIDILLVNMIPTWK 439
|
|
| TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 975 (348.3 bits), Expect = 1.6e-113, Sum P(2) = 1.6e-113
Identities = 180/273 (65%), Positives = 219/273 (80%)
Query: 12 SEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLY 71
++F E DP+GRY RY+++LG+GA KTVY+AFDE +GIEVAWN V + D +Q P LERLY
Sbjct: 17 ADFAEKDPSGRYIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLVSIEDVMQMPGQLERLY 76
Query: 72 CEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWC 131
E+HLLK LKH+NI+K + SWVD N+ IN +TE+FTSG+LR YR KH++V+ +A+K W
Sbjct: 77 SEVHLLKALKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVYRKKHRKVDPKAIKNWA 136
Query: 132 RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPE 191
RQIL+GL YLHS +PPVIHRDLKCDNIFVNGN GEVKIGDLGLA +L++ A +GTPE
Sbjct: 137 RQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLATVLQQPTARSVIGTPE 196
Query: 192 FMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK 251
FMAPE+YEE YNELVDIYSFGMC+LEMVT EYPY+EC + AQIYKKV S KP SL +V
Sbjct: 197 FMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIYKKVTSNIKPQSLGKVD 256
Query: 252 DPEVRRFVEKCLATVSLRLSARELLNDPFLQID 284
DP+VR+F+EKCL S R +A EL DPFL D
Sbjct: 257 DPQVRQFIEKCLLPASSRPTALELSKDPFLARD 289
|
|
| TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1068 (381.0 bits), Expect = 8.0e-110, Sum P(2) = 8.0e-110
Identities = 219/426 (51%), Positives = 284/426 (66%)
Query: 12 SEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLY 71
++FV+ DPTGRY RYN++LG+GA KTVY+AFDE EGIEVAWN + + D LQ P L+RLY
Sbjct: 4 ADFVQKDPTGRYIRYNDVLGRGAFKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRLY 63
Query: 72 CEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWC 131
E+HLL +LKH NI+K + SWVD N++IN +TE+FTSG+L YR KH++V+ +A+ W
Sbjct: 64 SEVHLLNSLKHDNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMNWA 123
Query: 132 RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPE 191
RQIL+GL YLHS PPVIHRDLKCDNIFVNGN G+VKIGDLGLAA++++ A +GTPE
Sbjct: 124 RQILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQQPTARSVIGTPE 183
Query: 192 FMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK 251
FMAPE+YEE YNELVDIYSFGMC+LEMVT EYPY EC + AQIYKKV SG KP SL +V
Sbjct: 184 FMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSKVD 243
Query: 252 DPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDC-ESNLRSLDYSRELDDMDPLIRQPH 310
DP+V++F+EKCL R +A ELL D L +D +S L + + M P
Sbjct: 244 DPQVKQFIEKCLLPAPSRPTALELLKDQLLAVDGAKDSTLTASSNTTFKPAMPPQCEYRP 303
Query: 311 IDFHHIDNSFSNGCANGYGYDTPSEWGY-SPVEVESNGIELFGYXXXXXXXXXXXXXKGK 369
+D + N+ + C++ + E +EV+ G+
Sbjct: 304 MDVEYKKNTSVSICSSA---KSSQECALLQTMEVQR------------VAESTEFKLSGE 348
Query: 370 RRDDGGIFLRLRIADKEGRIRNIYFPFDVETDTALSVATEMVAELDITDQDVTKIADMID 429
RRDD + LRIA G+ R + F F+++TDTA +V EMV ELD++ +VT IA+MID
Sbjct: 349 RRDDVAASMALRIAGSSGQARKVDFDFNLKTDTARAVTGEMVEELDLSSHEVTVIAEMID 408
Query: 430 GEIASL 435
I L
Sbjct: 409 ELIMKL 414
|
|
| TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 924 (330.3 bits), Expect = 9.0e-93, P = 9.0e-93
Identities = 174/281 (61%), Positives = 211/281 (75%)
Query: 8 EPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDL 67
+ D FVEVDPTGRYGRY E+LG GA K VYRAFD+ EGIEVAWNQVKL F P
Sbjct: 15 DKDSESFVEVDPTGRYGRYGELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRCFSDDPAMT 74
Query: 68 ERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAV 127
ERLY E+ LLK LK+ NI+ Y W D N +NF+TE+ TSG LR+YR KH+ V++RA+
Sbjct: 75 ERLYSEVRLLKNLKNSNIITLYKVWRDERNNTLNFITEICTSGNLREYRKKHRHVSMRAL 134
Query: 128 KLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV 187
K W +QIL+GL YLH+HDP +IHRDL C NIFVNGN G+VKIGDLGLAAI+ K+H AH +
Sbjct: 135 KKWSKQILKGLDYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGLAAIVGKNHLAHSI 194
Query: 188 -GTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDS 246
GTPEFMAPE+YEE Y E+VDIYS+GMC+LE+V+ E PYSEC A+IYK+V G KP++
Sbjct: 195 LGTPEFMAPELYEENYTEMVDIYSYGMCVLELVSLEIPYSECDSVAKIYKRVSKGLKPEA 254
Query: 247 LYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQ--IDD 285
L +V DPE + F+EKC+A R SA ELL DPF +DD
Sbjct: 255 LNKVNDPEAKAFIEKCIAQPRARPSAAELLCDPFFDGILDD 295
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q0D598 | WNK1_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6986 | 0.6456 | 0.6832 | yes | no |
| Q9CAV6 | WNK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6578 | 0.8013 | 0.8528 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 745 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-64 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-62 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-55 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-50 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-49 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-47 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-44 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-42 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-38 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-37 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-37 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-36 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-36 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-35 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-34 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-33 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-33 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-33 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-33 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-32 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-32 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-32 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-31 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-31 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-31 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-30 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-30 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-30 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-30 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-29 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-26 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-26 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-26 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-25 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-25 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-23 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-23 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-22 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-22 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-21 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-19 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-18 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-17 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-16 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-15 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 0.001 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 0.001 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 1e-64
Identities = 91/259 (35%), Positives = 128/259 (49%), Gaps = 14/259 (5%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E LG+G+ VY A D+ G VA +K + E + R EI +LK LKH NI++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILR---EIKILKKLKHPNIVR 61
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
Y + D + V E G L K R++ + + RQIL L YLHS
Sbjct: 62 LYDVFED--EDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG-- 117
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVY-EEAYNEL 205
++HRDLK +NI ++ + G VK+ D GLA L VGTPE+MAPEV + Y +
Sbjct: 118 IVHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 206 VDIYSFGMCIL-EMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK-DPEVRRFVEKCL 263
VDI+S G IL E++T + P+ +++KK+ K P PE + + K L
Sbjct: 177 VDIWSLG-VILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLL 235
Query: 264 AT-VSLRLSARELLNDPFL 281
RL+A E L PF
Sbjct: 236 VKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 208 bits (533), Expect = 3e-62
Identities = 93/260 (35%), Positives = 135/260 (51%), Gaps = 11/260 (4%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E+LG+G+ +VY A D+ G +A V+L S E+LE L EI +L +L+H NI++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSG--DSEEELEALEREIRILSSLQHPNIVR 63
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
+Y S D +N E + G+L K ++ ++ + RQIL GL YLHS+
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG-- 121
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC----VGTPEFMAPEVYE-EAY 202
++HRD+K NI V+ + G VK+ D G A L GTP +MAPEV E Y
Sbjct: 122 IVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 203 NELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKC 262
DI+S G ++EM T + P+SE +P K+ S +P + E + F+ KC
Sbjct: 181 GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKC 240
Query: 263 LAT-VSLRLSARELLNDPFL 281
L R +A ELL PFL
Sbjct: 241 LRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 4e-55
Identities = 82/263 (31%), Positives = 127/263 (48%), Gaps = 16/263 (6%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
LG G+ TVY+A + G VA +K + + + EI +L+ L H NI++
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHPNIVR 62
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
++ D ++ V E G L Y + ++ K QILRGL YLHS+
Sbjct: 63 LIDAFED--KDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG-- 118
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAA--ILRKSHAAHCVGTPEFMAPEV--YEEAYN 203
+IHRDLK +NI ++ N G VKI D GLA + S VGTP +MAPEV Y
Sbjct: 119 IIHRDLKPENILLDEN-GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 204 ELVDIYSFGMCILEMVTFEYPYSECTHPAQIYK--KVVSGKK--PDSLYRVKDPEVRRFV 259
VD++S G+ + E++T + P+S Q+ +++ + + E + +
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 260 EKCLAT-VSLRLSARELLNDPFL 281
+KCL S R +A E+L P+
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 2e-50
Identities = 82/256 (32%), Positives = 120/256 (46%), Gaps = 47/256 (18%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFY 89
LG+G TVY A D+ G +VA +K+ S LE L EI +LK L H NI+K Y
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVA---IKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 90 TSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPV 148
+ D ++ V E G+L+ + +++ + QIL GL YLHS+ +
Sbjct: 58 GVFED--ENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN--GI 113
Query: 149 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAAHCVGTPEFMAPEVYEEA--YNE 204
IHRDLK +NI ++ + G+VK+ D GL+ +L KS VGTP +MAPEV Y+E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 205 LVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA 264
DI+S G+ + E+ PE++ + K L
Sbjct: 174 KSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ 199
Query: 265 -TVSLRLSARELLNDP 279
R SA+E+L
Sbjct: 200 KDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 9e-49
Identities = 100/279 (35%), Positives = 140/279 (50%), Gaps = 32/279 (11%)
Query: 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
DP Y E +G+GAS VY+A D G EVA +++L ++ E + EI ++
Sbjct: 16 DPRELYKNL-EKIGEGASGEVYKATDRATGKEVAIKKMRLRK-----QNKELIINEILIM 69
Query: 78 KTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTL----RQYRLKHKRVNIRAVKLWCRQ 133
K KH NI+ +Y S++ + V E G+L Q ++ I V CR+
Sbjct: 70 KDCKHPNIVDYYDSYLV--GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV---CRE 124
Query: 134 ILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAAHCVGTPE 191
+L+GL YLHS VIHRD+K DNI ++ G VK+ D G AA L KS VGTP
Sbjct: 125 VLQGLEYLHSQ--NVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPY 181
Query: 192 FMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRV 250
+MAPEV + + Y VDI+S G+ +EM E PY P + + + P +
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP-PLRALFLITTKGIP----PL 236
Query: 251 KDP-----EVRRFVEKCLAT-VSLRLSARELLNDPFLQI 283
K+P E + F+ KCL R SA ELL PFL+
Sbjct: 237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 3e-47
Identities = 90/259 (34%), Positives = 140/259 (54%), Gaps = 17/259 (6%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E +GKG VY+A + G EVA +KL +S E E++ EI +LK KH NI+K
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKL----ESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQ-YRLKHKRVNIRAVKLWCRQILRGLLYLHSHDP 146
+Y S++ + V E + G+L+ + ++ + + C+++L+GL YLHS+
Sbjct: 62 YYGSYLK--KDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG- 118
Query: 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-HCVGTPEFMAPEVYE-EAYNE 204
+IHRD+K NI + + GEVK+ D GL+A L + A VGTP +MAPEV + Y+
Sbjct: 119 -IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDY 176
Query: 205 LVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK--DPEVRRFVEKC 262
DI+S G+ +E+ + PYSE ++K +G P L + E + F++KC
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG--PPGLRNPEKWSDEFKDFLKKC 234
Query: 263 LA-TVSLRLSARELLNDPF 280
L R +A +LL PF
Sbjct: 235 LQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 2e-45
Identities = 87/263 (33%), Positives = 135/263 (51%), Gaps = 23/263 (8%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+++G+GA VY+ + G VA Q+ L E L+ + EI LLK LKH NI+K
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
+ S ++T++ ++ + E +G+LRQ K V ++ Q+L+GL YLH
Sbjct: 64 YIGS-IETSD-SLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG-- 119
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA--AHCVGTPEFMAPEVYE-EAYNE 204
VIHRD+K NI + G VK+ D G+A L A VGTP +MAPEV E +
Sbjct: 120 VIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178
Query: 205 LVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP-----DSLYRVKDPEVRRFV 259
DI+S G ++E++T PY + P ++V P S PE++ F+
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLN-PMAALFRIVQDDHPPLPEGIS------PELKDFL 231
Query: 260 EKCLA-TVSLRLSARELLNDPFL 281
+C +LR +A++LL P++
Sbjct: 232 MQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 6e-44
Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 22/270 (8%)
Query: 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK 81
+Y +I GKG+ VY + +G ++ L S ++ E E+ +LK L
Sbjct: 1 KYEIIKQI-GKGSFGKVYLVRRKSDGKLYVLKEIDL--SNMSEKEREDALNEVKILKKLN 57
Query: 82 HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNI----RAVKLWCRQILRG 137
H NI+K+Y S+ + + V E G L Q K K+ + W Q+
Sbjct: 58 HPNIIKYYESFEE--KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAAHCVGTPEFMAP 195
L YLHS ++HRD+K NIF+ N G VK+GD G++ +L + A VGTP +++P
Sbjct: 116 LKYLHSRK--ILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSP 172
Query: 196 EVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPD--SLYRVKD 252
E+ + + YN DI+S G + E+ T ++P+ E + ++ K++ G+ P S Y
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKILKGQYPPIPSQY---S 228
Query: 253 PEVRRFVEKCLATV-SLRLSARELLNDPFL 281
E+R V L R S ++L PF+
Sbjct: 229 SELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 7e-42
Identities = 92/265 (34%), Positives = 138/265 (52%), Gaps = 17/265 (6%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ-SPEDLERLYCEIHLLKTLKHK 83
R E+LG G+ +VY + +G A +V L D Q E +++L EI LL L+H
Sbjct: 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS 143
NI+++ + + N+ E+ G+L + K+ ++L+ RQIL GL YLH
Sbjct: 63 NIVQYLGT--EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-ILRKSHAAHCVGTPEFMAPEVY--EE 200
+ +HRD+K NI V+ N G VK+ D G+A ++ S A G+P +MAPEV +
Sbjct: 121 RN--TVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 201 AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK---PDSLYRVKDPEVRR 257
Y DI+S G +LEM T + P+S+ A ++K S + PD L E +
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHL----SDEAKD 233
Query: 258 FVEKCL-ATVSLRLSARELLNDPFL 281
F+ KCL SLR +A ELL PF+
Sbjct: 234 FILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 76/259 (29%), Positives = 125/259 (48%), Gaps = 13/259 (5%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFY 89
LG+G+S VY+ + G A +K E ++L E+ L++ + ++K Y
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYA---LKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 90 TSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVI 149
++ I+ V E G+L K ++ + RQIL+GL YLH +I
Sbjct: 66 GAFYK--EGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH-TKRHII 122
Query: 150 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC--VGTPEFMAPEVYE-EAYNELV 206
HRD+K N+ +N ++GEVKI D G++ +L + VGT +M+PE + E+Y+
Sbjct: 123 HRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAA 181
Query: 207 DIYSFGMCILEMVTFEYPYS--ECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA 264
DI+S G+ +LE ++P+ ++ + + G P PE R F+ CL
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQ 241
Query: 265 TVSL-RLSARELLNDPFLQ 282
R SA ELL PF++
Sbjct: 242 KDPKKRPSAAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 85/281 (30%), Positives = 135/281 (48%), Gaps = 25/281 (8%)
Query: 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK 81
+ I GKG+ VY+A D+ VA +K+ D ++ +++E + EI L +
Sbjct: 2 LFTLLECI-GKGSFGEVYKAIDKRTNQVVA---IKVIDLEEAEDEIEDIQQEIQFLSQCR 57
Query: 82 HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYL 141
I K+Y S++ + I + E G+ LK +++ + R++L GL YL
Sbjct: 58 SPYITKYYGSFLKGSKLWI--IMEYCGGGSCLDL-LKPGKLDETYIAFILREVLLGLEYL 114
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------RKSHAAHCVGTPEFMAP 195
H IHRD+K NI ++ +G+VK+ D G++ L R + VGTP +MAP
Sbjct: 115 HEEG--KIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTF----VGTPFWMAP 167
Query: 196 EVY-EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK-DP 253
EV + Y+E DI+S G+ +E+ E P S+ HP ++ ++ P SL K
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPPLSD-LHPMRVL-FLIPKNNPPSLEGNKFSK 225
Query: 254 EVRRFVEKCL-ATVSLRLSARELLNDPFLQIDDCESNLRSL 293
+ FV CL R SA+ELL F++ S L L
Sbjct: 226 PFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTLL 266
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 7e-37
Identities = 93/275 (33%), Positives = 147/275 (53%), Gaps = 26/275 (9%)
Query: 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK 81
R+ R N+I G G VY A + G +A ++++ D P+ ++ + E+ +L+ LK
Sbjct: 1 RWQRGNKI-GGGTFGKVYTAVNLDTGELMAVKEIRIQD--NDPKTIKEIADEMKVLELLK 57
Query: 82 HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRV-NIRAVKLWCRQILRGLLY 140
H N++K+Y V+ + E + GTL + L+H R+ + ++++ Q+L GL Y
Sbjct: 58 HPNLVKYYG--VEVHREKVYIFMEYCSGGTLEEL-LEHGRILDEHVIRVYTLQLLEGLAY 114
Query: 141 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS------HAAHCVGTPEFMA 194
LHSH ++HRD+K NIF++ N G +K+GD G A L+ + GTP +MA
Sbjct: 115 LHSHG--IVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA 171
Query: 195 PEVYEEA----YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK---PDSL 247
PEV + DI+S G +LEM T + P+SE + QI V +G K PDSL
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSL 231
Query: 248 YRVKDPEVRRFVEKCLATV-SLRLSARELLNDPFL 281
PE + F+++CL + R +A ELL PF+
Sbjct: 232 Q--LSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 89/263 (33%), Positives = 138/263 (52%), Gaps = 22/263 (8%)
Query: 27 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIM 86
E LG+G+ +VY+A + G VA +K + EDL+ + EI +LK I+
Sbjct: 8 LEKLGEGSYGSVYKAIHKETGQVVA---IK---VVPVEEDLQEIIKEISILKQCDSPYIV 61
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQ-YRLKHKRVNIRAVKLWCRQILRGLLYLHSHD 145
K+Y S+ N ++ V E +G++ ++ +K + + Q L+GL YLHS+
Sbjct: 62 KYYGSYF--KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CVGTPEFMAPEVYEEA-Y 202
IHRD+K NI +N +G+ K+ D G++ L + A +GTP +MAPEV +E Y
Sbjct: 120 --KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 203 NELVDIYSFGMCILEMVTFEYPYSECTHPA-QIYKKVVSGKKPDSLYRVKD--PEVRRFV 259
N DI+S G+ +EM + PYS+ HP I+ ++ K P +L + PE FV
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSD-IHPMRAIF--MIPNKPPPTLSDPEKWSPEFNDFV 233
Query: 260 EKCLA-TVSLRLSARELLNDPFL 281
+KCL R SA +LL PF+
Sbjct: 234 KKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 81/265 (30%), Positives = 129/265 (48%), Gaps = 16/265 (6%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E +GKG+ TV + + +G + W ++ Y + E ++L E+++L+ LKH NI++
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEID-YGNMTEKEK-QQLVSEVNILRELKHPNIVR 63
Query: 88 FYTSWVDTANRNINFVTEMFTSGTL----RQYRLKHKRVNIRAVKLWCRQILRGLLYLHS 143
+Y +D +N+ + V E G L ++ + + K + + Q+L L H+
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 144 HDPP---VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AAHCVGTPEFMAPEVY 198
P V+HRDLK NIF++ N VK+GD GLA IL A VGTP +M+PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182
Query: 199 -EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257
+Y+E DI+S G I E+ P++ Q+ K+ GK YR E+
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLASKIKEGKFRRIPYR-YSSELNE 240
Query: 258 FVEKCLA-TVSLRLSARELLNDPFL 281
++ L R S ELL P +
Sbjct: 241 VIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 102/276 (36%), Positives = 140/276 (50%), Gaps = 27/276 (9%)
Query: 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
DP +Y R+ +I G+GAS TVY A D G EVA Q+ L Q P+ E + EI ++
Sbjct: 16 DPKKKYTRFEKI-GQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKK-ELIINEILVM 70
Query: 78 KTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHKRVNIRAVKLWCRQIL 135
+ KH NI+ + S++ + V E G+L I AV CR+ L
Sbjct: 71 RENKHPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECL 125
Query: 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAAHCVGTPEFM 193
+ L +LHS+ VIHRD+K DNI + G G VK+ D G A + +S + VGTP +M
Sbjct: 126 QALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182
Query: 194 APEVY-EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK----KPDSLY 248
APEV +AY VDI+S G+ +EMV E PY +Y +G P+ L
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL- 241
Query: 249 RVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQI 283
R F+ +CL V R SA+ELL PFL+I
Sbjct: 242 ---SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 93/280 (33%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
DP + +I G+G++ V A D+ G +VA VK D L+ + E L+ E+ ++
Sbjct: 16 DPRSYLDNFVKI-GEGSTGIVCIATDKSTGRQVA---VKKMD-LRKQQRRELLFNEVVIM 70
Query: 78 KTLKHKNIMKFYTS-------WVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLW 130
+ +H NI++ Y+S WV V E G L + H R+N +
Sbjct: 71 RDYQHPNIVEMYSSYLVGDELWV---------VMEFLEGGALTDI-VTHTRMNEEQIATV 120
Query: 131 CRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------RKSHAA 184
C +L+ L +LH+ VIHRD+K D+I + + G VK+ D G A + RKS
Sbjct: 121 CLAVLKALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRKS--- 174
Query: 185 HCVGTPEFMAPEVY-EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK 243
VGTP +MAPEV Y VDI+S G+ ++EMV E PY P Q K++
Sbjct: 175 -LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLP 232
Query: 244 PDSLYRVK-DPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281
P K P +R F+++ L + R +A ELLN PFL
Sbjct: 233 PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 8e-34
Identities = 85/271 (31%), Positives = 127/271 (46%), Gaps = 29/271 (10%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E++G GA+ VY A +VA +K D + ++ L E+ + H N++K
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVA---IKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 88 FYTSWVDTANRNINFVTEMFTSGTL-----RQYRLKHKRVNIRAVKLWCRQILRGLLYLH 142
+YTS+V + V + G+L Y I A L +++L+GL YLH
Sbjct: 64 YYTSFV--VGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLH 119
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-----RKSHAAHC-VGTPEFMAPE 196
S+ IHRD+K NI + G G VKI D G++A L R VGTP +MAPE
Sbjct: 120 SNG--QIHRDIKAGNILL-GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 197 VYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP----DSLYRV 250
V E+ Y+ DI+SFG+ +E+ T PYS+ P ++ + P + Y+
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP-PMKVLMLTLQNDPPSLETGADYKK 235
Query: 251 KDPEVRRFVEKCLAT-VSLRLSARELLNDPF 280
R+ + CL S R +A ELL F
Sbjct: 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 76/260 (29%), Positives = 113/260 (43%), Gaps = 36/260 (13%)
Query: 27 NEILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
+ LG+GA VY+ + + +EVA +K Q E+ R E +++ L H
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLR---EARIMRKLDH 60
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLY 140
NI+K V T + V E G L Y K++ + L + QI RG+ Y
Sbjct: 61 PNIVKLLG--VCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 141 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF----MAPE 196
L S IHRDL N V N VKI D GL+ L + V + MAPE
Sbjct: 119 LESK--NFIHRDLAARNCLVGENLV-VKISDFGLSRDL-YDDDYYKVKGGKLPIRWMAPE 174
Query: 197 VYEEA-YNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSL 247
+E + D++SFG+ + E+ T E PY + A++ + + G + P L
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLEYLKKGYRLPKPPNCPPEL 233
Query: 248 YRV------KDPEVR-RFVE 260
Y++ +DPE R F E
Sbjct: 234 YKLMLQCWAEDPEDRPTFSE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 83/268 (30%), Positives = 124/268 (46%), Gaps = 24/268 (8%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPED--LERLYCEIHLLKTLKHKNI 85
+ LG GA + Y+A D G +A QV S ++ +E L EI L+ L H +I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 86 MKFYTSWVDTANRNINFVTEM---FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLH 142
++ + + ++ N+ FV M S L +Y + V I + Q+LRGL YLH
Sbjct: 66 IRMLGATCEDSHFNL-FVEWMAGGSVSHLLSKYGAFKEAVIIN----YTEQLLRGLSYLH 120
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS------HAAHCVGTPEFMAPE 196
+ +IHRD+K N+ ++ ++I D G AA L +GT FMAPE
Sbjct: 121 --ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 197 VYE-EAYNELVDIYSFGMCILEMVTFEYPYSE---CTHPAQIYKKVVSGKKPDSLYRVKD 252
V E Y D++S G I+EM T + P++ H A I+ K+ S S+
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF-KIASATTAPSIPEHLS 237
Query: 253 PEVRRFVEKCL-ATVSLRLSARELLNDP 279
P +R +CL R +RELL P
Sbjct: 238 PGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 104/286 (36%), Positives = 146/286 (51%), Gaps = 27/286 (9%)
Query: 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
DP +Y RY +I G+GAS TV+ A D G EVA Q+ L Q E + EI ++
Sbjct: 16 DPKKKYTRYEKI-GQGASGTVFTAIDVATGQEVAIKQINL----QKQPKKELIINEILVM 70
Query: 78 KTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK--HKRVNIRAVKLWCRQIL 135
K LK+ NI+ F S++ + V E G+L + I AV CR+ L
Sbjct: 71 KELKNPNIVNFLDSFL--VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECL 125
Query: 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAAHCVGTPEFM 193
+ L +LH++ VIHRD+K DN+ + G G VK+ D G A + +S + VGTP +M
Sbjct: 126 QALEFLHANQ--VIHRDIKSDNVLL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182
Query: 194 APEVY-EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG----KKPDSLY 248
APEV +AY VDI+S G+ +EMV E PY +Y +G + P+ L
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL- 241
Query: 249 RVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSL 293
P R F+ +CL V R SA+ELL PFL++ S+L L
Sbjct: 242 ---SPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPL 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 83/269 (30%), Positives = 128/269 (47%), Gaps = 35/269 (13%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFY 89
+G G VY+A D G VA +KL +D E + EI +LK +H NI+ ++
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 90 TSWVDTANRNINFVTEMFTSGTLRQ-YRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPV 148
S++ + V E G+L+ Y++ ++ + CR+ L+GL YLH
Sbjct: 67 GSYL--RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--K 122
Query: 149 IHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------RKSHAAHCVGTPEFMAPEVYEEA- 201
IHRD+K NI + G+VK+ D G++A L RKS +GTP +MAPEV
Sbjct: 123 IHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSF----IGTPYWMAPEVAAVER 177
Query: 202 ---YNELVDIYSFGMCILEMVTFEYPYSECTHPAQ-IYKKVVSGKKPDSLYRVKD----- 252
Y+ DI++ G+ +E+ + P + HP + ++ S P L KD
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFD-LHPMRALFLISKSNFPPPKL---KDKEKWS 233
Query: 253 PEVRRFVEKCLA-TVSLRLSARELLNDPF 280
P F++KCL R +A +LL PF
Sbjct: 234 PVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 1e-32
Identities = 87/267 (32%), Positives = 134/267 (50%), Gaps = 15/267 (5%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPE---DLERLYCEIHLLKTLK 81
R ++LG+GA VY +D G E+A QV+ +SPE ++ L CEI LLK L
Sbjct: 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDP--ESPETSKEVNALECEIQLLKNLL 62
Query: 82 HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYL 141
H+ I+++Y D R ++ E G+++ + + + + RQIL G+ YL
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-----SHAAHCVGTPEFMAPE 196
HS+ ++HRD+K NI + + G VK+GD G + L+ + GTP +M+PE
Sbjct: 123 HSN--MIVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179
Query: 197 VYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEV 255
V E Y DI+S G ++EM+T + P++E A I+K P V D
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD-HC 238
Query: 256 RRFVEKCLATVSLRLSARELLNDPFLQ 282
R F+++ LR SA ELL F+
Sbjct: 239 RDFLKRIFVEAKLRPSADELLRHTFVH 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 70/254 (27%), Positives = 111/254 (43%), Gaps = 34/254 (13%)
Query: 27 NEILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
+ LG+GA VY+ + +EVA +K Q E+ R E +++ L H
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLR---EARIMRKLDH 60
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYL 141
N++K V T + V E G L Y K++ ++++ + + QI RG+ YL
Sbjct: 61 PNVVKLLG--VCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF----MAPEV 197
S IHRDL N V N VKI D GL+ L + + MAPE
Sbjct: 119 ESK--NFIHRDLAARNCLVGENLV-VKISDFGLSRDL-YDDDYYRKRGGKLPIRWMAPES 174
Query: 198 YEEA-YNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLY 248
+E + D++SFG+ + E+ T E PY + ++ + + +G + P LY
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLKNGYRLPQPPNCPPELY 233
Query: 249 RV------KDPEVR 256
+ +DPE R
Sbjct: 234 DLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 5e-32
Identities = 82/266 (30%), Positives = 134/266 (50%), Gaps = 11/266 (4%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKL-YDFLQSPEDLERLYCEIHLLKTLKHK 83
R ++LG+GA VY +D G E+A QV+ + ++ +++ L CEI LLK L+H+
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE 64
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS 143
I+++Y D A + + E G+++ + + + + RQIL G+ YLHS
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-----SHAAHCVGTPEFMAPEVY 198
+ ++HRD+K NI + + G VK+GD G + L+ + GTP +M+PEV
Sbjct: 125 N--MIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 199 E-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257
E Y D++S G ++EM+T + P++E A I+K P + + R
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE-HARD 240
Query: 258 FVEKCLATVSLRLSARELLNDPFLQI 283
F+ R SA ELL PF Q+
Sbjct: 241 FLGCIFVEARHRPSAEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 79/244 (32%), Positives = 127/244 (52%), Gaps = 18/244 (7%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFY 89
+GKG VY+A +G VA +V++++ + + + EI LLK L H N++K+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFE-MMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 90 TSWVDTANRNINFVTEMFTSGTLRQYRLKH----KRVNIRAVKLWCR--QILRGLLYLHS 143
S+++ N +N V E+ +G L + +KH KR+ I +W Q+ L ++HS
Sbjct: 69 ASFIE--NNELNIVLELADAGDLSRM-IKHFKKQKRL-IPERTIWKYFVQLCSALEHMHS 124
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-RKSHAAHC-VGTPEFMAPE-VYEE 200
++HRD+K N+F+ G VK+GDLGL K+ AAH VGTP +M+PE ++E
Sbjct: 125 KR--IMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 201 AYNELVDIYSFGMCILEMVTFEYP-YSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259
YN DI+S G + EM + P Y + + + KK+ P E+R V
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV 241
Query: 260 EKCL 263
+C+
Sbjct: 242 SRCI 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 87/278 (31%), Positives = 131/278 (47%), Gaps = 27/278 (9%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFY 89
LG GA VY+A + G+ A K+ +S E+LE EI +L KH NI+ Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAA---AKIIQI-ESEEELEDFMVEIDILSECKHPNIVGLY 68
Query: 90 TSWVDTANRNINFVTEMFTSGTLRQYRLKHKRV----NIRAVKLWCRQILRGLLYLHSHD 145
++ I + E G L L+ +R IR V CRQ+L L +LHSH
Sbjct: 69 EAYFYENKLWI--LIEFCDGGALDSIMLELERGLTEPQIRYV---CRQMLEALNFLHSHK 123
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CVGTPEFMAPEVY----- 198
VIHRDLK NI + G+VK+ D G++A + + +GTP +MAPEV
Sbjct: 124 --VIHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180
Query: 199 -EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK-DPEVR 256
+ Y+ DI+S G+ ++E+ E P+ E +P ++ K++ + P K
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPPHHE-LNPMRVLLKILKSEPPTLDQPSKWSSSFN 239
Query: 257 RFVEKCLA-TVSLRLSARELLNDPFLQIDDCESNLRSL 293
F++ CL R +A ELL PF+ ++ L
Sbjct: 240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDL 277
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 83/270 (30%), Positives = 131/270 (48%), Gaps = 26/270 (9%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLER----LYCEIHLLKTL 80
R ++LG+GA VY +D G E+A VK F + ++ L CEI LLK L
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELA---VKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 81 KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLY 140
+H+ I+++Y D + ++ E G+++ + + + + RQIL G+ Y
Sbjct: 62 QHERIVQYYGCLRD--DETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEY 119
Query: 141 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG----LAAILRKSHAAHCV-GTPEFMAP 195
LHS+ ++HRD+K NI + G VK+GD G L I V GTP +M+P
Sbjct: 120 LHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 196 EVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYK---KVVSGKKPDSLYRVK 251
EV E Y D++S G ++EM+T + P++E A I+K + + + P +
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV---- 232
Query: 252 DPEVRRFVEKCLA-TVSLRLSARELLNDPF 280
P+ R F+ + R SA ELL F
Sbjct: 233 SPDARNFLRRTFVENAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 91/270 (33%), Positives = 135/270 (50%), Gaps = 23/270 (8%)
Query: 23 YGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPED-LERLYCEIHLLKTLK 81
Y R E++G+GA VYR G VA +K+ + L +P+D + + E+ LL L+
Sbjct: 3 YQRL-ELIGRGAYGAVYRGKHVPTGRVVA---LKIIN-LDTPDDDVSDIQREVALLSQLR 57
Query: 82 H---KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGL 138
NI K+Y S++ I + E G++R +K + + + + R++L L
Sbjct: 58 QSQPPNITKYYGSYLKGPRLWI--IMEYAEGGSVRTL-MKAGPIAEKYISVIIREVLVAL 114
Query: 139 LYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC--VGTPEFMAPE 196
Y+H VIHRD+K NI V N G VK+ D G+AA+L ++ + VGTP +MAPE
Sbjct: 115 KYIHKV--GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE 171
Query: 197 VYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLY-RVKDP 253
V E Y+ DI+S G+ I EM T PYS+ A ++ KP L
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPYSD--VDAFRAMMLIPKSKPPRLEDNGYSK 229
Query: 254 EVRRFVEKCLATV-SLRLSARELLNDPFLQ 282
+R FV CL RLSA ELL +++
Sbjct: 230 LLREFVAACLDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 100/285 (35%), Positives = 150/285 (52%), Gaps = 25/285 (8%)
Query: 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
DP +Y R+ +I G+GAS TVY A D G EVA Q+ L Q P+ E + EI ++
Sbjct: 16 DPKKKYTRFEKI-GQGASGTVYTAIDIATGQEVAIKQMNLQ---QQPKK-ELIINEILVM 70
Query: 78 KTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRG 137
+ K+ NI+ + S++ + V E G+L + ++ + CR+ L+
Sbjct: 71 RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQA 127
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAAHCVGTPEFMAP 195
L +LHS+ VIHRD+K DNI + G G VK+ D G A + +S + VGTP +MAP
Sbjct: 128 LDFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 196 EVY-EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254
EV +AY VDI+S G+ +EMV E PY +P + + + P+ +++PE
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPE----LQNPE 239
Query: 255 -----VRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSL 293
R F+ +CL V R SA+ELL PFL++ S+L L
Sbjct: 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTPL 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 73/262 (27%), Positives = 107/262 (40%), Gaps = 36/262 (13%)
Query: 25 RYNEILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL 80
+ LG+GA VY+ E +VA VK S E+ E E ++K L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVA---VKTLKEGASEEEREEFLEEASIMKKL 58
Query: 81 KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGL 138
H NI++ V T + VTE G L + L+ + L QI +G+
Sbjct: 59 SHPNIVRLLG--VCTQGEPLYIVTEYMPGGDLLDF-LRKHGEKLTLKDLLQMALQIAKGM 115
Query: 139 LYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAAHCVGTPE---FMA 194
YL S +HRDL N V VKI D GL+ I + G +MA
Sbjct: 116 EYLESK--NFVHRDLAARNCLV-TENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA 172
Query: 195 PEVYEEA-YNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PD 245
PE ++ + D++SFG+ + E+ T E PY + ++ + + G + PD
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLELLEDGYRLPRPENCPD 231
Query: 246 SLYRV------KDPEVR-RFVE 260
LY + DPE R F E
Sbjct: 232 ELYELMLQCWAYDPEDRPTFSE 253
|
Length = 258 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 90/269 (33%), Positives = 128/269 (47%), Gaps = 31/269 (11%)
Query: 29 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKF 88
+LGKG VY A D + +A ++ D ++ L+ EI L LKH+NI+++
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERD----SRYVQPLHEEIALHSYLKHRNIVQY 70
Query: 89 YTSWVDTANRNINFVTEMFTSGTLRQYRLKHK----RVNIRAVKLWCRQILRGLLYLHSH 144
S D+ N E G+L L+ K + N + + + +QIL GL YLH +
Sbjct: 71 LGS--DSENGFFKIFMEQVPGGSLSAL-LRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127
Query: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLG----LAAILRKSHAAHCVGTPEFMAPEVYEE 200
++HRD+K DN+ VN G VKI D G LA I GT ++MAPEV ++
Sbjct: 128 Q--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDK 183
Query: 201 ---AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK----PDSLYRVKDP 253
Y DI+S G I+EM T + P+ E P KV K P+SL
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESL----SA 239
Query: 254 EVRRFVEKCLA-TVSLRLSARELLNDPFL 281
E + F+ +C R SA +LL DPFL
Sbjct: 240 EAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 99/285 (34%), Positives = 149/285 (52%), Gaps = 25/285 (8%)
Query: 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
DP +Y R+ +I G+GAS TVY A D G EVA Q+ L Q P+ E + EI ++
Sbjct: 17 DPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEILVM 71
Query: 78 KTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRG 137
+ K+ NI+ + S++ + V E G+L + ++ + CR+ L+
Sbjct: 72 RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQA 128
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAAHCVGTPEFMAP 195
L +LHS+ VIHRD+K DNI + G G VK+ D G A + +S + VGTP +MAP
Sbjct: 129 LEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 196 EVY-EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254
EV +AY VDI+S G+ +EM+ E PY +P + + + P+ +++PE
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPE----LQNPE 240
Query: 255 -----VRRFVEKCL-ATVSLRLSARELLNDPFLQIDDCESNLRSL 293
R F+ +CL V R SA+ELL FL+I S+L L
Sbjct: 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPL 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 80/263 (30%), Positives = 132/263 (50%), Gaps = 11/263 (4%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKL-YDFLQSPEDLERLYCEIHLLKTLKHK 83
R ++LG+GA VY +D G E+A QV D ++ +++ L CEI LLK L+H
Sbjct: 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS 143
I+++Y D + ++ E G+++ + + + + RQIL+G+ YLHS
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-----HCVGTPEFMAPEVY 198
+ ++HRD+K NI + + G VK+GD G + ++ + GTP +M+PEV
Sbjct: 125 N--MIVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 199 E-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257
E Y D++S ++EM+T + P++E A I+K KP V D R
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD-ACRD 240
Query: 258 FVEKCLATVSLRLSARELLNDPF 280
F+++ R +A LL PF
Sbjct: 241 FLKQIFVEEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 83/260 (31%), Positives = 129/260 (49%), Gaps = 19/260 (7%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC--EIHLLKTLKHKNIMK 87
LGKG+ +VY+ + A +V L S ER EI +L ++ H NI+
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDL----GSMSQKEREDAVNEIRILASVNHPNIIS 63
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHKRVNIRAVKLW--CRQILRGLLYLHS 143
+ +++D + V E G L + + K KR I ++W Q+LRGL LH
Sbjct: 64 YKEAFLD--GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYE-EAY 202
++HRDLK NI + N VKIGDLG++ +L+K+ A +GTP +MAPEV++ Y
Sbjct: 122 QK--ILHRDLKSANILLVAN-DLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPY 178
Query: 203 NELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKC 262
+ DI+S G + EM TF P+ E + KV GK P + + +++ F+
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYP-PIPPIYSQDLQNFIRSM 236
Query: 263 LAT-VSLRLSARELLNDPFL 281
L LR + ++L P +
Sbjct: 237 LQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-29
Identities = 87/272 (31%), Positives = 139/272 (51%), Gaps = 30/272 (11%)
Query: 29 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPED-----LERLYCEIHLLKTLKHK 83
++G G+ +VY + G +A QV+L S +D L+ L EI LLK L+H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 84 NIMKFYTSWVDTANRNI--NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYL 141
NI+++ S +D + NI +V + L Y + + V+ + RQIL+GL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFVRQILKGLNYL 122
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--------RKSHAAHCVGTPEFM 193
H+ +IHRD+K NI V+ N+G +KI D G++ L G+ +M
Sbjct: 123 HNRG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 194 APEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYK--KVVSGKKPDSLYRV 250
APEV ++ +Y DI+S G ++EM+T ++P+ +CT I+K + S + P ++
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNI--- 236
Query: 251 KDPEVRRFVEKCLAT-VSLRLSARELLNDPFL 281
E F+EK + R +A ELL PFL
Sbjct: 237 -SSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 84/287 (29%), Positives = 135/287 (47%), Gaps = 37/287 (12%)
Query: 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
DPTG + E++G+G VY+A + G VA +K+ D + ++ E + E ++L
Sbjct: 3 DPTGIFELV-EVIGEGTYGKVYKARHKKTGQLVA---IKIMDII--EDEEEEIKEEYNIL 56
Query: 78 KTL-KHKNIMKFYTSWVDTANRN----INFVTEMFTSGT----LRQYRLKHKRVNIRAVK 128
+ H NI FY +++ + V E+ G+ ++ R K KR+ +
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116
Query: 129 LWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--C 186
R+ LRGL YLH + VIHRD+K NI + N EVK+ D G++A L +
Sbjct: 117 YILRETLRGLAYLHENK--VIHRDIKGQNILLTKN-AEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 187 VGTPEFMAPEV------YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS 240
+GTP +MAPEV + +Y+ D++S G+ +E+ + P + HP + K+
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD-MHPMRALFKIPR 232
Query: 241 GKKPDSLYRVKDPE-----VRRFVEKCLA-TVSLRLSARELLNDPFL 281
P +K PE F+ +CL R ELL PF+
Sbjct: 233 NPPP----TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 118 bits (295), Expect = 1e-28
Identities = 80/348 (22%), Positives = 132/348 (37%), Gaps = 39/348 (11%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLY--DFLQSPEDLERLYCEIHLLKTLKH-KN 84
LG+G+ VY A D VA +K+ +++ER EI +L +L H N
Sbjct: 6 RKLGEGSFGEVYLARDR---KLVA---LKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQY---RLKHKRVNIRAVKLWCRQILRGLLYL 141
I+K Y + D ++ V E G+L + ++ QIL L YL
Sbjct: 60 IVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--------AAHCVGTPEFM 193
HS +IHRD+K +NI ++ + VK+ D GLA +L + VGTP +M
Sbjct: 118 HSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 194 APEVY----EEAYNELVDIYSFGMCILEMVTFEYPY---SECTHPAQIYKKVVSGKKPDS 246
APEV + DI+S G+ + E++T P+ + +Q K ++ P
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 247 LYRVK-------DPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDDCESNLRSLDYSRE 298
+ ++K LA RLS+ L+ L + + S +
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPD 295
Query: 299 LDDMDPLIRQPHIDFHHIDNSFSNGCANGYGYDTPSEWGYSPVEVESN 346
L P ++ + + D + S+
Sbjct: 296 DSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSS 343
|
Length = 384 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 87/300 (29%), Positives = 129/300 (43%), Gaps = 68/300 (22%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLE-------RLYCEIHLLKTL 80
E LG+G VY+A D+ G VA +++L + E R EI LLK L
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLD------NEEEGIPSTALR---EISLLKEL 55
Query: 81 KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKR--VNIRAVKLWCRQILRGL 138
KH NI+K V R + V E + L++Y L + ++ +K Q+LRGL
Sbjct: 56 KHPNIVKLLD--VIHTERKLYLVFE-YCDMDLKKY-LDKRPGPLSPNLIKSIMYQLLRGL 111
Query: 139 LYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR---KSHAAHCVGTPEFM-- 193
Y HSH ++HRDLK NI +N + G +K+ D GLA +++ T E +
Sbjct: 112 AYCHSHR--ILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTY------THEVVTL 162
Query: 194 ---APEVY--EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQI-------------- 234
APE+ + Y+ VDI+S G EM+T + + + Q+
Sbjct: 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222
Query: 235 ---------YKKVVSGKKPDSLYRV---KDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281
YK P L +V DPE + K L + R+SA+E L P+
Sbjct: 223 WPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 68/262 (25%), Positives = 107/262 (40%), Gaps = 44/262 (16%)
Query: 28 EILGKGASKTVYRAFDEYEGI-----EVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
+ LG+GA VY+ + +G EVA +K S E+ + E ++K L H
Sbjct: 1 KKLGEGAFGEVYKG--KLKGKDGKTTEVAVKTLKEDA---SEEERKDFLKEARVMKKLGH 55
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVK---------LWCRQ 133
N+++ V T + V E G L Y K + V K + Q
Sbjct: 56 PNVVRLLG--VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 134 ILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAAHCVGTPE- 191
I +G+ YL S +HRDL N V + VKI D GL+ + + G
Sbjct: 114 IAKGMEYLASK--KFVHRDLAARNCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLP 170
Query: 192 --FMAPEVYEE-AYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK---- 243
+MAPE ++ + D++SFG+ + E+ T PY + ++ + + G +
Sbjct: 171 IRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-NEEVLEYLRKGYRLPKP 229
Query: 244 ---PDSLYRV------KDPEVR 256
PD LY + DPE R
Sbjct: 230 EYCPDELYELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 67/224 (29%), Positives = 111/224 (49%), Gaps = 17/224 (7%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC--EIHLLKTLKHKNI 85
+GKG+ V++ + + A Q+ L ER E +L L I
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDL----SKMNRREREEAIDEARVLAKLDSSYI 61
Query: 86 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLW--CRQILRGLLYLHS 143
+++Y S++D NI V E +G L + + + ++W QIL GL +LHS
Sbjct: 62 IRYYESFLDKGKLNI--VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AAHCVGTPEFMAPEVYEEA 201
++HRD+K N+F++ VKIGDLG+A +L + A VGTP +++PE+ E+
Sbjct: 120 KK--ILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 202 -YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP 244
YNE D+++ G+ + E T ++P+ A I K++ G P
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALI-LKIIRGVFP 219
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 79/249 (31%), Positives = 131/249 (52%), Gaps = 18/249 (7%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC--EIHLLKTLKH 82
R + +G+G VYRA +G+ VA +V+++D + + R C EI LLK L H
Sbjct: 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKA---RADCIKEIDLLKQLNH 61
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTL----RQYRLKHKRVNIRAVKLWCRQILRGL 138
N++K+Y S+++ + +N V E+ +G L + ++ + + + + V + Q+ L
Sbjct: 62 PNVIKYYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 139 LYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-RKSHAAHC-VGTPEFMAPE 196
++HS V+HRD+K N+F+ G VK+GDLGL K+ AAH VGTP +M+PE
Sbjct: 120 EHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 197 -VYEEAYNELVDIYSFGMCILEMVTFEYP-YSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254
++E YN DI+S G + EM + P Y + + + KK+ P E
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 236
Query: 255 VRRFVEKCL 263
+R+ V C+
Sbjct: 237 LRQLVNMCI 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 68/246 (27%), Positives = 110/246 (44%), Gaps = 28/246 (11%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLY-------DFLQSPEDLERLYCEIHLLKTLKH 82
LGKG+ V + G KLY + +++E E ++L + H
Sbjct: 1 LGKGSFGKVLLVRKKDTG--------KLYAMKVLKKKKIIKRKEVEHTLTERNILSRINH 52
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLH 142
I+K + ++ + V E G L + K R + + + +I+ L YLH
Sbjct: 53 PFIVKLHYAFQT--EEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLH 110
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC---VGTPEFMAPEVYE 199
S +I+RDLK +NI ++ G +K+ D GLA L S + GTPE++APEV
Sbjct: 111 SLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKEL-SSEGSRTNTFCGTPEYLAPEVLL 166
Query: 200 EA-YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRF 258
Y + VD +S G+ + EM+T + P+ +IY+K++ K P PE R
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKIL--KDPLRFPEFLSPEARDL 223
Query: 259 VEKCLA 264
+ L
Sbjct: 224 ISGLLQ 229
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 83/258 (32%), Positives = 137/258 (53%), Gaps = 18/258 (6%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFY 89
+G+G++ V A +++ G +VA VK+ D L+ + E L+ E+ +++ +H+N+++ Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVA---VKMMD-LRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 90 TSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVI 149
S++ + + E G L + R+N + C +L+ L YLHS VI
Sbjct: 85 KSYL--VGEELWVLMEFLQGGALTDI-VSQTRLNEEQIATVCESVLQALCYLHSQG--VI 139
Query: 150 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAAHCVGTPEFMAPEVYEEA-YNELV 206
HRD+K D+I + + G VK+ D G A + K VGTP +MAPEV Y V
Sbjct: 140 HRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 207 DIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPD--SLYRVKDPEVRRFVEKCLA 264
DI+S G+ ++EMV E PY + P Q K++ P + +++ P +R F+E+ L
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDS-PVQAMKRLRDSPPPKLKNAHKIS-PVLRDFLERMLT 256
Query: 265 TVSL-RLSARELLNDPFL 281
R +A+ELL+ PFL
Sbjct: 257 REPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 74/260 (28%), Positives = 123/260 (47%), Gaps = 14/260 (5%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFY 89
LG G S V + G +A VK + +++ E+ +L I+ FY
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMA---VKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 90 TSWVDTANRNINFVTEMFTSGTLRQ-YRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPV 148
++ + N +I+ E G+L + + R+ R + +L+GL YLH +
Sbjct: 66 GAFYN--NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH-EKHKI 122
Query: 149 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPE-VYEEAYNELVD 207
IHRD+K NI VN ++G++K+ D G++ L S A VGT +MAPE + Y+ D
Sbjct: 123 IHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSD 181
Query: 208 IYSFGMCILEMVTFEYPYSECTHPA----QIYKKVVSGKKPDSLYRVKDPEVRRFVEKCL 263
I+S G+ ++E+ T +PY P ++ + +V+ P P+ + FV CL
Sbjct: 182 IWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCL 241
Query: 264 -ATVSLRLSARELLNDPFLQ 282
R S +ELL PF++
Sbjct: 242 IKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 85/263 (32%), Positives = 134/263 (50%), Gaps = 24/263 (9%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFY 89
+G+G++ V A +++ G +VA VK D L+ + E L+ E+ +++ H+N++ Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVA---VKKMD-LRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 90 TSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVI 149
S++ + V E G L + H R+N + C +LR L YLH+ VI
Sbjct: 86 NSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQIATVCLSVLRALSYLHNQG--VI 140
Query: 150 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAAHCVGTPEFMAPEVYEE-AYNELV 206
HRD+K D+I + + G +K+ D G A + K VGTP +MAPEV Y V
Sbjct: 141 HRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 207 DIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE-----VRRFVEK 261
DI+S G+ ++EM+ E PY P Q +++ P RVKD +R F++
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPP----RVKDSHKVSSVLRGFLDL 254
Query: 262 CLA-TVSLRLSARELLNDPFLQI 283
L S R +A+ELL PFL++
Sbjct: 255 MLVREPSQRATAQELLQHPFLKL 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 81/273 (29%), Positives = 121/273 (44%), Gaps = 28/273 (10%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPED------LERLYCEIHLLKTLK 81
E++GKG VY A + G +A QV+L + D ++ L EI LK L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 82 HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYL 141
H NI+++ +T ++ E G++ + R + V+ + Q+L GL YL
Sbjct: 67 HLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-------CVGTPEFMA 194
HS ++HRDLK DN+ V+ G KI D G I +KS + G+ +MA
Sbjct: 125 HSKG--ILHRDLKADNLLVD-ADGICKISDFG---ISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 195 PEV---YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP----DSL 247
PEV Y + Y+ VDI+S G +LEM P+S+ A ++K P D
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238
Query: 248 YRVKDPEVRRFVEKCLATVSLRLSARELLNDPF 280
+ + R +ARELL PF
Sbjct: 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 94/316 (29%), Positives = 140/316 (44%), Gaps = 54/316 (17%)
Query: 14 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCE 73
F + DP + EI G G+ VY A D VA ++ Y QS E + + E
Sbjct: 8 FSKDDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKM-SYSGKQSNEKWQDIIKE 65
Query: 74 IHLLKTLKHKNIMKF-------YTSWVDTANRNINFVTEMF---TSGTLRQYRLKHKRVN 123
+ L+ L+H N +++ +T+W+ V E S L ++ + V
Sbjct: 66 VRFLQQLRHPNTIEYKGCYLREHTAWL---------VMEYCLGSASDILEVHKKPLQEVE 116
Query: 124 IRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 183
I A+ C L+GL YLHSH+ IHRD+K NI + G VK+ D G A++ S A
Sbjct: 117 IAAI---CHGALQGLAYLHSHE--RIHRDIKAGNILLTEP-GTVKLADFGSASL--VSPA 168
Query: 184 AHCVGTPEFMAPEVY----EEAYNELVDIYSFGMCILEMVTFEYPY------SECTHPAQ 233
VGTP +MAPEV E Y+ VD++S G+ +E+ + P S H AQ
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
Query: 234 IYKKVVSGKKPDSLYRVK-DPEVRRFVEKCLATVSL-RLSARELLNDPFLQIDDCESNL- 290
+L R FV+ CL + R S+ ELL F+ + + +
Sbjct: 229 --------NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVII 280
Query: 291 ----RSLDYSRELDDM 302
R+ D RELD++
Sbjct: 281 DLIQRTKDAVRELDNL 296
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 79/265 (29%), Positives = 127/265 (47%), Gaps = 27/265 (10%)
Query: 29 ILGKGA--SKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIM 86
+LGKGA T+YR ++ V W +V L L E + L EI +L L+H NI+
Sbjct: 7 VLGKGAFGEATLYRRTED--DSLVVWKEVNLTR-LSEKERRDALN-EIVILSLLQHPNII 62
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNI---RAVKLWCRQILRGLLYLHS 143
+Y ++D I E GTL ++ ++ + V + QI+ + Y+H
Sbjct: 63 AYYNHFMDDNTLLIEM--EYANGGTLYD-KIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAAHCVGTPEFMAPEVYEEA 201
++HRD+K NIF+ G +K+GD G++ IL S A VGTP +M+PE+ +
Sbjct: 120 AG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGV 176
Query: 202 -YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDP---EVRR 257
YN DI++ G + E++T + + + T+P + K+V G V E+
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNYTP----VVSVYSSELIS 231
Query: 258 FVEKCLAT-VSLRLSARELLNDPFL 281
V L R +A E+L+ P L
Sbjct: 232 LVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 6e-25
Identities = 74/291 (25%), Positives = 129/291 (44%), Gaps = 56/291 (19%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPED------LERLYCEIHLLKT 79
+I+G+G+ TV A ++ E A +K+ D L E +E+ E+ L +
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYA---IKILDKRQLIK-EKKVKYVKIEK---EV-LTRL 58
Query: 80 LKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLL 139
H I+K Y ++ D N+ FV E +G L QY K+ ++ + + + +IL L
Sbjct: 59 NGHPGIIKLYYTFQD--EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116
Query: 140 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--------------------- 178
YLHS +IHRDLK +NI ++ + +KI D G A +L
Sbjct: 117 YLHSKG--IIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 179 -RKSHAAHCVGTPEFMAPEVYEEAY-NELVDIYSFGMCIL-EMVTFEYPYSECTHPAQIY 235
+ A VGT E+++PE+ E + D+++ G CI+ +M+T + P+ +
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALG-CIIYQMLTGKPPFRGSNEY-LTF 231
Query: 236 KKVVSGKKPDSLYRVKDPE-VRRFVEKCLAT-----VSLRLSARELLNDPF 280
+K++ + + P + +EK L + + EL PF
Sbjct: 232 QKILKL---EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 72/205 (35%), Positives = 111/205 (54%), Gaps = 17/205 (8%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC--EIHLLKTLKHKNIMK 87
+G+G VYRA + VA +V++++ + + R C EI LLK L H N++K
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKA---RQDCVKEIDLLKQLNHPNVIK 66
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQ---YRLKHKR-VNIRAVKLWCRQILRGLLYLHS 143
+ S++ + +N V E+ +G L Q Y K KR + R V + Q+ + ++HS
Sbjct: 67 YLDSFI--EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS 124
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-RKSHAAHC-VGTPEFMAPE-VYEE 200
V+HRD+K N+F+ G VK+GDLGL K+ AAH VGTP +M+PE ++E
Sbjct: 125 RR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 201 AYNELVDIYSFGMCILEMVTFEYPY 225
YN DI+S G + EM + P+
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 80/269 (29%), Positives = 135/269 (50%), Gaps = 27/269 (10%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFY 89
LG GA VY+A ++ G+ A K+ D +S E+LE EI +L + H NI+K
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAA---AKVID-TKSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 90 TSWVDTANRNINFVTEMFTSGTLRQYRLKHKR-VNIRAVKLWCRQILRGLLYLHSHDPPV 148
++ N+ + E G + L+ +R + +++ C+Q L L YLH + +
Sbjct: 69 DAFY--YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH--ENKI 124
Query: 149 IHRDLKCDNIFVNGNQGEVKIGDLGLAA-----ILRKSHAAHCVGTPEFMAPEVY----- 198
IHRDLK NI + G++K+ D G++A I R+ +GTP +MAPEV
Sbjct: 125 IHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSF---IGTPYWMAPEVVMCETS 180
Query: 199 -EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK-DPEVR 256
+ Y+ D++S G+ ++EM E P+ E +P ++ K+ + P + E +
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239
Query: 257 RFVEKCL-ATVSLRLSARELLNDPFLQID 284
F++KCL V R + +LL PF+ ++
Sbjct: 240 DFLKKCLEKNVDARWTTTQLLQHPFVTVN 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 71/207 (34%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 25 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
RY + +G GA V AFD G +VA KL QS +R Y E+ LLK + H
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHMDH 73
Query: 83 KNI---MKFYTSWVDTANRNIN---FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILR 136
+N+ + +T ++ + VT L +K ++++ ++ QILR
Sbjct: 74 ENVIGLLDVFTP--ASSLEDFQDVYLVTH-LMGADLNNI-VKCQKLSDDHIQFLVYQILR 129
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPE 196
GL Y+HS +IHRDLK NI VN + E+KI D GLA + V T + APE
Sbjct: 130 GLKYIHSAG--IIHRDLKPSNIAVNED-CELKILDFGLARHTDDEMTGY-VATRWYRAPE 185
Query: 197 VYEE--AYNELVDIYSFGMCIL-EMVT 220
+ YN+ VDI+S G CI+ E++T
Sbjct: 186 IMLNWMHYNQTVDIWSVG-CIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 82/272 (30%), Positives = 130/272 (47%), Gaps = 30/272 (11%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLY--DFLQSPEDLERLYCEIHLLKTLKHKNI 85
E+LGKGA TVY +G +A QV+L + L + ++ E+L E+ LLK+LKH NI
Sbjct: 6 EVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 86 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHD 145
+++ + +D + I+ E G++ + + + +QIL G+ YLH++
Sbjct: 65 VQYLGTCLD--DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-------------ILRKSHAAHCVGTPEF 192
V+HRD+K +N+ + N G +K+ D G A +L+ H GTP +
Sbjct: 123 --VVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSMH-----GTPYW 174
Query: 193 MAPEVYEEA-YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP-DSLYRV 250
MAPEV E+ Y DI+S G + EM T + P + A ++ + + + L
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-YIGAHRGLMPRLPDS 233
Query: 251 KDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281
FV CL R SA +LL FL
Sbjct: 234 FSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 58/264 (21%), Positives = 108/264 (40%), Gaps = 17/264 (6%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQV-KLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKF 88
LG G V + + A V K + + E ++ E +L+ H I+K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ--EHIFSEKEILEECNHPFIVKL 58
Query: 89 YTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPV 148
Y ++ D + I + E G L + + + ++ YLH+ +
Sbjct: 59 YRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--I 114
Query: 149 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC-VGTPEFMAPEVYE-EAYNELV 206
I+RDLK +N+ ++ + G VK+ D G A L+ GTPE++APE+ + Y+ V
Sbjct: 115 IYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSV 173
Query: 207 DIYSFGMCILEMVTFEYPYSEC-THPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEK-CLA 264
D +S G+ + E++T P+ E P +IY ++ G D + +++
Sbjct: 174 DYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR 233
Query: 265 TVSLRL-----SARELLNDPFLQI 283
RL +++ +
Sbjct: 234 NPEERLGNLKGGIKDIKKHKWFNG 257
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 82/268 (30%), Positives = 131/268 (48%), Gaps = 16/268 (5%)
Query: 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
DP + + I GKG+ VY+ D VA +K+ D ++ +++E + EI +L
Sbjct: 1 DPEELFTKLERI-GKGSFGEVYKGIDNRTKEVVA---IKIIDLEEAEDEIEDIQQEITVL 56
Query: 78 KTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRG 137
I ++Y S++ I + E G+ LK + + R+IL+G
Sbjct: 57 SQCDSPYITRYYGSYLKGTKLWI--IMEYLGGGSALDL-LKPGPLEETYIATILREILKG 113
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CVGTPEFMAP 195
L YLHS IHRD+K N+ ++ QG+VK+ D G+A L + VGTP +MAP
Sbjct: 114 LDYLHSERK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 196 EVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254
EV ++ AY+ DI+S G+ +E+ E P S+ HP ++ ++ P +L
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNSD-LHPMRVL-FLIPKNSPPTLEGQYSKP 228
Query: 255 VRRFVEKCL-ATVSLRLSARELLNDPFL 281
+ FVE CL R +A+ELL F+
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 83/278 (29%), Positives = 137/278 (49%), Gaps = 20/278 (7%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E +GKG+ V++ D VA +K+ D ++ +++E + EI +L + K
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
+Y S++ + + + E G+ L+ ++ + R+IL+GL YLHS
Sbjct: 67 YYGSYLK--DTKLWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLHSEKK- 122
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CVGTPEFMAPEVYEE-AYNE 204
IHRD+K N+ ++ GEVK+ D G+A L + VGTP +MAPEV ++ AY+
Sbjct: 123 -IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 205 LVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCL- 263
DI+S G+ +E+ E P+SE HP ++ ++ P +L ++ FVE CL
Sbjct: 181 KADIWSLGITAIELAKGEPPHSE-LHPMKVL-FLIPKNNPPTLEGNYSKPLKEFVEACLN 238
Query: 264 ATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDD 301
S R +A+ELL F+ + Y EL D
Sbjct: 239 KEPSFRPTAKELLKHKFIV-----RFAKKTSYLTELID 271
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 89/340 (26%), Positives = 135/340 (39%), Gaps = 71/340 (20%)
Query: 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK 81
RY + +G GA V A D+ G +VA K+ + D +R+ EI LL+ L+
Sbjct: 1 RY-ELLKPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLR 57
Query: 82 HKNIMKFYTSWVDTANRNINF-----VTEMFTSGTLRQYRLKHKRV-NIRAVKLWCRQIL 135
H+NI+ + +F VTE+ + L + +K + ++ + QIL
Sbjct: 58 HENIIGLLD--ILRPPSPEDFNDVYIVTELMET-DLHKV-IKSPQPLTDDHIQYFLYQIL 113
Query: 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFM-- 193
RGL YLHS + VIHRDLK NI VN N ++KI D GLA + F+
Sbjct: 114 RGLKYLHSAN--VIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDED-----EKGFLTE 165
Query: 194 --------APEVY--EEAYNELVDIYSFGMCIL-EMVT----FEYPYSECTH-------- 230
APE+ Y + +DI+S G CI E++T F P +
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVG-CIFAELLTRKPLF--PGRDYIDQLNLIVEV 222
Query: 231 ---PAQ--------------IYKKVVSGKKP-DSLYRVKDPEVRRFVEKCLA-TVSLRLS 271
P++ + KKP L+ PE +EK L R++
Sbjct: 223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT 282
Query: 272 ARELLNDPFLQIDDCESNL---RSLDYSRELDDMDPLIRQ 308
A E L P+L + + DD + +
Sbjct: 283 ADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDELTEEE 322
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 70/199 (35%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 25 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
RY ++ +G GA V A D+ G VA K+ +P +R Y E+ LLK L+H
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLH 142
+NI+ ++ + +I FVTE+ GT L + + + ++ + QILRGL Y+H
Sbjct: 69 ENIISLSDIFI-SPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH 125
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVY--EE 200
S V+HRDLK NI +N N ++KI D GLA I + V T + APE+ +
Sbjct: 126 SAG--VVHRDLKPSNILINEN-CDLKICDFGLARI-QDPQMTGYVSTRYYRAPEIMLTWQ 181
Query: 201 AYNELVDIYSFGMCILEMV 219
Y+ VDI+S G EM+
Sbjct: 182 KYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 83/270 (30%), Positives = 132/270 (48%), Gaps = 19/270 (7%)
Query: 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
DP + +I G+G++ V A + G VA VK D L+ + E L+ E+ ++
Sbjct: 17 DPRTYLDNFIKI-GEGSTGIVCIATVKSSGKLVA---VKKMD-LRKQQRRELLFNEVVIM 71
Query: 78 KTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRG 137
+ +H+N+++ Y S++ + V E G L + H R+N + C +L+
Sbjct: 72 RDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLKA 128
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAAHCVGTPEFMAP 195
L LH+ VIHRD+K D+I + + G VK+ D G A + K VGTP +MAP
Sbjct: 129 LSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 185
Query: 196 EVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK--D 252
E+ Y VDI+S G+ ++EMV E PY P K++ P L +
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF--NEPPLKAMKMIRDNLPPKLKNLHKVS 243
Query: 253 PEVRRFVEKCLA-TVSLRLSARELLNDPFL 281
P ++ F+++ L + R +A ELL PFL
Sbjct: 244 PSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 4e-23
Identities = 76/261 (29%), Positives = 133/261 (50%), Gaps = 23/261 (8%)
Query: 29 ILGKGASKTVY---RAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC--EIHLLKTLKHK 83
++G+GA V+ R D+ I +K Q +D ERL E +LK L H
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVI------IKQIPVEQMTKD-ERLAAQNECQVLKLLSHP 59
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKR--VNIRAVKLWCRQILRGLLYL 141
NI+++Y ++++ ++ + V E GTL +Y K ++ + + QIL L ++
Sbjct: 60 NIIEYYENFLE--DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-RKSHAAHCVGTPEFMAPEVYE- 199
H+ ++HRDLK NI ++ ++ VKIGD G++ IL KS A VGTP +++PE+ E
Sbjct: 118 HTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG 175
Query: 200 EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259
+ YN+ DI++ G + E+ + + + PA + K++SG R P++R+ +
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAANLPA-LVLKIMSGTFAPISDRYS-PDLRQLI 233
Query: 260 EKCLAT-VSLRLSARELLNDP 279
L S R +++ P
Sbjct: 234 LSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 9e-23
Identities = 50/155 (32%), Positives = 78/155 (50%), Gaps = 7/155 (4%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCR 132
E +L+ L H ++ + S+ D N+ V ++ G LR + + + + VK W
Sbjct: 50 ERRILQELNHPFLVNLWYSFQD--EENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC 107
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-SHAAHCVGTPE 191
+I+ L YLHS +IHRD+K DNI ++ QG V I D +A + + GTP
Sbjct: 108 EIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPG 164
Query: 192 FMAPEVYEEA-YNELVDIYSFGMCILEMVTFEYPY 225
+MAPEV Y+ VD +S G+ E + + PY
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 68/205 (33%), Positives = 102/205 (49%), Gaps = 25/205 (12%)
Query: 25 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLER-LYCEIHLLKTLK 81
RY + LG+G VY+A D+ G VA ++KL + ++ + + EI LL+ LK
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 82 HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRA--VKLWCRQILRGLL 139
H NI+ V NIN V E F L + +K K + + +K + LRGL
Sbjct: 61 HPNIIGLLD--VFGHKSNINLVFE-FMETDLEKV-IKDKSIVLTPADIKSYMLMTLRGLE 116
Query: 140 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA------HCVGTPEFM 193
YLHS+ ++HRDLK +N+ + + G +K+ D GLA +S + H V T +
Sbjct: 117 YLHSNW--ILHRDLKPNNLLIASD-GVLKLADFGLA----RSFGSPNRKMTHQVVTRWYR 169
Query: 194 APEVY--EEAYNELVDIYSFGMCIL 216
APE+ Y VD++S G CI
Sbjct: 170 APELLFGARHYGVGVDMWSVG-CIF 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 86/291 (29%), Positives = 137/291 (47%), Gaps = 26/291 (8%)
Query: 16 EVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIH 75
++DP + E LG GA VY+A ++ G A ++ +S E+LE EI
Sbjct: 7 DLDPNEVWEIIGE-LGDGAFGKVYKAKNKETGALAAAKVIET----KSEEELEDYMVEIE 61
Query: 76 LLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKR-VNIRAVKLWCRQI 134
+L T H I+K ++ I + E G + L+ R + +++ CRQ+
Sbjct: 62 ILATCNHPYIVKLLGAFYWDGKLWI--MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQM 119
Query: 135 LRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA----ILRKSHAAHCVGTP 190
L L YLHS +IHRDLK N+ + G++K+ D G++A L++ + +GTP
Sbjct: 120 LEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSF--IGTP 174
Query: 191 EFMAPEVY------EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP 244
+MAPEV + Y+ DI+S G+ ++EM E P+ E +P ++ K+ + P
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEPP 233
Query: 245 DSLYRVK-DPEVRRFVEKCL-ATVSLRLSARELLNDPFLQIDDCESNLRSL 293
K E R F++ L R SA +LL PF+ LR L
Sbjct: 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLREL 284
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 64/201 (31%), Positives = 95/201 (47%), Gaps = 23/201 (11%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFY 89
+G+G VY+A D+ G VA ++KL +S + EI LLK L H NI+K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKL--RFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 90 TSWVDTANRNINFVTEMFTSGTL-----RQYRLKHKRVNIRAVKLWCRQILRGLLYLHSH 144
V ++ V E + RQ L + K + Q+L+GL + HSH
Sbjct: 65 D--VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLI-----KSYLYQLLQGLAFCHSH 117
Query: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA--HCVGTPEFMAPEVYEEA- 201
++HRDLK +N+ +N G +K+ D GLA H V T + APE+
Sbjct: 118 G--ILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 202 -YNELVDIYSFGMCIL-EMVT 220
Y+ VDI+S G CI E+++
Sbjct: 175 GYSTPVDIWSVG-CIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 3e-22
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 34/210 (16%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC--------EIHLLKT 79
+G+G VY+A ++ G VA ++++ E EI LL+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRM----------ENEKEGFPITAIREIKLLQK 54
Query: 80 LKHKNIMKFYTSWVDTANRNINFVTEMFT---SGTLRQYRLKHKRVNIRAVKLWCRQILR 136
L+H NI++ +I V E +G L +K +K + +Q+L
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIKCYMKQLLE 111
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC---VGTPEFM 193
GL YLHS+ ++HRD+K NI +N N G +K+ D GLA K ++A V T +
Sbjct: 112 GLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVITLWYR 168
Query: 194 APEVY--EEAYNELVDIYSFGMCIL-EMVT 220
PE+ Y VD++S G CIL E+
Sbjct: 169 PPELLLGATRYGPEVDMWSVG-CILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 7e-22
Identities = 68/296 (22%), Positives = 137/296 (46%), Gaps = 32/296 (10%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
LG+GA +V + + G+ A +K +P+ +++ E+ + K+ K I+K
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFA---LKTITTDPNPDLQKQILRELEINKSCKSPYIVK 63
Query: 88 FYTSWVDTANRNINFVTEMFTSGTL----RQYRLKHKRVNIRAVKLWCRQILRGLLYLHS 143
+Y +++D ++ +I E G+L ++ + + R+ + + +L+GL YLHS
Sbjct: 64 YYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPE-VYEEAY 202
+IHRD+K NI + +G+VK+ D G++ L S A GT +MAPE + + Y
Sbjct: 124 RK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPY 180
Query: 203 NELVDIYSFGMCILEMVTFEYPY----SECTHPAQIYKKVVSGKKPD-----SLYRVKDP 253
+ D++S G+ +LE+ +P+ P ++ +V+ P+
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSE 240
Query: 254 EVRRFVEKCLATVSL-RLSARELLNDPFLQIDDCESNLRSLDYSRELDDMDPLIRQ 308
E + F+++CL R + ++L P++ ++ +M + Q
Sbjct: 241 EFKDFIKQCLEKDPTRRPTPWDMLEHPWI-----------KAQMKKKVNMAKFVAQ 285
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 82/287 (28%), Positives = 137/287 (47%), Gaps = 23/287 (8%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84
+Y EILG G TVY+A+ +A VK+ + E +++ E+ +L
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILA---VKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIR-AVKLWCRQILRGLLYLHS 143
I+ FY ++ NR I+ TE G+L YR + V R AV +++GL YL S
Sbjct: 61 IIGFYGAFF-VENR-ISICTEFMDGGSLDVYRKIPEHVLGRIAVA-----VVKGLTYLWS 113
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPE-VYEEAY 202
++HRD+K N+ VN +G+VK+ D G++ L S A VGT +MAPE + E Y
Sbjct: 114 LK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQY 170
Query: 203 NELVDIYSFGMCILEMVTFEYPYSECTH------PAQIYKKVVSGKKPDSLYRVKDPEVR 256
D++S G+ +E+ +PY + P Q+ + +V P +
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230
Query: 257 RFVEKCLATV-SLRLSARELLNDPFL-QIDDCESNLRSLDYSRELDD 301
F+ +C+ R + L++ PF+ Q +D + + S+ R L++
Sbjct: 231 HFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVVSMWVCRALEE 277
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 14/216 (6%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNI---RAVKL 129
E LL LKH NI+ + SW + ++ F G ++LK ++ + V
Sbjct: 49 EAQLLSQLKHPNIVAYRESW--EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVE 106
Query: 130 WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AAHCV 187
W QI L YLH + ++HRDLK N+F+ +K+GDLG+A +L A+ +
Sbjct: 107 WFVQIAMALQYLH--EKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLI 163
Query: 188 GTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDS 246
GTP +M+PE++ + YN D+++ G C+ EM T ++ ++ + +Y +++ GK P
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY-RIIEGKLP-P 221
Query: 247 LYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFL 281
+ + PE+ + L+ R S + +L P++
Sbjct: 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 55/173 (31%), Positives = 95/173 (54%), Gaps = 12/173 (6%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCR 132
E +L++++H ++ Y S+ D + N+ V E G L + K R + +
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQD--DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA 108
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF 192
Q++ L YLHS D +++RDLK +N+ + + G +KI D G A ++ C GTPE+
Sbjct: 109 QVVLALEYLHSLD--IVYRDLKPENLLL-DSDGYIKITDFGFAKRVKGRTYTLC-GTPEY 164
Query: 193 MAPEVYE-EAYNELVDIYSFGMCILEMVTFEYP--YSECTHPAQIYKKVVSGK 242
+APE+ + Y + VD ++ G+ I EM+ YP + + +P QIY+K++ GK
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLA-GYPPFFDD--NPIQIYEKILEGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 1e-21
Identities = 78/265 (29%), Positives = 129/265 (48%), Gaps = 25/265 (9%)
Query: 30 LGKGASKTVYRAFD----EYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNI 85
LGKG+ TVY D E ++V ++ + + +P + + E LL L H I
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVL-KEIPVGEL--NPNETVQANQEAQLLSKLDHPAI 64
Query: 86 MKFYTSWVDTANRNINFVTEMFTSG-----TLRQYRLKHKRVNIRAVKLWCRQILRGLLY 140
+KF+ S+++ +TE + G L + + K ++ V W Q+L G+ Y
Sbjct: 65 VKFHASFLE--RDAFCIITE-YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 141 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAAHCVGTPEFMAPEVY 198
+H ++HRDLK NIF+ N +KIGD G++ +L S A GTP +M+PE
Sbjct: 122 MHQRR--ILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177
Query: 199 E-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257
+ + Y+ DI+S G + EM + + E + + ++V G P SL ++
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSVVLRIVEGPTP-SLPETYSRQLNS 235
Query: 258 FVEKCL-ATVSLRLSARELLNDPFL 281
++ L SLR SA E+L +PF+
Sbjct: 236 IMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSP-EDLERLYCEIHLLKTLKHKNIM 86
+ +G+G+ +Y A + + +K D + P ++ E E+ LL +KH NI+
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCV---IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV 62
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKR---VNIRAVKLWCRQILRGLLYLHS 143
F+ S+ + N + V E G L + R+ +R + + W QI GL H
Sbjct: 63 TFFASFQE--NGRLFIVMEYCDGGDLMK-RINRQRGVLFSEDQILSWFVQISLGLK--HI 117
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AAHCVGTPEFMAPEVYE-E 200
HD ++HRD+K NIF++ N K+GD G+A L S A CVGTP +++PE+ +
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR 177
Query: 201 AYNELVDIYSFGMCILEMVTFEYPY 225
YN DI+S G + E+ T ++P+
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 8e-21
Identities = 83/288 (28%), Positives = 137/288 (47%), Gaps = 21/288 (7%)
Query: 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
DP + + I GKG+ V++ D VA +K+ D ++ +++E + EI +L
Sbjct: 1 DPEELFTKLERI-GKGSFGEVFKGIDNRTQQVVA---IKIIDLEEAEDEIEDIQQEITVL 56
Query: 78 KTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRG 137
+ K+Y S++ I + E G+ L+ + + ++IL+G
Sbjct: 57 SQCDSPYVTKYYGSYLKGTKLWI--IMEYLGGGSALDL-LRAGPFDEFQIATMLKEILKG 113
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CVGTPEFMAP 195
L YLHS IHRD+K N+ ++ QG+VK+ D G+A L + VGTP +MAP
Sbjct: 114 LDYLHSEKK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 196 EVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254
EV ++ AY+ DI+S G+ +E+ E P S+ HP ++ + P +L
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSD-MHPMRVLFLIPKNNPP-TLTGEFSKP 228
Query: 255 VRRFVEKCL-ATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDD 301
+ F++ CL S R +A+ELL F+ N + Y EL D
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELLKHKFIV-----KNAKKTSYLTELID 271
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 27/217 (12%)
Query: 24 GRYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK 81
RY ++ LG G++ V+ A D VA ++ L P+ ++ EI +++ L
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI----VLTDPQSVKHALREIKIIRRLD 60
Query: 82 HKNIMKFYTSWVDTANRNINFVTEMFTSGTL---RQYR-------LKHKRVNIRAVKLWC 131
H NI+K Y + + V + ++ ++Y L+ ++ +L+
Sbjct: 61 HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFM 120
Query: 132 RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-----RKSHAAHC 186
Q+LRGL Y+HS + V+HRDLK N+F+N +KIGD GLA I+ K + +
Sbjct: 121 YQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 187 VGTPEFMAPEV--YEEAYNELVDIYSFGMCIL-EMVT 220
+ T + +P + Y + +D+++ G CI EM+T
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 2e-19
Identities = 94/316 (29%), Positives = 147/316 (46%), Gaps = 41/316 (12%)
Query: 8 EPDCSE-FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPED 66
+P+ +E F + DP + EI G G+ VY A D VA ++ Y QS E
Sbjct: 11 DPEIAELFFKEDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMS-YSGKQSNEK 68
Query: 67 LERLYCEIHLLKTLKHKNIMKF-------YTSWVDTANRNINFVTEM---FTSGTLRQYR 116
+ + E+ L+ +KH N +++ +T+W+ V E S L ++
Sbjct: 69 WQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL---------VMEYCLGSASDLLEVHK 119
Query: 117 LKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176
+ V I A+ L+GL YLHSH+ +IHRD+K NI + G+VK+ D G A+
Sbjct: 120 KPLQEVEIAAIT---HGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSAS 173
Query: 177 ILRKSHAAHCVGTPEFMAPEVY----EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPA 232
I S A VGTP +MAPEV E Y+ VD++S G+ +E+ + P +
Sbjct: 174 IA--SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 231
Query: 233 QIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLATVSL-RLSARELLNDPFLQIDDCESNL- 290
+Y + + P R FV+ CL + R ++ ELL F+ + E+ L
Sbjct: 232 ALY-HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLI 290
Query: 291 ----RSLDYSRELDDM 302
R+ D RELD++
Sbjct: 291 DLIQRTKDAVRELDNL 306
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 20/222 (9%)
Query: 22 RYGRYNEILGKGASKTV----YRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
R+ ++ + LGKG +V Y + G VA +++ + + D ER EI +L
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-HSTAEHLRDFER---EIEIL 59
Query: 78 KTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILR 136
K+L+H NI+K+ RN+ V E G+LR Y KH+ R++ R + L+ QI +
Sbjct: 60 KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK 119
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPE----- 191
G+ YL S +HRDL NI V ++ VKIGD GL +L + + V P
Sbjct: 120 GMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176
Query: 192 FMAPE-VYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPA 232
+ APE + E ++ D++SFG+ + E+ F Y C+ PA
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYEL--FTYSDKSCSPPA 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 81/280 (28%), Positives = 131/280 (46%), Gaps = 26/280 (9%)
Query: 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
DP G + E++G G VY+ G A +K+ D + E E + EI++L
Sbjct: 13 DPAGIF-ELVEVVGNGTYGQVYKGRHVKTGQLAA---IKVMDVTEDEE--EEIKLEINML 66
Query: 78 KTLKH-KNIMKFYTSWVDTA----NRNINFVTEMFTSGTLRQYRLKHKRVNIRA--VKLW 130
K H +NI +Y +++ + + + V E +G++ K ++ +
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI 126
Query: 131 CRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CVG 188
CR+ILRGL +LH+H VIHRD+K N+ + N EVK+ D G++A L ++ +G
Sbjct: 127 CREILRGLAHLHAHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIG 183
Query: 189 TPEFMAPEVY------EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK 242
TP +MAPEV + Y+ DI+S G+ +EM P + HP + +
Sbjct: 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNP 242
Query: 243 KPDSLYRVKDPEVRRFVEKCLATVSL-RLSARELLNDPFL 281
P + + F+E CL L R S +LL PF+
Sbjct: 243 PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 64/237 (27%), Positives = 117/237 (49%), Gaps = 15/237 (6%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFY 89
+G G V+ D A + + + ++ ++ + ++ E +LK + H I++ +
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE-QHVHNEKRVLKEVSHPFIIRLF 67
Query: 90 TSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVI 149
+ D R + + E G L Y R + + +I+ L YLHS + ++
Sbjct: 68 WTEHD--QRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IV 123
Query: 150 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYE-EAYNELVDI 208
+RDLK +NI ++ +G +K+ D G A LR C GTPE++APEV + + +N+ VD
Sbjct: 124 YRDLKPENILLD-KEGHIKLTDFGFAKKLRDRTWTLC-GTPEYLAPEVIQSKGHNKAVDW 181
Query: 209 YSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK--PDSLYRVKDPEVRRFVEKCL 263
++ G+ I EM+ P+ + P IY+K+++GK P L D + ++K L
Sbjct: 182 WALGILIYEMLVGYPPFFDDN-PFGIYEKILAGKLEFPRHL----DLYAKDLIKKLL 233
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 4e-19
Identities = 90/310 (29%), Positives = 146/310 (47%), Gaps = 29/310 (9%)
Query: 8 EPDCSE-FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPED 66
+PD +E F + DP + EI G G+ VY A D VA ++ Y QS E
Sbjct: 1 DPDVAELFFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNEK 58
Query: 67 LERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKR----V 122
+ + E+ L+ L+H N +++ ++ + ++ + G+ HK+ V
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYL---REHTAWLVMEYCLGSASDLLEVHKKPLQEV 115
Query: 123 NIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 182
I AV L+GL YLHSH+ +IHRD+K NI ++ G VK+GD G A+I+ +
Sbjct: 116 EIAAVT---HGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIM--AP 167
Query: 183 AAHCVGTPEFMAPEVY----EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKV 238
A VGTP +MAPEV E Y+ VD++S G+ +E+ + P + +Y +
Sbjct: 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HI 226
Query: 239 VSGKKPDSLYRVKDPEVRRFVEKCLATVSL-RLSARELLNDPFLQIDDCESNL-----RS 292
+ P R FV+ CL + R ++ LL F+ + + + R+
Sbjct: 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRT 286
Query: 293 LDYSRELDDM 302
D RELD++
Sbjct: 287 KDAVRELDNL 296
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 25/231 (10%)
Query: 68 ERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK--RVNIR 125
+++ E +L + ++K Y S+ +N+ V E G L L ++
Sbjct: 38 DQVLTERDILSQAQSPYVVKLYYSF--QGKKNLYLVMEYLPGGDL--ASLLENVGSLDED 93
Query: 126 AVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---------- 175
+++ +I+ L YLHS+ +IHRDLK DNI ++ N G +K+ D GL+
Sbjct: 94 VARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQIN 150
Query: 176 AILRKSHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQI 234
+ VGTP+++APEV + +++ VD +S G + E + P+ T P +I
Sbjct: 151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-PEEI 209
Query: 235 YKKVVSGKKPDSLYRVKDPEVRRFVEKCL-ATVSLRL---SARELLNDPFL 281
++ +++GK E + K L RL S E+ N PF
Sbjct: 210 FQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 7e-19
Identities = 93/317 (29%), Positives = 140/317 (44%), Gaps = 46/317 (14%)
Query: 25 RYNEIL--GKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
RY ++ G GA TV A D G +VA KLY QS +R Y E+ LLK +KH
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMKH 73
Query: 83 KNIMKFYTSWVDTANRNI----NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGL 138
+N++ V T + ++ +F M GT +KH++++ ++ Q+L+GL
Sbjct: 74 ENVIGLLD--VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131
Query: 139 LYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVY 198
Y+H+ +IHRDLK N+ VN E+KI D GLA + V T + APEV
Sbjct: 132 KYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQTDSEMTGYVV-TRWYRAPEVI 187
Query: 199 EE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQI---------------------- 234
Y + VDI+S G + EM+T + + H Q+
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247
Query: 235 ----YKKVVSGKKPD--SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL-QIDDC 286
KK+ +K D SL +P +EK L R++A E L P+ + D
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307
Query: 287 ESNLRSLDYSRELDDMD 303
E + Y D++D
Sbjct: 308 EDETEAPPYDDSFDEVD 324
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 74/212 (34%), Positives = 100/212 (47%), Gaps = 37/212 (17%)
Query: 27 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLE-------RLYCEIHLLKT 79
EI G+GA TVY+A D G VA +V++ P E R EI LLK
Sbjct: 5 AEI-GEGAYGTVYKARDLNTGRFVALKKVRV------PLSEEGIPLSTLR---EIALLKQ 54
Query: 80 LK---HKNIMKFYTSWVDTANRN-----INFVTEMFTSGTLRQYRLKHKRVNI--RAVKL 129
L+ H NI++ V R + V E L Y K + + +K
Sbjct: 55 LESFEHPNIVRLLD--VCHGPRTDRELKLTLVFE-HVDQDLATYLSKCPKPGLPPETIKD 111
Query: 130 WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-RKSHAAHCVG 188
RQ+LRG+ +LHSH ++HRDLK NI V + G+VKI D GLA I + V
Sbjct: 112 LMRQLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVV 168
Query: 189 TPEFMAPEVY-EEAYNELVDIYSFGMCIL-EM 218
T + APEV + +Y VD++S G CI E+
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVG-CIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 67/224 (29%), Positives = 110/224 (49%), Gaps = 19/224 (8%)
Query: 22 RYGRYNEILGKGASKTVYRA----FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
R+ ++ + LG+G V + G +VA + Q D ER EI +L
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER---EIEIL 60
Query: 78 KTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILR 136
+TL H+NI+K+ R++ + E SG+LR Y +H+ ++N++ + L+ QI +
Sbjct: 61 RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICK 120
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPE----- 191
G+ YL S IHRDL NI V ++ VKI D GLA +L + + V P
Sbjct: 121 GMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 192 FMAPE-VYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQI 234
+ APE + ++ D++SFG+ + E+ F Y + PA+
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYEL--FTYGDPSQSPPAEF 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 79/281 (28%), Positives = 131/281 (46%), Gaps = 28/281 (9%)
Query: 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
DP G + E++G G VY+ G A +K+ D E E + EI++L
Sbjct: 3 DPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAA---IKVMDVTGDEE--EEIKQEINML 56
Query: 78 KTLKH-KNIMKFYTSWVDT----ANRNINFVTEMFTSGTLRQYRLKHKRVNI---RAVKL 129
K H +NI +Y +++ + + V E +G++ +K+ + N +
Sbjct: 57 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL-IKNTKGNTLKEEWIAY 115
Query: 130 WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CV 187
CR+ILRGL +LH H VIHRD+K N+ + N EVK+ D G++A L ++ +
Sbjct: 116 ICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFI 172
Query: 188 GTPEFMAPEVY------EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG 241
GTP +MAPEV + Y+ D++S G+ +EM P + HP + +
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRN 231
Query: 242 KKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281
P + + + F+E CL S R + +L+ PF+
Sbjct: 232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 91/316 (28%), Positives = 146/316 (46%), Gaps = 41/316 (12%)
Query: 8 EPDCSE-FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPED 66
+P+ ++ F + DP + +EI G G+ VY A + + VA ++ Y Q+ E
Sbjct: 7 DPEIADLFYKDDPEEIFVGLHEI-GHGSFGAVYFATNSHTNEVVAVKKMS-YSGKQTNEK 64
Query: 67 LERLYCEIHLLKTLKHKNIMKF-------YTSWVDTANRNINFVTEM---FTSGTLRQYR 116
+ + E+ L+ LKH N +++ +T+W+ V E S L ++
Sbjct: 65 WQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL---------VMEYCLGSASDLLEVHK 115
Query: 117 LKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176
+ V I A+ L+GL YLHSH+ +IHRD+K NI + G+VK+ D G A+
Sbjct: 116 KPLQEVEIAAIT---HGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSAS 169
Query: 177 ILRKSHAAHCVGTPEFMAPEVY----EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPA 232
S A VGTP +MAPEV E Y+ VD++S G+ +E+ + P +
Sbjct: 170 KS--SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 227
Query: 233 QIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLATVSL-RLSARELLNDPFLQIDDCESNL- 290
+Y + P R FV+ CL + R ++ ELL F++ D L
Sbjct: 228 ALY-HIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLI 286
Query: 291 ----RSLDYSRELDDM 302
R+ D RELD++
Sbjct: 287 DLIQRTKDAVRELDNL 302
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 59/170 (34%), Positives = 91/170 (53%), Gaps = 12/170 (7%)
Query: 62 QSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKR 121
+S +E E LL +KH NI+ F S+ A+ ++ V E G L Q ++K +R
Sbjct: 37 KSSSAVEDSRKEAVLLAKMKHPNIVAFKESF--EADGHLYIVMEYCDGGDLMQ-KIKLQR 93
Query: 122 VNI---RAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178
+ + W Q+ G+ H H+ V+HRD+K NIF+ N G+VK+GD G A +L
Sbjct: 94 GKLFPEDTILQWFVQMCLGVQ--HIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLL 150
Query: 179 RKSHAAHC--VGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPY 225
A C VGTP ++ PE++E YN DI+S G + E+ T ++P+
Sbjct: 151 TSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 69/199 (34%), Positives = 109/199 (54%), Gaps = 19/199 (9%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS-PEDLERLYCEIHLLKTLKHKNIM 86
E +G+G TV++A + VA +V+L D + P R EI LLK LKHKNI+
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKHKNIV 62
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHD 145
+ Y V +++ + V E + L++Y + ++ VK + Q+L+GL + HSH+
Sbjct: 63 RLYD--VLHSDKKLTLVFE-YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAAHCVGTPEFMAPEVYEEA- 201
V+HRDLK N+ +N N GE+K+ D GLA I + ++A V T + P+V A
Sbjct: 120 --VLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAK 175
Query: 202 -YNELVDIYSFGMCIL-EM 218
Y+ +D++S G CI E+
Sbjct: 176 LYSTSIDMWSAG-CIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 54/156 (34%), Positives = 79/156 (50%), Gaps = 9/156 (5%)
Query: 134 ILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC-VGTPEF 192
I++ L YLHS VIHRD+K N+ +N G+VK+ D G++ L S A G +
Sbjct: 112 IVKALEYLHSK-LSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPY 169
Query: 193 MAPE-----VYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSL 247
MAPE + ++ Y+ D++S G+ ++E+ T +PY P Q K+VV P
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP 229
Query: 248 YRVKDPEVRRFVEKCLATVS-LRLSARELLNDPFLQ 282
PE + FV KCL R + ELL PF +
Sbjct: 230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 5e-18
Identities = 69/209 (33%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 26 YNEI--LGKGASKTVYRAFDEYEGIEVAWNQVK--LYDFLQSPEDLERLYCEIHLLKTLK 81
Y I LG G +VY A ++ G VA ++K Y S E+ L E+ L+ L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY----SWEECMNLR-EVKSLRKLN 55
Query: 82 -HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHKRVNIRAVKLWCRQILRGL 138
H NI+K + + N + FV E + G L Q K K + ++ QIL+GL
Sbjct: 56 EHPNIVKLKEVFRE--NDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGL 112
Query: 139 LYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAAHCVGTPEFMAPE 196
++H H HRDLK +N+ V+G VKI D GLA +R + + V T + APE
Sbjct: 113 AHIHKHG--FFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPPYTDY-VSTRWYRAPE 168
Query: 197 VY--EEAYNELVDIYSFGMCIL-EMVTFE 222
+ +Y+ VDI++ G CI+ E+ T
Sbjct: 169 ILLRSTSYSSPVDIWALG-CIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-18
Identities = 76/261 (29%), Positives = 124/261 (47%), Gaps = 20/261 (7%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFY 89
+G G VY+A + G A +KL + ED + EI ++K KH NI+ ++
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKL----EPGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 90 TSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVI 149
S++ I E G+L+ ++ + R+ L+GL YLHS +
Sbjct: 73 GSYLRRDKLWICM--EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK--M 128
Query: 150 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CVGTPEFMAPEV----YEEAYN 203
HRD+K NI + N G VK+ D G++A + + A +GTP +MAPEV + YN
Sbjct: 129 HRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 204 ELVDIYSFGMCILEMVTFEYPYSECTHPAQ-IYKKVVSGKKPDSLY-RVK-DPEVRRFVE 260
+L DI++ G+ +E+ + P + HP + ++ S +P L ++K FV+
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFD-LHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVK 246
Query: 261 KCLA-TVSLRLSARELLNDPF 280
L R +A +LL PF
Sbjct: 247 MALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 59/191 (30%), Positives = 99/191 (51%), Gaps = 19/191 (9%)
Query: 63 SPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRV 122
SP++ E E+ +L +KH NI+++ S+ + N I V + G L +K++
Sbjct: 39 SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYI--VMDYCEGGDL------YKKI 90
Query: 123 NI-RAVKLWCRQILRGLLYL-----HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176
N R V QIL + + H HD ++HRD+K NIF+ G +K+GD G+A
Sbjct: 91 NAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT-KDGTIKLGDFGIAR 149
Query: 177 ILRKSH--AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQ 233
+L + A C+GTP +++PE+ E YN DI++ G + EM T ++ + E +
Sbjct: 150 VLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF-EAGNMKN 208
Query: 234 IYKKVVSGKKP 244
+ K++ G P
Sbjct: 209 LVLKIIRGSYP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 71/230 (30%), Positives = 111/230 (48%), Gaps = 26/230 (11%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCR 132
EI++LKTL H+NI+K+ + + + + E G+LR Y KHK +N+ + L+ +
Sbjct: 56 EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQ 114
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVG---- 188
QI G+ YLHS IHRDL N+ ++ N VKIGD GLA + + H + V
Sbjct: 115 QICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 189 TPEF-MAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYS-------ECTHPAQIYKKVV 239
+P F A E +E ++ D++SFG+ + E++T E P Q VV
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV 231
Query: 240 S----GKKPDSLYRVKD--PEVRRFVEKCLAT-VSLRLSARELLNDPFLQ 282
++ L K+ EV ++ C T R + R L+ P L+
Sbjct: 232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI--PILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 16/208 (7%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFY 89
+G G VY+A + + G A +KL + +D + EI ++K KH NI+ ++
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKL----EPGDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 90 TSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVI 149
S++ + + E G+L+ ++ + CR+ L+GL YLHS +
Sbjct: 73 GSYL--SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK--M 128
Query: 150 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CVGTPEFMAPEVY----EEAYN 203
HRD+K NI + N G+VK+ D G+AA + + A +GTP +MAPEV YN
Sbjct: 129 HRDIKGANILLTDN-GDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 204 ELVDIYSFGMCILEMVTFEYPYSECTHP 231
+L DI++ G+ +E+ + P + HP
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFD-LHP 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 62/247 (25%), Positives = 114/247 (46%), Gaps = 29/247 (11%)
Query: 29 ILGKGASKTVY----RAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLK-TLKHK 83
+LGKG+ V + +E+ I+ V L D +D+E E +L +H
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED-----DDVECTMVERRVLALAWEHP 56
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS 143
+ + ++ ++ FV E G L + R + + + +I+ GL +LH
Sbjct: 57 FLTHLFCTF--QTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA--ILRKSHAAHCVGTPEFMAPEVYE-E 200
+I+RDLK DN+ ++ G +KI D G+ + + A+ GTP+++APE+ + +
Sbjct: 115 KG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 201 AYNELVDIYSFGMCILEMVTFEYPYSEC---------THPAQIYKKVVSGKKPDSLYR-- 249
YNE VD +SFG+ + EM+ + P+ + + + +S + D L +
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLF 231
Query: 250 VKDPEVR 256
+DP R
Sbjct: 232 ERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 3e-17
Identities = 74/246 (30%), Positives = 119/246 (48%), Gaps = 18/246 (7%)
Query: 25 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
RY + +G GA +V AFD G+ VA KL QS +R Y E+ LLK +KH
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 75
Query: 83 KNIMKFYTSWVDTAN----RNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGL 138
+N++ + + ++ VT + G +K +++ V+ QILRGL
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 133
Query: 139 LYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVY 198
Y+HS D +IHRDLK N+ VN E+KI D GLA + V T + APE+
Sbjct: 134 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMTGY-VATRWYRAPEIM 189
Query: 199 EE--AYNELVDIYSFGMCILEMVTFE--YPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254
YN+ VDI+S G + E++T +P ++ ++ ++V + L ++
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249
Query: 255 VRRFVE 260
R +++
Sbjct: 250 ARNYIQ 255
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-17
Identities = 52/171 (30%), Positives = 90/171 (52%), Gaps = 8/171 (4%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCR 132
E +L L H I+ S+ D + F+ E G L + K R K +
Sbjct: 68 EKSILMELSHPFIVNMMCSFQD--ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA 125
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF 192
+++ YLHS D +I+RDLK +N+ ++ N+G VK+ D G A + C GTPE+
Sbjct: 126 ELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDRTFTLC-GTPEY 181
Query: 193 MAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK 242
+APEV + + + + VD ++ G+ + E + P+ + T P +IY+K+++G+
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-PFRIYEKILAGR 231
|
Length = 329 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 24/281 (8%)
Query: 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
DPT + E +GKG VY+ ++ +G A VK+ D + + E + E ++L
Sbjct: 19 DPTDTW-EIIETIGKGTYGKVYKVTNKKDGSLAA---VKILDPISDVD--EEIEAEYNIL 72
Query: 78 KTL-KHKNIMKFYTSWVDT---ANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQ 133
++L H N++KFY + + V E+ G++ + R +
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 134 ILRGLLY--LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CVGT 189
IL G L H H+ +IHRD+K +NI + +G VK+ D G++A L + VGT
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGT 191
Query: 190 PEFMAPEV------YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK 243
P +MAPEV Y+ +Y+ D++S G+ +E+ + P + HP + K+
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD-MHPVKTLFKIPRNPP 250
Query: 244 PDSLYRVK-DPEVRRFVEKCL-ATVSLRLSARELLNDPFLQ 282
P L+ K F+ +CL R S LL PF++
Sbjct: 251 PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-17
Identities = 67/271 (24%), Positives = 123/271 (45%), Gaps = 26/271 (9%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLER-LYCEIHLLKTLKHKNIMKF 88
LG G +V + G +A V + + + + + E+ ++ + I+ F
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVV----HIGAKSSVRKQILRELQIMHECRSPYIVSF 68
Query: 89 YTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS-HDPP 147
Y +++ NI E G+L + K + + + ++ GL YL++ H
Sbjct: 69 YGAFL--NENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR-- 124
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPE-VYEEAYNELV 206
++HRD+K NI VN +G++K+ D G++ L S A VGT +M+PE + Y
Sbjct: 125 IMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKS 183
Query: 207 DIYSFGMCILEMVTFEYPYSE-------CTHPAQIY---KKVVSGKKPDSLYRVKDPEV- 255
D++S G+ I+E+ ++P++ P I +++V + P L PE
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPPRLPSSDFPEDL 242
Query: 256 RRFVEKCL-ATVSLRLSARELL-NDPFLQID 284
R FV+ CL + R + ++L PF+Q
Sbjct: 243 RDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS-PEDLERLYCEIHLLKTLKHKNIM 86
E +G+G VY+A D+ G VA +++L + P R EI LLK L H NI+
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---EISLLKELNHPNIV 61
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHKRVNIRAVKLWCRQILRGLLYLHSH 144
+ V + + V E F L++Y ++ +K + Q+L+G+ Y HSH
Sbjct: 62 RLLD--VVHSENKLYLVFE-FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI----LRKSHAAHCVGTPEFMAPEVY-- 198
V+HRDLK N+ ++ +G +K+ D GLA +R H V T + APE+
Sbjct: 119 R--VLHRDLKPQNLLID-REGALKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLG 173
Query: 199 EEAYNELVDIYSFGMCIL-EMVT 220
Y+ VDI+S G CI EMV
Sbjct: 174 SRQYSTPVDIWSIG-CIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 53/177 (29%), Positives = 94/177 (53%), Gaps = 13/177 (7%)
Query: 70 LYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK-RVNIRAVK 128
L EI +L+ L H+NI+K+ + I + E SG+L++Y ++K ++N++
Sbjct: 53 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL 112
Query: 129 LWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV- 187
+ QI +G+ YL S +HRDL N+ V ++ +VKIGD GL + + V
Sbjct: 113 KYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVK 169
Query: 188 ---GTPEF-MAPE-VYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVV 239
+P F APE + + + D++SFG+ + E++T Y SE + P ++ K++
Sbjct: 170 DDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT--YCDSESS-PMTLFLKMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 68/271 (25%), Positives = 122/271 (45%), Gaps = 33/271 (12%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPED--LERLYCEIHLLKTLKHKNIMK 87
LGKG +VY+ G+ +A +++L ++ ++ E+ +L I+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRL-----ELDESKFNQIIMELDILHKAVSPYIVD 63
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQY---RLKHKRVNIRAVKLWCRQILRGLLYLHSH 144
FY ++ + E +G+L + + + + ++ +++GL +L
Sbjct: 64 FYGAF--FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL-KE 120
Query: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEE---- 200
+ +IHRD+K N+ VNGN G+VK+ D G++ L S A +G +MAPE +
Sbjct: 121 EHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPN 179
Query: 201 ---AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS------GKKPDSLYRVK 251
Y D++S G+ ILEM YPY P + Y + + P +L
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPY-----PPETYANIFAQLSAIVDGDPPTLPSGY 234
Query: 252 DPEVRRFVEKCLATV-SLRLSARELLNDPFL 281
+ + FV KCL + + R + +LL P+L
Sbjct: 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKL-YDFLQSPEDLERLYCEIHLLKTLKHKNIM 86
E +G+G VY+A ++ G VA +++L + P R EI LLK L H NI+
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 62
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYR--LKHKRVNIRAVKLWCRQILRGLLYLHSH 144
K V + V E F L+++ + + +K + Q+L+GL + HSH
Sbjct: 63 KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAAHCVGTPEFMAPEVY--E 199
V+HRDLK N+ +N +G +K+ D GLA + +++ H V T + APE+
Sbjct: 120 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGC 175
Query: 200 EAYNELVDIYSFGMCILEMVT 220
+ Y+ VDI+S G EMVT
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 64/228 (28%), Positives = 95/228 (41%), Gaps = 35/228 (15%)
Query: 16 EVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLY--CE 73
+ RY + LG+G V +A+D G VA +VK+ + +L C
Sbjct: 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62
Query: 74 IH--------LLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIR 125
IH ++ +KH+NIM +V+ IN V ++ + L++ + R+
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYVEGD--FINLVMDIM-ASDLKKVVDRKIRLTES 119
Query: 126 AVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA------AILR 179
VK QIL GL LH +HRDL NIF+N ++G KI D GLA
Sbjct: 120 QVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSD 176
Query: 180 KSHAAHCVGTPEFMAPEV----YE--------EAYNELVDIYSFGMCI 215
+ E M +V Y E Y+ VD++S G CI
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG-CI 223
|
Length = 335 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 59/168 (35%), Positives = 89/168 (52%), Gaps = 24/168 (14%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ-----YRLKHKRVNIRAV 127
EI LL+ LKH+N++ +++ A++++ + + + L Q + K + V
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFD-YAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 128 K--LWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGN---QGEVKIGDLGLAAILRK-- 180
K LW QIL G+ YLHS+ V+HRDLK NI V G +G VKIGDLGLA +
Sbjct: 111 KSLLW--QILNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 181 ---SHAAHCVGTPEFMAPEVYEEA--YNELVDIYSFGMCIL-EMVTFE 222
+ V T + APE+ A Y + +DI++ G CI E++T E
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG-CIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 66/202 (32%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E LG+G TVY+ + G VA ++ L +P R EI L+K LKH+NI++
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHENIVR 62
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKR---VNIRAVKLWCRQILRGLLYLHSH 144
+ + T N+ + V E + L++Y H ++ VK + Q+L+G+ + H +
Sbjct: 63 LHDV-IHTENK-LMLVFE-YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAAHCVGTPEFMAPEVY--E 199
V+HRDLK N+ +N +GE+K+ D GLA I + + V T + AP+V
Sbjct: 120 R--VLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGS 175
Query: 200 EAYNELVDIYSFGMCIL-EMVT 220
Y+ +DI+S G CI+ EM+T
Sbjct: 176 RTYSTSIDIWSVG-CIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 28/205 (13%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC----EIHLLKTLKHK 83
+ LG+G+ TVY+ + G VA +++L E E E LLK LKH
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRL-------EHEEGAPFTAIREASLLKDLKHA 63
Query: 84 NIMKFYTSWVDT--ANRNINFVTEMFTSGTLRQYRLKHKR-VNIRAVKLWCRQILRGLLY 140
NI+ + D + + V E + L+QY +++ V+L+ Q+LRGL Y
Sbjct: 64 NIVTLH----DIIHTKKTLTLVFE-YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118
Query: 141 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAAHCVGTPEFMAPEV 197
H V+HRDLK N+ ++ +GE+K+ D GLA ++ K++ ++ V T + P+V
Sbjct: 119 CHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTY-SNEVVTLWYRPPDV 174
Query: 198 Y--EEAYNELVDIYSFGMCILEMVT 220
Y+ +D++ G EM T
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 73/276 (26%), Positives = 129/276 (46%), Gaps = 35/276 (12%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIM 86
E +GKG V++ ++ G + A VK+ D + + E + E ++LK L H N++
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAA---VKILDPIHDID--EEIEAEYNILKALSDHPNVV 78
Query: 87 KFYTSWVDTANRN---INFVTEMFTSGTL----RQYRLKHKRVNIRAVKLWCRQILRGLL 139
KFY + +N + V E+ G++ + + + +R+ + + L GL
Sbjct: 79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138
Query: 140 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CVGTPEFMAPEV 197
+LH + IHRD+K +NI + +G VK+ D G++A L + VGTP +MAPEV
Sbjct: 139 HLHVNK--TIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195
Query: 198 ------YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK 251
+ Y+ D++S G+ +E+ + P ++ HP + K+ P +
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD-LHPMRALFKIPRNPPP----TLH 250
Query: 252 DPEV-----RRFVEKCLAT-VSLRLSARELLNDPFL 281
PE+ F+ KCL R + +LL F+
Sbjct: 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 65/254 (25%), Positives = 120/254 (47%), Gaps = 25/254 (9%)
Query: 28 EILGKGASKTVYRAFDEYEGIE-VAWNQVKLY------DFLQSPEDLERLYCEIHLLK-T 79
E LG GA VY+ + G +A ++ ++ D + + + + E+ ++K
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 80 LKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHKRVNIRAVKLWCR--QIL 135
L+H NI+++Y ++++ N + V ++ L ++ LK K+ ++W Q++
Sbjct: 66 LRHPNIVRYYKTFLE--NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-RKSHAAHCVGTPEFMA 194
L YLH + ++HRDL +NI + G +V I D GLA +S VGT +
Sbjct: 124 LALRYLHK-EKRIVHRDLTPNNIML-GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSC 181
Query: 195 PEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK---PDSLYRV 250
PE+ + E Y E D+++FG + +M T + P+ T+ + K+V P+ +Y
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEGMYSE 240
Query: 251 KDPEVRRFVEKCLA 264
V + CL
Sbjct: 241 D---VTDVITSCLT 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 22/213 (10%)
Query: 25 RYNEILGKGASKTVYRAFDEYEG----IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL 80
++LG GA TVY+ EG I VA +K+ SP+ + + E +++ ++
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVA---IKVLREETSPKANKEILDEAYVMASV 66
Query: 81 KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGL 138
H ++++ + + +T++ G L Y +++ + NI + L WC QI +G+
Sbjct: 67 DHPHVVRLLGI---CLSSQVQLITQLMPLGCLLDY-VRNHKDNIGSQYLLNWCVQIAKGM 122
Query: 139 LYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-RKSHAAHCVG--TP-EFMA 194
YL ++HRDL N+ V Q VKI D GLA +L H G P ++MA
Sbjct: 123 SYLEEKR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179
Query: 195 PE-VYEEAYNELVDIYSFGMCILEMVTF-EYPY 225
E + Y D++S+G+ + E++TF PY
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 69/252 (27%), Positives = 113/252 (44%), Gaps = 28/252 (11%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQV-KLYDFLQSPEDLERLYCEIHLLKTLKHKNIM 86
E +G GA V A D G +VA ++ +D + R E+ +L+ KH NI+
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAK---RTLRELKILRHFKHDNII 67
Query: 87 KFYTSWVDTAN--RNINFVTEMFTSGTLRQYRLKHKR--VNIRAVKLWCRQILRGLLYLH 142
+++ V ++ S + + H + ++ + Q+LRGL Y+H
Sbjct: 68 AIRDILRPPGADFKDVYVVMDLMESDL---HHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC------VGTPEFMAPE 196
S + VIHRDLK N+ VN + E++IGD G+A L S H V T + APE
Sbjct: 125 SAN--VIHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 197 ---VYEEAYNELVDIYSFGMCIL-EMVTFE--YPYSECTHPAQIYKKVVSGKKPDSLYRV 250
E Y +D++S G CI EM+ +P H ++ V+ + L R+
Sbjct: 182 LLLSLPE-YTTAIDMWSVG-CIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239
Query: 251 KDPEVRRFVEKC 262
VR++++
Sbjct: 240 GSDRVRKYIQNL 251
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 76/299 (25%), Positives = 127/299 (42%), Gaps = 62/299 (20%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLE------RLYCEIHLLKTLK 81
++G+GA V + ++ G VA +K F +S +D + R E+ +L+ L+
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVA---IK--KFKESEDDEDVKKTALR---EVKVLRQLR 58
Query: 82 HKNIMKFYTSWVDTANRN--INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLL 139
H+NI+ + R + V E L + AV+ + Q+L+ +
Sbjct: 59 HENIVNL----KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIA 114
Query: 140 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC---VGTPEFMAPE 196
Y HSH+ +IHRD+K +NI V+ + G +K+ D G A LR A+ V T + APE
Sbjct: 115 YCHSHN--IIHRDIKPENILVSES-GVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171
Query: 197 --VYEEAYNELVDIYSFGMCIL-EMVTFE--YPYSECTH--------------PAQIY-- 235
V + Y + VD+++ G CI+ E++ E +P + P+
Sbjct: 172 LLVGDTNYGKPVDVWAIG-CIMAELLDGEPLFP-GDSDIDQLYLIQKCLGPLPPSHQELF 229
Query: 236 --------KKVVSGKKPDSL---YRVK-DPEVRRFVEKCLAT-VSLRLSARELLNDPFL 281
+P+SL Y K F++ CL RL+ ELL P+
Sbjct: 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 3e-15
Identities = 72/209 (34%), Positives = 102/209 (48%), Gaps = 33/209 (15%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKF 88
LGKGA V++A D VA K++D ++ D +R + EI L+ L H NI+K
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALK--KIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 89 YTSWVDTA--NRNINFVTE-MFT--SGTLRQYRLK--HKRVNIRAVKLWCRQILRGLLYL 141
V A +++I V E M T +R L+ HKR + Q+L+ L Y+
Sbjct: 73 LN--VIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMY-------QLLKALKYI 123
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC-------VGTPEFMA 194
HS + VIHRDLK NI +N + VK+ D GLA L + V T + A
Sbjct: 124 HSGN--VIHRDLKPSNILLNSD-CRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180
Query: 195 PEVY--EEAYNELVDIYSFGMCIL-EMVT 220
PE+ Y + VD++S G CIL EM+
Sbjct: 181 PEILLGSTRYTKGVDMWSVG-CILGEMLL 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 49/174 (28%), Positives = 85/174 (48%), Gaps = 12/174 (6%)
Query: 59 DFLQSPEDLERLYCEIHLLKTL---KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY 115
+ + +++E L CE + +T +H ++ + + T + + FV E G L +
Sbjct: 35 GDIIARDEVESLMCEKRIFETANSERHPFLVNLF-ACFQTEDH-VCFVMEYAAGGDLMMH 92
Query: 116 RLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175
+ + + ++ GL YLH + +++RDLK DN+ ++ +G VKI D GL
Sbjct: 93 -IHTDVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLC 148
Query: 176 --AILRKSHAAHCVGTPEFMAPEVY-EEAYNELVDIYSFGMCILEMVTFEYPYS 226
+ + GTPEF+APEV E +Y VD + G+ I EM+ E P+
Sbjct: 149 KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 36/212 (16%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC-----EIHLLKTLKH 82
+G+GA V A + G++VA ++ SP + + +C EI +L+ KH
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKI-------SPFE-HQTFCQRTLREIKILRRFKH 62
Query: 83 KNIMKFY----TSWVDTANRNINFVTE-MFTSGTLRQYRL-KHKRVNIRAVKLWCRQILR 136
+NI+ ++ N ++ V E M T Y+L K + ++ ++ + QILR
Sbjct: 63 ENIIGILDIIRPPSFESFN-DVYIVQELMETD----LYKLIKTQHLSNDHIQYFLYQILR 117
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-----AHCVGTPE 191
GL Y+HS + V+HRDLK N+ +N N ++KI D GLA I H V T
Sbjct: 118 GLKYIHSAN--VLHRDLKPSNLLLNTN-CDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 192 FMAPEVY--EEAYNELVDIYSFGMCIL-EMVT 220
+ APE+ + Y + +DI+S G CIL EM++
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVG-CILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 63/236 (26%), Positives = 96/236 (40%), Gaps = 43/236 (18%)
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS- 143
I+ FY ++ + I+ E G+L Q K R+ + +LRGL YL
Sbjct: 61 IVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK 118
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYE-EAY 202
H ++HRD+K NI VN GE+K+ D G++ L S A VGT +M+PE + Y
Sbjct: 119 HK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 203 NELVDIYSFGMCILEMVTFEYP--------------------------------YSECTH 230
DI+S G+ ++EM YP +
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235
Query: 231 PAQIYK---KVVSGKKPDSLYRVKDPEVRRFVEKCLATV-SLRLSARELLNDPFLQ 282
P I++ +V+ P E + FV+KCL R +EL PF++
Sbjct: 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 29 ILGKGASKTV----YRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHK 83
+LGKG+ V + DE ++V V L D +D+E E +L KH
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD-----DDVECTMTEKRVLALAGKHP 56
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS 143
+ + + S T +R + FV E G L + + R + + + +I+ GL +LH
Sbjct: 57 FLTQLH-SCFQTKDR-LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE 114
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAAHCVGTPEFMAPEVY-EE 200
+I+RDLK DN+ ++ +G +KI D G+ IL + GTP+++APE+ +
Sbjct: 115 RG--IIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ 171
Query: 201 AYNELVDIYSFGMCILEMVTFEYPY 225
Y VD ++ G+ + EM+ + P+
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 33/207 (15%)
Query: 63 SPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRV 122
P+D E ++K L+H +++ Y V T I VTE+ G+L +Y L+
Sbjct: 44 DPKDFLA---EAQIMKKLRHPKLIQLYA--VCTLEEPIYIVTELMKYGSLLEY-LQGGAG 97
Query: 123 NIRAVKL-----WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177
RA+KL Q+ G+ YL + + IHRDL N+ V G K+ D GLA +
Sbjct: 98 --RALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLV-GENNICKVADFGLARV 152
Query: 178 LRKSHAAHCVGTP---EFMAPEVYEEAYNELV---DIYSFGMCILEMVTF-EYPYSECTH 230
+++ G ++ APE YN D++SFG+ + E+VT+ PY T+
Sbjct: 153 IKEDIYEAREGAKFPIKWTAPEAAL--YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210
Query: 231 PAQIYKKVVSGKK-------PDSLYRV 250
A++ ++V G + P LY +
Sbjct: 211 -AEVLQQVDQGYRMPCPPGCPKELYDI 236
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKL-YDFLQSPEDLERLYCEIHLLKTLKHKNIM 86
E +G+G VY+A D+ G VA + +L D P R EI LL+ L +
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR---EISLLQMLSESIYI 63
Query: 87 KFYTSWVDTANRN----INFVTEMFTSGTLRQYRLKHKRVNIR-----AVKLWCRQILRG 137
+N + V E + L+++ + R R +K + Q+L+G
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFE-YLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAAHCVGTPEFMA 194
+ + H H V+HRDLK N+ V+ +G +KI DLGL +I KS+ H + T + A
Sbjct: 123 VAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY-THEIVTLWYRA 179
Query: 195 PEVYEEA--YNELVDIYSFGMCILEMVT 220
PEV + Y+ VDI+S G EM
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 7e-15
Identities = 76/271 (28%), Positives = 122/271 (45%), Gaps = 31/271 (11%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC-EIHLLKTLKHK 83
R N I G GA TVY+ G A + + + + R C EI +L+ + H
Sbjct: 78 RVNRI-GSGAGGTVYKVIHRPTGRLYALKVI----YGNHEDTVRRQICREIEILRDVNHP 132
Query: 84 NIMKFYTSWVDTANRN--INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYL 141
N++K + D + N I + E G+L + ++ + RQIL G+ YL
Sbjct: 133 NVVKCH----DMFDHNGEIQVLLEFMDGGSLEGTHIADEQ----FLADVARQILSGIAYL 184
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AAHCVGTPEFMAPE--- 196
H ++HRD+K N+ +N + VKI D G++ IL ++ VGT +M+PE
Sbjct: 185 HRRH--IVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERIN 241
Query: 197 --VYEEAYNELV-DIYSFGMCILE--MVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK 251
+ AY+ DI+S G+ ILE + F + A + + + P++
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAP-ATA 300
Query: 252 DPEVRRFVEKCL-ATVSLRLSARELLNDPFL 281
E R F+ CL + R SA +LL PF+
Sbjct: 301 SREFRHFISCCLQREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 8e-15
Identities = 73/246 (29%), Positives = 118/246 (47%), Gaps = 18/246 (7%)
Query: 25 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
RY + +G GA +V A+D +VA KL QS R Y E+ LLK +KH
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVK--KLSRPFQSLIHARRTYRELRLLKHMKH 73
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRL----KHKRVNIRAVKLWCRQILRGL 138
+N++ V T +I E++ L L K ++++ V+ Q+LRGL
Sbjct: 74 ENVIGLLD--VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGL 131
Query: 139 LYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVY 198
Y+HS +IHRDLK N+ VN E++I D GLA + V T + APE+
Sbjct: 132 KYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLARQADDEMTGY-VATRWYRAPEIM 187
Query: 199 EE--AYNELVDIYSFGMCILEMVTFE--YPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254
YN+ VDI+S G + E++ + +P ++ + +VV P+ L ++
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247
Query: 255 VRRFVE 260
R++++
Sbjct: 248 ARKYIQ 253
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 28/255 (10%)
Query: 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK 81
RY + E++GKG+ V A D + G +VA K+ D + D R+ EI LL+ L+
Sbjct: 1 RY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KINDVFEHVSDATRILREIKLLRLLR 57
Query: 82 HKNIMKFYTSWVDTANR---NINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGL 138
H +I++ + + R +I V E+ S L Q + + + + Q+LR L
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 139 LYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---------AILRKSHAAHCVGT 189
Y+H+ + V HRDLK NI N + ++KI D GLA AI + V T
Sbjct: 117 KYIHTAN--VFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDY----VAT 169
Query: 190 PEFMAPEV---YEEAYNELVDIYSFGMCILEMVTFE--YPYSECTHPAQIYKKVVSGKKP 244
+ APE+ + Y +DI+S G E++T + +P H + ++ P
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229
Query: 245 DSLYRVKDPEVRRFV 259
+++ RV++ + RR++
Sbjct: 230 ETISRVRNEKARRYL 244
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 86/305 (28%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFY 89
+G GA V+ D +G VA K+ + Q+ +R++ E+ +L KH N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALK--KMPNVFQNLVSCKRVFRELKMLCFFKHDNVL--- 62
Query: 90 TSWVDTANR-NINFVTEMFTSGTLRQYRLKHK------RVNIRAVKLWCRQILRGLLYLH 142
S +D +I+ E++ L Q L HK ++ VK++ QILRGL YLH
Sbjct: 63 -SALDILQPPHIDPFEEIYVVTELMQSDL-HKIIVSPQPLSSDHVKVFLYQILRGLKYLH 120
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI--LRKS-HAAHCVGTPEFMAPEVYE 199
S ++HRD+K N+ VN N +KI D GLA + +S H V T + APE+
Sbjct: 121 SAG--ILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILM 177
Query: 200 EA--YNELVDIYSFGMCI-------------------LEMVT-------FEYPYSECTHP 231
+ Y VDI+S G CI L+++T E S C
Sbjct: 178 GSRHYTSAVDIWSVG-CIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236
Query: 232 -AQIYKKVVSGKKPDSLYRVKDP---EVRRFVEKCLA-TVSLRLSARELLNDPFLQIDDC 286
A I + LY + E + + L R+SA + L P+L
Sbjct: 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD---- 292
Query: 287 ESNLR 291
E LR
Sbjct: 293 EGRLR 297
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 31/208 (14%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC-EIHLLKTLKHKNIM 86
E +G+G VY+A D +A +++L Q E + EI LLK ++H NI+
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLE---QEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 87 KFYTSWVDTANRNINFVTE---------MFTSGTLRQYRLKHKRVNIRAVKLWCRQILRG 137
+ V + + + V E M +S + N R +K + QILRG
Sbjct: 65 RLQD--VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAK--------NPRLIKTYLYQILRG 114
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAAHCVGTPEFMA 194
+ Y HSH V+HRDLK N+ ++ +K+ D GLA I ++ H V T + A
Sbjct: 115 IAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF-THEVVTLWYRA 171
Query: 195 PEVY--EEAYNELVDIYSFGMCILEMVT 220
PE+ Y+ VDI+S G EMV
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 68/226 (30%), Positives = 91/226 (40%), Gaps = 53/226 (23%)
Query: 16 EVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLER------ 69
+ + N I G+G VYRA D G VA +V++ D ER
Sbjct: 2 RCRSVTEFEKLNRI-GEGTYGIVYRARDTTSGEIVALKKVRM--------DNERDGIPIS 52
Query: 70 -LYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTE------------MFTSGTLRQYR 116
L EI LL L+H NI++ V +I V E M T + Q
Sbjct: 53 SLR-EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQ-- 109
Query: 117 LKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176
VK Q+LRGL YLH + +IHRDLK N+ + G +KI D GLA
Sbjct: 110 ----------VKCLMLQLLRGLQYLHEN--FIIHRDLKVSNLLLTDK-GCLKIADFGLAR 156
Query: 177 ILRKSHAAH----CVGTPEFMAPEVY--EEAYNELVDIYSFGMCIL 216
A V T + APE+ Y +D+++ G CIL
Sbjct: 157 --TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVG-CIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 16/163 (9%)
Query: 134 ILRGLLYL---HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-AHCVGT 189
I++ L YL H VIHRD+K NI ++ + G VK+ D G++ L S A G
Sbjct: 123 IVKALHYLKEKHG----VIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSKAKTRSAGC 177
Query: 190 PEFMAPEVYE-----EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP 244
+MAPE + Y+ D++S G+ ++E+ T ++PY C ++ K++ + P
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237
Query: 245 DSLYRVK-DPEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDD 285
P+ FV+ CL R RELL PF++ +
Sbjct: 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 3e-14
Identities = 67/236 (28%), Positives = 119/236 (50%), Gaps = 38/236 (16%)
Query: 69 RLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ-----YRLKHKRVN 123
+L E+++++ LKHKNI+++ +++ AN+ + + E +G L + Y++ K +
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK-IE 116
Query: 124 IRAVKLWCRQILRGLLYLHS-HDPP----VIHRDLKCDNIFV--------------NGNQ 164
A+ RQ+L L Y H+ D P V+HRDLK NIF+ N
Sbjct: 117 EHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176
Query: 165 GE--VKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVY---EEAYNELVDIYSFGMCILEM 218
G KIGD GL+ + AH CVGTP + +PE+ ++Y++ D+++ G I E+
Sbjct: 177 GRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
Query: 219 VTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLATVSLRLSARE 274
+ + P+ + + +Q+ ++ G PD + K E+ ++ L LSA+E
Sbjct: 237 CSGKTPFHKANNFSQLISELKRG--PDLPIKGKSKELNILIKNLLN-----LSAKE 285
|
Length = 1021 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 65/258 (25%), Positives = 119/258 (46%), Gaps = 35/258 (13%)
Query: 28 EILGKGASKTVYRA----FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLK-TLKH 82
++LGKG+ V+ A +++ I+ V L D +D+E E +L +H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD-----DDVECTMVEKRVLSLAWEH 55
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLH 142
+ Y ++ N+ FV E G L + + ++ + +I+ GL +LH
Sbjct: 56 PFLTHLYCTF--QTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAAHCVGTPEFMAPEVY-E 199
S +++RDLK DNI ++ G +KI D G+ +L + GTP+++APE+
Sbjct: 114 SKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170
Query: 200 EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLY---RVKDPEVR 256
+ YN VD +SFG+ + EM+ + P+ G + L+ R+ +P
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPF--------------HGHDEEELFQSIRMDNPCYP 216
Query: 257 RFVEKCLATVSLRLSARE 274
R++ + + ++L RE
Sbjct: 217 RWLTREAKDILVKLFVRE 234
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 25 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLE------RLYCEIHL 76
+Y ++ +G+G+ V++ + G VA +K F++S +D R EI +
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVA---IK--KFVESEDDPVIKKIALR---EIRM 53
Query: 77 LKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILR 136
LK LKH N++ V R ++ V E L + + V +K Q L+
Sbjct: 54 LKQLKHPNLVNLIE--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQ 111
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CVGTPEFMA 194
+ + H H+ IHRD+K +NI + QG++K+ D G A IL + V T + A
Sbjct: 112 AVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRA 168
Query: 195 PE--VYEEAYNELVDIYSFGMCILEMVT 220
PE V + Y VD+++ G E++T
Sbjct: 169 PELLVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 16/197 (8%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFY 89
LG+G TVY+ + VA +++L +P R E+ LLK LKH NI+ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVTLH 70
Query: 90 TSWVDTANRNINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPV 148
+ +++ V E + L+QY +N+ VKL+ Q+LRGL Y H V
Sbjct: 71 D--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--V 125
Query: 149 IHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAAHCVGTPEFMAPEVY--EEAYN 203
+HRDLK N+ +N +GE+K+ D GLA +I K+++ V T + P++ Y+
Sbjct: 126 LHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYS 183
Query: 204 ELVDIYSFGMCILEMVT 220
+D++ G EM T
Sbjct: 184 TQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 25 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQV---KLYDFLQSPEDLERLYCEIHLLKT 79
RY + +G+GA V++A D G VA +V +L + P R EI L+
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGI--PNQALR---EIKALQA 55
Query: 80 LKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKR--VNIRAVKLWCRQILRG 137
+H ++K V V E S L+ + + VK + R +L+G
Sbjct: 56 CQHPYVVKLLD--VFPHGSGFVLVMEYMPSDLSE--VLRDEERPLPEAQVKSYMRMLLKG 111
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---RKSHAAHCVGTPEFMA 194
+ Y+H++ ++HRDLK N+ + G +KI D GLA + +H V T + A
Sbjct: 112 VAYMHANG--IMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRA 168
Query: 195 PEVY--EEAYNELVDIYSFGMCIL-EM 218
PE+ Y+ VD+++ G CI E+
Sbjct: 169 PELLYGARKYDPGVDLWAVG-CIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 62/198 (31%), Positives = 100/198 (50%), Gaps = 16/198 (8%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E LG+G+ TVY+ G VA + + P R E LLK LKH NI+
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR---EASLLKGLKHANIVL 67
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKR-VNIRAVKLWCRQILRGLLYLHSHDP 146
+ + + FV E + L QY ++H ++ V+L+ Q+LRGL Y+H
Sbjct: 68 LHD--IIHTKETLTFVFE-YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH- 123
Query: 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAAHCVGTPEFMAPEVYEEA-- 201
++HRDLK N+ ++ GE+K+ D GLA +I +++++ V T + P+V A
Sbjct: 124 -ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATD 180
Query: 202 YNELVDIYSFGMCILEMV 219
Y+ +DI+ G +EM+
Sbjct: 181 YSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 68/271 (25%), Positives = 114/271 (42%), Gaps = 71/271 (26%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNI---NFVTEMFTSGTLRQYRLKHKRVNIRAVKL 129
E LL+ + H ++++ + V A + ++ ++++T T R + + I +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS-----RPLPIDQALI 161
Query: 130 WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC--- 186
+QIL GL YLH+ +IHRD+K +NIF+N + +V IGDLG AA
Sbjct: 162 IEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLG---------AAQFPVV 209
Query: 187 -------VGTPEFMAPEVY-EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKV 238
GT E APEV + YN DI+S G+ + EM+ + P+ I++
Sbjct: 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAY---------PSTIFEDP 260
Query: 239 VSGKKPDSLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRS--LDYS 296
S P+ + + + + L++ E DP S L ++Y+
Sbjct: 261 PST--PEEYVKSCHSHLLKIIST------LKVHPEEFPRDP-------GSRLVRGFIEYA 305
Query: 297 RELDDMDPLIRQPHIDFH-------HIDNSF 320
L RQP+ + ID F
Sbjct: 306 S-------LERQPYTRYPCFQRVNLPIDGEF 329
|
Length = 357 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 41/104 (39%), Positives = 62/104 (59%), Gaps = 7/104 (6%)
Query: 125 RAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSH 182
RA + QI+ GL +LH +I+RDLK +N+ ++ N G V+I DLGLA L+ +S
Sbjct: 98 RAC-FYTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSK 153
Query: 183 AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPY 225
GTP FMAPE+ + E Y+ VD ++ G+ + EM+ P+
Sbjct: 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 72/308 (23%), Positives = 122/308 (39%), Gaps = 60/308 (19%)
Query: 29 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDL----ERLYCEIHLLKTLKHKN 84
++G+GA V+ D+ G A ++ D ++ + ER +L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERD-----ILADADSPW 62
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS- 143
I+K Y S+ D ++ V E G L ++ + + +++ L L S
Sbjct: 63 IVKLYYSFQD--EEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV---LALDSV 117
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-------------------- 183
H IHRD+K DNI + G +K+ D GL + K+
Sbjct: 118 HKLGFIHRDIKPDNILI-DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 184 --------AHC---VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYP--YSECT 229
VGTP+++APEV Y D +S G+ + EM+ + +P YS+
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML-YGFPPFYSDTL 235
Query: 230 HPAQIYKKVVSGKKPDSLYRVKDPEVRR----FVEKCLATVSLRL-SARELLNDPFLQID 284
+ Y K+++ K+ SL DP V + + L RL S E+ + PF +
Sbjct: 236 Q--ETYNKIINWKE--SLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGI 291
Query: 285 DCESNLRS 292
D E+ +
Sbjct: 292 DWENLRET 299
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-13
Identities = 78/271 (28%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 29 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL-QSPEDLERLYCEIHLLKTLKHKNIMK 87
+LG GA+ TV A +G A VK+ D S D R E+ L +I+K
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFA---VKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK 95
Query: 88 FYTSWVDTANRN------INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYL 141
+ + RN I V + +G LRQ +K + R R+ GLL++
Sbjct: 96 CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQ-EIKSRAKTNRTF----REHEAGLLFI 150
Query: 142 -------HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL----AAILRKSHAAHCVGTP 190
H H +IHRD+K NI + N G VK+GD G AA + GTP
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209
Query: 191 EFMAPEVYEEA-YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYR 249
++APE++ Y++ D++S G+ + E++T + P+ + + ++ K ++G+ D L
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-DGENMEEVMHKTLAGRY-DPLPP 267
Query: 250 VKDPEVRRFVEKCLAT-VSLRLSARELLNDP 279
PE++ V L++ R S+ +LLN P
Sbjct: 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 70/288 (24%), Positives = 114/288 (39%), Gaps = 55/288 (19%)
Query: 55 VKLYDF-LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLR 113
VK + S EDL+ L EI + L+H NI+ + TS++ + + V+ + G+
Sbjct: 30 VKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYGSCE 87
Query: 114 QYRLKHKRVNIR--AVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 171
H + A+ + +L L Y+HS IHR +K +I ++G+ G+V +
Sbjct: 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSG 144
Query: 172 LGLAAIL----RKSHAAHCVGTPE-----FMAPEVYE---EAYNELVDIYSFGMCILEMV 219
L + + ++ H +++PEV + + YNE DIYS G+ E+
Sbjct: 145 LRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELA 204
Query: 220 TFEYPYSECTHPAQIYKKVVSGKKPDSLYR-------------------------VKDPE 254
P+ + Q+ + V G P L + V P
Sbjct: 205 NGHVPFKD-MPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPY 263
Query: 255 VRRF-------VEKCLA-TVSLRLSARELLNDPFL-QIDDCESNLRSL 293
R F VE CL R SA +LLN F Q ++L L
Sbjct: 264 TRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTSLLDL 311
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 61/198 (30%), Positives = 101/198 (51%), Gaps = 18/198 (9%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFY 89
LG+G TV++ + VA +++L +P R E+ LLK LKH NI+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKNLKHANIVTLH 69
Query: 90 TSWVDTANRNINFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPP 147
+ R + V E S L+QY L + +++ VK++ Q+LRGL Y H
Sbjct: 70 D--IIHTERCLTLVFEYLDS-DLKQY-LDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK-- 123
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAAHCVGTPEFMAPEVY--EEAY 202
++HRDLK N+ +N +GE+K+ D GLA ++ K+++ V T + P+V Y
Sbjct: 124 ILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 203 NELVDIYSFGMCILEMVT 220
+ +D++ G + EM T
Sbjct: 182 STPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 73/245 (29%), Positives = 118/245 (48%), Gaps = 14/245 (5%)
Query: 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK 81
RY ++ G GA +V A D+ G +VA KL QS +R Y E+ LLK ++
Sbjct: 16 RYTSLKQV-GSGAYGSVCSAIDKRTGEKVAIK--KLSRPFQSEIFAKRAYRELTLLKHMQ 72
Query: 82 HKNIMKFYTSWVDTANRN--INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLL 139
H+N++ + + + +F M T Q + H ++ V+ Q+L GL
Sbjct: 73 HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP-LSEDKVQYLVYQMLCGLK 131
Query: 140 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYE 199
Y+HS +IHRDLK N+ VN E+KI D GLA + V T + APEV
Sbjct: 132 YIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLARHADAEMTGYVV-TRWYRAPEVIL 187
Query: 200 E--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYK--KVVSGKKPDSLYRVKDPEV 255
YN+ VDI+S G + EM+T + + + Q+ + KV P+ + +++D
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247
Query: 256 RRFVE 260
+ +++
Sbjct: 248 KSYIK 252
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 28 EILGKGASKTVYRAFDEYEG----IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHK 83
++LG GA TVY+ EG I VA +K SP+ + + E +++ ++ +
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMASVDNP 69
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLH 142
++ + + + + +T++ G L Y +HK + + + WC QI +G+ YL
Sbjct: 70 HVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---RKSHAAHCVGTP-EFMAPE-V 197
+ ++HRDL N+ V Q VKI D GLA +L K + A P ++MA E +
Sbjct: 127 --ERRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 198 YEEAYNELVDIYSFGMCILEMVTF-EYPY 225
Y D++S+G+ + E++TF PY
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 27 NEILGKGASKTVYRAF---DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHK 83
+G+G VY+ E E I VA VK SP E+ E ++++ H
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVA---VKTCKNCTSPSVREKFLQEAYIMRQFDHP 67
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLH 142
+I+K + + V E+ G LR Y +K +++ ++ L+ Q+ L YL
Sbjct: 68 HIVKLIGVITENP---VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAAHCVGTP-EFMAPE-VY 198
S +HRD+ N+ V+ VK+GD GL+ L + A P ++MAPE +
Sbjct: 125 SKR--FVHRDIAARNVLVSSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181
Query: 199 EEAYNELVDIYSFGMCILEMVTF 221
+ D++ FG+C+ E++
Sbjct: 182 FRRFTSASDVWMFGVCMWEILML 204
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 81/256 (31%), Positives = 119/256 (46%), Gaps = 39/256 (15%)
Query: 25 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
RY + +G GA V A+D G VA KL Q+ +R Y E+ L+K + H
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK--KLSRPFQNVTHAKRAYRELVLMKLVNH 74
Query: 83 KNIMKFYTSWVDTANRNIN------FVTEMFTSGTLR--QYRLKHKRVNIRAVKLWCRQI 134
KNI+ V T +++ V E+ + + Q L H+R++ ++ C
Sbjct: 75 KNIIGLLN--VFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC--- 129
Query: 135 LRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC----VGTP 190
G+ +LHS +IHRDLK NI V + +KI D GLA R + + V T
Sbjct: 130 --GIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA---RTAGTSFMMTPYVVTR 181
Query: 191 EFMAPEV-YEEAYNELVDIYSFGMCIL-EMV--TFEYPYSECTHPAQIYKKVVS--GKKP 244
+ APEV Y E VDI+S G CI+ EM+ T +P ++ H Q + K++ G
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVG-CIMGEMIRGTVLFPGTD--HIDQ-WNKIIEQLGTPS 237
Query: 245 DSLYRVKDPEVRRFVE 260
D P VR +VE
Sbjct: 238 DEFMSRLQPTVRNYVE 253
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 16/199 (8%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E LG+G TV++ + VA +++L +P R E+ LLK LKH NI+
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVT 68
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRV-NIRAVKLWCRQILRGLLYLHSHDP 146
+ + ++++ V E + L+QY + ++ VK++ QILRGL Y H
Sbjct: 69 LHD--IVHTDKSLTLVFE-YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK- 124
Query: 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAAHCVGTPEFMAPEVY--EEA 201
V+HRDLK N+ +N +GE+K+ D GLA ++ K+++ V T + P+V
Sbjct: 125 -VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSE 181
Query: 202 YNELVDIYSFGMCILEMVT 220
Y+ +D++ G EM +
Sbjct: 182 YSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 33/216 (15%)
Query: 63 SPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRV 122
SPE + E ++K L+H +++ Y V + I VTE + G+L + +
Sbjct: 44 SPEAFLQ---EAQIMKKLRHDKLVQLYA--VCSEEEPIYIVTEYMSKGSLLDFLKSGEGK 98
Query: 123 NIRAVKL--WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180
+R +L QI G+ YL S + IHRDL NI V G KI D GLA ++
Sbjct: 99 KLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILV-GENLVCKIADFGLARLIED 155
Query: 181 SHAAHCVGT--P-EFMAPEVYEEAYNELV---DIYSFGMCILEMVTF-EYPYSECTHPAQ 233
G P ++ APE Y D++SFG+ + E+VT+ PY +
Sbjct: 156 DEYTAREGAKFPIKWTAPEA--ANYGRFTIKSDVWSFGILLTEIVTYGRVPY-PGMTNRE 212
Query: 234 IYKKVVSGKK-------PDSLYRV------KDPEVR 256
+ ++V G + P+ LY + KDPE R
Sbjct: 213 VLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEER 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 11/159 (6%)
Query: 134 ILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-AHCVGTPEF 192
++ L YL + +IHRD+K NI ++ N G +K+ D G++ L S A G +
Sbjct: 116 TVKALNYLKE-ELKIIHRDVKPSNILLDRN-GNIKLCDFGISGQLVDSIAKTRDAGCRPY 173
Query: 193 MAPE----VYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP---D 245
MAPE + Y+ D++S G+ + E+ T ++PY + +VV G P +
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSN 233
Query: 246 SLYRVKDPEVRRFVEKCL-ATVSLRLSARELLNDPFLQI 283
S R P F+ CL S R +ELL PF++
Sbjct: 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 37/141 (26%), Positives = 69/141 (48%), Gaps = 13/141 (9%)
Query: 130 WCRQ----ILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH 185
W +Q ++ G+ LH +IHRD+K +N+ ++ G +K+ D GL+ ++
Sbjct: 98 WAKQYIAEVVLGVEDLH--QRGIIHRDIKPENLLID-QTGHLKLTDFGLSRNGLENK--K 152
Query: 186 CVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK- 243
VGTP+++APE +++ D +S G I E + F YP P ++ ++S +
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFL-FGYPPFHAETPDAVFDNILSRRIN 211
Query: 244 -PDSLYRVKDPEVRRFVEKCL 263
P+ + PE + + L
Sbjct: 212 WPEEVKEFCSPEAVDLINRLL 232
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 38/225 (16%)
Query: 24 GRYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS-PEDLERLYCEIHLLKTL 80
Y + LG+G VY+A G VA ++ +++ P R EI +LK L
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR---EIKILKKL 64
Query: 81 KHKNIMKFYTSWVDTANRNINFVTEMFT---------SGTLRQYRLKHKRVNIRAVKLWC 131
KH N++ V+ +++ ++ SG L +K + +K +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQIKCYM 121
Query: 132 RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR------------ 179
Q+L G+ YLH + ++HRD+K NI ++ NQG +KI D GLA
Sbjct: 122 LQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 180 -KSHAAHCVGTPEFMAPEVY--EEAYNELVDIYSFGMCIL-EMVT 220
+ V T + PE+ E Y VDI+ G C+ EM T
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG-CVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 40/127 (31%), Positives = 69/127 (54%), Gaps = 6/127 (4%)
Query: 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVN 161
FV E G L + R ++ + +I+ GL +LHS +I+RDLK DN+ ++
Sbjct: 73 FVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLD 130
Query: 162 GNQGEVKIGDLGLAA--ILRKSHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEM 218
+ G +KI D G+ + + A+ GTP+++APE+ + Y VD +SFG+ + EM
Sbjct: 131 RD-GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEM 189
Query: 219 VTFEYPY 225
+ + P+
Sbjct: 190 LIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 28 EILGKGASKTVYRAFDEYEG----IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHK 83
++LG GA TVY+ EG I VA +K+ + P+ E ++ ++ H
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMASMDHP 69
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYL 141
++++ + I VT++ G L Y +HK NI + L WC QI +G++YL
Sbjct: 70 HLVRLLGVCLSPT---IQLVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYL 125
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---RKSHAAHCVGTP-EFMAPE- 196
++HRDL N+ V + VKI D GLA +L K + A P ++MA E
Sbjct: 126 EERR--LVHRDLAARNVLVK-SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 197 VYEEAYNELVDIYSFGMCILEMVTF 221
++ + D++S+G+ I E++TF
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 19/198 (9%)
Query: 100 INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIF 159
++F+ ++ G L + +H + ++ + +I+ GL H H+ V++RDLK NI
Sbjct: 72 LSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE--HMHNRFVVYRDLKPANIL 129
Query: 160 VNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILE 217
++ + G V+I DLGLA K VGT +MAPEV ++ AY+ D +S G + +
Sbjct: 130 LDEH-GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 188
Query: 218 MVTFEYPY----SECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLAT-VSLRL-- 270
++ P+ ++ H ++ + PDS PE+R +E L V+ RL
Sbjct: 189 LLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF----SPELRSLLEGLLQRDVNRRLGC 244
Query: 271 ---SARELLNDPFLQIDD 285
A+E+ PF + D
Sbjct: 245 LGRGAQEVKEHPFFRSLD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 75/251 (29%), Positives = 115/251 (45%), Gaps = 29/251 (11%)
Query: 25 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
RY ++ +G GA V AFD GI VA KL Q+ +R Y E+ LLK + H
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVK--KLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 83 KNIMKFYTSWVDTAN----RNINFVTEMFTSGTLR--QYRLKHKRVNIRAVKLWCRQILR 136
KNI+ + + +++ V E+ + + L H+R++ ++ C
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC----- 134
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP-----E 191
G+ +LHS +IHRDLK NI V + +KI D GLA ++ + + TP
Sbjct: 135 GIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA----RTACTNFMMTPYVVTRY 187
Query: 192 FMAPEV-YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRV 250
+ APEV Y E VDI+S G + E+V + H Q K + P + +
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247
Query: 251 K-DPEVRRFVE 260
+ P VR +VE
Sbjct: 248 RLQPTVRNYVE 258
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 72/208 (34%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC--EIHLLKT 79
+Y EI G GA TVY+A D + G VA V++ Q+ ED L E+ LLK
Sbjct: 1 QYEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRV----QTNEDGLPLSTVREVALLKR 55
Query: 80 LK---HKNIMKFYTSWVDTANRNINFVTEMF--TSGTLRQY--RLKHKRVNIRAVKLWCR 132
L+ H NI++ + VT +F LR Y ++ + +K R
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMR 115
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-AHCVGTPE 191
Q LRGL +LH++ ++HRDLK +NI V + G+VK+ D GLA I A V T
Sbjct: 116 QFLRGLDFLHAN--CIVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLW 172
Query: 192 FMAPEV-YEEAYNELVDIYSFGMCILEM 218
+ APEV + Y VD++S G EM
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 53/183 (28%), Positives = 88/183 (48%), Gaps = 15/183 (8%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWC 131
E ++ L H+ +++ Y V T R I VTE ++G L Y R KR + C
Sbjct: 49 EAKVMMKLSHEKLVQLYG--VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC 106
Query: 132 RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP- 190
+ + G+ YL S IHRDL N V+ +QG VK+ D GL+ + VG+
Sbjct: 107 KDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTSSVGSKF 163
Query: 191 --EFMAPEVYEEA-YNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKKPDS 246
+ PEV + ++ D+++FG+ + E+ + + PY + ++ +KV G +
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETVEKVSQGLR--- 219
Query: 247 LYR 249
LYR
Sbjct: 220 LYR 222
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 34/170 (20%)
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC-VGTPE 191
QI+ GL +LH +++RDLK +N+ ++ + G V+I DLGLA L+ GTP
Sbjct: 103 QIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPG 159
Query: 192 FMAPEVY-EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK------- 243
+MAPEV E Y+ VD ++ G + EM+ P+ + K+ V ++
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF-------RQRKEKVEKEELKRRTLE 212
Query: 244 -----PDSLYRVKDPEVRRFVEKCLAT-VSLRL-----SARELLNDPFLQ 282
PD PE + E L RL SA E+ P +
Sbjct: 213 MAVEYPDKF----SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 64/199 (32%), Positives = 99/199 (49%), Gaps = 18/199 (9%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E LG+G+ TVY+ + G VA ++L + +P R E LLK LKH NI+
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR---EASLLKGLKHANIVL 67
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKR-VNIRAVKLWCRQILRGLLYLHSHDP 146
+ + + V E + L QY KH ++ VKL+ Q+LRGL Y+H
Sbjct: 68 LHD--IIHTKETLTLVFE-YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR-- 122
Query: 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC----VGTPEFMAPEVY--EE 200
++HRDLK N+ ++ + GE+K+ D GLA KS +H V T + P+V
Sbjct: 123 YILHRDLKPQNLLIS-DTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPDVLLGST 179
Query: 201 AYNELVDIYSFGMCILEMV 219
Y+ +D++ G +EM+
Sbjct: 180 EYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 28 EILGKGASKTVYRA----FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLK-TLKH 82
++LGKG+ V A DE I+V V L D +D++ E +L KH
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQD-----DDVDCTMTEKRILALAAKH 55
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLH 142
+ + + T +R + FV E G L + ++ + + + ++ L++LH
Sbjct: 56 PFLTALHCCF-QTKDR-LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAAHCVGTPEFMAPEVYEE 200
H VI+RDLK DNI ++ +G K+ D G+ IL GTP+++APE+ +E
Sbjct: 114 RHG--VIYRDLKLDNILLDA-EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE 170
Query: 201 -AYNELVDIYSFGMCILEMVTFEYPY 225
Y VD ++ G+ + EM+ + P+
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 8/196 (4%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFY 89
LG G V + + G+ +A KL P ++ E+ +L I+ FY
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 90 TSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVI 149
++ ++ I+ E G+L Q + KR+ + +LRGL YL ++
Sbjct: 70 GAFY--SDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ-IM 126
Query: 150 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEA-YNELVDI 208
HRD+K NI VN ++GE+K+ D G++ L S A VGT +M+PE + Y+ DI
Sbjct: 127 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185
Query: 209 YSFGMCILEMVTFEYP 224
+S G+ ++E+ YP
Sbjct: 186 WSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 29 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS-PEDLERLYCEIHLLKTLKHKNIMK 87
+G+G VY+A D+ G VA +V+L + + P R EI +L+ L H+NI+
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR---EIKILRQLNHRNIVN 70
Query: 88 FYTSWVDTAN--------RNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLL 139
D + V E + + +K + +Q+L GL
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLN 130
Query: 140 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA---AHCVGTPEFMAPE 196
Y H + +HRD+KC NI +N N+G++K+ D GLA + + + V T + PE
Sbjct: 131 YCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPE 187
Query: 197 VY--EEAYNELVDIYSFGMCIL-EMVT 220
+ EE Y +D++S G CIL E+ T
Sbjct: 188 LLLGEERYGPAIDVWSCG-CILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 10/153 (6%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL-WC 131
E ++ L H N+++ Y V T R I VTE +G L Y + K L C
Sbjct: 49 EAKVMMKLSHPNLVQLYG--VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC 106
Query: 132 RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP- 190
+ + YL S+ IHRDL N V G VK+ D GLA + GT
Sbjct: 107 SDVCEAMEYLESNG--FIHRDLAARNCLV-GEDNVVKVSDFGLARYVLDDQYTSSQGTKF 163
Query: 191 --EFMAPEVYEEA-YNELVDIYSFGMCILEMVT 220
++ PEV++ + ++ D++SFG+ + E+ +
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 56/178 (31%), Positives = 86/178 (48%), Gaps = 18/178 (10%)
Query: 55 VKLYDFLQSPEDLE------RLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFT 108
V + FL+S +D R EI +LK L+H+N++ V + + V E
Sbjct: 29 VAIKKFLESEDDKMVKKIAMR---EIRMLKQLRHENLVNLIE--VFRRKKRLYLVFEFVD 83
Query: 109 SGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVK 168
L ++ V+ + QILRG+ + HSH+ +IHRD+K +NI V+ + G VK
Sbjct: 84 HTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVK 140
Query: 169 IGDLGLAAILRKSHAAHC--VGTPEFMAPE--VYEEAYNELVDIYSFGMCILEMVTFE 222
+ D G A L + V T + APE V + Y VDI++ G + EM+T E
Sbjct: 141 LCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 5e-12
Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 38/216 (17%)
Query: 23 YGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPED----LERLYCEIHLLK 78
Y + N I +G VYRA D+ G VA ++K+ E + L EI++L
Sbjct: 7 YEKLNRI-EEGTYGVVYRARDKKTGEIVALKKLKM-----EKEKEGFPITSLR-EINILL 59
Query: 79 TLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK------HKRVNIRAVKLWCR 132
L+H NI+ V + I V E ++ LK + VK
Sbjct: 60 KLQHPNIVTVKEVVVGSNLDKIYMVMEYV------EHDLKSLMETMKQPFLQSEVKCLML 113
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-----SHAAHCV 187
Q+L G+ +LH + ++HRDLK N+ +N N+G +KI D GLA R+ V
Sbjct: 114 QLLSGVAHLHDN--WILHRDLKTSNLLLN-NRGILKICDFGLA---REYGSPLKPYTQLV 167
Query: 188 GTPEFMAPEVY--EEAYNELVDIYSFGMCIL-EMVT 220
T + APE+ + Y+ +D++S G CI E++T
Sbjct: 168 VTLWYRAPELLLGAKEYSTAIDMWSVG-CIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-12
Identities = 56/196 (28%), Positives = 95/196 (48%), Gaps = 8/196 (4%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFY 89
LG G V++ + G+ +A KL P ++ E+ +L I+ FY
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 90 TSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVI 149
++ ++ I+ E G+L Q K R+ + + +++GL YL ++
Sbjct: 70 GAFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 126
Query: 150 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEA-YNELVDI 208
HRD+K NI VN ++GE+K+ D G++ L S A VGT +M+PE + Y+ DI
Sbjct: 127 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185
Query: 209 YSFGMCILEMVTFEYP 224
+S G+ ++EM YP
Sbjct: 186 WSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 67/202 (33%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS-PEDLERLYCEIHLLKTLKHKNIM 86
E +G+G VY+ ++ G VA +++L + P R EI LLK L+H NI+
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR---EISLLKELQHPNIV 62
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYR---LKHKRVNIRAVKLWCRQILRGLLYLHS 143
V + + E F S L++Y K + ++ VK + QIL+G+L+ HS
Sbjct: 63 CLQD--VLMQESRLYLIFE-FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAAHCVGTPEFMAPEVY-- 198
V+HRDLK N+ ++ N+G +K+ D GLA I + + H V T + APEV
Sbjct: 120 RR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVY-THEVVTLWYRAPEVLLG 175
Query: 199 EEAYNELVDIYSFGMCILEMVT 220
Y+ VDI+S G EM T
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 65/250 (26%), Positives = 113/250 (45%), Gaps = 35/250 (14%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFY 89
+G+GA V A + +VA K+ + + D +R EI LL+ L H+N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIK--KIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 90 TSWVDTANRNIN---FVTE-MFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHD 145
N V E M T L Q + ++ + + Q+LRGL Y+HS +
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTD--LHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN 128
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFM----------AP 195
V+HRDLK N+ +N N ++KI D GLA R + +FM AP
Sbjct: 129 --VLHRDLKPSNLLLNAN-CDLKICDFGLA---RTTSEKG-----DFMTEYVVTRWYRAP 177
Query: 196 EVY--EEAYNELVDIYSFGMCIL-EMVTFE--YPYSECTHPAQIYKKVVSGKKPDSLYRV 250
E+ Y +D++S G CI E++ + +P + H ++ +++ + L +
Sbjct: 178 ELLLNCSEYTTAIDVWSVG-CIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236
Query: 251 KDPEVRRFVE 260
++ + RR++
Sbjct: 237 RNEKARRYIR 246
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 52/184 (28%), Positives = 87/184 (47%), Gaps = 22/184 (11%)
Query: 67 LERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSG----TLRQYRLKHKRV 122
++ E ++ +L H+N+++ Y + + VTE+ G LR+ L H
Sbjct: 40 MDDFLKEAAIMHSLDHENLIRLYGVVLTHP---LMMVTELAPLGSLLDRLRKDALGH--F 94
Query: 123 NIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 182
I + + QI G+ YL S IHRDL NI + + +VKIGD GL L ++
Sbjct: 95 LISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDD-KVKIGDFGLMRALPQNE 151
Query: 183 AAHCVGTPE------FMAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQI 234
H V + APE + ++ D++ FG+ + EM T+ E P++ + +QI
Sbjct: 152 D-HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS-GSQI 209
Query: 235 YKKV 238
KK+
Sbjct: 210 LKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 9e-12
Identities = 57/194 (29%), Positives = 94/194 (48%), Gaps = 28/194 (14%)
Query: 102 FVTEMFTSGTLRQ--YRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIF 159
V + G L+ Y + + + + V + QI G+L+LHS D +++RD+K +N+
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVL 127
Query: 160 VNGNQGEVKIGDLGLAAILRKSHA-AHCVGTPEFMAPEVY-EEAYNELVDIYSFGMCILE 217
++ +QG ++ DLGLA L+ GT +MAPE+ EE Y+ VD ++ G I E
Sbjct: 128 LD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYE 186
Query: 218 MVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVR----RFVEKCLATVSL----- 268
MV P+ + +K+ V+ K + R + EV+ F E+ L
Sbjct: 187 MVAGRTPFKD-------HKEKVA--KEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKK 237
Query: 269 ---RLSARELLNDP 279
RL +RE +DP
Sbjct: 238 PEDRLGSREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 39/162 (24%), Positives = 74/162 (45%), Gaps = 18/162 (11%)
Query: 103 VTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG 162
V E+ G L +Y K + + + +K Q+ G+ YL S +HRDL N+ +
Sbjct: 73 VMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV- 129
Query: 163 NQGEVKIGDLGLAAILRKSHAAHCVGT----P-EFMAPE-VYEEAYNELVDIYSFGMCIL 216
N+ + KI D G++ L + T P ++ APE + ++ D++S+G+ +
Sbjct: 130 NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLW 189
Query: 217 EMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLYRV 250
E ++ PY E ++ + SG++ P +Y +
Sbjct: 190 EAFSYGAKPYGEMKGA-EVIAMLESGERLPRPEECPQEIYSI 230
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 46/146 (31%), Positives = 78/146 (53%), Gaps = 10/146 (6%)
Query: 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVN 161
VT+ + G L + K R + K + +++ L +LH +D +++RDLK +NI ++
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD 130
Query: 162 GNQGEVKIGDLGLA-AILRKSHAAHC-VGTPEFMAPEVY--EEAYNELVDIYSFGMCILE 217
G + + D GL+ A L + + GT E++APEV E+ Y + VD +S G+ + E
Sbjct: 131 AT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
Query: 218 MVTFEYP-YSECTHPAQIYKKVVSGK 242
M P Y+E T Q+Y+ + GK
Sbjct: 190 MCCGWSPFYAEDTQ--QMYRNIAFGK 213
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 52/176 (29%), Positives = 87/176 (49%), Gaps = 14/176 (7%)
Query: 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVN 161
F+ ++ G L + +H + + ++ + +I+ GL H H+ V++RDLK NI ++
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE--HMHNRFVVYRDLKPANILLD 131
Query: 162 GNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMV 219
G V+I DLGLA K VGT +MAPEV ++ AY+ D +S G + +++
Sbjct: 132 -EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190
Query: 220 TFEYPY----SECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRL 270
P+ ++ H V+ + PDS PE++ +E L VS RL
Sbjct: 191 RGHSPFRQHKTKDKHEIDRMTLTVNVELPDSF----SPELKSLLEGLLQRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 46/148 (31%), Positives = 76/148 (51%), Gaps = 17/148 (11%)
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-ILRKSHAAHCVGTPEFMAPEV-YEEA 201
H+ IHRDLK +N F+ G +K+ D GL+ I+ +++ VG+P++MAPEV +
Sbjct: 118 HELGYIHRDLKPEN-FLIDASGHIKLTDFGLSKGIVTYANSV--VGSPDYMAPEVLRGKG 174
Query: 202 YNELVDIYSFGMCIL-EMVTFEYPYSECTHPAQIYKKVVSGKK-------PDSLYRVKDP 253
Y+ VD +S G C+L E + P+S T P + ++ + K+ D + + D
Sbjct: 175 YDFTVDYWSLG-CMLYEFLCGFPPFSGST-PNETWENLKYWKETLQRPVYDDPRFNLSD- 231
Query: 254 EVRRFVEKCLATVSLRL-SARELLNDPF 280
E + K + S R S ++ N PF
Sbjct: 232 EAWDLITKLINDPSRRFGSLEDIKNHPF 259
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 82/305 (26%), Positives = 143/305 (46%), Gaps = 25/305 (8%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+++GKG+ V A + E A ++ L+ E+ + LLK +KH ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRA-VKLWCRQILRGLLYLHSHDP 146
+ S+ TA++ + FV + G L Y L+ +R + + + +I L YLHS +
Sbjct: 61 LHFSF-QTADK-LYFVLDYINGGELF-YHLQRERCFLEPRARFYAAEIASALGYLHSLN- 116
Query: 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA--ILRKSHAAHCVGTPEFMAPEV-YEEAYN 203
+++RDLK +NI ++ +QG + + D GL I + GTPE++APEV +++ Y+
Sbjct: 117 -IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 204 ELVDIYSFGMCILEMVTFEYP-YSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKC 262
VD + G + EM+ P YS T A++Y +++ KP L R +E
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNT--AEMYDNILN--KPLQLKPNITNSARHLLEGL 230
Query: 263 LAT-VSLRLSARELLNDPFLQIDD----CESNLRSLDYSRELDDMDPLIRQPHIDFHHID 317
L + RL A+ D F++I + N L + +P + P+ D H D
Sbjct: 231 LQKDRTKRLGAK----DDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPN-DLRHFD 285
Query: 318 NSFSN 322
F+
Sbjct: 286 PEFTE 290
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 53/191 (27%), Positives = 92/191 (48%), Gaps = 24/191 (12%)
Query: 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQ 164
E+FT R++ + V+++ +I+ L +LH +I+RD+K +NI ++
Sbjct: 91 ELFTHLYQREHFTES------EVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE- 141
Query: 165 GEVKIGDLGLAAIL---RKSHAAHCVGTPEFMAPEVY---EEAYNELVDIYSFGMCILEM 218
G V + D GL+ + A GT E+MAPEV +++ VD +S G+ E+
Sbjct: 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
Query: 219 VTFEYPYS---ECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLAT-VSLRL---S 271
+T P++ E ++I ++++ K P + E R F++K L RL
Sbjct: 202 LTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDFIQKLLEKDPKKRLGANG 259
Query: 272 ARELLNDPFLQ 282
A E+ N PF Q
Sbjct: 260 ADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 61/254 (24%), Positives = 112/254 (44%), Gaps = 45/254 (17%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+++G+GA V + G A ++ D L+ E + + E +L ++K
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK-EQVAHIRAERDILVEADGAWVVK 65
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
+ S+ D RN+ + E G + +K ++ A + + + + + +H
Sbjct: 66 MFYSFQD--KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG-- 121
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH------------------------- 182
IHRD+K DN+ ++ +G VK+ D GL L+K+H
Sbjct: 122 FIHRDIKPDNLLLDA-KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 183 ------------AAHCVGTPEFMAPEVY-EEAYNELVDIYSFGMCILEMVTFEYPYSECT 229
A VGTP+++APEV+ + YN+L D +S G+ + EM+ P+ T
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 230 HPAQIYKKVVSGKK 243
P + Y+KV++ K+
Sbjct: 241 -PQETYRKVMNWKE 253
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLK-TLKHKNIM 86
+LGKG+ V A + G A +K LQ +D+E E +L H +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD-DDVECTMTEKRILSLARNHPFLT 59
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDP 146
+ Y + T +R + FV E G L + K +R + + + +I L++LH D
Sbjct: 60 QLYCCF-QTPDR-LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH--DK 115
Query: 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAAHCVGTPEFMAPEVY-EEAYN 203
+I+RDLK DN+ ++ ++G K+ D G+ I + GTP+++APE+ E Y
Sbjct: 116 GIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 204 ELVDIYSFGMCILEMVTFEYPY 225
VD ++ G+ + EM+ P+
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 52/225 (23%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 67 LERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRA 126
+ E+ LK L+HK+++ + V + + +TE+ G+L + + +
Sbjct: 46 QQDFQKEVQALKRLRHKHLISLFA--VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPV 103
Query: 127 VKL--WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-HA 183
L Q+ G+ YL + IHRDL NI V G K+ D GLA ++++ +
Sbjct: 104 ASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILV-GEDLVCKVADFGLARLIKEDVYL 160
Query: 184 AHCVGTP-EFMAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVS 240
+ P ++ APE ++ D++SFG+ + EM T+ + PY + ++Y ++ +
Sbjct: 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-HEVYDQITA 219
Query: 241 G-------KKPDSLYRV------KDPEVRRFVEKCLATVSLRLSA 272
G K P +Y++ +PE R + L
Sbjct: 220 GYRMPCPAKCPQEIYKIMLECWAAEPEDR----PSFKALREELDN 260
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 5e-11
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 29/211 (13%)
Query: 29 ILGKGASKTVYRA--FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIM 86
I+G G+ VY A D E +V + LQ P+ R E+ ++K L H NI+
Sbjct: 73 IIGNGSFGVVYEAICIDTSE-------KVAIKKVLQDPQYKNR---ELLIMKNLNHINII 122
Query: 87 ----KFYTSWVDTANRNI--NFVTEMFTSGTLRQYRLKHKRVN----IRAVKLWCRQILR 136
+YT +NI N V E F T+ +Y + R N + VKL+ Q+ R
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVME-FIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-ILRKSHAAHCVGTPEFMAP 195
L Y+HS + HRDLK N+ ++ N +K+ D G A +L + + + + AP
Sbjct: 182 ALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAP 239
Query: 196 EVYEEA--YNELVDIYSFGMCILEMVTFEYP 224
E+ A Y +D++S G I EM+ YP
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMI-LGYP 269
|
Length = 440 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 73/251 (29%), Positives = 111/251 (44%), Gaps = 29/251 (11%)
Query: 25 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
RY + +G GA V A+D VA KL Q+ +R Y E+ L+K + H
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 83 KNIMKFYTSWVDTAN----RNINFVTEMFTSGTLR--QYRLKHKRVNIRAVKLWCRQILR 136
KNI+ + + +++ V E+ + + Q L H+R++ ++ C
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC----- 137
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPE----- 191
G+ +LHS +IHRDLK NI V + +KI D GLA ++ + TP
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA----RTAGTSFMMTPYVVTRY 190
Query: 192 FMAPEV-YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRV 250
+ APEV Y E VDI+S G + EM+ + H Q K + P +
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250
Query: 251 K-DPEVRRFVE 260
K P VR +VE
Sbjct: 251 KLQPTVRTYVE 261
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 46/134 (34%), Positives = 69/134 (51%), Gaps = 10/134 (7%)
Query: 102 FVTEMFTSGTLRQYRLKHKRV--NIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIF 159
FV E G L + L +RV RA + + +I+ L YLHS D V++RD+K +N+
Sbjct: 72 FVMEYANGGELF-FHLSRERVFTEERA-RFYGAEIVSALEYLHSRD--VVYRDIKLENLM 127
Query: 160 VNGNQGEVKIGDLGLA--AILRKSHAAHCVGTPEFMAPEVYEEA-YNELVDIYSFGMCIL 216
++ G +KI D GL I + GTPE++APEV E+ Y VD + G+ +
Sbjct: 128 LD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186
Query: 217 EMVTFEYPYSECTH 230
EM+ P+ H
Sbjct: 187 EMMCGRLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 74/248 (29%), Positives = 111/248 (44%), Gaps = 23/248 (9%)
Query: 25 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
RY + +G GA V A+D VA KL Q+ +R Y E+ L+K + H
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 83 KNIMKFYTSWVDTAN----RNINFVTEMFTSGTLR--QYRLKHKRVNIRAVKLWCRQILR 136
KNI+ + + +++ V E+ + + Q L H+R++ ++ C
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC----- 130
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-AAHCVGTPEFMAP 195
G+ +LHS +IHRDLK NI V + +KI D GLA S V T + AP
Sbjct: 131 GIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 196 EV-YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS--GKKPDSLYRVKD 252
EV Y E VDI+S G + EMV + + + Q + KV+ G +
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKLQ 246
Query: 253 PEVRRFVE 260
P VR +VE
Sbjct: 247 PTVRNYVE 254
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 63/255 (24%), Positives = 111/255 (43%), Gaps = 47/255 (18%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+++G+GA V + G A ++ D L+ E + + E +L ++K
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK-EQVGHIRAERDILVEADSLWVVK 65
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS-HDP 146
+ S+ D N + + E G + +K + + + I +L + S H
Sbjct: 66 MFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKDTLTEEETQFY---IAETVLAIDSIHQL 120
Query: 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH------------------------ 182
IHRD+K DN+ ++ ++G VK+ D GL L+K+H
Sbjct: 121 GFIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179
Query: 183 -------------AAHCVGTPEFMAPEVY-EEAYNELVDIYSFGMCILEMVTFEYPYSEC 228
A VGTP+++APEV+ + YN+L D +S G+ + EM+ P+
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 229 THPAQIYKKVVSGKK 243
T P + YKKV++ K+
Sbjct: 240 T-PQETYKKVMNWKE 253
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 22/158 (13%)
Query: 73 EIHLLKTLK-HKNIMKFY-TSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLW 130
E+ LL+ + HKNI Y V N N ++ E L Q + + + +
Sbjct: 51 ELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSF 110
Query: 131 CRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP 190
QIL GL Y+HS + V+HRDLK N+ VN + E+KI D GLA R
Sbjct: 111 IYQILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLA---RGFSENPGENAG 164
Query: 191 EFM----------APEVY--EEAYNELVDIYSFGMCIL 216
FM APE+ ++Y + +D++S G CIL
Sbjct: 165 -FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVG-CIL 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 9/206 (4%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
++LGKG V ++ G A +K + + + +++ E +LK +H +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILK-KEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
S+ T +R + FV E G L + + + + + + +I+ L YLHS
Sbjct: 60 LKYSF-QTKDR-LCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK-- 115
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAAHCVGTPEFMAPEVYEEA-YNE 204
+++RDLK +N+ ++ + G +KI D GL I + GTPE++APEV E+ Y
Sbjct: 116 IVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 205 LVDIYSFGMCILEMVTFEYPYSECTH 230
VD + G+ + EM+ P+ H
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 68/254 (26%), Positives = 109/254 (42%), Gaps = 47/254 (18%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVK-----LYDFLQSPEDLERLYCEIHLLKTLKHKN 84
LG G VY + + VA +K + +FL+ E ++K +KH N
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----------EAAVMKEIKHPN 63
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLH 142
+++ V T +TE T G L Y + R + AV L QI + YL
Sbjct: 64 LVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR-KSHAAHCVGT-P-EFMAPEVYE 199
+ IHRDL N V G VK+ D GL+ ++ ++ AH P ++ APE
Sbjct: 122 KKN--FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL- 177
Query: 200 EAYNEL---VDIYSFGMCILEMVTF---EYPYSECTHPAQIYKKVVSGKKPDSLYRVKDP 253
AYN+ D+++FG+ + E+ T+ YP + + +Y+ + G YR++ P
Sbjct: 178 -AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEKG------YRMERP 227
Query: 254 E-----VRRFVEKC 262
E V + C
Sbjct: 228 EGCPPKVYELMRAC 241
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 29 ILGKGASKTVY----RAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84
+LGKG+ V + DE I++ V + D +D+E E +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-----DDVECTMVEKRVLALSGKPP 61
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSH 144
+ S T +R + FV E G L + R + +I GL +LHS
Sbjct: 62 FLTQLHSCFQTMDR-LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA--ILRKSHAAHCVGTPEFMAPEVYE-EA 201
+I+RDLK DN+ ++ ++G +KI D G+ + GTP+++APE+ +
Sbjct: 121 G--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP 177
Query: 202 YNELVDIYSFGMCILEMVTFEYPY 225
Y + VD ++FG+ + EM+ + P+
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 29 ILGKGASKTVYRAFDEYEG----IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84
+LG GA TVY+ +G I VA +K+ SP+ + + E +++ +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVA---IKVLRENTSPKANKEILDEAYVMAGVGSPY 70
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHS 143
+ + + + + VT++ G L Y ++K R+ + + WC QI +G+ YL
Sbjct: 71 VCRLLGICLTST---VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL-- 125
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----RKSHAAHCVGTPEFMAPE-VY 198
+ ++HRDL N+ V + VKI D GLA +L + HA ++MA E +
Sbjct: 126 EEVRLVHRDLAARNVLVK-SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 199 EEAYNELVDIYSFGMCILEMVTF 221
+ D++S+G+ + E++TF
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 29 ILGKGASKTVY----RAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84
+LGKG+ V + DE I++ V + D +D+E E +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQD-----DDVECTMVEKRVLALPGKPP 61
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLH 142
+ S T +R + FV E G L Y ++ K AV + +I GL +LH
Sbjct: 62 FLTQLHSCFQTMDR-LYFVMEYVNGGDL-MYHIQQVGKFKEPHAV-FYAAEIAIGLFFLH 118
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA--ILRKSHAAHCVGTPEFMAPE-VYE 199
S +I+RDLK DN+ ++ +G +KI D G+ I GTP+++APE +
Sbjct: 119 SKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY 175
Query: 200 EAYNELVDIYSFGMCILEMVTFEYPY 225
+ Y + VD ++FG+ + EM+ + P+
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 30 LGKGASKTVYRAFDEYEGIE-VAWNQVKLYDFLQS-PEDLERLYCEIHLLKTLKHKNIMK 87
+G+GA V++A D G VA +V++ + P R + L+T +H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 88 FYTSWVDTANRNINFVTEMF--TSGTLRQY--RLKHKRVNIRAVKLWCRQILRGLLYLHS 143
+ + +T +F L Y ++ V +K Q+LRGL +LHS
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR-KSHAAHCVGTPEFMAPEV-YEEA 201
H V+HRDLK NI V + G++K+ D GLA I + V T + APEV + +
Sbjct: 129 HR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 185
Query: 202 YNELVDIYSFGMCILEM 218
Y VD++S G EM
Sbjct: 186 YATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 49/167 (29%), Positives = 86/167 (51%), Gaps = 9/167 (5%)
Query: 76 LLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQIL 135
LLK +KH ++ + S+ TA++ + FV + G L + + + + + +I
Sbjct: 49 LLKNVKHPFLVGLHYSF-QTADK-LYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIA 106
Query: 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAAHCVGTPEFM 193
L YLHS + +I+RDLK +NI ++ +QG V + D GL I + GTPE++
Sbjct: 107 SALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYL 163
Query: 194 APEV-YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVV 239
APEV ++ Y+ VD + G + EM+ + P A++Y ++
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRDTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 65/232 (28%), Positives = 98/232 (42%), Gaps = 48/232 (20%)
Query: 28 EILGKGASKTVYRAFDEYEGIE-------VAWNQVKLYDFLQSPEDLERLYCEIHLLKTL 80
+ LG+GA V +A E G++ VA VK+ + +DL L E+ ++K +
Sbjct: 18 KPLGEGAFGQVVKA--EAVGLDNPNETSTVA---VKMLKDDATEKDLSDLVSEMEMMKMI 72
Query: 81 -KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCR------- 132
KHKNI+ V T + V E G LR + + A R
Sbjct: 73 GKHKNIINLLG--VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 133 ---------QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----- 178
Q+ RG+ +L S IHRDL N+ V +KI D GLA +
Sbjct: 131 QKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLV-TEDHVMKIADFGLARDIHHIDY 187
Query: 179 -RKSHAAHCVGTP-EFMAPE-VYEEAYNELVDIYSFGMCILEMVTF---EYP 224
RK+ P ++MAPE +++ Y D++SFG+ + E+ T YP
Sbjct: 188 YRKTTNGR---LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 48/167 (28%), Positives = 84/167 (50%), Gaps = 9/167 (5%)
Query: 76 LLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQIL 135
LLK +KH ++ + S+ T + FV + G L + + + + + +I
Sbjct: 49 LLKNVKHPFLVGLHYSFQTT--EKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIA 106
Query: 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAAHCVGTPEFM 193
L YLHS + +++RDLK +NI ++ +QG V + D GL I + GTPE++
Sbjct: 107 SALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYL 163
Query: 194 APEVY-EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVV 239
APEV ++ Y+ VD + G + EM+ + P C A++Y ++
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEML-YGLPPFYCRDVAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 45/147 (30%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 76 LLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQIL 135
LLK LKH ++ + S+ TA + + FV + G L + + + + + ++
Sbjct: 49 LLKNLKHPFLVGLHYSF-QTAEK-LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVA 106
Query: 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAAHCVGTPEFM 193
+ YLHS + +I+RDLK +NI ++ +QG V + D GL + + + GTPE++
Sbjct: 107 SAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYL 163
Query: 194 APEVY-EEAYNELVDIYSFGMCILEMV 219
APEV +E Y+ VD + G + EM+
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 56/238 (23%), Positives = 92/238 (38%), Gaps = 38/238 (15%)
Query: 30 LGKGASKTVYRAF-----DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84
LG+G+ VY VA +K + S + E ++K +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVA---IKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL-----------WCRQ 133
+++ V T + V E+ G L+ Y L+ +R +
Sbjct: 71 VVRLL-GVVSTGQPTL-VVMELMAKGDLKSY-LRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 134 ILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------RKSHAAHCV 187
I G+ YL + +HRDL N V + VKIGD G+ + RK
Sbjct: 128 IADGMAYLAAKK--FVHRDLAARNCMVAED-LTVKIGDFGMTRDIYETDYYRKGGKGL-- 182
Query: 188 GTP-EFMAPEVYEEA-YNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGK 242
P +MAPE ++ + D++SFG+ + EM T E PY ++ ++ K V+ G
Sbjct: 183 -LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVLKFVIDGG 238
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 53/163 (32%), Positives = 83/163 (50%), Gaps = 12/163 (7%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRV--NIRAVKLW 130
E +L+ +H + S+ T +R + FV E G L + L +RV RA + +
Sbjct: 45 ESRVLQNTRHPFLTALKYSF-QTHDR-LCFVMEYANGGELF-FHLSRERVFSEDRA-RFY 100
Query: 131 CRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAAHCVG 188
+I+ L YLHS D V++RDLK +N+ ++ + G +KI D GL I + G
Sbjct: 101 GAEIVSALGYLHSCD--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCG 157
Query: 189 TPEFMAPEVYEEA-YNELVDIYSFGMCILEMVTFEYPYSECTH 230
TPE++APEV E+ Y VD + G+ + EM+ P+ H
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 62/252 (24%), Positives = 104/252 (41%), Gaps = 34/252 (13%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E +GKG VY+ + EVA + P+ + E +LK H NI+K
Sbjct: 1 EKIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVK 56
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWCRQILRGLLYLHSHDP 146
V + I V E+ G+L + R K R+ ++ + G+ YL S +
Sbjct: 57 LIG--VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN- 113
Query: 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP-------EFMAPEVYE 199
IHRDL N V G +KI D G++ R+ + ++ APE
Sbjct: 114 -CIHRDLAARNCLV-GENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWTAPEALN 168
Query: 200 EA-YNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE--- 254
Y D++S+G+ + E + + PY ++ Q +++ SG YR+ P+
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-QQTRERIESG------YRMPAPQLCP 221
Query: 255 --VRRFVEKCLA 264
+ R + +C A
Sbjct: 222 EEIYRLMLQCWA 233
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 29 ILGKGASKTVY----RAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84
+LGKG+ V + DE I++ V + D +D+E E +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-----DDVECTMVEKRVLALQDKPP 61
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSH 144
+ S T +R + FV E G L + + + + +I GL +LH
Sbjct: 62 FLTQLHSCFQTVDR-LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV------GTPEFMAPEVY 198
+I+RDLK DN+ ++ ++G +KI D G+ K H V GTP+++APE+
Sbjct: 121 G--IIYRDLKLDNVMLD-SEGHIKIADFGMC----KEHMVDGVTTRTFCGTPDYIAPEII 173
Query: 199 E-EAYNELVDIYSFGMCILEMVTFEYPY 225
+ Y + VD +++G+ + EM+ + P+
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 38/142 (26%), Positives = 73/142 (51%), Gaps = 7/142 (4%)
Query: 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVN 161
V G L + + R ++ + + ++L L LH + VI+RDLK +NI ++
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD 127
Query: 162 GNQGEVKIGDLGLAAI-LRKSHAAHC-VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEM 218
QG + + D GL + ++ + GTPE++APE+ Y + VD ++ G+ + EM
Sbjct: 128 -YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEM 186
Query: 219 VTFEYPYSECTHPAQIYKKVVS 240
+T P+ + ++Y+K++
Sbjct: 187 LTGLPPFYDENVN-EMYRKILQ 207
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 63/221 (28%), Positives = 90/221 (40%), Gaps = 32/221 (14%)
Query: 29 ILGKGASKTVYR--AFDEY----EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
LG GA VY A D I VA VK + ++ + E HL+ H
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVA---VKTLRKGATDQEKKEFLKEAHLMSNFNH 58
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLW--------CRQI 134
NI+K + N + E+ G L Y L+ RV L C +
Sbjct: 59 PNIVKLLGVCLL--NEPQYIIMELMEGGDLLSY-LRDARVERFGPPLLTLKELLDICLDV 115
Query: 135 LRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGE----VKIGDLGLAAILRKSHAAHCVGTP 190
+G +YL IHRDL N V+ + VKIGD GLA + KS G
Sbjct: 116 AKGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 191 ----EFMAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPY 225
+MAPE + + + D++SFG+ + E++T + PY
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 55/181 (30%), Positives = 92/181 (50%), Gaps = 19/181 (10%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY---RLK-HKRVNIRAVK 128
E+H L H I+K + + ++ + + E + G L + RLK H V
Sbjct: 115 ELHCLAACDHFGIVKHFDDF--KSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 129 LWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS----HAA 184
L QI+ L +HS ++HRDLK NIF+ G +K+GD G + S A+
Sbjct: 173 LLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 185 HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQ--IYKKVVSG 241
GTP ++APE++E + Y++ D++S G+ + E++T P+ P+Q I ++V+ G
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK---GPSQREIMQQVLYG 286
Query: 242 K 242
K
Sbjct: 287 K 287
|
Length = 478 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 44/178 (24%), Positives = 87/178 (48%), Gaps = 8/178 (4%)
Query: 65 EDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNI 124
+ ++ ++ E +L + H + Y S+ D + + V E G + ++KR
Sbjct: 73 KQVDHVFSERKILNYINHPFCVNLYGSFKDESY--LYLVLEFVIGGEFFTFLRRNKRFPN 130
Query: 125 RAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 184
+ QI+ YL S + +++RDLK +N+ ++ + G +K+ D G A ++
Sbjct: 131 DVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDTRTYT 187
Query: 185 HCVGTPEFMAPEV-YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG 241
C GTPE++APE+ + + D ++ G+ I E++ P+ P IY+K++ G
Sbjct: 188 LC-GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY-ANEPLLIYQKILEG 243
|
Length = 340 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 8/206 (3%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
++LGKG V ++ G A +K + + + +++ E +L+ +H +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILK-KEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
S+ T +R + FV E G L + + + + + + +I+ L YLHS +
Sbjct: 60 LKYSF-QTHDR-LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS-EKN 116
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAAHCVGTPEFMAPEVYEEA-YNE 204
V++RDLK +N+ ++ + G +KI D GL I + GTPE++APEV E+ Y
Sbjct: 117 VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 205 LVDIYSFGMCILEMVTFEYPYSECTH 230
VD + G+ + EM+ P+ H
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQDH 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCR 132
E H+L+ + H +I++ ++ T N+ + + + L Y + + I + R
Sbjct: 133 EAHILRAINHPSIIQLKGTF--TYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIER 189
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI---LRKSHAAHCVGT 189
+LR + YLH + +IHRD+K +NIF+N + G+V +GD G A + + GT
Sbjct: 190 SVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 190 PEFMAPEVY-EEAYNELVDIYSFGMCILEMVT 220
APE+ + Y VDI+S G+ + EM T
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 19/157 (12%)
Query: 139 LYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---RKSHAAHCVGTPEFMA 194
L +HS H +HRD+K +N+ ++ G +K+ D G AA L + ++ VGTP+++A
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 195 PEVYEE-------AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSL 247
PEV Y D +S G+ EM+ P+ E T A+ Y +++ ++ L
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-SAKTYNNIMNFQR--FL 228
Query: 248 YRVKDPEV----RRFVEKCLATVSLRLSARELLNDPF 280
+DP+V ++ L RL L PF
Sbjct: 229 KFPEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 36/102 (35%), Positives = 59/102 (57%), Gaps = 6/102 (5%)
Query: 127 VKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAA 184
VK + ++ L +LHS +I+RDLK +NI ++ +G +K+ D GL+ +I + A
Sbjct: 100 VKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAY 156
Query: 185 HCVGTPEFMAPEVY-EEAYNELVDIYSFGMCILEMVTFEYPY 225
GT E+MAPEV + + D +SFG+ + EM+T P+
Sbjct: 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 66/246 (26%), Positives = 107/246 (43%), Gaps = 48/246 (19%)
Query: 17 VDPTGRYGRYNEILGK----GASKTVYRAFDEYEGIEVAWNQ------VKLYDFLQSPED 66
+DP + R +LGK G V RA E GI+ + VK+ + +D
Sbjct: 3 LDPKWEFPRDRLVLGKPLGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKD 60
Query: 67 LERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY---------- 115
L L E+ L+K + KHKNI+ V T + + E G LR++
Sbjct: 61 LADLISEMELMKLIGKHKNIINLLG--VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPD 118
Query: 116 ------RLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI 169
++ ++++ + + Q+ RG+ YL S IHRDL N+ V + +KI
Sbjct: 119 YTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDN-VMKI 175
Query: 170 GDLGLAAILRKSH-------AAHCVGTPEFMAPE-VYEEAYNELVDIYSFGMCILEMVTF 221
D GLA R H ++ ++MAPE +++ Y D++SFG+ + E+ T
Sbjct: 176 ADFGLA---RGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232
Query: 222 ---EYP 224
YP
Sbjct: 233 GGSPYP 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-09
Identities = 74/281 (26%), Positives = 113/281 (40%), Gaps = 50/281 (17%)
Query: 24 GRYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK 81
RY+ I +GKG VY A+D VA +++ D ++P +R E + L
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAADLI 60
Query: 82 HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIR-------------AVK 128
H I+ Y+ D + + T + G Y LK ++ +V
Sbjct: 61 HPGIVPVYSICSDG---DPVYYTMPYIEG----YTLKSLLKSVWQKESLSKELAEKTSVG 113
Query: 129 LWCR---QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---------- 175
+ +I + Y+HS V+HRDLK DNI + G GEV I D G A
Sbjct: 114 AFLSIFHKICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDL 170
Query: 176 AILRKSHAAHC----------VGTPEFMAPEVYEEA-YNELVDIYSFGMCILEMVTFEYP 224
+ C VGTP++MAPE +E DIY+ G+ + +M+T +P
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
Query: 225 YSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLAT 265
Y Y+ V+ + YR P + + K LA
Sbjct: 231 YRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAV 271
|
Length = 932 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 42/170 (24%), Positives = 82/170 (48%), Gaps = 7/170 (4%)
Query: 59 DFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 118
+ + ED++ + E H+ + + + S T +R + FV E G L + +
Sbjct: 31 ELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQR 89
Query: 119 HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--A 176
+++ + + +I L YLH +I+RDLK DN+ ++ ++G +K+ D G+
Sbjct: 90 QRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEG 146
Query: 177 ILRKSHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPY 225
+ + GTP ++APE+ E Y VD ++ G+ + EM+ P+
Sbjct: 147 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 17/178 (9%)
Query: 73 EIHLLKTLKHKNIMKF-----YTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAV 127
EI L L H+NI+K + + +F F ++ + RA+
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAI 272
Query: 128 KLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-- 185
+Q+L + Y+H D +IHRD+K +NIF+N + G++ +GD G A K A
Sbjct: 273 M---KQLLCAVEYIH--DKKLIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKEREAFDY 326
Query: 186 -CVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEY-PYSECT-HPAQIYKKVV 239
VGT +PE+ + Y E+ DI+S G+ +L+M++ ++ P + P + K++
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384
|
Length = 501 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 26/157 (16%)
Query: 125 RAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 184
RAV + +I GL LH +++RDLK +NI ++ + G ++I DLGLA + +
Sbjct: 103 RAV-FYAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETI 158
Query: 185 HC-VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK 242
VGT +MAPEV + E Y D + G I EM+ + P+ + K+
Sbjct: 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF-------RQRKE----- 206
Query: 243 KPDSLYRVKDPEVRRFVEKCLATVSLRLS--ARELLN 277
+VK EV R V++ S + S AR +
Sbjct: 207 ------KVKREEVERRVKEDQEEYSEKFSEAARSICR 237
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 58/233 (24%), Positives = 97/233 (41%), Gaps = 28/233 (12%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+GKG V +Y G +VA +K + E ++ TL+H N+++
Sbjct: 12 ATIGKGEFGDVMLG--DYRGQKVAVKCLK-----DDSTAAQAFLAEASVMTTLRHPNLVQ 64
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKR--VNIRAVKLWCRQILRGLLYLHSHD 145
V + VTE G+L Y R + + + + G+ YL +
Sbjct: 65 LLG--VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGT-P-EFMAPEVYEEA-Y 202
+HRDL N+ V+ K+ D GLA +++ G P ++ APE E +
Sbjct: 123 --FVHRDLAARNVLVS-EDLVAKVSDFGLA---KEASQGQDSGKLPVKWTAPEALREKKF 176
Query: 203 NELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254
+ D++SFG+ + E+ +F PY P K VV + YR++ PE
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPY-----PRIPLKDVV--PHVEKGYRMEAPE 222
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 39/143 (27%), Positives = 76/143 (53%), Gaps = 11/143 (7%)
Query: 99 NINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDN 157
++ VT++ G+L + +H+ ++ + + WC QI +G+ YL H ++HR+L N
Sbjct: 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARN 139
Query: 158 IFVNGNQGEVKIGDLGLAAIL---RKSHAAHCVGTP-EFMAPE-VYEEAYNELVDIYSFG 212
I + + V+I D G+A +L K + TP ++MA E + Y D++S+G
Sbjct: 140 ILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG 198
Query: 213 MCILEMVTF-EYPYSECTHPAQI 234
+ + EM+++ PY+ P ++
Sbjct: 199 VTVWEMMSYGAEPYAG-MRPHEV 220
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 61/276 (22%), Positives = 100/276 (36%), Gaps = 62/276 (22%)
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSH 144
++K Y S+ D N + FV + G + ++ + + ++ + +H
Sbjct: 63 VVKLYYSFQDKDN--LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120
Query: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH---------------------- 182
IHRD+K DNI ++ G +K+ D GL R +H
Sbjct: 121 G--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177
Query: 183 ----------------------AAHC-VGTPEFMAPEVYEE-AYNELVDIYSFGMCILEM 218
AH VGTP ++APEV Y +L D +S G+ + EM
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237
Query: 219 VTFEYPYSECTHPAQIYKKVVSGKKP-DSLYRVK-DPEVRRFVEKCLATVSLRL---SAR 273
+ + P+ T PA+ KV++ + + K E + + RL A
Sbjct: 238 LVGQPPFLADT-PAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGAD 296
Query: 274 ELLNDPFLQIDDCESNLRSLDYSRELDDMDPLIRQP 309
E+ PF + D S +R P I P
Sbjct: 297 EIKAHPFFKGIDFASLIRRQKAP-----YIPKITHP 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 45/135 (33%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAAHCVGTPEFMAPEVYE 199
H H +I+RDLK +NI ++ QG VK+ D GL +I + GT E+MAPE+
Sbjct: 115 HLHQQGIIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 200 EA-YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRF 258
+ + + VD +S G + +M+T P++ I K++ GK +L PE R
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI-DKILKGKL--NLPPYLTPEARDL 230
Query: 259 VEKCLA-TVSLRLSA 272
++K L S RL A
Sbjct: 231 LKKLLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 36/230 (15%)
Query: 13 EFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLE---- 68
EF D +Y + +I G+G V++A + VA +V + E
Sbjct: 4 EFPFCDEVSKYEKLAKI-GQGTFGEVFKARHKKTKQIVALKKVLM---ENEKEGFPITAL 59
Query: 69 RLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFT---------SGTLRQYRLKH 119
R EI +L+ LKH+N++ A + + +G L +K
Sbjct: 60 R---EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKF 116
Query: 120 KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA--I 177
I+ V + +L GL Y+H + ++HRD+K NI + + G +K+ D GLA
Sbjct: 117 TLSEIKKV---MKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLADFGLARAFS 170
Query: 178 LRKSHAAHC----VGTPEFMAPEVY--EEAYNELVDIYSFGMCIL-EMVT 220
L K+ + V T + PE+ E Y +D++ G CI+ EM T
Sbjct: 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG-CIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 39/138 (28%), Positives = 65/138 (47%), Gaps = 47/138 (34%)
Query: 149 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-------------------------- 182
IHRD+K DN+ ++ +G +K+ D GL L+KSH
Sbjct: 123 IHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181
Query: 183 --------------AAHCVGTPEFMAPEVY-EEAYNELVDIYSFGMCILEMVTFEYP--Y 225
A VGTP+++APEV+ + YN+ D +S G+ + EM+ YP
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV-GYPPFC 240
Query: 226 SECTHPAQIYKKVVSGKK 243
S+ +P + Y+K+++ K+
Sbjct: 241 SD--NPQETYRKIINWKE 256
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--W 130
E +L+KTL+H +++ Y V T I +TE G+L + + + KL +
Sbjct: 51 EANLMKTLQHDKLVRLYA--VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF 108
Query: 131 CRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP 190
QI G+ Y+ + IHRDL+ N+ V+ KI D GLA ++ + G
Sbjct: 109 SAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAK 165
Query: 191 ---EFMAPEVYE-EAYNELVDIYSFGMCILEMVTF-EYPY 225
++ APE ++ D++SFG+ + E+VT+ + PY
Sbjct: 166 FPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 21/192 (10%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---KRVNIRAVKL 129
E +L+K L+H +++ Y I +TE +G+L + LK ++ I +
Sbjct: 51 EANLMKQLQHPRLVRLYAV---VTQEPIYIITEYMENGSLVDF-LKTPEGIKLTINKLID 106
Query: 130 WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGT 189
QI G+ ++ + IHRDL+ NI V+ KI D GLA ++ + G
Sbjct: 107 MAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGA 163
Query: 190 P---EFMAPEVYEEA-YNELVDIYSFGMCILEMVTF-EYPYSECTHPAQI------YKKV 238
++ APE + D++SFG+ + E+VT+ PY T+P I Y+
Sbjct: 164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP 223
Query: 239 VSGKKPDSLYRV 250
P+ LY +
Sbjct: 224 RPDNCPEELYEL 235
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 28/200 (14%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY---------RLKHKRVN 123
E+ + + L HKN+++ + + + E G L+Q+ +LK ++
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115
Query: 124 IRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 183
+ C QI G+ +L + +HRDL N V+ +Q EVK+ L L+ + S
Sbjct: 116 TKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVS-SQREVKVSLLSLSKDVYNSEY 172
Query: 184 AHCVGT--P-EFMAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKV 238
P ++APE V E+ ++ D++SFG+ + E+ T E P+ + ++ ++
Sbjct: 173 YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-EEVLNRL 231
Query: 239 VSGK--------KPDSLYRV 250
+GK P LY++
Sbjct: 232 QAGKLELPVPEGCPSRLYKL 251
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 55/175 (31%), Positives = 83/175 (47%), Gaps = 23/175 (13%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTL-------RQYRLKHKRVNIR 125
EI LL+ LKH N++ ++ A+R + + + + L R + K V +
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFD-YAEHDLWHIIKFHRASKANKKPVQLP 106
Query: 126 --AVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGLAAILRK 180
VK QIL G+ YLH++ V+HRDLK NI V G +G VKI D+G A +
Sbjct: 107 RGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 181 -----SHAAHCVGTPEFMAPEVYEEA--YNELVDIYSFGMCILEMVTFEYPYSEC 228
+ V T + APE+ A Y + +DI++ G E++T E P C
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHC 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 34/91 (37%), Positives = 50/91 (54%), Gaps = 8/91 (8%)
Query: 132 RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA----HCV 187
RQ+L + Y+H +IHRD+K +N+ VNG + ++ +GD G A R S +
Sbjct: 267 RQLLSAIDYIHGEG--IIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGIA 323
Query: 188 GTPEFMAPEVYE-EAYNELVDIYSFGMCILE 217
GT + APEV + Y VDI+S G+ I E
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 30/198 (15%)
Query: 46 EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFVT 104
E + VA VK+ + +DL L E+ ++K + KHKNI+ + T + + +
Sbjct: 46 EAVTVA---VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--TQDGPLYVIV 100
Query: 105 EMFTSGTLRQY----------------RLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPV 148
E + G LR+Y R+ +++ + + Q+ RG+ YL S
Sbjct: 101 EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--C 158
Query: 149 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK----SHAAHCVGTPEFMAPE-VYEEAYN 203
IHRDL N+ V N +KI D GLA + + ++MAPE +++ Y
Sbjct: 159 IHRDLAARNVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT 217
Query: 204 ELVDIYSFGMCILEMVTF 221
D++SFG+ + E+ T
Sbjct: 218 HQSDVWSFGVLMWEIFTL 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 61/251 (24%), Positives = 102/251 (40%), Gaps = 41/251 (16%)
Query: 30 LGKGASKTVYRAFDEYEGI-------EVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
LG GA VY Y G +VA VK S +D E ++ H
Sbjct: 14 LGHGAFGEVYEG--LYRGRDGDAVELQVA---VKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVN--------IRAVKLWCRQI 134
+NI++ + R I + E+ G L+ + L+ R ++ + R +
Sbjct: 69 QNIVRLIGVSFERLPRFI--LLELMAGGDLKSF-LRENRPRPERPSSLTMKDLLFCARDV 125
Query: 135 LRGLLYLHSHDPPVIHRDLKCDNIFVN--GNQGEVKIGDLGLAA-ILRKSH--AAHCVGT 189
+G YL + IHRD+ N + G KI D G+A I R S+
Sbjct: 126 AKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 190 P-EFMAPEVYEEA-YNELVDIYSFGMCILEMVTFEY-PYSECTHPAQIYKKVVSGKK--- 243
P ++M PE + + + D++SFG+ + E+ + Y PY T+ ++ + V G +
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTGGGRLDP 242
Query: 244 ----PDSLYRV 250
P +YR+
Sbjct: 243 PKGCPGPVYRI 253
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 63 SPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTS-GTLRQY----RL 117
S + L E LL L H+NI+ V + FV + + G L+ + RL
Sbjct: 48 SEIQVTLLLQESCLLYGLSHQNILP--ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRL 105
Query: 118 ----KHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 173
+ ++ + + QI G+ YLH VIH+D+ N ++ + +VKI D
Sbjct: 106 GEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EELQVKITDNA 162
Query: 174 LAAILRKSHAAHCVGTPE-----FMAPEVYE-EAYNELVDIYSFGMCILEMVTF-EYPYS 226
L+ L HC+G E +MA E + Y+ D++SFG+ + E++T + PY
Sbjct: 163 LSRDLFPMDY-HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV 221
Query: 227 ECTHPAQIYKKVVSGKK-------PDSLYRV 250
E P ++ + G + PD L+ V
Sbjct: 222 E-IDPFEMAAYLKDGYRLAQPINCPDELFAV 251
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 43/170 (25%), Positives = 83/170 (48%), Gaps = 7/170 (4%)
Query: 59 DFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 118
+ + ED++ + E H+ +T + + S T +R + FV E + G L + +
Sbjct: 31 ELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESR-LFFVIEFVSGGDLMFHMQR 89
Query: 119 HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--A 176
+++ + + +I L +LH +I+RDLK DN+ ++ +G +K+ D G+
Sbjct: 90 QRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDA-EGHIKLTDYGMCKEG 146
Query: 177 ILRKSHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPY 225
I + GTP ++APE+ E Y VD ++ G+ + EM+ P+
Sbjct: 147 IRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-08
Identities = 48/186 (25%), Positives = 74/186 (39%), Gaps = 20/186 (10%)
Query: 69 RLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRV--NIRA 126
R E L L H NI+ S + V E TLR+ L
Sbjct: 24 RFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPGRTLRE-VLAADGALPAGET 81
Query: 127 VKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGE--VKIGDLGLAAILRKSHAA 184
+L Q+L L +H+ ++HRDLK NI V+ K+ D G+ +L A
Sbjct: 82 GRLML-QVLDALA--CAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138
Query: 185 ---------HCVGTPEFMAPE-VYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQI 234
+GTP + APE + E D+Y++G+ LE +T + + A+I
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ-RVVQGASVAEI 197
Query: 235 YKKVVS 240
+ +S
Sbjct: 198 LYQQLS 203
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 35/212 (16%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--- 129
E ++K L+H +++ Y + I VTE + G+L + K RA+KL
Sbjct: 51 EAQIMKKLRHDKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFL---KDGEGRALKLPNL 104
Query: 130 --WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV 187
Q+ G+ Y+ + IHRDL+ NI V G+ KI D GLA ++ +
Sbjct: 105 VDMAAQVAAGMAYIERMN--YIHRDLRSANILV-GDGLVCKIADFGLARLIEDNEYTARQ 161
Query: 188 GTP---EFMAPEVYEEAYNELV---DIYSFGMCILEMVTF-EYPYSECTHPAQI------ 234
G ++ APE Y D++SFG+ + E+VT PY + +
Sbjct: 162 GAKFPIKWTAPEA--ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG 219
Query: 235 YKKVVSGKKPDSLYRV------KDPEVRRFVE 260
Y+ P SL+ + KDPE R E
Sbjct: 220 YRMPCPQDCPISLHELMLQCWKKDPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 57/248 (22%), Positives = 107/248 (43%), Gaps = 53/248 (21%)
Query: 55 VKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ 114
VK+ S +L L E +LLK + H +++K Y + + + + + E G+LR
Sbjct: 35 VKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC--SQDGPLLLIVEYAKYGSLRS 92
Query: 115 Y-RLKHK-----------------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIH 150
+ R K + + + + QI RG+ YL + ++H
Sbjct: 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL--AEMKLVH 150
Query: 151 RDLKCDNIFVNGNQGEVKIGDLGLA-------AILRKSHAAHCVGTPEFMAPE-VYEEAY 202
RDL N+ V + ++KI D GL+ + +++S V ++MA E +++ Y
Sbjct: 151 RDLAARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPV---KWMAIESLFDHIY 206
Query: 203 NELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE-----VR 256
D++SFG+ + E+VT PY P +++ + +G YR++ PE +
Sbjct: 207 TTQSDVWSFGVLLWEIVTLGGNPYPGIA-PERLFNLLKTG------YRMERPENCSEEMY 259
Query: 257 RFVEKCLA 264
+ C
Sbjct: 260 NLMLTCWK 267
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 53/175 (30%), Positives = 83/175 (47%), Gaps = 23/175 (13%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTL-------RQYRLKHKRVNI- 124
EI LL+ LKH N++ ++ ++R + + + + L R + K + +
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFD-YAEHDLWHIIKFHRASKANKKPMQLP 106
Query: 125 -RAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGLAAILRK 180
VK QIL G+ YLH++ V+HRDLK NI V G +G VKI D+G A +
Sbjct: 107 RSMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 181 -----SHAAHCVGTPEFMAPEVYEEA--YNELVDIYSFGMCILEMVTFEYPYSEC 228
+ V T + APE+ A Y + +DI++ G E++T E P C
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHC 218
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 44/178 (24%), Positives = 89/178 (50%), Gaps = 24/178 (13%)
Query: 100 INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIF 159
++ + + G L + + +R + V+++ +I+ L +LH +I+RD+K +NI
Sbjct: 80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENIL 137
Query: 160 VNGNQGEVKIGDLGLAAIL---RKSHAAHCVGTPEFMAPEVY---EEAYNELVDIYSFGM 213
++ N G V + D GL+ A GT E+MAP++ + +++ VD +S G+
Sbjct: 138 LDSN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGV 196
Query: 214 CILEMVTFEYPYS---ECTHPAQIYKKVVSGKKP----------DSLYR--VKDPEVR 256
+ E++T P++ E A+I ++++ + P D + R +KDP+ R
Sbjct: 197 LMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 40/170 (23%), Positives = 79/170 (46%), Gaps = 7/170 (4%)
Query: 59 DFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 118
+ + ED++ + E H+ + + S T +R + V E G L + +
Sbjct: 31 ELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSR-LFLVIEYVNGGDLMFHMQR 89
Query: 119 HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--A 176
+++ + + +I L +LH +I+RDLK DN+ ++ + G +K+ D G+
Sbjct: 90 QRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDAD-GHIKLTDYGMCKEG 146
Query: 177 ILRKSHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPY 225
+ + GTP ++APE+ E Y VD ++ G+ + EM+ P+
Sbjct: 147 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 21/181 (11%)
Query: 82 HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLL 139
H NI++ V T +R + +TE +G+L ++ L+ +L R I G+
Sbjct: 64 HPNIIRLEG--VVTKSRPVMIITEYMENGSLDKF-LRENDGKFTVGQLVGMLRGIASGMK 120
Query: 140 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVG---TP-EFMAP 195
YL + +HRDL NI VN + K+ D GL+ L S A + P + AP
Sbjct: 121 YLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP 177
Query: 196 E-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKKPDSLYRVKDP 253
E + + D++SFG+ + E++++ E PY + ++ + K V G YR+ P
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDG------YRLPPP 230
Query: 254 E 254
Sbjct: 231 M 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 37/198 (18%)
Query: 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQ 164
EMFT R + V+ + +I+ L +LH +++RD+K +NI ++ ++
Sbjct: 91 EMFTHLYQRDN------FSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SE 141
Query: 165 GEVKIGDLGLAAIL---RKSHAAHCVGTPEFMAPEVY--EEAYNELVDIYSFGMCILEMV 219
G V + D GL+ K GT E+MAPE+ + + + VD +S G+ I E++
Sbjct: 142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201
Query: 220 TFEYPYS---ECTHPAQIYKKVVSGKKP----------DSLYR--VKDPEVRRFVEKCLA 264
T P++ E +++ ++++ P D L++ KDP+ R
Sbjct: 202 TGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKR-------- 253
Query: 265 TVSLRLSARELLNDPFLQ 282
+ A E+ PF +
Sbjct: 254 LGAGPQGASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 46/164 (28%), Positives = 72/164 (43%), Gaps = 16/164 (9%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWC 131
E ++ L H +++ Y V T I V E G L Y R + + + + C
Sbjct: 49 EAQVMMKLSHPKLVQLYG--VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106
Query: 132 RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP- 190
+ G+ YL S + VIHRDL N V NQ VK+ D G+ + GT
Sbjct: 107 LDVCEGMAYLESSN--VIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQYTSSTGTKF 163
Query: 191 --EFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHP 231
++ +PEV+ Y+ D++SFG+ + E+ +SE P
Sbjct: 164 PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV------FSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 15/164 (9%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--W 130
E ++ H NI++ V T + +TE +G L +Y L+ + +L
Sbjct: 56 EASIMGQFSHHNIIRL--EGVVTKFKPAMIITEYMENGALDKY-LRDHDGEFSSYQLVGM 112
Query: 131 CRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP 190
R I G+ YL D +HRDL NI VN + E K+ D GL+ +L +
Sbjct: 113 LRGIAAGMKYLS--DMNYVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSG 169
Query: 191 -----EFMAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSE 227
+ APE + + D++SFG+ + E+++F E PY +
Sbjct: 170 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 49/191 (25%), Positives = 88/191 (46%), Gaps = 19/191 (9%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--W 130
E +++KTL+H ++K + I +TE G+L + + KL +
Sbjct: 51 EANVMKTLQHDKLVKLHAV---VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 107
Query: 131 CRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP 190
QI G+ ++ + IHRDL+ NI V+ + KI D GLA ++ + G
Sbjct: 108 SAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAK 164
Query: 191 ---EFMAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQI------YKKVV 239
++ APE + ++ D++SFG+ ++E+VT+ PY ++P I Y+
Sbjct: 165 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR 224
Query: 240 SGKKPDSLYRV 250
P+ LY +
Sbjct: 225 PENCPEELYNI 235
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 37/133 (27%), Positives = 68/133 (51%), Gaps = 22/133 (16%)
Query: 127 VKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI--------L 178
+++ + + L YLH++ ++HRDLK DN+ + + G +K+ D GL+ I L
Sbjct: 103 ARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNL 159
Query: 179 RKSHAA---------HCVGTPEFMAPEV-YEEAYNELVDIYSFGMCILEMVTFEYPYSEC 228
+ H GTPE++APEV + Y + VD ++ G+ + E + P+
Sbjct: 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219
Query: 229 THPAQIYKKVVSG 241
T P +++ +V+S
Sbjct: 220 T-PEELFGQVISD 231
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 37/221 (16%)
Query: 30 LGKGASKTVYRA----FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKN 84
LG+G V A D+ + V VK+ + +DL L E+ ++K + KHKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKR-----------------VNIRAV 127
I+ + T + + + E + G LR+Y L+ +R ++ + +
Sbjct: 86 IINLLGAC--TQDGPLYVIVEYASKGNLREY-LRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 128 KLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV 187
Q+ RG+ YL S IHRDL N+ V + +KI D GLA + H +
Sbjct: 143 VSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIH--HIDYYK 197
Query: 188 GTP------EFMAPE-VYEEAYNELVDIYSFGMCILEMVTF 221
T ++MAPE +++ Y D++SFG+ + E+ T
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 12/154 (7%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLW-- 130
E ++ L H +++ Y V T + + VTE +G L Y L+ ++ + L
Sbjct: 49 EAKVMMKLSHPKLVQLYG--VCTQQKPLYIVTEFMENGCLLNY-LRQRQGKLSKDMLLSM 105
Query: 131 CRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP 190
C+ + G+ YL + IHRDL N V+ + G VK+ D G+ + G
Sbjct: 106 CQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAK 162
Query: 191 ---EFMAPEVYE-EAYNELVDIYSFGMCILEMVT 220
++ PEV+ Y+ D++SFG+ + E+ T
Sbjct: 163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 25/204 (12%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKF 88
+G+G V +A G A +K +S E + L EI L+ L H NI++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK--KHFKSLEQVNNLR-EIQALRRLSPHPNILRL 63
Query: 89 YTSWVDTANRNINFVTEM-------FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYL 141
D + V E+ G R+ L KRV K + Q+L+ L ++
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKG--RKRPLPEKRV-----KSYMYQLLKSLDHM 116
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG-LAAILRKSHAAHCVGTPEFMAPE--VY 198
H + + HRD+K +NI + +K+ D G I K + T + APE +
Sbjct: 117 HRNG--IFHRDIKPENILI--KDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLT 172
Query: 199 EEAYNELVDIYSFGMCILEMVTFE 222
+ Y +DI++ G E+++
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 41/160 (25%), Positives = 76/160 (47%), Gaps = 19/160 (11%)
Query: 81 KHKNIMKFYTS-WVDTA------NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQ 133
+ ++IM F S WV ++ + V E G L + + V + K + +
Sbjct: 92 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNL-MSNYDVPEKWAKFYTAE 150
Query: 134 ILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC---VGTP 190
++ L +HS +IHRD+K DN+ ++ G +K+ D G + ++ C VGTP
Sbjct: 151 VVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTP 207
Query: 191 EFMAPEVYEEA-----YNELVDIYSFGMCILEMVTFEYPY 225
++++PEV + Y D +S G+ + EM+ + P+
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 49/155 (31%), Positives = 75/155 (48%), Gaps = 26/155 (16%)
Query: 125 RAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 184
RAV + +I GL LH +++RDLK +NI ++ + G ++I DLGLA + +
Sbjct: 103 RAV-FYAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTI 158
Query: 185 HC-VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK 242
VGT +MAPEV + E Y D ++ G + EM+ + P+ Q KK
Sbjct: 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF-------QQRKK----- 206
Query: 243 KPDSLYRVKDPEVRRFVEKCLATVSLRLS--AREL 275
++K EV R V++ S + S AR L
Sbjct: 207 ------KIKREEVERLVKEVQEEYSEKFSPDARSL 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 31/204 (15%)
Query: 61 LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH- 119
L + +D +R E LL L+H++I+KFY D + V E G L ++ H
Sbjct: 48 LAARKDFQR---EAELLTNLQHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHG 102
Query: 120 ---------------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQ 164
+ + + QI G++YL S +HRDL N V G
Sbjct: 103 PDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV-GAN 159
Query: 165 GEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPE-VYEEAYNELVDIYSFGMCILEMV 219
VKIGD G++ + + H + +M PE + + D++SFG+ + E+
Sbjct: 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 219
Query: 220 TF-EYPYSECTHPAQIYKKVVSGK 242
T+ + P+ + + ++ + + G+
Sbjct: 220 TYGKQPWFQLS-NTEVIECITQGR 242
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 29/98 (29%), Positives = 54/98 (55%), Gaps = 11/98 (11%)
Query: 138 LLYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS---HAAHCVGTPEFM 193
+L +HS H +HRD+K DN+ ++ N G +++ D G + + ++ VGTP+++
Sbjct: 112 VLAIHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYI 170
Query: 194 APEVYEE------AYNELVDIYSFGMCILEMVTFEYPY 225
+PE+ + Y D +S G+C+ EM+ E P+
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 127 VKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC 186
+ +IL GL LH + ++RDLK +NI ++ + G ++I DLGLA + + +
Sbjct: 104 ALFYAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRG 160
Query: 187 -VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPY 225
VGT +MAPEV + Y D + G I EM+ + P+
Sbjct: 161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 21/158 (13%)
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC---VGTPEFMAPEVYEE 200
H IHRD+K DN+ ++ + G +K+ D G + + C VGTP++++PEV +
Sbjct: 159 HSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217
Query: 201 A-----YNELVDIYSFGMCILEMVTFEYP-YSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254
Y D +S G+ + EM+ + P Y++ Y K++ K +SL D E
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--VGTYSKIMDHK--NSLTFPDDIE 273
Query: 255 V----RRFVEKCLATVSLRL---SARELLNDPFLQIDD 285
+ + + L +RL E+ + PF + D
Sbjct: 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 8e-07
Identities = 51/230 (22%), Positives = 92/230 (40%), Gaps = 48/230 (20%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-FLQSPED-LERLYCEIHLLKTLKHKNI 85
++LGKG V+ + G A +K+ D + ++R+ E +L TL H +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFA---LKVLDKKEMIKRNKVKRVLTEQEILATLDHPFL 63
Query: 86 MKFYTSWVDTANRNINFVTEMFTSG----TLRQYRLKHKRVNIRAVKLWCRQILRGLLYL 141
Y + V + + G L Q + K ++ + + ++L L YL
Sbjct: 64 PTLY--ASFQTETYLCLVMD-YCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYL 119
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-----------AILRKSHAAH----- 185
H +++RDLK +NI ++ + G + + D L+ LRK
Sbjct: 120 HLLG--IVYRDLKPENILLHES-GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 186 ---------------CVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMV 219
VGT E++APEV + + VD ++ G+ + EM+
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 44/153 (28%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGT--LRQYRLKHKRVNIRAVKLW 130
EI +LKT+ H+ I+ A R + V + L Y + + +
Sbjct: 136 EIDILKTISHRAIINLIH-----AYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITI 190
Query: 131 CRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-HAAHC--- 186
R++L L YLH +IHRD+K +NIF++ +GD G A L C
Sbjct: 191 QRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGW 247
Query: 187 VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEM 218
GT E +PE+ + Y DI+S G+ + EM
Sbjct: 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 49/181 (27%), Positives = 81/181 (44%), Gaps = 33/181 (18%)
Query: 65 EDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-------- 115
+DL L E+ ++K + KHKNI+ + T + + + E + G LR+Y
Sbjct: 59 KDLSDLVSEMEMMKMIGKHKNIINLLGAC--TQDGPLYVLVEYASKGNLREYLRARRPPG 116
Query: 116 --------RLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEV 167
+L +++ + + Q+ RG+ YL S IHRDL N+ V +
Sbjct: 117 MDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVT-EDNVM 173
Query: 168 KIGDLGLAAILRKSHAAHCVGTP-------EFMAPE-VYEEAYNELVDIYSFGMCILEMV 219
KI D GLA R H ++MAPE +++ Y D++SFG+ + E+
Sbjct: 174 KIADFGLA---RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 230
Query: 220 T 220
T
Sbjct: 231 T 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 22/191 (11%)
Query: 72 CEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--KRVNIRAVKL 129
E ++ H NI+ V T ++ + VTE +G+L + KH + I+ V +
Sbjct: 54 SEASIMGQFDHPNIIHL--EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGM 111
Query: 130 WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGT 189
R I G+ YL D +HRDL NI VN N K+ D GL+ +L A
Sbjct: 112 -LRGIASGMKYLS--DMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTR 167
Query: 190 P-----EFMAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGK 242
+ APE + + D++S+G+ + E++++ E PY E ++ I K
Sbjct: 168 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI-------K 220
Query: 243 KPDSLYRVKDP 253
+ YR+ P
Sbjct: 221 AIEEGYRLPAP 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 33/110 (30%), Positives = 59/110 (53%), Gaps = 13/110 (11%)
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS---HAAHCVGTPEFMAPEVYEE 200
H +HRD+K DNI ++ N G +++ D G L + ++ VGTP++++PE+ +
Sbjct: 119 HQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 201 A------YNELVDIYSFGMCILEMVTFEYP-YSECTHPAQIYKKVVSGKK 243
Y D +S G+C+ EM+ E P Y+E + Y K+++ K+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHKE 225
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 58/263 (22%), Positives = 103/263 (39%), Gaps = 61/263 (23%)
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSH 144
++K Y S+ D N+ FV + G + ++ + + + ++ + +H
Sbjct: 63 VVKLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM 120
Query: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH---------------------- 182
IHRD+K DNI ++ + G +K+ D GL R +H
Sbjct: 121 G--FIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 183 ---------------------------AAHCVGTPEFMAPEV-YEEAYNELVDIYSFGMC 214
A VGTP ++APEV + Y +L D +S G+
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 215 ILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSL-YRVK-DPEVRRFVEKCLATVSLRL-- 270
+ EM+ + P+ T P + KV++ + + +VK PE + K + RL
Sbjct: 238 LFEMLVGQPPFLAPT-PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGR 296
Query: 271 -SARELLNDPFLQIDDCESNLRS 292
A ++ PF D S++R+
Sbjct: 297 NGADDIKAHPFFSEVDFSSDIRT 319
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 49/202 (24%), Positives = 82/202 (40%), Gaps = 28/202 (13%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWN---QVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIM 86
LG+G V+ WN +V + E E ++K L+H+ ++
Sbjct: 14 LGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 64
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLHSH 144
+ Y + I VTE + G+L + +R +L QI G+ Y+
Sbjct: 65 QLYAV---VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121
Query: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP---EFMAPEVYEEA 201
+ +HRDL+ NI V G K+ D GLA ++ + G ++ APE
Sbjct: 122 N--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA--AL 176
Query: 202 YNELV---DIYSFGMCILEMVT 220
Y D++SFG+ + E+ T
Sbjct: 177 YGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 28/232 (12%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
EI+G+G V + EY G +VA +K Q+ + E ++ L HKN+++
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQAFLE------ETAVMTKLHHKNLVR 63
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLHSHD 145
+ + + V E+ + G L + R + ++L + + G+ YL S
Sbjct: 64 LLGVIL---HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP-EFMAPEVYEEA-YN 203
++HRDL NI V+ G K+ D GLA + P ++ APE + ++
Sbjct: 121 --LVHRDLAARNILVS-EDGVAKVSDFGLARVGSM--GVDNSKLPVKWTAPEALKHKKFS 175
Query: 204 ELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254
D++S+G+ + E+ ++ PY + + ++ + V G YR++ PE
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVEKG------YRMEPPE 220
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 67/268 (25%), Positives = 113/268 (42%), Gaps = 41/268 (15%)
Query: 13 EFVEVDPTG-------RYGRYN----EILGKGA-----SKTVYRAFDEYEGIEVAWNQVK 56
E+V +DPT + R N + LG GA T Y ++VA VK
Sbjct: 15 EYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVA---VK 71
Query: 57 LYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY 115
+ + E L E+ ++ L H+NI+ + T I +TE G L +
Sbjct: 72 MLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC--TIGGPILVITEYCCYGDLLNF 129
Query: 116 --RLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEV-KIGDL 172
R + + + + + Q+ +G+ +L S + IHRDL N+ + G++ KI D
Sbjct: 130 LRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT--HGKIVKICDF 185
Query: 173 GLAAILRKSHAAHCVGTP----EFMAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYS 226
GLA + G ++MAPE ++ Y D++S+G+ + E+ + PY
Sbjct: 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP 245
Query: 227 ECTHPAQIYKKVVSGKKPDSLYRVKDPE 254
++ YK + G YR+ PE
Sbjct: 246 GMPVDSKFYKLIKEG------YRMAQPE 267
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 60/219 (27%), Positives = 87/219 (39%), Gaps = 34/219 (15%)
Query: 28 EILGKGASKTVYRA-----FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
LG+GA V+ E + VA +K + +D ER E LL +H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFER---EAELLTNFQH 67
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVK-------------L 129
+NI+KFY V T V E G L ++ H L
Sbjct: 68 ENIVKFYG--VCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 130 W-CRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVG 188
QI G++YL S +HRDL N V G VKIGD G++ + + G
Sbjct: 126 QIAVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLVVKIGDFGMSRDVYTTDYYRVGG 182
Query: 189 TP----EFMAPE--VYEEAYNELVDIYSFGMCILEMVTF 221
+M PE +Y + E D++SFG+ + E+ T+
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTY 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 46/142 (32%), Positives = 71/142 (50%), Gaps = 22/142 (15%)
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGE-VKIGDLGLAA-ILRKSHAAHCVGT- 189
Q+ G+ +L S + +HRDL N+ + +G+ VKI D GLA I+R S+ T
Sbjct: 247 QVANGMEFLASKN--CVHRDLAARNVLIC--EGKLVKICDFGLARDIMRDSNYISKGSTF 302
Query: 190 -P-EFMAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKKPD 245
P ++MAPE ++ Y L D++SFG+ + E+ T PY E Q Y + G
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRG---- 358
Query: 246 SLYRVKDP-----EVRRFVEKC 262
YR+ P E+ ++KC
Sbjct: 359 --YRMAKPAHASDEIYEIMQKC 378
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 26/192 (13%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---KRVNIRAVKL 129
E ++K L+H ++ Y + I VTE G+L + LK K + + +
Sbjct: 51 EAQIMKKLRHDKLVPLYAV---VSEEPIYIVTEFMGKGSLLDF-LKEGDGKYLKLPQLVD 106
Query: 130 WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGT 189
QI G+ Y+ + IHRDL+ NI V G+ KI D GLA ++ + G
Sbjct: 107 MAAQIADGMAYIERMN--YIHRDLRAANILV-GDNLVCKIADFGLARLIEDNEYTARQGA 163
Query: 190 P---EFMAPEVYEEAYNELV---DIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGK 242
++ APE Y D++SFG+ + E+VT PY P + ++V+ +
Sbjct: 164 KFPIKWTAPEA--ALYGRFTIKSDVWSFGILLTELVTKGRVPY-----PGMVNREVL--E 214
Query: 243 KPDSLYRVKDPE 254
+ + YR+ P+
Sbjct: 215 QVERGYRMPCPQ 226
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 29/80 (36%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC-VGTPEFMAPEVYE-EAYNEL 205
+++RDLK +NI ++ ++G ++I DLGLA + + VGT +MAPEV E Y
Sbjct: 123 IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 206 VDIYSFGMCILEMVTFEYPY 225
D + G I EM+ + P+
Sbjct: 182 PDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 81 KHKNIMKFYTS-WVDTA------NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQ 133
+ ++IM F S WV +R + V E G L + + V + + + +
Sbjct: 92 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL-MSNYDVPEKWARFYTAE 150
Query: 134 ILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC---VGTP 190
++ L +HS IHRD+K DN+ ++ G +K+ D G + K C VGTP
Sbjct: 151 VVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 207
Query: 191 EFMAPEVYEEA-----YNELVDIYSFGMCILEMVTFEYPY 225
++++PEV + Y D +S G+ + EM+ + P+
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 33/106 (31%), Positives = 57/106 (53%), Gaps = 17/106 (16%)
Query: 149 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-----SHAAHCVGTPEFMAPEVYEE--- 200
+HRD+K DN+ ++ N G +++ D G L S+ A VGTP++++PE+ +
Sbjct: 124 VHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVA--VGTPDYISPEILQAMED 180
Query: 201 ---AYNELVDIYSFGMCILEMVTFEYP-YSECTHPAQIYKKVVSGK 242
Y D +S G+C+ EM+ E P Y+E + Y K+++ K
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHK 224
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 7e-06
Identities = 41/185 (22%), Positives = 77/185 (41%), Gaps = 54/185 (29%)
Query: 76 LLKTLKHKN----------IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRL-------- 117
+ K +K KN +MK N NF+ ++ TL+ + L
Sbjct: 45 VQKIIKAKNFNAIEPMVHQLMKD----------NPNFIKLYYSVTTLKGHVLIMDYIKDG 94
Query: 118 -------KHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 170
K +++ VK RQ++ L LH H+ +IH D+K +N+ + + + +
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLC 152
Query: 171 DLGLAAILRKSHAAHCVGTP-------EFMAPE-VYEEAYNELVDIYSFGMCILEMVTFE 222
D GL +GTP ++ +PE + Y+ D ++ G+ E++T +
Sbjct: 153 DYGL---------CKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
Query: 223 YPYSE 227
+P+ E
Sbjct: 204 HPFKE 208
|
Length = 267 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 41/129 (31%), Positives = 67/129 (51%), Gaps = 17/129 (13%)
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGE-VKIGDLGLAA-ILRKSHAAHCVGT- 189
Q+ RG+ +L S + +HRDL N+ + QG+ VKI D GLA I+ S+ T
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLLA--QGKIVKICDFGLARDIMHDSNYVSKGSTF 300
Query: 190 --PEFMAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKKPD 245
++MAPE +++ Y L D++S+G+ + E+ + PY + Y K+ SG
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG---- 356
Query: 246 SLYRVKDPE 254
YR+ P+
Sbjct: 357 --YRMAKPD 363
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 33/125 (26%), Positives = 49/125 (39%), Gaps = 15/125 (12%)
Query: 131 CRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP 190
C Q L L LH L + + G V A + P
Sbjct: 23 CLQCLGALRELHRQAKS--GNILLTWDGLLK-LDGSV-------AFKTPEQS----RPDP 68
Query: 191 EFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYR 249
FMAPEV + +Y E DIYS G+ + E + +E PY+E + I + +++G D
Sbjct: 69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD 128
Query: 250 VKDPE 254
+ E
Sbjct: 129 RSNLE 133
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 15/163 (9%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWC 131
E ++ H NI+ V T +R + +TE +G L + R + + +
Sbjct: 55 EASIMGQFDHPNIIHL--EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGML 112
Query: 132 RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----AHCV 187
R I G+ YL + +HRDL NI VN N K+ D GL+ L + +
Sbjct: 113 RGIAAGMKYLS--EMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSL 169
Query: 188 GTP---EFMAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPY 225
G + APE + + D++S+G+ + E++++ E PY
Sbjct: 170 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 40/220 (18%)
Query: 30 LGKGASKTVYRA-----FDEYEGIEVAWNQVKLYDFLQSP-EDLERLYCEIHLLKTLKHK 83
LG+GA V+ A E + + VA +K + +S +D +R E LL L+H+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK--EASESARQDFQR---EAELLTVLQHQ 67
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK---------------RVNIRAVK 128
+I++FY V T R + V E G L ++ H ++ + +
Sbjct: 68 HIVRFYG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 129 LWCRQILRGLLYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV 187
QI G++YL S H +HRDL N V G VKIGD G++ + +
Sbjct: 126 AIASQIASGMVYLASLH---FVHRDLATRNCLV-GQGLVVKIGDFGMSRDIYSTDYYRVG 181
Query: 188 GTP----EFMAPE--VYEEAYNELVDIYSFGMCILEMVTF 221
G +M PE +Y + E DI+SFG+ + E+ T+
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTY 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANR--NINFVTEMFTSGTLRQYRLKHKRVNIRAVKLW 130
EI L+ + NI+K Y +D + ++ + E T G LR+ K K ++ KL
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSF-KTKL- 125
Query: 131 CRQIL---RGLLYLHSHD--PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH 185
+ +GL L+ + P +++L + V N ++KI GL IL S
Sbjct: 126 -DMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTEN-YKLKIICHGLEKIL-SSPPFK 179
Query: 186 CVGTPEFMAP----EVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG 241
V + + +++ E Y DIYS G+ + E+ T + P+ T +IY ++
Sbjct: 180 NVNFMVYFSYKMLNDIFSE-YTIKDDIYSLGVVLWEIFTGKIPFENLTT-KEIYDLII-- 235
Query: 242 KKPDSLY-RVKDP-EVRRFVEKCLATVSLR 269
K +SL + P E++ VE C + S++
Sbjct: 236 NKNNSLKLPLDCPLEIKCIVEACTSHDSIK 265
|
Length = 283 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 22/142 (15%)
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-------ILRKSHAAH 185
Q+ RG+ +L S IHRDL NI ++ N VKI D GLA +RK A
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 186 CVGTPEFMAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK 243
+ ++MAPE ++++ Y D++SFG+ + E+ + PY QI ++ K
Sbjct: 239 PL---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG----VQINEEFCQRLK 291
Query: 244 PDSLYRVKD---PEVRRFVEKC 262
+ R + PE+ R + C
Sbjct: 292 DGTRMRAPENATPEIYRIMLAC 313
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 40/121 (33%), Positives = 48/121 (39%), Gaps = 42/121 (34%)
Query: 132 RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGT-- 189
RQIL L LHS ++HRD+K NI + G KI DLG AA LR VG
Sbjct: 262 RQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLR-------VGINY 312
Query: 190 --------PEFMAPEVY------EEAYNELV-----------------DIYSFGMCILEM 218
P + APE Y A + V DIYS G+ L+M
Sbjct: 313 IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 372
Query: 219 V 219
Sbjct: 373 A 373
|
Length = 566 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 28/215 (13%)
Query: 45 YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104
+ G+ A VK +P++ E+ + L H N+++ +++ V
Sbjct: 17 HRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP--YLLVL 74
Query: 105 EMFTSGTLRQYRLKHKRVNIRAV-------KLWCRQILRGLLYLHSHDPPVIHRDLKCDN 157
E G L+ Y L+ R + + ++ C ++ GLL+LH D IH DL N
Sbjct: 75 EFCPLGDLKNY-LRSNRGMVAQMAQKDVLQRMAC-EVASGLLWLHQAD--FIHSDLALRN 130
Query: 158 IFVNGNQGEVKIGDLGLAAILRKSH---AAHCVGTP-EFMAPEVYEEAYNELV------- 206
+ + VKIGD GLA C P ++APE+ E +L+
Sbjct: 131 CQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKK 189
Query: 207 -DIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVV 239
+I+S G+ + E+ T + PY + + Q+ K+VV
Sbjct: 190 SNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQVV 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 17/103 (16%)
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-------RKSHAAH 185
Q+ RG+ +L S IHRDL NI ++ N VKI D GLA + RK A
Sbjct: 181 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARL 237
Query: 186 CVGTPEFMAPE-VYEEAYNELVDIYSFGMCILEMVTF---EYP 224
+ ++MAPE ++++ Y D++SFG+ + E+ + YP
Sbjct: 238 PL---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 57/226 (25%), Positives = 90/226 (39%), Gaps = 40/226 (17%)
Query: 25 RYNEILGKGASKTVYRA-----FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKT 79
R+ E LG+GA VY+ + VA +K + ++ + E L+
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ---EAELMSD 64
Query: 80 LKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK-------RVNIRAVK--LW 130
L+H NI+ V T + + E G L ++ +++ VK L
Sbjct: 65 LQHPNIVCLLG--VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLD 122
Query: 131 CR-------QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 183
C QI G+ YL SH +HRDL N V G VKI D GL+ R ++
Sbjct: 123 CSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLTVKISDFGLS---RDIYS 176
Query: 184 AHCVGTP-------EFMAPE-VYEEAYNELVDIYSFGMCILEMVTF 221
A +M PE + + DI+SFG+ + E+ ++
Sbjct: 177 ADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 20/224 (8%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+ +GKG V +Y G +VA +K + + E ++ L+H N+++
Sbjct: 12 QTIGKGEFGDV--MLGDYRGNKVAVKCIK------NDATAQAFLAEASVMTQLRHSNLVQ 63
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLHSHD 145
V+ + VTE G+L Y R + L + + + YL +++
Sbjct: 64 LLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN 122
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP-EFMAPE-VYEEAYN 203
+HRDL N+ V+ K+ D GL S P ++ APE + E+ ++
Sbjct: 123 --FVHRDLAARNVLVS-EDNVAKVSDFGLTK--EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 204 ELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKKPDS 246
D++SFG+ + E+ +F PY + +V G K D+
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKGYKMDA 220
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGIE----VAWNQVKLYDFLQSPEDLERLYCEIHLLKTL 80
R+ E LG+ A +Y+ G++ VA +K + Q + ++ E L+ L
Sbjct: 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQ---EASLMAEL 64
Query: 81 KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY---RLKHKRVNIRA-----VKL--- 129
H NI+ V T + + + E G L ++ R H V + VK
Sbjct: 65 HHPNIVCLLG--VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD 122
Query: 130 ------WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 182
QI G+ YL SH +H+DL NI + G Q VKI DLGL+ + +
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI-GEQLHVKISDLGLSREIYSADY 179
Query: 183 ---AAHCVGTPEFMAPE-VYEEAYNELVDIYSFGMCILEMVTF 221
+ +M PE + ++ DI+SFG+ + E+ +F
Sbjct: 180 YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSF 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 49/231 (21%), Positives = 91/231 (39%), Gaps = 75/231 (32%)
Query: 149 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-------------------------- 182
IHRD+K DNI ++ G +K+ D GL+ K H
Sbjct: 123 IHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181
Query: 183 -----------------------AAHCVGTPEFMAPEVY-EEAYNELVDIYSFGMCILEM 218
A VGTP+++APE++ ++ Y + D +S G + E
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFEC 241
Query: 219 VTFEYPY-SECTHPAQIYKKVVSGKKPDSLYRVKD----PEVRRFVEKCLATVSLRL--- 270
+ P+ SE +H + Y+K+++ + ++LY D E + + + RL
Sbjct: 242 LIGWPPFCSENSH--ETYRKIINWR--ETLYFPDDIHLSVEAEDLIRRLITNAENRLGRG 297
Query: 271 SARELLNDPFLQIDDCES----------NLRSLDYSR--ELDDMDPLIRQP 309
A E+ + PF + D ++ L+S+ + D+++ + P
Sbjct: 298 GAHEIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDTSYFPTDELEQVPEAP 348
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 54/205 (26%), Positives = 80/205 (39%), Gaps = 61/205 (29%)
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--------------------- 182
H IHRD+K DNI ++ G +K+ D GL R +H
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 183 ---AAHC-------------------------VGTPEFMAPEV-YEEAYNELVDIYSFGM 213
A+C VGTP ++APEV Y +L D +S G+
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 214 CILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLY---RVK-DPEVRRFVEKCLATVSLR 269
+ EM+ + P+ T P + KV++ + SL+ + K PE + K R
Sbjct: 237 ILYEMLVGQPPFLAQT-PLETQMKVINWQT--SLHIPPQAKLSPEASDLIIKLCRGPEDR 293
Query: 270 L---SARELLNDPFLQIDDCESNLR 291
L A E+ PF + D S+LR
Sbjct: 294 LGKNGADEIKAHPFFKTIDFSSDLR 318
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 50/192 (26%), Positives = 92/192 (47%), Gaps = 12/192 (6%)
Query: 29 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKF 88
++G+GA V + + VA + K D ++ E E E+ +L+TLK +NI++
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFK--DSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 89 YTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPV 148
++ + V E L V V+ + Q+++ + + H +D +
Sbjct: 66 KEAFRRRGK--LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--I 121
Query: 149 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH---CVGTPEFMAPEVYEEA-YNE 204
+HRD+K +N+ ++ N +K+ D G A L + A+ V T + +PE+ A Y +
Sbjct: 122 VHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 205 LVDIYSFGMCIL 216
VD++S G CIL
Sbjct: 181 AVDMWSVG-CIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 17/129 (13%)
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEV-KIGDLGLAAILRKSHAAHCVGTP- 190
Q+ +G+ +L S + IHRDL NI + G + KI D GLA +R G
Sbjct: 222 QVAKGMSFLASKN--CIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNAR 277
Query: 191 ---EFMAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKKPD 245
++MAPE ++ Y D++S+G+ + E+ + PY ++ YK + G
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG---- 333
Query: 246 SLYRVKDPE 254
YR+ PE
Sbjct: 334 --YRMLSPE 340
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 66/267 (24%), Positives = 114/267 (42%), Gaps = 46/267 (17%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHK 83
++ +++G+G V RA + +G+++ +K+ S D E+ +L L H
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMN-AAIKMLKEFASENDHRDFAGELEVLCKLGHHP 63
Query: 84 NIMKFYTSWVDTANRNINFVT-EMFTSGTLRQYRLKHK---------RVNIRAVKLWCRQ 133
NI+ + NR ++ E G L + K + + + A L +Q
Sbjct: 64 NIINLLGA---CENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 134 ILR-------GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILRKSH 182
+L+ G+ YL + IHRDL N+ V G KI D GL+ ++K+
Sbjct: 121 LLQFASDVATGMQYLS--EKQFIHRDLAARNVLV-GENLASKIADFGLSRGEEVYVKKTM 177
Query: 183 AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVS 240
V +MA E Y D++SFG+ + E+V+ PY T A++Y+K+
Sbjct: 178 GRLPV---RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-CAELYEKLPQ 233
Query: 241 GKKPDSLYRVKDP-----EVRRFVEKC 262
G YR++ P EV + +C
Sbjct: 234 G------YRMEKPRNCDDEVYELMRQC 254
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 43/167 (25%), Positives = 71/167 (42%), Gaps = 23/167 (13%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH------------- 119
E LL L+H++I+KFY V+ + V E G L ++ H
Sbjct: 57 EAELLTNLQHEHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRP 114
Query: 120 KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179
+ + +QI G++YL S +HRDL N V G VKIGD G++ +
Sbjct: 115 AELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV-GENLLVKIGDFGMSRDVY 171
Query: 180 KSH----AAHCVGTPEFMAPE-VYEEAYNELVDIYSFGMCILEMVTF 221
+ H + +M PE + + D++S G+ + E+ T+
Sbjct: 172 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTY 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 32/113 (28%), Positives = 52/113 (46%), Gaps = 15/113 (13%)
Query: 132 RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPE 191
+Q+ G+ YL + +HRDL N V N VKI D GL+ R ++A E
Sbjct: 137 KQVAAGMAYLS--ERKFVHRDLATRNCLVGENM-VVKIADFGLS---RNIYSADYYKASE 190
Query: 192 -------FMAPE-VYEEAYNELVDIYSFGMCILEMVTFEY-PYSECTHPAQIY 235
+M PE ++ Y D++++G+ + E+ ++ PY H IY
Sbjct: 191 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 65/264 (24%), Positives = 108/264 (40%), Gaps = 46/264 (17%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIM 86
+++G+G V +A + +G+ + +K S +D E+ +L L H NI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 87 KFYTSWVDTANRNINFVT-EMFTSGTLRQYRLKHK---------RVNIRAVKLWCRQILR 136
+ +R ++ E G L + K + N A L +Q+L
Sbjct: 60 NLLGA---CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 137 -------GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILRKSHAAH 185
G+ YL IHRDL NI V N KI D GL+ ++K+
Sbjct: 117 FAADVARGMDYLS--QKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRL 173
Query: 186 CVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK 243
V +MA E Y D++S+G+ + E+V+ PY T A++Y+K+ G
Sbjct: 174 PV---RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLPQG-- 227
Query: 244 PDSLYRVKDP-----EVRRFVEKC 262
YR++ P EV + +C
Sbjct: 228 ----YRLEKPLNCDDEVYDLMRQC 247
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 36/134 (26%), Positives = 61/134 (45%), Gaps = 16/134 (11%)
Query: 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVN 161
V E+ G L ++ K+K V + + Q+ G+ YL + +HRDL N+ +
Sbjct: 72 LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV 129
Query: 162 GNQGEVKIGDLGLAAILR--------KSHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFG 212
Q KI D GL+ L K+H V ++ APE ++ D++SFG
Sbjct: 130 -TQHYAKISDFGLSKALGADENYYKAKTHGKWPV---KWYAPECMNYYKFSSKSDVWSFG 185
Query: 213 MCILEMVTF-EYPY 225
+ + E ++ + PY
Sbjct: 186 VLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 15/102 (14%)
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-------ILRKSHAAH 185
Q+ +G+ +L S IHRDL NI ++ N VKI D GLA +RK A
Sbjct: 187 QVAKGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 186 CVGTPEFMAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPY 225
+ ++MAPE +++ Y D++SFG+ + E+ + PY
Sbjct: 244 PL---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 19/40 (47%), Positives = 28/40 (70%), Gaps = 3/40 (7%)
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177
L YLH H +IHRDLK DN+ ++ N+G +K+ D GL+ +
Sbjct: 117 LDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 60/250 (24%), Positives = 105/250 (42%), Gaps = 39/250 (15%)
Query: 28 EILGKGASKTVYRAF---DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84
+ILG+G +V D+ ++VA +KL S ++E E +K H N
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS--EIEEFLSEAACMKDFDHPN 62
Query: 85 IMKFYTSWVDTANRN---INFVTEMFTS-GTLRQYRLKHKRVNIRAVKLWCRQILR---- 136
+MK + ++ V F G L + L + R+ KL + +L+
Sbjct: 63 VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSF-LLYSRLGGLPEKLPLQTLLKFMVD 121
Query: 137 ---GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------RKSHAAHCV 187
G+ YL + + IHRDL N + + V + D GL+ + R+ A
Sbjct: 122 IALGMEYLSNRN--FIHRDLAARNCMLREDM-TVCVADFGLSKKIYSGDYYRQGRIAK-- 176
Query: 188 GTP-EFMAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKKP 244
P +++A E + + Y D+++FG+ + E+ T + PY + +IY + G
Sbjct: 177 -MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIYDYLRHGN-- 232
Query: 245 DSLYRVKDPE 254
R+K PE
Sbjct: 233 ----RLKQPE 238
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 59/251 (23%), Positives = 108/251 (43%), Gaps = 27/251 (10%)
Query: 28 EILGKGASKTVYRA-FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIM 86
++GKG VY + +G ++ VK + + E++E+ E ++K H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHC-AVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWCRQILRGLLYLHSHD 145
+ + + + M G LR + R + ++ + + Q+ +G+ YL S
Sbjct: 60 SLLGICLPSEGSPLVVLPYM-KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-ILRKS----HAAHCVGTP-EFMAPE-VY 198
+HRDL N ++ + VK+ D GLA I K H P ++MA E +
Sbjct: 119 --FVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 199 EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK-------PDSLYRV- 250
+ + D++SFG+ + E++T P I ++ G++ PD LY V
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVM 235
Query: 251 -----KDPEVR 256
PE+R
Sbjct: 236 LSCWHPKPEMR 246
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 66/268 (24%), Positives = 115/268 (42%), Gaps = 48/268 (17%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGI--EVAWNQVKLY-------DFLQSPEDLERLYCE-- 73
++ +++G+G V +A + +G+ + A ++K Y DF E L +L
Sbjct: 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 69
Query: 74 -IHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCR 132
I+LL +H+ + + N ++F+ + T + + + A L +
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNL-LDFLRKSRVLETDPAFAIANST----ASTLSSQ 124
Query: 133 QIL-------RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILRKS 181
Q+L RG+ YL IHRDL NI V G KI D GL+ ++K+
Sbjct: 125 QLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKT 181
Query: 182 HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVV 239
V +MA E Y D++S+G+ + E+V+ PY T A++Y+K+
Sbjct: 182 MGRLPV---RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLP 237
Query: 240 SGKKPDSLYRVKDP-----EVRRFVEKC 262
G YR++ P EV + +C
Sbjct: 238 QG------YRLEKPLNCDDEVYDLMRQC 259
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 745 | |||
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.51 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.35 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.2 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.17 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.96 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.8 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.79 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.71 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.7 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.63 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.61 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.52 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.42 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.33 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.31 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.22 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.17 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.07 | |
| PF12202 | 38 | OSR1_C: Oxidative-stress-responsive kinase 1 C ter | 98.01 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.98 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.86 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.84 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.69 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.54 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.48 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.45 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.42 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.38 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.33 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.3 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.3 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.29 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.12 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.07 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.01 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.51 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.45 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.44 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.4 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.26 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.08 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.95 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.89 | |
| PLN02236 | 344 | choline kinase | 95.89 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.72 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 95.71 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.7 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.31 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.13 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.89 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.6 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.33 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 92.84 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 92.16 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 91.22 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 88.82 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 86.58 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 86.53 | |
| PTZ00384 | 383 | choline kinase; Provisional | 86.09 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 83.44 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 83.37 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-94 Score=797.69 Aligned_cols=484 Identities=58% Similarity=0.914 Sum_probs=410.6
Q ss_pred CCCCCCCceEeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcc
Q 004564 7 LEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIM 86 (745)
Q Consensus 7 ~ep~~~~~~e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIV 86 (745)
.+|...+|+++||+|||.||.++||+|+|.+||+|+|..+|.+|||..+++.++.+++..+++|+.|+++|+.|+|||||
T Consensus 25 ~e~~~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIi 104 (632)
T KOG0584|consen 25 SEPDESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNII 104 (632)
T ss_pred hccccccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCcee
Confidence 45788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eEeEEEEecCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCc
Q 004564 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGE 166 (745)
Q Consensus 87 k~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~ 166 (745)
+||++|++..++++++|+|+|++|+|+.|++++++++.++++.|++|||+||.|||++.||||||||||+||||+|+.|.
T Consensus 105 rfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~ 184 (632)
T KOG0584|consen 105 RFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGE 184 (632)
T ss_pred eeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEcCcchhhhhhccCCCcccCCCCcCChhhhhhccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 004564 167 VKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDS 246 (745)
Q Consensus 167 VKL~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~ 246 (745)
|||+|+|||+.++.++..+.+|||.|||||+|++.|++++|||||||||+||+|+.+||++|.++++||++|++|.+|..
T Consensus 185 VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 185 VKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA 264 (632)
T ss_pred eeecchhHHHHhhccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHHHHHhhCccCCCCHHHHhcCCCCCccccccccccccccccccccCccccCCccccccCcCCC-CCCCC
Q 004564 247 LYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDMDPLIRQPHIDFHHIDNSF-SNGCA 325 (745)
Q Consensus 247 l~~~~s~el~d~I~kcL~dPskRpSa~ELL~hPff~~~~~~~~l~~l~~~~~l~~~~~~i~~p~~~~~~~~~s~-s~~~s 325 (745)
+.++.+|++++||++||...+.|+||.|||+||||+.+.....+.+.+ +...+.+. +.+......+ ..-..
T Consensus 265 l~kV~dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~d~g~~~~~~e~-----d~~~~~~~---~~~~~~~~~~~~~~~~ 336 (632)
T KOG0584|consen 265 LSKVKDPEVREFIEKCLATKSERLSAKELLKDPFFDEDGGIVELAPED-----DMSDPALS---LSLRDEDGKKNKRPKA 336 (632)
T ss_pred hhccCCHHHHHHHHHHhcCchhccCHHHHhhChhhccccccccccchh-----hccccccc---ccccccchhhcCCccc
Confidence 999999999999999999999999999999999999875431111100 00000010 0000000000 00001
Q ss_pred CCCCCCCCCCCCCCchhcccc--cccccc-ccCC------CCCCCccccccccccCCC-ceEEEEEEecCCCCccccccc
Q 004564 326 NGYGYDTPSEWGYSPVEVESN--GIELFG-YHDD------DHSSDVDISIKGKRRDDG-GIFLRLRIADKEGRIRNIYFP 395 (745)
Q Consensus 326 ~~~~~~~~~~~~~~~~e~~~~--~~~~~~-~~~~------~~~~~~~~~~~g~~~~~~-~i~L~LRi~d~~g~~~~I~F~ 395 (745)
+. ...+|+...++.+.. .+..++ ..++ ...++.++.|+|+++++. +++|.|||+|++|+.|||+||
T Consensus 337 n~----i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fp 412 (632)
T KOG0584|consen 337 NA----IQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFP 412 (632)
T ss_pred cc----ccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCC
Confidence 10 122333333322211 011111 1111 135678899999999887 999999999999999999999
Q ss_pred CcCCCCCHHHHHHHHHHccCCCcccHHHHHHHHHHHHHHhCCCCCCCCCCCCCC----CccCccccccCcCCCCCCCcch
Q 004564 396 FDVETDTALSVATEMVAELDITDQDVTKIADMIDGEIASLVPEWRPGPGIEETP----RFANQGFCSNCASNRTSTGSLM 471 (745)
Q Consensus 396 F~~~~DTa~sVA~EMV~~l~i~~~dv~~IA~~Id~~i~~l~p~w~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 471 (745)
|++++|||.+||.|||+++++++++|..||+|||++|.+|+|.|+.....++++ .....+.|.+|.++..+.++++
T Consensus 413 f~~~~dta~~Va~eMv~el~~~dq~v~~ia~mid~~i~~L~p~~~~~~~~~~s~~~~~~~~~~s~~~~~~s~~~~~~~~~ 492 (632)
T KOG0584|consen 413 FDLEGDTAPSVAHEMVEELEITDQPVVNIAEMIDGEISALVPNWKASTPNDESPHEQHTDNSVSIQRSSESATQSQKSFS 492 (632)
T ss_pred CcCCCcchhHHHHHHHhhcCCcccchhhHHHHHhchhhhcCCccCCCCCccccchhccCcccccccCCCccccccccccc
Confidence 999999999999999999999999999999999999999999999987666643 3446799999999999999999
Q ss_pred hhccCCCCCCccccccccC-CccccccccceeEE
Q 004564 472 EYFSNPYGTNLQLLQCCRN-GCASMHGRFGEITF 504 (745)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 504 (745)
+++-++. +....+|+.+ .|+..|+||...+.
T Consensus 493 ~~~~~~~--~~~~~~~~~~~~~~~~~~r~~~~~~ 524 (632)
T KOG0584|consen 493 SADPQQV--APFVQQSMEDPLSSDVESRFSKNEL 524 (632)
T ss_pred ccccccc--cccccccccCCCccccccccccccc
Confidence 8887662 2345566766 89999999997655
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-51 Score=434.77 Aligned_cols=252 Identities=31% Similarity=0.502 Sum_probs=230.2
Q ss_pred EeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEe
Q 004564 26 YNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTE 105 (745)
Q Consensus 26 l~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E 105 (745)
....||+|..|+||++.++.|++.+|+|.|... ..+....++.+|+++++..+||+||+||+.|+.... .++++||
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mE 158 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICME 158 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehh
Confidence 336799999999999999999999999998533 356778899999999999999999999999988443 6999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhh-CCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCCC
Q 004564 106 MFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 184 (745)
Q Consensus 106 ~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs-~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~~ 184 (745)
||++|+|..++.+.+++++..+..++++||+||.|||. ++ ||||||||.|||||. .|+|||||||.+..+.++...
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNs-kGeVKicDFGVS~~lvnS~a~ 235 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNS-KGEVKICDFGVSGILVNSIAN 235 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeecc-CCCEEeccccccHHhhhhhcc
Confidence 99999999999999999999999999999999999995 66 999999999999995 689999999999999999889
Q ss_pred cccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCC----CCCHHHHHHHHHcCCCCCCcccCCCHHHHHHH
Q 004564 185 HCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSE----CTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~----~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I 259 (745)
+++||..|||||.+.+ .|+.++||||||+.++||++|++||.. .....+++..|..+..|.......++++++||
T Consensus 236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV 315 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFV 315 (364)
T ss_pred cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence 9999999999999985 799999999999999999999999976 35788888888888877655556999999999
Q ss_pred HHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 260 EKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 260 ~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
..||+ +|.+|||++|||+|||++..
T Consensus 316 ~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 316 SCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred HHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 99999 99999999999999999743
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-52 Score=443.97 Aligned_cols=264 Identities=28% Similarity=0.381 Sum_probs=231.7
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHH---HHHHHHHHHHHHHhCCCCCcceEeEEEEecCC
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPE---DLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~---~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~ 97 (745)
..|+.+.+.||+|+||.|-+|+.+.+|+.||||++.......... ....+.+|+++|++|+|||||+++++|.. .
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~--~ 248 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV--P 248 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--C
Confidence 445688999999999999999999999999999998776443221 23346799999999999999999998866 6
Q ss_pred CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCC--CCcEEEcCcchh
Q 004564 98 RNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGN--QGEVKIGDLGLA 175 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~--~g~VKL~DFGlA 175 (745)
+..||||||+.||.|.+++..++.+.+..-+.+++|||.||.|||++| |+||||||+|||++.+ +-.+||+|||+|
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchh
Confidence 778999999999999999999999999999999999999999999999 9999999999999633 247999999999
Q ss_pred hhhhc-cCCCcccCCCCcCChhhhhh----ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC--Ccc
Q 004564 176 AILRK-SHAAHCVGTPEFMAPEVYEE----AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPD--SLY 248 (745)
Q Consensus 176 ~~l~~-~~~~~~vGTp~YmAPEvl~~----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~--~l~ 248 (745)
+.... +...+.+|||.|.|||++.. .|..++||||+||+||-+++|.+||++......+++.+..|..+. ..+
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 98764 34567789999999999962 355699999999999999999999999777777899999998763 356
Q ss_pred cCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcccccc
Q 004564 249 RVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDDCES 288 (745)
Q Consensus 249 ~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~~~~ 288 (745)
...+.++.+||.+||. ||++|||++|+|+||||+...+..
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s 447 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS 447 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence 6789999999999999 999999999999999999776544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-51 Score=452.20 Aligned_cols=258 Identities=33% Similarity=0.503 Sum_probs=234.8
Q ss_pred EeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEec
Q 004564 16 EVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT 95 (745)
Q Consensus 16 e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~ 95 (745)
-+|+..+++...++||+|||++||.+.+..+|..||+|+|.+.. .......+++.+||+|.++|+|||||+||++|.|
T Consensus 12 i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~-l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED- 89 (592)
T KOG0575|consen 12 IEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKL-LKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED- 89 (592)
T ss_pred eecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHH-hcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec-
Confidence 36666677788899999999999999999999999999997544 4456788999999999999999999999999987
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
..++|||+|+|..++|..++++++.++|..++.+++||+.||.|||+++ |||||||..|||++.+ .+|||+|||||
T Consensus 90 -s~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~-~~VKIgDFGLA 165 (592)
T KOG0575|consen 90 -SNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNEN-MNVKIGDFGLA 165 (592)
T ss_pred -CCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCc-CcEEeccccee
Confidence 7899999999999999999999999999999999999999999999999 9999999999999844 69999999999
Q ss_pred hhhhcc--CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCC
Q 004564 176 AILRKS--HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 176 ~~l~~~--~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s 252 (745)
+.+... ...+.+|||.|.|||++. ..++..+||||+||+||.||+|++||.. .+..++|.+|...... ++...+
T Consensus 166 t~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y~--~P~~ls 242 (592)
T KOG0575|consen 166 TQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEYS--MPSHLS 242 (592)
T ss_pred eeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCcc--cccccC
Confidence 998744 344568999999999997 5699999999999999999999999986 7799999999887764 344789
Q ss_pred HHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
.+++++|.++|. +|.+|||++++|.|+||.
T Consensus 243 ~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 243 AEAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 999999999999 999999999999999994
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=437.25 Aligned_cols=262 Identities=28% Similarity=0.412 Sum_probs=228.2
Q ss_pred eEeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEe
Q 004564 15 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVD 94 (745)
Q Consensus 15 ~e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd 94 (745)
.+..++..-|.+.+.||.|..++||+|+...++..||||++.+.+. ...++.+.+|++.|+.++||||+++|.+|+.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc---~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC---NNDLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh---hhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 4455666666899999999999999999999999999999998874 3448899999999999999999999999987
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCc
Q 004564 95 TANRNINFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 172 (745)
Q Consensus 95 ~~~~~iyLV~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DF 172 (745)
+..+|+||.||.+|++.++++.. ..+++..|..+++++|+||.|||++| .||||||+.||||+ .+|.|||+||
T Consensus 96 --~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~-~dG~VkLadF 170 (516)
T KOG0582|consen 96 --DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILID-SDGTVKLADF 170 (516)
T ss_pred --cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEc-CCCcEEEcCc
Confidence 78999999999999999998875 46999999999999999999999999 99999999999998 6699999999
Q ss_pred chhhhhhcc-----CC-CcccCCCCcCChhhhh---hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 004564 173 GLAAILRKS-----HA-AHCVGTPEFMAPEVYE---EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK 243 (745)
Q Consensus 173 GlA~~l~~~-----~~-~~~vGTp~YmAPEvl~---~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~ 243 (745)
|.+..+... .. .+++|||+|||||++. ..|+.|+|||||||+++||++|..||........+..++. |..
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq-n~p 249 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ-NDP 249 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-CCC
Confidence 998655321 12 5668999999999954 3699999999999999999999999999877777766654 444
Q ss_pred C--------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 244 P--------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 244 p--------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
| ....+.++..++.+|..||+ ||.+||||++||+|+||+...
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 3 33445567889999999999 999999999999999998654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=404.36 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=227.9
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.++||+|+||+||.++.+.+++.+|+|++++.... .....+....|..+|..++||.||+++-+|.+ ...+|||+
T Consensus 28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv-~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt--~~kLylVl 104 (357)
T KOG0598|consen 28 EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIV-EKKEVRHTKAERNILSKIKHPFIVKLIYSFQT--EEKLYLVL 104 (357)
T ss_pred eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhh-hhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc--CCeEEEEE
Confidence 7789999999999999999999999999999876543 34677889999999999999999999999976 78999999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc--cC
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SH 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~--~~ 182 (745)
||+.||.|+-.+++.+.+++..++.|+.+|+.||.|||++| ||||||||+|||+| .+|+|+|+|||+++..-. ..
T Consensus 105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd-~~GHi~LtDFgL~k~~~~~~~~ 181 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLD-EQGHIKLTDFGLCKEDLKDGDA 181 (357)
T ss_pred eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeec-CCCcEEEeccccchhcccCCCc
Confidence 99999999999999999999999999999999999999998 99999999999998 779999999999985433 23
Q ss_pred CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHH
Q 004564 183 AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEK 261 (745)
Q Consensus 183 ~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~k 261 (745)
..+++||+.|||||++. ..|+..+|+|||||++|||+||.+||.. .+...+++++..++.+ ..+...+.+++++|.+
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~~-~~p~~ls~~ardll~~ 259 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKLP-LPPGYLSEEARDLLKK 259 (357)
T ss_pred cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcCC-CCCccCCHHHHHHHHH
Confidence 44568999999999987 5799999999999999999999999987 7788999999988743 2345689999999999
Q ss_pred Hhh-CccCCC----CHHHHhcCCCCCccc
Q 004564 262 CLA-TVSLRL----SARELLNDPFLQIDD 285 (745)
Q Consensus 262 cL~-dPskRp----Sa~ELL~hPff~~~~ 285 (745)
+|+ +|.+|+ .++++-+||||...+
T Consensus 260 LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 260 LLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred HhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 999 999996 799999999998544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=424.90 Aligned_cols=267 Identities=35% Similarity=0.574 Sum_probs=237.6
Q ss_pred EeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEec
Q 004564 16 EVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT 95 (745)
Q Consensus 16 e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~ 95 (745)
..||..+|-.+ +.||+|+.|.||.|....++..||||++.+.. ....+-+.+|+.+|+.++|+|||+|+++|..
T Consensus 268 ~~dP~~~y~~~-~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~----Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv- 341 (550)
T KOG0578|consen 268 QGDPRSKYTDF-KKIGQGATGGVYVARKISTKQEVAIKRMDLRK----QPKKELLLNEILVMRDLHHPNIVNFLDSYLV- 341 (550)
T ss_pred CCChhhhhcch-hhhccccccceeeeeeccCCceEEEEEEEecc----CCchhhhHHHHHHHHhccchHHHHHHHHhcc-
Confidence 36888889555 67999999999999999999999999998665 2344568999999999999999999999987
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
+..+|+||||+.||+|.+.+.. ..+++.+++.+++++|.||+|||.+| |||||||.+|||++ .+|.|||+|||++
T Consensus 342 -~deLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~-~~g~vKltDFGFc 416 (550)
T KOG0578|consen 342 -GDELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLT-MDGSVKLTDFGFC 416 (550)
T ss_pred -cceeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEec-cCCcEEEeeeeee
Confidence 5789999999999999888654 45999999999999999999999999 99999999999997 6789999999999
Q ss_pred hhhhcc--CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCC
Q 004564 176 AILRKS--HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 176 ~~l~~~--~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s 252 (745)
..+... ...+.+|||.|||||++. ..|++++||||||++++||+-|++||-.......+|....+|..........+
T Consensus 417 aqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS 496 (550)
T KOG0578|consen 417 AQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLS 496 (550)
T ss_pred eccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccC
Confidence 887543 456678999999999997 57999999999999999999999999876777888888888888888888899
Q ss_pred HHHHHHHHHHhh-CccCCCCHHHHhcCCCCCccccccccccc
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDDCESNLRSL 293 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~~~~~l~~l 293 (745)
+++++|+.+||+ |+.+|++|.|||.||||+.+.....+.++
T Consensus 497 ~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ssL~pL 538 (550)
T KOG0578|consen 497 PELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKPESSLNPL 538 (550)
T ss_pred HHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCCHHHhHHH
Confidence 999999999999 99999999999999999877655554443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=404.08 Aligned_cols=258 Identities=28% Similarity=0.467 Sum_probs=225.8
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~ 98 (745)
.-|.| .+.+.||.|+||+||+|.++.++..||||.|..... ..+..+-+..||.+|+.++|||||.++++..+ ++
T Consensus 8 ~~~~y-~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~--~~ 82 (429)
T KOG0595|consen 8 VVGDY-ELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIED--DD 82 (429)
T ss_pred ccccc-eehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--CC
Confidence 45667 566679999999999999999999999999875542 56778889999999999999999999998765 67
Q ss_pred eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCC--C---CcEEEcCcc
Q 004564 99 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGN--Q---GEVKIGDLG 173 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~--~---g~VKL~DFG 173 (745)
.+|||||||.||+|..|+.+++.+++..++.++.||+.||++||+++ ||||||||+|||++.. . -.+||+|||
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 99999999999999999999999999999999999999999999999 9999999999999753 1 368999999
Q ss_pred hhhhhhccC-CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CCCcccC
Q 004564 174 LAAILRKSH-AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK-PDSLYRV 250 (745)
Q Consensus 174 lA~~l~~~~-~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~-p~~l~~~ 250 (745)
+|+.+.... ..+.+|+|.|||||++. +.|+.|+|+||+|+|+|+|++|+.||.. .++.+++..+..+.. ...+...
T Consensus 161 fAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~k~~~~~~~~~~~ 239 (429)
T KOG0595|consen 161 FARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIKKGNEIVPVLPAE 239 (429)
T ss_pred hhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHhccccccCchhhh
Confidence 999987643 44568999999999995 7899999999999999999999999998 567777777766553 3445556
Q ss_pred CCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 251 KDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 251 ~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
.+....+++...|+ ++..|.+..+-+.|+|+...
T Consensus 240 ~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 240 LSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred ccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 67777899999998 99999999999999999754
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=409.85 Aligned_cols=260 Identities=28% Similarity=0.497 Sum_probs=227.8
Q ss_pred eCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCC-HHHHHHHHHHHHHHHhCC-CCCcceEeEEEEe
Q 004564 17 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS-PEDLERLYCEIHLLKTLK-HKNIMKFYTSWVD 94 (745)
Q Consensus 17 ~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~-~~~~e~l~~Ei~iLk~L~-HpNIVk~~~sfvd 94 (745)
....|+| ++.+.||+|+||+|++|.+..++..||+|++........ ....+.+.+|+.+|+.++ ||||+++++++..
T Consensus 13 ~~~~g~y-~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 13 QLSIGKY-ELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred ccccCce-eeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 3456788 888999999999999999999999999997765422211 244566778999999999 9999999998755
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcch
Q 004564 95 TANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 174 (745)
Q Consensus 95 ~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGl 174 (745)
...+|+||||+.||+|.+++.+.+++.+..++.+++||+.|++|||++| |+||||||+|||++.+.+.+||+|||+
T Consensus 92 --~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 92 --PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred --CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 5569999999999999999999999999999999999999999999998 999999999999996658999999999
Q ss_pred hhhh--hccCCCcccCCCCcCChhhhhh-c-cC-ccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCccc
Q 004564 175 AAIL--RKSHAAHCVGTPEFMAPEVYEE-A-YN-ELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYR 249 (745)
Q Consensus 175 A~~l--~~~~~~~~vGTp~YmAPEvl~~-~-ys-~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~ 249 (745)
+... ......+.+|||.|+|||++.+ . |+ .++||||+||+||.|++|.+||.+ .+...++.++..+.... +.
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~~~--p~ 244 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEFKI--PS 244 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCccC--CC
Confidence 9988 3456677889999999999985 4 64 789999999999999999999998 67778888888887653 33
Q ss_pred CC-CHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 250 VK-DPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 250 ~~-s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
.. +++++.+|.+||. +|.+|+|+.+++.||||+..
T Consensus 245 ~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 245 YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 34 9999999999999 99999999999999999963
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-47 Score=404.31 Aligned_cols=254 Identities=33% Similarity=0.513 Sum_probs=218.3
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
...+.||+|+||+||+|.+..+|...|+|.+.... ... .+.+.+|+.+|++|+|||||++|+.........++++|
T Consensus 20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred hhhccccCccceEEEEEEecCCCcceeeeeeeccc---chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 66788999999999999999999999999998652 222 77899999999999999999999963221113799999
Q ss_pred eccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc---
Q 004564 105 EMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--- 180 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~-~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~--- 180 (745)
||+.+|+|.+++.+.+ ++++..++.+++|||+||+|||++| ||||||||+||||+..+|.+||+|||++.....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 9999999999999987 7999999999999999999999998 999999999999985368999999999987662
Q ss_pred --cCCCcccCCCCcCChhhhhhccC--ccccchhhhhHHHHHhhcCCCCCC-CCCHHHHHHHHHcCCCCCCcccCCCHHH
Q 004564 181 --SHAAHCVGTPEFMAPEVYEEAYN--ELVDIYSFGMCILEMVTFEYPYSE-CTHPAQIYKKVVSGKKPDSLYRVKDPEV 255 (745)
Q Consensus 181 --~~~~~~vGTp~YmAPEvl~~~ys--~ksDIWSLGvILyELlTG~~Pf~~-~~~~~~i~kkv~~g~~p~~l~~~~s~el 255 (745)
.......|||.|||||++...+. .++|||||||++.||+||+.||.+ ......++.....+..| .++...++++
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~ls~~a 252 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSLSDEA 252 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCcccCHHH
Confidence 22335679999999999984432 499999999999999999999988 45566666666666455 6777899999
Q ss_pred HHHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 256 RRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 256 ~d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
++||.+|++ +|.+||||++||+|||++...
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 999999999 999999999999999998543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=407.61 Aligned_cols=253 Identities=27% Similarity=0.436 Sum_probs=225.1
Q ss_pred eeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEE
Q 004564 24 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINF 102 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyL 102 (745)
+.|+++||.|+|++|++|.++.++++||||++.+.. +..+...+-+..|-..|..| .||.|+++|..|.| ...+|+
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~-Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~sLYF 151 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRY-IIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EESLYF 151 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHH-HHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--ccceEE
Confidence 489999999999999999999999999999886443 33445566677888999999 89999999999987 679999
Q ss_pred EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc-
Q 004564 103 VTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 181 (745)
Q Consensus 103 V~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~- 181 (745)
|+||+.+|+|.+|+.+.+.+++...+.|+.||+.||+|||++| ||||||||+||||+ .+|++||+|||.|+++...
T Consensus 152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd-~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLD-KDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEc-CCCcEEEeeccccccCChhh
Confidence 9999999999999999999999999999999999999999999 99999999999999 5689999999999886421
Q ss_pred --------------CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 004564 182 --------------HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDS 246 (745)
Q Consensus 182 --------------~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~ 246 (745)
....++||..|.+||++. +..++.+|||+||||||+|+.|.+||.+ .+...++++|..-...
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~NeyliFqkI~~l~y~-- 305 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-ANEYLIFQKIQALDYE-- 305 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-ccHHHHHHHHHHhccc--
Confidence 124579999999999997 5678999999999999999999999998 6778888988865543
Q ss_pred cccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 247 LYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 247 l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
++...++.+++||+++|. +|++|+|+++|.+||||...+
T Consensus 306 fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 306 FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 455677999999999999 999999999999999998654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=389.72 Aligned_cols=244 Identities=30% Similarity=0.456 Sum_probs=218.9
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.+.||+|.||+||+|.+..+|..||+|.|.... .+....+.+..|+.+|++|+|||||++|+.-+...+..+|+||
T Consensus 22 ~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~--md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 22 QILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM--MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHcCCcchheEEeeeccCcchhhhhhcchhh--ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 77889999999999999999999999999988433 4567788899999999999999999999943444566799999
Q ss_pred eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHhhhCCCC--EEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 105 EMFTSGTLRQYRLK----HKRVNIRAVKLWCRQILRGLLYLHSHDPP--VIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 105 E~~~gGsL~~~l~k----~~~L~e~~i~~ia~QIL~gL~yLHs~gp~--IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
||+.+|+|.+.++. ++.++++.++.++.|+++||..+|+.-+. |+||||||.|||++ ..|.|||+|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT-ANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc-CCCceeeccchhHhHh
Confidence 99999999987764 35699999999999999999999995455 99999999999998 5689999999999998
Q ss_pred hccC--CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHH
Q 004564 179 RKSH--AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEV 255 (745)
Q Consensus 179 ~~~~--~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el 255 (745)
.... ..+.+|||.||+||++. ..|+.++||||+||++|||+.-+.||.+ .+..++.+++..|..|+-....+|..+
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p~~~YS~~l 257 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLPDEHYSTDL 257 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCcHHHhhhHH
Confidence 7643 45678999999999987 6799999999999999999999999998 689999999999998877778899999
Q ss_pred HHHHHHHhh-CccCCCCH
Q 004564 256 RRFVEKCLA-TVSLRLSA 272 (745)
Q Consensus 256 ~d~I~kcL~-dPskRpSa 272 (745)
+.+|.-|+. ||..||+.
T Consensus 258 ~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 258 RELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHccCCcccCCCc
Confidence 999999999 99999987
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=404.33 Aligned_cols=254 Identities=25% Similarity=0.409 Sum_probs=223.8
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.++||+||||.||+|..+.||..+|+|++++... ....+++.++.|-.+|..-++|+||++|-+|.+ ..++||||
T Consensus 144 e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M-~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD--~~~LYLiM 220 (550)
T KOG0605|consen 144 ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM-LKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD--KEYLYLIM 220 (550)
T ss_pred hhheeeccccceeEEEEEEccCCcEEeeecccHHHH-HhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC--CCeeEEEE
Confidence 566889999999999999999999999999987663 345678889999999999999999999999987 78999999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc----
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK---- 180 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~---- 180 (745)
||++||++..++.+.+.|+++.++.|+.+++.|+..||++| ||||||||+|+||| ..|+|||+||||++.+..
T Consensus 221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD-~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLID-AKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeec-CCCCEeeccccccchhhhhhhh
Confidence 99999999999999999999999999999999999999999 99999999999998 679999999999854211
Q ss_pred ------------------cC---------------------------CCcccCCCCcCChhhhhh-ccCccccchhhhhH
Q 004564 181 ------------------SH---------------------------AAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMC 214 (745)
Q Consensus 181 ------------------~~---------------------------~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvI 214 (745)
.. ....+|||.|||||++.+ .|+..+|+||||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 00 112479999999999974 69999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCcccCCCHHHHHHHHHHhhCccCCCC---HHHHhcCCCCCccc
Q 004564 215 ILEMVTFEYPYSECTHPAQIYKKVVSGKK--PDSLYRVKDPEVRRFVEKCLATVSLRLS---ARELLNDPFLQIDD 285 (745)
Q Consensus 215 LyELlTG~~Pf~~~~~~~~i~kkv~~g~~--p~~l~~~~s~el~d~I~kcL~dPskRpS---a~ELL~hPff~~~~ 285 (745)
|||||.|.+||.. .++.+.+++|..+.. ..+-....++++++||.+||.+|.+|+. ++|+..||||+..+
T Consensus 378 myEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 378 MYEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCC
Confidence 9999999999987 788999999988762 2222334679999999999999999984 99999999998544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=380.82 Aligned_cols=250 Identities=28% Similarity=0.460 Sum_probs=227.6
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.+.||.|+||.|.++..+.+|..+|+|++++.+. ....+.+...+|.++|+.+.||++++++++|.+ ...+||||
T Consensus 47 e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v-VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d--~~~lymvm 123 (355)
T KOG0616|consen 47 ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV-VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD--NSNLYMVM 123 (355)
T ss_pred hheeeeccCccceEEEEEEccCCceeehhhcCHHHH-HHHHHHHHHhhHHHHHhhccCceeEEEEEeecc--CCeEEEEE
Confidence 344789999999999999999999999999987663 345678888999999999999999999999977 78999999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCCC
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 184 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~~ 184 (745)
||..||.|+.++++.+++++..++.|+.||+.||+|||+++ |++|||||+|||+| .+|.+||+|||+|+.+... ..
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD-~~G~iKitDFGFAK~v~~r-T~ 199 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLD-QNGHIKITDFGFAKRVSGR-TW 199 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeec-cCCcEEEEeccceEEecCc-EE
Confidence 99999999999999999999999999999999999999998 99999999999998 6699999999999887665 55
Q ss_pred cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHh
Q 004564 185 HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCL 263 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL 263 (745)
+.+|||.|+|||++. ..|+.++|.|||||++|||+.|.+||.. .++.++|.+|.+|+.- ++...+++++++|.++|
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~v~--fP~~fs~~~kdLl~~LL 276 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGKVK--FPSYFSSDAKDLLKKLL 276 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCccc--CCcccCHHHHHHHHHHH
Confidence 668999999999987 6799999999999999999999999987 6779999999998764 56678999999999999
Q ss_pred h-CccCC-----CCHHHHhcCCCCCcc
Q 004564 264 A-TVSLR-----LSARELLNDPFLQID 284 (745)
Q Consensus 264 ~-dPskR-----pSa~ELL~hPff~~~ 284 (745)
+ |-++| ....++.+||||+..
T Consensus 277 ~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 277 QVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred hhhhHhhhcCcCCCccccccCcccccc
Confidence 9 98888 468899999999844
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=408.82 Aligned_cols=258 Identities=25% Similarity=0.450 Sum_probs=232.2
Q ss_pred CCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCC
Q 004564 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 18 dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~ 97 (745)
+.-|=| ++++.||+|+.|.|-+|++..||+.+|||+|.+.. .........+.+||-||+.+.||||+++|+.|.. +
T Consensus 9 ~tiGpw-kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~-~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~ 84 (786)
T KOG0588|consen 9 NTIGPW-KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS-ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--K 84 (786)
T ss_pred ccccce-eccccccCCCCceehhhhcccccceeEEEeecccc-ccccccccchhhhhHHHHHhcCCCeeeeeeeecc--C
Confidence 445566 99999999999999999999999999999997553 2344566788999999999999999999999965 7
Q ss_pred CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 98 RNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
..+|+|.||+.+|.|++|+.+++++++...+++++||+.|+.|||..+ |+||||||+|+|++.+ ++|||+|||+|..
T Consensus 85 ~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~-~nIKIADFGMAsL 161 (786)
T KOG0588|consen 85 QHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVK-NNIKIADFGMASL 161 (786)
T ss_pred ceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcc-cCEeeeccceeec
Confidence 899999999999999999999999999999999999999999999998 9999999999999955 5699999999987
Q ss_pred hhc-cCCCcccCCCCcCChhhhhh-cc-CccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHH
Q 004564 178 LRK-SHAAHCVGTPEFMAPEVYEE-AY-NELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254 (745)
Q Consensus 178 l~~-~~~~~~vGTp~YmAPEvl~~-~y-s~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~e 254 (745)
... ....+.||+|.|+|||++.+ .| +.++||||.|||||.||||+.||.+ .+...++.||..|.+. ++..++++
T Consensus 162 e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f~--MPs~Is~e 238 (786)
T KOG0588|consen 162 EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVFE--MPSNISSE 238 (786)
T ss_pred ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCccc--CCCcCCHH
Confidence 544 45566789999999999985 45 5789999999999999999999996 8899999999999875 45788999
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 255 VRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 255 l~d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
++++|.+||. ||++|+|.+|+++|||++.-.
T Consensus 239 aQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 239 AQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 9999999999 999999999999999997543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=406.69 Aligned_cols=267 Identities=30% Similarity=0.526 Sum_probs=235.0
Q ss_pred ceEeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEE
Q 004564 14 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWV 93 (745)
Q Consensus 14 ~~e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfv 93 (745)
-..+++...|-++ +.||+|+||.||+|+|..+++.||+|++.+.. .+..++.+.+|+.+|.+++++||.++|++|+
T Consensus 6 ~~~~~~~~~~~~~-~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~~~~it~yygsyl 81 (467)
T KOG0201|consen 6 VLKIDPELLYTKL-ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCDSPNITEYYGSYL 81 (467)
T ss_pred hhcCCcccccccc-hhccccccceeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcCcchHHhhhhhee
Confidence 3456788888444 89999999999999999999999999998664 5677889999999999999999999999998
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcc
Q 004564 94 DTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 173 (745)
Q Consensus 94 d~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFG 173 (745)
. +..++++|||+.||++.+.++....+++..+..++++++.||.|||+++ .||||||+.||||... |.|||+|||
T Consensus 82 ~--g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~-g~vkl~Dfg 156 (467)
T KOG0201|consen 82 K--GTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSES-GDVKLADFG 156 (467)
T ss_pred e--cccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEecc-CcEEEEecc
Confidence 7 6789999999999999999888888899999999999999999999998 9999999999999844 999999999
Q ss_pred hhhhhhcc--CCCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccC
Q 004564 174 LAAILRKS--HAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRV 250 (745)
Q Consensus 174 lA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~ 250 (745)
++..+... ...+++|||.|||||++.+ .|+.++||||||++++||++|.+||..+..+..++ ++....|+.+...
T Consensus 157 Va~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf--lIpk~~PP~L~~~ 234 (467)
T KOG0201|consen 157 VAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF--LIPKSAPPRLDGD 234 (467)
T ss_pred eeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE--eccCCCCCccccc
Confidence 99887643 3467899999999999985 79999999999999999999999999977654444 3344556677778
Q ss_pred CCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCccccccccc
Q 004564 251 KDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDDCESNLR 291 (745)
Q Consensus 251 ~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~~~~~l~ 291 (745)
.++.+++||..||. +|..||+|.+||+|+|++.......+.
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~s~L~ 276 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAKKTSELK 276 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcCCchHHH
Confidence 89999999999999 999999999999999998755443333
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=380.96 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=221.4
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
..| .+.+.||+|+||+||+|.+..+++.||+|+++.... ......+.+.+|+.+|+.++||||+++++.+.+ +..+
T Consensus 18 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 93 (329)
T PTZ00263 18 SDF-EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI-LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRV 93 (329)
T ss_pred hhe-EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEE
Confidence 345 788999999999999999999999999999875432 223456778999999999999999999998876 6789
Q ss_pred EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 101 NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEC-CCCCEEEeeccCceEcCC
Confidence 999999999999999999899999999999999999999999998 99999999999998 568999999999976543
Q ss_pred cCCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHH
Q 004564 181 SHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259 (745)
Q Consensus 181 ~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I 259 (745)
.. ....||+.|+|||++. ..++.++|||||||++|+|+||..||.. .+..++++.+..+..+ ++...++.+++||
T Consensus 171 ~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~li 246 (329)
T PTZ00263 171 RT-FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRLK--FPNWFDGRARDLV 246 (329)
T ss_pred Cc-ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCcC--CCCCCCHHHHHHH
Confidence 32 3456999999999987 4588999999999999999999999986 5677788888877643 3456789999999
Q ss_pred HHHhh-CccCCCC-----HHHHhcCCCCCcc
Q 004564 260 EKCLA-TVSLRLS-----ARELLNDPFLQID 284 (745)
Q Consensus 260 ~kcL~-dPskRpS-----a~ELL~hPff~~~ 284 (745)
.+||+ +|.+|++ ++++++||||+..
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 99999 9999997 7999999999854
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=375.66 Aligned_cols=252 Identities=26% Similarity=0.407 Sum_probs=219.3
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+| ++.+.||+|+||+||+|.+..+++.||+|++..... ......+.+.+|+.+|+.++||||+++++.+.+ ...+|
T Consensus 2 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 77 (291)
T cd05612 2 DL-ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV-IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLY 77 (291)
T ss_pred Cc-eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEE
Confidence 45 677899999999999999999999999999875432 223456678899999999999999999998765 67899
Q ss_pred EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEEecCcchhccCC
Confidence 99999999999999999899999999999999999999999998 99999999999998 5689999999999776433
Q ss_pred CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHH
Q 004564 182 HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVE 260 (745)
Q Consensus 182 ~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~ 260 (745)
.....||+.|+|||++. ..++.++|||||||++|+|+||..||.. .+...++..+..+..+ +....++.++++|.
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~ 230 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKLE--FPRHLDLYAKDLIK 230 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcC--CCccCCHHHHHHHH
Confidence 23456999999999987 4588999999999999999999999987 5667778888776543 34556899999999
Q ss_pred HHhh-CccCCCC-----HHHHhcCCCCCcc
Q 004564 261 KCLA-TVSLRLS-----ARELLNDPFLQID 284 (745)
Q Consensus 261 kcL~-dPskRpS-----a~ELL~hPff~~~ 284 (745)
+||+ +|.+|++ ++++++||||+..
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 9999 9999995 9999999999743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=392.68 Aligned_cols=257 Identities=26% Similarity=0.347 Sum_probs=217.6
Q ss_pred eeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEE
Q 004564 23 YGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINF 102 (745)
Q Consensus 23 Y~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyL 102 (745)
|.++ ++||+|.||.||+|.+..+|+.||+|.|++.. ..+.......+||.||++|+|||||++.+..++.....+||
T Consensus 119 feki-~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~--~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 119 FEKI-EKIGEGTYGQVYKARDLETGKIVALKKVRFDN--EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred HHHH-HHhcCcchhheeEeeecccCcEEEEEEeeccc--CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 5333 67999999999999999999999999998664 23455666788999999999999999999888765689999
Q ss_pred EEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 103 VTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 103 V~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
|+|||+. +|..++.. .-++++.+|+.|++||+.||+|||++| |+|||||+.||||| +.|.+||+|||||+++...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLid-n~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILID-NNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEc-CCCCEEeccccceeeccCC
Confidence 9999986 77777665 347999999999999999999999998 99999999999998 7799999999999977543
Q ss_pred C---CCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCCCC----------
Q 004564 182 H---AAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-GKKPD---------- 245 (745)
Q Consensus 182 ~---~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~-g~~p~---------- 245 (745)
. .+..+-|.+|.|||++.+ .|+.++|+||+||||.||++|++.|.+.+..+|+-+.+.- |.+..
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 3 556689999999999975 5999999999999999999999999998877777654432 21111
Q ss_pred ---------------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcccc
Q 004564 246 ---------------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDDC 286 (745)
Q Consensus 246 ---------------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~~ 286 (745)
...+..++...+|+..+|. ||.+|.||.++|+++||.....
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~ 408 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPL 408 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCC
Confidence 1123357889999999999 9999999999999999965443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=375.15 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=212.8
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+|.++ .++|+|+||+||++.++.||+.||||.+... ..++...+-..+||++|++|+|||+|.++..|-. ++.++
T Consensus 3 kYE~L-gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es--edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklh 77 (396)
T KOG0593|consen 3 KYEKL-GKVGEGSYGVVMKCRNKDTGQIVAIKKFVES--EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLH 77 (396)
T ss_pred HHhhh-hccccCcceEEEEeccCCcccEEEEEeeccC--CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeE
Confidence 56555 4589999999999999999999999987533 2345556667899999999999999999997744 78999
Q ss_pred EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh-c
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR-K 180 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~-~ 180 (745)
+|+||++..-|..+-..-..++.+.++.+++|++.|+.|+|+++ +|||||||+||||+ .+|.|||||||+|+.+. +
T Consensus 78 LVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit-~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 78 LVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILIT-QNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred EEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEe-cCCcEEeccchhhHhhcCC
Confidence 99999988555555333457999999999999999999999999 99999999999998 66899999999999886 3
Q ss_pred -cCCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCC-------------
Q 004564 181 -SHAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-GKK------------- 243 (745)
Q Consensus 181 -~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~-g~~------------- 243 (745)
...+.++.|.+|.|||++-+ .|+..+||||+||++.||+||++.|++..+..++|..... |..
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 34556789999999999865 6999999999999999999999999999999999865432 221
Q ss_pred ------CC-----C---cccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 244 ------PD-----S---LYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 244 ------p~-----~---l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
|. . -+...+..+.+|+.+||+ ||.+|++.+|||.||||+
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 10 1 122245678899999999 999999999999999994
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=379.00 Aligned_cols=249 Identities=24% Similarity=0.408 Sum_probs=215.0
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEecc
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMF 107 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~ 107 (745)
++||+|+||+||+|.+..+|+.||+|+++.... ........+.+|+.+|+.++||||+++++.+.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCC
Confidence 469999999999999999999999999875432 234556778899999999999999999998865 67899999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc--cCCCc
Q 004564 108 TSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAAH 185 (745)
Q Consensus 108 ~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~--~~~~~ 185 (745)
.+|+|..++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++..... .....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccCCCcccc
Confidence 99999999999899999999999999999999999998 99999999999998 568999999999875322 22234
Q ss_pred ccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh
Q 004564 186 CVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA 264 (745)
Q Consensus 186 ~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~ 264 (745)
.+||+.|+|||++. ..|+.++|||||||++|||+||..||.. .+...++..+..+.. .++...++++++||.+||+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHcc
Confidence 56999999999987 4689999999999999999999999976 456666666665543 2445678999999999999
Q ss_pred -CccCCC-----CHHHHhcCCCCCccc
Q 004564 265 -TVSLRL-----SARELLNDPFLQIDD 285 (745)
Q Consensus 265 -dPskRp-----Sa~ELL~hPff~~~~ 285 (745)
+|.+|| ++.++++||||+..+
T Consensus 232 ~dP~~R~~~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 232 KDPKQRLGGGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred CCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 999999 899999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=375.90 Aligned_cols=255 Identities=22% Similarity=0.335 Sum_probs=217.2
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
++| .+.+.||+|+||.||+|.+..+++.||+|+++.... ........+..|+.+|+.++||||+++++.+.+ ...+
T Consensus 1 ~~y-~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~ 76 (333)
T cd05600 1 KDF-QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYL 76 (333)
T ss_pred CCc-EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEE
Confidence 356 778999999999999999999999999999875431 223456778899999999999999999998865 6789
Q ss_pred EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 101 NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
|+||||+.+|+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLID-ASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEEEeCcCCccccc
Confidence 999999999999999998889999999999999999999999998 99999999999998 568999999999976544
Q ss_pred cCCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcc------cCCCH
Q 004564 181 SHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLY------RVKDP 253 (745)
Q Consensus 181 ~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~------~~~s~ 253 (745)
.....+||+.|+|||++. ..++.++|||||||++|||++|..||.. .+..+++..+.........+ ...++
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~ 231 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSD 231 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCCCCCccccccCH
Confidence 334457999999999987 4689999999999999999999999987 55666666665433211111 23588
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 254 el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
++.+||.+||. +|.+||+++++++||||...
T Consensus 232 ~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 232 EAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999 78999999999999999843
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=379.59 Aligned_cols=254 Identities=25% Similarity=0.457 Sum_probs=215.9
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.++||+|+||+||+|.+..+|..||+|+++..... .......+.+|+.+|+.++||||+++++.|.+ ...+|+||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv~ 80 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYLIM 80 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEEEE
Confidence 6779999999999999999999999999999754321 23456678899999999999999999998876 67899999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC--
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-- 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~-- 182 (745)
||+.+|+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEeecccceeccccccc
Confidence 99999999999998889999999999999999999999998 99999999999998 56899999999986542211
Q ss_pred --------------------------------------CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCC
Q 004564 183 --------------------------------------AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEY 223 (745)
Q Consensus 183 --------------------------------------~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~ 223 (745)
....+||+.|+|||++. ..++.++|||||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 11236999999999986 568999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCc--ccCCCHHHHHHHHHHhhCccCCCC---HHHHhcCCCCCccc
Q 004564 224 PYSECTHPAQIYKKVVSGKKPDSL--YRVKDPEVRRFVEKCLATVSLRLS---ARELLNDPFLQIDD 285 (745)
Q Consensus 224 Pf~~~~~~~~i~kkv~~g~~p~~l--~~~~s~el~d~I~kcL~dPskRpS---a~ELL~hPff~~~~ 285 (745)
||.. .+..+.+..+..+...... ....++.++++|.+||.+|.+|++ ++++|.||||+..+
T Consensus 238 Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 238 PFCS-DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred CCCC-CCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCC
Confidence 9987 4456666666655432222 224689999999999999999997 99999999998543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=383.83 Aligned_cols=244 Identities=33% Similarity=0.517 Sum_probs=206.7
Q ss_pred EeEEecccCceEEEEEEEcCCCeE-EEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC-eEEEE
Q 004564 26 YNEILGKGASKTVYRAFDEYEGIE-VAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR-NINFV 103 (745)
Q Consensus 26 l~e~LG~GafgtVy~A~d~~tg~~-VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~-~iyLV 103 (745)
+.+.||.|+||+||+|. ..|.. ||+|++...... ....+.|.+|+.+|.+|+|||||+|++++.. .. ...+|
T Consensus 45 ~~~~iG~G~~g~V~~~~--~~g~~~vavK~~~~~~~~--~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~--~~~~~~iV 118 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGK--WRGTDVVAVKIISDPDFD--DESRKAFRREASLLSRLRHPNIVQFYGACTS--PPGSLCIV 118 (362)
T ss_pred hhhhcccCCceeEEEEE--eCCceeEEEEEecchhcC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCceEEE
Confidence 44559999999999994 55777 999998755532 2237899999999999999999999998754 33 68999
Q ss_pred EeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 104 TEMFTSGTLRQYRLK--HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k--~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
|||+.+|+|.+++.+ .+.++...+..|+.||++||.|||++++ ||||||||+||||+.+.-++||+|||+++.....
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999999988 6789999999999999999999999986 9999999999999844339999999999876653
Q ss_pred --CCCcccCCCCcCChhhhhh---ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHH
Q 004564 182 --HAAHCVGTPEFMAPEVYEE---AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVR 256 (745)
Q Consensus 182 --~~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~ 256 (745)
..+...||+.|||||++.+ .|+.++|||||||+||||+||+.||.........+..+..+..|. ++...++.+.
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~-~p~~~~~~l~ 276 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP-IPKECPPHLS 276 (362)
T ss_pred cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-CCccCCHHHH
Confidence 3333579999999999985 499999999999999999999999999776444445445555554 4555899999
Q ss_pred HHHHHHhh-CccCCCCHHHHhc
Q 004564 257 RFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 257 d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.+++.||. +|.+||+..+++.
T Consensus 277 ~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 277 SLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999 9999999999873
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=378.89 Aligned_cols=254 Identities=24% Similarity=0.412 Sum_probs=214.2
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.+.||+|+||+||+|.+..+++.||+|+++.... ........+..|+.+++.++||||+++++.+.+ ...+|+||
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~lv~ 80 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-LEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYLIM 80 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEEEE
Confidence 677899999999999999999999999999875432 223456778899999999999999999998866 67899999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC--
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-- 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~-- 182 (745)
||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~-~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCCEEEeeccCcccccccccc
Confidence 99999999999999999999999999999999999999998 99999999999998 56899999999986543210
Q ss_pred -----------------------------------CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCC
Q 004564 183 -----------------------------------AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYS 226 (745)
Q Consensus 183 -----------------------------------~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~ 226 (745)
....+||+.|+|||++. ..|+.++|||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 12347999999999986 568999999999999999999999998
Q ss_pred CCCCHHHHHHHHHcCCCCCCcc--cCCCHHHHHHHHHHhhCcc---CCCCHHHHhcCCCCCccc
Q 004564 227 ECTHPAQIYKKVVSGKKPDSLY--RVKDPEVRRFVEKCLATVS---LRLSARELLNDPFLQIDD 285 (745)
Q Consensus 227 ~~~~~~~i~kkv~~g~~p~~l~--~~~s~el~d~I~kcL~dPs---kRpSa~ELL~hPff~~~~ 285 (745)
. .+..++++++..+.....++ ...+++++++|.+++.+|. .||+++|+++||||+..+
T Consensus 238 ~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 238 S-ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred C-CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCC
Confidence 7 55677777777644322222 2368899999999877543 568999999999998554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=376.78 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=217.6
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+| .+.+.||+|+||+||+|.+..+|+.||+|+++.... ........+..|+.+|+.++||||+++++.|.+ +..+|
T Consensus 2 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~ 77 (350)
T cd05573 2 DF-EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM-IKRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLY 77 (350)
T ss_pred Cc-eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH-hhccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEE
Confidence 56 777999999999999999999999999999875432 223456778899999999999999999998865 67899
Q ss_pred EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
+||||+.+++|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+||||+ .++.+||+|||++......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILID-ADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEeecCCCCccCccc
Confidence 99999999999999998889999999999999999999999988 99999999999998 5689999999999765433
Q ss_pred C-------------------------------CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCC
Q 004564 182 H-------------------------------AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECT 229 (745)
Q Consensus 182 ~-------------------------------~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~ 229 (745)
. .....||+.|+|||++. ..++.++|||||||++|+|+||+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~- 233 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD- 233 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC-
Confidence 2 22346999999999987 46899999999999999999999999874
Q ss_pred CHHHHHHHHHcCC--CCCCcccCCCHHHHHHHHHHhhCccCCCC-HHHHhcCCCCCcc
Q 004564 230 HPAQIYKKVVSGK--KPDSLYRVKDPEVRRFVEKCLATVSLRLS-ARELLNDPFLQID 284 (745)
Q Consensus 230 ~~~~i~kkv~~g~--~p~~l~~~~s~el~d~I~kcL~dPskRpS-a~ELL~hPff~~~ 284 (745)
+....+.++.... .........++.+++||.+||.+|.+|++ ++++|+||||+..
T Consensus 234 ~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 234 TLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred CHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCC
Confidence 4556666666522 22222233689999999999999999999 9999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=387.41 Aligned_cols=260 Identities=31% Similarity=0.408 Sum_probs=218.6
Q ss_pred eCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceEeEEEEec
Q 004564 17 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTSWVDT 95 (745)
Q Consensus 17 ~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-HpNIVk~~~sfvd~ 95 (745)
+.-..|| .+.+.||.|.||.||+|..+.+|..||||.++..- -.-++.-. .+|++.|++|. |||||++.+.+.+.
T Consensus 6 ~~~m~RY-~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf--~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 6 VIFMDRY-TVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF--YSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred hhHHHHH-HHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh--ccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 4456788 66688999999999999999999999999987432 22233333 46999999998 99999999988774
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcch
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 174 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGl 174 (745)
. ..+|||||||+. +|.++++.+ +.+++..++.|++||+.||+|+|.+| +.||||||+||||.++ ..|||+|||+
T Consensus 82 ~-~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~-~~iKiaDFGL 156 (538)
T KOG0661|consen 82 D-RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGN-DVIKIADFGL 156 (538)
T ss_pred C-ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEeccc-ceeEeccccc
Confidence 3 399999999965 898888765 56999999999999999999999999 9999999999999865 5999999999
Q ss_pred hhhhhcc-CCCcccCCCCcCChhhhh--hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CC--------
Q 004564 175 AAILRKS-HAAHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-GK-------- 242 (745)
Q Consensus 175 A~~l~~~-~~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~-g~-------- 242 (745)
|+-.... -.+.++.|.+|+|||++. +.|+.++||||+|||++|+.+-++.|.+....+|||+...- |.
T Consensus 157 ARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 157 AREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred ccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 9877653 456678999999999885 57999999999999999999999999999999999986411 11
Q ss_pred -----------CC-------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 243 -----------KP-------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 243 -----------~p-------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
.| ..+....++++.++|.+||+ ||.+||||.|+|+||||+...
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 11 11222367899999999999 999999999999999999654
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=370.29 Aligned_cols=246 Identities=24% Similarity=0.387 Sum_probs=213.2
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEeccCC
Q 004564 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTS 109 (745)
Q Consensus 30 LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~~g 109 (745)
||+|+||+||+|.+..+++.||+|+++.... ........+..|+.+|+.++||||+++++.+.. ...+|+||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCC
Confidence 7999999999999999999999999874432 234556778899999999999999999998765 6789999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc--cCCCccc
Q 004564 110 GTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAAHCV 187 (745)
Q Consensus 110 GsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~--~~~~~~v 187 (745)
|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ......+
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEEC-CCCcEEEEECcccccCccCCCcccccc
Confidence 999999998889999999999999999999999998 99999999999997 568999999999875422 2223456
Q ss_pred CCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-C
Q 004564 188 GTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-T 265 (745)
Q Consensus 188 GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-d 265 (745)
||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+..++++.+..+.. .+....++.++++|.+||. +
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEPL--RFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHcCCC
Confidence 9999999999874 689999999999999999999999987 456677777766533 3455678999999999999 9
Q ss_pred ccCCC---CHHHHhcCCCCCcc
Q 004564 266 VSLRL---SARELLNDPFLQID 284 (745)
Q Consensus 266 PskRp---Sa~ELL~hPff~~~ 284 (745)
|.+|| ++.++|+||||...
T Consensus 232 p~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 232 PTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHHcCCCCCHHHHHcCCCcCCC
Confidence 99997 58999999999854
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=379.57 Aligned_cols=255 Identities=21% Similarity=0.372 Sum_probs=213.4
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
.| ++.+.||+|+||+||+|.+..+++.||+|++..... ......+.+.+|+.+|+.++||||++++++|.+ ...+|
T Consensus 2 ~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~ 77 (377)
T cd05629 2 DF-HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLY 77 (377)
T ss_pred Cc-eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeE
Confidence 45 677999999999999999999999999999875432 224456788999999999999999999998865 67899
Q ss_pred EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
+||||+.+|+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++ .+|.+||+|||+++.+...
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~-~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEEeecccccccccc
Confidence 99999999999999998889999999999999999999999998 99999999999997 5689999999998532110
Q ss_pred -------------------------------------------------CCCcccCCCCcCChhhhh-hccCccccchhh
Q 004564 182 -------------------------------------------------HAAHCVGTPEFMAPEVYE-EAYNELVDIYSF 211 (745)
Q Consensus 182 -------------------------------------------------~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSL 211 (745)
.....+||+.|+|||++. ..|+.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 001246999999999986 468999999999
Q ss_pred hhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcc--cCCCHHHHHHHHHHhhCccC---CCCHHHHhcCCCCCcc
Q 004564 212 GMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLY--RVKDPEVRRFVEKCLATVSL---RLSARELLNDPFLQID 284 (745)
Q Consensus 212 GvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~--~~~s~el~d~I~kcL~dPsk---RpSa~ELL~hPff~~~ 284 (745)
||++|||+||..||.. ......+..+........+. ...++++++||.+||.+|.+ |+++.++|.||||+..
T Consensus 235 Gvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 235 GAIMFECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred chhhhhhhcCCCCCCC-CCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCC
Confidence 9999999999999976 44566666666543222222 24688999999999996655 5699999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=390.89 Aligned_cols=250 Identities=26% Similarity=0.434 Sum_probs=222.0
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+|. +-+.||+|+||.||+|..+++.+.||+|.+.+.. ..++++..+.+|++|++.|+|||||.++++|.. ...+|
T Consensus 3 ~yh-v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g--r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~~~~~ 77 (808)
T KOG0597|consen 3 QYH-VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG--RNEKELKNLRQEVRILRSLKHPNIVEMLESFET--SAHLW 77 (808)
T ss_pred chh-HHHHhcCCccceeeecccccceeEEEEEEehhcC--CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--cceEE
Confidence 563 3478999999999999999999999999987554 567889999999999999999999999998854 68999
Q ss_pred EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
+|+||+.| +|+.++...+.++++.++.+++|++.||.|||+++ |+|||+||.|||+. ..|.+|+||||+|+.+...
T Consensus 78 vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLE-KGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred EEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeec-CCCceeechhhhhhhcccC
Confidence 99999987 99999999999999999999999999999999998 99999999999997 5689999999999987653
Q ss_pred C--CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHH
Q 004564 182 H--AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRF 258 (745)
Q Consensus 182 ~--~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~ 258 (745)
. .+..-|||-|||||+++ +.|+..+|+||||||+|||.+|++||.. ....++.+.|.... ..++...+..++.|
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d~--v~~p~~~S~~f~nf 230 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKDP--VKPPSTASSSFVNF 230 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcCC--CCCcccccHHHHHH
Confidence 3 33445999999999998 5699999999999999999999999986 56777777776543 33444789999999
Q ss_pred HHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 259 VEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 259 I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
+..+|. ||.+|+|..+|+.|||.+.
T Consensus 231 l~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 231 LQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred HHHHhhcChhhcccHHHHhcChHHhh
Confidence 999999 9999999999999999974
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=373.37 Aligned_cols=257 Identities=29% Similarity=0.421 Sum_probs=217.7
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEe---cC
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVD---TA 96 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd---~~ 96 (745)
..+| ...+.||+|+||.|+.|.++.+|..||||.+. +........++..+|+.+|+.++|+||+.+++.+.. ..
T Consensus 21 ~~~y-~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~--~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 21 PRYY-VLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL--NPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred ccee-cccccccCcceeeEEEEEEcCCCCEeehhhhh--hhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 3444 44588999999999999999999999999764 334567788999999999999999999999998754 23
Q ss_pred CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 97 NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 97 ~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
-..+|+|+|+| +.+|.+.++.++.++++.+..+++|||+||+|+|+.+ |+||||||.|+|+|. +..+||+|||+|+
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~-~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNA-DCDLKICDFGLAR 173 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeecc-CCCEEecccccee
Confidence 46899999999 5589999888888999999999999999999999988 999999999999994 5799999999999
Q ss_pred hhh----ccCCCcccCCCCcCChhhhh--hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc----------
Q 004564 177 ILR----KSHAAHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS---------- 240 (745)
Q Consensus 177 ~l~----~~~~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~---------- 240 (745)
... ....+..+-|..|.|||++. ..|+.++||||+||||.||++|++.|.+.....|+...+.-
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 885 44556778999999999886 57999999999999999999999999886665555332210
Q ss_pred --------------CCCC----CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 241 --------------GKKP----DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 241 --------------g~~p----~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
...| ..+....++.+.+++++||. ||.+|+||+|+|.||||..
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 1111 12344578999999999999 9999999999999999973
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=378.61 Aligned_cols=256 Identities=24% Similarity=0.360 Sum_probs=214.2
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+| .+.++||+|+||+||+|.+..++..||+|++..... ........+..|+.+|+.++||||+++++.|.+ +..+|
T Consensus 2 ~f-~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~ 77 (382)
T cd05625 2 MF-VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-LLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLY 77 (382)
T ss_pred Cc-EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEE
Confidence 45 667889999999999999999999999999875432 224556788999999999999999999999876 67899
Q ss_pred EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
+||||+.+|+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~-~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEeECCCCcccccc
Confidence 99999999999999988888999999999999999999999998 99999999999998 5689999999997532100
Q ss_pred -------------------------------------------------CCCcccCCCCcCChhhhh-hccCccccchhh
Q 004564 182 -------------------------------------------------HAAHCVGTPEFMAPEVYE-EAYNELVDIYSF 211 (745)
Q Consensus 182 -------------------------------------------------~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSL 211 (745)
.....+||+.|+|||++. ..|+.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 012246999999999986 569999999999
Q ss_pred hhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC--CcccCCCHHHHHHHHHHhhCccCCCC---HHHHhcCCCCCccc
Q 004564 212 GMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPD--SLYRVKDPEVRRFVEKCLATVSLRLS---ARELLNDPFLQIDD 285 (745)
Q Consensus 212 GvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~--~l~~~~s~el~d~I~kcL~dPskRpS---a~ELL~hPff~~~~ 285 (745)
||++|||+||+.||... ++.+...++....... ......++++.++|.+|+.+|.+|++ ++++++||||+..+
T Consensus 235 Gvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 235 GVILYEMLVGQPPFLAQ-TPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred hHHHHHHHhCCCCCCCC-CHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 99999999999999874 4455555555433222 22335689999999998889999987 99999999998543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=369.01 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=215.2
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
..+| ++.+.||+|+||.||+|.+..+|..||+|++.... .....+++.+|+.+|+.++||||+++++++.. +..
T Consensus 4 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 77 (331)
T cd06649 4 DDDF-ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGE 77 (331)
T ss_pred cccc-eEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCE
Confidence 4566 66788999999999999999999999999987532 34566789999999999999999999998876 578
Q ss_pred EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 100 INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
+++||||+.+++|.+++.+...+++..+..++.||+.||.|||+.+ +|+||||||+|||++ .++.+||+|||++....
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLI 155 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEc-CCCcEEEccCccccccc
Confidence 9999999999999999998889999999999999999999999852 399999999999998 56899999999997765
Q ss_pred ccCCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHH----------------------
Q 004564 180 KSHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYK---------------------- 236 (745)
Q Consensus 180 ~~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k---------------------- 236 (745)
........||+.|+|||++. ..++.++|||||||++|+|+||+.||... ...++..
T Consensus 156 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP-DAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccccCCccccCcccc
Confidence 55555567999999999987 45899999999999999999999999652 2222221
Q ss_pred ------------------------HHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 237 ------------------------KVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 237 ------------------------kv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
.+.....|.......++++++||.+||+ +|.+|||+.+||+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 1222222222233567899999999999 99999999999999999743
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=374.74 Aligned_cols=253 Identities=23% Similarity=0.406 Sum_probs=218.3
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCC-eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEG-IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg-~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
..| .+.+.||+|+||.||+|.+..++ ..||+|.+..... ......+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 30 ~~y-~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~ 105 (340)
T PTZ00426 30 EDF-NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI-IKQKQVDHVFSERKILNYINHPFCVNLYGSFKD--ESY 105 (340)
T ss_pred hhc-EEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe--CCE
Confidence 345 77789999999999999876655 7899999875432 234456778999999999999999999999866 678
Q ss_pred EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 100 INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
+|+||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEecCCCCeecC
Confidence 9999999999999999999999999999999999999999999998 99999999999997 56899999999997654
Q ss_pred ccCCCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHH
Q 004564 180 KSHAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRF 258 (745)
Q Consensus 180 ~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~ 258 (745)
.. .....||+.|||||++.+ .++.++|||||||++|+|+||..||.. .++..+++.+..+... ++...++.++++
T Consensus 183 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~l 258 (340)
T PTZ00426 183 TR-TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGIIY--FPKFLDNNCKHL 258 (340)
T ss_pred CC-cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC--CCCCCCHHHHHH
Confidence 32 234579999999999874 588999999999999999999999987 5667778888776542 345678899999
Q ss_pred HHHHhh-CccCCC-----CHHHHhcCCCCCcc
Q 004564 259 VEKCLA-TVSLRL-----SARELLNDPFLQID 284 (745)
Q Consensus 259 I~kcL~-dPskRp-----Sa~ELL~hPff~~~ 284 (745)
|.+||+ +|.+|+ +++++++||||+..
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999 999995 89999999999853
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=378.84 Aligned_cols=256 Identities=24% Similarity=0.353 Sum_probs=213.6
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
.| ++.+.||+|+||+||+|.+..+++.||+|++...... .......+.+|+.+|+.++||||+++++.|.+ +..+|
T Consensus 2 ~y-~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~ 77 (376)
T cd05598 2 MF-VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLY 77 (376)
T ss_pred Cc-eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEE
Confidence 35 7778999999999999999999999999998644321 22345678899999999999999999998866 67999
Q ss_pred EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
+||||+.+|+|.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|..+...
T Consensus 78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEEC-CCCCEEEEeCCCCcccccc
Confidence 99999999999999999889999999999999999999999998 99999999999998 5689999999997532100
Q ss_pred ---------------------------------------------CCCcccCCCCcCChhhhh-hccCccccchhhhhHH
Q 004564 182 ---------------------------------------------HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCI 215 (745)
Q Consensus 182 ---------------------------------------------~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvIL 215 (745)
.....+||+.|||||++. ..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 011346999999999987 4689999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCcccCCCHHHHHHHHHHhhCccCCC---CHHHHhcCCCCCccc
Q 004564 216 LEMVTFEYPYSECTHPAQIYKKVVSGKK--PDSLYRVKDPEVRRFVEKCLATVSLRL---SARELLNDPFLQIDD 285 (745)
Q Consensus 216 yELlTG~~Pf~~~~~~~~i~kkv~~g~~--p~~l~~~~s~el~d~I~kcL~dPskRp---Sa~ELL~hPff~~~~ 285 (745)
|+|+||+.||... .+......+..... +.......++.+.++|.+|+.+|.+|+ ++.++++||||+..+
T Consensus 235 yell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 235 YEMLVGQPPFLAD-TPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred eehhhCCCCCCCC-CHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 9999999999874 44444445544322 112233578999999999888999999 999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=376.85 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=210.8
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.+.||+|+||+||+|.+..++..||+|++..... ........+..|+.+|+.++||||+++++++.+ ...+|+||
T Consensus 4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv~ 80 (381)
T cd05626 4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV-LNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFVM 80 (381)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEEE
Confidence 667889999999999999999999999999875442 234556789999999999999999999999876 67899999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc---
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--- 181 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~--- 181 (745)
||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+||||+ ..|.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~-~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEEC-CCCCEEEeeCcCCccccccccc
Confidence 99999999999999889999999999999999999999988 99999999999998 5689999999997532100
Q ss_pred ----------------------------------------------CCCcccCCCCcCChhhhh-hccCccccchhhhhH
Q 004564 182 ----------------------------------------------HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMC 214 (745)
Q Consensus 182 ----------------------------------------------~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvI 214 (745)
.....+||+.|||||++. ..|+.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 012346999999999986 468999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCcccCCCHHHHHHHHHHhh---CccCCCCHHHHhcCCCCCccc
Q 004564 215 ILEMVTFEYPYSECTHPAQIYKKVVSGKK--PDSLYRVKDPEVRRFVEKCLA---TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 215 LyELlTG~~Pf~~~~~~~~i~kkv~~g~~--p~~l~~~~s~el~d~I~kcL~---dPskRpSa~ELL~hPff~~~~ 285 (745)
+|||+||..||.... ......++..... ........++++++||.+||. ++..|++++++++||||+..+
T Consensus 238 l~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 238 LFEMLVGQPPFLAPT-PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred HHHHHhCCCCCcCCC-HHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 999999999998744 4444444443222 222223478999999999765 455699999999999998543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=369.56 Aligned_cols=248 Identities=23% Similarity=0.401 Sum_probs=213.1
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEecc
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMF 107 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~ 107 (745)
++||+|+||.||+|.+..+|..||+|+++.... ........+..|+.+++.++||||+++++.|.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCC
Confidence 469999999999999999999999999875432 234556778889999999999999999998865 67899999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc--CCCc
Q 004564 108 TSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAAH 185 (745)
Q Consensus 108 ~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~--~~~~ 185 (745)
.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ +++.+||+|||++...... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEc-CCCCEEecccHHhccccCCCCcccc
Confidence 99999999988889999999999999999999999998 99999999999998 5689999999998753221 2233
Q ss_pred ccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh
Q 004564 186 CVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA 264 (745)
Q Consensus 186 ~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~ 264 (745)
..||+.|+|||++. +.++.++|||||||++|+|+||+.||.. .+...+++.+..+... ++...++.++++|.+||+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~~~~~~~~--~p~~~~~~~~~li~~~L~ 231 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHcc
Confidence 56999999999986 5689999999999999999999999976 4556666666544332 345678999999999999
Q ss_pred -CccCCC-----CHHHHhcCCCCCcc
Q 004564 265 -TVSLRL-----SARELLNDPFLQID 284 (745)
Q Consensus 265 -dPskRp-----Sa~ELL~hPff~~~ 284 (745)
+|.+|+ ++.++++||||...
T Consensus 232 ~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 232 KDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 999998 99999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=370.19 Aligned_cols=248 Identities=23% Similarity=0.396 Sum_probs=213.4
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEecc
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMF 107 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~ 107 (745)
++||+|+||.||+|.+..+|..||+|+++... .........+.+|+.+|+.++||||+++++.+.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEV-IIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEEeCC
Confidence 46999999999999999999999999987543 2234566788899999999999999999998765 67899999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc--cCCCc
Q 004564 108 TSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAAH 185 (745)
Q Consensus 108 ~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~--~~~~~ 185 (745)
.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... .....
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEEC-CCCcEEEecCcCCccCCCccccccc
Confidence 99999999988889999999999999999999999998 99999999999998 568999999999875322 22234
Q ss_pred ccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh
Q 004564 186 CVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA 264 (745)
Q Consensus 186 ~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~ 264 (745)
.+||+.|+|||++. ..++.++|||||||++|+|+||..||.. .+..++.+.+..+.. .++...++.+++||.+||+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~ 231 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEDI--KFPRTLSADAKSLLSGLLI 231 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhccCCc--cCCCCCCHHHHHHHHHHcC
Confidence 56999999999986 5689999999999999999999999976 455666666654433 2455678999999999999
Q ss_pred -CccCCC-----CHHHHhcCCCCCcc
Q 004564 265 -TVSLRL-----SARELLNDPFLQID 284 (745)
Q Consensus 265 -dPskRp-----Sa~ELL~hPff~~~ 284 (745)
+|.+|+ ++.++++||||...
T Consensus 232 ~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 232 KDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999997 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=367.01 Aligned_cols=255 Identities=29% Similarity=0.432 Sum_probs=206.1
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCC---C
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN---R 98 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~---~ 98 (745)
|| ++.++||+|+||.||+|.+..+|..||+|.++... .......++.+|+.+|+.++||||+++++++..... .
T Consensus 1 ry-~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred Ce-EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 46 78899999999999999999999999999886322 223445678899999999999999999998765332 3
Q ss_pred eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 99 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
.+|+||||+. ++|.+++.+...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 78 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 78 DIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVA 153 (338)
T ss_pred eEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEccCcccccc
Confidence 5899999995 689999988889999999999999999999999998 99999999999998 5689999999999754
Q ss_pred hccC-----CCcccCCCCcCChhhhh---hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHH--------------H
Q 004564 179 RKSH-----AAHCVGTPEFMAPEVYE---EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIY--------------K 236 (745)
Q Consensus 179 ~~~~-----~~~~vGTp~YmAPEvl~---~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~--------------k 236 (745)
.... ....+||+.|+|||++. ..++.++|||||||++|+|+||+.||.+......+. .
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 3211 12356999999999986 368899999999999999999999997643222111 1
Q ss_pred HHHc-----------CCCCC---CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 237 KVVS-----------GKKPD---SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 237 kv~~-----------g~~p~---~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
.+.. ...+. ......++.+.++|.+||+ +|.+|||++++|+||||+.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 1100 00111 1122457889999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=358.93 Aligned_cols=252 Identities=21% Similarity=0.323 Sum_probs=207.0
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+| .+.+.||+|+||+||+|.+..++..||+|+++... ......+.+.+|+.+++.++||||+++++.+.. ...+|
T Consensus 2 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 76 (287)
T cd07848 2 KF-EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE--ENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLY 76 (287)
T ss_pred Cc-eEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc--ccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEE
Confidence 56 77899999999999999999999999999987543 223456678899999999999999999998765 67899
Q ss_pred EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
+||||+.++++..+......+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 77 LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccCccccccc
Confidence 99999999887766555667999999999999999999999988 99999999999997 5689999999999776432
Q ss_pred C---CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH-cCCC-------------
Q 004564 182 H---AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVV-SGKK------------- 243 (745)
Q Consensus 182 ~---~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~-~g~~------------- 243 (745)
. .....||+.|+|||++. ..++.++|||||||++|+|++|+.||........+..... .+..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 2 22346899999999986 4689999999999999999999999987544333322111 0110
Q ss_pred ------CC---------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 244 ------PD---------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 244 ------p~---------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
|. ......++.+++||.+||+ +|.+|||++++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 0112367889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=369.81 Aligned_cols=248 Identities=25% Similarity=0.407 Sum_probs=212.6
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEecc
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMF 107 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~ 107 (745)
++||+|+||+||+|.+..+|..||+|+++... .........+..|+.+++.++||||+++++.|.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEV-IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 46999999999999999999999999987543 2234556778889999999999999999998765 67899999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhh-CCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc--cCCC
Q 004564 108 TSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 184 (745)
Q Consensus 108 ~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs-~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~--~~~~ 184 (745)
.+|+|..++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||++..... ....
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEEC-CCCCEEEecCCCCeecCCCCcccc
Confidence 999999999888899999999999999999999997 67 99999999999998 568999999999864322 2223
Q ss_pred cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHh
Q 004564 185 HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCL 263 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL 263 (745)
...||+.|||||++. ..++.++|||||||++|+|+||..||.. .+...+++.+..+.. .+....++++.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L 231 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLSPEAKSLLSGLL 231 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHh
Confidence 456999999999986 5689999999999999999999999987 455666666655433 244567899999999999
Q ss_pred h-CccCCC-----CHHHHhcCCCCCcc
Q 004564 264 A-TVSLRL-----SARELLNDPFLQID 284 (745)
Q Consensus 264 ~-dPskRp-----Sa~ELL~hPff~~~ 284 (745)
+ +|.+|+ ++.++++||||+..
T Consensus 232 ~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 232 KKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred hcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 9 999997 99999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=364.34 Aligned_cols=257 Identities=26% Similarity=0.448 Sum_probs=226.4
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
+..| .+.+.||+|.|+.||++.+..+|+.+|+|++....+.+. ..+.+.+|++|-+.|+||||++++++.-. ...
T Consensus 10 ~d~y-~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~ 84 (355)
T KOG0033|consen 10 SDNY-DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKLEREARICRKLQHPNIVRLHDSIQE--ESF 84 (355)
T ss_pred chhh-hHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHHHHHHHHHHhcCCCcEeehhhhhcc--cce
Confidence 3445 666889999999999999999999999999987765443 77889999999999999999999997643 678
Q ss_pred EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecC--CCCcEEEcCcchhhh
Q 004564 100 INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGLAAI 177 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~--~~g~VKL~DFGlA~~ 177 (745)
.|+|+|+++|++|..-+.++-..++..+..+++|||.+|.|+|.++ |||||+||.|+++-+ +..-|||+|||+|..
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999999999877777777899999999999999999999999 999999999999943 334799999999988
Q ss_pred hhccC-CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCcccCCCH
Q 004564 178 LRKSH-AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK--PDSLYRVKDP 253 (745)
Q Consensus 178 l~~~~-~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~--p~~l~~~~s~ 253 (745)
+.... ...++|||.|||||++. ..|+..+|||+.|||||-|+.|.+||.+ .+...+|+.+..|.. |...+...++
T Consensus 163 l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~is~ 241 (355)
T KOG0033|consen 163 VNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTVTP 241 (355)
T ss_pred eCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccccCCCCcccCcCCH
Confidence 77433 33457999999999997 5799999999999999999999999987 567889999999874 5667788999
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 254 el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
+++++|.+||. ||++|+||.|+|+|||++..
T Consensus 242 ~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 242 EAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 99999999999 99999999999999999754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=391.45 Aligned_cols=252 Identities=26% Similarity=0.461 Sum_probs=224.7
Q ss_pred eeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEE
Q 004564 24 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINF 102 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyL 102 (745)
.++.++||+|.||+|++|..+.+++.+|||++++...++ .++++..+.|-+++... +||.++.+|.+|.. ..++|+
T Consensus 370 F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~~~l~f 446 (694)
T KOG0694|consen 370 FRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-RDEVESLMCEKRIFELANRHPFLVNLFSCFQT--KEHLFF 446 (694)
T ss_pred eEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-cccHHHHHHHHHHHHHhccCCeEeeccccccc--CCeEEE
Confidence 488899999999999999999999999999999777554 57889999999999888 59999999999965 789999
Q ss_pred EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh--c
Q 004564 103 VTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--K 180 (745)
Q Consensus 103 V~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~--~ 180 (745)
||||..||+|..+ +..+.+++..++.|+..|+.||.|||++| |||||||.+|||+| ..|.+||+|||+++..- .
T Consensus 447 vmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD-~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 447 VMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLD-TEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEc-ccCcEEecccccccccCCCC
Confidence 9999999995443 55578999999999999999999999999 99999999999998 67999999999997543 3
Q ss_pred cCCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHH
Q 004564 181 SHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259 (745)
Q Consensus 181 ~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I 259 (745)
....+++|||.|||||++. +.|+.++|+|||||+||||++|+.||++ .+.++++..|...... ++...+.++..++
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d~~~--yP~~ls~ea~~il 599 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVNDEVR--YPRFLSKEAIAIM 599 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCCC--CCCcccHHHHHHH
Confidence 4566789999999999997 5799999999999999999999999998 7789999988876543 4567899999999
Q ss_pred HHHhh-CccCCCC-----HHHHhcCCCCCccc
Q 004564 260 EKCLA-TVSLRLS-----ARELLNDPFLQIDD 285 (745)
Q Consensus 260 ~kcL~-dPskRpS-----a~ELL~hPff~~~~ 285 (745)
.++|. +|.+|+. +.++..||||+..+
T Consensus 600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred HHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 99999 9999985 68999999999655
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=372.85 Aligned_cols=253 Identities=25% Similarity=0.436 Sum_probs=214.3
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.+.||+|+||+||+|.+..++..||+|+++.... ........+..|+.++..++||||+++++.|.+ ...+|+||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~lv~ 80 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM-LEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYLIM 80 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEEEE
Confidence 667899999999999999999999999999875432 223456788899999999999999999998865 67899999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC--
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-- 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~-- 182 (745)
||+.+|+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~-~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEeeccCCccccccccc
Confidence 99999999999998889999999999999999999999998 99999999999997 56899999999986442110
Q ss_pred -----------------------------------CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCC
Q 004564 183 -----------------------------------AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYS 226 (745)
Q Consensus 183 -----------------------------------~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~ 226 (745)
....+||+.|+|||++. ..|+.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 11346999999999986 568999999999999999999999998
Q ss_pred CCCCHHHHHHHHHcCCCCCCc--ccCCCHHHHHHHHHHhhCccCCC---CHHHHhcCCCCCcc
Q 004564 227 ECTHPAQIYKKVVSGKKPDSL--YRVKDPEVRRFVEKCLATVSLRL---SARELLNDPFLQID 284 (745)
Q Consensus 227 ~~~~~~~i~kkv~~g~~p~~l--~~~~s~el~d~I~kcL~dPskRp---Sa~ELL~hPff~~~ 284 (745)
. .++...+.++........+ ....+++++++|.+|+.+|.+|+ +++++++||||+..
T Consensus 238 ~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 238 S-ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred C-CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCC
Confidence 7 5566677777654322111 12368899999999888999888 58999999999854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=366.47 Aligned_cols=249 Identities=26% Similarity=0.380 Sum_probs=212.8
Q ss_pred EEecccCceEEEEEEEc---CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 28 EILGKGASKTVYRAFDE---YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~---~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
+.||+|+||.||+|.+. .+++.||+|+++.............+..|+.+|+.++||||+++++.|.. +..+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEEE
Confidence 57999999999999864 57899999999865433344556678899999999999999999998865 67899999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc--cC
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SH 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~--~~ 182 (745)
||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEeeCcCCeecccCCCc
Confidence 99999999999999889999999999999999999999998 99999999999998 568999999999864322 22
Q ss_pred CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHH
Q 004564 183 AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEK 261 (745)
Q Consensus 183 ~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~k 261 (745)
.....||+.|+|||++. ..++.++|||||||++|||+||..||.. .+....+..+..+..+ ++...++.+++||.+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~ 233 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGKLN--LPPYLTPEARDLLKK 233 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHH
Confidence 23346999999999987 4588999999999999999999999987 4455666666666543 345678999999999
Q ss_pred Hhh-CccCCC-----CHHHHhcCCCCCcc
Q 004564 262 CLA-TVSLRL-----SARELLNDPFLQID 284 (745)
Q Consensus 262 cL~-dPskRp-----Sa~ELL~hPff~~~ 284 (745)
||+ +|.+|| ++++++.||||+..
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999 999999 89999999999754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=366.27 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=209.4
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHH-HHHhCCCCCcceEeEEEEecCCCeEEEEEec
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIH-LLKTLKHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~-iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
++||+|+||+||+|.+..+|+.||+|++....... ......+..|.. +++.++||||+++++.|.. ...+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcC
Confidence 46999999999999999999999999987543222 233345555554 5688999999999998865 6789999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc--cCCC
Q 004564 107 FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 184 (745)
Q Consensus 107 ~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~--~~~~ 184 (745)
+.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeccCCCcccccCCCccc
Confidence 999999999999889999999999999999999999998 99999999999998 568999999999865322 2233
Q ss_pred cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHh
Q 004564 185 HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCL 263 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL 263 (745)
..+||+.|+|||++. ..++.++|||||||++|+|+||..||.. .+..++++.+..+... +....++.+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~l 231 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKPLR--LKPNISVSARHLLEGLL 231 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHh
Confidence 456999999999987 4689999999999999999999999986 5667777777765432 34456899999999999
Q ss_pred h-CccCCCCH----HHHhcCCCCCcc
Q 004564 264 A-TVSLRLSA----RELLNDPFLQID 284 (745)
Q Consensus 264 ~-dPskRpSa----~ELL~hPff~~~ 284 (745)
+ +|.+||++ .++++||||...
T Consensus 232 ~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 232 QKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred hcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 9 99999987 699999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=359.51 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=203.2
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
.+| .+.+.||.|+||+||+|.+..++..||+|+++.... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 5 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 78 (288)
T cd07871 5 ETY-VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCL 78 (288)
T ss_pred ccc-eEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeE
Confidence 456 677899999999999999999999999999875432 2233467789999999999999999998765 5689
Q ss_pred EEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 101 NFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~-~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
++||||+.+ +|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKS 154 (288)
T ss_pred EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEECcCcceeecc
Confidence 999999975 8999887654 5799999999999999999999988 99999999999998 56899999999986543
Q ss_pred cc--CCCcccCCCCcCChhhhh--hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CCCCC--------
Q 004564 180 KS--HAAHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS--GKKPD-------- 245 (745)
Q Consensus 180 ~~--~~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~--g~~p~-------- 245 (745)
.. ......||+.|+|||++. ..++.++|||||||++|+|+||+.||........+ ..+.. +..+.
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL-HLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCChHHhhcccc
Confidence 22 223346899999999885 35899999999999999999999999874433332 22211 11000
Q ss_pred ------------------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 246 ------------------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 246 ------------------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
......++++++||.+||+ +|.+|||++|+|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0012357889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=367.14 Aligned_cols=256 Identities=21% Similarity=0.322 Sum_probs=216.2
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
.| .+.+.||+|+||+||+|.+..+|..||+|+++.... ......+.+..|+.+++.++||||+++++.+.+ ...+|
T Consensus 2 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~ 77 (330)
T cd05601 2 DF-DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLY 77 (330)
T ss_pred Cc-eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEE
Confidence 35 778999999999999999999999999999885432 233456778899999999999999999998865 57899
Q ss_pred EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 102 FVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
+||||+.+|+|.+++.+. ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..+..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLID-RTGHIKLADFGSAARLTA 154 (330)
T ss_pred EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEEC-CCCCEEeccCCCCeECCC
Confidence 999999999999999886 68999999999999999999999988 99999999999998 568999999999976543
Q ss_pred cC---CCcccCCCCcCChhhhh-------hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCc--c
Q 004564 181 SH---AAHCVGTPEFMAPEVYE-------EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSL--Y 248 (745)
Q Consensus 181 ~~---~~~~vGTp~YmAPEvl~-------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l--~ 248 (745)
.. .....||+.|+|||++. ..++.++|||||||++|+|+||..||... +....+..+........+ .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~ 233 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMNFQRFLKFPED 233 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC-CHHHHHHHHHcCCCccCCCCC
Confidence 22 12346999999999985 34788999999999999999999999874 455566666654432222 2
Q ss_pred cCCCHHHHHHHHHHhhCccCCCCHHHHhcCCCCCccc
Q 004564 249 RVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 249 ~~~s~el~d~I~kcL~dPskRpSa~ELL~hPff~~~~ 285 (745)
...++.++++|.+||.+|.+|||+.+++.||||+..+
T Consensus 234 ~~~~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 234 PKVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred CCCCHHHHHHHHHHccChhhCCCHHHHhCCCCcCCCC
Confidence 2468899999999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=366.65 Aligned_cols=248 Identities=22% Similarity=0.396 Sum_probs=212.8
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEEEEec
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
++||+|+||+||+|.++.++..||+|+++.... ......+.+..|+.+++.+ +||||+++++++.. ...+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI-LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcC
Confidence 369999999999999999999999999875432 2234566778898988877 69999999998865 6789999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc--cCCC
Q 004564 107 FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 184 (745)
Q Consensus 107 ~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~--~~~~ 184 (745)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcCCCccc
Confidence 999999999998889999999999999999999999988 99999999999998 568999999999865321 2233
Q ss_pred cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHh
Q 004564 185 HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCL 263 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL 263 (745)
...||+.|+|||++. ..++.++|||||||++|+|+||+.||.. .+..++++.+..+... +....+++++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~L 231 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVV--YPTWLSQDAVDILKAFM 231 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHc
Confidence 456999999999987 4689999999999999999999999987 5567777777765543 34457899999999999
Q ss_pred h-CccCCCCH------HHHhcCCCCCcc
Q 004564 264 A-TVSLRLSA------RELLNDPFLQID 284 (745)
Q Consensus 264 ~-dPskRpSa------~ELL~hPff~~~ 284 (745)
+ +|.+|+++ +++++||||+..
T Consensus 232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 232 TKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred ccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 9 99999998 999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=360.37 Aligned_cols=254 Identities=27% Similarity=0.374 Sum_probs=204.3
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
..+| .+.+.||+|+||+||+|.+..++..||+|+++.... ......+.+|+.+++.++||||+++++++.+ ...
T Consensus 4 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 77 (303)
T cd07869 4 ADSY-EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDIIHT--KET 77 (303)
T ss_pred cccc-eEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCe
Confidence 4567 677899999999999999999999999999875432 1223456789999999999999999998865 578
Q ss_pred EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 100 INFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
+++||||+. ++|.+++.++ ..++++.++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++...
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 78 LTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLIS-DTGELKLADFGLARAK 153 (303)
T ss_pred EEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECCCCcceec
Confidence 999999995 5787777654 56899999999999999999999998 99999999999998 5689999999998654
Q ss_pred hcc--CCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CCC---------
Q 004564 179 RKS--HAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS--GKK--------- 243 (745)
Q Consensus 179 ~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~--g~~--------- 243 (745)
... ......||+.|+|||++.+ .++.++|||||||++|+|+||..||.+..+.......+.. +..
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 322 2234568999999999863 5888999999999999999999999876554443333211 100
Q ss_pred ------CCCcc-------------cCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 244 ------PDSLY-------------RVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 244 ------p~~l~-------------~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
+..+. ...++.+++||.+||+ +|.+|||++++|+||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 00000 0134678999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=364.44 Aligned_cols=253 Identities=21% Similarity=0.360 Sum_probs=212.8
Q ss_pred eEeEEecccCceEEEEEEEc---CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeE
Q 004564 25 RYNEILGKGASKTVYRAFDE---YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~---~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~i 100 (745)
++.+.||+|+||+||+|.+. .++..||+|+++...........+.+..|+.+|+.+ +||||+++++.+.. ...+
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~~ 80 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EAKL 80 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CCEE
Confidence 67899999999999998764 578999999987554333445567788999999999 59999999998765 6789
Q ss_pred EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 101 NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
++||||+.+|+|.+++.+++.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEEC-CCCCEEEeeCcCCccccc
Confidence 999999999999999998889999999999999999999999998 99999999999998 568999999999976432
Q ss_pred c---CCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCC---CCHHHHHHHHHcCCCCCCcccCCC
Q 004564 181 S---HAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSEC---THPAQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 181 ~---~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~---~~~~~i~kkv~~g~~p~~l~~~~s 252 (745)
. ......||+.|||||++.+ .++.++|||||||++|+|+||..||... .....+...+..... .+....+
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 235 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP--PFPSFIG 235 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCC
Confidence 2 1223469999999999874 4788999999999999999999999642 234455555554433 2445678
Q ss_pred HHHHHHHHHHhh-CccCCC-----CHHHHhcCCCCCcc
Q 004564 253 PEVRRFVEKCLA-TVSLRL-----SARELLNDPFLQID 284 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRp-----Sa~ELL~hPff~~~ 284 (745)
+.++++|.+||+ +|++|| +++++++||||+..
T Consensus 236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999 999999 89999999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=364.80 Aligned_cols=248 Identities=21% Similarity=0.377 Sum_probs=209.4
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEEEEec
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
++||+|+||+||+|.+..++..||+|+++... .......+.+..|+.+++.+ +||||+++++++.+ ...+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~-~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKEL-VNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeC
Confidence 46999999999999999999999999998543 22345567788999999998 79999999998865 6789999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh--ccCCC
Q 004564 107 FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAA 184 (745)
Q Consensus 107 ~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~--~~~~~ 184 (745)
+.+|+|..++.+.+++++..++.|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEECcCccccccccCCCccc
Confidence 999999999988889999999999999999999999998 99999999999998 56899999999986432 22233
Q ss_pred cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCC--------CHHHHHHHHHcCCCCCCcccCCCHHH
Q 004564 185 HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECT--------HPAQIYKKVVSGKKPDSLYRVKDPEV 255 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~--------~~~~i~kkv~~g~~p~~l~~~~s~el 255 (745)
..+||+.|+|||++. ..++.++|||||||++|+|+||+.||.... ....+++.+..+.. .++...++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~ 232 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--RIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--CCCCCCCHHH
Confidence 456999999999987 468999999999999999999999996321 22334555554432 2445678999
Q ss_pred HHHHHHHhh-CccCCCC------HHHHhcCCCCCc
Q 004564 256 RRFVEKCLA-TVSLRLS------ARELLNDPFLQI 283 (745)
Q Consensus 256 ~d~I~kcL~-dPskRpS------a~ELL~hPff~~ 283 (745)
.++|.+||+ +|.+|++ ++++++||||..
T Consensus 233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999 9999987 799999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=356.46 Aligned_cols=253 Identities=20% Similarity=0.314 Sum_probs=209.6
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.+.||+|+||+||+|.+..+|..||+|.+...... .......+.+|+.+|+.++|+||+++++.+.+ ...+++||
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~~~~lv~ 79 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KDALCLVL 79 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CCeEEEEE
Confidence 6778999999999999999999999999998754322 22334567889999999999999999998865 56899999
Q ss_pred eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc-
Q 004564 105 EMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 181 (745)
Q Consensus 105 E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~- 181 (745)
||+.+|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeCCCcEEcCCCC
Confidence 999999998887643 46899999999999999999999988 99999999999997 5689999999999765432
Q ss_pred CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCH---HHHHHHHHcCCCCCCcccCCCHHHHH
Q 004564 182 HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHP---AQIYKKVVSGKKPDSLYRVKDPEVRR 257 (745)
Q Consensus 182 ~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~---~~i~kkv~~g~~p~~l~~~~s~el~d 257 (745)
......||+.|||||++. ..|+.++|||||||++|+|++|+.||...... ..+...+..+ +..+....++.+.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~ 234 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED--QEEYSEKFSEDAKS 234 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc--cccCCccCCHHHHH
Confidence 223456999999999987 56899999999999999999999999764321 2233333222 22344567899999
Q ss_pred HHHHHhh-CccCCCC-----HHHHhcCCCCCccc
Q 004564 258 FVEKCLA-TVSLRLS-----ARELLNDPFLQIDD 285 (745)
Q Consensus 258 ~I~kcL~-dPskRpS-----a~ELL~hPff~~~~ 285 (745)
||.+||+ +|.+||+ ++++++||||+..+
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 235 ICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 9999999 9999997 99999999998544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=363.72 Aligned_cols=248 Identities=21% Similarity=0.351 Sum_probs=213.1
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEEEEec
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
++||+|+||.||+|.+..++..||+|+++.... ......+.+..|+.+++.+ +||||++++++|.. ...+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeC
Confidence 469999999999999999999999999875432 2345566778899999876 79999999998865 6789999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc--cCCC
Q 004564 107 FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 184 (745)
Q Consensus 107 ~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~--~~~~ 184 (745)
+.+|+|..++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLD-AEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeecccceecccCCcccc
Confidence 999999999998889999999999999999999999998 99999999999998 568999999999865322 2233
Q ss_pred cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHh
Q 004564 185 HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCL 263 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL 263 (745)
...||+.|+|||++. ..++.++|||||||++|+|+||+.||.. .+...++..+..+... ++...++++.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~ll~~~L 231 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDVL--YPVWLSKEAVSILKAFM 231 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHh
Confidence 456999999999987 4689999999999999999999999987 5567777777766543 33457899999999999
Q ss_pred h-CccCCC-------CHHHHhcCCCCCcc
Q 004564 264 A-TVSLRL-------SARELLNDPFLQID 284 (745)
Q Consensus 264 ~-dPskRp-------Sa~ELL~hPff~~~ 284 (745)
+ +|.+|+ +++++++||||...
T Consensus 232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred ccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 9 999999 99999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=370.30 Aligned_cols=256 Identities=20% Similarity=0.348 Sum_probs=214.6
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
..| .+.++||+|+||+||+|.+..++..||+|+++.... ........+..|+.+++.++||||+++++++.+ ...+
T Consensus 43 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~~~ 118 (370)
T cd05596 43 EDF-DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DKYL 118 (370)
T ss_pred HHc-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCEE
Confidence 456 777999999999999999999999999999874332 123345567889999999999999999998865 6789
Q ss_pred EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 101 NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEc-CCCCEEEEeccceeeccC
Confidence 999999999999998765 46899999999999999999999988 99999999999998 568999999999976543
Q ss_pred cC---CCcccCCCCcCChhhhhh-----ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcc--cC
Q 004564 181 SH---AAHCVGTPEFMAPEVYEE-----AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLY--RV 250 (745)
Q Consensus 181 ~~---~~~~vGTp~YmAPEvl~~-----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~--~~ 250 (745)
.. ....+||+.|||||++.. .++.++|||||||++|||+||..||.. .+...++.++..+.....++ ..
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~ 273 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPDDIE 273 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCcCCCCCcCC
Confidence 21 234569999999999853 378899999999999999999999987 45566777777654332222 24
Q ss_pred CCHHHHHHHHHHhh-CccC--CCCHHHHhcCCCCCccc
Q 004564 251 KDPEVRRFVEKCLA-TVSL--RLSARELLNDPFLQIDD 285 (745)
Q Consensus 251 ~s~el~d~I~kcL~-dPsk--RpSa~ELL~hPff~~~~ 285 (745)
.+.++++||.+||. +|.+ |++++++++||||+..+
T Consensus 274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred CCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence 68999999999999 7876 99999999999998543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=374.63 Aligned_cols=256 Identities=28% Similarity=0.465 Sum_probs=226.0
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceEeEEEEecCCCe
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-HpNIVk~~~sfvd~~~~~ 99 (745)
.+| .+.+.||+|.||.||++.++.+|..+|+|.+++.... .....+.+.+|+.+|++|. |||||.+++.|.+ ...
T Consensus 35 ~~Y-~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~-~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~~ 110 (382)
T KOG0032|consen 35 EKY-ELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLR-GKEDREDVRREVAILQQLSGHPNIVQLKDAFED--PDS 110 (382)
T ss_pred ccE-EehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcc-ccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc--CCe
Confidence 345 8889999999999999999999999999999866533 3346678999999999998 9999999999876 569
Q ss_pred EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCC---CcEEEcCcchhh
Q 004564 100 INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQ---GEVKIGDLGLAA 176 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~---g~VKL~DFGlA~ 176 (745)
+++|||++.||.|++.+.+. .+++..+..+++||+.++.|||+.| |+||||||+|+|+.... +.+|++|||+|.
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999998887 4999999999999999999999988 99999999999996442 489999999998
Q ss_pred hhhcc-CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCcccCCC
Q 004564 177 ILRKS-HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK--PDSLYRVKD 252 (745)
Q Consensus 177 ~l~~~-~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~--p~~l~~~~s 252 (745)
..... .....+|||.|+|||++. ..|+..+||||+|+++|.|++|..||.+ .+...++.++..|.. +...+...+
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~-~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG-ETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC-CChhHHHHHHHcCCCCCCCCCccccC
Confidence 87763 344567999999999998 6899999999999999999999999987 455566667887765 556677789
Q ss_pred HHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
..+++||.+||. ||.+|+||.++|+|||++..
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 999999999999 99999999999999999854
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=363.54 Aligned_cols=255 Identities=26% Similarity=0.448 Sum_probs=214.1
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
..+| ++.+.||+|+||.||+|.+..++..+|+|+++... .....+.+.+|+++|+.++||||+++++++.+ +..
T Consensus 4 ~~~y-~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 77 (333)
T cd06650 4 DDDF-EKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGE 77 (333)
T ss_pred hhhh-heeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCE
Confidence 4567 77789999999999999999999999999887532 34556779999999999999999999999876 678
Q ss_pred EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhC-CCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 100 INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSH-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~-gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
+++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+. + |+||||||+|||++ .+|.+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQL 154 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEc-CCCCEEEeeCCcchhh
Confidence 999999999999999999888999999999999999999999974 5 99999999999998 5689999999999776
Q ss_pred hccCCCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHH-----------------------
Q 004564 179 RKSHAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQI----------------------- 234 (745)
Q Consensus 179 ~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i----------------------- 234 (745)
.........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ..++
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 155 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD-AKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred hhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc-hhHHHHHhcCcccCCccccccCcccCC
Confidence 5544445679999999999874 58899999999999999999999996522 2222
Q ss_pred ---------------------HHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 235 ---------------------YKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 235 ---------------------~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
...+.....|.......++++++||.+||+ +|.+|||+.|++.||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 111222222222223467889999999999 99999999999999999743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=369.49 Aligned_cols=256 Identities=20% Similarity=0.364 Sum_probs=212.6
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
.++| ++.++||+|+||.||+|.+..+++.||+|++..... ........+..|+.+++.++||||++++++|.+ ...
T Consensus 42 ~~~y-~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~ 117 (370)
T cd05621 42 AEDY-DVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKY 117 (370)
T ss_pred HHHC-eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCE
Confidence 3566 788999999999999999999999999999874332 223345668889999999999999999998865 678
Q ss_pred EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 100 INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
+|+||||+.+|+|.+++... .+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~-~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEEecccceecc
Confidence 99999999999999998654 6899999999999999999999998 99999999999998 66899999999997654
Q ss_pred ccC---CCcccCCCCcCChhhhhh-----ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcc--c
Q 004564 180 KSH---AAHCVGTPEFMAPEVYEE-----AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLY--R 249 (745)
Q Consensus 180 ~~~---~~~~vGTp~YmAPEvl~~-----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~--~ 249 (745)
... ....+||+.|||||++.+ .++.++|||||||++|+|+||..||.. .+....+..+........++ .
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 272 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPEDV 272 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcccCCCCcc
Confidence 322 234569999999999863 278899999999999999999999987 45566666666543222222 2
Q ss_pred CCCHHHHHHHHHHhhC-cc--CCCCHHHHhcCCCCCcc
Q 004564 250 VKDPEVRRFVEKCLAT-VS--LRLSARELLNDPFLQID 284 (745)
Q Consensus 250 ~~s~el~d~I~kcL~d-Ps--kRpSa~ELL~hPff~~~ 284 (745)
..++.++++|.+||.+ +. .|+++.++++||||+..
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 4688999999999984 33 38899999999999854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=373.92 Aligned_cols=254 Identities=22% Similarity=0.398 Sum_probs=214.4
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCC----------HHHHHHHHHHHHHHHhCCCCCcceEeEEEEe
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS----------PEDLERLYCEIHLLKTLKHKNIMKFYTSWVD 94 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~----------~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd 94 (745)
.+.+.||+|.||+|-+|++..+++.||||++.+.+.... ...++++++||.+|++|.|||||+++...=+
T Consensus 100 ~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDD 179 (576)
T KOG0585|consen 100 ELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDD 179 (576)
T ss_pred ehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecC
Confidence 566779999999999999999999999999976542211 1235789999999999999999999997656
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcc
Q 004564 95 TANRNINFVTEMFTSGTLRQYRLKHKR-VNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 173 (745)
Q Consensus 95 ~~~~~iyLV~E~~~gGsL~~~l~k~~~-L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFG 173 (745)
.....+|||+|||..|.+... ...+. +++.+.+.|++.++.||+|||.+| ||||||||+|+||+ .+|+|||+|||
T Consensus 180 P~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~-~~g~VKIsDFG 255 (576)
T KOG0585|consen 180 PESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLS-SDGTVKISDFG 255 (576)
T ss_pred cccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEc-CCCcEEeeccc
Confidence 667899999999999887543 33344 899999999999999999999999 99999999999998 45999999999
Q ss_pred hhhhhhcc-------CCCcccCCCCcCChhhhhhc-----cCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 004564 174 LAAILRKS-------HAAHCVGTPEFMAPEVYEEA-----YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG 241 (745)
Q Consensus 174 lA~~l~~~-------~~~~~vGTp~YmAPEvl~~~-----ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g 241 (745)
.+...... .....+|||.|||||+..+. -+.+.||||+||+||.|+.|+.||.+ ....+++.+|++.
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIvn~ 334 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIVND 334 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHhcC
Confidence 99765322 12235799999999988642 35789999999999999999999987 6678889999876
Q ss_pred CCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 242 KKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 242 ~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
..-........+.++++|.+||+ ||.+|++..++..|||...
T Consensus 335 pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 335 PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 65444444578999999999999 9999999999999999964
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=360.50 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=214.1
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC-CcceEeEEEEecCCCeEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHK-NIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~Hp-NIVk~~~sfvd~~~~~iyLV 103 (745)
++.+.||+|+||.||+|.+..+++.||+|+++.... ......+.+..|+.+++.+.|+ +|+++++++.. ...+|+|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv 79 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYFV 79 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEEE
Confidence 678999999999999999999999999999875432 2345567788899999999765 57888888765 5789999
Q ss_pred EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh--cc
Q 004564 104 TEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KS 181 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~--~~ 181 (745)
|||+.+|+|..++.+...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... ..
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEc-CCCCEEEeecCcceecCCCCC
Confidence 999999999999998889999999999999999999999988 99999999999998 56899999999986432 22
Q ss_pred CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHH
Q 004564 182 HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVE 260 (745)
Q Consensus 182 ~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~ 260 (745)
.....+||+.|+|||++. ..++.++|||||||++|+|+||+.||.. .+..+++..+..+.. .++...++++.++|.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~ 233 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSICK 233 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHH
Confidence 223446999999999987 4689999999999999999999999986 456677777766543 244567899999999
Q ss_pred HHhh-CccCCCCH-----HHHhcCCCCCcc
Q 004564 261 KCLA-TVSLRLSA-----RELLNDPFLQID 284 (745)
Q Consensus 261 kcL~-dPskRpSa-----~ELL~hPff~~~ 284 (745)
+||. +|.+|+++ +++++||||+..
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999 99999976 899999999754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=380.45 Aligned_cols=254 Identities=27% Similarity=0.392 Sum_probs=205.0
Q ss_pred CCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC-
Q 004564 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA- 96 (745)
Q Consensus 18 dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~- 96 (745)
.+.++| ++.++||+|+||+||+|.+..+++.||+|.+.... ....+|+.+|+.++||||++++++|....
T Consensus 63 ~~~~~y-~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~ 133 (440)
T PTZ00036 63 SPNKSY-KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECF 133 (440)
T ss_pred CcCCeE-EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence 456777 88899999999999999999999999999875321 12346999999999999999998875421
Q ss_pred -----CCeEEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcE
Q 004564 97 -----NRNINFVTEMFTSGTLRQYRL----KHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEV 167 (745)
Q Consensus 97 -----~~~iyLV~E~~~gGsL~~~l~----k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~V 167 (745)
...+++||||+.+ +|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.+++.+
T Consensus 134 ~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~v 210 (440)
T PTZ00036 134 KKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTL 210 (440)
T ss_pred ccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCce
Confidence 2357799999975 6766654 3467999999999999999999999998 99999999999998666689
Q ss_pred EEcCcchhhhhhcc-CCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCC
Q 004564 168 KIGDLGLAAILRKS-HAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-GKK 243 (745)
Q Consensus 168 KL~DFGlA~~l~~~-~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~-g~~ 243 (745)
||+|||+|..+... .....+||+.|||||++.+ .|+.++|||||||+||||+||.+||.+.....++.+.+.. |..
T Consensus 211 kL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p 290 (440)
T PTZ00036 211 KLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP 290 (440)
T ss_pred eeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99999999876433 2334578999999998863 5899999999999999999999999886655555443321 110
Q ss_pred -----------------CC--------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 244 -----------------PD--------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 244 -----------------p~--------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
|. .++...++++++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 10 1122356789999999999 9999999999999999963
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=360.06 Aligned_cols=250 Identities=26% Similarity=0.433 Sum_probs=210.3
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHH---HhCCCCCcceEeEEEEecCCCeEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL---KTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iL---k~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
++.+.||+|+||+||+|.+..++..||+|+++.... ......+.+..|++++ +.++||||+++++++.. ...+|
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~ 78 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI-IARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC 78 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence 678999999999999999999999999999975432 2234556777777665 46689999999998865 67899
Q ss_pred EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc-
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK- 180 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~- 180 (745)
+||||+.+++|..++. .+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 79 lv~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~-~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 79 FVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCcEEeCcccCCccCCCC
Confidence 9999999999998865 457999999999999999999999988 99999999999998 568999999999865322
Q ss_pred -cCCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHH
Q 004564 181 -SHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRF 258 (745)
Q Consensus 181 -~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~ 258 (745)
......+||+.|||||++. ..++.++|||||||++|+|++|+.||.. .+..+++..+..+... ++...++.+.++
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~l 231 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEVR--YPRFLSREAISI 231 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHHHH
Confidence 2233456999999999987 4688999999999999999999999987 4566666666665432 344578999999
Q ss_pred HHHHhh-CccCCC-----CHHHHhcCCCCCcc
Q 004564 259 VEKCLA-TVSLRL-----SARELLNDPFLQID 284 (745)
Q Consensus 259 I~kcL~-dPskRp-----Sa~ELL~hPff~~~ 284 (745)
|.+||+ +|.+|| ++.++++||||+..
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 999999 999999 79999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=350.01 Aligned_cols=254 Identities=28% Similarity=0.429 Sum_probs=213.0
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
.||.++ ++||+|.||.||+|.|..+|+.||||.|++..... ...-...+||++|+.++|+||+.+.+.|-. ...+
T Consensus 2 ~rY~~~-~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd--Gi~~talREIK~Lqel~h~nIi~LiD~F~~--~~~l 76 (318)
T KOG0659|consen 2 DRYEKL-EKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD--GINRTALREIKLLQELKHPNIIELIDVFPH--KSNL 76 (318)
T ss_pred chhhhh-hhhcCcceEEEEEEEecCCCcEEEEEEeecccccc--CccHHHHHHHHHHHHccCcchhhhhhhccC--CCce
Confidence 367444 77999999999999999999999999999775332 223356789999999999999999998854 7889
Q ss_pred EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 101 NFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
.+|+||+.. +|...++.. ..++...++.|+.++++||+|||++. |+||||||.|+|++ .+|.+||+|||+|+.+.
T Consensus 77 ~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis-~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLIS-SDGQLKIADFGLARFFG 152 (318)
T ss_pred EEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEc-CCCcEEeecccchhccC
Confidence 999999965 788776644 56899999999999999999999999 99999999999997 66899999999999886
Q ss_pred ccC--CCcccCCCCcCChhhhh--hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCC-----------
Q 004564 180 KSH--AAHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-GKK----------- 243 (745)
Q Consensus 180 ~~~--~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~-g~~----------- 243 (745)
... ..+.+-|..|.|||++. +.|+..+||||+|||+.||+-|.+-|.+.++.+|+-..+.. |.+
T Consensus 153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 543 33447899999999986 46999999999999999999999999998888887665432 111
Q ss_pred ---------C----CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 244 ---------P----DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 244 ---------p----~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
| ..+....+..+-+|+.++|. +|.+|+|+.|+|+|+||+.
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 1 01223346778999999999 9999999999999999984
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=382.58 Aligned_cols=249 Identities=33% Similarity=0.519 Sum_probs=219.6
Q ss_pred EecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEeccC
Q 004564 29 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFT 108 (745)
Q Consensus 29 ~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~~ 108 (745)
+||+|.||+||.|.|..+....|||.|... .....+-+..||.+.++|+|.|||++++++- .++.+-+.||-++
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek----dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s--enGf~kIFMEqVP 655 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK----DSREVQPLHEEIALHSTLRHKNIVRYLGSVS--ENGFFKIFMEQVP 655 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc----cchhhccHHHHHHHHHHHhhHhHHHHhhccC--CCCeEEEEeecCC
Confidence 599999999999999999999999988633 3567788999999999999999999999863 4678889999999
Q ss_pred CCCHHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh--ccCC
Q 004564 109 SGTLRQYRLKH-KRV--NIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHA 183 (745)
Q Consensus 109 gGsL~~~l~k~-~~L--~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~--~~~~ 183 (745)
||+|..++... +++ ++.++..|.+|||.||.|||.+. |||||||-+|||||.-.|.+||.|||.++.+. +...
T Consensus 656 GGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T 733 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT 733 (1226)
T ss_pred CCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence 99999987754 677 89999999999999999999998 99999999999999999999999999998875 3455
Q ss_pred CcccCCCCcCChhhhh---hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHH
Q 004564 184 AHCVGTPEFMAPEVYE---EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVE 260 (745)
Q Consensus 184 ~~~vGTp~YmAPEvl~---~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~ 260 (745)
.++.||..|||||++. +.|+.++|||||||++.||+||++||.+..++...+-+|---+..+.++...+.+++.||.
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fil 813 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFIL 813 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHH
Confidence 6778999999999997 3599999999999999999999999998777766555553333445566778899999999
Q ss_pred HHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 261 KCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 261 kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
+|.. +|.+||+|.+||.+||++..+
T Consensus 814 rcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 814 RCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred HHcCCCcccCccHHHhccCcccccCC
Confidence 9999 999999999999999998663
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=360.81 Aligned_cols=249 Identities=21% Similarity=0.371 Sum_probs=209.3
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEEEEec
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
++||+|+||+||+|.+..+++.||+|+++.... ........+..|+.++..+ +||||+++++++.. ...+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh-cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeC
Confidence 469999999999999999999999999985432 2345567788899998877 89999999998876 6789999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc--cCCC
Q 004564 107 FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 184 (745)
Q Consensus 107 ~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~--~~~~ 184 (745)
+.+|+|..++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCCEEEeeCCccccccCCCCccc
Confidence 999999999988889999999999999999999999998 99999999999998 568999999999865322 2223
Q ss_pred cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCC--------CCHHHHHHHHHcCCCCCCcccCCCHHH
Q 004564 185 HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSEC--------THPAQIYKKVVSGKKPDSLYRVKDPEV 255 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~--------~~~~~i~kkv~~g~~p~~l~~~~s~el 255 (745)
...||+.|+|||++. ..++.++|||||||++|+|+||+.||... .....+++.+..+.. .++...+..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~~~~~ 232 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--CCCCCCCHHH
Confidence 456999999999987 46889999999999999999999999521 122334455544332 2455678999
Q ss_pred HHHHHHHhh-CccCCCC------HHHHhcCCCCCcc
Q 004564 256 RRFVEKCLA-TVSLRLS------ARELLNDPFLQID 284 (745)
Q Consensus 256 ~d~I~kcL~-dPskRpS------a~ELL~hPff~~~ 284 (745)
.++|.+||+ +|.+|++ +.++++||||+..
T Consensus 233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999999 9999998 5899999999754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=360.84 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=207.2
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHH-HHHHhCCCCCcceEeEEEEecCCCeEEEEEec
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEI-HLLKTLKHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei-~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
+.||+|+||+||+|.+..++..||+|++........ .....+..|. .+++.++||||+++++.+.. ...+|+||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeC
Confidence 469999999999999999999999999875432222 2233444444 45788999999999998865 6789999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc--cCCC
Q 004564 107 FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 184 (745)
Q Consensus 107 ~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~--~~~~ 184 (745)
+.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEEccCCCCcccccCCCCcc
Confidence 999999999998888999999999999999999999998 99999999999998 568999999999875422 2233
Q ss_pred cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHh
Q 004564 185 HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCL 263 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL 263 (745)
..+||+.|||||++. ..++.++|||||||++|+|++|..||.. .+..++++.+..+.. .+....++.++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPL--QLKPNITNSARHLLEGLL 231 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCc--CCCCCCCHHHHHHHHHHc
Confidence 456999999999987 4688999999999999999999999986 556667777765433 234467899999999999
Q ss_pred h-CccCCCCHH----HHhcCCCCCcc
Q 004564 264 A-TVSLRLSAR----ELLNDPFLQID 284 (745)
Q Consensus 264 ~-dPskRpSa~----ELL~hPff~~~ 284 (745)
+ +|.+|+++. ++++|+||...
T Consensus 232 ~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 232 QKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred ccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 9 999999876 89999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=359.24 Aligned_cols=249 Identities=25% Similarity=0.422 Sum_probs=210.3
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEEEEec
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
++||+|+||.||+|.+..+|..||+|+++..... .......+..|+.+++.+ +||||+++++.|.+ +..+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECC
Confidence 4699999999999999999999999998754321 123455677788888754 89999999998866 6799999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh--ccCCC
Q 004564 107 FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAA 184 (745)
Q Consensus 107 ~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~--~~~~~ 184 (745)
+.+|+|..++.+...+++..+..++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLD-RDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEeCccCCCeecccCCCcee
Confidence 999999999988889999999999999999999999998 99999999999998 56899999999986432 22233
Q ss_pred cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHh
Q 004564 185 HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCL 263 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL 263 (745)
..+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..++++.+..+.. .+....+++++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l 231 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDTP--HYPRWITKESKDILEKLF 231 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHc
Confidence 456999999999997 4689999999999999999999999976 456677776665432 234467899999999999
Q ss_pred h-CccCCCCH-HHHhcCCCCCccc
Q 004564 264 A-TVSLRLSA-RELLNDPFLQIDD 285 (745)
Q Consensus 264 ~-dPskRpSa-~ELL~hPff~~~~ 285 (745)
. +|.+|+++ +++++||||+..+
T Consensus 232 ~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 232 ERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred cCCHHHcCCChHHHHcCCCcCCCC
Confidence 9 99999997 5899999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=358.89 Aligned_cols=249 Identities=25% Similarity=0.431 Sum_probs=209.5
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEEEEec
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
++||+|+||+||+|.+..+++.||+|+++.... ......+.+..|..++..+ +||||+++++.+.. ...+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVV-LEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcC
Confidence 469999999999999999999999999875432 1234455666777777654 89999999998765 6789999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc--cCCC
Q 004564 107 FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 184 (745)
Q Consensus 107 ~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~--~~~~ 184 (745)
+.+|+|..++.....+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCCCCccc
Confidence 999999999988889999999999999999999999988 99999999999997 568999999999875432 2233
Q ss_pred cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHh
Q 004564 185 HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCL 263 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL 263 (745)
..+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+++..+..... .++...++++.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~ll~~~l 231 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDRP--HFPRWISKEAKDCLSKLF 231 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHc
Confidence 456999999999987 4689999999999999999999999987 456677776665432 244567899999999999
Q ss_pred h-CccCCCCH-HHHhcCCCCCccc
Q 004564 264 A-TVSLRLSA-RELLNDPFLQIDD 285 (745)
Q Consensus 264 ~-dPskRpSa-~ELL~hPff~~~~ 285 (745)
. +|.+||++ .++++||||+..+
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 232 ERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred cCCHHHcCCChHHHHcCcccCCCC
Confidence 9 99999986 5899999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=357.65 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=214.8
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyLV 103 (745)
++.+.||+|+||+||+|.+..++..||+|+++.... ......+.+..|..++..+ .|++|+++++++.. ...+|+|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv 79 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYFV 79 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEEE
Confidence 677899999999999999999999999999875432 2234556677788888877 58899999998765 6789999
Q ss_pred EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc--c
Q 004564 104 TEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--S 181 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~--~ 181 (745)
|||+.+|+|..++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... .
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEEC-CCCcEEEccCCCceecCCCCC
Confidence 999999999999988889999999999999999999999998 99999999999998 568999999999865322 2
Q ss_pred CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHH
Q 004564 182 HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVE 260 (745)
Q Consensus 182 ~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~ 260 (745)
......||+.|+|||++. +.++.++|||||||++|+|+||+.||.. .+...++..+..+... ++...++++++++.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~ 233 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVA--YPKSMSKEAVAICK 233 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCcCCHHHHHHHH
Confidence 233456999999999987 5689999999999999999999999987 5567777777765432 34567899999999
Q ss_pred HHhh-CccCCCC-----HHHHhcCCCCCccc
Q 004564 261 KCLA-TVSLRLS-----ARELLNDPFLQIDD 285 (745)
Q Consensus 261 kcL~-dPskRpS-----a~ELL~hPff~~~~ 285 (745)
+||+ +|.+|++ ..++++||||+..+
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred HHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 9999 9999997 58999999998543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=355.32 Aligned_cols=257 Identities=25% Similarity=0.296 Sum_probs=217.2
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
-..|.++ ..|++|+||.||+|.|+.|++.||+|.++... .....--.-.+||.+|.+++|||||.+-...+....+.
T Consensus 75 v~efe~l-nrI~EGtyGiVYRakdk~t~eIVALKr~kmek--ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 75 VEEFEKL-NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK--EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred HHHHHHH-hhcccCcceeEEEeccCCcceeEEeeeccccc--ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 3345444 55899999999999999999999999998765 22223334678999999999999999999998888889
Q ss_pred EEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 100 INFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~~-~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
+|+||||+.. +|...+..-+ ++...+++.++.|+|+||+|||.+. |+|||||++|+|++ +.|.+||+|||+|+.+
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~-~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLS-HKGILKIADFGLAREY 227 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeec-cCCcEEecccchhhhh
Confidence 9999999976 8998888755 8999999999999999999999999 99999999999998 7799999999999988
Q ss_pred hcc--CCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCCCCC-------
Q 004564 179 RKS--HAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-GKKPDS------- 246 (745)
Q Consensus 179 ~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~-g~~p~~------- 246 (745)
... ..+..+-|..|.|||++.+ .|+.++|+||+|||+.||+++++.|.+.....|+.+.+.- |.+...
T Consensus 228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 765 3445678999999999875 5999999999999999999999999998888888776532 111000
Q ss_pred --------------------cc-cCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 247 --------------------LY-RVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 247 --------------------l~-~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
+. ...+....+|+..+|. ||.+|.||.|.|+|+||..
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 00 0135778899999999 9999999999999999984
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=359.19 Aligned_cols=249 Identities=23% Similarity=0.401 Sum_probs=213.2
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEEEEec
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
++||+|+||+||+|.+..++..||+|+++... .........+..|+.+++.+ +||||+++++.+.. ...+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDV-ILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-HhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcC
Confidence 46999999999999999999999999987543 22334567788899999888 69999999998865 6789999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh--ccCCC
Q 004564 107 FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAA 184 (745)
Q Consensus 107 ~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~--~~~~~ 184 (745)
+.+|+|..++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEEC-CCCcEEecccCCCeecCcCCCccc
Confidence 999999999988889999999999999999999999998 99999999999998 56899999999986432 22223
Q ss_pred cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHh
Q 004564 185 HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCL 263 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL 263 (745)
..+||+.|+|||++. ..++.++|||||||++|+|+||+.||.. .+...++..+..+... +....++.+++||.+||
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~l 231 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDEVR--YPRWLSKEAKSILKSFL 231 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCC--CCCcCCHHHHHHHHHHc
Confidence 346999999999987 4689999999999999999999999976 4566777766655432 34567899999999999
Q ss_pred h-CccCCCCH-----HHHhcCCCCCccc
Q 004564 264 A-TVSLRLSA-----RELLNDPFLQIDD 285 (745)
Q Consensus 264 ~-dPskRpSa-----~ELL~hPff~~~~ 285 (745)
+ +|.+||++ .+++.||||+..+
T Consensus 232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 232 TKNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred cCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 9 99999999 9999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=358.82 Aligned_cols=248 Identities=26% Similarity=0.374 Sum_probs=208.3
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHH-HHHhCCCCCcceEeEEEEecCCCeEEEEEec
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIH-LLKTLKHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~-iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
++||+|+||+||+|.+..++..||+|++...... .......+..|+. +++.++||||+++++.+.+ ...+|+||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcC
Confidence 4699999999999999999999999998754322 2233445555554 6888999999999998765 6789999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc--cCCC
Q 004564 107 FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 184 (745)
Q Consensus 107 ~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~--~~~~ 184 (745)
+.+|+|..++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+||||+ .+|.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEccCCCCccCCCCCCccc
Confidence 999999999888888999999999999999999999988 99999999999998 568999999999875322 2233
Q ss_pred cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHh
Q 004564 185 HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCL 263 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL 263 (745)
..+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+++..+..+.. .+....+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHKPL--QLPGGKTVAACDLLVGLL 231 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHc
Confidence 456999999999987 4689999999999999999999999987 466777777766543 344567889999999999
Q ss_pred h-CccCCCCH----HHHhcCCCCCcc
Q 004564 264 A-TVSLRLSA----RELLNDPFLQID 284 (745)
Q Consensus 264 ~-dPskRpSa----~ELL~hPff~~~ 284 (745)
+ +|.+|+++ .++++||||...
T Consensus 232 ~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 232 HKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred cCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 9 99999875 599999999743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=360.65 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=208.5
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHH-HHHhCCCCCcceEeEEEEecCCCeEEEEEec
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIH-LLKTLKHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~-iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
++||+|+||+||+|.+..+|..||+|++...... .......+..|.. +++.++||||+++++.+.. ...+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcC
Confidence 4699999999999999999999999998754322 2234455556655 5778999999999998865 6789999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh--ccCCC
Q 004564 107 FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAA 184 (745)
Q Consensus 107 ~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~--~~~~~ 184 (745)
+.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEeecCCcccCCCCCCCcc
Confidence 999999999998889999999999999999999999998 99999999999998 56899999999986532 22233
Q ss_pred cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHh
Q 004564 185 HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCL 263 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL 263 (745)
..+||+.|||||++. +.++.++|||||||++|+|++|..||.. .+..+++..+..+... +....+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~ll 231 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKPLV--LRPGASLTAWSILEELL 231 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCCcc--CCCCCCHHHHHHHHHHh
Confidence 456999999999987 4689999999999999999999999986 5567777777765432 23357889999999999
Q ss_pred h-CccCCCCH----HHHhcCCCCCcc
Q 004564 264 A-TVSLRLSA----RELLNDPFLQID 284 (745)
Q Consensus 264 ~-dPskRpSa----~ELL~hPff~~~ 284 (745)
+ +|.+||++ .++++||||...
T Consensus 232 ~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 232 EKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred ccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 9 99999876 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.31 Aligned_cols=252 Identities=29% Similarity=0.399 Sum_probs=199.4
Q ss_pred ceeeEeEEecccCceEEEEEEEcC-CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC---CCCCcceEeEEEEe---
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEY-EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL---KHKNIMKFYTSWVD--- 94 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~-tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L---~HpNIVk~~~sfvd--- 94 (745)
+| ++.+.||+|+||+||+|.+.. ++..||+|.++..... ......+.+|+.+++.+ +||||+++++.+..
T Consensus 2 ~Y-~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 2 QY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred Cc-ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC--CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 56 777899999999999999854 4788999988754321 22233455677777665 69999999998753
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCc
Q 004564 95 TANRNINFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 172 (745)
Q Consensus 95 ~~~~~iyLV~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DF 172 (745)
.....+++||||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~-~~~~~kl~Df 154 (290)
T cd07862 79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADF 154 (290)
T ss_pred CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEc-CCCCEEEccc
Confidence 12456899999996 6899988764 45899999999999999999999998 99999999999998 5689999999
Q ss_pred chhhhhhccC-CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC-CC--C--
Q 004564 173 GLAAILRKSH-AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK-KP--D-- 245 (745)
Q Consensus 173 GlA~~l~~~~-~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~-~p--~-- 245 (745)
|++....... .....||+.|+|||++. ..++.++|||||||++|||++|..||........+ ..+.... .| .
T Consensus 155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~-~~i~~~~~~~~~~~~ 233 (290)
T cd07862 155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-GKILDVIGLPGEEDW 233 (290)
T ss_pred cceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH-HHHHHHhCCCChhhc
Confidence 9997654332 23446899999999986 56889999999999999999999999875544433 3332211 00 0
Q ss_pred --------------------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 246 --------------------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 246 --------------------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
.+....++.++++|.+||+ +|.+|||+.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0112357788999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=357.61 Aligned_cols=249 Identities=25% Similarity=0.429 Sum_probs=210.0
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHh-CCCCCcceEeEEEEecCCCeEEEEEec
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKT-LKHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~-L~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
+.||+|+||+||+|.+..++..||+|+++.... ........+..|..+++. ++||||+++++++.+ ...+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVV-LMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeC
Confidence 469999999999999999999999999875432 122345566778888876 499999999998876 6789999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh--ccCCC
Q 004564 107 FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAA 184 (745)
Q Consensus 107 ~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~--~~~~~ 184 (745)
+.+|+|..++.+...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEccCCcceECCCCCCcee
Confidence 999999999988888999999999999999999999988 99999999999998 56899999999986432 22233
Q ss_pred cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHh
Q 004564 185 HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCL 263 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL 263 (745)
...||+.|+|||++. ..++.++|||||||++|+|+||..||.. .+..++++.+..+.. .+....+..++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDNP--CYPRWLTREAKDILVKLF 231 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHHh
Confidence 456999999999987 4689999999999999999999999987 456677776655432 234457889999999999
Q ss_pred h-CccCCCCHH-HHhcCCCCCccc
Q 004564 264 A-TVSLRLSAR-ELLNDPFLQIDD 285 (745)
Q Consensus 264 ~-dPskRpSa~-ELL~hPff~~~~ 285 (745)
+ +|.+||++. ++++||||+..+
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 232 VREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred ccCHhhcCCChHHHHcCcccCCCC
Confidence 9 999999996 999999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=358.60 Aligned_cols=247 Identities=24% Similarity=0.365 Sum_probs=210.4
Q ss_pred EEecccCceEEEEEEE---cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 28 EILGKGASKTVYRAFD---EYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 28 e~LG~GafgtVy~A~d---~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
+.||+|+||+||++.+ ..+|..||+|+++.... ......++..|+.+|++++||||+++++.+.. ...+|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEE
Confidence 5799999999999976 45789999999875432 22345567889999999999999999998865 67899999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc--C
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--H 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~--~ 182 (745)
||+.+|+|.+++.+...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...... .
T Consensus 78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEEC-CCCcEEEeeccCCcccCCCCCc
Confidence 99999999999988888999999999999999999999998 99999999999998 5689999999998765433 2
Q ss_pred CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHH
Q 004564 183 AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEK 261 (745)
Q Consensus 183 ~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~k 261 (745)
.....||+.|+|||++. ..++.++|||||||++|+|+||+.||.. .+..+.+..+..+... ++...++.++++|.+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~~ 231 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKAKLG--MPQFLSPEAQSLLRA 231 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHH
Confidence 23456999999999987 4688999999999999999999999987 4556666666655432 345578999999999
Q ss_pred Hhh-CccCCCC-----HHHHhcCCCCCcc
Q 004564 262 CLA-TVSLRLS-----ARELLNDPFLQID 284 (745)
Q Consensus 262 cL~-dPskRpS-----a~ELL~hPff~~~ 284 (745)
||+ +|.+||+ ++++++||||+..
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 999 9999999 7889999999854
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=363.39 Aligned_cols=256 Identities=21% Similarity=0.357 Sum_probs=214.1
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
.+| ++.+.||+|+||.||+|.+..+++.||+|++..... ........+.+|+.+++.++||||+++++.|.+ ...+
T Consensus 43 ~~y-~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~ 118 (371)
T cd05622 43 EDY-EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYL 118 (371)
T ss_pred hhc-EEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEE
Confidence 556 788999999999999999999999999999874332 223345667889999999999999999998865 6789
Q ss_pred EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 101 NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
|+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+..
T Consensus 119 ~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~-~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNK 194 (371)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEC-CCCCEEEEeCCceeEcCc
Confidence 999999999999998765 45899999999999999999999998 99999999999998 568999999999976543
Q ss_pred cC---CCcccCCCCcCChhhhhh-----ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC--cccC
Q 004564 181 SH---AAHCVGTPEFMAPEVYEE-----AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDS--LYRV 250 (745)
Q Consensus 181 ~~---~~~~vGTp~YmAPEvl~~-----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~--l~~~ 250 (745)
.. ....+||+.|||||++.+ .++.++|||||||++|||++|..||.. .+....+.++........ ....
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~ 273 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDND 273 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcCC
Confidence 22 234569999999999863 278899999999999999999999986 566777777776543222 2235
Q ss_pred CCHHHHHHHHHHhhCccC---CCCHHHHhcCCCCCccc
Q 004564 251 KDPEVRRFVEKCLATVSL---RLSARELLNDPFLQIDD 285 (745)
Q Consensus 251 ~s~el~d~I~kcL~dPsk---RpSa~ELL~hPff~~~~ 285 (745)
.++.++++|.+||.+|.. |++++++++||||+...
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 789999999999995433 78999999999997543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=356.57 Aligned_cols=255 Identities=19% Similarity=0.355 Sum_probs=210.4
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+| ++.+.||+|+||+||+|.+..+++.||+|++..... ......+.+..|+.+++.++||||+++++.+.+ ...+|
T Consensus 2 ~y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~ 77 (331)
T cd05597 2 DF-EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-LKRAETACFREERDVLVNGDRRWITNLHYAFQD--ENNLY 77 (331)
T ss_pred Cc-eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--CCeEE
Confidence 45 778999999999999999999999999999874332 223455678899999999999999999998865 67899
Q ss_pred EEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 102 FVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
+||||+.+|+|.+++.+ ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+..
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLA 154 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEEC-CCCCEEEEECCceeecCC
Confidence 99999999999999876 467999999999999999999999998 99999999999997 568999999999866543
Q ss_pred cCC---CcccCCCCcCChhhhh------hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC---CCcc
Q 004564 181 SHA---AHCVGTPEFMAPEVYE------EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP---DSLY 248 (745)
Q Consensus 181 ~~~---~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p---~~l~ 248 (745)
... ...+||+.|||||++. +.++.++|||||||++|+|++|+.||.. .+..+.+..+...... ....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 233 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEHFQFPPDV 233 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcc
Confidence 221 2246999999999986 3478899999999999999999999986 4556666666543321 1112
Q ss_pred cCCCHHHHHHHHHHhhC---ccCCCCHHHHhcCCCCCcc
Q 004564 249 RVKDPEVRRFVEKCLAT---VSLRLSARELLNDPFLQID 284 (745)
Q Consensus 249 ~~~s~el~d~I~kcL~d---PskRpSa~ELL~hPff~~~ 284 (745)
...++.++++|.+||.. +..|++++++|+||||...
T Consensus 234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 34688999999999973 3348899999999999753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=356.22 Aligned_cols=250 Identities=20% Similarity=0.354 Sum_probs=210.9
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEEEEec
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
++||+|+||+||+|.+..+++.||+|+++... .......+.+..|+.++..+ +||||+++++++.. ...+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKEL-VHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeC
Confidence 36999999999999999999999999998543 22345667788999999988 69999999998866 5789999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh--ccCCC
Q 004564 107 FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAA 184 (745)
Q Consensus 107 ~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~--~~~~~ 184 (745)
+.+|+|..++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEe-CCCCEEEeccccceeccCCCCcee
Confidence 999999999988889999999999999999999999998 99999999999998 56899999999986532 22233
Q ss_pred cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCC------CCHHHHHHHHHcCCCCCCcccCCCHHHHH
Q 004564 185 HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSEC------THPAQIYKKVVSGKKPDSLYRVKDPEVRR 257 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~------~~~~~i~kkv~~g~~p~~l~~~~s~el~d 257 (745)
..+||+.|+|||++. ..++.++|||||||++|+|+||..||... .....++..+... +..++...++.+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~ 232 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASH 232 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHH
Confidence 457999999999986 56899999999999999999999999532 2234455555443 33355667899999
Q ss_pred HHHHHhh-CccCCCC------HHHHhcCCCCCccc
Q 004564 258 FVEKCLA-TVSLRLS------ARELLNDPFLQIDD 285 (745)
Q Consensus 258 ~I~kcL~-dPskRpS------a~ELL~hPff~~~~ 285 (745)
+|.+||. +|.+|++ +++++.||||+..+
T Consensus 233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 9999999 9999998 57999999998543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=372.40 Aligned_cols=253 Identities=31% Similarity=0.497 Sum_probs=223.8
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
..| -+.+++|+|+||.++++.++..+..++||.|.+.... ........+|+.++++++|||||.++++|+.. +..+
T Consensus 4 ~~Y-e~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t--~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-~~~l 79 (426)
T KOG0589|consen 4 DNY-EVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT--EPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-GQLL 79 (426)
T ss_pred chh-hhhhhcCccccchhhhhhhccCCceEEEEEEeccccC--chhhHHHHHHHHHHHhccCCCeeeeccchhcC-CceE
Confidence 456 5568899999999999999999999999999987643 34445788999999999999999999999873 3349
Q ss_pred EEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 101 NFVTEMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
+|||+|++||+|.+.+.+.+ .++++.+..|+.||+.|+.|||++. |+|||||+.|||++ .++.|||+|||+|+.+
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Niflt-k~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLT-KDKKVKLGDFGLAKIL 156 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcc-ccCceeecchhhhhhc
Confidence 99999999999999988765 5899999999999999999999887 99999999999998 5578899999999999
Q ss_pred hcc--CCCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHH
Q 004564 179 RKS--HAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEV 255 (745)
Q Consensus 179 ~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el 255 (745)
... ...+.+|||.||.||++.+ .|+.++||||||||+|||++-+++|.+ .+...+..++..+.. .+++..++.++
T Consensus 157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~~-~Plp~~ys~el 234 (426)
T KOG0589|consen 157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGLY-SPLPSMYSSEL 234 (426)
T ss_pred CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhccC-CCCCccccHHH
Confidence 876 5667789999999999985 799999999999999999999999998 667777777777763 33567789999
Q ss_pred HHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 256 RRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 256 ~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
+.+|..||. +|..||+|.+||.+|.++
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 999999999 999999999999999886
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=341.97 Aligned_cols=250 Identities=34% Similarity=0.554 Sum_probs=207.7
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.+.||+|+||+||+|.+..++..||+|++..... ..........|+.+++.++||||+++++.+.+ ...+++||
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~ 77 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVM 77 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEE
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhccccccccccccccccccc--cccccccc
Confidence 888999999999999999999999999999985531 12223334569999999999999999998877 78899999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh--hccC
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSH 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l--~~~~ 182 (745)
|++.+++|.+++.+.+.+++..+..++.||+.||.+||+++ |+|+||||+|||++ .++.++|+|||++... ....
T Consensus 78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLD-ENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEES-TTSEEEESSGTTTEESTSTTSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-cccccccccccccccccccccc
Confidence 99999999999998899999999999999999999999998 99999999999998 6789999999998753 2233
Q ss_pred CCcccCCCCcCChhhhh--hccCccccchhhhhHHHHHhhcCCCCCCCC--CHHHHHHHHHcCCCCCCc--ccCCCHHHH
Q 004564 183 AAHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECT--HPAQIYKKVVSGKKPDSL--YRVKDPEVR 256 (745)
Q Consensus 183 ~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~--~~~~i~kkv~~g~~p~~l--~~~~s~el~ 256 (745)
.....+|+.|+|||++. ..++.++||||||+++|+|++|..||.... +.............+... .....+.+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELR 234 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHH
Confidence 34456999999999987 568999999999999999999999998752 223333323221111111 111237999
Q ss_pred HHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 257 RFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 257 d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
++|.+||+ +|++||++.++++||||
T Consensus 235 ~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 235 DLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHccCChhHCcCHHHHhcCCCC
Confidence 99999999 99999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=338.16 Aligned_cols=251 Identities=32% Similarity=0.547 Sum_probs=213.6
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccC-CCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL-QSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~-~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV 103 (745)
.+.+.||+|++|.||+|.+..++..||+|.+...... ........+.+|+.+++.++||||+++++++.+ ...+++|
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v 82 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETLSIF 82 (263)
T ss_pred cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeEEEE
Confidence 6778999999999999999999999999988754322 123345678999999999999999999998876 5699999
Q ss_pred EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCC
Q 004564 104 TEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 183 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~ 183 (745)
+||+.+++|.+++.+.+.+++..++.++.||+.||.|||+.+ |+||||+|+||+++ .++.++|+|||++........
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~-~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceecccccc
Confidence 999999999999998888999999999999999999999998 99999999999998 568999999999875532211
Q ss_pred -----CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHH
Q 004564 184 -----AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257 (745)
Q Consensus 184 -----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d 257 (745)
....|++.|+|||++. ..++.++||||||+++|+|++|+.||........+. .+........+....+..+.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-HHhccCCCCCCCccCCHHHHH
Confidence 2345889999999987 458899999999999999999999998754444444 344444444456678899999
Q ss_pred HHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 258 FVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 258 ~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
+|.+||. +|.+|||+.++|+||||
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999 99999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=348.29 Aligned_cols=246 Identities=25% Similarity=0.409 Sum_probs=204.3
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEeccCC
Q 004564 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTS 109 (745)
Q Consensus 30 LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~~g 109 (745)
||+|+||+||+|.+..+++.||+|.+..... ......+.+..|+.+|+.++||||+++++.+.. +..+|+||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL-KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHH-hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCC
Confidence 7999999999999999999999999874432 223445678889999999999999999998755 5789999999999
Q ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC--C
Q 004564 110 GTLRQYRLK----HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--A 183 (745)
Q Consensus 110 GsL~~~l~k----~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~--~ 183 (745)
|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ +++.+||+|||++..+.... .
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~ 154 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKT 154 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCccceecCCCCccc
Confidence 999887643 356899999999999999999999998 99999999999997 56899999999987654322 2
Q ss_pred CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCC---HHHHHHHHHcCCCCCCcccCCCHHHHHHH
Q 004564 184 AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTH---PAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259 (745)
Q Consensus 184 ~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~---~~~i~kkv~~g~~p~~l~~~~s~el~d~I 259 (745)
....||+.|+|||++. ..++.++|||||||++|+|+||+.||..... ...+...+..+ +..+....++.+++++
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li 232 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFC 232 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHH
Confidence 2346999999999987 5688999999999999999999999976332 22333333322 2234456789999999
Q ss_pred HHHhh-CccCCC-----CHHHHhcCCCCCc
Q 004564 260 EKCLA-TVSLRL-----SARELLNDPFLQI 283 (745)
Q Consensus 260 ~kcL~-dPskRp-----Sa~ELL~hPff~~ 283 (745)
.+||+ +|.+|| +++++++||||+.
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 99999 999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=359.28 Aligned_cols=254 Identities=30% Similarity=0.404 Sum_probs=203.0
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC---
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA--- 96 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~--- 96 (745)
..+| ++.+.||+|+||.||+|.+..+|..||+|+++... .......++.+|+.+++.++||||+++++.+....
T Consensus 20 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 20 LKRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhce-EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc--cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 4677 77799999999999999999999999999886442 23455677889999999999999999999876432
Q ss_pred -CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 97 -NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 97 -~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
...+|+||||+.+ +|.+++. ..+++..+..++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~-~~~~~kl~Dfg~a 170 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA 170 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEecCCCc
Confidence 1358999999975 5666543 35899999999999999999999998 99999999999998 5689999999999
Q ss_pred hhhhcc-CCCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH--------------
Q 004564 176 AILRKS-HAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVV-------------- 239 (745)
Q Consensus 176 ~~l~~~-~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~-------------- 239 (745)
...... ......||+.|+|||++.+ .++.++|||||||++|+|+||..||.+......+...+.
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred cccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 764332 2234568999999999874 689999999999999999999999987543222211110
Q ss_pred -------cCC--CC----------------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 240 -------SGK--KP----------------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 240 -------~g~--~p----------------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
... .+ .......++.+++||.+||+ +|.+|||+.|+|+||||+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence 000 00 01112346789999999999 999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.66 Aligned_cols=247 Identities=26% Similarity=0.377 Sum_probs=208.2
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC---CCCCcceEeEEEEecCCCeEEEEEec
Q 004564 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL---KHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 30 LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L---~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
||+|+||+||+|.+..++..||+|++...... .......+..|..++..+ +||||++++..|.. ...+|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcC
Confidence 79999999999999999999999998754322 233445566677777665 69999999998865 6789999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc--cCCC
Q 004564 107 FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 184 (745)
Q Consensus 107 ~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~--~~~~ 184 (745)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD-ATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCCCCCcc
Confidence 999999999998889999999999999999999999998 99999999999998 568999999999865322 2233
Q ss_pred cccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHH
Q 004564 185 HCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKC 262 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kc 262 (745)
..+||+.|||||++.+ .++.++|||||||++|+|+||..||.. .+..++++.+..+..... ....++.+++||.+|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~-~~~~~~~~~~li~~~ 232 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRFP-KNVLSDEGRQFVKGL 232 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCCC-CccCCHHHHHHHHHH
Confidence 4569999999999863 488999999999999999999999986 566777777776654321 234688999999999
Q ss_pred hh-CccCCC----CHHHHhcCCCCCcc
Q 004564 263 LA-TVSLRL----SARELLNDPFLQID 284 (745)
Q Consensus 263 L~-dPskRp----Sa~ELL~hPff~~~ 284 (745)
|+ +|.+|| ++.++++||||...
T Consensus 233 L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 99 999998 79999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=357.77 Aligned_cols=248 Identities=28% Similarity=0.431 Sum_probs=209.0
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC---eEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR---NIN 101 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~---~iy 101 (745)
.-.+++|.|+||.||+|....++++||||.+-..+... -+|+.+|+.++|||||++.-+|...... .++
T Consensus 27 ~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 27 EAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 55688999999999999999999999999886443221 2499999999999999999988765555 566
Q ss_pred EEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 102 FVTEMFTSGTLRQYRLK----HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k----~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
+||||++ .+|.++++. +.+++.-.++-+++||++||.|||++| |+||||||.|||||...|.+||||||.|+.
T Consensus 99 lVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 99 LVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 8999995 588887764 578999999999999999999999988 999999999999999999999999999998
Q ss_pred hhccCC-CcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CC-----------
Q 004564 178 LRKSHA-AHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-GK----------- 242 (745)
Q Consensus 178 l~~~~~-~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~-g~----------- 242 (745)
+..... .+++-|..|+|||++.+ .|+.+.||||.||++.||+-|++-|.+.....|+...+.- |.
T Consensus 176 L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 176 LVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred eccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 865443 45568999999999874 6999999999999999999999999987666666543311 11
Q ss_pred ------CC--------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 243 ------KP--------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 243 ------~p--------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
.| ..+.+..++++.+|+.++|+ +|.+|.++.|+|.||||+.
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 01 12445578999999999999 9999999999999999973
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=380.79 Aligned_cols=264 Identities=27% Similarity=0.463 Sum_probs=224.7
Q ss_pred ceEeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEE
Q 004564 14 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWV 93 (745)
Q Consensus 14 ~~e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfv 93 (745)
|--++|...|..+++ ||-|+||+||+|..+.++...|.|+|. ..+.+.++.+.-||.||..++||+||++|+.|+
T Consensus 25 ~rdlnP~d~WeIiGE-LGDGAFGKVyKA~nket~~lAAaKvIe----tkseEELEDylVEIeILa~CdHP~ivkLl~ayy 99 (1187)
T KOG0579|consen 25 YRDLNPRDHWEIIGE-LGDGAFGKVYKAVNKETKLLAAAKVIE----TKSEEELEDYLVEIEILAECDHPVIVKLLSAYY 99 (1187)
T ss_pred hccCCHHHHHHHHhh-hcCccchhhhhhhcccchhhhhhhhhc----ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh
Confidence 445677777855544 799999999999999999999999887 345788999999999999999999999999887
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCc
Q 004564 94 DTANRNINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 172 (745)
Q Consensus 94 d~~~~~iyLV~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DF 172 (745)
. .+.+|++.|||.||-....+.. ...|.+.+|..+++|+|.||.|||+++ |||||||..|||++ -+|.|+|+||
T Consensus 100 ~--enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~T-ldGdirLADF 174 (1187)
T KOG0579|consen 100 F--ENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLT-LDGDIRLADF 174 (1187)
T ss_pred c--cCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEE-ecCcEeeecc
Confidence 6 6789999999999999887665 567999999999999999999999998 99999999999998 6699999999
Q ss_pred chhhhhhc--cCCCcccCCCCcCChhhhh------hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 004564 173 GLAAILRK--SHAAHCVGTPEFMAPEVYE------EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP 244 (745)
Q Consensus 173 GlA~~l~~--~~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p 244 (745)
|++..... .....++|||.|||||++. .+|+.++|||||||+|.||+.+++|.++...+..+.+.-.+..+.
T Consensus 175 GVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPT 254 (1187)
T KOG0579|consen 175 GVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 254 (1187)
T ss_pred cccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCc
Confidence 99876533 3456789999999999873 579999999999999999999999999966666665544433322
Q ss_pred CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCccccc
Q 004564 245 DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDDCE 287 (745)
Q Consensus 245 ~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~~~ 287 (745)
...+...+..+++|+.+||. +|..||++.+||+|||++..+..
T Consensus 255 LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 255 LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence 33344567889999999999 99999999999999999955433
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=342.79 Aligned_cols=253 Identities=30% Similarity=0.376 Sum_probs=199.1
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC---CCCCcceEeEEEEec---
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL---KHKNIMKFYTSWVDT--- 95 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L---~HpNIVk~~~sfvd~--- 95 (745)
+| ++.+.||+|+||+||+|.+..++..||+|.++..... ......+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y-~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QY-EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE--DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred Cc-eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC--CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 45 6778899999999999999999999999998754321 11122345666666655 799999999987642
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcc
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 173 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFG 173 (745)
....+++|||++. ++|..++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++ +++.+||+|||
T Consensus 78 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~kl~dfg 153 (288)
T cd07863 78 RETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFG 153 (288)
T ss_pred CCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccC
Confidence 2356899999997 4898888764 35899999999999999999999998 99999999999997 56899999999
Q ss_pred hhhhhhccC-CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CC-----CC-
Q 004564 174 LAAILRKSH-AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-GK-----KP- 244 (745)
Q Consensus 174 lA~~l~~~~-~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~-g~-----~p- 244 (745)
++....... .....||+.|+|||++. ..++.++|||||||++|+|++|.+||........+.+.+.. +. .|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 154 LARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 997765332 23346899999999886 46899999999999999999999999775443333222211 00 00
Q ss_pred -----------------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 245 -----------------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 245 -----------------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
.......+..++++|.+||+ ||.+|||+.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01112356788999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=340.70 Aligned_cols=254 Identities=28% Similarity=0.513 Sum_probs=210.7
Q ss_pred CCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecC
Q 004564 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTA 96 (745)
Q Consensus 18 dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~ 96 (745)
+|+|+| ++.+.||+|+||.||+|.+..++..||+|++.... .....+..|+.+++.+ +||||+++++.+....
T Consensus 3 ~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 3 DPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred Chhhhh-hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 689999 77788999999999999999999999999886432 2345678899999998 6999999999987532
Q ss_pred ----CCeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEc
Q 004564 97 ----NRNINFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 170 (745)
Q Consensus 97 ----~~~iyLV~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~ 170 (745)
...+|++|||+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~-~~~~~~l~ 153 (272)
T cd06637 77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLV 153 (272)
T ss_pred CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEEC-CCCCEEEc
Confidence 24689999999999999998864 46899999999999999999999988 99999999999998 56799999
Q ss_pred Ccchhhhhhcc--CCCcccCCCCcCChhhhh------hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 004564 171 DLGLAAILRKS--HAAHCVGTPEFMAPEVYE------EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK 242 (745)
Q Consensus 171 DFGlA~~l~~~--~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~ 242 (745)
|||++...... ......|++.|+|||++. ..|+.++|||||||++|+|++|+.||......... ..+....
T Consensus 154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-~~~~~~~ 232 (272)
T cd06637 154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-FLIPRNP 232 (272)
T ss_pred cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-HHHhcCC
Confidence 99998765332 223456899999999884 24788999999999999999999999764433333 2333333
Q ss_pred CCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 243 KPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 243 ~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
.+.......+..+++|+.+||. +|.+|||+.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 3333344567899999999999 99999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=354.67 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=205.0
Q ss_pred CCCceeeEeEEecccCceEEEEEEE-----cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEE
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFD-----EYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSW 92 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d-----~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sf 92 (745)
|..|| ++.++||+|+||+||+|.+ ..++..||+|+++.. ........+.+|+.+|+.+ +||||+++++++
T Consensus 5 ~~~~~-~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 5 PRDRL-RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG---ATASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred chhHc-eeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc---cchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 45677 8889999999999999974 345678999988632 2344567789999999999 899999999987
Q ss_pred EecCCCeEEEEEeccCCCCHHHHHHHc-----------------------------------------------------
Q 004564 93 VDTANRNINFVTEMFTSGTLRQYRLKH----------------------------------------------------- 119 (745)
Q Consensus 93 vd~~~~~iyLV~E~~~gGsL~~~l~k~----------------------------------------------------- 119 (745)
.. .+..+++||||+.+|+|.+++...
T Consensus 81 ~~-~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 81 TK-PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred cC-CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 54 345789999999999999998753
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC----CCcc
Q 004564 120 ---------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AAHC 186 (745)
Q Consensus 120 ---------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~----~~~~ 186 (745)
..+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....... ....
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEc-CCCcEEEeecccccccccCcchhcccCC
Confidence 24778899999999999999999988 99999999999998 56899999999997653221 1223
Q ss_pred cCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh
Q 004564 187 VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA 264 (745)
Q Consensus 187 vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~ 264 (745)
.+++.|||||++. +.++.++|||||||++|||++ |..||........+...+..+..+. .....++.++++|.+||+
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~ 315 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR-APENATPEIYRIMLACWQ 315 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcc
Confidence 4678999999886 568999999999999999997 9999987555555556666555433 345678899999999999
Q ss_pred -CccCCCCHHHHhc
Q 004564 265 -TVSLRLSARELLN 277 (745)
Q Consensus 265 -dPskRpSa~ELL~ 277 (745)
+|.+|||+.++++
T Consensus 316 ~dp~~RPs~~el~~ 329 (338)
T cd05102 316 GDPKERPTFSALVE 329 (338)
T ss_pred CChhhCcCHHHHHH
Confidence 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=365.36 Aligned_cols=246 Identities=26% Similarity=0.369 Sum_probs=199.0
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
++| .+.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.+|+.|+||||++++++|.. +...
T Consensus 92 ~~y-~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~ 158 (391)
T PHA03212 92 AGF-SILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFTY--NKFT 158 (391)
T ss_pred CCc-EEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEEE--CCee
Confidence 457 77899999999999999999999999999643 2346789999999999999999998865 6789
Q ss_pred EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 101 NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
++|+|++. ++|..++.....+++..++.|+.||+.||.|||+++ ||||||||+|||++ ..|.+||+|||+|.....
T Consensus 159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVD 234 (391)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEc-CCCCEEEEeCCccccccc
Confidence 99999985 689999888888999999999999999999999998 99999999999998 568999999999965322
Q ss_pred ---cCCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCC-------CHHHHHHHHH-cCCCCCC--
Q 004564 181 ---SHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECT-------HPAQIYKKVV-SGKKPDS-- 246 (745)
Q Consensus 181 ---~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~-------~~~~i~kkv~-~g~~p~~-- 246 (745)
......+||+.|+|||++. ..|+.++|||||||++|||+||..||.+.. ...++...+. .|..|..
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 2223457999999999986 468999999999999999999998874321 1111111110 0111100
Q ss_pred ------------------------c-----ccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 247 ------------------------L-----YRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 247 ------------------------l-----~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
. ....+.++.++|.+||+ +|.+||||+|+|+||||+.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 0 00135678999999999 9999999999999999974
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=351.49 Aligned_cols=252 Identities=21% Similarity=0.356 Sum_probs=213.3
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceEeEEEEecCCCeEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-HpNIVk~~~sfvd~~~~~iyLV 103 (745)
.+.++||+|+||+||+|.+..+|..||+|+++.... ......+.+..|+.+++.+. |++|+++++++.. ...+|+|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv 79 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYFV 79 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEEE
Confidence 567889999999999999999999999999875432 22345667888999998886 5678889888765 5689999
Q ss_pred EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc--
Q 004564 104 TEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-- 181 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~-- 181 (745)
|||+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~-~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeccccccccCCCCc
Confidence 999999999999998889999999999999999999999988 99999999999998 5689999999998754322
Q ss_pred CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHH
Q 004564 182 HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVE 260 (745)
Q Consensus 182 ~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~ 260 (745)
......||+.|+|||++. +.++.++|||||||++|+|+||..||.. .+...+++.+..+... ++...++.+++++.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~ 233 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNVS--YPKSLSKEAVSICK 233 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCccCCHHHHHHHH
Confidence 223346999999999987 4689999999999999999999999987 4566777777665432 34567899999999
Q ss_pred HHhh-CccCCCC-----HHHHhcCCCCCccc
Q 004564 261 KCLA-TVSLRLS-----ARELLNDPFLQIDD 285 (745)
Q Consensus 261 kcL~-dPskRpS-----a~ELL~hPff~~~~ 285 (745)
+||+ +|.+|++ .+++++||||+..+
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 9999 9999997 58999999998543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=351.90 Aligned_cols=253 Identities=19% Similarity=0.332 Sum_probs=209.6
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.++||+|+||+||+|.+..+++.||+|++..... ........+..|+.+++.++|+||+++++.+.+ ...+|+||
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 80 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-LKRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLYLVM 80 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEEEEE
Confidence 778999999999999999999999999999864322 123344568889999999999999999998865 67899999
Q ss_pred eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC-
Q 004564 105 EMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~- 182 (745)
||+.+|+|.+++.+ ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~-~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEeecchheecccCCc
Confidence 99999999999887 467999999999999999999999988 99999999999998 56899999999986543221
Q ss_pred --CCcccCCCCcCChhhhh------hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC---CcccCC
Q 004564 183 --AAHCVGTPEFMAPEVYE------EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPD---SLYRVK 251 (745)
Q Consensus 183 --~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~---~l~~~~ 251 (745)
....+||+.|||||++. +.++.++|||||||++|||++|+.||.. .+..+.+.++....... ......
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCccccCCCccccC
Confidence 12346999999999985 3478899999999999999999999987 45666666666543221 122346
Q ss_pred CHHHHHHHHHHhh-Cc--cCCCCHHHHhcCCCCCcc
Q 004564 252 DPEVRRFVEKCLA-TV--SLRLSARELLNDPFLQID 284 (745)
Q Consensus 252 s~el~d~I~kcL~-dP--skRpSa~ELL~hPff~~~ 284 (745)
+++++++|.+||. ++ ..|++++++++||||+..
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 8999999999997 33 347899999999999854
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=375.06 Aligned_cols=261 Identities=29% Similarity=0.457 Sum_probs=227.9
Q ss_pred CceEeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEE
Q 004564 13 EFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSW 92 (745)
Q Consensus 13 ~~~e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sf 92 (745)
=|..-||..+|.-+.+ ||.|+||.||.|.|..+...||||.+.... .++.+..+.+.+|+.+|++|+|||+|.+-++|
T Consensus 18 LF~k~DPEklf~dLrE-IGHGSFGAVYfArd~~n~evVAIKKMsySG-KQs~EKWqDIlKEVrFL~~l~HPntieYkgCy 95 (948)
T KOG0577|consen 18 LFFKDDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDILKEVRFLRQLRHPNTIEYKGCY 95 (948)
T ss_pred HHccCCHHHHHHHHHH-hcCCccceeEEeeccCccceeeeeeccccc-cccHHHHHHHHHHHHHHHhccCCCccccccee
Confidence 3577899999977744 899999999999999999999999998665 45677889999999999999999999999999
Q ss_pred EecCCCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcC
Q 004564 93 VDTANRNINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 171 (745)
Q Consensus 93 vd~~~~~iyLV~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~D 171 (745)
+. ..+.|+|||||- |+-.+++.= .+++-+-.|..|+.+.|.||.|||+++ .||||||..|||++ +.|.|||+|
T Consensus 96 Lr--e~TaWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLs-e~g~VKLaD 169 (948)
T KOG0577|consen 96 LR--EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLS-EPGLVKLAD 169 (948)
T ss_pred ec--cchHHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEec-CCCeeeecc
Confidence 86 568999999996 577777664 467999999999999999999999999 99999999999997 669999999
Q ss_pred cchhhhhhccCCCcccCCCCcCChhhhh----hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCc
Q 004564 172 LGLAAILRKSHAAHCVGTPEFMAPEVYE----EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSL 247 (745)
Q Consensus 172 FGlA~~l~~~~~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l 247 (745)
||.|.+..+ ...++|||.|||||++. +.|+-++|||||||+..||+-.++|+...+.+..+|. |..+..|.-.
T Consensus 170 FGSAsi~~P--AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH-IAQNesPtLq 246 (948)
T KOG0577|consen 170 FGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNESPTLQ 246 (948)
T ss_pred ccchhhcCc--hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH-HHhcCCCCCC
Confidence 999987654 45689999999999873 7899999999999999999999999988776777775 5555556544
Q ss_pred ccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 248 YRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 248 ~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
..-.+..++.||..||+ -|..|||.++||+|+|..-.
T Consensus 247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 247 SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 55567889999999999 79999999999999998643
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=357.81 Aligned_cols=247 Identities=28% Similarity=0.429 Sum_probs=202.8
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.+.||+|+||+||+|.+..+++.||+|++.... .......+.+|+.+|+.++|+||++++++|.. ...+|+||
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 151 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQVLL 151 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEEEEE
Confidence 45578999999999999999999999999886432 34556788999999999999999999998865 67899999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC--
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-- 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~-- 182 (745)
||+.+|+|... ...++..+..++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||++..+....
T Consensus 152 e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 152 EFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred ecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEcccccceeccccccc
Confidence 99999998643 34678889999999999999999998 99999999999998 56899999999997664322
Q ss_pred CCcccCCCCcCChhhhhh------ccCccccchhhhhHHHHHhhcCCCCCCCC--CHHHHHHHHHcCCCCCCcccCCCHH
Q 004564 183 AAHCVGTPEFMAPEVYEE------AYNELVDIYSFGMCILEMVTFEYPYSECT--HPAQIYKKVVSGKKPDSLYRVKDPE 254 (745)
Q Consensus 183 ~~~~vGTp~YmAPEvl~~------~ys~ksDIWSLGvILyELlTG~~Pf~~~~--~~~~i~kkv~~g~~p~~l~~~~s~e 254 (745)
....+||+.|+|||++.. .++.++|||||||++|||++|+.||.... ....+...+..+. +.......+++
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 303 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-PPEAPATASRE 303 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-CCCCCCccCHH
Confidence 234579999999998742 23468999999999999999999997422 2233333333332 23344567899
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 255 VRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 255 l~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
+++||.+||+ +|.+|||+.|+|+||||...
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 9999999999 99999999999999999753
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=352.40 Aligned_cols=256 Identities=17% Similarity=0.338 Sum_probs=211.1
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+| ++.+.||+|+||+||+|.+..+++.||+|++..... ........+..|+.+++.++|+||+++++.+.+ ...+|
T Consensus 2 ~y-~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~ 77 (331)
T cd05624 2 DF-EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-LKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLY 77 (331)
T ss_pred Cc-eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEE
Confidence 45 778999999999999999999999999999874321 223445668889999999999999999998865 67899
Q ss_pred EEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 102 FVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
+||||+.+|+|.+++.+ ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++.....
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEc-CCCCEEEEeccceeeccC
Confidence 99999999999999887 467999999999999999999999988 99999999999998 568999999999876543
Q ss_pred cCC---CcccCCCCcCChhhhhh------ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCc---c
Q 004564 181 SHA---AHCVGTPEFMAPEVYEE------AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSL---Y 248 (745)
Q Consensus 181 ~~~---~~~vGTp~YmAPEvl~~------~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l---~ 248 (745)
... ....||+.|||||++.+ .++.++|||||||++|+|+||+.||.. .+..+.+.++........+ .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 233 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEERFQFPSHI 233 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCcccCCCcc
Confidence 222 23469999999999863 578899999999999999999999987 4556666666554321111 2
Q ss_pred cCCCHHHHHHHHHHhhC-ccC--CCCHHHHhcCCCCCccc
Q 004564 249 RVKDPEVRRFVEKCLAT-VSL--RLSARELLNDPFLQIDD 285 (745)
Q Consensus 249 ~~~s~el~d~I~kcL~d-Psk--RpSa~ELL~hPff~~~~ 285 (745)
...++.++++|.+||.. +.+ |++++++++||||+..+
T Consensus 234 ~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 33578999999999984 332 57999999999998543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=334.91 Aligned_cols=254 Identities=32% Similarity=0.543 Sum_probs=213.9
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeeccc-CCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF-LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~-~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV 103 (745)
++.++||+|+||.||+|.+..++..||+|.+..... .......+.+.+|+.+++.++||||++++++|.+.....++++
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence 778999999999999999999999999998875432 2234557789999999999999999999998876555678999
Q ss_pred EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc--
Q 004564 104 TEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-- 181 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~-- 181 (745)
|||+.+++|.+++.+...+++..+..++.||+.||.|||+++ |+|+||||+|||++ .++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 85 MEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-CCCCEEECcCccccccccccc
Confidence 999999999999988888999999999999999999999998 99999999999997 6689999999998754321
Q ss_pred ---CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHH
Q 004564 182 ---HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257 (745)
Q Consensus 182 ---~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d 257 (745)
......|+..|+|||++. ..++.++|||||||++|+|++|+.||........+.+ ..........+...+..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH-HhcCCCCCCCchhhCHHHHH
Confidence 122345899999999886 4588999999999999999999999987554554443 33332223344556788999
Q ss_pred HHHHHhhCccCCCCHHHHhcCCCCC
Q 004564 258 FVEKCLATVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 258 ~I~kcL~dPskRpSa~ELL~hPff~ 282 (745)
+|.+||.+|.+||+++++++|||++
T Consensus 241 ~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhcChhhCCCHHHHhcCcccC
Confidence 9999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=371.02 Aligned_cols=253 Identities=23% Similarity=0.306 Sum_probs=198.8
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC------CCcceEeEEEE
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH------KNIMKFYTSWV 93 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~H------pNIVk~~~sfv 93 (745)
.++| ++.++||+|+||+||+|.+..+++.||+|+++.. ......+..|+.+++.++| ++|++++++|.
T Consensus 128 ~~~y-~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 128 TQRF-KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CCcE-EEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 4677 7889999999999999999999999999998632 2233445667777777755 45888888875
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhh-CCCCEEeecCCCcceeecCCC--------
Q 004564 94 DTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS-HDPPVIHRDLKCDNIFVNGNQ-------- 164 (745)
Q Consensus 94 d~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs-~gp~IIHRDLKpdNILld~~~-------- 164 (745)
. ....+|+||+++ +++|.+++.+++.+++..++.++.||+.||.|||+ .| ||||||||+|||++..+
T Consensus 202 ~-~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 202 N-ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred c-CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccc
Confidence 4 346789999988 77899999888899999999999999999999998 47 99999999999997432
Q ss_pred -------CcEEEcCcchhhhhhccCCCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 004564 165 -------GEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYK 236 (745)
Q Consensus 165 -------g~VKL~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k 236 (745)
+.+||+|||++..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||........+..
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH-SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred cccCCCCceEEECCCCccccCcc-ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 2599999998764332 2334579999999999874 699999999999999999999999987544333221
Q ss_pred HHH-cCCCCCCc--------------------------------------ccCCCHHHHHHHHHHhh-CccCCCCHHHHh
Q 004564 237 KVV-SGKKPDSL--------------------------------------YRVKDPEVRRFVEKCLA-TVSLRLSARELL 276 (745)
Q Consensus 237 kv~-~g~~p~~l--------------------------------------~~~~s~el~d~I~kcL~-dPskRpSa~ELL 276 (745)
... .|..|..+ ....++.+.+||.+||+ ||.+|||++|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 110 11111100 01124668899999999 999999999999
Q ss_pred cCCCCCc
Q 004564 277 NDPFLQI 283 (745)
Q Consensus 277 ~hPff~~ 283 (745)
+||||+.
T Consensus 437 ~Hp~~~~ 443 (467)
T PTZ00284 437 THPYVLK 443 (467)
T ss_pred cCccccc
Confidence 9999974
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=344.48 Aligned_cols=253 Identities=22% Similarity=0.352 Sum_probs=208.1
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.++||+|+||+||+|.+..++..||+|++..... ........+.+|+.+++.++||||+++++.+.. ...+++||
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 79 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVL 79 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh-hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEEE
Confidence 667889999999999999999999999999874332 122334567789999999999999999998765 56899999
Q ss_pred eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC
Q 004564 105 EMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~ 182 (745)
||+.+|+|..++.+. ..+++..+..++.||+.||.|||+++ |+||||||+||+++ +.+.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEEC-CCCCEEEeeCCCceecCCCC
Confidence 999999999887654 46899999999999999999999988 99999999999997 55899999999987654322
Q ss_pred -CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHH---HHHHHHHcCCCCCCcccCCCHHHHH
Q 004564 183 -AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPA---QIYKKVVSGKKPDSLYRVKDPEVRR 257 (745)
Q Consensus 183 -~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~---~i~kkv~~g~~p~~l~~~~s~el~d 257 (745)
....+|++.|+|||++. ..++.++|||||||++|+|++|+.||....... .+...+..+ +.......++.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 234 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--QEEYSEKFSEAARS 234 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc--ccccCcccCHHHHH
Confidence 22346999999999986 468899999999999999999999998643221 222222222 22334557889999
Q ss_pred HHHHHhh-CccCCC-----CHHHHhcCCCCCccc
Q 004564 258 FVEKCLA-TVSLRL-----SARELLNDPFLQIDD 285 (745)
Q Consensus 258 ~I~kcL~-dPskRp-----Sa~ELL~hPff~~~~ 285 (745)
+|.+||. +|.+|| ++++|++||||...+
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 235 ICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred HHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 9999999 999999 999999999998543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=373.86 Aligned_cols=259 Identities=26% Similarity=0.423 Sum_probs=220.8
Q ss_pred eCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC
Q 004564 17 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA 96 (745)
Q Consensus 17 ~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~ 96 (745)
..+.++| ++.++||+|+||+||+|.+..+|+.||+|++.... .......++.+|+.+|..++|+||++++..+....
T Consensus 28 ~~~~~rY-~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 28 KEQAKKY-WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG--MSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred cccCCCE-EEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc--CCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 3466788 88899999999999999999999999999987654 24566778899999999999999999998775422
Q ss_pred C------CeEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCc
Q 004564 97 N------RNINFVTEMFTSGTLRQYRLKH----KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGE 166 (745)
Q Consensus 97 ~------~~iyLV~E~~~gGsL~~~l~k~----~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~ 166 (745)
. ..+++||||+.+|+|.+++..+ ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~-~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLC-SNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEe-CCCC
Confidence 1 1478999999999999988653 46899999999999999999999988 99999999999998 5689
Q ss_pred EEEcCcchhhhhhcc----CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 004564 167 VKIGDLGLAAILRKS----HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG 241 (745)
Q Consensus 167 VKL~DFGlA~~l~~~----~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g 241 (745)
+||+|||++..+... .....+||+.|+|||++. ..|+.++|||||||++|||+||+.||.. .+...++..+..+
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~~ 260 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAG 260 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcC
Confidence 999999998765432 223456999999999997 4689999999999999999999999986 5667777777766
Q ss_pred CCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 242 KKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 242 ~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
..+ .+....+++++++|.+||+ +|.+||++.++|+|||++.
T Consensus 261 ~~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 261 RYD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 554 2455678999999999999 9999999999999999873
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=361.68 Aligned_cols=261 Identities=28% Similarity=0.463 Sum_probs=222.0
Q ss_pred eCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC
Q 004564 17 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA 96 (745)
Q Consensus 17 ~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~ 96 (745)
.-|..-| .+.++||+|+||.||+|+++.+|..||||++.+. .+++.+.+||.+|++++.|+||++|++|+.
T Consensus 29 K~PEEVF-Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-- 99 (502)
T KOG0574|consen 29 KPPEEVF-DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFK-- 99 (502)
T ss_pred CChHHHH-HHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhcc--
Confidence 3344445 4557799999999999999999999999998743 578899999999999999999999999986
Q ss_pred CCeEEEEEeccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 97 NRNINFVTEMFTSGTLRQYRL-KHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 97 ~~~iyLV~E~~~gGsL~~~l~-k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
...+|+|||||..|+..+.++ ++++++++.+..+++.-|+||+|||-.. -||||||..|||+| .+|..||+|||+|
T Consensus 100 ~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLN-T~G~AKLADFGVA 176 (502)
T KOG0574|consen 100 HSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLN-TDGIAKLADFGVA 176 (502)
T ss_pred CCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEc-ccchhhhhhcccc
Confidence 568999999999999999866 5678999999999999999999999876 79999999999998 5699999999999
Q ss_pred hhhhccC--CCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCc--ccC
Q 004564 176 AILRKSH--AAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSL--YRV 250 (745)
Q Consensus 176 ~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l--~~~ 250 (745)
..+.... ..+.+|||.|||||++++ .|+.++||||||++..||+.|++||.+......|+-.- ...|+.+ +..
T Consensus 177 GQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP--T~PPPTF~KPE~ 254 (502)
T KOG0574|consen 177 GQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP--TKPPPTFKKPEE 254 (502)
T ss_pred chhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc--CCCCCCCCChHh
Confidence 8876543 445679999999999986 69999999999999999999999999877666665322 2233222 233
Q ss_pred CCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCccccccccc
Q 004564 251 KDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDDCESNLR 291 (745)
Q Consensus 251 ~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~~~~~l~ 291 (745)
.+.++.+||.+||. .|.+|.||.+|++|||++.+.....++
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~ 296 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQ 296 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHH
Confidence 57889999999998 899999999999999999766544333
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=370.60 Aligned_cols=249 Identities=25% Similarity=0.417 Sum_probs=213.3
Q ss_pred eeEeEEecccCceEEEEEEEcCC-CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEE
Q 004564 24 GRYNEILGKGASKTVYRAFDEYE-GIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINF 102 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d~~t-g~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyL 102 (745)
+.+.++||+|+||.||+|.+..+ +..||+|.+... .......+..|+.+|+.++|||||++++.|.. ...+|+
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~l 142 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLLL 142 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCEEEE
Confidence 48889999999999999998888 788999876533 34556678889999999999999999999876 678999
Q ss_pred EEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 103 VTEMFTSGTLRQYRLK----HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 103 V~E~~~gGsL~~~l~k----~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
||||+.+|+|.+++.. ..++++..+..++.||+.||.|||+++ |+||||||+||||+ ..+.+||+|||++..+
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEEC-CCCcEEEEeCcCceec
Confidence 9999999999987653 346899999999999999999999988 99999999999998 5689999999999765
Q ss_pred hccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCH
Q 004564 179 RKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDP 253 (745)
Q Consensus 179 ~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~ 253 (745)
.... ....+||+.|+|||++. ..++.++|||||||++|+|+||..||.. .+..+++..+..+..+. .....++
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~~-~~~~~s~ 297 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLYGKYDP-FPCPVSS 297 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCC-CCccCCH
Confidence 4322 23446999999999987 4689999999999999999999999986 45566667676665442 3445788
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 254 el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
.++++|.+||. +|.+||++.++|.|||++.
T Consensus 298 ~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 298 GMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 99999999999 9999999999999999964
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.33 Aligned_cols=261 Identities=34% Similarity=0.518 Sum_probs=219.4
Q ss_pred ceEeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEE
Q 004564 14 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWV 93 (745)
Q Consensus 14 ~~e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfv 93 (745)
+...++..+| .+.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++.|.
T Consensus 13 ~~~~~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~ 87 (296)
T cd06654 13 VSVGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYL 87 (296)
T ss_pred cccCCcccce-eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC----cchHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3456788899 66788999999999999999999999999887543 234567889999999999999999999887
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcc
Q 004564 94 DTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 173 (745)
Q Consensus 94 d~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFG 173 (745)
. ....|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 88 ~--~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~-~~~~~kl~dfg 161 (296)
T cd06654 88 V--GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFG 161 (296)
T ss_pred e--CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEECccc
Confidence 6 5789999999999999998754 46899999999999999999999988 99999999999997 66899999999
Q ss_pred hhhhhhccC--CCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccC
Q 004564 174 LAAILRKSH--AAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRV 250 (745)
Q Consensus 174 lA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~ 250 (745)
++....... .....|++.|+|||.+.+ .++.++|||||||++|+|+||+.||........++.....+..+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06654 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (296)
T ss_pred cchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccc
Confidence 987654322 233468999999998874 57899999999999999999999998755444444444444333334455
Q ss_pred CCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 251 KDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 251 ~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
.++.+.++|.+||. +|.+|||+.++++||||....
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 77889999999999 999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=335.96 Aligned_cols=253 Identities=33% Similarity=0.549 Sum_probs=212.7
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccC-CCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL-QSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~-~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV 103 (745)
.+.++||+|+||.||+|.+..++..||+|.++..... ........+.+|+.+++.++||||+++++++.+.....++++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 5678999999999999999999999999988755422 233456788999999999999999999998876556789999
Q ss_pred EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc--
Q 004564 104 TEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-- 181 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~-- 181 (745)
+||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++..+...
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~-~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCCCccccccccc
Confidence 999999999999988888999999999999999999999988 99999999999998 5679999999998755321
Q ss_pred ---CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHH
Q 004564 182 ---HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257 (745)
Q Consensus 182 ---~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d 257 (745)
......++..|+|||.+. ..++.++|||||||++|+|+||+.||........+.+....+. ...+....++.+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT-NPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC-CCCCchhcCHHHHH
Confidence 112245889999999987 4588899999999999999999999987655555554433332 33445567889999
Q ss_pred HHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 258 FVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 258 ~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
+| +||. +|.+||+++++++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99 5665 999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=341.10 Aligned_cols=253 Identities=26% Similarity=0.469 Sum_probs=218.7
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+| ++.+.||+|+||.||+|.+..+++.||+|+++.... ......+.+.+|+.+|+.++||||+++++++.+ ...+|
T Consensus 2 ~y-~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 77 (290)
T cd05580 2 DF-EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLY 77 (290)
T ss_pred ce-EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEE
Confidence 35 778999999999999999999999999999874432 233556788999999999999999999998866 67899
Q ss_pred EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
+||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||+|+||||+ .+|.+||+|||++......
T Consensus 78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEeeCCCccccCCC
Confidence 99999999999999999999999999999999999999999988 99999999999998 5689999999999776544
Q ss_pred CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHH
Q 004564 182 HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVE 260 (745)
Q Consensus 182 ~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~ 260 (745)
.....|++.|+|||.+. ..++.++||||||+++|+|+||..||... .....++.+..+..+ +....++.++++|.
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 230 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD-NPIQIYEKILEGKVR--FPSFFSPDAKDLIR 230 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCcc--CCccCCHHHHHHHH
Confidence 33446899999999886 45788999999999999999999999873 456666666665543 34456899999999
Q ss_pred HHhh-CccCCC-----CHHHHhcCCCCCccc
Q 004564 261 KCLA-TVSLRL-----SARELLNDPFLQIDD 285 (745)
Q Consensus 261 kcL~-dPskRp-----Sa~ELL~hPff~~~~ 285 (745)
+||. +|.+|+ ++++|++||||+..+
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 9999 999999 999999999997533
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=341.60 Aligned_cols=257 Identities=32% Similarity=0.548 Sum_probs=217.9
Q ss_pred eCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC
Q 004564 17 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA 96 (745)
Q Consensus 17 ~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~ 96 (745)
++|..+| .+.+.||.|+||+||+|.+..++..||+|+++.. .....+.+..|+.+++.++||||+++++.+..
T Consensus 1 ~~~~~~~-~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 73 (280)
T cd06611 1 VNPNDIW-EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFY-- 73 (280)
T ss_pred CCchhHH-HHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--
Confidence 4688888 7778899999999999999999999999998743 35667789999999999999999999998865
Q ss_pred CCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 97 NRNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 97 ~~~iyLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
+..+|+||||+.+++|..++.+. ..+++..++.++.||+.||.|||+++ |+|+||||+||+++ .++.++|+|||++
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~-~~~~~~l~d~g~~ 150 (280)
T cd06611 74 ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVS 150 (280)
T ss_pred CCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEC-CCCCEEEccCccc
Confidence 67899999999999999998764 56999999999999999999999998 99999999999997 5689999999998
Q ss_pred hhhhcc--CCCcccCCCCcCChhhhh------hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-C
Q 004564 176 AILRKS--HAAHCVGTPEFMAPEVYE------EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPD-S 246 (745)
Q Consensus 176 ~~l~~~--~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~-~ 246 (745)
...... ......+|+.|+|||++. ..++.++|+||||+++|+|++|..||... .......++..+..|. .
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~ 229 (280)
T cd06611 151 AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLD 229 (280)
T ss_pred hhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhcCCCCCcC
Confidence 765432 223346899999999874 23677899999999999999999999874 4445555565554432 2
Q ss_pred cccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 247 LYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 247 l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
.....+..+.++|.+||+ +|.+||++.++|+||||...
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 234567899999999999 99999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=347.98 Aligned_cols=246 Identities=26% Similarity=0.368 Sum_probs=192.4
Q ss_pred eEEecccCceEEEEEEEc--CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 27 NEILGKGASKTVYRAFDE--YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 27 ~e~LG~GafgtVy~A~d~--~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.++||+|+||+||+|.++ .++..||+|.++... ....+.+|+.+|+.++||||+++++.|.......+|++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 357999999999999865 477899999886332 123467899999999999999999998876677899999
Q ss_pred eccCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeec---CCCCcEEEcCc
Q 004564 105 EMFTSGTLRQYRLKH---------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVN---GNQGEVKIGDL 172 (745)
Q Consensus 105 E~~~gGsL~~~l~k~---------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld---~~~g~VKL~DF 172 (745)
||+. ++|..++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ ...+.+||+||
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9985 5888876532 25899999999999999999999998 99999999999994 24578999999
Q ss_pred chhhhhhcc-----CCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCC---------HHHHHH
Q 004564 173 GLAAILRKS-----HAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTH---------PAQIYK 236 (745)
Q Consensus 173 GlA~~l~~~-----~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~---------~~~i~k 236 (745)
|++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|+||++||..... ..++.+
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 999765432 1234568999999998864 488999999999999999999999964221 111111
Q ss_pred HHHc-CCC-----------C-----------------------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCC
Q 004564 237 KVVS-GKK-----------P-----------------------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPF 280 (745)
Q Consensus 237 kv~~-g~~-----------p-----------------------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPf 280 (745)
.+.. |.. | .......+..+.++|.+||+ ||.+|||++|+|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 1100 000 0 00011235678999999999 9999999999999999
Q ss_pred C
Q 004564 281 L 281 (745)
Q Consensus 281 f 281 (745)
|
T Consensus 317 f 317 (317)
T cd07868 317 F 317 (317)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=338.20 Aligned_cols=252 Identities=28% Similarity=0.470 Sum_probs=210.0
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~ 98 (745)
+.++| ++.+.||+|+||.||+|.+..++..||+|+++... ......+.+|+.+++.++||||+++++.+.. ..
T Consensus 7 ~~~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~ 79 (267)
T cd06645 7 PQEDF-ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RD 79 (267)
T ss_pred cHHHH-HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CC
Confidence 44566 67788999999999999999999999999987442 3345668889999999999999999998876 67
Q ss_pred eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 99 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
.+|+||||+.+++|.+++...+.+++..++.++.||+.||.|||++| |+|+||||+||+++ ..+.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLT-DNGHVKLADFGVSAQI 156 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECcceeeeEc
Confidence 89999999999999999988889999999999999999999999998 99999999999997 5689999999998655
Q ss_pred hccC--CCcccCCCCcCChhhhh----hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcc--cC
Q 004564 179 RKSH--AAHCVGTPEFMAPEVYE----EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLY--RV 250 (745)
Q Consensus 179 ~~~~--~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~--~~ 250 (745)
.... .....|++.|+|||++. +.++.++|+|||||++|+|++|..||........+.........+.... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06645 157 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK 236 (267)
T ss_pred cCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCC
Confidence 4322 23346999999999873 3588899999999999999999999976544444433322222222221 13
Q ss_pred CCHHHHHHHHHHhh-CccCCCCHHHHhcCCC
Q 004564 251 KDPEVRRFVEKCLA-TVSLRLSARELLNDPF 280 (745)
Q Consensus 251 ~s~el~d~I~kcL~-dPskRpSa~ELL~hPf 280 (745)
.+..++++|.+||+ +|.+||+++++++|||
T Consensus 237 ~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 237 WSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 56789999999999 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=355.83 Aligned_cols=254 Identities=26% Similarity=0.362 Sum_probs=216.3
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.+.||+|.-|+||+|....++..+|+|+|.+.. +...+.+.++..|-.||+.++||.++.+|.+|.. ++.+|++|
T Consensus 80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~-l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~~~~cl~m 156 (459)
T KOG0610|consen 80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKES-LASRKKLKRAQTEREILSLLDHPFLPTLYASFET--DKYSCLVM 156 (459)
T ss_pred HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHH-HhhhhHHHHHHHHHHHHHhcCCCccchhhheeec--cceeEEEE
Confidence 56688999999999999999999999999997654 3446778899999999999999999999999854 78999999
Q ss_pred eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh---
Q 004564 105 EMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--- 179 (745)
Q Consensus 105 E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~--- 179 (745)
|||.||+|..+++++ +.+++..++.|+.+|+.||+|||..| ||+|||||+||||. ++|+|.|+||.|+....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvr-edGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVR-EDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEe-cCCcEEeeeccccccCCCCC
Confidence 999999999998876 46999999999999999999999988 99999999999997 77999999999973210
Q ss_pred -------------------------------c-c-----------------------CCCcccCCCCcCChhhhhh-ccC
Q 004564 180 -------------------------------K-S-----------------------HAAHCVGTPEFMAPEVYEE-AYN 203 (745)
Q Consensus 180 -------------------------------~-~-----------------------~~~~~vGTp~YmAPEvl~~-~ys 203 (745)
. . ....++||-+|.|||++.+ ..+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 0113579999999999985 689
Q ss_pred ccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCC----HHHHhcC
Q 004564 204 ELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLS----ARELLND 278 (745)
Q Consensus 204 ~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpS----a~ELL~h 278 (745)
.+||+|+|||.+|||+.|..||.+..+.+.++..+.+ .....-....+..++++|.++|. ||++|+. |.|+-+|
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-PLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-CCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 9999999999999999999999996666666554433 22211222567899999999999 9999998 9999999
Q ss_pred CCCCccc
Q 004564 279 PFLQIDD 285 (745)
Q Consensus 279 Pff~~~~ 285 (745)
|||+-.+
T Consensus 393 pFF~gVn 399 (459)
T KOG0610|consen 393 PFFEGVN 399 (459)
T ss_pred ccccCCC
Confidence 9998543
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=343.80 Aligned_cols=250 Identities=28% Similarity=0.453 Sum_probs=210.1
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.+.||+|+||.||+|.+..++..+|+|.++... ......++.+|+.++++++||||+++++++.+ +..+++||
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 78 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISICM 78 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEEe
Confidence 77889999999999999999999999999886432 34556778999999999999999999999876 67899999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhh-CCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCC
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 183 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs-~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~ 183 (745)
||+.+++|.+++.+.+.+++..+..++.||+.||.|||+ ++ ++||||||+|||++ .++.+||+|||++........
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~ 155 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA 155 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEe-cCCcEEEccCCCccccccccc
Confidence 999999999999988899999999999999999999997 46 99999999999998 568999999999876655445
Q ss_pred CcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHH------------------------
Q 004564 184 AHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKV------------------------ 238 (745)
Q Consensus 184 ~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv------------------------ 238 (745)
....|++.|+|||++.+ .++.++|+||||+++|+|+||..||.... .......+
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 55679999999999874 58889999999999999999999996532 22222211
Q ss_pred ------------HcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 239 ------------VSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 239 ------------~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
.....|.......++++++||.+||. +|++|||+.++++||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 11111221222367889999999999 9999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=354.31 Aligned_cols=255 Identities=29% Similarity=0.392 Sum_probs=203.7
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC---
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA--- 96 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~--- 96 (745)
.++| ++.+.||+|+||.||+|.+..+++.||+|.+.... .......++.+|+.+++.++||||+++++.|....
T Consensus 16 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 16 LKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhce-eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc--cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 4678 77799999999999999999999999999886432 23455678889999999999999999999876432
Q ss_pred -CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 97 -NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 97 -~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
...+|+||||+.+ +|.+++.. .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~-~~~~~kl~Dfg~~ 166 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA 166 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEC-CCCCEEEeeCccc
Confidence 2468999999975 66666543 5889999999999999999999998 99999999999997 5689999999999
Q ss_pred hhhhccC-CCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-------------
Q 004564 176 AILRKSH-AAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS------------- 240 (745)
Q Consensus 176 ~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~------------- 240 (745)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........+..
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred ccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 7654432 234579999999999874 6899999999999999999999999764332222111110
Q ss_pred --------CC-------CC-----------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 241 --------GK-------KP-----------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 241 --------g~-------~p-----------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
.. .| .......+..+++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 00 00 00112235678999999999 9999999999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=337.22 Aligned_cols=257 Identities=28% Similarity=0.462 Sum_probs=211.3
Q ss_pred ceEeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEE
Q 004564 14 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWV 93 (745)
Q Consensus 14 ~~e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfv 93 (745)
+++..+...| ++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~ 76 (267)
T cd06646 2 ILRRNPQHDY-ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76 (267)
T ss_pred ccccCchhhc-chhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEE
Confidence 4566777888 77789999999999999999999999999886432 234456888999999999999999999987
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcc
Q 004564 94 DTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 173 (745)
Q Consensus 94 d~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFG 173 (745)
. +..+|+||||+.+++|.+++.+..++++..+..++.||+.||.|||+++ |+||||||+||+++ ..+.+||+|||
T Consensus 77 ~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg 151 (267)
T cd06646 77 S--REKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLT-DNGDVKLADFG 151 (267)
T ss_pred e--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEECcCc
Confidence 6 5789999999999999999888888999999999999999999999988 99999999999997 56799999999
Q ss_pred hhhhhhccC--CCcccCCCCcCChhhhh----hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCc
Q 004564 174 LAAILRKSH--AAHCVGTPEFMAPEVYE----EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSL 247 (745)
Q Consensus 174 lA~~l~~~~--~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l 247 (745)
++....... .....|++.|+|||.+. ..++.++|+|||||++|+|++|+.||..................+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06646 152 VAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL 231 (267)
T ss_pred cceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCC
Confidence 997654322 23346899999999874 347789999999999999999999997643322222211111122111
Q ss_pred --ccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCC
Q 004564 248 --YRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPF 280 (745)
Q Consensus 248 --~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPf 280 (745)
....+..+.+||.+||. +|.+|||++++|+|+|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 12357899999999999 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=348.98 Aligned_cols=255 Identities=30% Similarity=0.419 Sum_probs=211.6
Q ss_pred eeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC-cceEeEEEEecC----C
Q 004564 23 YGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN-IMKFYTSWVDTA----N 97 (745)
Q Consensus 23 Y~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpN-IVk~~~sfvd~~----~ 97 (745)
|.++ ++||+|+||+||+|.++.+|+.||+|.+++..-. +..-....+|+.+|+.|+|+| |+++++++.... .
T Consensus 13 ~~~~-eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 13 YEKV-EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHH-HHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4344 5599999999999999999999999999876421 223445678999999999999 999999876532 2
Q ss_pred CeEEEEEeccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcc
Q 004564 98 RNINFVTEMFTSGTLRQYRLKHK----RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 173 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k~~----~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFG 173 (745)
..+++|+||+. -+|..|+.... .++...++.+++||++||.|||+++ |+||||||.||||+ +.|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~-~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLIS-SSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEEC-CCCcEeeeccc
Confidence 38999999996 49999998765 5888999999999999999999999 99999999999998 57999999999
Q ss_pred hhhhhhc--cCCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCC-----
Q 004564 174 LAAILRK--SHAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-GKK----- 243 (745)
Q Consensus 174 lA~~l~~--~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~-g~~----- 243 (745)
+|+...- ...++.++|..|.|||++-+ .|+..+||||+|||++||++++..|.+.....++.+.... |.+
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 9987653 33566789999999999874 5999999999999999999999999998887777665432 111
Q ss_pred C------------------CCc---ccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 244 P------------------DSL---YRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 244 p------------------~~l---~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
| ..+ ....++...+++.+||+ +|.+|.||+.+|.||||+..
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 0 000 11124689999999999 99999999999999999854
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=356.50 Aligned_cols=254 Identities=24% Similarity=0.453 Sum_probs=226.5
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
.-|| .+.+.||+|.||+|-+|.+...|+.||||.|++.. +.++.++-.+++||+||..|+||||+.+|..|.. ...
T Consensus 52 kHRy-E~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdk-IkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN--kdK 127 (668)
T KOG0611|consen 52 KHRY-EITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDK-IKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN--KDK 127 (668)
T ss_pred hhHH-HHHHHhcCCcccceeehhhccCCcEeehhhhhhhh-cccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC--Cce
Confidence 4466 67789999999999999999999999999998655 5678889999999999999999999999998854 778
Q ss_pred EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 100 INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
+.+||||..+|.|.+|+...+.|++...+.+++||.+|+.|||.++ ++|||||.+|||+| .++++||+|||++..+.
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD-~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLD-QNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeec-CCCCeeeeccchhhhhc
Confidence 9999999999999999999999999999999999999999999998 99999999999998 55899999999998775
Q ss_pred c-cCCCcccCCCCcCChhhhhhc-c-CccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHH
Q 004564 180 K-SHAAHCVGTPEFMAPEVYEEA-Y-NELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVR 256 (745)
Q Consensus 180 ~-~~~~~~vGTp~YmAPEvl~~~-y-s~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~ 256 (745)
. ....+++|+|-|.+||++++. | ++.+|.|||||+||.|+.|..||.+ .+-..+.+.+.+|..... ..+..+.
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYrEP---~~PSdA~ 280 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYREP---ETPSDAS 280 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhcccccCC---CCCchHH
Confidence 4 445678999999999999964 4 6889999999999999999999998 566778888888876432 2345788
Q ss_pred HHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 257 RFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 257 d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
-+|..||. +|.+|.|++++-.|=|+.-.
T Consensus 281 gLIRwmLmVNP~RRATieDiAsHWWvNwg 309 (668)
T KOG0611|consen 281 GLIRWMLMVNPERRATIEDIASHWWVNWG 309 (668)
T ss_pred HHHHHHHhcCcccchhHHHHhhhheeecc
Confidence 99999998 99999999999999998743
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=341.85 Aligned_cols=242 Identities=21% Similarity=0.282 Sum_probs=206.6
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEe--cCCCeEEEEEe
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVD--TANRNINFVTE 105 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd--~~~~~iyLV~E 105 (745)
..||+|+++.||+|.. +|..||+|.++... .......+.+.+|+.+|++++||||+++++++.+ .....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccc-cccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 3589999999999966 79999999987543 2233446788899999999999999999999876 44467899999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhC-CCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCCC
Q 004564 106 MFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSH-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 184 (745)
Q Consensus 106 ~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~-gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~~ 184 (745)
|+.+|+|.+++.+.+.+++.....++.|++.||.|||+. + ++||||||+|||++ +++.+||+|||++..+.... .
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~-~~~~~kl~dfg~~~~~~~~~-~ 178 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVT-ENYKLKIICHGLEKILSSPP-F 178 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEEC-CCCcEEEcccchHhhhcccc-c
Confidence 999999999999888999999999999999999999984 6 88999999999998 56899999999998764332 3
Q ss_pred cccCCCCcCChhhhhh---ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHH
Q 004564 185 HCVGTPEFMAPEVYEE---AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEK 261 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~k 261 (745)
..+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.. .+..+++..+..+.....++...++.+++|+.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4568999999999863 689999999999999999999999987 456677777765544444455678999999999
Q ss_pred Hhh-CccCCCCHHHHhc
Q 004564 262 CLA-TVSLRLSARELLN 277 (745)
Q Consensus 262 cL~-dPskRpSa~ELL~ 277 (745)
||+ +|.+|||+.+++.
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 999 9999999999984
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.08 Aligned_cols=252 Identities=27% Similarity=0.388 Sum_probs=203.8
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
.+| ++.+.||+|+||+||+|.+..++..||+|.++.... ......+.+|+.+++.++||||+++++.+.. +..+
T Consensus 6 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 79 (309)
T cd07872 6 ETY-IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSL 79 (309)
T ss_pred Cce-EEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc---CCcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeE
Confidence 457 777899999999999999999999999999875432 2223456789999999999999999998865 6789
Q ss_pred EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 101 NFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++....
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 80 TLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKS 155 (309)
T ss_pred EEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECccccceecC
Confidence 999999975 888887665 45899999999999999999999988 99999999999998 56899999999986543
Q ss_pred cc--CCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CC-----------
Q 004564 180 KS--HAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS--GK----------- 242 (745)
Q Consensus 180 ~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~--g~----------- 242 (745)
.. ......+|+.|+|||++.+ .++.++|||||||++|+|+||+.||....... ....+.. +.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhhcc
Confidence 22 2223468999999998863 58899999999999999999999998744322 2222211 00
Q ss_pred --------CCC-------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 243 --------KPD-------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 243 --------~p~-------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
.|. ......+++++++|.+||+ +|.+|||++|+|+||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 000 0112357889999999999 9999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=334.26 Aligned_cols=254 Identities=30% Similarity=0.463 Sum_probs=211.9
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCC--CHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ--SPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINF 102 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~--~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyL 102 (745)
+..++||+|++|.||+|.+..++..||+|+++...... .....+.+.+|+.+|+.++||||+++++.+.+ ...+++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~ 80 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DSHFNL 80 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CCeEEE
Confidence 56688999999999999999999999999987543221 23356789999999999999999999998865 678999
Q ss_pred EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC
Q 004564 103 VTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 182 (745)
Q Consensus 103 V~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~ 182 (745)
|+||+.+++|.+++.+.+++++..++.|+.||+.||.|||++| ++||||+|+||+++.++..+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 9999999999999988889999999999999999999999998 99999999999998665579999999987664321
Q ss_pred ------CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCC--HHHHHHHHHcCCCCCCcccCCCH
Q 004564 183 ------AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTH--PAQIYKKVVSGKKPDSLYRVKDP 253 (745)
Q Consensus 183 ------~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~--~~~i~kkv~~g~~p~~l~~~~s~ 253 (745)
.....||..|+|||++. ..++.++|+||||+++|+|++|..||..... .......+.....+.......++
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 12235889999999886 4688999999999999999999999964332 22222223233334445556789
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 254 el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
.+++++.+||. +|.+||++.++++||||+
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999998 999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=338.77 Aligned_cols=249 Identities=28% Similarity=0.496 Sum_probs=209.9
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.++||+|+||+||+|.+..++..||+|.+.... .......+.+|+.++++++||||+++++.+.. ....++||
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 78 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISICT 78 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEEE
Confidence 67789999999999999999999999999886432 34456678999999999999999999999876 57889999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCCC
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 184 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~~ 184 (745)
||+.+++|..+ ..+++..+..++.||+.||.|||+++ |+|+||||+|||++ .++.+||+|||++.........
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~~~~~ 151 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAK 151 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEEC-CCCCEEEeeCCcceeccccccc
Confidence 99999999765 35789999999999999999999988 99999999999998 5689999999999776555555
Q ss_pred cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCC------CHHHHHHHHHcCCCCCCcccCCCHHHHH
Q 004564 185 HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECT------HPAQIYKKVVSGKKPDSLYRVKDPEVRR 257 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~------~~~~i~kkv~~g~~p~~l~~~~s~el~d 257 (745)
..+||+.|+|||++. ..++.++|+||||+++|+|+||..||.... ......+.+.....+.......++++++
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHH
Confidence 567999999999886 468899999999999999999999996422 1223334444333333334457889999
Q ss_pred HHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 258 FVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 258 ~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
||.+||+ +|.+||+++++++||||+..+
T Consensus 232 li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 232 FITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 9999999 999999999999999998543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=329.37 Aligned_cols=248 Identities=28% Similarity=0.501 Sum_probs=214.1
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.+.||+|++|.||+|.+..++..|++|.+..... .......+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIVM 78 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEEE
Confidence 667889999999999999999999999998875432 34567789999999999999999999998876 57899999
Q ss_pred eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC
Q 004564 105 EMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~ 182 (745)
||+.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++ .++.+||+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~-~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEe-CCCCEEEcccccceeccCcc
Confidence 999999999998774 57899999999999999999999988 99999999999998 56899999999987654332
Q ss_pred --CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHH
Q 004564 183 --AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259 (745)
Q Consensus 183 --~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I 259 (745)
.....|++.|+|||++. ..++.++|+|||||++|+|+||+.||.. .+...+..++..+..+. .....++.+.++|
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i 233 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA-NNQGALILKIIRGVFPP-VSQMYSQQLAQLI 233 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHHHHH
Confidence 22345899999999987 4588999999999999999999999976 44666666677666544 3336788999999
Q ss_pred HHHhh-CccCCCCHHHHhcCCCC
Q 004564 260 EKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 260 ~kcL~-dPskRpSa~ELL~hPff 281 (745)
.+||+ +|++||++.++++|||+
T Consensus 234 ~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 234 DQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHccCCcccCcCHHHHhhCCCC
Confidence 99999 99999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=353.93 Aligned_cols=253 Identities=30% Similarity=0.411 Sum_probs=204.1
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC---
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA--- 96 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~--- 96 (745)
.++| ++.+.||+|+||.||+|.+..+++.||+|++.... .......++.+|+.+++.++||||+++++.+....
T Consensus 23 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 23 LKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hcce-eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 4677 77799999999999999999999999999886432 23455677889999999999999999999875421
Q ss_pred -CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 97 -NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 97 -~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
...+|+||||+.+ +|..++.. .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a 173 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA 173 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEEC-CCCcEEEEeCCCc
Confidence 2468999999965 67777653 5889999999999999999999988 99999999999998 5689999999999
Q ss_pred hhhhccC-CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC-----------
Q 004564 176 AILRKSH-AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK----------- 242 (745)
Q Consensus 176 ~~l~~~~-~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~----------- 242 (745)
....... .....||+.|+|||++. ..++.++|||||||++|+|+||+.||..... ...+.++....
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHhh
Confidence 7654432 23457999999999987 4689999999999999999999999987443 33333332210
Q ss_pred ----------CC-------------------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 243 ----------KP-------------------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 243 ----------~p-------------------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
.| .......+..+++||.+||+ ||.+|||++++|+||||+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 00 00111235678999999999 999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=329.10 Aligned_cols=250 Identities=31% Similarity=0.501 Sum_probs=216.6
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.+.||.|+||.||+|.+..++..||+|.++... ......+++..|+.+++.++||||+++++.+....+..++++|
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN--MTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEeccc--CCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 66788999999999999999999999999887543 2355677899999999999999999999988776677899999
Q ss_pred eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHhh-----hCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 105 EMFTSGTLRQYRLK----HKRVNIRAVKLWCRQILRGLLYLH-----SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 105 E~~~gGsL~~~l~k----~~~L~e~~i~~ia~QIL~gL~yLH-----s~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
||+.+++|.+++.+ ..++++..+..++.||+.||.||| +.+ |+|+||||+||+++ +.+.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~-~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLD-ANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEe-cCCCEEEeccccc
Confidence 99999999999876 357899999999999999999999 766 99999999999998 5689999999999
Q ss_pred hhhhccC--CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCC
Q 004564 176 AILRKSH--AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 176 ~~l~~~~--~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s 252 (745)
....... .....+++.|+|||++. ..++.++|+||||+++|+|++|..||... +...+.+.+..+..+ .+....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 235 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGKFR-RIPYRYS 235 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc-CHHHHHHHHhcCCCC-CCccccC
Confidence 8765433 33456899999999986 45788999999999999999999999874 466677777666544 3445678
Q ss_pred HHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
..+.+++.+||. +|.+||++.++|+|||+
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 899999999999 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=346.21 Aligned_cols=249 Identities=25% Similarity=0.443 Sum_probs=216.8
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCC----HHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEE
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS----PEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINF 102 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~----~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyL 102 (745)
++||+|..++|-++..+.+|.++|+|++........ ...++.-.+|+.||+++ .||+|+++.++|.. +..+++
T Consensus 23 eilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes--~sF~Fl 100 (411)
T KOG0599|consen 23 EILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES--DAFVFL 100 (411)
T ss_pred HHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--cchhhh
Confidence 679999999999999999999999999987653322 23455667899999999 69999999998854 678899
Q ss_pred EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC
Q 004564 103 VTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 182 (745)
Q Consensus 103 V~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~ 182 (745)
|+|+|..|.|++|+...-.++++..+++++|++.|++|||.++ ||||||||+|||++ ++.+|||+|||+|+.+..+.
T Consensus 101 VFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILld-dn~~i~isDFGFa~~l~~Ge 177 (411)
T KOG0599|consen 101 VFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLD-DNMNIKISDFGFACQLEPGE 177 (411)
T ss_pred hhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeec-cccceEEeccceeeccCCch
Confidence 9999999999999999999999999999999999999999999 99999999999998 44699999999999887653
Q ss_pred -CCcccCCCCcCChhhhh-------hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CCcccCCC
Q 004564 183 -AAHCVGTPEFMAPEVYE-------EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP--DSLYRVKD 252 (745)
Q Consensus 183 -~~~~vGTp~YmAPEvl~-------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p--~~l~~~~s 252 (745)
....+|||.|+|||.+. ..|+..+|+||+|||||.|+.|.+||.. ...-.+.+.+.+|+.. .+-+...+
T Consensus 178 kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-RkQmlMLR~ImeGkyqF~speWadis 256 (411)
T KOG0599|consen 178 KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-RKQMLMLRMIMEGKYQFRSPEWADIS 256 (411)
T ss_pred hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-HHHHHHHHHHHhcccccCCcchhhcc
Confidence 45568999999999874 3588999999999999999999999976 3344456778888764 34456678
Q ss_pred HHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
...+++|.+||+ ||.+|+|++|+|.||||.
T Consensus 257 ~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 257 ATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred ccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 899999999999 999999999999999995
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=333.00 Aligned_cols=254 Identities=29% Similarity=0.521 Sum_probs=210.4
Q ss_pred CCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecC
Q 004564 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTA 96 (745)
Q Consensus 18 dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~ 96 (745)
+|.++| ++.+.||+|++|+||+|.+..++..+++|++.... ...+.+.+|+.+++.+ .||||+++++.+....
T Consensus 3 ~~~~~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (275)
T cd06608 3 DPTGIF-ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKN 76 (275)
T ss_pred Cchhhe-eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence 578999 77899999999999999999999999999887432 2446788999999999 7999999999987633
Q ss_pred ----CCeEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEE
Q 004564 97 ----NRNINFVTEMFTSGTLRQYRLK----HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVK 168 (745)
Q Consensus 97 ----~~~iyLV~E~~~gGsL~~~l~k----~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VK 168 (745)
...+|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++ .++.+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~-~~~~~~ 153 (275)
T cd06608 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLT-KNAEVK 153 (275)
T ss_pred CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEc-cCCeEE
Confidence 4568999999999999998765 357999999999999999999999998 99999999999998 468999
Q ss_pred EcCcchhhhhhcc--CCCcccCCCCcCChhhhhh------ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 004564 169 IGDLGLAAILRKS--HAAHCVGTPEFMAPEVYEE------AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS 240 (745)
Q Consensus 169 L~DFGlA~~l~~~--~~~~~vGTp~YmAPEvl~~------~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~ 240 (745)
|+|||++...... ......|++.|+|||++.. .++.++|||||||+||+|+||..||........+. .+..
T Consensus 154 l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~ 232 (275)
T cd06608 154 LVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF-KIPR 232 (275)
T ss_pred ECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH-Hhhc
Confidence 9999998654322 2234468999999998742 36788999999999999999999998644444433 3444
Q ss_pred CCCCCCcc-cCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 241 GKKPDSLY-RVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 241 g~~p~~l~-~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
+..+.... ...+..++++|.+||. +|.+|||+.++++|||+
T Consensus 233 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 233 NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 43332221 2256789999999999 99999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=348.16 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=202.5
Q ss_pred EeEEeccc--CceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEE
Q 004564 26 YNEILGKG--ASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 26 l~e~LG~G--afgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV 103 (745)
+.++||+| +|++||++.+..+|+.||+|.++.... .....+.+.+|+.+++.++||||++++++|.. +..+|+|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEE
Confidence 45789999 789999999999999999999875432 23455678889999999999999999999876 6789999
Q ss_pred EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 104 TEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
|||+.+|+|.+++..+ ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.++|+||+.+......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEe-cCCcEEEcccchhhccccc
Confidence 9999999999998764 45899999999999999999999988 99999999999998 5679999999876433211
Q ss_pred ---------CCCcccCCCCcCChhhhhh---ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC----
Q 004564 182 ---------HAAHCVGTPEFMAPEVYEE---AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPD---- 245 (745)
Q Consensus 182 ---------~~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~---- 245 (745)
......++..|+|||++.+ .|+.++|||||||++|+|++|+.||....... .......+..|.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 233 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKLNGTVPCLLDT 233 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH-HHHHHhcCCccccccc
Confidence 1122357788999999863 48899999999999999999999997644333 222222222110
Q ss_pred ----------------------------------------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 246 ----------------------------------------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 246 ----------------------------------------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
......++.+++||.+||+ +|.+|||+++||+||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 1122346789999999999 9999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=356.63 Aligned_cols=252 Identities=27% Similarity=0.392 Sum_probs=205.6
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC---CCeEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA---NRNIN 101 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~---~~~iy 101 (745)
.+.+.||+|+||+||+|.+..+|..||+|.+... ........++.+|+.+|+.++||||+++++++.... ...+|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV--FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEecccc--ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5668899999999999999999999999987532 223445678899999999999999999999876532 12789
Q ss_pred EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
+||||+. ++|..++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEEC-CCCCEEeccccceeecccC
Confidence 9999986 588888888888999999999999999999999998 99999999999998 5689999999999765432
Q ss_pred C---CCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc----------------
Q 004564 182 H---AAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS---------------- 240 (745)
Q Consensus 182 ~---~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~---------------- 240 (745)
. ....++|+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.... .....+..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHHhhHH
Confidence 2 223468999999999874 4789999999999999999999999874433 22222211
Q ss_pred --------CCCCC------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 241 --------GKKPD------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 241 --------g~~p~------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
...+. .+....++++.+||.+||+ +|.+|||+.++|+||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 11111 1223357889999999999 9999999999999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=332.39 Aligned_cols=251 Identities=31% Similarity=0.451 Sum_probs=209.7
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeeccc--CCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF--LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINF 102 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~--~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyL 102 (745)
++.+.||+|+||+||+|.+. ++..+|+|+++.... .........+.+|+.+|+.++|+||+++++++.+ ...+++
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 79 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTISI 79 (265)
T ss_pred cccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeEEE
Confidence 67788999999999999874 788999999875432 1223456778999999999999999999998865 578999
Q ss_pred EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc-
Q 004564 103 VTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 181 (745)
Q Consensus 103 V~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~- 181 (745)
++||+.+++|.+++.+...+++..+..++.||+.||+|||+.+ |+|+||+|+||+++ ..+.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEEC-CCCeEEeccchhhHhhhhcc
Confidence 9999999999999988888999999999999999999999988 99999999999998 5689999999999765321
Q ss_pred -------CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCH
Q 004564 182 -------HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDP 253 (745)
Q Consensus 182 -------~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~ 253 (745)
......|++.|+|||++. ..++.++|+|||||++|+|+||..||.....................+....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence 112345899999999987 458899999999999999999999998755444444333221222334556789
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 254 el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
.+.+||.+||. +|.+||++.++|.||||
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999998 99999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=329.34 Aligned_cols=252 Identities=31% Similarity=0.514 Sum_probs=212.4
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~ 98 (745)
|..+| .+.+.||.|+||.||+|.+..++..+|+|++.... ....+.+.+|+.+++.++||||+++++.+.+ ..
T Consensus 1 ~~~~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~ 73 (262)
T cd06613 1 PQEDY-ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLR--RD 73 (262)
T ss_pred Cccce-EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEe--CC
Confidence 56677 77799999999999999999999999999987543 3356789999999999999999999998876 67
Q ss_pred eEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 99 NINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
.+|++|||+.+++|..++... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++ .++.+||+|||++..
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~ 150 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQ 150 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEEC-CCCCEEECccccchh
Confidence 899999999999999998876 78999999999999999999999998 99999999999998 668999999999977
Q ss_pred hhcc--CCCcccCCCCcCChhhhh-h---ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC--ccc
Q 004564 178 LRKS--HAAHCVGTPEFMAPEVYE-E---AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDS--LYR 249 (745)
Q Consensus 178 l~~~--~~~~~vGTp~YmAPEvl~-~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~--l~~ 249 (745)
.... ......++..|+|||++. . .++.++|+|||||++|+|+||..||........++.....+..+.. ...
T Consensus 151 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (262)
T cd06613 151 LTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKE 230 (262)
T ss_pred hhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchh
Confidence 6542 223456899999999886 3 5888999999999999999999999876544444433332222211 122
Q ss_pred CCCHHHHHHHHHHhh-CccCCCCHHHHhcCCC
Q 004564 250 VKDPEVRRFVEKCLA-TVSLRLSARELLNDPF 280 (745)
Q Consensus 250 ~~s~el~d~I~kcL~-dPskRpSa~ELL~hPf 280 (745)
..+.++++||.+||. +|..|||+.+++.|||
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 346789999999999 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=328.57 Aligned_cols=249 Identities=27% Similarity=0.518 Sum_probs=211.5
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.+.||+|++|.||+|.+..+++.||+|.+.... ......+.+..|+.+++.++||||+++++.+.. ....+|+++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~ 79 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN--ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYIVM 79 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh--cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEEEe
Confidence 78899999999999999999999999999987543 234456678899999999999999999997643 345789999
Q ss_pred eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc-
Q 004564 105 EMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 181 (745)
Q Consensus 105 E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~- 181 (745)
||+.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++ .++.++|+|||++......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~-~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEe-cCCcEEEecccceEEecccC
Confidence 999999999988763 45899999999999999999999988 99999999999997 5689999999998765332
Q ss_pred -CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHH
Q 004564 182 -HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259 (745)
Q Consensus 182 -~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I 259 (745)
......+++.|+|||++. ..++.++|+||||+++|+|++|+.||.. .+.......+..+..+. .....++.+.+||
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li 234 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA-KDMNSLVYRIIEGKLPP-MPKDYSPELGELI 234 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCC-CccccCHHHHHHH
Confidence 223346899999999987 4588999999999999999999999986 34455555566665543 3456789999999
Q ss_pred HHHhh-CccCCCCHHHHhcCCCC
Q 004564 260 EKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 260 ~kcL~-dPskRpSa~ELL~hPff 281 (745)
.+||+ +|.+||++.++++||||
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 235 ATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHhccCcccCCCHHHHhcCCCC
Confidence 99999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=332.43 Aligned_cols=250 Identities=33% Similarity=0.525 Sum_probs=211.2
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCC-----HHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS-----PEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~-----~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
.+.+.||+|+||.||+|.+..++..||+|.+........ ....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 80 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--ADH 80 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCc
Confidence 677899999999999999999999999998875543222 2345678899999999999999999998876 578
Q ss_pred EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 100 INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
.++||||+.+++|..++.+.+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ ..+.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~-~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEc-CCCCEEecccCCCcccc
Confidence 8999999999999999998889999999999999999999999988 99999999999997 56899999999987664
Q ss_pred cc--------CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccC
Q 004564 180 KS--------HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRV 250 (745)
Q Consensus 180 ~~--------~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~ 250 (745)
.. ......|++.|+|||.+. ..++.++|+|||||++|+|++|+.||........+. .+..+..| .+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~-~~~~~ 235 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KIGENASP-EIPSN 235 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH-HHhccCCC-cCCcc
Confidence 21 111235889999999986 458889999999999999999999998765544443 33333333 34455
Q ss_pred CCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 251 KDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 251 ~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
.+..++++|.+||+ +|.+||++.++++||||
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 236 ISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 78899999999999 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=339.11 Aligned_cols=258 Identities=31% Similarity=0.500 Sum_probs=216.4
Q ss_pred eCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC
Q 004564 17 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA 96 (745)
Q Consensus 17 ~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~ 96 (745)
++|.+.| ++.+.||.|+||.||+|.+..++..||+|.+... .....+.+..|+.+++.++||||+++++.+..
T Consensus 8 ~~~~~~y-~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 80 (292)
T cd06644 8 LDPNEVW-EIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYW-- 80 (292)
T ss_pred cCcchhh-hhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--
Confidence 5677888 8888999999999999999999999999988643 45667889999999999999999999998866
Q ss_pred CCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 97 NRNINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 97 ~~~iyLV~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
+..+|+||||+.+++|..++.+ ...+++..+..++.||+.+|.|||+++ |+||||||+||+++ .++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~ 157 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVS 157 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEc-CCCCEEEccCccc
Confidence 5689999999999999887654 457899999999999999999999988 99999999999997 5689999999998
Q ss_pred hhhhcc--CCCcccCCCCcCChhhhh------hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-C
Q 004564 176 AILRKS--HAAHCVGTPEFMAPEVYE------EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPD-S 246 (745)
Q Consensus 176 ~~l~~~--~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~-~ 246 (745)
...... ......+++.|+|||++. ..++.++|||||||++|+|+||..||.... ....+.++..+..|. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~ 236 (292)
T cd06644 158 AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLS 236 (292)
T ss_pred eeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-HHHHHHHHhcCCCccCC
Confidence 654322 123346899999999874 246789999999999999999999997643 445555555444432 2
Q ss_pred cccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 247 LYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 247 l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
.....+..+.++|.+||. +|.+||++.++++||||....
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 334567899999999999 999999999999999997543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=334.23 Aligned_cols=250 Identities=30% Similarity=0.495 Sum_probs=214.8
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.+.||.|+||.||+|.+..+++.||+|.+.... ......++.+|+.+++.++||||+++++.+.. ...+++++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISICM 78 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEEE
Confidence 56678999999999999999999999999887542 23556778999999999999999999998876 57899999
Q ss_pred eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhh-CCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC
Q 004564 105 EMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs-~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~ 182 (745)
||+.+++|.+++... ..+++..+..++.||+.||.|||+ .+ ++|+||||+||+++ +++.+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~-~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEEC-CCCCEEEeecccchhhHHHH
Confidence 999999999998876 789999999999999999999999 87 99999999999998 56899999999987765443
Q ss_pred CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCC----CCHHHHHHHHHcCCCCCCcccCCCHHHHH
Q 004564 183 AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSEC----THPAQIYKKVVSGKKPDSLYRVKDPEVRR 257 (745)
Q Consensus 183 ~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~----~~~~~i~kkv~~g~~p~~l~~~~s~el~d 257 (745)
.....+++.|+|||.+. ..++.++||||||+++|+|++|..||... .......+.+..+..|.......++.+++
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06605 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235 (265)
T ss_pred hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 33367899999999886 46889999999999999999999999764 23444555555555544333347899999
Q ss_pred HHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 258 FVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 258 ~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
+|.+||. +|.+|||+.+++.||||+
T Consensus 236 li~~~l~~~p~~Rpt~~~ll~~~~~~ 261 (265)
T cd06605 236 FVNLCLIKDPRERPSYKELLEHPFIK 261 (265)
T ss_pred HHHHHcCCCchhCcCHHHHhhCchhh
Confidence 9999999 999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=386.41 Aligned_cols=259 Identities=25% Similarity=0.430 Sum_probs=219.5
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
++| .+.+.||+|+||+||+|.+..++..||+|++.... ........+..|+.+|+.|+|||||++++.|++.....+
T Consensus 13 ~~Y-eIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~--l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 13 NEY-EVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG--LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred CCE-EEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc--cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 467 78899999999999999999999999999987554 234566789999999999999999999999987767889
Q ss_pred EEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHhhhCC-----CCEEeecCCCcceeecCC--------
Q 004564 101 NFVTEMFTSGTLRQYRLKH----KRVNIRAVKLWCRQILRGLLYLHSHD-----PPVIHRDLKCDNIFVNGN-------- 163 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~----~~L~e~~i~~ia~QIL~gL~yLHs~g-----p~IIHRDLKpdNILld~~-------- 163 (745)
||||||+.+|+|.+++... ..+++..++.|+.||+.||.|||+.+ .+||||||||+||||+..
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999988753 57999999999999999999999854 349999999999999531
Q ss_pred --------CCcEEEcCcchhhhhhcc-CCCcccCCCCcCChhhhh---hccCccccchhhhhHHHHHhhcCCCCCCCCCH
Q 004564 164 --------QGEVKIGDLGLAAILRKS-HAAHCVGTPEFMAPEVYE---EAYNELVDIYSFGMCILEMVTFEYPYSECTHP 231 (745)
Q Consensus 164 --------~g~VKL~DFGlA~~l~~~-~~~~~vGTp~YmAPEvl~---~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~ 231 (745)
.+.+||+|||++..+... .....+||+.|+|||++. ..++.++||||||||||+|+||..||......
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 235899999999766432 233457999999999985 34889999999999999999999999877777
Q ss_pred HHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 232 AQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 232 ~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
.++...+..+.. ......++++.+||..||. +|.+||++.|+|.|||++..
T Consensus 250 ~qli~~lk~~p~--lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 250 SQLISELKRGPD--LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHHHhcCCC--CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 777776655432 2234568899999999999 99999999999999999743
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=336.15 Aligned_cols=255 Identities=29% Similarity=0.516 Sum_probs=212.5
Q ss_pred eCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEec
Q 004564 17 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDT 95 (745)
Q Consensus 17 ~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~ 95 (745)
.+|.|+| ++.+.||+|+||.||+|.+..++..||+|++... ......+..|+.+++.+ +||||++++++|+..
T Consensus 12 ~~~~~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 12 RDPAGIF-ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred cChhhhh-hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3578889 7778999999999999999999999999987643 23456788899999998 699999999998642
Q ss_pred ----CCCeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEE
Q 004564 96 ----ANRNINFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI 169 (745)
Q Consensus 96 ----~~~~iyLV~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL 169 (745)
....+|++|||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++ +.+.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~-~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLT-ENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEE
Confidence 246789999999999999988764 35889999999999999999999998 99999999999997 6689999
Q ss_pred cCcchhhhhhcc--CCCcccCCCCcCChhhhh------hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 004564 170 GDLGLAAILRKS--HAAHCVGTPEFMAPEVYE------EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG 241 (745)
Q Consensus 170 ~DFGlA~~l~~~--~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g 241 (745)
+|||++...... ......|++.|+|||++. ..++.++|+|||||++|+|+||..||........+.. +...
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-~~~~ 241 (282)
T cd06636 163 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-IPRN 241 (282)
T ss_pred eeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-HhhC
Confidence 999998765432 233456999999999874 3478899999999999999999999987554444433 3333
Q ss_pred CCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 242 KKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 242 ~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
..+.......++.+.+||.+||. +|.+||++.+||+||||
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 242 PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 33333444578899999999999 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=351.90 Aligned_cols=254 Identities=30% Similarity=0.438 Sum_probs=204.1
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC---
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA--- 96 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~--- 96 (745)
..+| ++.+.||+|+||+||+|.+..++..||+|+++... .......++.+|+.+|+.++||||++++++|....
T Consensus 14 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 14 PERY-QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhh-hhheecccCCCeEEEEEEECCCCCEEEEEEeCchh--hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 3567 66789999999999999999999999999886432 22334567888999999999999999999875422
Q ss_pred -CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 97 -NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 97 -~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
...+|++++++ +++|..++. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~ 165 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLA 165 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEEC-CCCCEEEcCCccc
Confidence 24578999987 778988764 457999999999999999999999998 99999999999998 5689999999999
Q ss_pred hhhhccCCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CCC--------
Q 004564 176 AILRKSHAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS--GKK-------- 243 (745)
Q Consensus 176 ~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~--g~~-------- 243 (745)
...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||....... .+..+.. +..
T Consensus 166 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 166 RQADDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred eecCCC-cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhc
Confidence 765433 334579999999999864 58899999999999999999999997643322 2222211 100
Q ss_pred ---------------C----CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 244 ---------------P----DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 244 ---------------p----~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
+ .......++.+.+||.+||. +|.+|||+.|+|.||||..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 0 01112356778999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.39 Aligned_cols=251 Identities=29% Similarity=0.412 Sum_probs=203.1
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
|| .+.+.||+|+||.||+|.+..+|..||+|.++.... .......+.+|+.+++.++||||+++++++.+ ...++
T Consensus 1 ~y-~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~ 75 (284)
T cd07839 1 KY-EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHS--DKKLT 75 (284)
T ss_pred Cc-eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CCceE
Confidence 45 667889999999999999999999999999875432 22234567789999999999999999998876 56899
Q ss_pred EEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 102 FVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
+|+||+. ++|..++.+ .+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.....
T Consensus 76 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLIN-KNGELKLADFGLARAFGI 151 (284)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEc-CCCcEEECccchhhccCC
Confidence 9999996 578887765 567999999999999999999999988 99999999999998 568999999999976543
Q ss_pred cC--CCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC--------------
Q 004564 181 SH--AAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK-------------- 242 (745)
Q Consensus 181 ~~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~-------------- 242 (745)
.. .....+++.|+|||++.+ .++.++|||||||++|+|+||..||....+....++.+....
T Consensus 152 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 152 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 22 223457899999998864 478999999999999999999988654444444433332110
Q ss_pred -----CC--------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 243 -----KP--------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 243 -----~p--------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
.+ .......++++++||.+||+ +|.+|||++++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 01112357889999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=340.03 Aligned_cols=258 Identities=35% Similarity=0.558 Sum_probs=216.0
Q ss_pred CCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCC
Q 004564 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 18 dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~ 97 (745)
++..+| ++.+.||.|+||+||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 16 ~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 88 (296)
T cd06655 16 DPKKKY-TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELKNPNIVNFLDSFLV--G 88 (296)
T ss_pred CCcceE-EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHHHHHHHHHHHhcCCCceeeeeeeEec--C
Confidence 456677 67788999999999999999999999999886432 2345678899999999999999999998865 6
Q ss_pred CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 98 RNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
..+|+|+||+.+++|..++.+ ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++..
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~-~~~~~kl~dfg~~~~ 164 (296)
T cd06655 89 DELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLG-MDGSVKLTDFGFCAQ 164 (296)
T ss_pred ceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccchh
Confidence 789999999999999998764 46899999999999999999999998 99999999999997 568999999999876
Q ss_pred hhccC--CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHH
Q 004564 178 LRKSH--AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254 (745)
Q Consensus 178 l~~~~--~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~e 254 (745)
..... .....+++.|+|||.+. +.++.++|+|||||++|+|+||..||........+......+..+.......++.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06655 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPI 244 (296)
T ss_pred cccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHH
Confidence 54322 22346899999999886 4588999999999999999999999987554444443333333333344567889
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhcCCCCCcccc
Q 004564 255 VRRFVEKCLA-TVSLRLSARELLNDPFLQIDDC 286 (745)
Q Consensus 255 l~d~I~kcL~-dPskRpSa~ELL~hPff~~~~~ 286 (745)
++++|.+||. +|.+||++.+++.||||+....
T Consensus 245 ~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 9999999999 9999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=327.61 Aligned_cols=253 Identities=34% Similarity=0.520 Sum_probs=214.1
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccC-CCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL-QSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~-~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
|| +..+.||+|+||+||+|.+..++..|++|.+...... ...+..+.+..|+.+++.++||||+++++++.+ ...+
T Consensus 1 ~~-~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~ 77 (258)
T cd06632 1 RW-RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--EDNL 77 (258)
T ss_pred Cc-cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--CCeE
Confidence 45 6778999999999999999999999999998754322 234567789999999999999999999998765 6789
Q ss_pred EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 101 NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
|+++||+.+++|.+++.+...+++..+..++.||+.||.|||+++ |+|+||+|+||+++ .++.+||+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVD-TNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccceeccc
Confidence 999999999999999998888999999999999999999999988 99999999999998 568999999999876544
Q ss_pred cC-CCcccCCCCcCChhhhh-hc-cCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHH
Q 004564 181 SH-AAHCVGTPEFMAPEVYE-EA-YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257 (745)
Q Consensus 181 ~~-~~~~vGTp~YmAPEvl~-~~-ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d 257 (745)
.. .....|++.|+|||.+. .. ++.++|+||||+++|+|++|+.||........+.+....+. ...+....++.+++
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (258)
T cd06632 155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-LPPIPDHLSDEAKD 233 (258)
T ss_pred cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-CCCcCCCcCHHHHH
Confidence 33 23446899999999886 33 88999999999999999999999987654444443332222 33344567899999
Q ss_pred HHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 258 FVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 258 ~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
|+.+||. +|.+||++.++|.|||+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999999 99999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=338.51 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=206.9
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
+..++||+|+||+||+|.+..+++.||+|.+..... ........+..|+.+++.++|+||+++++.+.+ ...+++||
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~ 79 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVL 79 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhc-cchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEEE
Confidence 566889999999999999999999999998875432 223344567889999999999999999998765 57899999
Q ss_pred eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC
Q 004564 105 EMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~ 182 (745)
||+.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++ ..+.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeccceeecCCCc
Confidence 999999999987654 35899999999999999999999988 99999999999998 56799999999986553322
Q ss_pred -CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCH--HHHHHHHHcCCCCCCcccCCCHHHHHH
Q 004564 183 -AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHP--AQIYKKVVSGKKPDSLYRVKDPEVRRF 258 (745)
Q Consensus 183 -~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~--~~i~kkv~~g~~p~~l~~~~s~el~d~ 258 (745)
.....||+.|+|||++. ..++.++||||||+++|+|++|+.||...... ......+... .+.......++.+++|
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 235 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEKFSPDARSL 235 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcCccCCHHHHHH
Confidence 22346999999999986 46899999999999999999999999764321 1112222111 1223445678899999
Q ss_pred HHHHhh-CccCCCC-----HHHHhcCCCCCc
Q 004564 259 VEKCLA-TVSLRLS-----ARELLNDPFLQI 283 (745)
Q Consensus 259 I~kcL~-dPskRpS-----a~ELL~hPff~~ 283 (745)
+.+||+ +|.+||| ++++++||||+.
T Consensus 236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 999999 9999999 999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=366.67 Aligned_cols=250 Identities=28% Similarity=0.433 Sum_probs=210.8
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-C-----CCcceEeEEEEec
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-H-----KNIMKFYTSWVDT 95 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-H-----pNIVk~~~sfvd~ 95 (745)
|| .+.++||+|+||.|.+|+|..|++.||||+++. ......+...|+.+|..|+ | -|||++|++|+.
T Consensus 187 rY-~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-----~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f- 259 (586)
T KOG0667|consen 187 RY-EVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-----KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF- 259 (586)
T ss_pred EE-EEEEEecccccceeEEEEecCCCcEEEEEeecc-----ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-
Confidence 44 557999999999999999999999999999983 4567778888999999996 4 489999999977
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecC-CCCcEEEcCc
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG-NQGEVKIGDL 172 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~-~~g~VKL~DF 172 (745)
..++|||+|++ +.+|.++++.++ +++...++.++.|||.||.+||+.+ |||.||||+||||.. ....|||+||
T Consensus 260 -r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 260 -RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred -ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEec
Confidence 78999999998 569999999874 6899999999999999999999988 999999999999952 3348999999
Q ss_pred chhhhhhccCCCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH-cCCCCC-----
Q 004564 173 GLAAILRKSHAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVV-SGKKPD----- 245 (745)
Q Consensus 173 GlA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~-~g~~p~----- 245 (745)
|.|+....... .++-+..|+|||++.+ .|+.+.||||||||++||+||.+.|.+....+|+...+. -|.+|.
T Consensus 336 GSSc~~~q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 336 GSSCFESQRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred ccccccCCcce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 99998877666 7789999999999875 799999999999999999999999988666666654321 011110
Q ss_pred ------------------------------------------------------CcccCCCHHHHHHHHHHhh-CccCCC
Q 004564 246 ------------------------------------------------------SLYRVKDPEVRRFVEKCLA-TVSLRL 270 (745)
Q Consensus 246 ------------------------------------------------------~l~~~~s~el~d~I~kcL~-dPskRp 270 (745)
.+.......+.+||.+||. ||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 0001223468899999999 999999
Q ss_pred CHHHHhcCCCCCc
Q 004564 271 SARELLNDPFLQI 283 (745)
Q Consensus 271 Sa~ELL~hPff~~ 283 (745)
|+.++|+||||..
T Consensus 495 tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 495 TPAQALNHPFLTG 507 (586)
T ss_pred CHHHHhcCccccc
Confidence 9999999999984
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=337.66 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=202.4
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEeccCC
Q 004564 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTS 109 (745)
Q Consensus 30 LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~~g 109 (745)
||+|+||+||+|.+..+|+.||+|.+..... ........+..|+.+|+.++||||+++++.+.. +..+|+||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRL-KKKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHh-hcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCC
Confidence 7999999999999999999999999864332 112223445679999999999999999998765 6789999999999
Q ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCC-Ccc
Q 004564 110 GTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-AHC 186 (745)
Q Consensus 110 GsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~-~~~ 186 (745)
++|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++ +.+.+||+|||++........ ...
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~ 154 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQR 154 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEc-CCCCEEEeeceeeeecCCCceeecc
Confidence 99998876543 5899999999999999999999988 99999999999998 568999999999876543322 234
Q ss_pred cCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCC---CHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHH
Q 004564 187 VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECT---HPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKC 262 (745)
Q Consensus 187 vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~---~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kc 262 (745)
.||+.|+|||++. ..++.++|||||||++|+|++|..||.... ...++.+....+..+. .....+++++++|.+|
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~ 233 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLF 233 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHHHHH
Confidence 6899999999986 468999999999999999999999997533 2234444444433322 2235789999999999
Q ss_pred hh-CccCCCCH----HHHhcCCCCCc
Q 004564 263 LA-TVSLRLSA----RELLNDPFLQI 283 (745)
Q Consensus 263 L~-dPskRpSa----~ELL~hPff~~ 283 (745)
|+ +|.+||++ +++++||||+.
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcC
Confidence 99 99999999 77889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=329.21 Aligned_cols=253 Identities=30% Similarity=0.524 Sum_probs=215.6
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecc-cCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-FLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~-~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV 103 (745)
++.++||+|+||.||+|.+..++..||+|.+.... ..........+.+|+.+++.++||||+++++.+.+.....++++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 78899999999999999999999999999876432 12234567789999999999999999999999876556778999
Q ss_pred EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc--
Q 004564 104 TEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-- 181 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~-- 181 (745)
+||+.+++|.+++.+.+.+++..++.|+.||+.||.|||+++ |+|+||||+||+++ .++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 85 VEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECccccccccccccc
Confidence 999999999999988888999999999999999999999998 99999999999998 5679999999999765321
Q ss_pred ---CCCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHH
Q 004564 182 ---HAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257 (745)
Q Consensus 182 ---~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d 257 (745)
......+++.|+|||++.+ .++.++|+|||||++|+|++|+.||........+.+ +.....+..++...++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK-IATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH-HHcCCCCCCCCcccCHHHHH
Confidence 1123458999999999874 578899999999999999999999987655555544 33333344556678899999
Q ss_pred HHHHHhhCccCCCCHHHHhcCCCC
Q 004564 258 FVEKCLATVSLRLSARELLNDPFL 281 (745)
Q Consensus 258 ~I~kcL~dPskRpSa~ELL~hPff 281 (745)
+|.+||++|.+||++.++|.|||.
T Consensus 241 ~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhcCcccCccHHHHhcCCCC
Confidence 999999988999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=341.61 Aligned_cols=260 Identities=35% Similarity=0.529 Sum_probs=217.7
Q ss_pred eEeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEe
Q 004564 15 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVD 94 (745)
Q Consensus 15 ~e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd 94 (745)
...++..+| ++.+.||.|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++.|..
T Consensus 13 ~~~~~~~~y-~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 87 (297)
T cd06656 13 SVGDPKKKY-TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLV 87 (297)
T ss_pred ccCChhhhc-eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc----cchHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 346788889 77789999999999999999999999999887443 2345678899999999999999999998876
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcch
Q 004564 95 TANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 174 (745)
Q Consensus 95 ~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGl 174 (745)
...+|+||||+.+++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||+
T Consensus 88 --~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~-~~~~~~l~Dfg~ 161 (297)
T cd06656 88 --GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGF 161 (297)
T ss_pred --CCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEECcCcc
Confidence 6789999999999999999754 46899999999999999999999988 99999999999997 668999999999
Q ss_pred hhhhhccC--CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCC
Q 004564 175 AAILRKSH--AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK 251 (745)
Q Consensus 175 A~~l~~~~--~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~ 251 (745)
+....... .....+++.|+|||.+. ..++.++|+|||||++|+|+||..||........++.....+..+.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (297)
T cd06656 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241 (297)
T ss_pred ceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCcccc
Confidence 87654322 22346899999999887 4588999999999999999999999976544444443333343333344567
Q ss_pred CHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 252 DPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 252 s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
++.+++||.+||. +|.+||++.++|+||||+...
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 7889999999999 999999999999999998544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=334.22 Aligned_cols=249 Identities=29% Similarity=0.418 Sum_probs=203.7
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.+.||.|++|.||+|.+..++..||+|.++... ........+.+|+.+++.++||||+++++.+.+ +..+|+||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES--EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF 78 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEecccc--ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence 67788999999999999999999999999887543 222344678889999999999999999999876 67899999
Q ss_pred eccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 105 EMFTSGTLRQYRLKH---KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 105 E~~~gGsL~~~l~k~---~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEc-CCCcEEECcccceeecCCC
Confidence 9997 6888887653 46899999999999999999999988 99999999999997 5689999999998755322
Q ss_pred --CCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Q 004564 182 --HAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP------------- 244 (745)
Q Consensus 182 --~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p------------- 244 (745)
......+++.|+|||++.+ .++.++|||||||++|+|+||+.||.+......++........+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 1223457899999998863 47889999999999999999999998755444444322211000
Q ss_pred -------------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 245 -------------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 245 -------------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
.......+++++++|.+||+ +|.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 01123467899999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=330.38 Aligned_cols=247 Identities=24% Similarity=0.409 Sum_probs=212.6
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEeccCC
Q 004564 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTS 109 (745)
Q Consensus 30 LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~~g 109 (745)
||.|++|.||+|.+..++..||+|++..... ......+.+.+|+.+++.++||||+++++.+.+ +..+|+++||+.+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI-VETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcc-hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCC
Confidence 7999999999999999999999999875432 223456789999999999999999999998765 6789999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC-CCcccC
Q 004564 110 GTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-AAHCVG 188 (745)
Q Consensus 110 GsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~-~~~~vG 188 (745)
++|.+++.+...+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.+||+|||++....... .....|
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~-~~~~~~l~df~~~~~~~~~~~~~~~~~ 154 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCG 154 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEc-CCCCEEEeeCCcccccCcccccccccC
Confidence 999999998888999999999999999999999988 99999999999998 56899999999998765432 223468
Q ss_pred CCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCC-CHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-C
Q 004564 189 TPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECT-HPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-T 265 (745)
Q Consensus 189 Tp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~-~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-d 265 (745)
++.|+|||.+. ..++.++|+||||+++|+|++|..||.... +...++.++..+......+...+++++++|.+||. +
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence 99999999886 458899999999999999999999997644 35666666665444444444558899999999999 9
Q ss_pred ccCCCC-----HHHHhcCCCCC
Q 004564 266 VSLRLS-----ARELLNDPFLQ 282 (745)
Q Consensus 266 PskRpS-----a~ELL~hPff~ 282 (745)
|.+||+ ++|+++||||+
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~ 256 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFN 256 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhh
Confidence 999999 99999999997
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=338.36 Aligned_cols=252 Identities=28% Similarity=0.405 Sum_probs=204.2
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
.+| .+.+.||.|+||.||+|.+..++..||+|.++.... ......+.+|+.+++.|+||||+++++++.. ...+
T Consensus 6 ~~y-~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~ 79 (301)
T cd07873 6 ETY-IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSL 79 (301)
T ss_pred cce-EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc---cCchhHHHHHHHHHHhcCCCCcceEEEEEec--CCeE
Confidence 456 777889999999999999999999999999875432 2233457789999999999999999998865 6789
Q ss_pred EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 101 NFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
++||||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKS 155 (301)
T ss_pred EEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEEC-CCCcEEECcCcchhccC
Confidence 99999997 5898887764 56899999999999999999999988 99999999999998 56899999999987643
Q ss_pred cc--CCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CC-----------
Q 004564 180 KS--HAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS--GK----------- 242 (745)
Q Consensus 180 ~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~--g~----------- 242 (745)
.. ......+++.|+|||++.+ .++.++|||||||++|+|+||+.||.......+ ...+.. +.
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 156 IPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred CCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhhchhhhc
Confidence 22 2223457999999998864 478899999999999999999999987443322 222111 00
Q ss_pred --------CCC-------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 243 --------KPD-------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 243 --------~p~-------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
.|. ......++.+++||.+||+ +|.+|||++++|+||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 010 0112457889999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=334.23 Aligned_cols=250 Identities=30% Similarity=0.541 Sum_probs=209.3
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.+.||+|+||.||+|.+..++..+|+|.+... .....+.+.+|+.+++.++||||+++++.+.. +...|+|+
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v~ 81 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILI 81 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEEE
Confidence 6668899999999999999999999999987533 35567788999999999999999999998876 57899999
Q ss_pred eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc--
Q 004564 105 EMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-- 181 (745)
Q Consensus 105 E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~-- 181 (745)
||+.+++|..++.+ ..++++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++......
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-cCCCEEEcccccccccccccc
Confidence 99999999988765 467999999999999999999999988 99999999999997 5689999999998654322
Q ss_pred CCCcccCCCCcCChhhhh------hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCcccCCCHH
Q 004564 182 HAAHCVGTPEFMAPEVYE------EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP-DSLYRVKDPE 254 (745)
Q Consensus 182 ~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p-~~l~~~~s~e 254 (745)
......+++.|+|||++. ..++.++|||||||++|+|++|+.||.... ..+....+..+..+ .......+.+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSE 237 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHHhhcCCCCCCCccccCHH
Confidence 123346899999999873 347789999999999999999999998744 33344444443332 2233456789
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 255 VRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 255 l~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
+++||.+||+ +|.+||++.++++||||...
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 238 FKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 9999999999 99999999999999999854
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.09 Aligned_cols=252 Identities=37% Similarity=0.570 Sum_probs=219.0
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.+.||+|++|.||+|.+..++..|++|++..... .....+.+.+|+.++++++||||+++++.+.+.....+++++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 677899999999999999999999999999875542 256678899999999999999999999988764337899999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC--
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-- 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~-- 182 (745)
|++.+++|.+++.+...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++ .++.+||+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVD-SDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEcccccEEeccccccc
Confidence 99999999999998889999999999999999999999988 99999999999998 46899999999997766543
Q ss_pred --CCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHH
Q 004564 183 --AAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259 (745)
Q Consensus 183 --~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I 259 (745)
.....++..|+|||.+.. .++.++||||||+++|+|++|..||....+.......+..+.....+....+..+++||
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 334568999999998874 48899999999999999999999998766555555555544444455566789999999
Q ss_pred HHHhh-CccCCCCHHHHhcCCCC
Q 004564 260 EKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 260 ~kcL~-dPskRpSa~ELL~hPff 281 (745)
.+||. +|.+||++.++++||||
T Consensus 238 ~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 238 RKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHhCcCChhhCCCHHHHhhCCCC
Confidence 99999 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=336.11 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=223.5
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+++.||+|-||.||+|+.+.++..||+|++.+.. +.....-.++.+|+.+-..|+||||+++|++|.+ ...+|+++
T Consensus 25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsq-i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd--~~riyLil 101 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ-ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD--SKRIYLIL 101 (281)
T ss_pred cccccccCCccccEeEeeeccCCcEEEEeeeeHHH-HHHhcchhhhhheeEeecccCCccHHhhhhheec--cceeEEEE
Confidence 56688999999999999999999999999987655 2233445678999999999999999999999988 68999999
Q ss_pred eccCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC
Q 004564 105 EMFTSGTLRQYRL--KHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 182 (745)
Q Consensus 105 E~~~gGsL~~~l~--k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~ 182 (745)
||...|+|...++ +.+++++.....|++|++.||.|+|..+ ||||||||+|+|+. ..|.+||+|||-+.....+.
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg-~~~~lkiAdfGwsV~~p~~k 178 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSNK 178 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccC-CCCCeeccCCCceeecCCCC
Confidence 9999999999998 6678999999999999999999999987 99999999999996 56899999999998887777
Q ss_pred CCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHH
Q 004564 183 AAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEK 261 (745)
Q Consensus 183 ~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~k 261 (745)
..+.+||..|.|||+.++ .++..+|+|++|++.||++.|.+||.... ..+.|+++..-... ++...+..++++|.+
T Consensus 179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~~--~p~~is~~a~dlI~~ 255 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDLK--FPSTISGGAADLISR 255 (281)
T ss_pred ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcccc--CCcccChhHHHHHHH
Confidence 888899999999999985 69999999999999999999999998744 78889888765432 236788999999999
Q ss_pred Hhh-CccCCCCHHHHhcCCCCC
Q 004564 262 CLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 262 cL~-dPskRpSa~ELL~hPff~ 282 (745)
||. +|.+|++..|++.|||+.
T Consensus 256 ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 256 LLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred HhccCccccccHHHHhhhHHHH
Confidence 999 999999999999999985
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.84 Aligned_cols=248 Identities=31% Similarity=0.518 Sum_probs=209.2
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.+.||.|+||+||+|....++..+|+|++..... ......+.+|+.+|+.++|+||+++++.+.. ....|+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~ 78 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLVM 78 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEEE
Confidence 778899999999999999999999999998864432 2367789999999999999999999998876 67899999
Q ss_pred eccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 105 EMFTSGTLRQYRLKH---KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 105 E~~~gGsL~~~l~k~---~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
|++.+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||+|+||+++ +++.+||+|||++..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~-~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLG-EDGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEcccchHHHhccC
Confidence 999999999998764 45899999999999999999999988 99999999999998 4589999999999776543
Q ss_pred CC------CcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCc----cc
Q 004564 182 HA------AHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSL----YR 249 (745)
Q Consensus 182 ~~------~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l----~~ 249 (745)
.. ....|++.|+|||.+.. .++.++|+|||||++|+|++|+.||..... ...+.....+..+... ..
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-MKVLMLTLQNDPPSLETGADYK 234 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh-hhhHHHHhcCCCCCcCCccccc
Confidence 22 23468999999998863 588999999999999999999999987544 3444444444322111 12
Q ss_pred CCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 250 VKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 250 ~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
..++.+.+++.+||+ +|.+||++.+|++||||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 457889999999999 99999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=329.58 Aligned_cols=246 Identities=33% Similarity=0.494 Sum_probs=204.7
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEecc
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMF 107 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~ 107 (745)
.+||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.++|+||+++++++.. ...+++|+||+
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~ 87 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGFFKIFMEQV 87 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCEEEEEEecC
Confidence 5799999999999999999999999987633 34566789999999999999999999998765 67899999999
Q ss_pred CCCCHHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC--
Q 004564 108 TSGTLRQYRLKH-KRV--NIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-- 182 (745)
Q Consensus 108 ~gGsL~~~l~k~-~~L--~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~-- 182 (745)
.+++|..++... ..+ ++..+..++.||+.||.|||+++ |+||||||+||+++...+.+||+|||++.......
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 999999998765 455 88999999999999999999988 99999999999998667899999999987653322
Q ss_pred CCcccCCCCcCChhhhhh---ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHH
Q 004564 183 AAHCVGTPEFMAPEVYEE---AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259 (745)
Q Consensus 183 ~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I 259 (745)
.....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.....................+....++++++|+
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFI 245 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHH
Confidence 223358999999999853 37889999999999999999999998754433332222211222334556788999999
Q ss_pred HHHhh-CccCCCCHHHHhcCCCC
Q 004564 260 EKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 260 ~kcL~-dPskRpSa~ELL~hPff 281 (745)
.+||. +|.+|||+.+++.||||
T Consensus 246 ~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 246 LRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHcCCCchhCCCHHHHHhCCCC
Confidence 99999 99999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=327.62 Aligned_cols=250 Identities=34% Similarity=0.531 Sum_probs=209.1
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~ 98 (745)
|..+| .+.+.||.|+||.||+|....++..||+|.++... ..+.+.+|+.+++.++||||+++++.+.+ ..
T Consensus 1 ~~~~y-~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~ 71 (256)
T cd06612 1 PEEVF-DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFK--NT 71 (256)
T ss_pred Ccccc-hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeec--CC
Confidence 45677 77788999999999999999889999999886332 26789999999999999999999998876 57
Q ss_pred eEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 99 NINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
.+|+++||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||+|+||+++ +++.+||+|||++..
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~-~~~~~~l~dfg~~~~ 148 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQ 148 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEC-CCCcEEEcccccchh
Confidence 89999999999999999876 457899999999999999999999988 99999999999998 568999999999987
Q ss_pred hhccC--CCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CCCcccCCCH
Q 004564 178 LRKSH--AAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK-PDSLYRVKDP 253 (745)
Q Consensus 178 l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~-p~~l~~~~s~ 253 (745)
..... .....++..|+|||++.+ .++.++||||||+++|+|+||+.||.......... .+..... ........+.
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 227 (256)
T cd06612 149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-MIPNKPPPTLSDPEKWSP 227 (256)
T ss_pred cccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-hhccCCCCCCCchhhcCH
Confidence 65432 223458999999999874 58889999999999999999999998744333222 2222111 1122334678
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 254 el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
.+.++|.+||+ +|.+|||+.++|.||||
T Consensus 228 ~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 228 EFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 89999999999 99999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.75 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=208.5
Q ss_pred CCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecC
Q 004564 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTA 96 (745)
Q Consensus 18 dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~ 96 (745)
++.++| .+.+.||+|+||.||+|.+..+++.+|+|.+.... .....+.+|+.+++.+ +||||+++++.+....
T Consensus 19 ~~~~~y-~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 19 DPTDTW-EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCCe-EEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 467888 77789999999999999999999999999876321 2345678899999999 8999999999886532
Q ss_pred ---CCeEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEE
Q 004564 97 ---NRNINFVTEMFTSGTLRQYRLK----HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI 169 (745)
Q Consensus 97 ---~~~iyLV~E~~~gGsL~~~l~k----~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL 169 (745)
...+|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~-~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLT-TEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEE
Confidence 2568999999999999988753 457899999999999999999999988 99999999999997 5689999
Q ss_pred cCcchhhhhhccC--CCcccCCCCcCChhhhhh------ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 004564 170 GDLGLAAILRKSH--AAHCVGTPEFMAPEVYEE------AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG 241 (745)
Q Consensus 170 ~DFGlA~~l~~~~--~~~~vGTp~YmAPEvl~~------~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g 241 (745)
+|||++....... .....|++.|+|||++.. .++.++|||||||++|+|++|+.||........+. .+..+
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~-~~~~~ 248 (291)
T cd06639 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF-KIPRN 248 (291)
T ss_pred eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH-HHhcC
Confidence 9999987654322 233468999999998852 26789999999999999999999998754434443 34333
Q ss_pred CCCC-CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 242 KKPD-SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 242 ~~p~-~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
..+. .........+.++|.+||+ +|.+||++.+++.||||+
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 3221 1122356789999999999 999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=324.76 Aligned_cols=250 Identities=29% Similarity=0.490 Sum_probs=215.7
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
|| ++.++||.|+||.||.+.+..++..+++|.+..... ......++.+|+.+|++++|+||+++++++.+ ...++
T Consensus 1 ~y-~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 75 (256)
T cd08221 1 HY-IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLL 75 (256)
T ss_pred Cc-eEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEE
Confidence 46 777999999999999999999999999998875542 34556778899999999999999999999876 67899
Q ss_pred EEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 102 FVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
++|||+.+++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++ .++.+||+|||++....
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~-~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILG 152 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEe-CCCCEEECcCcceEEcc
Confidence 999999999999998775 46899999999999999999999988 99999999999998 56899999999987654
Q ss_pred ccC--CCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHH
Q 004564 180 KSH--AAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVR 256 (745)
Q Consensus 180 ~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~ 256 (745)
... .....|++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .+..++...+..+..+.. ....+..+.
T Consensus 153 ~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 230 (256)
T cd08221 153 SEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTPV-VSVYSSELI 230 (256)
T ss_pred cccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCC-ccccCHHHH
Confidence 332 234568999999998864 578899999999999999999999977 455666666666665443 356788999
Q ss_pred HHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 257 RFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 257 d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
++|.+||. +|.+||++.++|+|||+
T Consensus 231 ~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 231 SLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHcccCcccCCCHHHHhhCcCC
Confidence 99999998 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=332.29 Aligned_cols=253 Identities=29% Similarity=0.488 Sum_probs=215.0
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+| .+.+.||.|++|.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++.+ ...+|
T Consensus 2 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 75 (274)
T cd06609 2 LF-TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLW 75 (274)
T ss_pred hh-hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEE
Confidence 56 66688999999999999999999999999887442 24456678899999999999999999999876 57899
Q ss_pred EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
+|+||+.+++|.+++... ++++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++......
T Consensus 76 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLS-EEGDVKLADFGVSGQLTST 151 (274)
T ss_pred EEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEcccccceeeccc
Confidence 999999999999997765 8999999999999999999999988 99999999999998 5689999999999776543
Q ss_pred --CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHH
Q 004564 182 --HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRF 258 (745)
Q Consensus 182 --~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~ 258 (745)
......+++.|+|||.+. ..++.++||||||+++|+|+||..||.... +......+..+..|.......++.+.++
T Consensus 152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
T cd06609 152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-PMRVLFLIPKNNPPSLEGNKFSKPFKDF 230 (274)
T ss_pred ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc-hHHHHHHhhhcCCCCCcccccCHHHHHH
Confidence 233456899999999886 458999999999999999999999997643 4455555555544433333378899999
Q ss_pred HHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 259 VEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 259 I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
+.+||. +|.+|||++++++||||+...
T Consensus 231 l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 231 VSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred HHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 999998 999999999999999998544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.04 Aligned_cols=252 Identities=27% Similarity=0.418 Sum_probs=207.4
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+| .+.+.||+|+||.||+|.+..+|..||+|.+..... .....+.+.+|+.+++.++||||+++++.+.. ...++
T Consensus 2 ~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 76 (286)
T cd07847 2 KY-EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLH 76 (286)
T ss_pred ce-eeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEE
Confidence 56 677889999999999999999999999998864431 22234567889999999999999999999876 67899
Q ss_pred EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
+||||+.+++|..++.+...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++......
T Consensus 77 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 77 LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGP 153 (286)
T ss_pred EEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEc-CCCcEEECccccceecCCC
Confidence 99999999999888777778999999999999999999999988 99999999999998 5689999999999766443
Q ss_pred C--CCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CC--------------
Q 004564 182 H--AAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-GK-------------- 242 (745)
Q Consensus 182 ~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~-g~-------------- 242 (745)
. .....++..|+|||++.+ .++.++||||||+++|+|+||+.||.+..+.+.++..... +.
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 2 223458899999998863 4789999999999999999999999876655554432211 00
Q ss_pred -----CCC--------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 243 -----KPD--------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 243 -----~p~--------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
.|. ......+..+.+||.+||+ +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 0112347789999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=323.86 Aligned_cols=251 Identities=26% Similarity=0.457 Sum_probs=212.7
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+| ++.+.||+|+||.||+|.+..++..+|+|.+..... .......+.+|+.+|+.++||||+++++.+.. ...++
T Consensus 1 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~ 75 (256)
T cd08220 1 KY-EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALM 75 (256)
T ss_pred Cc-eEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEE
Confidence 35 777899999999999999999999999999875432 34557789999999999999999999998765 67899
Q ss_pred EEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 102 FVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
+||||+.+++|.+++.+. ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.+++.+||+|||++....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence 999999999999998764 35899999999999999999999998 99999999999998666679999999997665
Q ss_pred ccC-CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHH
Q 004564 180 KSH-AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257 (745)
Q Consensus 180 ~~~-~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d 257 (745)
... .....|++.|+|||.+. ..++.++||||||+++|+|++|..||.... .......+..+..+ .+....++.+++
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~l~~ 231 (256)
T cd08220 154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-LPALVLKIMSGTFA-PISDRYSPDLRQ 231 (256)
T ss_pred CCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-hHHHHHHHHhcCCC-CCCCCcCHHHHH
Confidence 432 22346899999999987 457889999999999999999999998744 44445555544433 234457889999
Q ss_pred HHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 258 FVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 258 ~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
+|.+||. +|.+|||+.+++.||||
T Consensus 232 li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 232 LILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHccCChhhCCCHHHHhhCCCC
Confidence 9999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=332.08 Aligned_cols=254 Identities=27% Similarity=0.472 Sum_probs=207.2
Q ss_pred CCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEec-
Q 004564 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDT- 95 (745)
Q Consensus 18 dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~- 95 (745)
++..+| .+.+.||+|+||+||+|.+..++..+|+|+++... .....+..|+.+++.+ +||||+++++.+...
T Consensus 15 ~~~~~~-~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 15 DPSDTW-EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred Ccccce-eeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 467788 77789999999999999999999999999875321 2235678899999999 699999999987542
Q ss_pred --CCCeEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEE
Q 004564 96 --ANRNINFVTEMFTSGTLRQYRLK----HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI 169 (745)
Q Consensus 96 --~~~~iyLV~E~~~gGsL~~~l~k----~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL 169 (745)
....+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ ..+.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLT-TEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEEC-CCCCEEE
Confidence 34679999999999999988653 356899999999999999999999988 99999999999998 5578999
Q ss_pred cCcchhhhhhcc--CCCcccCCCCcCChhhhh------hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 004564 170 GDLGLAAILRKS--HAAHCVGTPEFMAPEVYE------EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG 241 (745)
Q Consensus 170 ~DFGlA~~l~~~--~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g 241 (745)
+|||++...... ......|++.|+|||++. ..++.++|||||||++|+|++|+.||........+.+ +..+
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~-~~~~ 244 (286)
T cd06638 166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK-IPRN 244 (286)
T ss_pred ccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh-cccc
Confidence 999998765432 223346999999999874 3478899999999999999999999987544444332 3233
Q ss_pred CCC-CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 242 KKP-DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 242 ~~p-~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
..+ .......+..++++|.+||+ +|.+|||+.++|+|+||
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 222 22334467889999999999 99999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=338.20 Aligned_cols=247 Identities=27% Similarity=0.367 Sum_probs=191.6
Q ss_pred EeEEecccCceEEEEEEEc--CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEE
Q 004564 26 YNEILGKGASKTVYRAFDE--YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 26 l~e~LG~GafgtVy~A~d~--~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV 103 (745)
...+||+|+||+||+|.+. .++..||+|.++... ....+.+|+.+|+.++||||+++++++....+..+++|
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 3467999999999999865 467899999876332 22357789999999999999999999887667889999
Q ss_pred EeccCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeec---CCCCcEEEcC
Q 004564 104 TEMFTSGTLRQYRLKH---------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVN---GNQGEVKIGD 171 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~---------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld---~~~g~VKL~D 171 (745)
+||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ...+.+||+|
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 99986 4777776532 24889999999999999999999988 99999999999994 2457899999
Q ss_pred cchhhhhhccC-----CCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCC---------HHHHH
Q 004564 172 LGLAAILRKSH-----AAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTH---------PAQIY 235 (745)
Q Consensus 172 FGlA~~l~~~~-----~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~---------~~~i~ 235 (745)
||++....... ....+||+.|+|||++.+ .++.++|||||||++|||+||+.||..... ..++.
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHH
Confidence 99997654322 223468999999999864 488999999999999999999999964221 11111
Q ss_pred HHHHc-CCC-----------C-----------------------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCC
Q 004564 236 KKVVS-GKK-----------P-----------------------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDP 279 (745)
Q Consensus 236 kkv~~-g~~-----------p-----------------------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hP 279 (745)
+.+.. |.. + .......+..+.++|.+||. ||.+|||+.|+|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred HHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence 11100 000 0 00011235668899999999 999999999999999
Q ss_pred CC
Q 004564 280 FL 281 (745)
Q Consensus 280 ff 281 (745)
||
T Consensus 316 ~f 317 (317)
T cd07867 316 YF 317 (317)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=356.04 Aligned_cols=255 Identities=25% Similarity=0.422 Sum_probs=222.0
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
|-| -+.+.||+|-|+.|-+|.+..+|..||+|+|.+.+. +.-....+.+|++.|+..+|||||++|.. ....-.+
T Consensus 18 GLY-DLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl--D~~st~hlfqEVRCMKLVQHpNiVRLYEV--iDTQTKl 92 (864)
T KOG4717|consen 18 GLY-DLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DTLSTGHLFQEVRCMKLVQHPNIVRLYEV--IDTQTKL 92 (864)
T ss_pred eee-hhhhhhcCCceehhhhhhhhcccceeEEEEeccccc--chhhhhHHHHHHHHHHHhcCcCeeeeeeh--hcccceE
Confidence 445 788899999999999999999999999999986653 33445678999999999999999999994 3456789
Q ss_pred EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 101 NFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
|+|+|+-++|+|.+|+.++ ..++++..+.|+.||+.|+.|+|+.. +|||||||+||.+-.+.|-|||+|||++..+.
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 9999999999999999987 46999999999999999999999987 99999999999887889999999999997765
Q ss_pred cc-CCCcccCCCCcCChhhhhh-ccC-ccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHH
Q 004564 180 KS-HAAHCVGTPEFMAPEVYEE-AYN-ELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVR 256 (745)
Q Consensus 180 ~~-~~~~~vGTp~YmAPEvl~~-~ys-~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~ 256 (745)
+. ...+.+|+..|-|||++.+ .|+ +++||||||||||.|++|++||.+..+ .+..-+|..+++. .+...+.+.+
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND-SETLTmImDCKYt--vPshvS~eCr 247 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND-SETLTMIMDCKYT--VPSHVSKECR 247 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc-hhhhhhhhccccc--CchhhhHHHH
Confidence 54 4567789999999999875 454 789999999999999999999998544 4445556666654 3556789999
Q ss_pred HHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 257 RFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 257 d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
++|..||. +|++|.+.+++..++|++..+
T Consensus 248 dLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 248 DLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred HHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 99999999 999999999999999998655
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.43 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=201.0
Q ss_pred EecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHH---HHHhCCCCCcceEeEEEEecCCCeEEEEEe
Q 004564 29 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIH---LLKTLKHKNIMKFYTSWVDTANRNINFVTE 105 (745)
Q Consensus 29 ~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~---iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E 105 (745)
+||+|+||.||+|.+..++..||+|.+........ .....+..|.. ++....||||+++++.+.. .+.+++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEe
Confidence 48999999999999999999999998875432211 22222334443 3444579999999998765 568999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCCCc
Q 004564 106 MFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH 185 (745)
Q Consensus 106 ~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~~~ 185 (745)
|+.+++|..++..++.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..........
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~ 154 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHA 154 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEEC-CCCCEEEccCCcceeccccCccC
Confidence 9999999999988889999999999999999999999998 99999999999998 56899999999987655444444
Q ss_pred ccCCCCcCChhhhh--hccCccccchhhhhHHHHHhhcCCCCCCCCC--HHHHHHHHHcCCCCCCcccCCCHHHHHHHHH
Q 004564 186 CVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTH--PAQIYKKVVSGKKPDSLYRVKDPEVRRFVEK 261 (745)
Q Consensus 186 ~vGTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~--~~~i~kkv~~g~~p~~l~~~~s~el~d~I~k 261 (745)
..||+.|+|||.+. ..++.++|||||||++|+|+||..||..... ...+.... ...+..++...++.++++|.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh--hcCCcCCccccCHHHHHHHHH
Confidence 57999999999885 3488999999999999999999999975332 22222221 122334555678999999999
Q ss_pred Hhh-CccCCC-----CHHHHhcCCCCCccc
Q 004564 262 CLA-TVSLRL-----SARELLNDPFLQIDD 285 (745)
Q Consensus 262 cL~-dPskRp-----Sa~ELL~hPff~~~~ 285 (745)
||. +|++|+ +++++++||||+..+
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 999 999999 699999999998543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=328.72 Aligned_cols=249 Identities=27% Similarity=0.407 Sum_probs=212.8
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.+.||.|+||.||+|.+..++..||+|++..... ......+.+.+|+.++++++||||+++++.+.. ...+++|+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 79 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EENMYLVV 79 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CCeEEEEE
Confidence 778999999999999999999999999999875432 233567889999999999999999999998755 67899999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc-CC
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-HA 183 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~-~~ 183 (745)
||+.+++|..++.+..++++..+..|+.||+.||.|||+++ ++|+||+|+||+++ +++.++|+|||++...... ..
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEc-CCCCEEEeecccccccCCCccc
Confidence 99999999999988888999999999999999999999988 99999999999998 5689999999998776543 22
Q ss_pred CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCC--HHHHHHHHHcCCCCCCcccCCCHHHHHHHH
Q 004564 184 AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTH--PAQIYKKVVSGKKPDSLYRVKDPEVRRFVE 260 (745)
Q Consensus 184 ~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~--~~~i~kkv~~g~~p~~l~~~~s~el~d~I~ 260 (745)
....|+..|+|||++. ..++.++|+||||+++|+|++|..||..... ...+...... .....+...++.+.++|.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAIN 234 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHH
Confidence 3345899999999986 4578999999999999999999999987543 4444433332 222344456789999999
Q ss_pred HHhh-CccCCCCH--HHHhcCCCC
Q 004564 261 KCLA-TVSLRLSA--RELLNDPFL 281 (745)
Q Consensus 261 kcL~-dPskRpSa--~ELL~hPff 281 (745)
+||. +|.+||++ +++++||||
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHccCChhHcCCccHHHHhcCCCC
Confidence 9999 99999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=323.98 Aligned_cols=251 Identities=33% Similarity=0.581 Sum_probs=212.8
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
|| .+.+.||+|+||.||+|.+..++..||+|.++.... .......+..|+.+++.++|+||+++++.+.. ...++
T Consensus 1 ~y-~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~ 75 (264)
T cd06626 1 RW-QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVY 75 (264)
T ss_pred Cc-eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEE
Confidence 56 777999999999999999999999999999876542 24678889999999999999999999997654 67899
Q ss_pred EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
+|+||+.+++|.+++.+...+++..++.++.||+.||.|||+++ |+|+||+|+||+++ ..+.+||+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~-~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEcccccccccCCC
Confidence 99999999999999988888999999999999999999999988 99999999999998 5689999999999776432
Q ss_pred CC------CcccCCCCcCChhhhhh-c---cCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCccc--
Q 004564 182 HA------AHCVGTPEFMAPEVYEE-A---YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYR-- 249 (745)
Q Consensus 182 ~~------~~~vGTp~YmAPEvl~~-~---ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~-- 249 (745)
.. ....+++.|+|||++.+ . ++.++||||||+++|+|++|+.||........+...+..+..+. ++.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~ 231 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP-IPDSL 231 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCC-CCccc
Confidence 21 12357899999999863 3 78899999999999999999999977555444444444443322 222
Q ss_pred CCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 250 VKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 250 ~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
..++.+.+||.+||+ +|.+|||+.+++.|||+
T Consensus 232 ~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 232 QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 348899999999998 99999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=325.21 Aligned_cols=252 Identities=30% Similarity=0.505 Sum_probs=218.2
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.+.||.|++|.||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++.+.. ...+++|+
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEISIVL 78 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEEE
Confidence 667899999999999999999999999998875432 2556789999999999999999999998876 57899999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhh-CCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCC
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 183 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs-~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~ 183 (745)
||+.+++|.+++.....+++..+..++.||+.||.|||+ .+ ++||||+|+||+++ .++.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~-~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEEC-CCCCEEEccCccceecccCCC
Confidence 999999999999888899999999999999999999999 88 99999999999998 568999999999977654333
Q ss_pred C--cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCC--CHHHHHHHHHcCCCCCCcccCCCHHHHHH
Q 004564 184 A--HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECT--HPAQIYKKVVSGKKPDSLYRVKDPEVRRF 258 (745)
Q Consensus 184 ~--~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~--~~~~i~kkv~~g~~p~~l~~~~s~el~d~ 258 (745)
. ...++..|+|||.+. ..++.++|+||||+++|+|+||..||.... ...++.+.+.....+.......+..+.++
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 2 346899999999886 458889999999999999999999998764 56666666665555443333378899999
Q ss_pred HHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 259 VEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 259 I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
|.+||. +|++||++.++++|||++..
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 999999 99999999999999999743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=336.19 Aligned_cols=255 Identities=22% Similarity=0.371 Sum_probs=212.1
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+| ++.+.||+|+||+||+|.+..++..||+|.+..... ........+..|+.+++.++||||+++++.+.+ ...+|
T Consensus 2 ~y-~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 77 (316)
T cd05574 2 HF-KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM-IKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLC 77 (316)
T ss_pred ce-EEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc-chHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEE
Confidence 45 677899999999999999999999999999875532 223466789999999999999999999998765 67899
Q ss_pred EEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 102 FVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
+||||+.+++|.+++.+. ..+++..++.++.||+.||.|||+.+ ++|+||||+|||++ .++.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLH-ESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEc-CCCCEEEeecchhhccc
Confidence 999999999999998764 56899999999999999999999988 99999999999998 56899999999986542
Q ss_pred ccC-------------------------------CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCC
Q 004564 180 KSH-------------------------------AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSE 227 (745)
Q Consensus 180 ~~~-------------------------------~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~ 227 (745)
... ....+||..|+|||++. ..++.++||||||+++|+|++|..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 211 11246899999999986 4588899999999999999999999987
Q ss_pred CCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCC----HHHHhcCCCCCcc
Q 004564 228 CTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLS----ARELLNDPFLQID 284 (745)
Q Consensus 228 ~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpS----a~ELL~hPff~~~ 284 (745)
... ...+..+.....+.......++.++++|.+||+ +|.+||| ++++|+||||+..
T Consensus 235 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 235 SNR-DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred Cch-HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 444 444444444333222222368999999999999 9999999 9999999999854
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=333.59 Aligned_cols=250 Identities=28% Similarity=0.502 Sum_probs=210.4
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.+.||+|+||.||+|.+..++..||+|.++.. ........+.+|+.+++.++||||+++++.+.. ...+|+||
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMCM 78 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEEE
Confidence 6678899999999999999999999999988643 234556789999999999999999999998765 67899999
Q ss_pred eccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHhhh-CCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 105 EMFTSGTLRQYRLKH---KRVNIRAVKLWCRQILRGLLYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 105 E~~~gGsL~~~l~k~---~~L~e~~i~~ia~QIL~gL~yLHs-~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
||+.+++|..++... ..+++..+..++.||+.||.|||+ ++ |+||||||+||+++ .++.+||+|||++..+..
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVN-GNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEEC-CCCCEEEeecCCcccccC
Confidence 999999999988763 379999999999999999999996 46 99999999999998 468999999999977655
Q ss_pred cCCCcccCCCCcCChhhhhh-------ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHH---HHHcCCCCCCcccC
Q 004564 181 SHAAHCVGTPEFMAPEVYEE-------AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYK---KVVSGKKPDSLYRV 250 (745)
Q Consensus 181 ~~~~~~vGTp~YmAPEvl~~-------~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k---kv~~g~~p~~l~~~ 250 (745)
.......+++.|+|||++.+ .++.++|||||||++|+|+||..||.... ....+. .+..+..+ .+...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~-~~~~~ 233 (286)
T cd06622 156 SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDGDPP-TLPSG 233 (286)
T ss_pred CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhhcCCC-CCCcc
Confidence 55555678999999998852 25789999999999999999999997633 223332 33334333 34455
Q ss_pred CCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 251 KDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 251 ~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
.++++++||.+||+ +|.+||++.+++.||||...
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 88999999999999 99999999999999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=332.88 Aligned_cols=253 Identities=22% Similarity=0.343 Sum_probs=208.0
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
+..++||+|+||+||+|.+..+++.||+|++..... ........+.+|+.+|+.++|+||+++++.+.. +..++++|
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~ 79 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI-KKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLVL 79 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh-hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEEE
Confidence 555889999999999999999999999999875432 223344567889999999999999999998765 67899999
Q ss_pred eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc-
Q 004564 105 EMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 181 (745)
Q Consensus 105 E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~- 181 (745)
||+.+++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++ +.+.+||+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEC-CCCCEEEecCCcceecCCCC
Confidence 999999999887653 46999999999999999999999988 99999999999998 4579999999998654322
Q ss_pred CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHH---HHHHHHHcCCCCCCcccCCCHHHHH
Q 004564 182 HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPA---QIYKKVVSGKKPDSLYRVKDPEVRR 257 (745)
Q Consensus 182 ~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~---~i~kkv~~g~~p~~l~~~~s~el~d 257 (745)
......|++.|+|||++. ..++.++|+|||||++|+|+||..||....... .+...+..+. .......++.+.+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 234 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE--EVYSAKFSEEAKS 234 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc--cccCccCCHHHHH
Confidence 223446999999999986 568999999999999999999999998743322 2222232222 2234457789999
Q ss_pred HHHHHhh-CccCCCC-----HHHHhcCCCCCccc
Q 004564 258 FVEKCLA-TVSLRLS-----ARELLNDPFLQIDD 285 (745)
Q Consensus 258 ~I~kcL~-dPskRpS-----a~ELL~hPff~~~~ 285 (745)
|+.+||+ +|.+||+ +.++++||||+...
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 235 ICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred HHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 9999999 9999999 99999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.06 Aligned_cols=252 Identities=26% Similarity=0.412 Sum_probs=206.9
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+| ++.+.||.|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++.+ ...+|
T Consensus 1 ~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~ 75 (286)
T cd07832 1 RY-KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFV 75 (286)
T ss_pred Cc-eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeE
Confidence 35 778899999999999999999999999999875432 23445678899999999999999999998876 67899
Q ss_pred EEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 102 FVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
+|+||+ +++|.+++.. ...+++..++.++.||+.||.|||+++ |+|+||||+||+++ ..+.++|+|||++.....
T Consensus 76 ~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~-~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLIS-ADGVLKIADFGLARLFSE 151 (286)
T ss_pred EEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEc-CCCcEEEeeeeecccccC
Confidence 999999 9999998765 456999999999999999999999998 99999999999998 468999999999977654
Q ss_pred cC---CCcccCCCCcCChhhhh--hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-----------
Q 004564 181 SH---AAHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP----------- 244 (745)
Q Consensus 181 ~~---~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p----------- 244 (745)
.. .....|++.|+|||++. ..++.++||||||+++|+|+||.+||....+...+...+..-..|
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence 33 33456899999999885 347899999999999999999988887644433332222111000
Q ss_pred ----------------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 245 ----------------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 245 ----------------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
.......+..+.++|.+||. +|.+|||++++|+||||.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 01112346889999999999 999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=328.59 Aligned_cols=252 Identities=28% Similarity=0.462 Sum_probs=203.9
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHH-HHhCCCCCcceEeEEEEecCCCeEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHL-LKTLKHKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~i-Lk~L~HpNIVk~~~sfvd~~~~~iyLV 103 (745)
++.+.||+|+||.||+|.+..+|..||+|.++... .. ....++..|+.+ ++.++||||+++++++.. +..+|++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~lv 78 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV--NS-QEQKRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWIC 78 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCC--Cc-HHHHHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEEE
Confidence 67788999999999999999999999999887442 11 223345556654 677799999999998865 5679999
Q ss_pred EeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHhhhC-CCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 104 TEMFTSGTLRQYRLK----HKRVNIRAVKLWCRQILRGLLYLHSH-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k----~~~L~e~~i~~ia~QIL~gL~yLHs~-gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
|||+. |+|.+++.. ...+++..+..++.||+.||.|||++ + ++||||||+|||++ .++.+||+|||++...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~-~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLIN-RNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeeccccccc
Confidence 99996 688777654 24689999999999999999999997 6 99999999999998 5689999999999765
Q ss_pred hccCC-CcccCCCCcCChhhhh-----hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCC
Q 004564 179 RKSHA-AHCVGTPEFMAPEVYE-----EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 179 ~~~~~-~~~vGTp~YmAPEvl~-----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s 252 (745)
..... ....|+..|+|||++. ..++.++|+|||||++|+|++|+.||.......+.+..+..+..+.......+
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 43322 2246899999999885 34688999999999999999999999764444444444455544443344578
Q ss_pred HHHHHHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
.++.+||.+||. +|.+||++.+++.||||+...
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 899999999999 999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=331.93 Aligned_cols=251 Identities=24% Similarity=0.411 Sum_probs=211.5
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.+.||+|+||+||+|.+..+|..||+|++.... .......+.+|+.+++.++||||+++++++.. ...+++||
T Consensus 8 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 82 (284)
T cd06620 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLN--ENNICMCM 82 (284)
T ss_pred HHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEec--CCEEEEEE
Confidence 66788999999999999999999999999886432 34456788999999999999999999999876 57899999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhh-CCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCC
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 183 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs-~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~ 183 (745)
||+.+++|..++.+.+.+++..+..++.||+.||.|||+ ++ ++||||||+||+++ +++.++|+|||++........
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVN-SRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEEC-CCCcEEEccCCcccchhhhcc
Confidence 999999999999888889999999999999999999997 56 99999999999997 668999999999876544444
Q ss_pred CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCH----------HHHHHHHHcCCCCCCcccCCC
Q 004564 184 AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHP----------AQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 184 ~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~----------~~i~kkv~~g~~p~~l~~~~s 252 (745)
....|+..|+|||++. +.++.++|||||||++|+|+||..||...... ..+...+.....+.......+
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence 4557999999999885 56889999999999999999999999753321 123333443333332223367
Q ss_pred HHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
..+.+||.+||+ +|.+|||+.++++||||..
T Consensus 240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 889999999999 9999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=329.99 Aligned_cols=256 Identities=26% Similarity=0.465 Sum_probs=212.0
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+| ...+.||.|++|.||+|.+..++..||+|.+.... ......++.+|+++++.++||||+++++.+.+.....+|
T Consensus 2 ~~-~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 2 KI-VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred ce-EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 45 56688999999999999999999999999887443 234567789999999999999999999998776667899
Q ss_pred EEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 102 FVTEMFTSGTLRQYRLK----HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k----~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
+||||+.+++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++ ..+.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEe-cCCeEEEeecccccc
Confidence 99999999999887653 345899999999999999999999988 99999999999998 567999999999876
Q ss_pred hhccCCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCC----CCHHHHHHHHHcCCCCCCc---c-
Q 004564 178 LRKSHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSEC----THPAQIYKKVVSGKKPDSL---Y- 248 (745)
Q Consensus 178 l~~~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~----~~~~~i~kkv~~g~~p~~l---~- 248 (745)
..........++..|+|||.+. ..++.++|||||||++|+|+||..||... ....++...+.....+... .
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 155 LVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred ccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 5544444556889999999886 56889999999999999999999999764 2344455544443322111 1
Q ss_pred -cCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 249 -RVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 249 -~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
...++.+++||.+||. +|++|||+.|+++||||+..
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 1235789999999999 99999999999999999643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=322.40 Aligned_cols=250 Identities=25% Similarity=0.483 Sum_probs=213.4
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
|| ++.+.||+|+||+||++.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++.+.. ....+
T Consensus 1 ~y-~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 75 (256)
T cd08218 1 KY-VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLY 75 (256)
T ss_pred Cc-eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEE
Confidence 45 778999999999999999999999999999875432 23455688999999999999999999998765 67899
Q ss_pred EEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 102 FVTEMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
+|+||+.+++|.+++.... .+++..+..|+.||+.||.|||+++ ++|+||+|+|||++ .++.++|+|||++....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~-~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTIKLGDFGIARVLN 152 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEEeeccceeecC
Confidence 9999999999999887643 5899999999999999999999988 99999999999997 56799999999987654
Q ss_pred ccC--CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHH
Q 004564 180 KSH--AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVR 256 (745)
Q Consensus 180 ~~~--~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~ 256 (745)
... .....|++.|+|||++. +.++.++|+|||||++|+|+||..||.. .....++..+..+..+. .....+..+.
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd08218 153 STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA-GNMKNLVLKIIRGSYPP-VSSHYSYDLR 230 (256)
T ss_pred cchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC-CCHHHHHHHHhcCCCCC-CcccCCHHHH
Confidence 322 22346899999999986 4678899999999999999999999986 45566666666666543 3445788999
Q ss_pred HHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 257 RFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 257 d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
++|.+||+ +|.+||++.++|+||||
T Consensus 231 ~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 231 NLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 99999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=330.75 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=201.6
Q ss_pred EecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHH---HHHHHhCCCCCcceEeEEEEecCCCeEEEEEe
Q 004564 29 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCE---IHLLKTLKHKNIMKFYTSWVDTANRNINFVTE 105 (745)
Q Consensus 29 ~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~E---i~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E 105 (745)
+||+|+||.||+|.+..+++.||+|.+........ .....+..| +.+++.+.||||+++++.+.. ...+++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEe
Confidence 48999999999999999999999999875432211 111223333 345556689999999998765 578999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCCCc
Q 004564 106 MFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH 185 (745)
Q Consensus 106 ~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~~~ 185 (745)
|+.+++|..++.+.+.+++..++.|+.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++..........
T Consensus 78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~ 154 (278)
T cd05606 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHA 154 (278)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEEC-CCCCEEEccCcCccccCccCCcC
Confidence 9999999999988888999999999999999999999988 99999999999998 55899999999987665444445
Q ss_pred ccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCC--CHHHHHHHHHcCCCCCCcccCCCHHHHHHHHH
Q 004564 186 CVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECT--HPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEK 261 (745)
Q Consensus 186 ~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~--~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~k 261 (745)
..|++.|+|||++.+ .++.++|||||||++|+|++|..||.... ....+.+.... .+..+....++.+.++|.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRSLLEG 232 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--cCCCCCCcCCHHHHHHHHH
Confidence 579999999999863 48899999999999999999999997642 22333322222 2223444568999999999
Q ss_pred Hhh-CccCCC-----CHHHHhcCCCCCcc
Q 004564 262 CLA-TVSLRL-----SARELLNDPFLQID 284 (745)
Q Consensus 262 cL~-dPskRp-----Sa~ELL~hPff~~~ 284 (745)
||. +|.+|| ++.++++||||+..
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 999 899999 99999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=327.05 Aligned_cols=254 Identities=30% Similarity=0.480 Sum_probs=210.1
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCC------CHHHHHHHHHHHHHHHhCCCCCcceEeEEEEec
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ------SPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT 95 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~------~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~ 95 (745)
+| .+.+.||.|+||.||+|.+..+|..||+|.++...... .....+.+..|+.+++.++||||+++++++..
T Consensus 2 ~~-~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 79 (272)
T cd06629 2 KW-VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT- 79 (272)
T ss_pred ce-eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc-
Confidence 45 67789999999999999999999999999887532211 12235678899999999999999999998755
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
...+++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~d~~~~ 155 (272)
T cd06629 80 -EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVD-ADGICKISDFGIS 155 (272)
T ss_pred -CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEc-CCCeEEEeecccc
Confidence 6789999999999999999988889999999999999999999999988 99999999999998 5689999999998
Q ss_pred hhhhcc----CCCcccCCCCcCChhhhhh---ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC---CCC
Q 004564 176 AILRKS----HAAHCVGTPEFMAPEVYEE---AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK---KPD 245 (745)
Q Consensus 176 ~~l~~~----~~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~---~p~ 245 (745)
...... ......|+..|+|||++.. .++.++|+||||+++|+|++|..||........+.+...... .+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP 235 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCc
Confidence 764322 1223358899999999863 378899999999999999999999976554444443322222 233
Q ss_pred CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 246 SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 246 ~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
......+..++++|.+||. +|.+|||++++|+|||+
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 3334568899999999999 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=334.79 Aligned_cols=258 Identities=24% Similarity=0.302 Sum_probs=207.8
Q ss_pred CCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCC
Q 004564 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 18 dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~ 97 (745)
.+..+| ++.+.||+|+||.||+|.+..+|..||+|.++..... ......+.+|+.+++.++|+||+++++.+.+...
T Consensus 4 ~~~~~y-~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 4 RSVTEF-EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGKHL 80 (309)
T ss_pred ccccce-eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence 455667 7778899999999999999999999999998754321 1222345679999999999999999999877555
Q ss_pred CeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 98 RNINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
..+++||||+.+ +|.+++.+ ...+++..++.++.||+.||.|||+++ ++||||||+||+++ +.+.+||+|||++.
T Consensus 81 ~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~kL~dfg~~~ 156 (309)
T cd07845 81 DSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLT-DKGCLKIADFGLAR 156 (309)
T ss_pred CeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccceee
Confidence 789999999964 88888775 367999999999999999999999998 99999999999998 56899999999997
Q ss_pred hhhcc--CCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC--CCCC-----
Q 004564 177 ILRKS--HAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG--KKPD----- 245 (745)
Q Consensus 177 ~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g--~~p~----- 245 (745)
..... ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||..... .+.+..+... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-IEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCChhhchh
Confidence 66532 2223346889999999863 578999999999999999999999987443 3333333221 0000
Q ss_pred --------------C-------cccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 246 --------------S-------LYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 246 --------------~-------l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
. .....++.+.++|.+||+ +|.+|||++++|.||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0 012247889999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=333.68 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=197.8
Q ss_pred CCCceeeEeEEecccCceEEEEEEEc----------------CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDE----------------YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~----------------~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~H 82 (745)
|.++| ++.+.||+|+||.||+|.+. .++..||+|+++... .......+.+|+.+|+.++|
T Consensus 3 ~~~~~-~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h 78 (304)
T cd05096 3 PRGHL-LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKD 78 (304)
T ss_pred chhhC-eeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCC
Confidence 55778 88899999999999999753 245579999886432 34556779999999999999
Q ss_pred CCcceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHcC-------------------CCCHHHHHHHHHHHHHHHHHhhh
Q 004564 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK-------------------RVNIRAVKLWCRQILRGLLYLHS 143 (745)
Q Consensus 83 pNIVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~-------------------~L~e~~i~~ia~QIL~gL~yLHs 143 (745)
|||+++++++.+ ...+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+
T Consensus 79 ~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 79 PNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred CCeeEEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 999999998876 567999999999999999986542 36778899999999999999999
Q ss_pred CCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHH
Q 004564 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEM 218 (745)
Q Consensus 144 ~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyEL 218 (745)
++ |+||||||+|||++ .++.+||+|||++..+.... .....+++.|||||++. +.++.++|||||||++|+|
T Consensus 157 ~~--ivH~dlkp~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 233 (304)
T cd05096 157 LN--FVHRDLATRNCLVG-ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233 (304)
T ss_pred CC--ccccCcchhheEEc-CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHH
Confidence 98 99999999999998 56899999999997653322 22234678999999886 5689999999999999999
Q ss_pred hh--cCCCCCCCCCHHHHHHHHHc----CC--CCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHh
Q 004564 219 VT--FEYPYSECTHPAQIYKKVVS----GK--KPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELL 276 (745)
Q Consensus 219 lT--G~~Pf~~~~~~~~i~kkv~~----g~--~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL 276 (745)
++ +..||.... ..++...+.. .. .........++.+.++|.+||. +|.+|||+.++.
T Consensus 234 ~~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 234 LMLCKEQPYGELT-DEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred HHccCCCCCCcCC-HHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 87 568887644 3333333221 11 1111223467889999999999 999999999984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=322.67 Aligned_cols=246 Identities=27% Similarity=0.447 Sum_probs=210.8
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEeccCC
Q 004564 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTS 109 (745)
Q Consensus 30 LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~~g 109 (745)
||.|+||.||+|.+..+|..||+|.+..... ......+.+.+|+.+++.++||||+++++.+.. +..+|+++||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-hhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCC
Confidence 6999999999999999999999998864432 224567789999999999999999999998754 6789999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc--------
Q 004564 110 GTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-------- 181 (745)
Q Consensus 110 GsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~-------- 181 (745)
++|..++.+.+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEc-CCCCEEEEecccchhcccCcccccccc
Confidence 999999988889999999999999999999999988 99999999999998 5689999999998765432
Q ss_pred --CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHH
Q 004564 182 --HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRF 258 (745)
Q Consensus 182 --~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~ 258 (745)
......+++.|+|||.+. ..++.++|+||||+++|+|+||..||.. ....+++..+..+..+.......++.+.+|
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcCCCccccCCHHHHHH
Confidence 222345889999999886 4588899999999999999999999976 456667777766554432222348999999
Q ss_pred HHHHhh-CccCCCCH---HHHhcCCCCC
Q 004564 259 VEKCLA-TVSLRLSA---RELLNDPFLQ 282 (745)
Q Consensus 259 I~kcL~-dPskRpSa---~ELL~hPff~ 282 (745)
|.+||+ +|.+|||+ .++|+||||+
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~ 261 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKNHPFFK 261 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence 999999 99999999 9999999997
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=349.45 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=199.3
Q ss_pred CCceeeEeEEecccCceEEEEEEEc--CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCC
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDE--YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~--~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~ 97 (745)
.++| .+.+.||+|+||.||+|... .++..||+|.+... ..+.+|+.+|+.|+||||+++++.|.. .
T Consensus 91 ~~~y-~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~--~ 158 (392)
T PHA03207 91 RMQY-NILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRW--K 158 (392)
T ss_pred cCce-EEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEee--C
Confidence 3457 77799999999999999753 45788999977532 134579999999999999999998865 5
Q ss_pred CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 98 RNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
..+|++||++. ++|.+++.+...+++..++.|+.||+.||.|||++| ||||||||+|||++ ..+.+||+|||++..
T Consensus 159 ~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~-~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACK 234 (392)
T ss_pred CEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEccCccccc
Confidence 78999999985 689899877888999999999999999999999998 99999999999998 568999999999976
Q ss_pred hhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCC---HHHHHHHHHc--CC-----
Q 004564 178 LRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTH---PAQIYKKVVS--GK----- 242 (745)
Q Consensus 178 l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~---~~~i~kkv~~--g~----- 242 (745)
+.... ....+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+... ..++. .+.. +.
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~-~i~~~~~~~~~~~ 313 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLR-SIIRCMQVHPLEF 313 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHH-HHHHHhccCcccc
Confidence 54322 22346999999999987 4689999999999999999999999965332 11121 1111 00
Q ss_pred -------------------CC-CCc-----ccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 243 -------------------KP-DSL-----YRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 243 -------------------~p-~~l-----~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
.+ ... ....+.++++||.+||. +|.+|||+.++|.||||...
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 00 000 01246688999999999 99999999999999999753
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=345.99 Aligned_cols=246 Identities=28% Similarity=0.380 Sum_probs=193.9
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
..+| ++.+.||+|+||.||+|.+..++..||+|+.... ....|+.+|+.++||||+++++++.. ...
T Consensus 65 ~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 131 (357)
T PHA03209 65 SLGY-TVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVS--GAI 131 (357)
T ss_pred hcCc-EEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEe--CCe
Confidence 3446 7889999999999999999999999999974321 23469999999999999999998876 568
Q ss_pred EEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 100 INFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
.++|+|++. ++|..++.+ ...+++..++.|+.||+.||.|||+++ ||||||||+|||++ ..+.+||+|||++...
T Consensus 132 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 132 TCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFP 207 (357)
T ss_pred eEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEecCcccccc
Confidence 899999995 578887765 467999999999999999999999998 99999999999998 5679999999998754
Q ss_pred hc-cCCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCC----------HHHHHHHHHc-CCCCC
Q 004564 179 RK-SHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTH----------PAQIYKKVVS-GKKPD 245 (745)
Q Consensus 179 ~~-~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~----------~~~i~kkv~~-g~~p~ 245 (745)
.. .......||+.|+|||++. ..|+.++|||||||++|||+++..|+..... ...+.+.+.. +..|.
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred ccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 32 2223456999999999986 4689999999999999999996555422111 1122222211 11111
Q ss_pred Ccc------------------------------cCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 246 SLY------------------------------RVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 246 ~l~------------------------------~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
.+. ...+..+.+||.+||+ ||.+||||.|+|+||||+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~ 355 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA 355 (357)
T ss_pred hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence 111 1235567789999999 999999999999999997
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=324.42 Aligned_cols=247 Identities=23% Similarity=0.392 Sum_probs=204.1
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHH-HHhCCCCCcceEeEEEEecCCCeEEEEEec
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHL-LKTLKHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~i-Lk~L~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
+.||.|+||.||+|.+..+++.||+|.++...... ......+..|..+ .+.++||||+++++.+.. +..+|+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-KNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH-HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEec
Confidence 56899999999999999999999999886443211 2233344555544 445689999999998865 6789999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCCCcc
Q 004564 107 FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC 186 (745)
Q Consensus 107 ~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~~~~ 186 (745)
+.+++|.+++...+.+++..+..++.||+.||.|||+++ |+||||+|+|||++ ..+.+||+|||++..... ....
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~--~~~~ 153 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLE--NKKF 153 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEeecccceeccc--cccC
Confidence 999999999988889999999999999999999999988 99999999999998 568999999999865433 2334
Q ss_pred cCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCcccCCCHHHHHHHHHHh
Q 004564 187 VGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK--PDSLYRVKDPEVRRFVEKCL 263 (745)
Q Consensus 187 vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~--p~~l~~~~s~el~d~I~kcL 263 (745)
.|++.|+|||.+.+ .++.++||||||+++|+|+||..||.. .+..+++..+..+.. +.......++.+.++|.+||
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 232 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence 68999999999874 478999999999999999999999976 445666666555432 33444467899999999999
Q ss_pred h-CccCCCC---HHHHhcCCCCCc
Q 004564 264 A-TVSLRLS---ARELLNDPFLQI 283 (745)
Q Consensus 264 ~-dPskRpS---a~ELL~hPff~~ 283 (745)
. +|++||+ ++|+|.||||+.
T Consensus 233 ~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 233 CMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred cCCHHHccCCCcHHHHHcChHhhc
Confidence 9 9999995 579999999963
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=323.05 Aligned_cols=251 Identities=27% Similarity=0.444 Sum_probs=210.8
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
++| .+.+.||+|+||.||+|.+..++..||+|.++.... ........+.+|+.+++.++||||+++++.+.+ ...+
T Consensus 2 ~~~-~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 77 (267)
T cd08228 2 ANF-QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNEL 77 (267)
T ss_pred cce-eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeE
Confidence 356 788999999999999999999999999998875432 335566778999999999999999999998876 5689
Q ss_pred EEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 101 NFVTEMFTSGTLRQYRLK----HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k----~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
++++||+.+++|..++.. ...+++..+..++.||+.||.|||+++ |+|+||||+||+++ .++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~d~g~~~ 154 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEc-CCCCEEECccccce
Confidence 999999999999988753 345899999999999999999999988 99999999999997 56899999999987
Q ss_pred hhhccC--CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCC-CCHHHHHHHHHcCCCCCCcccCCC
Q 004564 177 ILRKSH--AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSEC-THPAQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 177 ~l~~~~--~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~-~~~~~i~kkv~~g~~p~~l~~~~s 252 (745)
...... .....|++.|+|||.+. ..++.++|+||||+++|+|+||+.||... .+...+...+..+..|.......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 654322 22346899999999886 46888999999999999999999999643 244566666666665555555677
Q ss_pred HHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
..++++|.+||+ +|++||++.++|+.
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 899999999999 99999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=334.21 Aligned_cols=264 Identities=36% Similarity=0.531 Sum_probs=216.2
Q ss_pred EeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEec
Q 004564 16 EVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT 95 (745)
Q Consensus 16 e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~ 95 (745)
..++.++| .+.+.||.|+||+||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++.+..
T Consensus 14 ~~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~- 87 (293)
T cd06647 14 VGDPKKKY-TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYLV- 87 (293)
T ss_pred ccCchhhc-eeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheeee-
Confidence 45667888 67789999999999999999999999999876432 2345678999999999999999999998876
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
....|+|+||+.+++|.+++.+. .+++..+..++.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++
T Consensus 88 -~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~-~~~~~kL~dfg~~ 162 (293)
T cd06647 88 -GDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFC 162 (293)
T ss_pred -CCcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEc-CCCCEEEccCcce
Confidence 56899999999999999997654 5889999999999999999999998 99999999999997 5689999999988
Q ss_pred hhhhcc--CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCC
Q 004564 176 AILRKS--HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 176 ~~l~~~--~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s 252 (745)
...... ......|++.|+|||.+. +.++.++|+||||+++|+|++|+.||.......++......+..+.......+
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd06647 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242 (293)
T ss_pred ecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccC
Confidence 655432 222346899999999886 45889999999999999999999999775444443332222322222334467
Q ss_pred HHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcccccccc
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDDCESNL 290 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~~~~~l 290 (745)
..++++|.+||. +|.+||++.+++.||||+.......+
T Consensus 243 ~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~ 281 (293)
T cd06647 243 AIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSL 281 (293)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccc
Confidence 889999999999 99999999999999999866543333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=320.37 Aligned_cols=251 Identities=28% Similarity=0.483 Sum_probs=211.2
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+| .+.+.||+|+||.||+|.++.+|..||+|.+..... .....+.+.+|+.+++.++|+||+++++.+.. ...++
T Consensus 1 ~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~ 75 (257)
T cd08225 1 RY-EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLF 75 (257)
T ss_pred Cc-eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEE
Confidence 35 677899999999999999999999999999875432 22345678899999999999999999998765 67899
Q ss_pred EEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 102 FVTEMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
+|+||+.+++|.+++.+.. .+++..++.|+.||+.||.|||+++ |+|+||||+||+++.+...+||+|||.+....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 9999999999999987654 4799999999999999999999988 99999999999998665568999999997765
Q ss_pred ccC--CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHH
Q 004564 180 KSH--AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVR 256 (745)
Q Consensus 180 ~~~--~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~ 256 (745)
... .....|++.|+|||++. ..++.++|+||||+++|+|++|..||... +..+....+..+..+ ......+..++
T Consensus 154 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (257)
T cd08225 154 DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFA-PISPNFSRDLR 231 (257)
T ss_pred CCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhcccCC-CCCCCCCHHHH
Confidence 432 22346899999999886 56889999999999999999999999764 445555555544433 23345678999
Q ss_pred HHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 257 RFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 257 d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
++|.+||. +|++|||+.++++||||
T Consensus 232 ~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 232 SLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHhccChhhCcCHHHHhhCCCC
Confidence 99999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=329.11 Aligned_cols=249 Identities=29% Similarity=0.439 Sum_probs=203.7
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.+.||.|++|.||+|.++.+|..||+|.++... ........+.+|+.++++++||||+++++++.+ ....++||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVF 78 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEccccc--cccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEEe
Confidence 67788999999999999999999999999886443 122344578899999999999999999998765 67899999
Q ss_pred eccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC
Q 004564 105 EMFTSGTLRQYRLK--HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k--~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~ 182 (745)
||+. ++|..++.. ...+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++.......
T Consensus 79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~-~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEeeccchhhcccCc
Confidence 9995 689888765 356899999999999999999999988 99999999999998 56899999999987654322
Q ss_pred --CCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-------------
Q 004564 183 --AAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPD------------- 245 (745)
Q Consensus 183 --~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~------------- 245 (745)
.....+++.|+|||++.+ .++.++||||||+++|+|+||+.||........+.+.+.....|.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 223357899999998864 368899999999999999999999987555444444332211110
Q ss_pred -------------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 246 -------------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 246 -------------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
......++.++++|.+||+ +|++|||++++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 1123467889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.71 Aligned_cols=250 Identities=30% Similarity=0.534 Sum_probs=215.5
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+| ++.+.||.|+||.||+|.+..++..||+|.+.... ........+..|+.+++.++|||++++++.+.. ...++
T Consensus 1 ~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~ 75 (258)
T cd08215 1 KY-EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN--MSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLC 75 (258)
T ss_pred Cc-eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc--CChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEE
Confidence 35 67789999999999999999999999999987543 234567788999999999999999999998876 47899
Q ss_pred EEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 102 FVTEMFTSGTLRQYRLKH----KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~----~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
+|+|++.+++|.+++.+. ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++ +++.++|+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~-~~~~~~l~d~~~~~~ 152 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEc-CCCcEEECCccceee
Confidence 999999999999998764 67999999999999999999999998 99999999999998 568999999999976
Q ss_pred hhccC--CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHH
Q 004564 178 LRKSH--AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254 (745)
Q Consensus 178 l~~~~--~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~e 254 (745)
..... .....|++.|+|||.+. ..++.++|+||||+++++|++|..||.. .....+...+..+..+ .+....+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 230 (258)
T cd08215 153 LSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG-ENLLELALKILKGQYP-PIPSQYSSE 230 (258)
T ss_pred cccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCC-CcHHHHHHHHhcCCCC-CCCCCCCHH
Confidence 65432 23346899999999876 4588999999999999999999999976 4466666666655433 344567889
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 255 VRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 255 l~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
+.+++.+||. +|.+|||+.++|+||||
T Consensus 231 ~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 231 LRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=332.35 Aligned_cols=261 Identities=28% Similarity=0.450 Sum_probs=215.2
Q ss_pred ceEeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEE
Q 004564 14 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWV 93 (745)
Q Consensus 14 ~~e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfv 93 (745)
+...+|..+| .+.+.||+|+||+||+|.+..++..||+|.+.... .......+.+.+|+.+++.++||||+++++.+.
T Consensus 8 ~~~~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 8 FSKDDPEKLF-TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred hcCCCcchhh-hhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc-cCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 3446788888 67788999999999999999999999999886443 233455677899999999999999999999987
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCc
Q 004564 94 DTANRNINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 172 (745)
Q Consensus 94 d~~~~~iyLV~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DF 172 (745)
+ ....|+|+||+. |+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||+|+||+++ .++.+||+||
T Consensus 86 ~--~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~-~~~~~kL~df 159 (307)
T cd06607 86 R--EHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADF 159 (307)
T ss_pred e--CCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEC-CCCCEEEeec
Confidence 6 568899999997 577676554 457999999999999999999999988 99999999999997 5689999999
Q ss_pred chhhhhhccCCCcccCCCCcCChhhhh----hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcc
Q 004564 173 GLAAILRKSHAAHCVGTPEFMAPEVYE----EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLY 248 (745)
Q Consensus 173 GlA~~l~~~~~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~ 248 (745)
|++...... ....+++.|+|||++. +.++.++||||||+++|+|+||..||........++ .+..+..+....
T Consensus 160 g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~ 236 (307)
T cd06607 160 GSASLVSPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLSS 236 (307)
T ss_pred CcceecCCC--CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH-HHhcCCCCCCCc
Confidence 998654322 3346899999999873 458889999999999999999999997644333333 344444444334
Q ss_pred cCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 249 RVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 249 ~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
...+..++++|.+||. +|.+||++.+++.||||....
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred hhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 4567889999999999 999999999999999998544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=329.83 Aligned_cols=254 Identities=28% Similarity=0.401 Sum_probs=206.7
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCC-CHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ-SPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~-~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
|| .+.+.||+|+||.||+|.+..+|..||+|.++...... .......+..|+.+++.++|+||+++++++.+ ...+
T Consensus 1 ~y-~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~ 77 (298)
T cd07841 1 RY-EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNI 77 (298)
T ss_pred Cc-eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEE
Confidence 45 56688999999999999999999999999997654321 12234567789999999999999999999876 6789
Q ss_pred EEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 101 NFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~-~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
++||||+ +++|.+++.+.. .+++..++.++.||+.||.|||+++ |+|+||||+|||++ .+|.+||+|||++....
T Consensus 78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIA-SDGVLKLADFGLARSFG 153 (298)
T ss_pred EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEc-CCCCEEEccceeeeecc
Confidence 9999999 899999988776 7999999999999999999999998 99999999999998 56899999999997665
Q ss_pred ccC--CCcccCCCCcCChhhhh--hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC-CC----------
Q 004564 180 KSH--AAHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK-KP---------- 244 (745)
Q Consensus 180 ~~~--~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~-~p---------- 244 (745)
... .....+++.|+|||.+. ..++.++|||||||++|+|++|.+||........ +.++.... .|
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 154 SPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ-LGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred CCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH-HHHHHHHcCCCchhhhhhccc
Confidence 432 22335788999999885 3578899999999999999999888876444333 33332110 00
Q ss_pred ---------------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 245 ---------------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 245 ---------------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
.......+..+.+||.+||+ +|++|||+.++|.||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 01123346789999999999 9999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.00 Aligned_cols=255 Identities=22% Similarity=0.367 Sum_probs=213.6
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.+.||+|+||.||+|.+..++..||+|.+.... .......+.+.+|+.+++.++||||+++++.+.. +..+++||
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 80 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN-LILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCMVM 80 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh-hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEEEE
Confidence 67789999999999999999999999999887443 1223456788899999999999999999998755 67899999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc---
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--- 181 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~--- 181 (745)
||+.+++|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+||+++ ..|.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~-~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEEC-CCCCEEEeeCCCccccCcCccc
Confidence 99999999999988888999999999999999999999988 99999999999997 6689999999988532100
Q ss_pred --------------CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-
Q 004564 182 --------------HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPD- 245 (745)
Q Consensus 182 --------------~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~- 245 (745)
......+++.|+|||.+. ..++.++|+|||||++|+|+||..||.+ ....+++..+..+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~ 236 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWP 236 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCCC
Confidence 011235788999999875 5689999999999999999999999986 45667777666554322
Q ss_pred CcccCCCHHHHHHHHHHhh-CccCCCC---HHHHhcCCCCCcccc
Q 004564 246 SLYRVKDPEVRRFVEKCLA-TVSLRLS---ARELLNDPFLQIDDC 286 (745)
Q Consensus 246 ~l~~~~s~el~d~I~kcL~-dPskRpS---a~ELL~hPff~~~~~ 286 (745)
......++.++++|.+||+ +|.+||+ +.++|.||||...+-
T Consensus 237 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~ 281 (305)
T cd05609 237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW 281 (305)
T ss_pred CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence 1222568889999999999 9999997 899999999975443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=326.98 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=209.3
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
++| ++.+.||+|+||.||+|.+..++..||+|.++... ......+.+.+|+++++.++|+||+++++.+.. +..+
T Consensus 1 ~~y-~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 75 (288)
T cd07833 1 NKY-EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE--DDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRL 75 (288)
T ss_pred Cce-eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc--ccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEE
Confidence 356 78899999999999999999999999999886443 234456788999999999999999999999876 6789
Q ss_pred EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 101 NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
+++|||+.++.+..+..+...+++..+..++.||+.||.|||+++ |+||||+|+||+++ .++.+||+|||++.....
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVS-ESGVLKLCDFGFARALRA 152 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEEeeecccccCC
Confidence 999999998877777666677999999999999999999999988 99999999999998 568999999999877654
Q ss_pred cC---CCcccCCCCcCChhhhh-h-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCC-----------
Q 004564 181 SH---AAHCVGTPEFMAPEVYE-E-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-GKK----------- 243 (745)
Q Consensus 181 ~~---~~~~vGTp~YmAPEvl~-~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~-g~~----------- 243 (745)
.. .....+++.|+|||++. . .++.++||||||+++|+|++|..||........+...... +..
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 32 23456889999999986 3 5789999999999999999999999875554444332110 000
Q ss_pred --------C---------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 244 --------P---------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 244 --------p---------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
+ .......++++++||.+||. +|.+|||++++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 01122347889999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=327.46 Aligned_cols=255 Identities=27% Similarity=0.357 Sum_probs=203.1
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceEeEEEEecCC---
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTSWVDTAN--- 97 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-HpNIVk~~~sfvd~~~--- 97 (745)
+| .+.+.||.|+||.||+|.+..++..||+|.++... ........+.+|+.+++.+. ||||+++++.+.....
T Consensus 2 ~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 2 AY-EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM--DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred Cc-eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc--cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 46 67788999999999999999999999999876542 12233456788999999995 6999999998765321
Q ss_pred CeEEEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCc
Q 004564 98 RNINFVTEMFTSGTLRQYRLKH-----KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 172 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k~-----~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DF 172 (745)
..+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+.+.+||+||
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeec
Confidence 238999999985 788887653 35799999999999999999999988 9999999999999864789999999
Q ss_pred chhhhhhcc--CCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC----
Q 004564 173 GLAAILRKS--HAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP---- 244 (745)
Q Consensus 173 GlA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p---- 244 (745)
|++...... ......+++.|+|||++.+ .++.++||||||+++|+|+||..||.......++.+.+..-..|
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 998755322 2223457899999998853 47899999999999999999999998765555544322210000
Q ss_pred ---------------------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 245 ---------------------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 245 ---------------------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
.......++.+.+||.+||. +|.+||++.++|.||||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00112367889999999999 999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.00 Aligned_cols=245 Identities=28% Similarity=0.425 Sum_probs=209.5
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.+.||.|+||.||++.+..++..||+|.++... .....+.+..|+.+++.++||||+++++.|.+ +..+|++|
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 67899999999999999999999999999987543 24566788899999999999999999999866 67899999
Q ss_pred eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC
Q 004564 105 EMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~ 182 (745)
||+.+++|.+++... ..+++..+..|+.||+.||.|||+++ |+|+||||+||+++ .++.++|+|||++.......
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEC-CCCcEEEcccCcceeecccc
Confidence 999999999987653 45899999999999999999999998 99999999999997 56899999999987654322
Q ss_pred --CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHH
Q 004564 183 --AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259 (745)
Q Consensus 183 --~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I 259 (745)
.....|++.|+|||++. ..++.++|+||||+++|+|++|..||.. .+...+...+..+..+. +....+..++++|
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li 232 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYKP-LPSHYSYELRSLI 232 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCCC-CCcccCHHHHHHH
Confidence 22346899999999987 4588999999999999999999999986 45566666666665432 3445788999999
Q ss_pred HHHhh-CccCCCCHHHHhcCC
Q 004564 260 EKCLA-TVSLRLSARELLNDP 279 (745)
Q Consensus 260 ~kcL~-dPskRpSa~ELL~hP 279 (745)
.+||+ +|.+||++.+++.--
T Consensus 233 ~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 233 KQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred HHHHhCCcccCCCHHHHhhcc
Confidence 99999 999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.20 Aligned_cols=244 Identities=19% Similarity=0.261 Sum_probs=202.3
Q ss_pred eeEeEEecccCceEEEEEEEc---CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 24 GRYNEILGKGASKTVYRAFDE---YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d~---~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
+++.++||+|+||.||+|... ..+..||+|.++... .......+.+|+.+|+.++||||+++++.+.. +..+
T Consensus 7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 81 (266)
T cd05064 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNTM 81 (266)
T ss_pred eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CCCc
Confidence 388899999999999999765 456789999887432 34455678899999999999999999998764 6789
Q ss_pred EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 101 NFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
++||||+.+|+|.+++.+. ..+++..+..++.||+.||+|||+++ ++||||||+|||++ .++.+||+|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~-~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVN-SDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEc-CCCcEEECCCccccccc
Confidence 9999999999999998874 57899999999999999999999988 99999999999998 56899999999875532
Q ss_pred ccC---CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHH
Q 004564 180 KSH---AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254 (745)
Q Consensus 180 ~~~---~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~e 254 (745)
... .....+++.|+|||.+. +.++.++|||||||++|||++ |..||... ....+.+.+..+..+. .....+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 236 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM-SGQDVIKAVEDGFRLP-APRNCPNL 236 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCCC-CCCCCCHH
Confidence 211 11223567899999886 568999999999999999775 99999874 4555666666664433 34567889
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhc
Q 004564 255 VRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 255 l~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
+.+++.+||+ +|.+||+++++++
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=325.92 Aligned_cols=244 Identities=23% Similarity=0.318 Sum_probs=206.5
Q ss_pred eEeEEecccCceEEEEEEEcCCC-----eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 25 RYNEILGKGASKTVYRAFDEYEG-----IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg-----~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
++.+.||+|+||.||+|.+...+ ..||+|.++.. ........+.+|+.+++.++||||+++++++.+ ...
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~ 82 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN---AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--EQP 82 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC---CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC--CCc
Confidence 67789999999999999876655 78999987633 234556778999999999999999999998765 567
Q ss_pred EEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCC
Q 004564 100 INFVTEMFTSGTLRQYRLKH----------------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGN 163 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~----------------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~ 163 (745)
.+++|||+.+++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ +
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~-~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG-E 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc-C
Confidence 89999999999999998875 45788999999999999999999998 99999999999997 5
Q ss_pred CCcEEEcCcchhhhhhcc----CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHH
Q 004564 164 QGEVKIGDLGLAAILRKS----HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKK 237 (745)
Q Consensus 164 ~g~VKL~DFGlA~~l~~~----~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kk 237 (745)
++.+||+|||++...... ......+++.|+|||.+. +.++.++|||||||++|||+| |..||.+ ....++...
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~~~~ 238 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEVIEM 238 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHH
Confidence 689999999998754322 122345788999999876 578999999999999999998 9999987 456677777
Q ss_pred HHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 238 VVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 238 v~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
+..+..+. .....++++.+++.+||+ +|.+||++.+++++
T Consensus 239 i~~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 239 IRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77766543 345678999999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=354.52 Aligned_cols=246 Identities=26% Similarity=0.354 Sum_probs=198.7
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
.++| ++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+++|+.|+|||||++++++.. ...
T Consensus 168 ~~gy-~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~ 234 (461)
T PHA03211 168 GLGF-AIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVV--GGL 234 (461)
T ss_pred cCCe-EEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEE--CCE
Confidence 4466 888999999999999999999999999995431 235679999999999999999998766 578
Q ss_pred EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 100 INFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
.++|||++. ++|..++... ..+++..++.|+.||+.||.|||++| ||||||||+||||+ ..+.+||+|||+++..
T Consensus 235 ~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~-~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 235 TCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVN-GPEDICLGDFGAACFA 310 (461)
T ss_pred EEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEEC-CCCCEEEcccCCceec
Confidence 899999995 6888887764 46999999999999999999999998 99999999999998 5579999999999765
Q ss_pred hccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCC-------CCHHHHHHHHHcCCC---
Q 004564 179 RKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSEC-------THPAQIYKKVVSGKK--- 243 (745)
Q Consensus 179 ~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~-------~~~~~i~kkv~~g~~--- 243 (745)
.... .....||+.|||||++. ..++.++|||||||+||||++|..|+... ....++.+.+..+..
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 4322 12346999999999987 46899999999999999999987655321 113444444433221
Q ss_pred --CCC-------------------------c--ccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 244 --PDS-------------------------L--YRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 244 --p~~-------------------------l--~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
+.. + +...++.+.+||.+||+ ||.+|||+.|||+||||+
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~ 459 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ 459 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccC
Confidence 100 0 01245689999999999 999999999999999997
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=346.04 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=203.7
Q ss_pred ceeeEeEEecccCceEEEEEEE-----cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEec
Q 004564 22 RYGRYNEILGKGASKTVYRAFD-----EYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDT 95 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d-----~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~ 95 (745)
+| ++.+.||+|+||+||+|.+ ..++..||+|+++... .....+.+.+|+.+|+.+ +||||+++++++.+
T Consensus 36 ~~-~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~- 110 (375)
T cd05104 36 RL-SFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGACTV- 110 (375)
T ss_pred He-ehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc-
Confidence 45 8889999999999999964 4567789999886432 234557788999999999 89999999998865
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHcC-------------------------------------------------------
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKHK------------------------------------------------------- 120 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~~------------------------------------------------------- 120 (745)
....++||||+.+|+|.+++....
T Consensus 111 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 111 -GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred -CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 568999999999999999886532
Q ss_pred --------------------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 121 --------------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 121 --------------------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
.+++..+..|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEE-CCCcEEEecCccceeccC
Confidence 4788899999999999999999988 99999999999998 567999999999976543
Q ss_pred cCC----CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHH
Q 004564 181 SHA----AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254 (745)
Q Consensus 181 ~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~e 254 (745)
... ....+++.|+|||++. ..++.++|||||||++|+|+| |..||........+++.+..+..+. .+...+.+
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 345 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML-SPECAPSE 345 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC-CCCCCCHH
Confidence 221 1223567899999986 468999999999999999998 8999987666666777666665432 33456789
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 255 VRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 255 l~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
++++|.+||+ +|++|||+.++++.
T Consensus 346 l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 346 MYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHHccCChhHCcCHHHHHHH
Confidence 9999999999 99999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=327.69 Aligned_cols=253 Identities=28% Similarity=0.419 Sum_probs=201.5
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~ 98 (745)
..++| ++.+.||+|+||.||+|.+..+|..||+|.++.... ......+.+|+.+++.++|+||+++++++.. +.
T Consensus 3 ~~~~y-~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~ 76 (291)
T cd07870 3 AATSY-LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDIIHT--KE 76 (291)
T ss_pred cccee-EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CC
Confidence 34567 778999999999999999999999999999865432 1223356789999999999999999998765 67
Q ss_pred eEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 99 NINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
..|+|+||+. ++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~ 152 (291)
T cd07870 77 TLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARA 152 (291)
T ss_pred eEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEc-CCCcEEEeccccccc
Confidence 8999999995 6777776553 56889999999999999999999998 99999999999997 568999999999875
Q ss_pred hhcc--CCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CCC--------
Q 004564 178 LRKS--HAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS--GKK-------- 243 (745)
Q Consensus 178 l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~--g~~-------- 243 (745)
.... ......+++.|+|||++.+ .++.++|||||||++|+|+||..||.......+...++.. |..
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 153 KSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred cCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhh
Confidence 4322 1223457999999998864 4788999999999999999999999875544343333211 100
Q ss_pred ---------------CCCc---c--cCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 244 ---------------PDSL---Y--RVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 244 ---------------p~~l---~--~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
+..+ . ...++.+.+++.+||+ +|++|||++++|.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 0 0125689999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=325.24 Aligned_cols=255 Identities=33% Similarity=0.561 Sum_probs=212.8
Q ss_pred CCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCC
Q 004564 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 18 dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~ 97 (745)
|+..+|..+ +.||.|++|.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 16 ~~~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~ 88 (285)
T cd06648 16 DPRSYLDNF-VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--G 88 (285)
T ss_pred cchHhhhcc-eEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEEc--C
Confidence 444455443 68999999999999999999999999886432 3445668899999999999999999998865 6
Q ss_pred CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 98 RNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
...++++||+.+++|.+++.. .++++..+..++.||+.||.|||+++ |+||||+|+||+++ .++.++|+|||++..
T Consensus 89 ~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~d~g~~~~ 164 (285)
T cd06648 89 DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQ 164 (285)
T ss_pred CeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEc-CCCcEEEcccccchh
Confidence 789999999999999999877 67999999999999999999999998 99999999999998 568999999998876
Q ss_pred hhccC--CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCc-ccCCCH
Q 004564 178 LRKSH--AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSL-YRVKDP 253 (745)
Q Consensus 178 l~~~~--~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l-~~~~s~ 253 (745)
..... .....|++.|+|||.+. ..++.++||||||+++|+|++|+.||.. .++...+..+..+..+... ....+.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (285)
T cd06648 165 VSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSP 243 (285)
T ss_pred hccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCCH
Confidence 54322 22346899999999986 4588999999999999999999999976 4455566666655333221 223678
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 254 el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
.+.+||.+||. +|.+||++.++++||||+..
T Consensus 244 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 244 RLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred HHHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence 99999999999 99999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=336.26 Aligned_cols=261 Identities=27% Similarity=0.380 Sum_probs=210.7
Q ss_pred eCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCH----------HHHHHHHHHHHHHHhCCCCCcc
Q 004564 17 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSP----------EDLERLYCEIHLLKTLKHKNIM 86 (745)
Q Consensus 17 ~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~----------~~~e~l~~Ei~iLk~L~HpNIV 86 (745)
.+..+||..+.+.||.|+||+||+|.+..++..||+|.++........ .....+.+|+.+++.++||||+
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 356789988889999999999999999999999999998754322111 0112577899999999999999
Q ss_pred eEeEEEEecCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCc
Q 004564 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGE 166 (745)
Q Consensus 87 k~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~ 166 (745)
++++++.. ...+++||||+. |+|.+++.....+++..+..++.||+.||.|||+++ |+||||+|+|||++ ..+.
T Consensus 84 ~~~~~~~~--~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~-~~~~ 157 (335)
T PTZ00024 84 GLVDVYVE--GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGI 157 (335)
T ss_pred eeeEEEec--CCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEEC-CCCC
Confidence 99998865 678999999996 689999988888999999999999999999999988 99999999999997 5689
Q ss_pred EEEcCcchhhhhhc----------------cCCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCC
Q 004564 167 VKIGDLGLAAILRK----------------SHAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSEC 228 (745)
Q Consensus 167 VKL~DFGlA~~l~~----------------~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~ 228 (745)
+||+|||++..... .......+++.|+|||.+.+ .++.++|+|||||++|+|+||..||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999876541 11122347889999998864 4788999999999999999999999875
Q ss_pred CCHHHHHHHHHc--CCCCC------------------------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 229 THPAQIYKKVVS--GKKPD------------------------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 229 ~~~~~i~kkv~~--g~~p~------------------------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
.....+ ..+.. +..+. ......+..+.++|.+||+ +|++|||++++|.||||
T Consensus 238 ~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 238 NEIDQL-GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred CHHHHH-HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 443333 22221 10000 0112346789999999999 99999999999999999
Q ss_pred Ccc
Q 004564 282 QID 284 (745)
Q Consensus 282 ~~~ 284 (745)
+..
T Consensus 317 ~~~ 319 (335)
T PTZ00024 317 KSD 319 (335)
T ss_pred CCC
Confidence 854
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=325.32 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=204.9
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEeccCC
Q 004564 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTS 109 (745)
Q Consensus 30 LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~~g 109 (745)
||+|+||+||+|.+..+|+.||+|.+.... .........+..|+.+|+.++||||+++++.+.. ...+|+||||+.+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKR-LKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhh-hhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCC
Confidence 699999999999999999999999887433 2223345567789999999999999999998755 6789999999999
Q ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc-CCCcc
Q 004564 110 GTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-HAAHC 186 (745)
Q Consensus 110 GsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~-~~~~~ 186 (745)
++|.+++.+.+ .+++..+..++.||+.||.|||+++ ++||||+|+||+++ +++.+||+|||++...... .....
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGR 154 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEccCcchhhhccCCccccc
Confidence 99999988766 7999999999999999999999988 99999999999998 5689999999998765432 22334
Q ss_pred cCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCC---HHHHHHHHHcCCCCCCcccCCCHHHHHHHHHH
Q 004564 187 VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTH---PAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKC 262 (745)
Q Consensus 187 vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~---~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kc 262 (745)
.++..|+|||.+. +.++.++||||||+++|+|++|+.||..... ..++.+.+.. .+.......++.++++|.+|
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHH
Confidence 6889999999986 4588899999999999999999999966432 2333332222 23334456789999999999
Q ss_pred hh-CccCCC-----CHHHHhcCCCCCc
Q 004564 263 LA-TVSLRL-----SARELLNDPFLQI 283 (745)
Q Consensus 263 L~-dPskRp-----Sa~ELL~hPff~~ 283 (745)
|+ +|.+|| ++.+|+.||||..
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhc
Confidence 99 999999 9999999999963
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=331.02 Aligned_cols=247 Identities=32% Similarity=0.545 Sum_probs=206.6
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEecc
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMF 107 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~ 107 (745)
..||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.++||||+++++.+.. ....|+||||+
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv~e~~ 101 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVVMEFL 101 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEEEeCC
Confidence 6699999999999999999999999987632 24556778999999999999999999998865 57899999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC--CCc
Q 004564 108 TSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AAH 185 (745)
Q Consensus 108 ~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~--~~~ 185 (745)
.+++|..++. .+.+++..+..++.||+.||.|||+++ |+||||||+||+++ +++.+||+|||++....... ...
T Consensus 102 ~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 102 EGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred CCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEccCcchhhcccccccCce
Confidence 9999999864 456899999999999999999999988 99999999999997 55899999999987653322 223
Q ss_pred ccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-CcccCCCHHHHHHHHHHh
Q 004564 186 CVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPD-SLYRVKDPEVRRFVEKCL 263 (745)
Q Consensus 186 ~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~-~l~~~~s~el~d~I~kcL 263 (745)
..|++.|+|||++. ..++.++||||||+++|||++|+.||... .....+..+.....+. ......+..+++|+.+||
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 256 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE-PPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLML 256 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCccccccccCHHHHHHHHHHc
Confidence 46899999999986 46889999999999999999999999763 4444444444332221 122346788999999999
Q ss_pred h-CccCCCCHHHHhcCCCCCccc
Q 004564 264 A-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 264 ~-dPskRpSa~ELL~hPff~~~~ 285 (745)
. +|.+|||++++|+||||+...
T Consensus 257 ~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 257 VREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred cCChhHCcCHHHHhhChhhhccC
Confidence 9 999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=325.78 Aligned_cols=256 Identities=29% Similarity=0.505 Sum_probs=214.0
Q ss_pred CCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCC
Q 004564 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 18 dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~ 97 (745)
|+.+.| ...+.||.|+||.||+|.+..++..||+|+++... .....+.+.+|+.+++.+.||||+++++++.+ .
T Consensus 1 ~~~~~y-~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 74 (277)
T cd06640 1 DPEELF-TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--G 74 (277)
T ss_pred ChHHhh-hhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--C
Confidence 355667 45577999999999999999999999999887443 24567789999999999999999999999876 6
Q ss_pred CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 98 RNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
..+|+||||+.+++|.+++.. .++++..+..++.|++.||.|||+.+ ++|+||+|+||+++ ..+.++|+|||++..
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~ 150 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLS-EQGDVKLADFGVAGQ 150 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEc-CCCCEEEccccccee
Confidence 789999999999999998764 56899999999999999999999988 99999999999998 568999999999966
Q ss_pred hhccC--CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHH
Q 004564 178 LRKSH--AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254 (745)
Q Consensus 178 l~~~~--~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~e 254 (745)
..... .....++..|+|||++. ..++.++|+|||||++|+|+||..||.... +......+..+. +..+....+..
T Consensus 151 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~ 228 (277)
T cd06640 151 LTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH-PMRVLFLIPKNN-PPTLTGEFSKP 228 (277)
T ss_pred ccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC-hHhHhhhhhcCC-CCCCchhhhHH
Confidence 54322 22345889999999886 458899999999999999999999998744 444444343333 33444556788
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 255 VRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 255 l~d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
+.++|.+||. +|.+||++.++++||||....
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 229 FKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred HHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 9999999999 999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=350.21 Aligned_cols=241 Identities=25% Similarity=0.356 Sum_probs=203.3
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCe-EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGI-EVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~-~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
+..++.+.||+|-||.||.|... +. .||+|.++... ...+.|.+|+.+|++|+|+|||++|+.+.. .+.+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~--~~~~vavk~ik~~~-----m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~--~~pi 276 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN--GSTKVAVKTIKEGS-----MSPEAFLREAQIMKKLRHEKLVKLYGVCTK--QEPI 276 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc--CCCcccceEEeccc-----cChhHHHHHHHHHHhCcccCeEEEEEEEec--CCce
Confidence 34466678999999999999654 44 79999988432 223567799999999999999999997643 5689
Q ss_pred EEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 101 NFVTEMFTSGTLRQYRLK--HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k--~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
|||||||..|+|.+|++. +..++...+..|+.||+.|++||++++ +|||||...||||+ +++.|||+|||+|+..
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~-~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVD-EDLVVKISDFGLARLI 353 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeec-cCceEEEccccccccc
Confidence 999999999999999997 467999999999999999999999999 99999999999997 6679999999999954
Q ss_pred hccCCCccc---CCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCH
Q 004564 179 RKSHAAHCV---GTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDP 253 (745)
Q Consensus 179 ~~~~~~~~v---GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~ 253 (745)
......... -...|.|||.+. +.++.++|||||||+|+||+| |+.||.+ .+..++.+.+.+|.+.+. +..+++
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-msn~ev~~~le~GyRlp~-P~~CP~ 431 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-MSNEEVLELLERGYRLPR-PEGCPD 431 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC-CCHHHHHHHHhccCcCCC-CCCCCH
Confidence 443332222 245799999997 789999999999999999999 8999988 556777788888876432 446899
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHh
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELL 276 (745)
Q Consensus 254 el~d~I~kcL~-dPskRpSa~ELL 276 (745)
++.+++..||. +|.+|||++.|.
T Consensus 432 ~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 432 EVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHHHHhhCCcccCCCHHHHH
Confidence 99999999999 999999998664
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=310.34 Aligned_cols=246 Identities=35% Similarity=0.583 Sum_probs=208.4
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.+.||+|++|.||+|.+..++..|++|++.... ......+.+|+.+++.++||||+++++.+.. ....++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~~ 76 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES----KEKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIVM 76 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEE
Confidence 67788999999999999999999999999887443 2466789999999999999999999998866 57899999
Q ss_pred eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC-
Q 004564 105 EMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~- 182 (745)
||+.+++|.+++... ..+++..+..++.||+.||.|||.++ ++||||+|+||+++ +++.++|+|||++.......
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEc-cCCeEEEeecccccccccccc
Confidence 999999999998876 68999999999999999999999988 99999999999998 56899999999997765543
Q ss_pred CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCccc-CCCHHHHHHHH
Q 004564 183 AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYR-VKDPEVRRFVE 260 (745)
Q Consensus 183 ~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~-~~s~el~d~I~ 260 (745)
.....++..|+|||.+. ..++.++|+||||+++|+|++|..||........+..... ...+..... ..+..+.++|.
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~ 232 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLK 232 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHH
Confidence 33456899999999887 4578899999999999999999999987544444433332 222222222 23788999999
Q ss_pred HHhh-CccCCCCHHHHhcCCC
Q 004564 261 KCLA-TVSLRLSARELLNDPF 280 (745)
Q Consensus 261 kcL~-dPskRpSa~ELL~hPf 280 (745)
+||+ +|++|||+.++|+|||
T Consensus 233 ~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHccCChhhCCCHHHHhcCCC
Confidence 9999 9999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.18 Aligned_cols=249 Identities=24% Similarity=0.405 Sum_probs=201.8
Q ss_pred EeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceEeEEEEecCCCeEEEEE
Q 004564 26 YNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 26 l~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
..+.||+|+||.||++.+..++..||+|.+..... ......+.+|+.++.++. ||||+++++.+.. ....+++|
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~~ 82 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWICM 82 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEEE
Confidence 34679999999999999999999999998874432 245667889999999996 9999999998765 56788999
Q ss_pred eccCCCCHHHHH---H--HcCCCCHHHHHHHHHHHHHHHHHhhhC-CCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 105 EMFTSGTLRQYR---L--KHKRVNIRAVKLWCRQILRGLLYLHSH-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 105 E~~~gGsL~~~l---~--k~~~L~e~~i~~ia~QIL~gL~yLHs~-gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
||+.. ++.++. . ....+++..+..++.|++.||+|||+. + |+||||||+|||++ ..+.+||+|||++..+
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLD-RNGNIKLCDFGISGQL 158 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEc-cCCcEEEeecchhHHh
Confidence 99864 554432 2 246799999999999999999999974 6 99999999999997 5689999999999776
Q ss_pred hccCC-CcccCCCCcCChhhhhh----ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcc---cC
Q 004564 179 RKSHA-AHCVGTPEFMAPEVYEE----AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLY---RV 250 (745)
Q Consensus 179 ~~~~~-~~~vGTp~YmAPEvl~~----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~---~~ 250 (745)
..... ....|++.|+|||++.+ .++.++|||||||++|+|++|+.||.......+....+..+..|.... ..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 54332 33468999999999863 488999999999999999999999987554333334444444332222 23
Q ss_pred CCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 251 KDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 251 ~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
.++++.+||.+||+ +|++|||++++++||||+.
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 68899999999999 9999999999999999973
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=316.50 Aligned_cols=250 Identities=29% Similarity=0.498 Sum_probs=211.3
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
++| ++.+.||+|+||.||+|.+..+|..||+|.++.... ......+++.+|+.+++.++|+||+++++.+.. ....
T Consensus 2 ~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~ 77 (267)
T cd08224 2 GNF-KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNEL 77 (267)
T ss_pred Cce-eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeE
Confidence 467 888999999999999999999999999999875442 234557789999999999999999999999876 5788
Q ss_pred EEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 101 NFVTEMFTSGTLRQYRLK----HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k----~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
++||||+.+++|..++.. ...+++..+..|+.||+.||.|||++| |+||||+|+||+++ ..+.++|+|||++.
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~-~~~~~~l~d~~~~~ 154 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFIT-ATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEEC-CCCcEEEeccceee
Confidence 999999999999998764 245899999999999999999999988 99999999999998 56899999999987
Q ss_pred hhhccC--CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCC-CCHHHHHHHHHcCCCCCCcccCCC
Q 004564 177 ILRKSH--AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSEC-THPAQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 177 ~l~~~~--~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~-~~~~~i~kkv~~g~~p~~l~~~~s 252 (745)
...... .....+++.|+|||.+. ..++.++|+|||||++|+|++|+.||... .+...+...+..+..+.......+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcC
Confidence 654322 22346899999999886 45889999999999999999999999543 344556666666666554444678
Q ss_pred HHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
..++++|.+||. +|++|||+.++++
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 899999999999 9999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=325.38 Aligned_cols=254 Identities=28% Similarity=0.393 Sum_probs=205.2
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+| .+.+.||+|++|+||+|.+..+|+.||+|.++.... .......+.+|+.+++.++||||+++++++.+ ...+|
T Consensus 3 ~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 77 (294)
T PLN00009 3 QY-EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRLY 77 (294)
T ss_pred ce-EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeEE
Confidence 56 677889999999999999999999999998865431 22345678889999999999999999999875 67899
Q ss_pred EEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 102 FVTEMFTSGTLRQYRLKHKR--VNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~~--L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
+||||+. ++|.+++..... +++..++.++.||+.||+|||+++ |+||||+|+||+++..++.+||+|||++....
T Consensus 78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 9999995 578887765443 588999999999999999999988 99999999999998666789999999997653
Q ss_pred cc--CCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCCCC---------
Q 004564 180 KS--HAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-GKKPD--------- 245 (745)
Q Consensus 180 ~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~-g~~p~--------- 245 (745)
.. ......+++.|+|||.+.+ .++.++|||||||++|+|+||..||........+.+.+.. +..+.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 32 2233467899999998864 4788999999999999999999999875544444433211 11000
Q ss_pred ----------------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 246 ----------------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 246 ----------------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
......++.+.++|.+||+ +|.+||++.++|+||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 0112357889999999999 9999999999999999974
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.74 Aligned_cols=253 Identities=26% Similarity=0.299 Sum_probs=204.6
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
.| .+.+.||.|+||.||+|.+..++..||+|.++..... ......+.+|+.+++.++||||+++++++.......+|
T Consensus 6 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 6 EY-EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hh-hhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 34 6668899999999999999999999999999755422 23344677899999999999999999998875558999
Q ss_pred EEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 102 FVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~-~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
+||||+. ++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++ +.|.+||+|||++.....
T Consensus 83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCcEEEeecCceeeccC
Confidence 9999997 48988887654 5899999999999999999999988 99999999999998 568999999999876654
Q ss_pred c--CCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-------------
Q 004564 181 S--HAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK------------- 243 (745)
Q Consensus 181 ~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~------------- 243 (745)
. ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||........+.+.+..-..
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 3 2223458899999998864 3688999999999999999999999875443333221110000
Q ss_pred ---------------CCCcccC-CCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 244 ---------------PDSLYRV-KDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 244 ---------------p~~l~~~-~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
...+... .++.++++|.+||+ +|++|||++|+|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0011111 47889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.02 Aligned_cols=257 Identities=29% Similarity=0.422 Sum_probs=206.5
Q ss_pred CCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC-
Q 004564 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA- 96 (745)
Q Consensus 18 dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~- 96 (745)
+..+|| ++.+.||.|+||.||+|.+..+|..||+|.+.... ....+.+.+|+.+|+.++||||+++++.+....
T Consensus 2 ~~~~~y-~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~----~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 2 DLGSRY-MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD----PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred CcCcce-EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC----CchHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 567888 77799999999999999999999999999987544 245567888999999999999999998765432
Q ss_pred -----------CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCC
Q 004564 97 -----------NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQG 165 (745)
Q Consensus 97 -----------~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g 165 (745)
...+|+||||+. ++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+||+++..++
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~ 152 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCc
Confidence 135799999997 58988865 457999999999999999999999998 999999999999986667
Q ss_pred cEEEcCcchhhhhhccC-----CCcccCCCCcCChhhhh--hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 004564 166 EVKIGDLGLAAILRKSH-----AAHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKV 238 (745)
Q Consensus 166 ~VKL~DFGlA~~l~~~~-----~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv 238 (745)
.+||+|||++..+.... .....++..|+|||++. ..++.++|||||||++|+|++|+.||............+
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 89999999987653221 12235788999999875 358889999999999999999999997654333322211
Q ss_pred HcC-----------------------CCC----CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 239 VSG-----------------------KKP----DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 239 ~~g-----------------------~~p----~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
... ..+ ..+....+.++++||.+||+ +|.+|||+.++|.||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 110 000 01122467889999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=323.15 Aligned_cols=257 Identities=37% Similarity=0.577 Sum_probs=214.9
Q ss_pred eCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC
Q 004564 17 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA 96 (745)
Q Consensus 17 ~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~ 96 (745)
.++...| .+.+.||.|++|.||+|.+..++..||+|+++.... ..+.+.+|+.+++.++|+||+++++.+..
T Consensus 15 ~~~~~~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 86 (286)
T cd06614 15 GDPRELY-KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLV-- 86 (286)
T ss_pred CCccccc-hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--
Confidence 3555566 677889999999999999999999999999874431 56678899999999999999999999877
Q ss_pred CCeEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 97 NRNINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 97 ~~~iyLV~E~~~gGsL~~~l~k~~-~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
...+|+|+||+.+++|.+++..+. .++...+..++.||+.||.|||++| |+|+||+|+||+++ .++.++|+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~-~~~~~~l~d~~~~ 163 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLADFGFA 163 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEc-CCCCEEECccchh
Confidence 578999999999999999998877 8999999999999999999999988 99999999999998 5689999999998
Q ss_pred hhhhccC--CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCcccCC
Q 004564 176 AILRKSH--AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP-DSLYRVK 251 (745)
Q Consensus 176 ~~l~~~~--~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p-~~l~~~~ 251 (745)
....... .....+++.|+|||.+. ..++.++|+||||+++|+|+||..||..... ......+.....+ .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T cd06614 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-LRALFLITTKGIPPLKNPEKW 242 (286)
T ss_pred hhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCcchhhC
Confidence 7654321 22335889999999886 4588999999999999999999999986443 3333333333322 2222336
Q ss_pred CHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 252 DPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 252 s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
+..+++||.+||+ +|.+||++.++|.||||....
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 7899999999999 999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.58 Aligned_cols=251 Identities=28% Similarity=0.416 Sum_probs=200.0
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
.+| .+.+.||.|++|+||+|.+..++..||+|.+...... .....+.+|+.+++.++||||+++++++.+ +..+
T Consensus 5 ~~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~ 78 (291)
T cd07844 5 ETY-KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFTAIREASLLKDLKHANIVTLHDIIHT--KKTL 78 (291)
T ss_pred cce-eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchhHHHHHHHHhhCCCcceeeEEEEEec--CCeE
Confidence 456 7779999999999999999999999999998754311 122346689999999999999999998765 6789
Q ss_pred EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 101 NFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
++||||+.+ +|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++....
T Consensus 79 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKS 154 (291)
T ss_pred EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEc-CCCCEEECccccccccC
Confidence 999999974 899988764 46899999999999999999999988 99999999999998 56899999999986543
Q ss_pred cc--CCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CCC----------
Q 004564 180 KS--HAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS--GKK---------- 243 (745)
Q Consensus 180 ~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~--g~~---------- 243 (745)
.. ......+++.|+|||++.+ .++.++||||||+++|+|++|+.||.......+..+.+.. +..
T Consensus 155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 21 1222357899999998863 4789999999999999999999999765433333222211 000
Q ss_pred -------------CC---CcccCCC--HHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 244 -------------PD---SLYRVKD--PEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 244 -------------p~---~l~~~~s--~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
+. ......+ ..+.++|.+||+ +|.+|||+.++|.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 0001223 788999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=364.89 Aligned_cols=249 Identities=23% Similarity=0.373 Sum_probs=209.3
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceEeEE-EEec---C
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTS-WVDT---A 96 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-HpNIVk~~~s-fvd~---~ 96 (745)
--.++.+.|.+|||+.||+|.+...|..||+|.+-.. ++..++.+.+||.+||.|+ |||||.|+++ .... .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 3448889999999999999999999899999987643 5889999999999999997 9999999994 3221 1
Q ss_pred -CCeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcc
Q 004564 97 -NRNINFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 173 (745)
Q Consensus 97 -~~~iyLV~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFG 173 (745)
...+.|+||||.||.|-+++..+ .+|++.+|.+|++|+++|+.+||...|||||||||-+||||+ .+|..||||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls-~~g~~KLCDFG 191 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS-ADGNYKLCDFG 191 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc-CCCCEEeCccc
Confidence 24688999999999999998853 569999999999999999999999999999999999999997 56899999999
Q ss_pred hhhhhhccC-C----------CcccCCCCcCChhhhh----hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 004564 174 LAAILRKSH-A----------AHCVGTPEFMAPEVYE----EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKV 238 (745)
Q Consensus 174 lA~~l~~~~-~----------~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv 238 (745)
.|+...... . ....-|+.|+|||+++ ...++|+|||+|||+||-|+.+..||.+....+ |
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-----I 266 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-----I 266 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-----E
Confidence 996532211 1 1124699999999886 358999999999999999999999998854332 5
Q ss_pred HcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCC
Q 004564 239 VSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPF 280 (745)
Q Consensus 239 ~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPf 280 (745)
..|.+..+....++..+++||..||+ +|.+||++-|++.+-|
T Consensus 267 lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 267 LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 56665544456788999999999999 9999999999996533
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=344.42 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=201.5
Q ss_pred CceeeEeEEecccCceEEEEEEEcCC-----CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEe
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYE-----GIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVD 94 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~t-----g~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd 94 (745)
.+| .+.+.||+|+||.||+|.+... +..||+|.++... .....+.+.+|+.+|+.+ +||||+++++++..
T Consensus 38 ~~~-~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 38 DNL-QFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred HHc-eehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 345 7889999999999999986443 3579999886432 234567789999999999 89999999998865
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHHc-------------------------------------------------------
Q 004564 95 TANRNINFVTEMFTSGTLRQYRLKH------------------------------------------------------- 119 (745)
Q Consensus 95 ~~~~~iyLV~E~~~gGsL~~~l~k~------------------------------------------------------- 119 (745)
...+++||||+.+|+|.+++.+.
T Consensus 114 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 114 --GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred --CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 56899999999999999987643
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCCC
Q 004564 120 ---------------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 184 (745)
Q Consensus 120 ---------------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~~ 184 (745)
.++++..+..|+.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~-~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEe-CCCeEEEeeceeeeeccCCcce
Confidence 24788899999999999999999988 99999999999998 5689999999999765432221
Q ss_pred ----cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHH
Q 004564 185 ----HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRF 258 (745)
Q Consensus 185 ----~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~ 258 (745)
...+++.|||||++. ..++.++|||||||++|+|++ |..||........+++.+..+..+ ......+++++++
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 347 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-SRPDFAPPEIYSI 347 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc-cCCCCCCHHHHHH
Confidence 223567899999886 579999999999999999997 999998755444455555444332 3344568999999
Q ss_pred HHHHhh-CccCCCCHHHHhc
Q 004564 259 VEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 259 I~kcL~-dPskRpSa~ELL~ 277 (745)
|.+||+ +|.+|||+.++++
T Consensus 348 i~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=314.87 Aligned_cols=241 Identities=24% Similarity=0.354 Sum_probs=207.3
Q ss_pred EEecccCceEEEEEEEcCC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 28 EILGKGASKTVYRAFDEYE---GIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~t---g~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++||+|+||.||+|.+... +..||+|+++... .....+.+.+|+.+++.++|+||+++++++.. ...+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA---SEEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeecccc---chhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEE
Confidence 4699999999999999866 9999999887443 12257789999999999999999999998765 67899999
Q ss_pred eccCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 105 EMFTSGTLRQYRLKH---------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 105 E~~~gGsL~~~l~k~---------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
||+.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~-~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVG-EDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEEC-CCCcEEEcccccc
Confidence 999999999998886 77999999999999999999999988 99999999999998 5589999999999
Q ss_pred hhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCccc
Q 004564 176 AILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYR 249 (745)
Q Consensus 176 ~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~ 249 (745)
....... .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ...++...+..+..+. ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~ 230 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRLP-KPE 230 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCCC-CCc
Confidence 8765432 33345889999999887 468999999999999999999 69999874 6677777777655432 344
Q ss_pred CCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 250 VKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 250 ~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
..++++.+++.+||+ +|.+|||+.+++++
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 231 YCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 568999999999999 99999999999865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=376.64 Aligned_cols=254 Identities=23% Similarity=0.378 Sum_probs=221.9
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.++||+|+||.|.++..+.+++.||+|++++-..+. .....-|..|-++|..-+.+.|+.++-.|.| +.++|+||
T Consensus 78 eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD--~~~LYlVM 154 (1317)
T KOG0612|consen 78 EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-RAETACFREERDIMVFGNSEWIVQLHYAFQD--ERYLYLVM 154 (1317)
T ss_pred HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-chhHHHHHHHhHHHHcCCcHHHHHHHHHhcC--ccceEEEE
Confidence 56789999999999999999999999999987543222 2345568889999999999999999999977 78999999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc---
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--- 181 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~--- 181 (745)
||+.||+|..++.+..+++++.++.|+..|+.||..||+.| +|||||||+|||++ ..|+|||+|||.+..+...
T Consensus 155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld-~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLD-KSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEec-ccCcEeeccchhHHhcCCCCcE
Confidence 99999999999999999999999999999999999999988 99999999999998 6799999999999887633
Q ss_pred CCCcccCCCCcCChhhhh------hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcc--cCCCH
Q 004564 182 HAAHCVGTPEFMAPEVYE------EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLY--RVKDP 253 (745)
Q Consensus 182 ~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~--~~~s~ 253 (745)
.....+|||.|.+||++. +.|+..+|+||+|||+|||+.|..||.. ....+.|.+|.+-+....++ ...|+
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~~VSe 310 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDETDVSE 310 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcccccCH
Confidence 233458999999999984 4599999999999999999999999987 67788888887643222222 34899
Q ss_pred HHHHHHHHHhhCccCCCC---HHHHhcCCCCCccc
Q 004564 254 EVRRFVEKCLATVSLRLS---ARELLNDPFLQIDD 285 (745)
Q Consensus 254 el~d~I~kcL~dPskRpS---a~ELL~hPff~~~~ 285 (745)
++++||.++|.+|..|+. ++++.+||||...+
T Consensus 311 eakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 311 EAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred HHHHHHHHHhcChhhhcccccHHHHHhCccccCCC
Confidence 999999999999999998 99999999998655
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=323.83 Aligned_cols=258 Identities=24% Similarity=0.335 Sum_probs=202.2
Q ss_pred EeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEec
Q 004564 16 EVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT 95 (745)
Q Consensus 16 e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~ 95 (745)
-.+.-++| .+.+.||+|+||.||+|.+..++..||+|.+..... .......+.+|+.+++.++||||+++++.+...
T Consensus 7 ~~~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 7 FCDEVSKY-EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred ccchhhhe-EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 35566778 677889999999999999999999999998865432 122334567899999999999999999987653
Q ss_pred C------CCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEE
Q 004564 96 A------NRNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVK 168 (745)
Q Consensus 96 ~------~~~iyLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VK 168 (745)
. ...+++||||+. ++|..++.+. ..+++..++.++.||+.||.|||+++ ++|+||||+||+++ ..+.+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~k 159 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGILK 159 (310)
T ss_pred cccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEC-CCCcEE
Confidence 2 246799999996 4787776654 37899999999999999999999998 99999999999997 568999
Q ss_pred EcCcchhhhhhccCC------CcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 004564 169 IGDLGLAAILRKSHA------AHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS 240 (745)
Q Consensus 169 L~DFGlA~~l~~~~~------~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~ 240 (745)
|+|||++........ ....++..|+|||++.+ .++.++||||||+++|+|+||..||..... ......+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-~~~~~~~~~ 238 (310)
T cd07865 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-QHQLTLISQ 238 (310)
T ss_pred ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH
Confidence 999999976543221 23457889999998864 378899999999999999999999976432 222111111
Q ss_pred --CCCCCC----------------------------cccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 241 --GKKPDS----------------------------LYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 241 --g~~p~~----------------------------l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
|..|.. .....++.+++||.+||. +|.+|||++++|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 111110 011246778899999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=320.90 Aligned_cols=248 Identities=29% Similarity=0.435 Sum_probs=201.8
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.+.||.|++|+||+|.+..+|..||+|.++.... ....+.+.+|+.+++.++||||+++++++.+ ....++||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVF 77 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEE
Confidence 677899999999999999999999999999875432 2234567789999999999999999999876 56889999
Q ss_pred eccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 105 EMFTSGTLRQYRLKH---KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 105 E~~~gGsL~~~l~k~---~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
||+.+ +|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++ +++.+||+|||++......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLIN-KRGELKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCcEEEeecchhhhhcCC
Confidence 99975 888887654 35899999999999999999999988 99999999999998 5689999999999765432
Q ss_pred C--CCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Q 004564 182 H--AAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP------------- 244 (745)
Q Consensus 182 ~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p------------- 244 (745)
. .....+++.|+|||++.+ .++.++||||||+++|+|++|..||.+........+.+.....|
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 2 223457899999998854 47889999999999999999999998755443332222111000
Q ss_pred ------C-------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 245 ------D-------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 245 ------~-------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
. .+....++.++++|.+||+ +|.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 0112347789999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.14 Aligned_cols=250 Identities=33% Similarity=0.517 Sum_probs=207.6
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC---CCCcceEeEEEEecCCCeEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK---HKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~---HpNIVk~~~sfvd~~~~~iy 101 (745)
.+.+.||.|+||.||+|.+..++..||+|.++... .....+.+.+|+.+++.++ ||||+++++++.+ +..++
T Consensus 4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~ 78 (277)
T cd06917 4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLW 78 (277)
T ss_pred hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEE
Confidence 56678999999999999999999999999886432 3455677889999999996 9999999998876 67899
Q ss_pred EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
+||||+.+++|.+++.. ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+++ ..+.++|+|||++..+...
T Consensus 79 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 79 IIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVT-NTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEc-CCCCEEEccCCceeecCCC
Confidence 99999999999999765 47999999999999999999999988 99999999999998 5689999999999766443
Q ss_pred C--CCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHH
Q 004564 182 H--AAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257 (745)
Q Consensus 182 ~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d 257 (745)
. .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||..... ......+.....|.......++++.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-FRAMMLIPKSKPPRLEDNGYSKLLRE 233 (277)
T ss_pred ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-hhhhhccccCCCCCCCcccCCHHHHH
Confidence 2 233468999999998863 468899999999999999999999977433 33322232232232222237789999
Q ss_pred HHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 258 FVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 258 ~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
|+.+||. +|.+||++.++++||||+..
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 9999999 99999999999999999743
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.42 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=198.5
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceEeEEEEecCCCeEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-HpNIVk~~~sfvd~~~~~iyLV 103 (745)
++.+.||+|+||.||+|.+..++..||+|.++... ..... ....+|+.+++++. ||||+++++++.+.....+++|
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~--~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF--KSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhcc--CCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 67788999999999999999999999999876432 12222 23457888999885 9999999999887544789999
Q ss_pred EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC
Q 004564 104 TEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 182 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~ 182 (745)
|||+. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++. +.+||+|||++.......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD--DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC--CCeEEEecccccccccCC
Confidence 99997 577777765 357899999999999999999999988 999999999999985 899999999997664332
Q ss_pred C-CcccCCCCcCChhhhh--hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CCC--------------
Q 004564 183 A-AHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS--GKK-------------- 243 (745)
Q Consensus 183 ~-~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~--g~~-------------- 243 (745)
. ....+++.|+|||.+. +.++.++|||||||++|+|++|..||..... ...+..+.. +..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-LDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-HHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 2 3346899999999774 3478899999999999999999999976433 222222211 110
Q ss_pred ----CC-------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 244 ----PD-------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 244 ----p~-------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
|. .+....+..++++|.+||. +|.+||+++++|+||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00 0112357899999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=313.89 Aligned_cols=250 Identities=31% Similarity=0.498 Sum_probs=215.3
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+| ++.+.||.|+||.||+|.+..++..+|+|.+..... .......+..|+.+++.++||||+++++.+.+ ....|
T Consensus 1 ~y-~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 75 (256)
T cd08530 1 DF-KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLC 75 (256)
T ss_pred Cc-eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEE
Confidence 35 677899999999999999999999999998875432 24556778899999999999999999998876 57899
Q ss_pred EEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 102 FVTEMFTSGTLRQYRLK----HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k----~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
+|+||+.+++|..++.+ ...+++..+..++.||+.||.|||++| ++|+||+|+||+++ .++.+||+|||++..
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~-~~~~~kl~d~g~~~~ 152 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLV-ANDLVKIGDLGISKV 152 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEe-cCCcEEEeeccchhh
Confidence 99999999999998776 356899999999999999999999998 99999999999998 468999999999987
Q ss_pred hhccCCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHH
Q 004564 178 LRKSHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVR 256 (745)
Q Consensus 178 l~~~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~ 256 (745)
..........+++.|+|||.+. ..++.++|+||||+++|+|++|..||... +...+...+..+..+. .....+.+++
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd08530 153 LKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDLRYKVQRGKYPP-IPPIYSQDLQ 230 (256)
T ss_pred hccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCC-CchhhCHHHH
Confidence 7665444456899999999886 45888999999999999999999999874 5556666666665553 3346788999
Q ss_pred HHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 257 RFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 257 d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
+++.+||. +|.+||++.++|+||++
T Consensus 231 ~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 231 NFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 99999998 99999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=335.67 Aligned_cols=253 Identities=30% Similarity=0.432 Sum_probs=202.6
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC---
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA--- 96 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~--- 96 (745)
..+| ++.+.||+|+||+||+|.+..+|..||+|.+.... .......++.+|+.+++.++||||++++++|....
T Consensus 15 ~~~y-~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 15 LKRY-QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF--QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hcce-EEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc--cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 4667 67789999999999999999999999999875332 23455667889999999999999999999876422
Q ss_pred -CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 97 -NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 97 -~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
...+|+||||+. ++|.+++... +++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~ 165 (353)
T cd07850 92 EFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA 165 (353)
T ss_pred ccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCccc
Confidence 245799999996 5888877654 899999999999999999999998 99999999999998 5589999999999
Q ss_pred hhhhccCC-CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CCC--------
Q 004564 176 AILRKSHA-AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS--GKK-------- 243 (745)
Q Consensus 176 ~~l~~~~~-~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~--g~~-------- 243 (745)
........ ....+|+.|+|||++. ..++.++|||||||++|+|++|+.||....... .+.++.. +..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHh
Confidence 76544322 2346899999999886 468999999999999999999999997643322 2222211 000
Q ss_pred -----------C------------CCc--------ccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 244 -----------P------------DSL--------YRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 244 -----------p------------~~l--------~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
+ ... ....++.++++|.+||+ +|++|||+.|+|.||||+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 0 000 11345678999999999 999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=311.28 Aligned_cols=248 Identities=35% Similarity=0.580 Sum_probs=212.9
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.+.||+|++|.||+|.+..++..||+|.+..... .....+.+.+|+.+++.++||||+++++++.+ ...++++|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIIL 78 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEE
Confidence 677899999999999999999999999999875542 24567889999999999999999999998765 57899999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCC-
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA- 183 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~- 183 (745)
||+.+++|.+++.+...+++..+..++.|++.||.|||++| |+||||+|+||+++ .++.+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTT-KDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEC-CCCCEEEeccccceecCCCccc
Confidence 99999999999998889999999999999999999999988 99999999999998 468999999999977654332
Q ss_pred -CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHH
Q 004564 184 -AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEK 261 (745)
Q Consensus 184 -~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~k 261 (745)
....+++.|+|||.+. ..++.++||||||+++|+|++|..||..........+ +.....+ .+....+..++++|.+
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR-IVQDDHP-PLPEGISPELKDFLMQ 233 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HhccCCC-CCCCCCCHHHHHHHHH
Confidence 3346899999999886 3478899999999999999999999987554333333 3333333 3455678899999999
Q ss_pred Hhh-CccCCCCHHHHhcCCCC
Q 004564 262 CLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 262 cL~-dPskRpSa~ELL~hPff 281 (745)
||. +|++|||+.+++.||||
T Consensus 234 ~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 234 CFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHhCChhhCcCHHHHhcCCCC
Confidence 999 99999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=385.78 Aligned_cols=252 Identities=29% Similarity=0.484 Sum_probs=225.0
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
...-.||.|.||.||-|.+..+|+..|+|.+++.+.. ......+.+|..+|..|+|||+|++|+.=+ +.+.+||.|
T Consensus 1238 qrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv--HRekv~IFM 1313 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEV--HREKVYIFM 1313 (1509)
T ss_pred ccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceee--cHHHHHHHH
Confidence 4456699999999999999999999999999987643 566777899999999999999999999544 478899999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC--
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-- 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~-- 182 (745)
|||.+|+|.+.+...+-.++...+.|..|++.||.|||++| ||||||||.|||++ ..|.+|++|||.|..+.+..
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld-~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLD-FNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeee-cCCcEEeecccceeEecCchhc
Confidence 99999999999888888899999999999999999999999 99999999999998 55899999999997765442
Q ss_pred ----CCcccCCCCcCChhhhhh----ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHH
Q 004564 183 ----AAHCVGTPEFMAPEVYEE----AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254 (745)
Q Consensus 183 ----~~~~vGTp~YmAPEvl~~----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~e 254 (745)
.....|||.|||||++.+ ....++|||||||+++||+||+.||.+..+.-+|+-+|-.|..|....+ .+++
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~-ls~~ 1469 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER-LSSE 1469 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh-hhHh
Confidence 223579999999999964 3567899999999999999999999999999999999999999876555 8999
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 255 VRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 255 l~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
.++||+.||. ||++|+++.|||.|.|-+..
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 9999999999 99999999999999998743
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=328.26 Aligned_cols=250 Identities=32% Similarity=0.532 Sum_probs=207.7
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. +..+|+|+
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv~ 97 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVLM 97 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc----cchHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEEE
Confidence 34457999999999999999999999999986433 2334668899999999999999999998876 67899999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC--
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-- 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~-- 182 (745)
||+.+++|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.......
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPK 173 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEc-cCCcEEEeechhHhhccccccc
Confidence 99999999987644 56899999999999999999999998 99999999999997 66899999999987654322
Q ss_pred CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCcccCCCHHHHHHHH
Q 004564 183 AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP-DSLYRVKDPEVRRFVE 260 (745)
Q Consensus 183 ~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p-~~l~~~~s~el~d~I~ 260 (745)
.....|++.|+|||++. ..++.++|||||||++|+|++|+.||... ...+....+.....+ .......++.+.++|.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 252 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE 252 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhccCCCCccccCCCCHHHHHHHH
Confidence 23356999999999986 46889999999999999999999999763 344444444433222 1223346788999999
Q ss_pred HHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 261 KCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 261 kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
+||+ +|.+||++.++++||||....
T Consensus 253 ~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 253 RMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHhcCCcccCcCHHHHhhChhhccCC
Confidence 9999 999999999999999997544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=321.05 Aligned_cols=246 Identities=24% Similarity=0.349 Sum_probs=205.0
Q ss_pred CceeeEeEEecccCceEEEEEEEc-----CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEec
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDE-----YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT 95 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~-----~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~ 95 (745)
++| .+.+.||+|+||.||+|.+. .++..||+|.++... ..+..+.+.+|+.+|+.++||||+++++++..
T Consensus 5 ~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 79 (280)
T cd05049 5 DTI-VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTE- 79 (280)
T ss_pred HHh-hHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEec-
Confidence 345 66788999999999999764 346889999876432 23456789999999999999999999998876
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeec
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKHK--------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVN 161 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~~--------------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld 161 (745)
....++||||+.+++|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++
T Consensus 80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~ 156 (280)
T cd05049 80 -GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVG 156 (280)
T ss_pred -CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEc
Confidence 578999999999999999987653 4788999999999999999999998 99999999999998
Q ss_pred CCCCcEEEcCcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHH
Q 004564 162 GNQGEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIY 235 (745)
Q Consensus 162 ~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~ 235 (745)
.++.+||+|||++....... .....+++.|+|||++. +.++.++|||||||++|+|++ |..||... +...+.
T Consensus 157 -~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~-~~~~~~ 234 (280)
T cd05049 157 -YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVI 234 (280)
T ss_pred -CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHH
Confidence 55899999999987543221 22334678999999887 568999999999999999999 99999874 456666
Q ss_pred HHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 236 KKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 236 kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
..+..+..+. .....+..+++++.+||+ +|.+||++.|+++
T Consensus 235 ~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 235 ECITQGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 7777666543 334678899999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=326.91 Aligned_cols=252 Identities=30% Similarity=0.506 Sum_probs=209.1
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~ 98 (745)
+...| +..+.||+|+||.||+|.+..++..||+|.++... .....+.+.+|+.+++.++||||+++++.+.. +.
T Consensus 2 ~~~~y-~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 75 (277)
T cd06642 2 PEELF-TKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GT 75 (277)
T ss_pred hHHHH-HHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhccccc--CC
Confidence 34445 45577999999999999999999999999876432 23456789999999999999999999998865 67
Q ss_pred eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 99 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
.+|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++ +++.+||+|||++..+
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~ 151 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLS-EQGDVKLADFGVAGQL 151 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEe-CCCCEEEccccccccc
Confidence 89999999999999998754 56899999999999999999999988 99999999999997 5689999999998765
Q ss_pred hccC--CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHH
Q 004564 179 RKSH--AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEV 255 (745)
Q Consensus 179 ~~~~--~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el 255 (745)
.... .....|+..|+|||.+. ..++.++|+|||||++|+|+||..||.... +......+..+..+ .+....+..+
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~ 229 (277)
T cd06642 152 TDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH-PMRVLFLIPKNSPP-TLEGQYSKPF 229 (277)
T ss_pred cCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc-hhhHHhhhhcCCCC-CCCcccCHHH
Confidence 4322 12345889999999987 458889999999999999999999997633 33333333333333 3444567889
Q ss_pred HHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 256 RRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 256 ~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
.++|.+||+ +|.+||++.++++||||.
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06642 230 KEFVEACLNKDPRFRPTAKELLKHKFIT 257 (277)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence 999999999 999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=325.41 Aligned_cols=255 Identities=29% Similarity=0.415 Sum_probs=199.8
Q ss_pred ceeeEeEEecccCceEEEEEEEcC--CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEY--EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~--tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
+| ++.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+.+|+.+++.++||||+++++.+.+.....
T Consensus 1 ~y-~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KY-EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS 78 (316)
T ss_pred Cc-eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence 45 677889999999999999988 899999999875321 22334466788999999999999999999998755578
Q ss_pred EEEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecC---CCCcEEEcC
Q 004564 100 INFVTEMFTSGTLRQYRLKH-----KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG---NQGEVKIGD 171 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~-----~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~---~~g~VKL~D 171 (745)
+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ..+.+||+|
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECC
Confidence 9999999965 676665432 26899999999999999999999988 999999999999974 168999999
Q ss_pred cchhhhhhccC-----CCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHH--------HHHH
Q 004564 172 LGLAAILRKSH-----AAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPA--------QIYK 236 (745)
Q Consensus 172 FGlA~~l~~~~-----~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~--------~i~k 236 (745)
||++....... .....+|+.|+|||++.+ .++.++|||||||++|+|++|+.||....... ....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 99997654322 123458899999998864 47899999999999999999999996532211 0000
Q ss_pred HHHc------------------------CCCCCCc-----------ccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCC
Q 004564 237 KVVS------------------------GKKPDSL-----------YRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPF 280 (745)
Q Consensus 237 kv~~------------------------g~~p~~l-----------~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPf 280 (745)
.+.. ....... ....++.+.++|.+||+ +|++|||+.++++|||
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 0000 0000000 01456789999999999 9999999999999999
Q ss_pred C
Q 004564 281 L 281 (745)
Q Consensus 281 f 281 (745)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=336.06 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=204.4
Q ss_pred CCCceeeEeEEecccCceEEEEEEEc-----CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEE
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDE-----YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSW 92 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~-----~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sf 92 (745)
|..|| ++.++||+|+||.||+|.+. .+++.||+|+++... .....+.+..|+.+++++ +||||+++++++
T Consensus 5 ~~~~~-~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 5 PRDRL-KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred CHHHh-hhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 45677 88899999999999999643 345789999886322 234567788999999999 899999999987
Q ss_pred EecCCCeEEEEEeccCCCCHHHHHHHc-----------------------------------------------------
Q 004564 93 VDTANRNINFVTEMFTSGTLRQYRLKH----------------------------------------------------- 119 (745)
Q Consensus 93 vd~~~~~iyLV~E~~~gGsL~~~l~k~----------------------------------------------------- 119 (745)
... +..+++++||+.+++|.+++...
T Consensus 81 ~~~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 81 TKP-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred ecC-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 643 56789999999999999987642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC----CCccc
Q 004564 120 --------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AAHCV 187 (745)
Q Consensus 120 --------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~----~~~~v 187 (745)
..+++..+..++.||+.||.|||+++ |+||||||.|||++ .++.+||+|||++..+.... .....
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~-~~~~vkL~DfG~a~~~~~~~~~~~~~~~~ 236 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDAR 236 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEe-CCCcEEEeccccchhcccCcchhhccCCC
Confidence 26789999999999999999999988 99999999999998 56899999999998753221 12234
Q ss_pred CCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-
Q 004564 188 GTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA- 264 (745)
Q Consensus 188 GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~- 264 (745)
++..|+|||++. ..++.++|||||||++|||++ |..||.+......+...+..+..+ ......++++.+++.+||+
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~ 315 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHN 315 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHccC
Confidence 678899999876 569999999999999999998 999998744444444445444433 2344678899999999999
Q ss_pred CccCCCCHHHHhcC
Q 004564 265 TVSLRLSARELLND 278 (745)
Q Consensus 265 dPskRpSa~ELL~h 278 (745)
+|.+||++.++++|
T Consensus 316 ~p~~RPs~~ell~~ 329 (337)
T cd05054 316 NPEDRPTFSELVEI 329 (337)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=322.53 Aligned_cols=249 Identities=28% Similarity=0.413 Sum_probs=203.6
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.+.||.|++|.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++.+ ....|+++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv~ 77 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENKLYLVF 77 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheecc--CCeEEEEE
Confidence 566889999999999999999999999998875432 22334567889999999999999999998865 57899999
Q ss_pred eccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc-
Q 004564 105 EMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 181 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~- 181 (745)
||+. ++|.+++.... .+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++......
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLID-REGALKLADFGLARAFGVPV 153 (283)
T ss_pred eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCcEEEeecccccccCCCc
Confidence 9995 68999988776 7999999999999999999999988 99999999999998 4789999999998655322
Q ss_pred -CCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--------------
Q 004564 182 -HAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP-------------- 244 (745)
Q Consensus 182 -~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p-------------- 244 (745)
......+++.|+|||++.+ .++.++||||||+++|+|+||+.||.......++++.+.....|
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 2233457899999998753 47889999999999999999999998754444443322211100
Q ss_pred ------------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 245 ------------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 245 ------------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
.......++.+.++|.+||+ +|.+|||+++++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 11123456889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=323.32 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=204.9
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+| .+.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.+|+.+|+.++||||+++++++.. +..+|
T Consensus 2 ~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 76 (286)
T cd07846 2 KY-ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESE--DDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLY 76 (286)
T ss_pred ce-eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhcc--CcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEE
Confidence 45 67799999999999999999999999999876433 222345678889999999999999999998865 67899
Q ss_pred EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
+|+||+.+++|..+......+++..++.++.||+.||.|||+.+ |+||||+|+||+++ .++.+||+|||++......
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~-~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 77 LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCcEEEEeeeeeeeccCC
Confidence 99999999999888777777999999999999999999999988 99999999999997 5689999999998765432
Q ss_pred C--CCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CC--------------
Q 004564 182 H--AAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-GK-------------- 242 (745)
Q Consensus 182 ~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~-g~-------------- 242 (745)
. .....++..|+|||++.+ .++.++||||||+++|+|+||+.||..........+.... +.
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 2 223468999999998863 4778999999999999999999999764433332221110 00
Q ss_pred -----CCC--------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 243 -----KPD--------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 243 -----~p~--------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
.|. ......+..+.+|+.+||. +|.+||++.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 0122357789999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=319.00 Aligned_cols=250 Identities=28% Similarity=0.469 Sum_probs=211.9
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceEeEEEEecCCCeE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-HpNIVk~~~sfvd~~~~~i 100 (745)
+| .+.+.||+|+||.||+|.+..++..||+|++..... ........+..|+.+++.+. ||||+++++.+.+ ...+
T Consensus 2 ~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~ 77 (280)
T cd05581 2 DF-KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL-IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENL 77 (280)
T ss_pred Cc-eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc-cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceE
Confidence 45 777899999999999999999999999998865432 23445577889999999998 9999999998755 6789
Q ss_pred EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 101 NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
++|||++.+++|.+++.+.+.+++..+..|+.||+.||.|||+++ ++|+||+|+||+++ .+|.++|+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~-~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEecCCccccccCC
Confidence 999999999999999999889999999999999999999999998 99999999999997 668999999999876543
Q ss_pred cC----------------------CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 004564 181 SH----------------------AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKK 237 (745)
Q Consensus 181 ~~----------------------~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kk 237 (745)
.. .....++..|+|||++. ..++.++|+||||+++++|++|+.||.... ..+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~ 233 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQK 233 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHH
Confidence 22 12235789999999886 458889999999999999999999998744 4444555
Q ss_pred HHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCH----HHHhcCCCC
Q 004564 238 VVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSA----RELLNDPFL 281 (745)
Q Consensus 238 v~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa----~ELL~hPff 281 (745)
+...... +....++.+.+||.+||. +|.+||++ ++||+||||
T Consensus 234 ~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEYS--FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCCC--CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 5443322 334558899999999999 99999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=317.46 Aligned_cols=249 Identities=29% Similarity=0.503 Sum_probs=209.1
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+| .+.+.||+|+||.||+|.+..++..||+|.+...+. ........+.+|+.+++.++||||+++++++.. +..++
T Consensus 3 ~y-~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (267)
T cd08229 3 NF-RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELN 78 (267)
T ss_pred hh-hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEE
Confidence 45 677889999999999999999999999998875442 234556788999999999999999999999876 57899
Q ss_pred EEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 102 FVTEMFTSGTLRQYRLK----HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k----~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
++|||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++..
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~ 155 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRF 155 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEECcchhhhc
Confidence 99999999999998764 356899999999999999999999998 99999999999998 568999999999876
Q ss_pred hhccC--CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCC-CHHHHHHHHHcCCCCCCcccCCCH
Q 004564 178 LRKSH--AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECT-HPAQIYKKVVSGKKPDSLYRVKDP 253 (745)
Q Consensus 178 l~~~~--~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~-~~~~i~kkv~~g~~p~~l~~~~s~ 253 (745)
..... .....|++.|+|||.+. ..++.++|+||||+++|+|++|..||.... ....+.+.+..+..+.......++
T Consensus 156 ~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08229 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 235 (267)
T ss_pred cccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccH
Confidence 64322 22346899999999986 468889999999999999999999996533 334555666665555555556788
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 254 el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.++++|.+||+ +|.+|||+.++++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999999 9999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=331.40 Aligned_cols=255 Identities=28% Similarity=0.455 Sum_probs=202.3
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC--
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA-- 96 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~-- 96 (745)
-+++| .+.++||+|+||+||+|.+..+|..||+|+++... ......++..|+.+++.++||||+++++.+....
T Consensus 3 ~~~~y-~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (336)
T cd07849 3 VGPRY-QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE 78 (336)
T ss_pred cccce-EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence 45677 77899999999999999999999999999886322 2345667888999999999999999998765432
Q ss_pred -CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 97 -NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 97 -~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
...+|+++||+. ++|.+++ +.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~ 153 (336)
T cd07849 79 SFNDVYIVQELME-TDLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLA 153 (336)
T ss_pred ccceEEEEehhcc-cCHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEECcccce
Confidence 246899999996 4887776 4457999999999999999999999998 99999999999998 5689999999998
Q ss_pred hhhhccC-----CCcccCCCCcCChhhhh--hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CC----
Q 004564 176 AILRKSH-----AAHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS--GK---- 242 (745)
Q Consensus 176 ~~l~~~~-----~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~--g~---- 242 (745)
....... .....||+.|+|||.+. ..++.++|||||||++|+|+||+.||.+...... ...+.. +.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~-~~~~~~~~~~~~~~ 232 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ-LNLILGVLGTPSQE 232 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCCHH
Confidence 7653221 12346899999999875 3588999999999999999999999976332211 111100 00
Q ss_pred ----------------CCC-------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 243 ----------------KPD-------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 243 ----------------~p~-------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
.+. ......++++.+||.+||+ +|.+|||+.++++||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~ 297 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence 000 0112347789999999999 9999999999999999973
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=320.55 Aligned_cols=252 Identities=30% Similarity=0.502 Sum_probs=210.7
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
..-| ++.+.||.|+||.||+|.+..++..||+|++.... .......+.+|+.+++.++||||+++++++.. +..
T Consensus 3 ~~~~-~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 76 (277)
T cd06641 3 EELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTK 76 (277)
T ss_pred HHhh-hhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCe
Confidence 3345 56678999999999999999999999999876432 23456778999999999999999999999876 678
Q ss_pred EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 100 INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
.|+||||+.+++|..++.+ ..+++..+..++.||+.||.|||+++ ++|+||||+||+++ +++.++|+|||++..+.
T Consensus 77 ~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~ 152 (277)
T cd06641 77 LWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLT 152 (277)
T ss_pred EEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEEC-CCCCEEEeecccceecc
Confidence 9999999999999998764 46899999999999999999999988 99999999999998 56899999999986543
Q ss_pred ccC--CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHH
Q 004564 180 KSH--AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVR 256 (745)
Q Consensus 180 ~~~--~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~ 256 (745)
... .....++..|+|||.+. ..++.++|+|||||++|+|++|..||... ....+...+..+.. ..+....+..+.
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~ 230 (277)
T cd06641 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNNP-PTLEGNYSKPLK 230 (277)
T ss_pred cchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc-chHHHHHHHhcCCC-CCCCcccCHHHH
Confidence 321 22345889999999886 45788999999999999999999999763 34444544444433 334456788999
Q ss_pred HHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 257 RFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 257 d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
++|.+||. +|.+||++.++++||||..
T Consensus 231 ~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 231 EFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred HHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 99999999 9999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=314.70 Aligned_cols=240 Identities=22% Similarity=0.342 Sum_probs=198.5
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEecc
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMF 107 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~ 107 (745)
+.||+|+||.||+|.+..++..||+|.+... ...+....+.+|+.+++.++||||+++++++.. ...+++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeec
Confidence 4699999999999999999999999987532 234556789999999999999999999998765 57899999999
Q ss_pred CCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCCCcc
Q 004564 108 TSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC 186 (745)
Q Consensus 108 ~gGsL~~~l~k~~-~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~~~~ 186 (745)
.+++|.+++.+.+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...........
T Consensus 76 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred cCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEc-CCCcEEECccccCccccccccccc
Confidence 9999999987654 5899999999999999999999988 99999999999997 568999999999875443221111
Q ss_pred ----cCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHH
Q 004564 187 ----VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVE 260 (745)
Q Consensus 187 ----vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~ 260 (745)
.++..|+|||.+. +.++.++||||||+++|+|++ |..||... ........+..+..+ ......+..+.+++.
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 230 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTREAIEQGVRL-PCPELCPDAVYRLME 230 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCCC-CCcccCCHHHHHHHH
Confidence 2345799999886 568899999999999999998 88999763 445555555544333 344566889999999
Q ss_pred HHhh-CccCCCCHHHHhc
Q 004564 261 KCLA-TVSLRLSARELLN 277 (745)
Q Consensus 261 kcL~-dPskRpSa~ELL~ 277 (745)
+||+ +|.+|||+.++++
T Consensus 231 ~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 231 RCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 9999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=330.48 Aligned_cols=250 Identities=28% Similarity=0.421 Sum_probs=217.6
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEEEEec
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
++||+|+|+.|--+....+|.++|+|+|.+.. --...++.+|++++.++ .|+||++++++|.+ +..+|+|||.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~----gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FYLVfEK 157 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP----GHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFYLVFEK 157 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC----chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEEEEEec
Confidence 67999999999999999999999999987553 34567899999999999 59999999999877 6799999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCC--CcEEEcCcchhhhhhc----
Q 004564 107 FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQ--GEVKIGDLGLAAILRK---- 180 (745)
Q Consensus 107 ~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~--g~VKL~DFGlA~~l~~---- 180 (745)
|.||+|...+++++.+++..+.++++.|+.||.|||.+| |.||||||+|||....+ .-||||||.+......
T Consensus 158 m~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 158 MRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 999999999999999999999999999999999999998 99999999999996332 2489999999865421
Q ss_pred -----cCCCcccCCCCcCChhhhh------hccCccccchhhhhHHHHHhhcCCCCCCCC--------------CHHHHH
Q 004564 181 -----SHAAHCVGTPEFMAPEVYE------EAYNELVDIYSFGMCILEMVTFEYPYSECT--------------HPAQIY 235 (745)
Q Consensus 181 -----~~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~--------------~~~~i~ 235 (745)
....+.+|+.+|||||+.. ..|+.++|.||||||||-|+.|.+||.+.- -...++
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 2233457999999999874 249999999999999999999999995521 145678
Q ss_pred HHHHcCCC--CCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 236 KKVVSGKK--PDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 236 kkv~~g~~--p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
..|..|+. |..-+..++.+++++|..+|. ++..|++|.++|+|||++...
T Consensus 316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 88888874 777788899999999999999 999999999999999998543
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=346.63 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=203.9
Q ss_pred CceEeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceEeEE
Q 004564 13 EFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTS 91 (745)
Q Consensus 13 ~~~e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-HpNIVk~~~s 91 (745)
+++.+ .||-+.+.+.||+||.+.||++.....+ .||+|.+... ..+...++-+..||.+|.+|+ |.+||++|++
T Consensus 354 ~~i~V--kg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~--~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY 428 (677)
T KOG0596|consen 354 EIIKV--KGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLL--EADNQTLDGYRNEIALLNKLKGHDKIIQLYDY 428 (677)
T ss_pred eeEEE--CcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHh--hcCHHHHHHHHHHHHHHHHhcCCceEEEEeee
Confidence 44544 4555577789999999999999866544 4565555433 346778899999999999995 9999999997
Q ss_pred EEecCCCeEEEEEeccCCCCHHHHHHHcCCC-CHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEc
Q 004564 92 WVDTANRNINFVTEMFTSGTLRQYRLKHKRV-NIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 170 (745)
Q Consensus 92 fvd~~~~~iyLV~E~~~gGsL~~~l~k~~~L-~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~ 170 (745)
-+. ++.+|||||+- ..+|..++++.... +.-.++.|++|||.++.++|.+| |||.||||.|+|+- .|.+||+
T Consensus 429 Ev~--d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV--kG~LKLI 501 (677)
T KOG0596|consen 429 EVT--DGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV--KGRLKLI 501 (677)
T ss_pred ecc--CceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE--eeeEEee
Confidence 654 78999999986 46899998887654 44689999999999999999999 99999999999984 4899999
Q ss_pred CcchhhhhhccC----CCcccCCCCcCChhhhhh------------ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHH
Q 004564 171 DLGLAAILRKSH----AAHCVGTPEFMAPEVYEE------------AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQI 234 (745)
Q Consensus 171 DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~~------------~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i 234 (745)
|||+|..+.... ....+||+.||+||.+.. ..+.++||||||||||+|+.|+.||....+...-
T Consensus 502 DFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aK 581 (677)
T KOG0596|consen 502 DFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAK 581 (677)
T ss_pred eechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHH
Confidence 999998876543 234589999999998731 1457899999999999999999999875544333
Q ss_pred HHHHHcCCCCCCcccCCC-HHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 235 YKKVVSGKKPDSLYRVKD-PEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 235 ~kkv~~g~~p~~l~~~~s-~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
+..++.-.-...++.... .++.++++.||+ ||++||++.+||+|||++.
T Consensus 582 l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 582 LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 333333211112222222 349999999999 9999999999999999986
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=319.38 Aligned_cols=243 Identities=28% Similarity=0.468 Sum_probs=200.2
Q ss_pred eEeEEecccCceEEEEEEEc----CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 25 RYNEILGKGASKTVYRAFDE----YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~----~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
.+.+.||.|+||.||+|... ..+..|++|.++. ....+..+.+.+|++++++++||||+++++++.. ...+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~---~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~--~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP---SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE--NEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST---TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--SSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc---ccccccceeeeecccccccccccccccccccccc--cccc
Confidence 46788999999999999877 5578899998853 2345668899999999999999999999999874 5569
Q ss_pred EEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 101 NFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
++|+||+.+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+|++|+++|||++ .++.+||+|||++...
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~-~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLD-SNGQVKLSDFGLSRPI 153 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEE-TTTEEEEESTTTGEET
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-cccccccccccccccc
Confidence 9999999999999999987 67999999999999999999999998 99999999999998 4579999999999776
Q ss_pred hcc----CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCC
Q 004564 179 RKS----HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 179 ~~~----~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s 252 (745)
... ......+...|+|||.+. ..++.++||||||+++|||+| |+.||... +..++..++..+..+. .....+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~ 231 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRLP-IPDNCP 231 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEETT-SBTTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccce-eccchh
Confidence 221 122234778999999987 458999999999999999999 78999875 6777777787766544 345678
Q ss_pred HHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
..+.++|.+||. +|.+|||+.++++
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 899999999999 9999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=322.85 Aligned_cols=266 Identities=23% Similarity=0.435 Sum_probs=222.5
Q ss_pred CCceEeCCCCcee------eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCC
Q 004564 12 SEFVEVDPTGRYG------RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKN 84 (745)
Q Consensus 12 ~~~~e~dp~gRY~------rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpN 84 (745)
..|++.+.+.||. .+...||.|+.|.|+++....+|...|+|++.... +.++.+++...++++..- +.|.
T Consensus 76 tg~lti~~g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~---Nkee~kRILmDldvv~~s~dcpy 152 (391)
T KOG0983|consen 76 TGYLTIGGGQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPY 152 (391)
T ss_pred ceeEEecCCcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC---CHHHHHHHHHhhhHHhhccCCCe
Confidence 5677777666662 12345999999999999999999999999998654 678889999999886655 5899
Q ss_pred cceEeEEEEecCCCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCC
Q 004564 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGN 163 (745)
Q Consensus 85 IVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~ 163 (745)
||+.|++|+. +..+++.||.|.. .+..++++ .+++++..+-.+...++.||.||-.+. +|||||+||+|||+| .
T Consensus 153 IV~c~GyFi~--n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlD-e 227 (391)
T KOG0983|consen 153 IVQCFGYFIT--NTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLD-E 227 (391)
T ss_pred eeeeeeEEee--CchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEc-c
Confidence 9999999987 5678889999843 44444443 567999999999999999999997642 399999999999998 6
Q ss_pred CCcEEEcCcchhhhhhccCCCc-ccCCCCcCChhhhh----hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 004564 164 QGEVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVYE----EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKV 238 (745)
Q Consensus 164 ~g~VKL~DFGlA~~l~~~~~~~-~vGTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv 238 (745)
.|+|||||||++..+..+...+ ..|-+.|||||.+. ..|+-.+|||||||+++||+||++||.+|...-+..-++
T Consensus 228 ~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv 307 (391)
T KOG0983|consen 228 RGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV 307 (391)
T ss_pred CCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH
Confidence 7999999999998877665544 35999999999996 358999999999999999999999999998888888888
Q ss_pred HcCCCCCCccc-CCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 239 VSGKKPDSLYR-VKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 239 ~~g~~p~~l~~-~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
.+...|.-... ..++.+++|+..||. |+.+||...+||+|||+..-+
T Consensus 308 ln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 308 LNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 88555433332 279999999999999 999999999999999997543
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=326.02 Aligned_cols=260 Identities=28% Similarity=0.424 Sum_probs=214.9
Q ss_pred eEeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEe
Q 004564 15 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVD 94 (745)
Q Consensus 15 ~e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd 94 (745)
...|+...| ...+.||+|+||+||+|.+..++..||+|.+..... ........+..|+.+++.++||||+++++.+.+
T Consensus 15 ~~~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 92 (313)
T cd06633 15 YKDDPEEIF-VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK 92 (313)
T ss_pred ccCCHHHHh-hcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 567777788 444679999999999999999999999998875432 334556778899999999999999999998876
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcc
Q 004564 95 TANRNINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 173 (745)
Q Consensus 95 ~~~~~iyLV~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFG 173 (745)
....|+||||+. |+|..++.. ..++++..+..++.||+.||.|||++| |+||||+|+||+++ .++.+||+|||
T Consensus 93 --~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~-~~~~~kL~dfg 166 (313)
T cd06633 93 --EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFG 166 (313)
T ss_pred --CCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEEC-CCCCEEEeecC
Confidence 578999999996 577776654 457899999999999999999999988 99999999999997 56899999999
Q ss_pred hhhhhhccCCCcccCCCCcCChhhhh----hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCccc
Q 004564 174 LAAILRKSHAAHCVGTPEFMAPEVYE----EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYR 249 (745)
Q Consensus 174 lA~~l~~~~~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~ 249 (745)
++.... ......|++.|+|||++. +.++.++|||||||++|+|++|..||........++ .+..+..|.....
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 243 (313)
T cd06633 167 SASKSS--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLQSN 243 (313)
T ss_pred CCcccC--CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCCCCcc
Confidence 985432 223456899999999873 458889999999999999999999998755444444 3444444544445
Q ss_pred CCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 250 VKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 250 ~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
..+..+++||.+||+ +|.+||++.++++||||+...
T Consensus 244 ~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 244 EWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 567889999999999 999999999999999998644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=326.87 Aligned_cols=246 Identities=25% Similarity=0.421 Sum_probs=202.5
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeE----EEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIE----VAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA 96 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~----VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~ 96 (745)
.+| ++.+.||+|+||+||+|.+..++.. ||+|.++.. ......+++..|+.+++.++||||+++++++..
T Consensus 7 ~~f-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-- 80 (316)
T cd05108 7 TEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-- 80 (316)
T ss_pred hhc-eeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC--
Confidence 345 7778999999999999987666554 898887632 234566789999999999999999999998764
Q ss_pred CCeEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 97 NRNINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 97 ~~~iyLV~E~~~gGsL~~~l~k~~-~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
...++|+||+.+|+|.+++.+.. .++...+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 81 -~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~-~~~~~kl~DfG~a 156 (316)
T cd05108 81 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVK-TPQHVKITDFGLA 156 (316)
T ss_pred -CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEec-CCCcEEEcccccc
Confidence 35789999999999999988754 6899999999999999999999988 99999999999997 5679999999999
Q ss_pred hhhhccCC----CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCccc
Q 004564 176 AILRKSHA----AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYR 249 (745)
Q Consensus 176 ~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~ 249 (745)
........ ....++..|+|||++. ..++.++|||||||++|||+| |..||.+ ....++...+..+..+. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~ 234 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPP 234 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhCCCCCC-CCC
Confidence 87643221 1122467899999886 568999999999999999998 9999976 44556655555544432 234
Q ss_pred CCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 250 VKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 250 ~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
..+..+.+++.+||. +|.+||++.+++.+
T Consensus 235 ~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 235 ICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 577899999999999 99999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=331.98 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=206.0
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCC--
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN-- 97 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~-- 97 (745)
..+| ++.+.||+|+||+||+|.+..++..||+|.++... .......++..|+.+++.++||||+++++.+.....
T Consensus 4 ~~~y-~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 4 DTKY-VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF--DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred ccce-eEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc--cccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 4567 67789999999999999999999999999886432 223345677889999999999999999997764322
Q ss_pred -CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 98 -RNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 98 -~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
..+|+|+||+. ++|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~ 156 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLN-ANCDLKICDFGLAR 156 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECcCcccc
Confidence 35899999995 689999888889999999999999999999999988 99999999999997 56899999999997
Q ss_pred hhhcc--CCCcccCCCCcCChhhhh--hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH---cC--------
Q 004564 177 ILRKS--HAAHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVV---SG-------- 241 (745)
Q Consensus 177 ~l~~~--~~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~---~g-------- 241 (745)
..... ......++..|+|||.+. ..++.++|||||||++|+|++|+.||.... ....+..+. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD-YVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHHhCCCChHHhhh
Confidence 65432 223346899999999886 358899999999999999999999997532 211111111 00
Q ss_pred ----------------CCC--CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 242 ----------------KKP--DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 242 ----------------~~p--~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
..+ .......++.++++|.+||+ +|.+|||++++|+||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 000 01123467889999999999 9999999999999999973
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.78 Aligned_cols=243 Identities=26% Similarity=0.380 Sum_probs=204.0
Q ss_pred eeEeEEecccCceEEEEEEE-----cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC
Q 004564 24 GRYNEILGKGASKTVYRAFD-----EYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d-----~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~ 98 (745)
+.+.+.||+|+||+||++.+ ..++..+|+|.++.. .....+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--GD 80 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 47889999999999999975 345677999987632 34567789999999999999999999998865 57
Q ss_pred eEEEEEeccCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCC
Q 004564 99 NINFVTEMFTSGTLRQYRLKHK-------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQG 165 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~~-------------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g 165 (745)
.+++||||+.+++|.+++..++ .+++..+..++.||+.||+|||+++ ++||||||+|||++ .++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~-~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG-ENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc-cCC
Confidence 8999999999999999987654 4899999999999999999999988 99999999999998 568
Q ss_pred cEEEcCcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 004564 166 EVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVV 239 (745)
Q Consensus 166 ~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~ 239 (745)
.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|+| |..||... ....+...+.
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~-~~~~~~~~i~ 236 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-SNNEVIECIT 236 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHH
Confidence 99999999997653221 22334678899999887 568899999999999999999 89999764 4566677777
Q ss_pred cCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 240 SGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 240 ~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.+..+. .....++.+.+++.+||+ +|.+|||+.+++.
T Consensus 237 ~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QGRVLQ-RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 766443 345678899999999999 9999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.62 Aligned_cols=242 Identities=24% Similarity=0.343 Sum_probs=205.1
Q ss_pred eeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEE
Q 004564 24 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV 103 (745)
+.+.+.||.|+||.||+|.+..++..||+|.++.. ......+.+|+.+++.++||||+++++.+.. ...+++|
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYII 80 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcC--CCCcEEE
Confidence 37788999999999999999999999999987632 2345678899999999999999999998755 5688999
Q ss_pred EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 104 TEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
|||+.+++|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+|||++ +++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCcEEeCCCccccccccc
Confidence 9999999999998764 35899999999999999999999988 99999999999997 6689999999999766543
Q ss_pred CCCc---ccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHH
Q 004564 182 HAAH---CVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVR 256 (745)
Q Consensus 182 ~~~~---~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~ 256 (745)
.... ..+++.|+|||.+. +.++.++|||||||++|+|+| |..||.. .....++..+..+..+ ......++++.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 235 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRM-ERPEGCPPKVY 235 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHH
Confidence 2221 22466899999886 568899999999999999998 8999976 5567777777665443 34456789999
Q ss_pred HHHHHHhh-CccCCCCHHHHhc
Q 004564 257 RFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 257 d~I~kcL~-dPskRpSa~ELL~ 277 (745)
++|.+||+ +|++|||+.++++
T Consensus 236 ~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 236 ELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHccCCcccCCCHHHHHH
Confidence 99999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=316.37 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=203.1
Q ss_pred eEeEEecccCceEEEEEEEcCCCe--EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC----CC
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGI--EVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA----NR 98 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~--~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~----~~ 98 (745)
.+.++||+|+||.||+|.+..++. .||+|.++... ......+.+.+|+.+++.++||||+++++.++... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI--CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 467889999999999999877765 68999876432 34566788999999999999999999999765422 23
Q ss_pred eEEEEEeccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCc
Q 004564 99 NINFVTEMFTSGTLRQYRLKH------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 172 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DF 172 (745)
..++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLN-ENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEc-CCCCEEECCC
Confidence 578999999999999987532 34889999999999999999999988 99999999999997 5689999999
Q ss_pred chhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCC
Q 004564 173 GLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDS 246 (745)
Q Consensus 173 GlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~ 246 (745)
|++....... .....+++.|+|||.+. ..++.++|||||||++|+|++ |+.||.. ....+++..+..+..+.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~- 234 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLK- 234 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC-
Confidence 9998764322 11224678899999986 568999999999999999999 8999976 45677777777766543
Q ss_pred cccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 247 LYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 247 l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
.....+..+.++|.+||+ +|.+|||+.+|++.
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 233567889999999999 99999999999854
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=313.92 Aligned_cols=239 Identities=23% Similarity=0.332 Sum_probs=201.3
Q ss_pred EecccCceEEEEEEE--cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEec
Q 004564 29 ILGKGASKTVYRAFD--EYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 29 ~LG~GafgtVy~A~d--~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
.||+|+||+||+|.. ..++..||+|+++... ......+.+..|+.+++.++||||+++++.+. ....++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICE---AESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc---CCCcEEEEec
Confidence 589999999999954 5678899999876442 33456778999999999999999999999763 3567899999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCC---
Q 004564 107 FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA--- 183 (745)
Q Consensus 107 ~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~--- 183 (745)
+.+++|.+++.+...+++..+..++.||+.||.|||+++ |+||||||.|||++ +++.+||+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEc-CCCeEEECCCccccccCCCCCeee
Confidence 999999999988888999999999999999999999988 99999999999998 567999999999976543321
Q ss_pred --CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHH
Q 004564 184 --AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259 (745)
Q Consensus 184 --~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I 259 (745)
....+++.|+|||.+. ..++.++|||||||++|||+| |..||.. .....+...+..+..+. .+...++++.++|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li 231 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGERME-CPQRCPPEMYDLM 231 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCCHHHHHHH
Confidence 1223467999999886 468889999999999999998 9999976 45567777777766543 4456789999999
Q ss_pred HHHhh-CccCCCCHHHHhc
Q 004564 260 EKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 260 ~kcL~-dPskRpSa~ELL~ 277 (745)
.+||+ +|.+||++.++..
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 232 KLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHhccCchhCcCHHHHHH
Confidence 99999 9999999998854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=318.22 Aligned_cols=235 Identities=22% Similarity=0.359 Sum_probs=192.9
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEEEEeccC
Q 004564 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFVTEMFT 108 (745)
Q Consensus 30 LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyLV~E~~~ 108 (745)
||.|+||.||++.++.++..+|+|.+....... . |+..+..+ +||||+++++.|.. ...+|+||||+.
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~-----e~~~~~~~~~h~~iv~~~~~~~~--~~~~~iv~e~~~ 92 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----I-----EPMVHQLMKDNPNFIKLYYSVTT--LKGHVLIMDYIK 92 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----h-----hHHHHHHhhcCCCEEEEEEEEec--CCeeEEEEEcCC
Confidence 699999999999999999999999987443211 1 22222222 79999999998876 568999999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCCCcccC
Q 004564 109 SGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVG 188 (745)
Q Consensus 109 gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~~~~vG 188 (745)
+++|.+++.+...+++..++.|+.||+.||.|||+.+ ++||||||+||+++.+.+.++|+|||++...... ....|
T Consensus 93 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~ 168 (267)
T PHA03390 93 DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--SCYDG 168 (267)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--ccCCC
Confidence 9999999988889999999999999999999999988 9999999999999855449999999998765432 23468
Q ss_pred CCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCH----HHHHHHHHcCCCCCCcccCCCHHHHHHHHHHh
Q 004564 189 TPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHP----AQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCL 263 (745)
Q Consensus 189 Tp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~----~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL 263 (745)
++.|+|||++. ..++.++|||||||++|+|+||..||...... ..+.... ..+....+..++.+++||.+||
T Consensus 169 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l 245 (267)
T PHA03390 169 TLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNVSKNANDFVQSML 245 (267)
T ss_pred CCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cccCCcccccCHHHHHHHHHHh
Confidence 99999999987 46889999999999999999999999753321 2222222 2233445578999999999999
Q ss_pred h-CccCCCC-HHHHhcCCCCC
Q 004564 264 A-TVSLRLS-ARELLNDPFLQ 282 (745)
Q Consensus 264 ~-dPskRpS-a~ELL~hPff~ 282 (745)
+ +|.+|++ ++++|+||||.
T Consensus 246 ~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 246 KYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred ccChhhCCchHHHHhcCCccc
Confidence 9 9999996 59999999996
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=332.47 Aligned_cols=258 Identities=27% Similarity=0.410 Sum_probs=207.6
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEec--C
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT--A 96 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~--~ 96 (745)
.+.+| .+.+.||+|+||.||+|.+..+|..||+|.+.... ........+.+|+.+|+.++||||+++++.+... .
T Consensus 3 ~~~~y-~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 79 (334)
T cd07855 3 VGSRY-KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF--DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGAD 79 (334)
T ss_pred hhhce-eeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc--ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCC
Confidence 34566 67789999999999999999999999999887432 2234566788899999999999999999877532 2
Q ss_pred CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 97 NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 97 ~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
...+++||||+. ++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~~~ 155 (334)
T cd07855 80 FKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVN-EDCELRIGDFGMAR 155 (334)
T ss_pred CceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEecccccce
Confidence 357899999995 689999888888999999999999999999999988 99999999999998 56899999999986
Q ss_pred hhhccC------CCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH-cCCCC---
Q 004564 177 ILRKSH------AAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVV-SGKKP--- 244 (745)
Q Consensus 177 ~l~~~~------~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~-~g~~p--- 244 (745)
...... .....|+..|+|||++.+ .++.++|||||||++|+|++|+.||.......++..... .|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 653221 123468999999998853 588999999999999999999999976443332211111 01110
Q ss_pred --------------------C----CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 245 --------------------D----SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 245 --------------------~----~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
. .+....++.++++|.+||+ +|.+||++.++|.||||..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~ 299 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence 0 0123457889999999999 9999999999999999973
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=318.35 Aligned_cols=250 Identities=27% Similarity=0.411 Sum_probs=199.8
Q ss_pred CCceeeEeEEecccCceEEEEEE----EcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEec
Q 004564 20 TGRYGRYNEILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT 95 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~----d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~ 95 (745)
.+||+++.++||+|+||+||++. ...++..||+|.++... .......+.+|+.+|+.++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 46888899999999999998764 34578899999886432 234556788999999999999999999987765
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
....+++||||+.+++|.+++.+. .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~ 154 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLA 154 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEc-CCCcEEEeecccc
Confidence 566799999999999999998664 5999999999999999999999998 99999999999997 5689999999999
Q ss_pred hhhhccCC-----CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHH--------------HHH
Q 004564 176 AILRKSHA-----AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPA--------------QIY 235 (745)
Q Consensus 176 ~~l~~~~~-----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~--------------~i~ 235 (745)
........ ....++..|+|||.+. +.++.++||||||+++|+|+||..||....... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 76543221 1223567799999886 568899999999999999999999986532110 111
Q ss_pred HHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 236 KKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 236 kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
..+..+..+ ......+.++++++.+||+ +|++|||+++++.
T Consensus 235 ~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 235 ELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111112111 1234567899999999999 9999999999984
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=322.16 Aligned_cols=254 Identities=26% Similarity=0.363 Sum_probs=200.0
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC---
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA--- 96 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~--- 96 (745)
.++| ++.+.||.|+||.||+|.+..++..||+|.+..... .......+.+|+.+++.++||||+++++.+.+..
T Consensus 7 ~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDY-EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccE-EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC--CCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 4677 788999999999999999999999999998875432 1122345678999999999999999999876533
Q ss_pred ---CCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCc
Q 004564 97 ---NRNINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 172 (745)
Q Consensus 97 ---~~~iyLV~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DF 172 (745)
...+++|+||+.+ +|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~df 159 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADF 159 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECcC
Confidence 2368999999865 66666554 457999999999999999999999998 99999999999998 5689999999
Q ss_pred chhhhhhccC-------------CCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 004564 173 GLAAILRKSH-------------AAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKK 237 (745)
Q Consensus 173 GlA~~l~~~~-------------~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kk 237 (745)
|++....... .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+...... ...
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~~ 238 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LHL 238 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence 9997653221 122357889999998863 478999999999999999999999987444332 222
Q ss_pred HHc--CC-CC----------------------C---CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 238 VVS--GK-KP----------------------D---SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 238 v~~--g~-~p----------------------~---~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
+.. +. .+ . ......++.+.+||.+||+ +|.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 221 00 00 0 0012234678999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=318.20 Aligned_cols=248 Identities=21% Similarity=0.351 Sum_probs=201.9
Q ss_pred CCceeeEeEEecccCceEEEEEEEc-----CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEe
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDE-----YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVD 94 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~-----~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd 94 (745)
..+| ++.+.||+|+||+||+|.+. .++..||+|.++... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~-~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 5 REKI-TMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred HHHc-eeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 3456 78899999999999999764 345789999875322 23455678899999999999999999998754
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCC
Q 004564 95 TANRNINFVTEMFTSGTLRQYRLKHK----------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQ 164 (745)
Q Consensus 95 ~~~~~iyLV~E~~~gGsL~~~l~k~~----------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~ 164 (745)
...+++||||+.+++|.+++.+.. .++...+..++.||+.||.|||+++ ++||||||+||+++ .+
T Consensus 81 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~-~~ 155 (277)
T cd05062 81 --GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-ED 155 (277)
T ss_pred --CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEc-CC
Confidence 568999999999999999987632 3577889999999999999999988 99999999999998 56
Q ss_pred CcEEEcCcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 004564 165 GEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKV 238 (745)
Q Consensus 165 g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv 238 (745)
+.+||+|||++....... .....+++.|||||.+. +.++.++|||||||++|||++ |..||.+ .+...+.+.+
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~-~~~~~~~~~~ 234 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-MSNEQVLRFV 234 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHH
Confidence 899999999987543221 11234678899999987 568999999999999999999 7899977 4556666666
Q ss_pred HcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 239 VSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 239 ~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
..+..+. .....++.++++|.+||+ +|.+|||+.+++++
T Consensus 235 ~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 235 MEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HcCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6554432 345567899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.39 Aligned_cols=254 Identities=22% Similarity=0.374 Sum_probs=210.5
Q ss_pred eEeEEecccCceEEEEEEEc---CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeE
Q 004564 25 RYNEILGKGASKTVYRAFDE---YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~---~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~i 100 (745)
++.+.||.|+||.||+|.+. .+|..||+|+++...........+.+..|+.+|+.+ +|+||+++++.+.. +..+
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~~ 80 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DTKL 80 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CCeE
Confidence 67789999999999999874 478999999987544333344567788999999999 59999999998765 5789
Q ss_pred EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 101 NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
|+||||+.+++|.+++.+...+++..+..++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEC-CCCCEEEeeCccceeccc
Confidence 999999999999999998888999999999999999999999988 99999999999998 568999999999876543
Q ss_pred cC---CCcccCCCCcCChhhhhh---ccCccccchhhhhHHHHHhhcCCCCCCCC---CHHHHHHHHHcCCCCCCcccCC
Q 004564 181 SH---AAHCVGTPEFMAPEVYEE---AYNELVDIYSFGMCILEMVTFEYPYSECT---HPAQIYKKVVSGKKPDSLYRVK 251 (745)
Q Consensus 181 ~~---~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~---~~~~i~kkv~~g~~p~~l~~~~ 251 (745)
.. .....|+..|+|||.+.. .++.++||||||+++|+|+||..||.... ....+.+.+..+..+ .....
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 235 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEM 235 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC--CCccC
Confidence 21 223458999999998863 47789999999999999999999996422 233444444433332 34557
Q ss_pred CHHHHHHHHHHhh-CccCCC-----CHHHHhcCCCCCccc
Q 004564 252 DPEVRRFVEKCLA-TVSLRL-----SARELLNDPFLQIDD 285 (745)
Q Consensus 252 s~el~d~I~kcL~-dPskRp-----Sa~ELL~hPff~~~~ 285 (745)
++.+.+++.+||+ +|.+|| ++++++.||||+...
T Consensus 236 ~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 8999999999999 999997 899999999998543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.54 Aligned_cols=245 Identities=22% Similarity=0.321 Sum_probs=203.1
Q ss_pred eeEeEEecccCceEEEEEEE----cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 24 GRYNEILGKGASKTVYRAFD----EYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d----~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
+++.+.||+|+||+||+|.. ..++..||+|.++.. ........+.+|+.+++.++||||+++++++.. ...
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 81 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI---NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ--EQP 81 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CCc
Confidence 37889999999999999985 345678999988632 234556788999999999999999999998765 568
Q ss_pred EEEEEeccCCCCHHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecC
Q 004564 100 INFVTEMFTSGTLRQYRLKH-----------------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG 162 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~-----------------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~ 162 (745)
.|++|||+.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~- 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG- 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc-
Confidence 89999999999999998643 24788899999999999999999988 99999999999998
Q ss_pred CCCcEEEcCcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHH
Q 004564 163 NQGEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYK 236 (745)
Q Consensus 163 ~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k 236 (745)
.++.+||+|||++....... .....++..|+|||.+. +.++.++|||||||++|||++ |..||.+ .....+..
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~~~ 237 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEVIE 237 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHH
Confidence 56799999999997653321 22334677899999886 568999999999999999998 9999976 34566666
Q ss_pred HHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 237 KVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 237 kv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
.+..+..+ ......++.+++++.+||+ +|.+||++.+++++
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 238 MVRKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 66655543 3455678999999999999 99999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.95 Aligned_cols=246 Identities=20% Similarity=0.335 Sum_probs=201.9
Q ss_pred eeEeEEecccCceEEEEEEEcC-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC
Q 004564 24 GRYNEILGKGASKTVYRAFDEY-----EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d~~-----tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~ 98 (745)
+.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+..|+.+++.++|+||+++++++.+ ..
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 82 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--RL 82 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CC
Confidence 3777999999999999999887 78899999775332 23445678899999999999999999998765 56
Q ss_pred eEEEEEeccCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCC--CCcEEE
Q 004564 99 NINFVTEMFTSGTLRQYRLKHK-------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGN--QGEVKI 169 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~~-------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~--~g~VKL 169 (745)
..++||||+.+++|.+++.+.+ .+++..+..++.||+.||.|||+++ ++||||||+|||++.+ ...+||
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEe
Confidence 7899999999999999987754 4899999999999999999999998 9999999999999743 236999
Q ss_pred cCcchhhhhhccCC----CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCC
Q 004564 170 GDLGLAAILRKSHA----AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKK 243 (745)
Q Consensus 170 ~DFGlA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~ 243 (745)
+|||++........ .....++.|+|||++. ..++.++|||||||++|+|++ |..||... ....+...+..+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~-~~~~~~~~~~~~~~ 239 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-TNQEVMEFVTGGGR 239 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCc
Confidence 99999976532211 1223456899999986 569999999999999999997 99999874 44556666655443
Q ss_pred CCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 244 PDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 244 p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
+. .....++.+.+++.+||+ +|++||++.++|+|
T Consensus 240 ~~-~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 LD-PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 32 345568899999999999 99999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=328.77 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=200.5
Q ss_pred EEeccc--CceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEe
Q 004564 28 EILGKG--ASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTE 105 (745)
Q Consensus 28 e~LG~G--afgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E 105 (745)
+.||+| +|++||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||++++++|.. +..+++|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN--CTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEe
Confidence 456777 99999999999999999999987543 234556889999999999999999999999876 678999999
Q ss_pred ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCC
Q 004564 106 MFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 183 (745)
Q Consensus 106 ~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~ 183 (745)
|+.+++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+|++||+.+........
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILIS-GDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEe-CCCcEEEechHHHhhhhccCc
Confidence 99999999998765 35899999999999999999999988 99999999999997 568999999987644322110
Q ss_pred ---------CcccCCCCcCChhhhhh---ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-C------
Q 004564 184 ---------AHCVGTPEFMAPEVYEE---AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK-P------ 244 (745)
Q Consensus 184 ---------~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~-p------ 244 (745)
....++..|||||++.+ .++.++|||||||++|+|++|..||........+...+..... |
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence 01235667999999864 3789999999999999999999999875544444333221100 0
Q ss_pred -------------------------------------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 245 -------------------------------------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 245 -------------------------------------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
.......++.+.+||.+||+ +|.+|||+.++|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 00112245679999999999 999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=313.04 Aligned_cols=247 Identities=20% Similarity=0.322 Sum_probs=202.8
Q ss_pred eEeEEecccCceEEEEEEEcC---CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCC----
Q 004564 25 RYNEILGKGASKTVYRAFDEY---EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN---- 97 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~---tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~---- 97 (745)
++.++||+|+||.||+|.... ++..||+|.++... ......+.+.+|+.+++.++||||+++++.+.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI--HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 577889999999999998765 34889999887543 234567789999999999999999999997754322
Q ss_pred CeEEEEEeccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcC
Q 004564 98 RNINFVTEMFTSGTLRQYRLKH------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 171 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k~------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~D 171 (745)
...++++||+.+|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLR-EDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEEC-CCCeEEECC
Confidence 2479999999999999987543 36899999999999999999999988 99999999999998 568999999
Q ss_pred cchhhhhhccCC----CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCC
Q 004564 172 LGLAAILRKSHA----AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPD 245 (745)
Q Consensus 172 FGlA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~ 245 (745)
||++........ ....++..|+|||.+. ..++.++|||||||++|||++ |..||.+ ....++++.+..+..+.
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~ 235 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG-VENHEIYDYLRHGNRLK 235 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC
Confidence 999876543221 1123567899999886 568899999999999999999 8999977 44556667676665443
Q ss_pred CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 246 SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 246 ~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
.....++.+.+++.+||+ +|++|||+.+++++
T Consensus 236 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 236 -QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 345678999999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=313.47 Aligned_cols=246 Identities=22% Similarity=0.360 Sum_probs=203.6
Q ss_pred CceeeEeEEecccCceEEEEEEEcCC-----CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEec
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYE-----GIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT 95 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~t-----g~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~ 95 (745)
.+| ++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (277)
T cd05032 6 EKI-TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVST- 80 (277)
T ss_pred HHe-eEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC-
Confidence 355 6789999999999999987654 4889999875332 33455678899999999999999999998765
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCC
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKHK----------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQG 165 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~~----------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g 165 (745)
....++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++
T Consensus 81 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~-~~~ 156 (277)
T cd05032 81 -GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVA-EDL 156 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEc-CCC
Confidence 578999999999999999986532 3678899999999999999999988 99999999999998 568
Q ss_pred cEEEcCcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 004564 166 EVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVV 239 (745)
Q Consensus 166 ~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~ 239 (745)
.+||+|||++....... .....++..|+|||.+. +.++.++|||||||++|+|+| |..||.. .+..++.+.+.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~~ 235 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKFVI 235 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHHHHHh
Confidence 99999999987654332 22334688999999886 568899999999999999998 9999987 45666777666
Q ss_pred cCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 240 SGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 240 ~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.+..+. .+...+..+.++|.+||+ +|++|||+.+++.
T Consensus 236 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 DGGHLD-LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred cCCCCC-CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 554332 344568899999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=324.18 Aligned_cols=261 Identities=28% Similarity=0.435 Sum_probs=215.6
Q ss_pred CceEeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEE
Q 004564 13 EFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSW 92 (745)
Q Consensus 13 ~~~e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sf 92 (745)
.|.+.+|..+| ...+.||.|+||.||+|.+..++..||+|.+..... .......++.+|+.+++.++|+||+++++++
T Consensus 7 ~~~~~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 84 (308)
T cd06634 7 LFFKDDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY 84 (308)
T ss_pred hhhcCCcHHHH-HHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 45667788888 455779999999999999999999999998874332 2345567788999999999999999999988
Q ss_pred EecCCCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcC
Q 004564 93 VDTANRNINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 171 (745)
Q Consensus 93 vd~~~~~iyLV~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~D 171 (745)
.. ....++|+||+. |+|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|
T Consensus 85 ~~--~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~kl~d 158 (308)
T cd06634 85 LR--EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGD 158 (308)
T ss_pred Ec--CCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEEC-CCCcEEECC
Confidence 76 578899999996 577776654 456899999999999999999999988 99999999999997 568999999
Q ss_pred cchhhhhhccCCCcccCCCCcCChhhhh----hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCc
Q 004564 172 LGLAAILRKSHAAHCVGTPEFMAPEVYE----EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSL 247 (745)
Q Consensus 172 FGlA~~l~~~~~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l 247 (745)
||++...... ....+++.|+|||.+. +.++.++|||||||++|+|++|..||........++ .+..+..|...
T Consensus 159 fg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~ 235 (308)
T cd06634 159 FGSASIMAPA--NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQ 235 (308)
T ss_pred cccceeecCc--ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-HHhhcCCCCcC
Confidence 9998655432 3346899999999874 357889999999999999999999997744333333 34455555544
Q ss_pred ccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 248 YRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 248 ~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
....+..++++|.+||+ +|.+||+++++++|||+...
T Consensus 236 ~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 55678899999999999 99999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.41 Aligned_cols=239 Identities=22% Similarity=0.341 Sum_probs=199.3
Q ss_pred EEecccCceEEEEEEEcCCC---eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 28 EILGKGASKTVYRAFDEYEG---IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg---~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
+.||+|+||.||+|+...++ ..||+|.+..... ....+.+..|+.+++.++||||+++++++. ...+++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCK---GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEc---CCceEEEE
Confidence 46999999999999876655 7899998874432 245677899999999999999999999764 34689999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCCC
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 184 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~~ 184 (745)
||+.+++|.+++.+...+++..+..|+.||+.||.|||.++ ++||||||+|||++ .++.+||+|||++.........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 75 ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred EeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEc-CCCcEEeccccccceeecCCcc
Confidence 99999999999998888999999999999999999999988 99999999999998 5689999999999765432211
Q ss_pred -----cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHH
Q 004564 185 -----HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257 (745)
Q Consensus 185 -----~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d 257 (745)
...++..|+|||.+. ..++.++|||||||++|+|++ |..||... +..++.+.+..+... ......++.+++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 229 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESGERL-PRPEECPQEIYS 229 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHcCCcC-CCCCCCCHHHHH
Confidence 112346799999886 468899999999999999998 99999874 455666666665433 344567889999
Q ss_pred HHHHHhh-CccCCCCHHHHhc
Q 004564 258 FVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 258 ~I~kcL~-dPskRpSa~ELL~ 277 (745)
+|.+||. +|.+||++.++++
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 9999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=346.06 Aligned_cols=233 Identities=31% Similarity=0.436 Sum_probs=198.6
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEecc
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMF 107 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~ 107 (745)
+.||.|+.|.||+|. ..++.||||.++.. -..+|+-|++|+|||||.|.+.+ +....++||||||
T Consensus 130 eWlGSGaQGAVF~Gr--l~netVAVKKV~el-----------kETdIKHLRkLkH~NII~FkGVC--tqsPcyCIiMEfC 194 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGR--LHNETVAVKKVREL-----------KETDIKHLRKLKHPNIITFKGVC--TQSPCYCIIMEFC 194 (904)
T ss_pred hhhccCcccceeeee--ccCceehhHHHhhh-----------hhhhHHHHHhccCcceeeEeeee--cCCceeEEeeecc
Confidence 559999999999994 56889999977621 23478889999999999999966 4567899999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc-cCCCcc
Q 004564 108 TSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-SHAAHC 186 (745)
Q Consensus 108 ~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~-~~~~~~ 186 (745)
..|-|...++...++....+..|.++|+.|+.|||.|. |||||||.-||||..+ ..|||+|||.+..... +....+
T Consensus 195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~STkMSF 271 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYD-DVVKISDFGTSKELSDKSTKMSF 271 (904)
T ss_pred ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeecc-ceEEeccccchHhhhhhhhhhhh
Confidence 99999999999999999999999999999999999998 9999999999999844 6999999999987654 344567
Q ss_pred cCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-
Q 004564 187 VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA- 264 (745)
Q Consensus 187 vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~- 264 (745)
.||..|||||++. +..++++|||||||+|||||||+.||.+....+-|+ -|-++.....++..++.-++-||++||+
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw-GVGsNsL~LpvPstcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW-GVGSNSLHLPVPSTCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE-eccCCcccccCcccCchHHHHHHHHHHhc
Confidence 8999999999997 568999999999999999999999998855444333 3333334444556677789999999999
Q ss_pred CccCCCCHHHHhcCC
Q 004564 265 TVSLRLSARELLNDP 279 (745)
Q Consensus 265 dPskRpSa~ELL~hP 279 (745)
+|..||++.++|.|-
T Consensus 351 KpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 351 KPRNRPSFRQILLHL 365 (904)
T ss_pred CCCCCccHHHHHHHH
Confidence 999999999999883
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.24 Aligned_cols=248 Identities=22% Similarity=0.275 Sum_probs=202.2
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCC----------------eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEG----------------IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHK 83 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg----------------~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~Hp 83 (745)
.++| ++.+.||+|+||.||+|.+...+ ..||+|.+.... .....+.+.+|+.+|+.++||
T Consensus 4 ~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~~ 79 (296)
T cd05051 4 RQPL-NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSDP 79 (296)
T ss_pred hhhC-cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCCC
Confidence 4567 78899999999999999876544 568999876432 345677899999999999999
Q ss_pred CcceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeec
Q 004564 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK-----------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRD 152 (745)
Q Consensus 84 NIVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~-----------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRD 152 (745)
||+++++++.. +..++++||++.+++|.+++.+.. .+++..+..++.||+.||.|||+++ |+|||
T Consensus 80 ~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~d 155 (296)
T cd05051 80 NIARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRD 155 (296)
T ss_pred CEeEEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccc
Confidence 99999998865 578999999999999999988766 7899999999999999999999988 99999
Q ss_pred CCCcceeecCCCCcEEEcCcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh--cCCCC
Q 004564 153 LKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT--FEYPY 225 (745)
Q Consensus 153 LKpdNILld~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT--G~~Pf 225 (745)
|||+||+++ +.+.++|+|||++....... .....+++.|||||.+. +.++.++|||||||++|+|++ +..||
T Consensus 156 lkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 156 LATRNCLVG-KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred cchhceeec-CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 999999998 55899999999987653322 22334678899999886 478999999999999999998 67888
Q ss_pred CCCCCHHHHHHHHHcC----C--CCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 226 SECTHPAQIYKKVVSG----K--KPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 226 ~~~~~~~~i~kkv~~g----~--~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.... ..+++..+... . .........+.++.++|.+||+ +|.+|||+.++++
T Consensus 235 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 235 EHLT-DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCcC-hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 7643 44444444332 1 1112233456899999999999 9999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.10 Aligned_cols=252 Identities=22% Similarity=0.341 Sum_probs=204.1
Q ss_pred CceeeEeEEecccCceEEEEEEEc-----CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEec
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDE-----YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT 95 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~-----~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~ 95 (745)
.|| .+.+.||+|+||.||+|.++ ..+..||+|.++... .......+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~-~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 80 (288)
T cd05061 6 EKI-TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK- 80 (288)
T ss_pred HHc-eeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 466 77799999999999999754 235689999875332 23445568889999999999999999998755
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCC
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKHK----------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQG 165 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~~----------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g 165 (745)
....|+||||+.+|+|.+++.+.+ .++...+..++.||+.||.|||+++ |+||||||+|||++ .++
T Consensus 81 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~-~~~ 156 (288)
T cd05061 81 -GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVA-HDF 156 (288)
T ss_pred -CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEc-CCC
Confidence 567899999999999999987532 3466788999999999999999988 99999999999998 568
Q ss_pred cEEEcCcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 004564 166 EVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVV 239 (745)
Q Consensus 166 ~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~ 239 (745)
.+||+|||++....... .....++..|+|||.+. +.++.++|+|||||++|||++ |..||.. ....++++.+.
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~~~ 235 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKFVM 235 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHH
Confidence 99999999987543221 11224577899999886 568999999999999999999 7899976 45566666666
Q ss_pred cCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc------CCCCCc
Q 004564 240 SGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN------DPFLQI 283 (745)
Q Consensus 240 ~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~------hPff~~ 283 (745)
.+..+. .....++.+++++.+||+ +|.+|||+.++++ ||||+-
T Consensus 236 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 236 DGGYLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred cCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 655443 233457899999999999 9999999999986 888874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.94 Aligned_cols=262 Identities=27% Similarity=0.414 Sum_probs=216.0
Q ss_pred CceEeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEE
Q 004564 13 EFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSW 92 (745)
Q Consensus 13 ~~~e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sf 92 (745)
.|...+|...| ...+.||+|+||.||+|.+..++..||+|.+..... ...+....+.+|+.+++.++|||++++++++
T Consensus 17 ~~~~~~~~~~f-~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 94 (317)
T cd06635 17 LFFKEDPEKLF-TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCY 94 (317)
T ss_pred HhcCCCchhhh-hhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34667777777 566789999999999999999999999998875432 2345667899999999999999999999988
Q ss_pred EecCCCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcC
Q 004564 93 VDTANRNINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 171 (745)
Q Consensus 93 vd~~~~~iyLV~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~D 171 (745)
.+ ....++||||+.+ +|.+++.. ..++++..+..++.||+.||.|||+++ |+||||+|+||+++ .++.+||+|
T Consensus 95 ~~--~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~-~~~~~kl~d 168 (317)
T cd06635 95 LR--EHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLAD 168 (317)
T ss_pred ee--CCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEEC-CCCCEEEec
Confidence 76 5688999999975 77776654 456899999999999999999999988 99999999999997 568999999
Q ss_pred cchhhhhhccCCCcccCCCCcCChhhhh----hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCc
Q 004564 172 LGLAAILRKSHAAHCVGTPEFMAPEVYE----EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSL 247 (745)
Q Consensus 172 FGlA~~l~~~~~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l 247 (745)
||++..... .....|++.|+|||.+. +.++.++|||||||++|+|++|..||........+ ..+..+..+...
T Consensus 169 fg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~ 245 (317)
T cd06635 169 FGSASIASP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNESPTLQ 245 (317)
T ss_pred CCCccccCC--cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH-HHHHhccCCCCC
Confidence 999865432 23346899999999873 45888999999999999999999999875444444 444444444444
Q ss_pred ccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 248 YRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 248 ~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
....++.++++|.+||+ +|.+||++.++++|+|+....
T Consensus 246 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 246 SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 45677899999999999 999999999999999996543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.40 Aligned_cols=245 Identities=25% Similarity=0.365 Sum_probs=202.9
Q ss_pred CceeeEeEEecccCceEEEEEEEc-----CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEec
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDE-----YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT 95 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~-----~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~ 95 (745)
+.| .+.+.||+|+||.||+|.+. .++..+++|.++.. .....+.+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~-~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 78 (291)
T cd05094 5 RDI-VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEHIVKFYGVCGD- 78 (291)
T ss_pred HHe-EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-
Confidence 345 77789999999999999753 35667998887532 24455678899999999999999999998765
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCccee
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKHK----------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIF 159 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~~----------------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNIL 159 (745)
....++||||+.+++|.+++..+. .+++..+..++.||+.||+|||+++ |+||||||+|||
T Consensus 79 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil 155 (291)
T cd05094 79 -GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCL 155 (291)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEE
Confidence 567999999999999999987643 3789999999999999999999998 999999999999
Q ss_pred ecCCCCcEEEcCcchhhhhhcc----CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHH
Q 004564 160 VNGNQGEVKIGDLGLAAILRKS----HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQ 233 (745)
Q Consensus 160 ld~~~g~VKL~DFGlA~~l~~~----~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~ 233 (745)
++ .++.+||+|||++...... ......+++.|+|||.+. ..++.++|||||||++|+|+| |..||.. .+...
T Consensus 156 ~~-~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~ 233 (291)
T cd05094 156 VG-ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ-LSNTE 233 (291)
T ss_pred Ec-cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHH
Confidence 98 5689999999999765332 123345788999999886 568899999999999999999 9999976 34555
Q ss_pred HHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 234 IYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 234 i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
+...+..+..+. .....+..+.+++.+||+ +|++|||+.++++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 234 VIECITQGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHhCCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 666666665543 345578899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.31 Aligned_cols=248 Identities=26% Similarity=0.385 Sum_probs=205.3
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCC-----CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEE
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYE-----GIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWV 93 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~t-----g~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfv 93 (745)
.++| ++.+.||+|+||.||+|..... ...+|+|.++.. ........+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~~~-~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 11 RDRL-TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred HhHe-EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC---CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3456 7779999999999999987644 378999987643 2345567789999999999 8999999999875
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcc
Q 004564 94 DTANRNINFVTEMFTSGTLRQYRLKH----------------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDN 157 (745)
Q Consensus 94 d~~~~~iyLV~E~~~gGsL~~~l~k~----------------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdN 157 (745)
. +..+++||||+.+|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 87 ~--~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N 162 (293)
T cd05053 87 Q--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN 162 (293)
T ss_pred C--CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence 5 56899999999999999998653 45889999999999999999999988 9999999999
Q ss_pred eeecCCCCcEEEcCcchhhhhhccCC----CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCH
Q 004564 158 IFVNGNQGEVKIGDLGLAAILRKSHA----AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHP 231 (745)
Q Consensus 158 ILld~~~g~VKL~DFGlA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~ 231 (745)
||++ +++.+||+|||++..+..... ....+++.|+|||++. ..++.++|||||||++|+|++ |..||.. ...
T Consensus 163 il~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~ 240 (293)
T cd05053 163 VLVT-EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPV 240 (293)
T ss_pred EEEc-CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC-CCH
Confidence 9997 668999999999976543221 1123567899999876 568999999999999999997 9999986 456
Q ss_pred HHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 232 AQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 232 ~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
.++++.+..+..+. .....+..+.+++.+||. +|.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 241 EELFKLLKEGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 67777777765543 333567899999999999 99999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=327.85 Aligned_cols=252 Identities=24% Similarity=0.407 Sum_probs=221.7
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.|.++||+|.||+|.++..+.+|+.+|+|++++.- ....+....-..|-++|+..+||.+..+--+|.. .+.+++||
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKev-iiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt--~drlCFVM 247 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEV-IIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT--QDRLCFVM 247 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhh-eeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc--CceEEEEE
Confidence 46688999999999999999999999999988554 4445666777789999999999999999888854 78999999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh--ccC
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSH 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~--~~~ 182 (745)
||..||.|.-.+.+.+.++++..+.|-..|+.||.|||+++ ||+||||.+|+|++ .+|+|||+|||+++-.- ...
T Consensus 248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLD-kDGHIKitDFGLCKE~I~~g~t 324 (516)
T KOG0690|consen 248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLD-KDGHIKITDFGLCKEEIKYGDT 324 (516)
T ss_pred EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheec-cCCceEeeecccchhcccccce
Confidence 99999999988899899999999999999999999999998 99999999999998 77999999999986432 344
Q ss_pred CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHH
Q 004564 183 AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEK 261 (745)
Q Consensus 183 ~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~k 261 (745)
..+++|||.|+|||+++ ..|+.++|+|.+||+||||++|+.||.. .+-..++..+.-+.. .+++..+++++.++..
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-~dh~kLFeLIl~ed~--kFPr~ls~eAktLLsG 401 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-KDHEKLFELILMEDL--KFPRTLSPEAKTLLSG 401 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-cchhHHHHHHHhhhc--cCCccCCHHHHHHHHH
Confidence 56789999999999997 6799999999999999999999999987 556777777765543 3567789999999999
Q ss_pred Hhh-CccCCC-----CHHHHhcCCCCCccc
Q 004564 262 CLA-TVSLRL-----SARELLNDPFLQIDD 285 (745)
Q Consensus 262 cL~-dPskRp-----Sa~ELL~hPff~~~~ 285 (745)
+|. ||.+|+ .|.|+.+|+||...+
T Consensus 402 LL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 402 LLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred HhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 999 999997 499999999998654
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=329.74 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=205.0
Q ss_pred CCCceeeEeEEecccCceEEEEEEE-----cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEE
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFD-----EYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSW 92 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d-----~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sf 92 (745)
|.+|| ++.++||+|+||+||+|.+ ..+++.||+|+++... .......+.+|+.+|..+ +||||+++++++
T Consensus 5 ~~~~~-~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 5 PRDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred chhHh-cccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 55688 8899999999999999974 4567899999986432 234567788999999999 689999999987
Q ss_pred EecCCCeEEEEEeccCCCCHHHHHHHc-----------------------------------------------------
Q 004564 93 VDTANRNINFVTEMFTSGTLRQYRLKH----------------------------------------------------- 119 (745)
Q Consensus 93 vd~~~~~iyLV~E~~~gGsL~~~l~k~----------------------------------------------------- 119 (745)
... +..++++|||+.+|+|.+++...
T Consensus 81 ~~~-~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 81 TKP-GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred ecC-CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 543 45789999999999999987653
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC---
Q 004564 120 --------------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--- 182 (745)
Q Consensus 120 --------------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~--- 182 (745)
..+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 236 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYV 236 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEc-CCCcEEEEecccccccccCcchh
Confidence 23678888999999999999999988 99999999999998 56899999999987653221
Q ss_pred -CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHH
Q 004564 183 -AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259 (745)
Q Consensus 183 -~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I 259 (745)
.....+++.|+|||++. ..++.++||||||+++|+|++ |..||........+...+..+..+. .....++.+.+++
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 315 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-APDYTTPEMYQTM 315 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC-CCCCCCHHHHHHH
Confidence 11223567899999886 568999999999999999997 9999987655555666565555432 2345688999999
Q ss_pred HHHhh-CccCCCCHHHHhcC
Q 004564 260 EKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 260 ~kcL~-dPskRpSa~ELL~h 278 (745)
..||+ +|.+|||+.++++|
T Consensus 316 ~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 316 LDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999 99999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=327.31 Aligned_cols=254 Identities=31% Similarity=0.438 Sum_probs=209.3
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC---CC
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA---NR 98 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~---~~ 98 (745)
|| ++.+.||.|++|.||+|.+..++..||+|.+.... ......+.+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~y-~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RY-ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred Cc-eeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 45 78899999999999999999999999999886432 22455678999999999999999999999876532 24
Q ss_pred eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 99 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
.+|++|||+. ++|.+++.+...+++..++.++.||+.||.|||++| |+||||||+|||++ .++.++|+|||++...
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~-~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 78 DVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVN-SNCDLKICDFGLARGV 153 (330)
T ss_pred ceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEcccCceEee
Confidence 7899999997 589999888889999999999999999999999998 99999999999998 4589999999999876
Q ss_pred hccC-----CCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CCCCC----
Q 004564 179 RKSH-----AAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS--GKKPD---- 245 (745)
Q Consensus 179 ~~~~-----~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~--g~~p~---- 245 (745)
.... .....+|+.|+|||++.+ .++.++|+||||+++|+|+||..||.... ..+.++.+.. +..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD-YIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC-HHHHHHHHHHhcCCCChhHhh
Confidence 5432 334468999999999863 58899999999999999999999998744 3444444332 11110
Q ss_pred -----------------------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 246 -----------------------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 246 -----------------------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
......++.+.++|.+||+ +|.+|||++++|.||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 0112357889999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=308.51 Aligned_cols=243 Identities=28% Similarity=0.449 Sum_probs=210.2
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEeccCC
Q 004564 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTS 109 (745)
Q Consensus 30 LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~~g 109 (745)
||+|+||.||+|.+..++..||+|+++.... ......+.+..|+.+++.++||||+++++.+.. +..+++||||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCC
Confidence 6999999999999999999999999875542 334567789999999999999999999998754 6789999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc--CCCccc
Q 004564 110 GTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAAHCV 187 (745)
Q Consensus 110 GsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~--~~~~~v 187 (745)
++|.+++.+...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++ ..+.++|+|||++...... ......
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEc-CCCcEEEeecCcceecccCCCcccCCc
Confidence 999999998888999999999999999999999988 99999999999998 5689999999999776543 233456
Q ss_pred CCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-C
Q 004564 188 GTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-T 265 (745)
Q Consensus 188 GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-d 265 (745)
++..|+|||.+.+ .++.++|+||||+++|+|++|..||.. ....+++..+..+..+ +....+..+.++|.+||. +
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDPLR--FPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHhcCC
Confidence 8999999998864 578899999999999999999999976 4456667766664332 444568899999999999 9
Q ss_pred ccCCCCH---HHHhcCCCC
Q 004564 266 VSLRLSA---RELLNDPFL 281 (745)
Q Consensus 266 PskRpSa---~ELL~hPff 281 (745)
|.+||++ +++++||||
T Consensus 232 p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 232 PTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhhCCCcccHHHHHhCCCC
Confidence 9999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=322.99 Aligned_cols=243 Identities=27% Similarity=0.409 Sum_probs=196.3
Q ss_pred CceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEeccCCCCHH
Q 004564 34 ASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLR 113 (745)
Q Consensus 34 afgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~~gGsL~ 113 (745)
+++.||++.+..++..||+|.++... ......+.+..|+.+++.++||||++++++|.+ ....+++|||+.+++|.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDS--CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYGSCE 87 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccc--cchhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEeccCCCCHH
Confidence 45666777778899999999987543 244577889999999999999999999999876 57899999999999999
Q ss_pred HHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC---------
Q 004564 114 QYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--------- 182 (745)
Q Consensus 114 ~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~--------- 182 (745)
+++.+. ..+++..++.+++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||.+..+....
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLS-GDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEe-cCCceEEecCccceeeccccccccccccc
Confidence 998764 46899999999999999999999998 99999999999998 56899999999886543211
Q ss_pred CCcccCCCCcCChhhhhh---ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--------C-------
Q 004564 183 AAHCVGTPEFMAPEVYEE---AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK--------P------- 244 (745)
Q Consensus 183 ~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~--------p------- 244 (745)
.....++..|+|||++.. .|+.++|||||||++|+|++|..||........+..++..... |
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcC
Confidence 122347889999999863 4889999999999999999999999875544444443321110 0
Q ss_pred ----------------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 245 ----------------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 245 ----------------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
.......+..+.+|+.+||. +|++|||++++|+||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 01111234678899999999 9999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=310.08 Aligned_cols=241 Identities=22% Similarity=0.370 Sum_probs=199.9
Q ss_pred eeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEE
Q 004564 24 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV 103 (745)
+++.+.||+|+||.||+|.+. .+..||+|.++.. ....+.+..|+.+++.++||||+++++.+.+ ....+++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 79 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG-----TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEPIYII 79 (261)
T ss_pred eEEeeecCCcCCceEEEEEec-CCceEEEEEccCC-----chhHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCcEEE
Confidence 488899999999999999865 5667999987632 2345788999999999999999999998754 6778999
Q ss_pred EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 104 TEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
|||+.+++|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEec-CCCcEEECCCccceecCCC
Confidence 9999999999998764 56889999999999999999999988 99999999999998 5689999999999765432
Q ss_pred CC---CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHH
Q 004564 182 HA---AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVR 256 (745)
Q Consensus 182 ~~---~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~ 256 (745)
.. ....++..|+|||.+. +.++.++|||||||++|+|+| |..||.. .....+...+..+..+. .....+..+.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 234 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSALQRGYRMP-RMENCPDELY 234 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCHHHH
Confidence 21 1223567899999886 568889999999999999998 9999977 44555666666554332 3345778999
Q ss_pred HHHHHHhh-CccCCCCHHHHhc
Q 004564 257 RFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 257 d~I~kcL~-dPskRpSa~ELL~ 277 (745)
+++.+||. +|.+||+++++++
T Consensus 235 ~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 235 DIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 99999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=313.72 Aligned_cols=250 Identities=26% Similarity=0.392 Sum_probs=203.9
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.+.||.|+||.||+|.+..++..||+|.+.... ........+..|+.+++.++||||+++++.+.+.....+++|+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 56788999999999999999999999999988553 2234456788899999999999999999988764337899999
Q ss_pred eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC-
Q 004564 105 EMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~- 182 (745)
||+.+ +|..++.+. ..+++..++.++.||+.||+|||+++ ++|+||||+|||++ +++.+||+|||++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~-~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEc-CCCCEEEccccceeeccCCCc
Confidence 99974 888887765 57999999999999999999999988 99999999999998 56899999999997765432
Q ss_pred --CCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC-CCC-------------
Q 004564 183 --AAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG-KKP------------- 244 (745)
Q Consensus 183 --~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g-~~p------------- 244 (745)
.....++..|+|||.+.+ .++.++||||||+++|+|+||+.||........+ ..+... ..|
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL-EKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCchhhccccccchh
Confidence 233457889999997753 4789999999999999999999999875543333 222211 000
Q ss_pred ---------------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 245 ---------------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 245 ---------------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
..+....++.+.++|.+||. +|.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00111137889999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=314.03 Aligned_cols=243 Identities=24% Similarity=0.388 Sum_probs=201.0
Q ss_pred eeEeEEecccCceEEEEEEEcCCCe----EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 24 GRYNEILGKGASKTVYRAFDEYEGI----EVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d~~tg~----~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
+++.++||+|+||+||+|....++. .||+|+++... .......+.+|+.+++.+.||||+++++.+.. ..
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~ 82 (279)
T cd05109 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLT---ST 82 (279)
T ss_pred eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---CC
Confidence 3777999999999999998776665 48999876432 34556778899999999999999999998754 45
Q ss_pred EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 100 INFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
.++++||+.+|+|.+++... +.+++..+..|+.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++...
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~-~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVK-SPNHVKITDFGLARLL 159 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc-CCCcEEECCCCceeec
Confidence 78999999999999998764 56999999999999999999999988 99999999999997 5679999999999766
Q ss_pred hccCC----CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCC
Q 004564 179 RKSHA----AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 179 ~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s 252 (745)
..... ....+++.|+|||.+. +.++.++|||||||++|||+| |..||.. .....+...+..+..+. .....+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~ 237 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLLEKGERLP-QPPICT 237 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcCC-CCccCC
Confidence 43221 1123567899999886 568999999999999999998 8999976 44555666666555443 344578
Q ss_pred HHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
+.+.++|.+||. +|.+||++.+++.
T Consensus 238 ~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 238 IDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999999 9999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=344.18 Aligned_cols=256 Identities=26% Similarity=0.415 Sum_probs=223.9
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~ 98 (745)
-.|-| .+.+.||+|.|++|.+|.+..++..||||++.... .+...+..+.+|+++|+.|+|||||++|.... ...
T Consensus 54 ~vg~y-~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~--ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~--t~~ 128 (596)
T KOG0586|consen 54 SVGLY-VIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQ--LNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE--TEA 128 (596)
T ss_pred cccce-eeeeeeccceeEEEEeeEecCCCceEEEEEehhcc--cChHHHHHHHHHHHHHHhcCCcceeeeeeeee--ecc
Confidence 34555 78899999999999999999999999999887554 44566677999999999999999999999654 378
Q ss_pred eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 99 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
.+|+||||..+|.+++|+.++++..+..++.++.|++++++|||+++ |||||||.+|||++.+ ..|||+|||++..+
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~-mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDEN-MNIKIADFGFSTFF 205 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccc-cceeeeccccceee
Confidence 99999999999999999999999999999999999999999999998 9999999999999854 57999999999887
Q ss_pred hcc-CCCcccCCCCcCChhhhhhc--cCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHH
Q 004564 179 RKS-HAAHCVGTPEFMAPEVYEEA--YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEV 255 (745)
Q Consensus 179 ~~~-~~~~~vGTp~YmAPEvl~~~--ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el 255 (745)
... ...+.+|+|.|+|||++.+. -++.+|+||+|+++|.|+.|..||.+ .+...+...++.|+.-. +-..+.+.
T Consensus 206 ~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~rI--p~~ms~dc 282 (596)
T KOG0586|consen 206 DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKYRI--PFYMSCDC 282 (596)
T ss_pred cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeeeecc--cceeechh
Confidence 643 45567899999999999853 46899999999999999999999987 55666667777776543 33467889
Q ss_pred HHHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 256 RRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 256 ~d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
+++|.++|. +|.+|++.+++.+|.|.....
T Consensus 283 e~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 283 EDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred HHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 999999999 999999999999999997543
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=320.11 Aligned_cols=246 Identities=22% Similarity=0.355 Sum_probs=203.5
Q ss_pred ceeeEeEEecccCceEEEEEEE-----cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEec
Q 004564 22 RYGRYNEILGKGASKTVYRAFD-----EYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDT 95 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d-----~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~ 95 (745)
+| .+.+.||+|+||.||+|.+ ..++..||+|.++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 36 ~~-~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 110 (302)
T cd05055 36 NL-SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGACTI- 110 (302)
T ss_pred He-EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec-
Confidence 44 7888999999999999975 3456689999876432 245567899999999999 79999999998765
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcc
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 173 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFG 173 (745)
...+|++|||+.+|+|..++.+.. .+++..+..++.||+.||.|||+++ |+|+||||+|||++ ..+.+||+|||
T Consensus 111 -~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~dfg 186 (302)
T cd05055 111 -GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT-HGKIVKICDFG 186 (302)
T ss_pred -CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEc-CCCeEEECCCc
Confidence 567999999999999999987643 3899999999999999999999988 99999999999997 56799999999
Q ss_pred hhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCc
Q 004564 174 LAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSL 247 (745)
Q Consensus 174 lA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l 247 (745)
++....... .....+++.|+|||.+. +.++.++|||||||++|+|+| |..||........+++.+..+..+ ..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~ 265 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-AQ 265 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-CC
Confidence 997654322 11234678899999876 568999999999999999998 999998766555566655555433 23
Q ss_pred ccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 248 YRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 248 ~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
....++.+.+++.+||. +|.+|||+.+++.
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 44568899999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=319.25 Aligned_cols=248 Identities=26% Similarity=0.402 Sum_probs=204.2
Q ss_pred CCceeeEeEEecccCceEEEEEEEcC-------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEE
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEY-------EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTS 91 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~-------tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~s 91 (745)
.++| .+.+.||+|+||.||+|.+.. ++..+|+|.++.. ........+..|+.+++.+ +||||++++++
T Consensus 17 ~~~~-~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 17 RDRL-VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred hHHe-EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC---CChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 4567 888999999999999997643 3357999987643 2345567788999999999 79999999998
Q ss_pred EEecCCCeEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCC
Q 004564 92 WVDTANRNINFVTEMFTSGTLRQYRLKHK----------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKC 155 (745)
Q Consensus 92 fvd~~~~~iyLV~E~~~gGsL~~~l~k~~----------------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKp 155 (745)
+.. ...+|+||||+.+|+|.+++.+++ .+++..+..++.||+.||+|||+++ ++||||||
T Consensus 93 ~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 168 (307)
T cd05098 93 CTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAA 168 (307)
T ss_pred Eec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence 765 568999999999999999987653 4788999999999999999999988 99999999
Q ss_pred cceeecCCCCcEEEcCcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCC
Q 004564 156 DNIFVNGNQGEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECT 229 (745)
Q Consensus 156 dNILld~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~ 229 (745)
+|||++ .++.+||+|||++....... .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||.. .
T Consensus 169 ~Nill~-~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~ 246 (307)
T cd05098 169 RNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-V 246 (307)
T ss_pred HheEEc-CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-C
Confidence 999998 55899999999987553211 11123457899999886 458899999999999999998 8899976 5
Q ss_pred CHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 230 HPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 230 ~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
+..++++.+..+..+. .....+.++.++|.+||. +|.+|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 247 PVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CHHHHHHHHHcCCCCC-CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 6677777776665433 345578899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=310.47 Aligned_cols=244 Identities=22% Similarity=0.336 Sum_probs=202.4
Q ss_pred eEeEEecccCceEEEEEEEcCC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYE---GIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~t---g~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
++.+.||+|+||+||+|....+ ...||+|.++.. ........+..|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 81 (266)
T cd05033 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG---SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRPVM 81 (266)
T ss_pred eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC---CChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCceE
Confidence 7889999999999999988654 457999987633 234556678899999999999999999998755 67799
Q ss_pred EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 102 FVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
++|||+.+++|.+++.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~-~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCCEEECccchhhcccc
Confidence 999999999999998765 46899999999999999999999988 99999999999998 568999999999987642
Q ss_pred cC--CC--cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHH
Q 004564 181 SH--AA--HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254 (745)
Q Consensus 181 ~~--~~--~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~e 254 (745)
.. .. ...+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ...++...+..+..+. .....++.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 236 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM-SNQDVIKAVEDGYRLP-PPMDCPSA 236 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCCHH
Confidence 11 11 123567899999887 568899999999999999998 99999764 4555666666554332 23456889
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 255 VRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 255 l~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
+.+++.+||+ +|.+||++.+++++
T Consensus 237 l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 237 LYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=308.92 Aligned_cols=240 Identities=22% Similarity=0.354 Sum_probs=199.2
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.+.||+|+||.||+|..+ .+..+|+|.++... ...+.+..|+.+|+.++||||+++++++.. ...+++||
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~ 78 (256)
T cd05114 7 TFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIVT 78 (256)
T ss_pred EEeeEecCCcCceEEEEEec-cCceEEEEecccCC-----ccHHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEEE
Confidence 67788999999999999765 45679999876332 223568889999999999999999998755 67899999
Q ss_pred eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCC
Q 004564 105 EMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 183 (745)
Q Consensus 105 E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~ 183 (745)
||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEc-CCCeEEECCCCCccccCCCce
Confidence 999999999998754 46899999999999999999999988 99999999999998 567999999999876533221
Q ss_pred C---cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHH
Q 004564 184 A---HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRF 258 (745)
Q Consensus 184 ~---~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~ 258 (745)
. ...++..|+|||++. +.++.++||||||+++|+|+| |+.||.. .+..++...+..+..+. .....+..+.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~l 233 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMISRGFRLY-RPKLASMTVYEV 233 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCCHHHHHH
Confidence 1 223566899999987 568899999999999999999 8999976 45566677777665442 244567899999
Q ss_pred HHHHhh-CccCCCCHHHHhc
Q 004564 259 VEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 259 I~kcL~-dPskRpSa~ELL~ 277 (745)
+.+||+ +|.+||+++++++
T Consensus 234 i~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 234 MYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=346.93 Aligned_cols=241 Identities=29% Similarity=0.454 Sum_probs=205.5
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.+.||+|.||+||+|+.- | .||||+++.... +++.++.|++|+.+|++-+|.||+-|.+++.. ..+.||+
T Consensus 395 ~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~---p~~AIiT 466 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDP--TPEQLQAFKNEVAVLKKTRHENILLFMGACMN---PPLAIIT 466 (678)
T ss_pred hccceeccccccceeecccc--c-ceEEEEEecCCC--CHHHHHHHHHHHHHHhhcchhhheeeehhhcC---Cceeeee
Confidence 67788999999999999543 3 699999987763 56699999999999999999999999998754 4459999
Q ss_pred eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc--
Q 004564 105 EMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-- 181 (745)
Q Consensus 105 E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~-- 181 (745)
.+|.|.+|..++.- ..++.....+.|++||+.|+.|||.++ |||||||..|||+. +++.|||+|||+++....-
T Consensus 467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~-~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLH-EDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEc-cCCcEEEecccceeeeeeecc
Confidence 99999999988653 357999999999999999999999998 99999999999997 5689999999999764322
Q ss_pred --CCCcccCCCCcCChhhhh----hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC---CCCcccCCC
Q 004564 182 --HAAHCVGTPEFMAPEVYE----EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK---PDSLYRVKD 252 (745)
Q Consensus 182 --~~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~---p~~l~~~~s 252 (745)
.....-|...|||||++. ..|++.+|||||||++|||+||..||. ..+.++|.-.+-.|.. +........
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~p 622 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNCP 622 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccCH
Confidence 222334888999999986 359999999999999999999999999 6889999888888843 333333445
Q ss_pred HHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.++++|+..||+ ++.+||...+||.
T Consensus 623 k~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 623 KAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHhcCcccCccHHHHHH
Confidence 699999999999 9999999999884
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=309.67 Aligned_cols=243 Identities=23% Similarity=0.349 Sum_probs=200.8
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
.+| ++.+.||+|++|.||+|.+. .+..||+|.++... ...+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~-~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 76 (261)
T cd05068 6 TSI-QLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPI 76 (261)
T ss_pred hhe-eeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-----ccHHHHHHHHHHHHHCCCCCccceeEEEec--CCCe
Confidence 345 88899999999999999875 45789999886432 224568889999999999999999998755 5688
Q ss_pred EEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 101 NFVTEMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
|++|||+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVG-ENNICKVADFGLARVI 153 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEc-CCCCEEECCcceEEEc
Confidence 99999999999999987654 6899999999999999999999988 99999999999998 5689999999999766
Q ss_pred hccCCCcccC---CCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCH
Q 004564 179 RKSHAAHCVG---TPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDP 253 (745)
Q Consensus 179 ~~~~~~~~vG---Tp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~ 253 (745)
.........| +..|+|||.+. ..++.++||||||+++|+|+| |+.||.. .....++..+..+..+ ......+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG-MTNAEVLQQVDQGYRM-PCPPGCPK 231 (261)
T ss_pred cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCcCCH
Confidence 5332222223 45799999886 468899999999999999999 9999987 4455666666555332 23345678
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 254 el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.+.+++.+||+ +|.+||++.+|++
T Consensus 232 ~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 232 ELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHHH
Confidence 99999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.16 Aligned_cols=256 Identities=28% Similarity=0.363 Sum_probs=207.0
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCC
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~ 98 (745)
.++| .+.+.||+|+||.||+|.+..+|..||+|.+.... ........+.+|+.+++++ +||||+++++++......
T Consensus 6 ~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 6 LRKY-EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF--RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhHH-HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc--CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 3556 67789999999999999999999999999875321 2334456788899999999 999999999988665556
Q ss_pred eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 99 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
.+|+||||+. ++|..++.+. .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++...
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~-~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSL 157 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccchhcc
Confidence 7899999997 5999987765 7899999999999999999999988 99999999999998 5689999999999765
Q ss_pred hcc-------CCCcccCCCCcCChhhhh--hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC------
Q 004564 179 RKS-------HAAHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK------ 243 (745)
Q Consensus 179 ~~~-------~~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~------ 243 (745)
... ......||+.|+|||.+. ..++.++||||||+++|+|+||+.||........+.+.+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 432 122346899999999875 35788999999999999999999999765444333222111100
Q ss_pred ----------------------CCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 244 ----------------------PDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 244 ----------------------p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
+.......+.++.++|.+||+ +|++|||+.++|+|||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 111223367889999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=336.77 Aligned_cols=248 Identities=25% Similarity=0.341 Sum_probs=202.4
Q ss_pred CCceeeEeEEecccCceEEEEEEEcC-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceEeEEEE
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEY-----EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTSWV 93 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~-----tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-HpNIVk~~~sfv 93 (745)
.++| ++.++||+|+||+||+|.+.. .+..||+|+++... .....+.+.+|+.+|+.+. ||||++++++|.
T Consensus 36 ~~~~-~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 36 RDGL-VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred ccce-ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3444 677999999999999998643 34579999886432 3445678999999999996 999999999886
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHHc------------------------------------------------------
Q 004564 94 DTANRNINFVTEMFTSGTLRQYRLKH------------------------------------------------------ 119 (745)
Q Consensus 94 d~~~~~iyLV~E~~~gGsL~~~l~k~------------------------------------------------------ 119 (745)
. ...+|+||||+.+|+|.+++.+.
T Consensus 112 ~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 112 K--SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred c--CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 5 67899999999999999987653
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcc
Q 004564 120 ------------------------------------------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDN 157 (745)
Q Consensus 120 ------------------------------------------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdN 157 (745)
..+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~N 267 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHh
Confidence 23778888999999999999999988 9999999999
Q ss_pred eeecCCCCcEEEcCcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCH
Q 004564 158 IFVNGNQGEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHP 231 (745)
Q Consensus 158 ILld~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~ 231 (745)
||++ .++.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||......
T Consensus 268 ill~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 268 VLLA-QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EEEe-CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 9998 56799999999997653321 12234778899999886 568999999999999999997 99999875555
Q ss_pred HHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 232 AQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 232 ~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
..++..+..+..+. .....++.+.+++.+||+ +|++||++.+|.+
T Consensus 347 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 STFYNKIKSGYRMA-KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHHhcCCCCC-CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 66666666664432 344568899999999999 9999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=319.53 Aligned_cols=244 Identities=24% Similarity=0.363 Sum_probs=198.6
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEE--EEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEV--AWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~V--AiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iy 101 (745)
.+.+.||+|+||.||+|.+..++..+ |+|.++. .........+.+|+.++..+ +||||+++++++.. ...+|
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~---~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~~~ 84 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY 84 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEecc---cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCCce
Confidence 78899999999999999988877654 6655442 22345567888999999999 89999999998755 57899
Q ss_pred EEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCC
Q 004564 102 FVTEMFTSGTLRQYRLKHK----------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQG 165 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~----------------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g 165 (745)
+||||+.+++|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+|||++ .++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~-~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEec-CCC
Confidence 9999999999999987543 4789999999999999999999988 99999999999998 567
Q ss_pred cEEEcCcchhhhhhccC-CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCC
Q 004564 166 EVKIGDLGLAAILRKSH-AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGK 242 (745)
Q Consensus 166 ~VKL~DFGlA~~l~~~~-~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~ 242 (745)
.+||+|||++....... .....++..|+|||.+. ..++.++|||||||++|+|+| |..||.. .+..++++.+..+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~ 240 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGY 240 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc-CChHHHHHHHhcCC
Confidence 99999999985432111 11123467899999886 458899999999999999998 9999976 44566666665543
Q ss_pred CCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 243 KPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 243 ~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
.+. .....++.+.++|.+||+ +|.+||+++++|..
T Consensus 241 ~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 RLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 332 233467899999999999 99999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.78 Aligned_cols=240 Identities=26% Similarity=0.366 Sum_probs=198.8
Q ss_pred EEecccCceEEEEEEEcC-CC--eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 28 EILGKGASKTVYRAFDEY-EG--IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~-tg--~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++||+|++|+||+|.+.. .+ ..||+|.++..... ...+++.+|+.++++++||||+++++.+.+ ..+++|+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEE
Confidence 468999999999998765 33 36999988754421 667889999999999999999999998765 6889999
Q ss_pred eccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC
Q 004564 105 EMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~ 182 (745)
||+.+++|.+++.+.. .+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++..+....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~-~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLA-SDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEe-cCCEEEeccccccccccccc
Confidence 9999999999988764 6899999999999999999999988 99999999999998 45899999999997764321
Q ss_pred -----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHH
Q 004564 183 -----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEV 255 (745)
Q Consensus 183 -----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el 255 (745)
.....++..|+|||.+. ..++.++|||||||++|+|+| |..||... +..++.+.+.............+..+
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDKEGERLERPEACPQDI 230 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCcCCCCccCCHHH
Confidence 11234778899999886 568999999999999999999 99999764 44556555553222222334567899
Q ss_pred HHHHHHHhh-CccCCCCHHHHhc
Q 004564 256 RRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 256 ~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.+++.+||+ +|++||++.+++.
T Consensus 231 ~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 231 YNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHCCCCcccCCCHHHHHH
Confidence 999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=311.13 Aligned_cols=242 Identities=23% Similarity=0.355 Sum_probs=200.2
Q ss_pred eeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEE
Q 004564 24 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV 103 (745)
+++.+.||+|+||.||+|.+. ++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-----MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK--QRPIFIV 77 (256)
T ss_pred cchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-----CCHHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCceEEE
Confidence 377889999999999999876 46689999875322 123467889999999999999999998754 5688999
Q ss_pred EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC
Q 004564 104 TEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 182 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~ 182 (745)
|||+.+++|.+++.++ ..+++..+..++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEEC-CCCcEEECCcccceeccccc
Confidence 9999999999998764 46899999999999999999999998 99999999999998 56899999999987654332
Q ss_pred CCccc---CCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHH
Q 004564 183 AAHCV---GTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257 (745)
Q Consensus 183 ~~~~v---GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d 257 (745)
..... ++..|+|||.+. ..++.++||||||+++|+|+| |..||.. ....++...+..+..+ ......++.+.+
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER-FSNSEVVESVSAGYRL-YRPKLAPTEVYT 232 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHcCCcC-CCCCCCCHHHHH
Confidence 22222 345799999887 568899999999999999999 8999976 4456666777665433 234567899999
Q ss_pred HHHHHhh-CccCCCCHHHHhcC
Q 004564 258 FVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 258 ~I~kcL~-dPskRpSa~ELL~h 278 (745)
++.+||. +|.+|||+.++++.
T Consensus 233 li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 233 IMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHH
Confidence 9999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=317.89 Aligned_cols=244 Identities=23% Similarity=0.368 Sum_probs=200.2
Q ss_pred eEeEEecccCceEEEEEEEcCCCe--EEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGI--EVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~--~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iy 101 (745)
++.++||+|+||.||+|.+..++. .+++|.++.. ......+.+.+|+.+++++ +||||+++++++.. ...+|
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~ 79 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF---ASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYLY 79 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc---CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcce
Confidence 788999999999999999887765 4687776522 2344567789999999999 79999999998765 56799
Q ss_pred EEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCC
Q 004564 102 FVTEMFTSGTLRQYRLKHK----------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQG 165 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~----------------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g 165 (745)
+++||+.+++|.+++.+.. .+++..++.++.||+.||+|||+++ |+||||||+|||++ .++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVG-ENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEEC-CCC
Confidence 9999999999999987643 4888999999999999999999988 99999999999997 567
Q ss_pred cEEEcCcchhhhhhccCCCc-ccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCC
Q 004564 166 EVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGK 242 (745)
Q Consensus 166 ~VKL~DFGlA~~l~~~~~~~-~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~ 242 (745)
.+||+|||++.......... ...+..|+|||.+. +.++.++|||||||++|+|+| |..||.. .....++.++..+.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~~~~ 235 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGY 235 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCC
Confidence 99999999986433221111 22355799999886 468999999999999999997 9999977 45566677776654
Q ss_pred CCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 243 KPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 243 ~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
.+. .....++.+++||.+||+ +|.+|||++++++.
T Consensus 236 ~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RME-KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 332 345678899999999999 99999999999755
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=314.33 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=202.5
Q ss_pred CCceeeEeEEecccCceEEEEEEE----cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEec
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFD----EYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT 95 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d----~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~ 95 (745)
++|++++.+.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 456778889999999999999973 4578899999876332 345567899999999999999999999988765
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcch
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 174 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~~-~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGl 174 (745)
....+++||||+.+++|.+++.+.. .+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||+
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~-~~~~~~l~dfg~ 155 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGL 155 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEc-CCCCEEECCCcc
Confidence 5578999999999999999987654 5899999999999999999999988 99999999999997 568999999999
Q ss_pred hhhhhccC-----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCC--------------CCHHHH
Q 004564 175 AAILRKSH-----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSEC--------------THPAQI 234 (745)
Q Consensus 175 A~~l~~~~-----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~--------------~~~~~i 234 (745)
+..+.... .....++..|+|||++. +.++.++|||||||++|+|+|+..|+... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 97654322 12345778899999876 46889999999999999999987665221 111222
Q ss_pred HHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 235 YKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 235 ~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
.+.+..+... ......+..+.+||.+||+ +|.+|||+.++++.
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 236 VRVLEEGKRL-PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHHcCccC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 2223333322 2334578899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=308.02 Aligned_cols=240 Identities=21% Similarity=0.335 Sum_probs=203.9
Q ss_pred eeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEE
Q 004564 23 YGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINF 102 (745)
Q Consensus 23 Y~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyL 102 (745)
.+.+.+.||.|+||.||+|... |..||+|.++... ...+++.+|+.+++.++|+||+++++.+.+ ...+++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 77 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYI 77 (256)
T ss_pred hccceeeeecCCCceEEEEEec--CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEE
Confidence 3478899999999999999764 8899999887432 256789999999999999999999998765 678999
Q ss_pred EEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 103 VTEMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 103 V~E~~~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
||||+.+++|.+++.+.. .+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~-~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEe-CCCCEEEccccccccccc
Confidence 999999999999988765 6999999999999999999999998 99999999999998 568999999999977643
Q ss_pred cCCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHH
Q 004564 181 SHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRF 258 (745)
Q Consensus 181 ~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~ 258 (745)
... ...++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .+...+...+..+..+ ......++.+.++
T Consensus 155 ~~~-~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 231 (256)
T cd05039 155 GQD-SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKGYRM-EAPEGCPPEVYKV 231 (256)
T ss_pred ccc-cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC-CCccCCCHHHHHH
Confidence 322 233567899999876 568889999999999999997 9999987 4566666666655433 3345578999999
Q ss_pred HHHHhh-CccCCCCHHHHhc
Q 004564 259 VEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 259 I~kcL~-dPskRpSa~ELL~ 277 (745)
|.+||. +|.+|||+.++++
T Consensus 232 i~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 232 MKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHhccChhhCcCHHHHHH
Confidence 999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=313.68 Aligned_cols=243 Identities=25% Similarity=0.388 Sum_probs=201.2
Q ss_pred eeEeEEecccCceEEEEEEE-----cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC
Q 004564 24 GRYNEILGKGASKTVYRAFD-----EYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d-----~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~ 98 (745)
+++.+.||+|+||+||+|.. ..++..+|+|.++. ......+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE----ASESARQDFQREAELLTVLQHQHIVRFYGVCTE--GR 80 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc----CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec--CC
Confidence 37788999999999999964 34577899987653 235667789999999999999999999998865 56
Q ss_pred eEEEEEeccCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCC
Q 004564 99 NINFVTEMFTSGTLRQYRLKHK---------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGN 163 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~~---------------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~ 163 (745)
.++++|||+.+++|.+++..++ .+++..+..++.||+.||+|||+++ |+||||||+|||++ +
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~-~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVG-Q 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEc-C
Confidence 7899999999999999987753 4889999999999999999999988 99999999999997 5
Q ss_pred CCcEEEcCcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHH
Q 004564 164 QGEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKK 237 (745)
Q Consensus 164 ~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kk 237 (745)
++.+||+|||++....... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.... .......
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~ 236 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS-NTEAIEC 236 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC-HHHHHHH
Confidence 6899999999986543221 12233578899999886 568999999999999999998 899997644 4455555
Q ss_pred HHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 238 VVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 238 v~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
+..+..+. .....++.+.++|.+||+ +|.+||++.+++.
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGRELE-RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCccCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 66654432 345678899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.47 Aligned_cols=245 Identities=22% Similarity=0.371 Sum_probs=204.9
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
...| .+.++||.|+||+||+|.+.. +..+|+|.++... ......+..|+.+++.++||||+++++.+.+ ...
T Consensus 5 ~~~y-~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 76 (261)
T cd05148 5 REEF-TLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSV--GEP 76 (261)
T ss_pred HHHH-HHhhhhccCCCccEEEeEecC-CCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEec--CCC
Confidence 3445 677899999999999999987 8899999886432 3345678899999999999999999998755 568
Q ss_pred EEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 100 INFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
+++||||+.+++|.+++.+. ..+++..+..|+.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~-~~~~~kl~d~g~~~~ 153 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVG-EDLVCKVADFGLARL 153 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEc-CCceEEEccccchhh
Confidence 99999999999999998763 46899999999999999999999988 99999999999998 568999999999976
Q ss_pred hhccCC--CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCH
Q 004564 178 LRKSHA--AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDP 253 (745)
Q Consensus 178 l~~~~~--~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~ 253 (745)
...... ....++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .+..+++..+..+..+ ......++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (261)
T cd05148 154 IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQITAGYRM-PCPAKCPQ 231 (261)
T ss_pred cCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHhCCcC-CCCCCCCH
Confidence 643221 1223667899999886 568899999999999999998 8999976 4456666666655433 23456789
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 254 el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.+.++|.+||+ +|.+|||+.+|++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 232 EIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=339.64 Aligned_cols=266 Identities=27% Similarity=0.445 Sum_probs=223.2
Q ss_pred CCCceeeE-eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCC
Q 004564 19 PTGRYGRY-NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 19 p~gRY~rl-~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~ 97 (745)
-..-|..| +++||.|-||+||-|++..+|+.||+|+|.+..+-.. .-..+++|+.||+++.||.||.+-.-|. ..
T Consensus 560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k--qesqlR~EVaILq~l~HPGiV~le~M~E--T~ 635 (888)
T KOG4236|consen 560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK--QESQLRNEVAILQNLHHPGIVNLECMFE--TP 635 (888)
T ss_pred HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc--hHHHHHHHHHHHHhcCCCCeeEEEEeec--CC
Confidence 33445444 3789999999999999999999999999987775443 3378999999999999999999988664 47
Q ss_pred CeEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCC--CcEEEcCcc
Q 004564 98 RNINFVTEMFTSGTLRQYRLK--HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQ--GEVKIGDLG 173 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k--~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~--g~VKL~DFG 173 (745)
+.+++|||.+.| ++.+.+.. .+++++..-+.++.|||.||.|||-++ |+|.||||+|||+...+ .+|||||||
T Consensus 636 ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFG 712 (888)
T KOG4236|consen 636 ERVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFG 712 (888)
T ss_pred ceEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeecccc
Confidence 899999999965 55555443 468999999999999999999999998 99999999999996543 489999999
Q ss_pred hhhhhhcc-CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC--CCCCCccc
Q 004564 174 LAAILRKS-HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG--KKPDSLYR 249 (745)
Q Consensus 174 lA~~l~~~-~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g--~~p~~l~~ 249 (745)
+|++.... .....+|||.|+|||++. ..|+..-|+||+|||+|--+.|.+||.+.. +|-.++.+. ..|...++
T Consensus 713 fARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE---dIndQIQNAaFMyPp~PW~ 789 (888)
T KOG4236|consen 713 FARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE---DINDQIQNAAFMYPPNPWS 789 (888)
T ss_pred ceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc---chhHHhhccccccCCCchh
Confidence 99988754 555678999999999997 579999999999999999999999998743 344444443 45777888
Q ss_pred CCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcccccccccccc
Q 004564 250 VKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDDCESNLRSLD 294 (745)
Q Consensus 250 ~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~~~~~l~~l~ 294 (745)
..++++.+||..+|+ ...+|.|+++.|.|||+|....-..++.+.
T Consensus 790 eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE 835 (888)
T KOG4236|consen 790 EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELE 835 (888)
T ss_pred hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHH
Confidence 999999999999999 999999999999999999766555555543
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=311.76 Aligned_cols=244 Identities=22% Similarity=0.327 Sum_probs=200.3
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~ 98 (745)
|.++| ++.+.||+|+||+||+|.+..++ .||+|+++.... ..+.+.+|+.+++.++||||+++++.+. ..
T Consensus 4 ~~~~~-~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~ 73 (262)
T cd05071 4 PRESL-RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVS---EE 73 (262)
T ss_pred ChHHe-eEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEEC---CC
Confidence 56777 88899999999999999887664 599998874321 2356888999999999999999999763 34
Q ss_pred eEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 99 NINFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
..|+||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++ +++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~-~~~~~~L~dfg~~~ 150 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLAR 150 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEc-CCCcEEeccCCcee
Confidence 579999999999999998764 35899999999999999999999988 99999999999997 56899999999997
Q ss_pred hhhccCCC---cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCC
Q 004564 177 ILRKSHAA---HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVK 251 (745)
Q Consensus 177 ~l~~~~~~---~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~ 251 (745)
........ ...++..|+|||++. +.++.++|||||||++|+|+| |..||.. ....+++..+..+..+ ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~ 228 (262)
T cd05071 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRM-PCPPEC 228 (262)
T ss_pred eccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CChHHHHHHHhcCCCC-CCcccc
Confidence 65433221 223667899999886 568999999999999999999 8889976 3455566666554332 233457
Q ss_pred CHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 252 DPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 252 s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
++.+.++|.+||+ +|.+||++.+++.
T Consensus 229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 229 PESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 8899999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=314.71 Aligned_cols=253 Identities=24% Similarity=0.384 Sum_probs=208.0
Q ss_pred eEeEEecccCceEEEEEEEc---CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeE
Q 004564 25 RYNEILGKGASKTVYRAFDE---YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~---~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~i 100 (745)
++.+.||+|++|.||+|.+. .++..||+|.++...........+.+..|+.+++.+ +||||+++++.+.. +..+
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~~~ 80 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DTKL 80 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CCEE
Confidence 67789999999999999864 467899999987554333345567788999999999 59999999998754 6789
Q ss_pred EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 101 NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
|+||||+.+++|.+++.+...+++..++.|+.|++.||.|||+.+ ++||||||+||+++ .++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLD-SEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEEECcccccccc
Confidence 999999999999999988888999999999999999999999987 99999999999998 458999999999876543
Q ss_pred cCC---CcccCCCCcCChhhhhhc---cCccccchhhhhHHHHHhhcCCCCCCCC---CHHHHHHHHHcCCCCCCcccCC
Q 004564 181 SHA---AHCVGTPEFMAPEVYEEA---YNELVDIYSFGMCILEMVTFEYPYSECT---HPAQIYKKVVSGKKPDSLYRVK 251 (745)
Q Consensus 181 ~~~---~~~vGTp~YmAPEvl~~~---ys~ksDIWSLGvILyELlTG~~Pf~~~~---~~~~i~kkv~~g~~p~~l~~~~ 251 (745)
... ....|++.|+|||.+.+. ++.++|+||||+++|+|+||..||.... ....+.+.+.....+ .....
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 235 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTM 235 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC--CCccc
Confidence 321 223589999999998642 6789999999999999999999996422 233444444444332 34457
Q ss_pred CHHHHHHHHHHhh-CccCCCC---HHHHhcCCCCCcc
Q 004564 252 DPEVRRFVEKCLA-TVSLRLS---ARELLNDPFLQID 284 (745)
Q Consensus 252 s~el~d~I~kcL~-dPskRpS---a~ELL~hPff~~~ 284 (745)
++.++++|.+||+ +|++||| +.++|+||||+..
T Consensus 236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 236 SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred CHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 8899999999999 9999998 6788999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=324.26 Aligned_cols=257 Identities=30% Similarity=0.414 Sum_probs=206.5
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCC-
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN- 97 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~- 97 (745)
..+|| .+.+.||+|+||+||+|.+..++..||+|++.... ........+.+|+.+|+.++||||+++++.+.....
T Consensus 13 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 13 VPDRY-RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred cccce-EEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 46678 67788999999999999999999999999886432 234455678899999999999999999998764321
Q ss_pred ---CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcch
Q 004564 98 ---RNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 174 (745)
Q Consensus 98 ---~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGl 174 (745)
..+++||||+ +++|..++. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ +.+.+||+|||+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~-~~~~~kl~dfg~ 164 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGL 164 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeeccc
Confidence 2568999998 779988765 467999999999999999999999988 99999999999998 568999999999
Q ss_pred hhhhhccCCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC-C--------
Q 004564 175 AAILRKSHAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK-K-------- 243 (745)
Q Consensus 175 A~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~-~-------- 243 (745)
+...... .....+++.|+|||++.+ .++.++|+||||+++|+|++|..||..........+.+.... .
T Consensus 165 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 165 ARQTDSE-MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred ccccccC-ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 8765432 233468999999998864 478899999999999999999999987544333222111100 0
Q ss_pred ------------C-------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 244 ------------P-------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 244 ------------p-------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
| ..+....++.+.++|.+||+ +|.+|||+.+++.||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 0 01123467789999999999 99999999999999999843
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=306.99 Aligned_cols=239 Identities=21% Similarity=0.327 Sum_probs=200.1
Q ss_pred eeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEE
Q 004564 24 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV 103 (745)
+.+.+.||+|+||.||+|.. .|..||+|.++.. ...+.+.+|+.+++.++|+||+++++++... +..++++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv 78 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIV 78 (256)
T ss_pred CeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEEE
Confidence 37889999999999999965 4888999987532 2356788999999999999999999976543 4678999
Q ss_pred EeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 104 TEMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
+||+.+++|.+++.+.. .+++..+..++.||+.||.|||+++ |+||||||+||+++ +++.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEc-CCCcEEecCCccceecccc
Confidence 99999999999987654 3889999999999999999999988 99999999999997 6689999999998754332
Q ss_pred CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHH
Q 004564 182 HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259 (745)
Q Consensus 182 ~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I 259 (745)
. ....++..|+|||++. ..++.++|||||||++|+|++ |+.||.. .+..++...+..+..+ ......++.++++|
T Consensus 156 ~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 232 (256)
T cd05082 156 Q-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPVVYDVM 232 (256)
T ss_pred C-CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHH
Confidence 2 2234567899999887 458899999999999999998 9999976 4566777767665443 34456789999999
Q ss_pred HHHhh-CccCCCCHHHHhc
Q 004564 260 EKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 260 ~kcL~-dPskRpSa~ELL~ 277 (745)
.+||. +|.+|||+.++++
T Consensus 233 ~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 233 KQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHhcCChhhCcCHHHHHH
Confidence 99999 9999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=310.50 Aligned_cols=241 Identities=22% Similarity=0.283 Sum_probs=190.1
Q ss_pred EecccCceEEEEEEEc--CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEec
Q 004564 29 ILGKGASKTVYRAFDE--YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 29 ~LG~GafgtVy~A~d~--~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
.||+|+||.||+|... .++..+|+|.++... .......+.+|+.+++.++||||+++++.+.+ ...+++||||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~ 76 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVMEF 76 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEEC
Confidence 5899999999999754 456789999876443 23344578889999999999999999998765 5678999999
Q ss_pred cCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 107 FTSGTLRQYRLKHK-----RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 107 ~~gGsL~~~l~k~~-----~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
+.+|+|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLT-ADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEECCccccccccCc
Confidence 99999999987532 4567788899999999999999988 99999999999998 5689999999998654322
Q ss_pred C----CCcccCCCCcCChhhhhh--------ccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCC--C-C
Q 004564 182 H----AAHCVGTPEFMAPEVYEE--------AYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKK--P-D 245 (745)
Q Consensus 182 ~----~~~~vGTp~YmAPEvl~~--------~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~--p-~ 245 (745)
. .....+++.|+|||++.+ .++.++||||||+++|||++ |..||............+..... + .
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 1 122357889999999853 25789999999999999996 99999875544433333332221 1 2
Q ss_pred CcccCCCHHHHHHHHHHhhCccCCCCHHHHhc
Q 004564 246 SLYRVKDPEVRRFVEKCLATVSLRLSARELLN 277 (745)
Q Consensus 246 ~l~~~~s~el~d~I~kcL~dPskRpSa~ELL~ 277 (745)
.+....++.+.+++..|+.+|.+|||+++|+.
T Consensus 234 ~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred ccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 22334678899999999989999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=308.91 Aligned_cols=241 Identities=24% Similarity=0.378 Sum_probs=199.6
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.+.||+|+||+||+|.... +..||+|.++... ...+.+.+|+.+++.++||||+++++++.. ...+++||
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-----MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYIVT 78 (256)
T ss_pred EEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-----ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEEEE
Confidence 777899999999999997653 4569999876332 123568899999999999999999998754 56789999
Q ss_pred eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCC
Q 004564 105 EMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 183 (745)
Q Consensus 105 E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~ 183 (745)
||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ ++|+||||+|||++ .++.+||+|||++........
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCCEEECCCccceecCCCce
Confidence 999999999998764 46899999999999999999999988 99999999999998 568999999999875533222
Q ss_pred Cc---ccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHH
Q 004564 184 AH---CVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRF 258 (745)
Q Consensus 184 ~~---~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~ 258 (745)
.. ..++..|+|||.+. ..++.++|||||||++|+|+| |..||... +...+...+..+..+. .....++.++++
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 233 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF-NNSETVEKVSQGLRLY-RPHLASEKVYAI 233 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHhcCCCCC-CCCCCCHHHHHH
Confidence 11 23557899999987 568899999999999999999 99999874 4555666676665443 344568899999
Q ss_pred HHHHhh-CccCCCCHHHHhcC
Q 004564 259 VEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 259 I~kcL~-dPskRpSa~ELL~h 278 (745)
+.+||+ +|.+||++.+++.+
T Consensus 234 i~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 234 MYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHcCCCcccCCCHHHHHHh
Confidence 999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.28 Aligned_cols=254 Identities=22% Similarity=0.275 Sum_probs=205.4
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEec---
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT--- 95 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~--- 95 (745)
-+.|| |+.+.||.|||+-||++....++..+|+|.|... ..++.+...+||+..++++||||++++++-+..
T Consensus 19 n~~Ry-ri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 19 NNKRY-RIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred cCceE-EEeeeecCCCceeeeeecccCcccchhhheeecc----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 35677 9999999999999999999999999999998744 357888999999999999999999999876542
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcC
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKH----KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 171 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~----~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~D 171 (745)
....+|+++.|+..|+|.+.+.+. ..+++..+..|+.+|++||++||+..||++||||||+|||+. ..+.++|.|
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls-~~~~~vl~D 172 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS-DSGLPVLMD 172 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec-CCCceEEEe
Confidence 245799999999999999987653 369999999999999999999999999999999999999997 468999999
Q ss_pred cchhhhhhccC-----------CCcccCCCCcCChhhhh----hccCccccchhhhhHHHHHhhcCCCCCCCC-CHHHHH
Q 004564 172 LGLAAILRKSH-----------AAHCVGTPEFMAPEVYE----EAYNELVDIYSFGMCILEMVTFEYPYSECT-HPAQIY 235 (745)
Q Consensus 172 FGlA~~l~~~~-----------~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~-~~~~i~ 235 (745)
||.++...-.. .....-|..|.|||++. ...++++|||||||+||+|+.|..||...- ....+-
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 99997653211 11123689999999997 246899999999999999999999994310 000000
Q ss_pred HHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 236 KKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 236 kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
-.+.++.....-...++..+.++|+.||+ ||.+||++.+|+.+
T Consensus 253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 01222332222233478999999999999 99999999999854
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=317.82 Aligned_cols=248 Identities=26% Similarity=0.412 Sum_probs=203.6
Q ss_pred CCCceeeEeEEecccCceEEEEEEEc-------CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeE
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDE-------YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYT 90 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~-------~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~ 90 (745)
|.++| .+.+.||+|+||.||+|.+. .....||+|.++.. ........+..|+.+++.+ +||||+++++
T Consensus 10 ~~~~~-~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 10 PRDRL-VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN---ATDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cHHHe-eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC---CChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 55678 78899999999999999763 23567999987633 2345577889999999999 6999999999
Q ss_pred EEEecCCCeEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCC
Q 004564 91 SWVDTANRNINFVTEMFTSGTLRQYRLKH----------------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLK 154 (745)
Q Consensus 91 sfvd~~~~~iyLV~E~~~gGsL~~~l~k~----------------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLK 154 (745)
++.+ ...+|++|||+.+|+|.+++... ..+++..+..++.||+.||.|||++| |+|||||
T Consensus 86 ~~~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlk 161 (314)
T cd05099 86 VCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLA 161 (314)
T ss_pred EEcc--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecccc
Confidence 8765 56799999999999999998764 24888999999999999999999988 9999999
Q ss_pred CcceeecCCCCcEEEcCcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCC
Q 004564 155 CDNIFVNGNQGEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSEC 228 (745)
Q Consensus 155 pdNILld~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~ 228 (745)
|+|||++ .++.+||+|||++....... .....+++.|||||++. +.++.++|||||||++|+|++ |..||..
T Consensus 162 p~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~- 239 (314)
T cd05099 162 ARNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG- 239 (314)
T ss_pred ceeEEEc-CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC-
Confidence 9999997 56899999999997654221 11123456899999886 568899999999999999999 8999976
Q ss_pred CCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 229 THPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 229 ~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.+...++..+..+..+. .....+.+++++|.+||. +|.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 240 IPVEELFKLLREGHRMD-KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 55677777776665433 234567889999999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=310.30 Aligned_cols=241 Identities=21% Similarity=0.289 Sum_probs=189.6
Q ss_pred EecccCceEEEEEEEcC--CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEec
Q 004564 29 ILGKGASKTVYRAFDEY--EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 29 ~LG~GafgtVy~A~d~~--tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
.||+|+||+||+|.... ....+|+|.+... ........+.+|+.+++.++||||+++++.+.. ....|+||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS---ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc---CChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEe
Confidence 58999999999996432 3456777765432 234455678899999999999999999998765 5679999999
Q ss_pred cCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 107 FTSGTLRQYRLKHK-----RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 107 ~~gGsL~~~l~k~~-----~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
+.+|+|.+++.+.. ..++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLT-ADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEec-CCCcEEEeccccccccccc
Confidence 99999999987753 2467888999999999999999998 99999999999998 5689999999998643221
Q ss_pred ----CCCcccCCCCcCChhhhhh--------ccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCC---C
Q 004564 182 ----HAAHCVGTPEFMAPEVYEE--------AYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKP---D 245 (745)
Q Consensus 182 ----~~~~~vGTp~YmAPEvl~~--------~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p---~ 245 (745)
......+++.|+|||++.. .++.++|||||||++|||++ |..||....+...+...+..+..+ .
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 1122346778999998742 36789999999999999999 789998755444444444443321 2
Q ss_pred CcccCCCHHHHHHHHHHhhCccCCCCHHHHhc
Q 004564 246 SLYRVKDPEVRRFVEKCLATVSLRLSARELLN 277 (745)
Q Consensus 246 ~l~~~~s~el~d~I~kcL~dPskRpSa~ELL~ 277 (745)
......++.+.+++..|+.+|.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred cccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 23445778899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.55 Aligned_cols=251 Identities=30% Similarity=0.483 Sum_probs=206.9
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccC-CCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL-QSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~-~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
|| .+.+.||+|+||+||+|.+..++..+++|+++..... ........+..|+.+++.++||||+++++.+.+ ....
T Consensus 1 ~y-~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 77 (260)
T cd08222 1 RY-ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAF 77 (260)
T ss_pred Cc-eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CCce
Confidence 56 7779999999999999999888887887776643321 122344567789999999999999999998865 5678
Q ss_pred EEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 101 NFVTEMFTSGTLRQYRLK----HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k----~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
++|+||+.+++|..++.+ ...+++..++.++.||+.||.|||+++ ++|+||||+||+++ .+.+||+|||++.
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~--~~~~~l~d~g~~~ 153 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLK--NNLLKIGDFGVSR 153 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEee--cCCEeecccCcee
Confidence 999999999999988753 356899999999999999999999988 99999999999996 3579999999987
Q ss_pred hhhccC--CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCH
Q 004564 177 ILRKSH--AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDP 253 (745)
Q Consensus 177 ~l~~~~--~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~ 253 (745)
...... .....|++.|+|||.+. ..++.++|+||||+++|+|++|..||.. .........+..+..|. +....+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (260)
T cd08222 154 LLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTPS-LPETYSR 231 (260)
T ss_pred ecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCCCCC-CcchhcH
Confidence 653321 22345889999999886 4578899999999999999999999976 34455555565555443 4456788
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 254 el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
++.++|.+||. +|.+||++.++++||||
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 232 QLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 99999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=315.64 Aligned_cols=252 Identities=26% Similarity=0.397 Sum_probs=200.9
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC-----
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA----- 96 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~----- 96 (745)
+| .+.+.||+|+||+||+|.+..+|..||+|.++.... .......+.+|+.+++.++||||+++++.+.+..
T Consensus 8 ~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 8 KF-DIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE--KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hh-heeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc--ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 44 677899999999999999999999999999875432 1223356778999999999999999999876532
Q ss_pred ---CCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCc
Q 004564 97 ---NRNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 172 (745)
Q Consensus 97 ---~~~iyLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DF 172 (745)
...+++|+||+.+ +|..++.+. ..+++..+..++.||+.||.|||+++ |+||||||+||+++ +.+.+||+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~kl~df 160 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADF 160 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCcEEeCcc
Confidence 2379999999976 677766654 46999999999999999999999988 99999999999998 5689999999
Q ss_pred chhhhhhccCC---CcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc---CCCC
Q 004564 173 GLAAILRKSHA---AHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS---GKKP 244 (745)
Q Consensus 173 GlA~~l~~~~~---~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~---g~~p 244 (745)
|++........ ....+++.|+|||++.+ .++.++|||||||++|+|++|++||........+ ..+.. +..+
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~-~~~~~~~~~~~~ 239 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL-ELISRLCGSPCP 239 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCh
Confidence 99976643321 22346889999998863 4788999999999999999999999764433322 22221 1111
Q ss_pred C-------------------------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 245 D-------------------------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 245 ~-------------------------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
. ......++.+.++|.+||+ +|++||++.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 1 0112357899999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=312.21 Aligned_cols=244 Identities=23% Similarity=0.391 Sum_probs=199.3
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeE----EEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCC
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIE----VAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~----VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~ 97 (745)
.| ++.+.||+|+||+||+|....++.. |++|.+.. ........++..|+.+++.++||||+++++++. .
T Consensus 8 ~~-~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~---~ 80 (279)
T cd05111 8 EL-RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD---RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP---G 80 (279)
T ss_pred hc-eeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc---ccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC---C
Confidence 45 6778899999999999998777764 66665532 123345567888999999999999999999764 3
Q ss_pred CeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 98 RNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
...++++||+.+|+|.+++... +.+++..+..|+.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++.
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~-~~~~~kl~Dfg~~~ 157 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLK-SDSIVQIADFGVAD 157 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEEcCCccce
Confidence 4678999999999999998764 57899999999999999999999988 99999999999998 56899999999997
Q ss_pred hhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccC
Q 004564 177 ILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRV 250 (745)
Q Consensus 177 ~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~ 250 (745)
...... .....++..|+|||.+. +.++.++|||||||++|||+| |..||.+. .+..+...+..+..+. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~ 235 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM-RPHEVPDLLEKGERLA-QPQI 235 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCCCcCC-CCCC
Confidence 653321 12234678899999986 569999999999999999998 99999773 4555555565555443 3345
Q ss_pred CCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 251 KDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 251 ~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.+..+.+++.+||. +|.+|||+.++++
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 236 CTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 67789999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=313.78 Aligned_cols=244 Identities=20% Similarity=0.253 Sum_probs=201.7
Q ss_pred eEeEEecccCceEEEEEEEcC-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 25 RYNEILGKGASKTVYRAFDEY-----EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~-----tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
++.+.||+|+||+||+|.+.. .+..||+|.++... .....+.+..|+.+++.++||||+++++.+.. ...
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~ 82 (283)
T cd05091 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK--EQP 82 (283)
T ss_pred HHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CCc
Confidence 677889999999999998754 36789999886332 23456778999999999999999999998755 567
Q ss_pred EEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCC
Q 004564 100 INFVTEMFTSGTLRQYRLKH----------------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGN 163 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~----------------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~ 163 (745)
+++++||+.+++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ +
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~-~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF-D 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec-C
Confidence 99999999999999997532 34788899999999999999999988 99999999999997 5
Q ss_pred CCcEEEcCcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHH
Q 004564 164 QGEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKK 237 (745)
Q Consensus 164 ~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kk 237 (745)
++.+||+|||++....... .....+++.|+|||.+. +.++.++|||||||++|||+| |..||.+ ....+++..
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~ 238 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVIEM 238 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHH
Confidence 6799999999987553221 12334678999999886 568999999999999999998 8889877 455677777
Q ss_pred HHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 238 VVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 238 v~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
+..+..+. .....+..+.+++.+||+ +|.+||++.+++..
T Consensus 239 i~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 239 IRNRQVLP-CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHcCCcCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 77665432 344578889999999999 99999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=326.15 Aligned_cols=255 Identities=30% Similarity=0.441 Sum_probs=206.3
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC--
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA-- 96 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~-- 96 (745)
-.++| .+.+.||+|++|.||+|.+..++..||+|.+.... ......+.+.+|+.+++.++||||+++++.+....
T Consensus 13 ~~~~y-~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 13 VPDRY-QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred ccCce-EEEEEeccCCceEEEEEEECCCCcEEEEEeccccc--chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 35567 67789999999999999999999999999876432 23345567888999999999999999998765422
Q ss_pred --CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcch
Q 004564 97 --NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 174 (745)
Q Consensus 97 --~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGl 174 (745)
...+++|+||+ +++|.+++.. .++++..+..++.||+.||.|||++| |+||||||+||+++ .++.+||+|||+
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~-~~~~~kL~dfg~ 164 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVN-EDCELKILDFGL 164 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEccccc
Confidence 13489999998 6799998765 57999999999999999999999988 99999999999998 568999999999
Q ss_pred hhhhhccCCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC--CCC-----
Q 004564 175 AAILRKSHAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK--KPD----- 245 (745)
Q Consensus 175 A~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~--~p~----- 245 (745)
+...... .....+++.|+|||++.+ .++.++|||||||++|+|+||+.||...... ..+..+.... .+.
T Consensus 165 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 165 ARHTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred ccccccc-ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHHHhh
Confidence 9766433 334468999999998864 5788999999999999999999999864433 3333332211 000
Q ss_pred ----------------------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 246 ----------------------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 246 ----------------------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
......++.+.+||.+||+ +|.+|||+.+||.||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 1112358899999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=316.05 Aligned_cols=247 Identities=31% Similarity=0.519 Sum_probs=205.2
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEecc
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMF 107 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~ 107 (745)
.+||+|+||.||+|....++..||+|.+... .......+.+|+.+++.++||||+++++.+.. ....++||||+
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~ 99 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVMEFL 99 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEecC
Confidence 5699999999999999999999999987532 23456678999999999999999999998876 67899999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC--CCc
Q 004564 108 TSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AAH 185 (745)
Q Consensus 108 ~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~--~~~ 185 (745)
.+++|.+++. ..++++..++.++.||+.||+|||++| ++||||+|.||+++ .++.++|+|||++....... ...
T Consensus 100 ~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 100 EGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEcccccceecccccccccc
Confidence 9999998764 456899999999999999999999988 99999999999998 55899999999986554322 223
Q ss_pred ccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-CcccCCCHHHHHHHHHHh
Q 004564 186 CVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPD-SLYRVKDPEVRRFVEKCL 263 (745)
Q Consensus 186 ~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~-~l~~~~s~el~d~I~kcL 263 (745)
..|++.|+|||.+. ..++.++|+||||+++|+|++|..||... ........+..+..+. ......++.+.+++.+||
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-PPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL 254 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence 46899999999886 46788999999999999999999999763 3344444443333221 122346889999999999
Q ss_pred h-CccCCCCHHHHhcCCCCCccc
Q 004564 264 A-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 264 ~-dPskRpSa~ELL~hPff~~~~ 285 (745)
. +|.+||++.++|.||||....
T Consensus 255 ~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 255 VRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred hCCcccCcCHHHHhcChHHhccC
Confidence 9 999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=303.55 Aligned_cols=243 Identities=27% Similarity=0.395 Sum_probs=205.8
Q ss_pred eEeEEecccCceEEEEEEEcCCC----eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEG----IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg----~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
.+.+.||.|+||.||+|.+...+ ..||+|.++... .....+.+..|+.+++.++|+||+++++.+.+ ....
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCee
Confidence 45678999999999999998776 899999886432 23367789999999999999999999998866 4789
Q ss_pred EEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 101 NFVTEMFTSGTLRQYRLKHKR--VNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~~--L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
+++|||+.+++|.+++..... +++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++...
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~-~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVG-ENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEc-cCCeEEEcccCCceec
Confidence 999999999999999877554 999999999999999999999998 99999999999998 5679999999999766
Q ss_pred hccCCC---cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCH
Q 004564 179 RKSHAA---HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDP 253 (745)
Q Consensus 179 ~~~~~~---~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~ 253 (745)
...... ...+++.|+|||.+. ..++.++||||||+++|+|++ |..||.. .+...++..+..+..+. .....+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRLP-KPENCPP 231 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCH
Confidence 543111 123678999999886 468999999999999999998 7888876 56677777777766543 3445789
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 254 el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.+.+++.+||. +|.+|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 99999999999 9999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=314.42 Aligned_cols=250 Identities=25% Similarity=0.456 Sum_probs=203.5
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyLV 103 (745)
.+.+.||.|+||+||+|.+..++..||+|.++... .......+..|+.++..+ .||||+++++++.+ ...+|++
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v 92 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDVFIC 92 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC---ChHHHHHHHHHHHHHHhccCCCchHhhheeeec--CCeEEEE
Confidence 77899999999999999999999999999987443 223455666787766666 59999999999876 6689999
Q ss_pred EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhh-CCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 104 TEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs-~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
|||+. ++|..++.. ...+++..+..++.||+.||.|||+ ++ |+||||+|+||+++ +++.+||+|||++..+...
T Consensus 93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~-~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEc-CCCCEEECccccchhccCC
Confidence 99985 577777665 4578999999999999999999997 46 99999999999998 5689999999998765432
Q ss_pred C-CCcccCCCCcCChhhhhh-----ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCc-ccCCCHH
Q 004564 182 H-AAHCVGTPEFMAPEVYEE-----AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSL-YRVKDPE 254 (745)
Q Consensus 182 ~-~~~~vGTp~YmAPEvl~~-----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l-~~~~s~e 254 (745)
. .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.......+.+..+..+..+... ....+.+
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHH
Confidence 2 223357889999999863 37889999999999999999999997654445555555554433221 2246789
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 255 VRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 255 l~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
+++||.+||. +|.+||++.++++||||+.
T Consensus 249 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 249 FCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred HHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 9999999999 9999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=312.65 Aligned_cols=249 Identities=28% Similarity=0.424 Sum_probs=203.9
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.+.||.|++|.||+|.+..++..+|+|.++.... .......+..|+.+|+.++||||+++++.+.+ ...+++|+
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 77 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KGDLYLVF 77 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCCEEEEE
Confidence 455789999999999999999999999998874432 22455678889999999999999999998765 57899999
Q ss_pred eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC-
Q 004564 105 EMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~- 182 (745)
||+.+ +|.+++.. ...+++..+..++.||+.||.|||+++ |+|+||||+||+++ .++.+||+|||.+.......
T Consensus 78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEEC-CCCcEEEeeeeeeEecCCCcc
Confidence 99975 88877766 468999999999999999999999998 99999999999998 56899999999987665432
Q ss_pred -CCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC---------------
Q 004564 183 -AAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP--------------- 244 (745)
Q Consensus 183 -~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p--------------- 244 (745)
.....++..|+|||.+.+ .++.++|+||||+++|+|+||+.||.......++.+.......+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 223458899999998863 58899999999999999999999998755544443332221111
Q ss_pred ------------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 245 ------------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 245 ------------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
.......+..+++||.+||+ +|.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 01112357789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=307.95 Aligned_cols=244 Identities=23% Similarity=0.327 Sum_probs=199.0
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~ 98 (745)
+.++| ++.+.||+|++|.||+|.+..++ .+|+|.+.... ...+.+.+|+.+++.++||||+++++.+. ..
T Consensus 4 ~~~~~-~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~ 73 (260)
T cd05069 4 PRESL-RLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT-----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS---EE 73 (260)
T ss_pred ChHHe-eeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC-----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc---CC
Confidence 44667 88899999999999999876554 59999875332 22456888999999999999999998763 34
Q ss_pred eEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 99 NINFVTEMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
..+++|||+.+++|.+++.+.. .+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~-~~~~~~l~dfg~~~ 150 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVG-DNLVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCeEEECCCccce
Confidence 6789999999999999987643 4889999999999999999999988 99999999999997 56899999999997
Q ss_pred hhhccCC---CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCC
Q 004564 177 ILRKSHA---AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVK 251 (745)
Q Consensus 177 ~l~~~~~---~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~ 251 (745)
....... ....++..|+|||... +.++.++||||||+++|+|+| |..||.+. ....+...+..+..+ ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 228 (260)
T cd05069 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-VNREVLEQVERGYRM-PCPQGC 228 (260)
T ss_pred EccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCccc
Confidence 6543221 1223667899999886 568899999999999999999 89999874 445555666554333 234457
Q ss_pred CHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 252 DPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 252 s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
+..+++++.+||. +|.+||+++++++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 229 PESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 8899999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=357.19 Aligned_cols=251 Identities=28% Similarity=0.397 Sum_probs=201.8
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
||| ++.++||+|+||+||+|.+..+|+.||+|+++... .......+++.+|+.+++.++||||+++++.+.+ ++.+
T Consensus 2 grY-eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l-~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~l 77 (932)
T PRK13184 2 QRY-DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPV 77 (932)
T ss_pred CCe-EEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc-ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEE
Confidence 678 78899999999999999999999999999986432 2344566789999999999999999999998765 6789
Q ss_pred EEEEeccCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEE
Q 004564 101 NFVTEMFTSGTLRQYRLKH-----------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI 169 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~-----------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL 169 (745)
|++|||+.||+|.+++... ..++...+..++.||+.||.|||++| |+||||||+|||++ .+|.+||
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd-~dg~vKL 154 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLG-LFGEVVI 154 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEc-CCCCEEE
Confidence 9999999999999987642 23566788999999999999999988 99999999999997 5689999
Q ss_pred cCcchhhhhhcc--------------------CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCC
Q 004564 170 GDLGLAAILRKS--------------------HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSEC 228 (745)
Q Consensus 170 ~DFGlA~~l~~~--------------------~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~ 228 (745)
+|||++...... .....+||+.|||||++. ..++.++|||||||++|||+||..||...
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 999999765110 111246999999999987 46899999999999999999999999764
Q ss_pred CCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 229 THPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 229 ~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
......+................++.+.+++.+||+ +|++|++..+.|.+
T Consensus 235 ~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 333322222222111112234567899999999999 99999877666644
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.00 Aligned_cols=247 Identities=28% Similarity=0.426 Sum_probs=197.0
Q ss_pred ceeeEeEEecccCceEEEEEE----EcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCC
Q 004564 22 RYGRYNEILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~----d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~ 97 (745)
+| ++.+.||+|+||+||+|. +..++..||+|.++.. .....+.+.+|+.+|+.++||||+++++++.....
T Consensus 5 ~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 5 HL-KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cc-eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 44 778999999999999986 5567899999987633 34567789999999999999999999998766556
Q ss_pred CeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 98 RNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
..+++||||+.+++|.+++.+. ..+++..+..++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEEC-CCCeEEECCCcccc
Confidence 6799999999999999998765 46899999999999999999999988 99999999999997 56899999999998
Q ss_pred hhhccCCC-----cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCH---------------HHHH
Q 004564 177 ILRKSHAA-----HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHP---------------AQIY 235 (745)
Q Consensus 177 ~l~~~~~~-----~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~---------------~~i~ 235 (745)
........ ...++..|+|||++. ..++.++|||||||++|||++|..|+...... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 66433221 112345699999887 46889999999999999999987775331100 0111
Q ss_pred HHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 236 KKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 236 kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
..+..+..+ ......+..+.++|.+||. +|.+|||+.++++
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 237 ELLKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHhcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 122222221 2234567899999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=338.17 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=218.4
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEecc
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMF 107 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~ 107 (745)
+.||-|+||.|.++....|...+|+|.+++.+++. ......++.|-.||...+.+.||++|-+|.| +.++||||+|+
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~-rnQvaHVKAERDILAEADn~WVVrLyySFQD--kdnLYFVMdYI 711 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM-RNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFVMDYI 711 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHh-hhhhhhhhhhhhhHhhcCCcceEEEEEEecc--CCceEEEEecc
Confidence 67999999999999999999999999998777654 4566778999999999999999999999987 78999999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC-----
Q 004564 108 TSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----- 182 (745)
Q Consensus 108 ~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~----- 182 (745)
.||+|-.++.+-+-+.++.++.|+.++..|+++.|..| +|||||||+||||| .+|+|||+||||++-+...+
T Consensus 712 PGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILID-rdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 712 PGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred CCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEc-cCCceeeeeccccccceeccccccc
Confidence 99999999999999999999999999999999999988 99999999999998 67999999999996542110
Q ss_pred ---------------------------------------CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcC
Q 004564 183 ---------------------------------------AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFE 222 (745)
Q Consensus 183 ---------------------------------------~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~ 222 (745)
....+||+.|+|||++. ..|+..+|+||.|||||||+.|+
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 12237999999999987 57999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCC--CCCcccCCCHHHHHHHHHHhhCccCCC---CHHHHhcCCCCCcccccccccc
Q 004564 223 YPYSECTHPAQIYKKVVSGKK--PDSLYRVKDPEVRRFVEKCLATVSLRL---SARELLNDPFLQIDDCESNLRS 292 (745)
Q Consensus 223 ~Pf~~~~~~~~i~kkv~~g~~--p~~l~~~~s~el~d~I~kcL~dPskRp---Sa~ELL~hPff~~~~~~~~l~~ 292 (745)
.||...+. .+...+|++... .......+++++.++|.++.+.++.|+ .++++..||||+..+... ++.
T Consensus 869 ~pf~~~tp-~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfss-lRk 941 (1034)
T KOG0608|consen 869 PPFLADTP-GETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSS-LRK 941 (1034)
T ss_pred CCccCCCC-CcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHh-hhh
Confidence 99987443 333334444332 223345679999999999999998887 488899999999877554 443
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=322.89 Aligned_cols=254 Identities=31% Similarity=0.447 Sum_probs=202.2
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC---
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA--- 96 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~--- 96 (745)
..+| .+.+.||+|+||.||+|.+..++..||+|.++... ......+.+.+|+.++++++||||+++++.+....
T Consensus 16 ~~~y-~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 16 PERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred cCce-EEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 4667 67789999999999999999999999999886432 22334567888999999999999999999875421
Q ss_pred -CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 97 -NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 97 -~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
...+|++++++ +++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~dfg~~ 167 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLA 167 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEc-CCCCEEEeccccc
Confidence 23578888876 7899887654 46999999999999999999999998 99999999999998 5689999999998
Q ss_pred hhhhccCCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CC---------
Q 004564 176 AILRKSHAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS--GK--------- 242 (745)
Q Consensus 176 ~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~--g~--------- 242 (745)
...... .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||....... .+..+.. +.
T Consensus 168 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 168 RHTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred cccccc-ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHhhc
Confidence 765332 233468999999998864 57889999999999999999999997643322 2222211 00
Q ss_pred --------------CCC----CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 243 --------------KPD----SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 243 --------------~p~----~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
.|. ......++.+++||.+||+ +|.+||++.++|.||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 000 0112357889999999999 9999999999999999973
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=321.71 Aligned_cols=260 Identities=21% Similarity=0.331 Sum_probs=218.2
Q ss_pred CceEeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEE
Q 004564 13 EFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTS 91 (745)
Q Consensus 13 ~~~e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~s 91 (745)
.|-+..-+..|..-.++||-|-.|.|-.++++.||+.+|+|++. +..+.++|+++.-.. .|||||.+++.
T Consensus 53 ~~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~---------Ds~KARrEVeLHw~~s~h~~iV~IidV 123 (400)
T KOG0604|consen 53 DFKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL---------DSPKARREVELHWMASGHPHIVSIIDV 123 (400)
T ss_pred chhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh---------cCHHHHhHhhhhhhhcCCCceEEeehh
Confidence 34444456677555578999999999999999999999999765 224567788875555 69999999998
Q ss_pred EEecC--CCeEEEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecC--CCC
Q 004564 92 WVDTA--NRNINFVTEMFTSGTLRQYRLKHKR--VNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG--NQG 165 (745)
Q Consensus 92 fvd~~--~~~iyLV~E~~~gGsL~~~l~k~~~--L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~--~~g 165 (745)
|.... .+.+.+|||.++||.|+..++.++. ++++.+..|++||..|+.|||+.+ |.||||||+|+|..+ .+.
T Consensus 124 yeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na 201 (400)
T KOG0604|consen 124 YENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNA 201 (400)
T ss_pred hhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCc
Confidence 75432 4678899999999999999988764 999999999999999999999999 999999999999954 334
Q ss_pred cEEEcCcchhhhhh-ccCCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCC---HHHHHHHHHc
Q 004564 166 EVKIGDLGLAAILR-KSHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTH---PAQIYKKVVS 240 (745)
Q Consensus 166 ~VKL~DFGlA~~l~-~~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~---~~~i~kkv~~ 240 (745)
.+||+|||+|+... +....+.+-||.|.|||++. +.|+..+|+||+|||||-|++|.+||..... ...+..+|..
T Consensus 202 ~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~ 281 (400)
T KOG0604|consen 202 PLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT 281 (400)
T ss_pred ceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc
Confidence 78999999998765 34455567899999999997 6799999999999999999999999965332 3345667777
Q ss_pred CC--CCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 241 GK--KPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 241 g~--~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
|. +|..-+...|..++++|.++|. +|++|+|+++++.|||+..
T Consensus 282 gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 282 GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 76 4777778889999999999999 9999999999999999974
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=320.14 Aligned_cols=251 Identities=27% Similarity=0.375 Sum_probs=200.8
Q ss_pred eEeEEecccCceEEEEEEEcCC--CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEec--CCCe
Q 004564 25 RYNEILGKGASKTVYRAFDEYE--GIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDT--ANRN 99 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~t--g~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~--~~~~ 99 (745)
++.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+.+|+.+++.+ +||||+++++.+... ....
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 7789999999999999999888 9999999876322 2233456788899999999 599999999875432 2346
Q ss_pred EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 100 INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
+|++++++. ++|..++.....+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..+.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~-~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVN-ADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEc-CCCCEEeCcCCCceecc
Confidence 788899885 689999888889999999999999999999999998 99999999999998 56899999999997654
Q ss_pred ccC------CCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--C--------
Q 004564 180 KSH------AAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS--G-------- 241 (745)
Q Consensus 180 ~~~------~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~--g-------- 241 (745)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ..+..+.. |
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEETLS 235 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHHHH
Confidence 221 223468999999998753 5889999999999999999999999763322 22211111 0
Q ss_pred ---------------CCC----CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 242 ---------------KKP----DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 242 ---------------~~p----~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
..+ .......++.+++|+.+||+ +|.+|||+.+|+.||||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~ 296 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence 000 11122357889999999999 999999999999999996
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=311.44 Aligned_cols=248 Identities=29% Similarity=0.405 Sum_probs=202.4
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceEeEEEEecCCCeEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-HpNIVk~~~sfvd~~~~~iyLV 103 (745)
.+.+.||.|++|+||+|.+..+++.||+|.+..... . .......+|+..++.++ ||||+++++.+.+ +...|+|
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv 76 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFV 76 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEE
Confidence 677899999999999999999999999998764321 1 22234557999999999 9999999998866 6789999
Q ss_pred EeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 104 TEMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
|||+ +|+|.+++.... .+++..+..++.||+.+|.|||+++ ++|+||+|+||+++ ..+.++|+|||++......
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~-~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVS-GPEVVKIADFGLAREIRSR 152 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCCEEEeecccceeccCC
Confidence 9999 789999887765 7899999999999999999999998 99999999999998 5689999999999766443
Q ss_pred C-CCcccCCCCcCChhhhh--hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-------------
Q 004564 182 H-AAHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPD------------- 245 (745)
Q Consensus 182 ~-~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~------------- 245 (745)
. .....++..|+|||++. ..++.++|+||||+++++|++|+.||........+++.......|.
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 2 23456899999999885 3578999999999999999999999987655555443322111100
Q ss_pred --------------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 246 --------------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 246 --------------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
......++.+.+||.+||+ +|.+|||++|++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0111235789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=314.63 Aligned_cols=249 Identities=25% Similarity=0.347 Sum_probs=197.9
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCC--------------CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYE--------------GIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~t--------------g~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpN 84 (745)
|..|| ++.+.||+|+||.||+|.+..+ ...||+|.++.. ......+.+.+|+++|+.++|||
T Consensus 3 ~~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~ei~~l~~l~h~~ 78 (295)
T cd05097 3 PRQQL-RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD---VTKTARNDFLKEIKIMSRLKNPN 78 (295)
T ss_pred chHhC-eehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCC
Confidence 45678 8889999999999999987543 235899987632 23456678999999999999999
Q ss_pred cceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeec
Q 004564 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRD 152 (745)
Q Consensus 85 IVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~------------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRD 152 (745)
|+++++++.. ...+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ ++|||
T Consensus 79 i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~d 154 (295)
T cd05097 79 IIRLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRD 154 (295)
T ss_pred cCeEEEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccc
Confidence 9999998865 678999999999999999986542 3688899999999999999999998 99999
Q ss_pred CCCcceeecCCCCcEEEcCcchhhhhhccCC----CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh--cCCCC
Q 004564 153 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT--FEYPY 225 (745)
Q Consensus 153 LKpdNILld~~~g~VKL~DFGlA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT--G~~Pf 225 (745)
|||+|||++ +++.+||+|||++........ ....+++.|+|||.+. +.++.++|||||||++|+|++ +..||
T Consensus 155 lkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~ 233 (295)
T cd05097 155 LATRNCLVG-NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233 (295)
T ss_pred cChhhEEEc-CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 999999998 567999999999876533221 1223577899999876 568999999999999999998 67888
Q ss_pred CCCCCHHHHHHHHHc-----CC-CCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 226 SECTHPAQIYKKVVS-----GK-KPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 226 ~~~~~~~~i~kkv~~-----g~-~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.... ..++...+.. +. .........++.+++||.+||+ +|.+||++.++++
T Consensus 234 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 234 SLLS-DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cccC-hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 7643 3443333211 11 1122234567899999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.50 Aligned_cols=237 Identities=21% Similarity=0.340 Sum_probs=196.3
Q ss_pred ecccCceEEEEEEEc--CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEecc
Q 004564 30 LGKGASKTVYRAFDE--YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMF 107 (745)
Q Consensus 30 LG~GafgtVy~A~d~--~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~ 107 (745)
||+|+||.||+|... ..+..||+|++... ......+.+.+|+.++++++||||+++++.+. ....++||||+
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~---~~~~~lv~e~~ 76 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE---NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE---AEALMLVMEMA 76 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccc---cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc---CCCeEEEEEeC
Confidence 899999999999765 45667999987643 23455677999999999999999999999763 35789999999
Q ss_pred CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCC---
Q 004564 108 TSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA--- 183 (745)
Q Consensus 108 ~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~--- 183 (745)
.+++|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++........
T Consensus 77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEc-CCCcEEeccCCccccccCCcccee
Confidence 99999999875 457899999999999999999999998 99999999999997 568999999999875533211
Q ss_pred --CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHH
Q 004564 184 --AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259 (745)
Q Consensus 184 --~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I 259 (745)
....+++.|+|||.+. +.++.++|||||||++|+|++ |..||... ....+...+..+..+. .....++++.++|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~l~~li 231 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQGKRLD-CPAECPPEMYALM 231 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCCC-CCCCCCHHHHHHH
Confidence 1112457899999886 568899999999999999996 99999874 4555666676666543 4456789999999
Q ss_pred HHHhh-CccCCCCHHHHhc
Q 004564 260 EKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 260 ~kcL~-dPskRpSa~ELL~ 277 (745)
.+||. +|.+||++.++++
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 99999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=307.96 Aligned_cols=246 Identities=23% Similarity=0.277 Sum_probs=204.7
Q ss_pred ceeeEeEEecccCceEEEEEEEcC----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCC
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEY----EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~----tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~ 97 (745)
+| ++.++||+|+||.||+|.+.. ++..||+|.++.. ......+.+.+|+.+|+.++||||++++++++.. +
T Consensus 7 ~~-~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~ 81 (280)
T cd05043 7 RV-TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-G 81 (280)
T ss_pred he-EEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-C
Confidence 44 888999999999999999876 3688999987522 3456678899999999999999999999987653 4
Q ss_pred CeEEEEEeccCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEE
Q 004564 98 RNINFVTEMFTSGTLRQYRLKH--------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI 169 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k~--------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL 169 (745)
...+++++|+.+++|..++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ ..+.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEc-CCCcEEE
Confidence 6789999999999999998764 35889999999999999999999988 99999999999997 5589999
Q ss_pred cCcchhhhhhccCC----CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCC
Q 004564 170 GDLGLAAILRKSHA----AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKK 243 (745)
Q Consensus 170 ~DFGlA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~ 243 (745)
+|||+++.+..... ....++..|+|||++. ..++.++|||||||++|+|++ |+.||... ++..+...+..+..
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI-DPFEMAAYLKDGYR 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC-CHHHHHHHHHcCCC
Confidence 99999976533211 1234677899999886 458899999999999999999 99999874 56677776666654
Q ss_pred CCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 244 PDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 244 p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
+. .....++++.+++.+||. +|++|||+.++++
T Consensus 238 ~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 LA-QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 33 234467899999999999 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.61 Aligned_cols=239 Identities=26% Similarity=0.367 Sum_probs=198.0
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEecc
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMF 107 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~ 107 (745)
++||+|+||.||+|.+.. ++.||+|.++.... ......+.+|+.++++++||||+++++++.+ ....++|+||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEEcC
Confidence 469999999999999887 99999998875432 2466789999999999999999999998765 56889999999
Q ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCC---
Q 004564 108 TSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA--- 183 (745)
Q Consensus 108 ~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~--- 183 (745)
.+++|.+++.+. ..+++..+..++.|++.+|.|||+++ ++||||||+|||++ .++.+||+|||++........
T Consensus 75 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~ 151 (251)
T cd05041 75 PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSREEEGGIYTVS 151 (251)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEc-CCCcEEEeeccccccccCCcceec
Confidence 999999998664 56899999999999999999999998 99999999999998 568999999999876542111
Q ss_pred -CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHH
Q 004564 184 -AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVE 260 (745)
Q Consensus 184 -~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~ 260 (745)
....++..|+|||.+. +.++.++|+||||+++|+|+| |..||... ........+..+.. .......+..+.+++.
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 229 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERIESGYR-MPAPQLCPEEIYRLML 229 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC-CHHHHHHHHhcCCC-CCCCccCCHHHHHHHH
Confidence 1122456799999886 568899999999999999999 88999763 34555555554432 2234566889999999
Q ss_pred HHhh-CccCCCCHHHHhc
Q 004564 261 KCLA-TVSLRLSARELLN 277 (745)
Q Consensus 261 kcL~-dPskRpSa~ELL~ 277 (745)
+||. +|.+|||+.++|+
T Consensus 230 ~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 230 QCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHhccChhhCcCHHHHHH
Confidence 9999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.30 Aligned_cols=247 Identities=21% Similarity=0.267 Sum_probs=202.5
Q ss_pred CCceeeEeEEecccCceEEEEEEEc-----CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEe
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDE-----YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVD 94 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~-----~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd 94 (745)
..+| ++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNI-EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhc-eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 3455 77788999999999999874 367899999876332 34556778999999999999999999998765
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeec
Q 004564 95 TANRNINFVTEMFTSGTLRQYRLKHK----------------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRD 152 (745)
Q Consensus 95 ~~~~~iyLV~E~~~gGsL~~~l~k~~----------------------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRD 152 (745)
+..+++|+||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ ++|||
T Consensus 80 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~d 155 (288)
T cd05050 80 --GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRD 155 (288)
T ss_pred --CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eeccc
Confidence 567899999999999999987542 3678889999999999999999988 99999
Q ss_pred CCCcceeecCCCCcEEEcCcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCC
Q 004564 153 LKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYS 226 (745)
Q Consensus 153 LKpdNILld~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~ 226 (745)
|||+|||++ .++.+||+|||++....... ......++.|+|||.+. +.++.++|||||||++|+|++ |..||.
T Consensus 156 l~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 156 LATRNCLVG-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred ccHhheEec-CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999997 56899999999987543221 11223567899999886 568999999999999999998 888997
Q ss_pred CCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 227 ECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 227 ~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
+ ....++...+..+..+. .....+.++.+||.+||+ +|.+|||+.|+++
T Consensus 235 ~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 235 G-MAHEEVIYYVRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred C-CCHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6 45566667676665432 234567899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=312.15 Aligned_cols=243 Identities=23% Similarity=0.371 Sum_probs=199.9
Q ss_pred eEeEEecccCceEEEEEEEcC-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 25 RYNEILGKGASKTVYRAFDEY-----EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~-----tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
++.++||+|+||+||+|.+.. ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.. ...
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 77 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DGP 77 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCC
Confidence 677899999999999998753 23578888775332 34456789999999999999999999998765 567
Q ss_pred EEEEEeccCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCC
Q 004564 100 INFVTEMFTSGTLRQYRLKH------------------------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKC 155 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~------------------------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKp 155 (745)
.++++||+.+++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp 155 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAA 155 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhh
Confidence 89999999999999997653 24788999999999999999999988 99999999
Q ss_pred cceeecCCCCcEEEcCcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCC
Q 004564 156 DNIFVNGNQGEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECT 229 (745)
Q Consensus 156 dNILld~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~ 229 (745)
+|||++ +++.+||+|||++....... .....++..|+|||.+. ..++.++||||||+++|+|+| |..||.+ .
T Consensus 156 ~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~ 233 (290)
T cd05045 156 RNVLVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-I 233 (290)
T ss_pred heEEEc-CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC-C
Confidence 999997 56899999999987643221 11224577899999876 568899999999999999999 9999976 5
Q ss_pred CHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 230 HPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 230 ~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.+..++..+..+..+. .....+..+.+|+.+||+ +|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 234 APERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 5677777666554433 345578899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.73 Aligned_cols=243 Identities=23% Similarity=0.340 Sum_probs=200.0
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
..+| ++.+.||+|+||+||+|.+. .+..||+|.+.... ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~-~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 75 (261)
T cd05034 5 RESL-KLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEP 75 (261)
T ss_pred hhhe-eeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-----cCHHHHHHHHHHHhhCCCCCEeeeeeeeec--CCc
Confidence 4456 88899999999999999876 45789999876432 234578899999999999999999998754 567
Q ss_pred EEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 100 INFVTEMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
+++||||+.+++|.+++.... .+++..+..|+.||+.||.|||+++ |+|+||||+||+++ .++.+||+|||++..
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~ 152 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVG-ENLVCKIADFGLARL 152 (261)
T ss_pred eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEc-CCCCEEECcccccee
Confidence 999999999999999987653 6899999999999999999999998 99999999999997 568999999999876
Q ss_pred hhccCC---CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCC
Q 004564 178 LRKSHA---AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 178 l~~~~~---~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s 252 (745)
...... ....++..|+|||.+. +.++.++||||||+++|+|+| |+.||.+. ........+..+..+. .....+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~ 230 (261)
T cd05034 153 IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-TNREVLEQVERGYRMP-RPPNCP 230 (261)
T ss_pred ccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCC
Confidence 543211 1123467899999887 468889999999999999999 99999874 4555666665553322 233457
Q ss_pred HHHHHHHHHHhh-CccCCCCHHHHh
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELL 276 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRpSa~ELL 276 (745)
..+.+++.+||. +|.+||++++++
T Consensus 231 ~~~~~~i~~~l~~~p~~Rp~~~~l~ 255 (261)
T cd05034 231 EELYDLMLQCWDKDPEERPTFEYLQ 255 (261)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHH
Confidence 899999999999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.86 Aligned_cols=243 Identities=22% Similarity=0.348 Sum_probs=200.0
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
...| ++.++||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++. ...
T Consensus 5 ~~~~-~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~ 74 (260)
T cd05067 5 RETL-KLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-----MSPEAFLAEANLMKQLQHPRLVRLYAVVT---QEP 74 (260)
T ss_pred hHHc-eeeeeeccCccceEEeeecC-CCceEEEEEecCCC-----CcHHHHHHHHHHHHhcCCcCeeeEEEEEc---cCC
Confidence 3445 78899999999999999865 57789999876332 23457889999999999999999999753 356
Q ss_pred EEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 100 INFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
++++|||+.+++|.+++.+. ..+++..+..++.||+.||+|||+++ ++||||||+||+++ .++.++|+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~ 151 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARL 151 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEc-CCCCEEEccCcceee
Confidence 89999999999999988764 36899999999999999999999988 99999999999998 568999999999876
Q ss_pred hhccCC---CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCC
Q 004564 178 LRKSHA---AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 178 l~~~~~---~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s 252 (745)
...... ....++..|+|||++. ..++.++||||||+++|+|++ |+.||.+. +...+.+.+..+..+ ......+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 229 (260)
T cd05067 152 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQNLERGYRM-PRPDNCP 229 (260)
T ss_pred cCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHcCCCC-CCCCCCC
Confidence 542221 1234567899999886 568889999999999999999 99999874 445566666555433 3344567
Q ss_pred HHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.++.++|.+||. +|.+||++++++.
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 230 EELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHH
Confidence 899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.57 Aligned_cols=249 Identities=23% Similarity=0.359 Sum_probs=196.9
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcC----------------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEY----------------EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~----------------tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~H 82 (745)
|.++| .+.+.||+|+||+||+|.+.. ++..||+|.++... .....+.+.+|+.+|+.++|
T Consensus 3 ~~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~ 78 (296)
T cd05095 3 PRKRL-TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKD 78 (296)
T ss_pred Chhhc-eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCC
Confidence 56777 888999999999999985432 34578999876332 34556789999999999999
Q ss_pred CCcceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEee
Q 004564 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK-----------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHR 151 (745)
Q Consensus 83 pNIVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~-----------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHR 151 (745)
|||+++++++.. ...+++||||+.+++|.+++.+.. .+++..+..++.||+.||+|||+++ |+||
T Consensus 79 ~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~ 154 (296)
T cd05095 79 PNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHR 154 (296)
T ss_pred CCcceEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecc
Confidence 999999998866 567899999999999999987643 3667889999999999999999998 9999
Q ss_pred cCCCcceeecCCCCcEEEcCcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh--cCCC
Q 004564 152 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT--FEYP 224 (745)
Q Consensus 152 DLKpdNILld~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT--G~~P 224 (745)
||||+|||++ .++.+||+|||++..+.... .....+++.|+|||... +.++.++|||||||++|||+| |..|
T Consensus 155 dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 155 DLATRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred cCChheEEEc-CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence 9999999997 56899999999987653322 11223467899999765 678999999999999999998 7799
Q ss_pred CCCCCCHHHHHHHHHc-----CC-CCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 225 YSECTHPAQIYKKVVS-----GK-KPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 225 f~~~~~~~~i~kkv~~-----g~-~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
|.... ..++...+.. +. .........++.+++|+.+||+ +|.+||++.++++
T Consensus 234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 234 YSQLS-DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccccC-hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 97643 3333332211 10 1111223456899999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.49 Aligned_cols=248 Identities=26% Similarity=0.409 Sum_probs=203.9
Q ss_pred CCceeeEeEEecccCceEEEEEEEc-------CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEE
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDE-------YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTS 91 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~-------~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~s 91 (745)
..+| .+.+.||+|+||.||+|.+. .++..||+|.++.. ........+.+|+.+++.+ +||||++++++
T Consensus 14 ~~~~-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 14 RDKL-TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred HHHe-eecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc---cchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 3445 78899999999999999742 34567999987632 2345567899999999999 89999999998
Q ss_pred EEecCCCeEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCC
Q 004564 92 WVDTANRNINFVTEMFTSGTLRQYRLKHK----------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKC 155 (745)
Q Consensus 92 fvd~~~~~iyLV~E~~~gGsL~~~l~k~~----------------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKp 155 (745)
+.. ...+|+||||+.+|+|.+++.+.. .++...+..++.||+.||.|||++| |+||||||
T Consensus 90 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 165 (304)
T cd05101 90 CTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAA 165 (304)
T ss_pred Eec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 765 578999999999999999987642 4778889999999999999999998 99999999
Q ss_pred cceeecCCCCcEEEcCcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCC
Q 004564 156 DNIFVNGNQGEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECT 229 (745)
Q Consensus 156 dNILld~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~ 229 (745)
+|||++ .++.+||+|||++....... .....+++.|+|||++. ..++.++||||||+++|+|+| |..||.. .
T Consensus 166 ~Nili~-~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~ 243 (304)
T cd05101 166 RNVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-I 243 (304)
T ss_pred ceEEEc-CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc-C
Confidence 999997 56899999999997654321 11223667899999886 468999999999999999998 7888876 4
Q ss_pred CHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 230 HPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 230 ~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
+..++++.+..+..+. .....+..+++||.+||. +|.+|||+.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 244 PVEELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 6777777776665432 334578899999999999 99999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.33 Aligned_cols=250 Identities=31% Similarity=0.373 Sum_probs=198.0
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC---CCCCcceEeEEEEecCC---C
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL---KHKNIMKFYTSWVDTAN---R 98 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L---~HpNIVk~~~sfvd~~~---~ 98 (745)
++.+.||+|+||.||+|.+..++..||+|.++.... .......+.+|+.+++.+ +||||+++++++..... .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 677889999999999999998999999999875432 222334566788777666 59999999999876322 2
Q ss_pred eEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 99 NINFVTEMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
.++++|||+.+ +|.+++.+.. .+++..++.++.||+.||.|||+++ ++|+||+|+||+++. ++.+||+|||++.
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~-~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTS-DGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEcc-CCCEEEeccCcce
Confidence 38999999974 8988887643 5899999999999999999999988 999999999999985 4899999999987
Q ss_pred hhhccC-CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC-CC------C---
Q 004564 177 ILRKSH-AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG-KK------P--- 244 (745)
Q Consensus 177 ~l~~~~-~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g-~~------p--- 244 (745)
...... .....+++.|+|||++. ..++.++|+|||||++|+|+||..||....... .+.++... .. +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCChHhcCCCc
Confidence 764332 22345889999999886 468899999999999999999999998744433 33333221 00 0
Q ss_pred ---------------CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 245 ---------------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 245 ---------------~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
.......++.+.++|.+||+ +|++||++.++|.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00111235778999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.33 Aligned_cols=240 Identities=25% Similarity=0.365 Sum_probs=195.4
Q ss_pred EEecccCceEEEEEEEcCCCeE--EEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEEEE
Q 004564 28 EILGKGASKTVYRAFDEYEGIE--VAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~--VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++||+|+||.||+|.+..++.. +|+|.++.. ......+.+..|+.+++.+ +||||+++++++.. ...+|++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc---CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEE
Confidence 4699999999999999888764 577766522 2345567889999999999 89999999998765 56789999
Q ss_pred eccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEE
Q 004564 105 EMFTSGTLRQYRLKHK----------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVK 168 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~----------------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VK 168 (745)
||+.+|+|.+++.+.. .+++..+..++.||+.||+|||+++ ++||||||+|||++ .++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~-~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEc-CCCeEE
Confidence 9999999999987643 4789999999999999999999988 99999999999998 568999
Q ss_pred EcCcchhhhhhccCC-CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCC
Q 004564 169 IGDLGLAAILRKSHA-AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPD 245 (745)
Q Consensus 169 L~DFGlA~~l~~~~~-~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~ 245 (745)
|+|||++........ .....++.|+|||++. ..++.++|||||||++|+|++ |..||.. .+...++..+..+..+.
T Consensus 153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~~~ 231 (270)
T cd05047 153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRLE 231 (270)
T ss_pred ECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhCCCCCC
Confidence 999999853322111 1123466799999886 568899999999999999997 9999976 45556666666554332
Q ss_pred CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 246 SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 246 ~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.....+.++.+++.+||. +|.+|||+.+++.
T Consensus 232 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 232 -KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 334567899999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.86 Aligned_cols=246 Identities=25% Similarity=0.410 Sum_probs=204.6
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCe----EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEec
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGI----EVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT 95 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~----~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~ 95 (745)
.++| ++.+.||+|+||+||+|.+..+|. .||+|.++... .......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~-~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 6 ETEL-EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred HHHc-EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 4566 888999999999999998876664 58888765332 35566788999999999999999999998764
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcch
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 174 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGl 174 (745)
..+++||||+.+|+|.+++.+. ..+++..+..|+.||+.||+|||+++ |+||||||+||+++ .++.+||+|||+
T Consensus 81 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kL~dfg~ 155 (279)
T cd05057 81 --SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVK-TPQHVKITDFGL 155 (279)
T ss_pred --CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEc-CCCeEEECCCcc
Confidence 6789999999999999998774 46899999999999999999999988 99999999999997 567999999999
Q ss_pred hhhhhccCCC----cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcc
Q 004564 175 AAILRKSHAA----HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLY 248 (745)
Q Consensus 175 A~~l~~~~~~----~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~ 248 (745)
+......... ...++..|+|||.+. ..++.++|+||||+++|||+| |..||.. ....++...+..+... ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~ 233 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG-IPAVEIPDLLEKGERL-PQP 233 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhCCCCC-CCC
Confidence 9766432211 112457899999886 568899999999999999999 9999987 4567777777765433 234
Q ss_pred cCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 249 RVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 249 ~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
...+..+.+++.+||. +|..||++.++++
T Consensus 234 ~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 234 PICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 4578899999999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=304.95 Aligned_cols=246 Identities=21% Similarity=0.335 Sum_probs=202.0
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCC---eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCC
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEG---IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg---~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~ 97 (745)
++| ++.+.||+|+||.||+|.+..++ ..+|+|.++... .....+.+..|+.+++.++||||+++++++.. +
T Consensus 4 ~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 77 (267)
T cd05066 4 SCI-KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--S 77 (267)
T ss_pred HHe-EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence 356 78899999999999999886544 379988876332 24456788999999999999999999998754 5
Q ss_pred CeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 98 RNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
..+|+||||+.+++|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~~~~l~dfg~~~ 154 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVN-SNLVCKVSDFGLSR 154 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEEC-CCCeEEeCCCCccc
Confidence 7899999999999999998775 46899999999999999999999988 99999999999997 56799999999997
Q ss_pred hhhccCC-----CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCccc
Q 004564 177 ILRKSHA-----AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYR 249 (745)
Q Consensus 177 ~l~~~~~-----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~ 249 (745)
....... ....++..|+|||.+. +.++.++|+||||+++|+|++ |..||.+. ...++...+..+..+. ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~ 232 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKAIEEGYRLP-APM 232 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHHHhCCCcCC-CCC
Confidence 6543221 1112356899999987 568999999999999999886 99999874 3455666666654332 233
Q ss_pred CCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 250 VKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 250 ~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
..++.+.+++.+||+ +|.+||++.++++
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 233 DCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 567899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=304.35 Aligned_cols=233 Identities=22% Similarity=0.334 Sum_probs=188.8
Q ss_pred EEecccCceEEEEEEEcCCC----------eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCC
Q 004564 28 EILGKGASKTVYRAFDEYEG----------IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg----------~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~ 97 (745)
+.||+|+||.||+|.+..++ ..|++|.+.... .....+.+|+.+|+.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR--- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec---
Confidence 46999999999999998777 457777665322 226778899999999999999999998765
Q ss_pred CeEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCC-------cEEE
Q 004564 98 RNINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQG-------EVKI 169 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k~~-~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g-------~VKL 169 (745)
...++||||+.+|+|.+++.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.. + .+||
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~-~~~~~~~~~~kl 149 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARY-GLNEGYVPFIKL 149 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecC-ccccCCceeEEe
Confidence 45789999999999999988766 7999999999999999999999988 9999999999999743 4 6999
Q ss_pred cCcchhhhhhccCCCcccCCCCcCChhhhhh---ccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCC
Q 004564 170 GDLGLAAILRKSHAAHCVGTPEFMAPEVYEE---AYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPD 245 (745)
Q Consensus 170 ~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~ 245 (745)
+|||++..... .....++..|+|||++.+ .++.++||||||+++|+|++ |..||.... ............
T Consensus 150 ~Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~~--- 223 (259)
T cd05037 150 SDPGIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQH--- 223 (259)
T ss_pred CCCCccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcCC---
Confidence 99999976543 223457889999999874 58899999999999999999 588887654 222222222111
Q ss_pred CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 246 SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 246 ~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.........+.++|.+||. +|.+|||+.++++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 224 RLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1122234789999999999 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.57 Aligned_cols=248 Identities=21% Similarity=0.312 Sum_probs=203.8
Q ss_pred CceeeEeEEecccCceEEEEEEEcC-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEec
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEY-----EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT 95 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~-----tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~ 95 (745)
.+| ++.+.||+|+||+||+|..+. +...||+|.+... ......+.+..|+.+|+.++||||+++++++.+
T Consensus 5 ~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 79 (275)
T cd05046 5 SNL-QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT---KDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE- 79 (275)
T ss_pred Hhc-eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc---cchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-
Confidence 445 667889999999999998654 3467888876532 223457789999999999999999999997754
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCc
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKHK---------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGE 166 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~~---------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~ 166 (745)
....++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.
T Consensus 80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~ 155 (275)
T cd05046 80 -AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVS-SQRE 155 (275)
T ss_pred -CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEe-CCCc
Confidence 567899999999999999988766 6899999999999999999999998 99999999999997 5689
Q ss_pred EEEcCcchhhhhhccC---CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcC
Q 004564 167 VKIGDLGLAAILRKSH---AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSG 241 (745)
Q Consensus 167 VKL~DFGlA~~l~~~~---~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g 241 (745)
++|+|||++....... .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ....++..+..+
T Consensus 156 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-~~~~~~~~~~~~ 234 (275)
T cd05046 156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-SDEEVLNRLQAG 234 (275)
T ss_pred EEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-chHHHHHHHHcC
Confidence 9999999986543221 12234678899999876 567889999999999999999 88999764 345566666666
Q ss_pred CCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 242 KKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 242 ~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
..+.......+..+.+++.+||+ +|.+|||+.+++..
T Consensus 235 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 55444455678899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=304.53 Aligned_cols=244 Identities=20% Similarity=0.316 Sum_probs=200.4
Q ss_pred eeEeEEecccCceEEEEEEEcCCCe---EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 24 GRYNEILGKGASKTVYRAFDEYEGI---EVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d~~tg~---~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
+++.+.||+|+||.||+|.+..++. .||+|.++.. ........+..|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~ 80 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SRPV 80 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--CCce
Confidence 4889999999999999999887665 6999987633 235567889999999999999999999998754 6778
Q ss_pred EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 101 NFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
++||||+.+++|.+++... +.+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~-~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEc-CCCcEEECCCccccccc
Confidence 9999999999999998764 56899999999999999999999988 99999999999998 45799999999987654
Q ss_pred ccCCC-----ccc--CCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccC
Q 004564 180 KSHAA-----HCV--GTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRV 250 (745)
Q Consensus 180 ~~~~~-----~~v--GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~ 250 (745)
..... ... .+..|+|||.+. +.++.++|||||||++|||++ |..||... ....+.+.+..... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~-~~~~~~~~i~~~~~-~~~~~~ 235 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVINAIEQDYR-LPPPMD 235 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCc-CCCccc
Confidence 32111 111 245799999987 568999999999999999886 99999763 44556666654432 222345
Q ss_pred CCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 251 KDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 251 ~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.++.+.+++.+||+ +|.+||++.+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 67889999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.47 Aligned_cols=242 Identities=22% Similarity=0.330 Sum_probs=198.1
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCe
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~ 99 (745)
..+| ++.+.||+|+||.||+|.+. .+..||+|.++.... ..+.+.+|+.+++.++||||+++++.+. ...
T Consensus 5 ~~~~-~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~ 74 (260)
T cd05070 5 RESL-QLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-----SPESFLEEAQIMKKLRHDKLVQLYAVVS---EEP 74 (260)
T ss_pred hHHh-hhhheeccccCceEEEEEec-CCceeEEEEecCCCC-----CHHHHHHHHHHHHhcCCCceEEEEeEEC---CCC
Confidence 3456 77889999999999999876 556799998874332 2356889999999999999999999763 356
Q ss_pred EEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 100 INFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
+|++|||+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ +++.+||+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~-~~~~~~l~dfg~~~~ 151 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVG-DGLVCKIADFGLARL 151 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEe-CCceEEeCCceeeee
Confidence 89999999999999998764 45899999999999999999999988 99999999999997 568999999999976
Q ss_pred hhccCCC---cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCC
Q 004564 178 LRKSHAA---HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 178 l~~~~~~---~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s 252 (745)
+...... ...++..|+|||.+. ..++.++||||||+++|+|++ |..||... +...+...+..+..+ ......+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 229 (260)
T cd05070 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQVERGYRM-PCPQDCP 229 (260)
T ss_pred ccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCC
Confidence 5432211 223566899999876 568899999999999999999 89999774 445555666554333 2345678
Q ss_pred HHHHHHHHHHhh-CccCCCCHHHHh
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELL 276 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRpSa~ELL 276 (745)
..+++++.+||. +|.+|||+.+++
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHH
Confidence 899999999999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=337.52 Aligned_cols=245 Identities=24% Similarity=0.362 Sum_probs=207.7
Q ss_pred EeEEecccCceEEEEEEEcCCCe---E-EEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 26 YNEILGKGASKTVYRAFDEYEGI---E-VAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 26 l~e~LG~GafgtVy~A~d~~tg~---~-VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
+.++||+|+||.||+|..+..+. . ||+|..+... ....+.+..+.+|+++|++|+|||||+|||..++ ...+|
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~--~~Pl~ 237 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL--EEPLM 237 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCccE
Confidence 44889999999999997765432 3 8999887422 3457889999999999999999999999997655 78999
Q ss_pred EEEeccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 102 FVTEMFTSGTLRQYRLKHKR-VNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~~-L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
+|||+|.||+|.+|+++.+. ++......++.+.+.||+|||+++ +|||||-..|+|++ .++.+||+|||+++....
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~-~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYS-KKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheec-CCCeEEeCccccccCCcc
Confidence 99999999999999999885 999999999999999999999998 99999999999997 556789999999876542
Q ss_pred cCCC--cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHH
Q 004564 181 SHAA--HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVR 256 (745)
Q Consensus 181 ~~~~--~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~ 256 (745)
.... ..--...|+|||.+. +.|++++|||||||++||+.+ |..||.+ ....++..+|.....+...+...++.+.
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g-~~~~~v~~kI~~~~~r~~~~~~~p~~~~ 393 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG-MKNYEVKAKIVKNGYRMPIPSKTPKELA 393 (474)
T ss_pred eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC-CCHHHHHHHHHhcCccCCCCCCCHHHHH
Confidence 2111 122457899999997 679999999999999999998 8889998 5677888888555555556667788999
Q ss_pred HHHHHHhh-CccCCCCHHHHhc
Q 004564 257 RFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 257 d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.++.+|+. +|..||++.++.+
T Consensus 394 ~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 394 KVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHhccCChhhccCHHHHHH
Confidence 99999999 9999999998764
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=300.23 Aligned_cols=240 Identities=23% Similarity=0.336 Sum_probs=196.9
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEecc
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMF 107 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~ 107 (745)
++||+|+||.||+|... ++..||+|.++... .......+.+|+.+++.++||||+++++.+.. ...+++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECC
Confidence 46999999999999864 68899999875322 34445578899999999999999999998765 56789999999
Q ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCC---
Q 004564 108 TSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA--- 183 (745)
Q Consensus 108 ~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~--- 183 (745)
.+++|.+++... ..+++..+..++.||+.+|.|||+++ ++||||||+||+++ .++.+||+|||++........
T Consensus 75 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~ 151 (250)
T cd05085 75 PGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYSSS 151 (250)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEc-CCCeEEECCCccceeccccccccC
Confidence 999999998754 46899999999999999999999988 99999999999997 568999999999865433221
Q ss_pred CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHH
Q 004564 184 AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEK 261 (745)
Q Consensus 184 ~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~k 261 (745)
....+++.|+|||++. +.++.++||||||+++|+|++ |..||... ........+..+..+ ......+..+.+++.+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 229 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRM-SCPQKCPDDVYKVMQR 229 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHH
Confidence 1123467899999987 568899999999999999998 99999874 455555556555433 2334567899999999
Q ss_pred Hhh-CccCCCCHHHHhcC
Q 004564 262 CLA-TVSLRLSARELLND 278 (745)
Q Consensus 262 cL~-dPskRpSa~ELL~h 278 (745)
||. +|.+||++.++++.
T Consensus 230 ~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 230 CWDYKPENRPKFSELQKE 247 (250)
T ss_pred HcccCcccCCCHHHHHHH
Confidence 999 99999999999753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.40 Aligned_cols=252 Identities=30% Similarity=0.412 Sum_probs=200.7
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC----
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA---- 96 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~---- 96 (745)
.+| .+.+.||+|+||+||+|.+..+|..||+|.++... ........+.+|+.+++.++||||+++++++....
T Consensus 15 ~~y-~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 15 ERY-TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF--QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cce-EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc--ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 577 66789999999999999999999999999886432 22334556889999999999999999999876432
Q ss_pred CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 97 NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 97 ~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
...+|+|+||+. .+|..++ ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 92 ~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~-~~~~~kL~dfg~~~ 165 (342)
T cd07879 92 FQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLAR 165 (342)
T ss_pred CceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCCCCc
Confidence 135799999986 4777664 346899999999999999999999998 99999999999998 56899999999986
Q ss_pred hhhccCCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC-C----------
Q 004564 177 ILRKSHAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK-K---------- 243 (745)
Q Consensus 177 ~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~-~---------- 243 (745)
..... .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||....... .+..+.... .
T Consensus 166 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 166 HADAE-MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCCCC-CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHhc
Confidence 54322 223468899999998864 48889999999999999999999998743333 333222210 0
Q ss_pred -----------CC-------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 244 -----------PD-------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 244 -----------p~-------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
|. ......++.+.+||.+||+ +|.+||+++++|.||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~ 302 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence 00 0112356789999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=302.70 Aligned_cols=242 Identities=21% Similarity=0.325 Sum_probs=195.3
Q ss_pred EEecccCceEEEEEEEcC---CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 28 EILGKGASKTVYRAFDEY---EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~---tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++||+|+||.||+|.+.. .+..||+|.+... ......+.+.+|+.+++.++||||+++++.+... +...+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI---TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc---CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEE
Confidence 468999999999998653 3467999976422 2345677889999999999999999999976532 45688999
Q ss_pred eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC-
Q 004564 105 EMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~- 182 (745)
||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++.......
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~-~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCccccccccCCcc
Confidence 999999999998764 45678888999999999999999988 99999999999998 56899999999987543211
Q ss_pred -----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhc-CCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHH
Q 004564 183 -----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEV 255 (745)
Q Consensus 183 -----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG-~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el 255 (745)
.....+++.|+|||.+. ..++.++|||||||++|||+|| .+||.. .+...+...+..+..+. .....++.+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRLL-QPEYCPDPL 231 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCHHH
Confidence 11234677899999886 5688999999999999999995 556655 55666666676665443 234567899
Q ss_pred HHHHHHHhh-CccCCCCHHHHhcC
Q 004564 256 RRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 256 ~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
.+++.+||+ +|++||++.++++.
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999 99999999999853
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=309.12 Aligned_cols=237 Identities=20% Similarity=0.307 Sum_probs=189.1
Q ss_pred EEecccCceEEEEEEEcCCCe-------EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 28 EILGKGASKTVYRAFDEYEGI-------EVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~-------~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
+.||.|+||+||+|.+...+. .||+|.+... .....+.+..|+.+++.++||||+++++.+.. +...
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCc
Confidence 469999999999998865543 4888876522 24456788899999999999999999999876 5678
Q ss_pred EEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCC-------cEEEcCc
Q 004564 101 NFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQG-------EVKIGDL 172 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~-~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g-------~VKL~DF 172 (745)
++||||+.+|+|..++.+++ .+++..++.++.||+.||.|||+++ |+||||||+||+++.+.. .++|+||
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999999999999987754 5899999999999999999999988 999999999999974432 3799999
Q ss_pred chhhhhhccCCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhc-CCCCCCCCCHHHHHHHHHcCCCCCCccc
Q 004564 173 GLAAILRKSHAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKKPDSLYR 249 (745)
Q Consensus 173 GlA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG-~~Pf~~~~~~~~i~kkv~~g~~p~~l~~ 249 (745)
|++...... ....+++.|+|||++.+ .++.++|||||||++|+|++| ..||.... ......... .. ..++.
T Consensus 153 g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-~~~~~~~~~-~~--~~~~~ 226 (258)
T cd05078 153 GISITVLPK--EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-SQKKLQFYE-DR--HQLPA 226 (258)
T ss_pred ccccccCCc--hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-HHHHHHHHH-cc--ccCCC
Confidence 998654322 23458899999999874 478899999999999999998 46665533 332222222 11 12333
Q ss_pred CCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 250 VKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 250 ~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
..+.++.++|.+||+ +|.+|||++++++.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 227 PKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 456889999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=301.69 Aligned_cols=244 Identities=22% Similarity=0.362 Sum_probs=199.9
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~ 98 (745)
+.++| ++.+.||+|+||.||+|.+. .+..+|+|.++.. ....+.+.+|+.+++.++|+||+++++.+.. .
T Consensus 4 ~~~~~-~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~ 73 (260)
T cd05073 4 PRESL-KLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---E 73 (260)
T ss_pred cccce-eEEeEecCccceEEEEEEec-CCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---C
Confidence 45666 88999999999999999765 4556999977632 3345678999999999999999999998754 5
Q ss_pred eEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 99 NINFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
..+++|||+.+++|.+++.+. ..+++..+..|+.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~ 150 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLAR 150 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCCccee
Confidence 689999999999999998764 35788999999999999999999988 99999999999997 56899999999987
Q ss_pred hhhccCCC---cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCC
Q 004564 177 ILRKSHAA---HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVK 251 (745)
Q Consensus 177 ~l~~~~~~---~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~ 251 (745)
........ ...++..|+|||++. +.++.++|+|||||++|+|+| |..||... +...+...+..+... ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 228 (260)
T cd05073 151 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRM-PRPENC 228 (260)
T ss_pred eccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhCCCCC-CCcccC
Confidence 65432211 223567899999887 458889999999999999999 89999874 445555556555433 234567
Q ss_pred CHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 252 DPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 252 s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
+.++.+++.+||+ +|.+||++.+++.
T Consensus 229 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 229 PEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 7899999999999 9999999998863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=356.70 Aligned_cols=247 Identities=32% Similarity=0.550 Sum_probs=209.5
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEec------------
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT------------ 95 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~------------ 95 (745)
++||+||||.||++..+-+|..||||.|.+.. +.....++.+|+.+|.+|+|||||++|.+|+.+
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~ 561 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVAS 561 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccccc
Confidence 56999999999999999999999999987653 456778899999999999999999999999710
Q ss_pred ------------------------------------------C-------------------------------------
Q 004564 96 ------------------------------------------A------------------------------------- 96 (745)
Q Consensus 96 ------------------------------------------~------------------------------------- 96 (745)
.
T Consensus 562 ~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~ 641 (1351)
T KOG1035|consen 562 DSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVI 641 (1351)
T ss_pred chhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccc
Confidence 0
Q ss_pred ------------------C--------CeEEEEEeccCCCCHHHHHHHcCCC-CHHHHHHHHHHHHHHHHHhhhCCCCEE
Q 004564 97 ------------------N--------RNINFVTEMFTSGTLRQYRLKHKRV-NIRAVKLWCRQILRGLLYLHSHDPPVI 149 (745)
Q Consensus 97 ------------------~--------~~iyLV~E~~~gGsL~~~l~k~~~L-~e~~i~~ia~QIL~gL~yLHs~gp~II 149 (745)
+ ..+||-||||...+|++++.++... ....++++++||+.||.|+|++| ||
T Consensus 642 ~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g--iI 719 (1351)
T KOG1035|consen 642 LDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG--II 719 (1351)
T ss_pred cCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc--ee
Confidence 0 2478889999988888887766654 57888999999999999999998 99
Q ss_pred eecCCCcceeecCCCCcEEEcCcchhhhhh--------------------ccCCCcccCCCCcCChhhhh--h--ccCcc
Q 004564 150 HRDLKCDNIFVNGNQGEVKIGDLGLAAILR--------------------KSHAAHCVGTPEFMAPEVYE--E--AYNEL 205 (745)
Q Consensus 150 HRDLKpdNILld~~~g~VKL~DFGlA~~l~--------------------~~~~~~~vGTp~YmAPEvl~--~--~ys~k 205 (745)
||||||.|||++ ..+.|||+|||+|+... ....+..+||.-|+|||++. . .|+.|
T Consensus 720 HRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 720 HRDLKPRNIFLD-SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eccCCcceeEEc-CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999 56799999999998721 11334568999999999996 2 59999
Q ss_pred ccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC--cccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 206 VDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDS--LYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 206 sDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~--l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
+|||||||||+||+. ||........+...+..|..|.. +....-+.-+.+|..||+ ||++||||.|||++.||.
T Consensus 799 iDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred hhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 999999999999984 78777778888888888888765 233345678899999999 999999999999999998
Q ss_pred c
Q 004564 283 I 283 (745)
Q Consensus 283 ~ 283 (745)
-
T Consensus 876 p 876 (1351)
T KOG1035|consen 876 P 876 (1351)
T ss_pred c
Confidence 3
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=304.09 Aligned_cols=243 Identities=24% Similarity=0.410 Sum_probs=199.3
Q ss_pred eEeEEecccCceEEEEEEEcCC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYE---GIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~t---g~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
.+.+.||+|+||.||+|.+... ...||+|..... ......+.+.+|+.+++.++||||+++++++.+ ...|
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~~ 82 (270)
T cd05056 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC---TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPVW 82 (270)
T ss_pred eeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc---CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCcE
Confidence 6789999999999999987544 456888876533 224567789999999999999999999998754 4578
Q ss_pred EEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 102 FVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~-~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
+||||+.+++|.+++.+.. .+++..+..++.||+.||.|||+++ ++||||||+|||++ ..+.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVS-SPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEe-cCCCeEEccCceeeeccc
Confidence 9999999999999987744 5899999999999999999999988 99999999999998 557999999999876543
Q ss_pred cCC---CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHH
Q 004564 181 SHA---AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEV 255 (745)
Q Consensus 181 ~~~---~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el 255 (745)
... ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||..... .+....+..+..+. .....++.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~ 237 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERLP-MPPNCPPTL 237 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCcCC-CCCCCCHHH
Confidence 221 1122456899999886 568899999999999999996 9999987544 44455566655442 345678899
Q ss_pred HHHHHHHhh-CccCCCCHHHHhcC
Q 004564 256 RRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 256 ~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
.++|.+||. +|.+|||+.+++..
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999 99999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=346.93 Aligned_cols=149 Identities=25% Similarity=0.350 Sum_probs=134.2
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
.+| ++.+.||+|+||+||+|.+..++..||+|+++.... ........+..|+.+++.++||||++++..+.. ...+
T Consensus 4 ~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~ 79 (669)
T cd05610 4 EEF-VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNV 79 (669)
T ss_pred CCE-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEE
Confidence 356 778999999999999999999999999999875442 345566789999999999999999999988765 6789
Q ss_pred EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 101 NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
|+||||+.+++|..++...+.+++..++.|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||++.
T Consensus 80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~-~~g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEc-CCCCEEEEeCCCCc
Confidence 999999999999999988888999999999999999999999988 99999999999997 56899999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=302.04 Aligned_cols=243 Identities=22% Similarity=0.354 Sum_probs=200.0
Q ss_pred eEeEEecccCceEEEEEEEcCCCe---EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGI---EVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~---~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
...+.||+|+||.||+|.++.++. .+|+|.++.. ......+.+..|+.+++.++||||+++++++.+ ...+|
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 82 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG---YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK--FKPAM 82 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc--CCCcE
Confidence 677899999999999999876655 6888877533 234556788999999999999999999998755 56889
Q ss_pred EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 102 FVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
+||||+.+++|..++.+. ..+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVN-SNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEc-CCCcEEECCCccceeccc
Confidence 999999999999998764 57899999999999999999999988 99999999999998 568999999999876543
Q ss_pred cCCCc-----ccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCH
Q 004564 181 SHAAH-----CVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDP 253 (745)
Q Consensus 181 ~~~~~-----~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~ 253 (745)
..... ...++.|+|||++. +.++.++|||||||++|+|+| |..||... ....+.+.+..+..+. .....+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~-~~~~~~~~i~~~~~~~-~~~~~~~ 237 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKAINDGFRLP-APMDCPS 237 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHHHHhcCCCCC-CCCCCCH
Confidence 22111 12345799999886 568899999999999999998 99999764 4556666666554322 2334678
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 254 el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.+.+++.+||+ +|.+||++.++++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999999 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=305.90 Aligned_cols=240 Identities=19% Similarity=0.286 Sum_probs=187.5
Q ss_pred EecccCceEEEEEEEcCC--CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEec
Q 004564 29 ILGKGASKTVYRAFDEYE--GIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 29 ~LG~GafgtVy~A~d~~t--g~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
.||+|+||+||+|..... ...+++|.++.. ......+.+.+|+.+++.++||||+++++.+.+ ...+|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN---ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC---CChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEec
Confidence 589999999999965433 234555554432 234556789999999999999999999998865 5678999999
Q ss_pred cCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc-
Q 004564 107 FTSGTLRQYRLKH----KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 181 (745)
Q Consensus 107 ~~gGsL~~~l~k~----~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~- 181 (745)
+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~-~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLT-SDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEc-CCccEEecccccccccCcch
Confidence 9999999998764 34677888999999999999999988 99999999999998 5689999999998543211
Q ss_pred ---CCCcccCCCCcCChhhhhh--------ccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCC----C
Q 004564 182 ---HAAHCVGTPEFMAPEVYEE--------AYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKP----D 245 (745)
Q Consensus 182 ---~~~~~vGTp~YmAPEvl~~--------~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p----~ 245 (745)
......+++.|+|||++.. .++.++|||||||++|||++ |..||..... ..++.++..+... .
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~ 232 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIKDQQVKLFKP 232 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhhcccccCCC
Confidence 1223468899999998742 35678999999999999997 5778876544 4444444433221 2
Q ss_pred CcccCCCHHHHHHHHHHhhCccCCCCHHHHhc
Q 004564 246 SLYRVKDPEVRRFVEKCLATVSLRLSARELLN 277 (745)
Q Consensus 246 ~l~~~~s~el~d~I~kcL~dPskRpSa~ELL~ 277 (745)
.+....++.+.+++..||.+|.+||+++++++
T Consensus 233 ~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 233 QLELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred ccCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 23345688899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=340.94 Aligned_cols=257 Identities=26% Similarity=0.359 Sum_probs=188.5
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCC-eEEEEEEEe-------------ecccCCCHHHHHHHHHHHHHHHhCCCCCcc
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEG-IEVAWNQVK-------------LYDFLQSPEDLERLYCEIHLLKTLKHKNIM 86 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg-~~VAiK~ik-------------~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIV 86 (745)
++| ++.+.||+|+||+||+|...... ..++.|.+. .............+.+|+.+|+.|+||||+
T Consensus 148 ~~Y-~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 148 AHF-RVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hcc-EEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 456 78899999999999998654322 222222110 001112234556788999999999999999
Q ss_pred eEeEEEEecCCCeEEEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeec
Q 004564 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-----KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVN 161 (745)
Q Consensus 87 k~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~-----~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld 161 (745)
++++++.. ....|+|++++. ++|..++... .......++.|+.||+.||.|||+++ ||||||||+|||++
T Consensus 227 ~l~~~~~~--~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~ 301 (501)
T PHA03210 227 KIEEILRS--EANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN 301 (501)
T ss_pred cEeEEEEE--CCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC
Confidence 99998866 567899999985 5777776543 23456778899999999999999998 99999999999998
Q ss_pred CCCCcEEEcCcchhhhhhccC---CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCC-CCCCC-C-HHHH
Q 004564 162 GNQGEVKIGDLGLAAILRKSH---AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYP-YSECT-H-PAQI 234 (745)
Q Consensus 162 ~~~g~VKL~DFGlA~~l~~~~---~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~P-f~~~~-~-~~~i 234 (745)
.+|.+||+|||++..+.... ....+||+.|+|||++. ..|+.++|||||||++|||++|..| |.... . ..++
T Consensus 302 -~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 -CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred -CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 56899999999997664322 22356999999999987 4689999999999999999998754 43321 2 2333
Q ss_pred HHHHHcCC-----CCC-------------------Cc-----ccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 235 YKKVVSGK-----KPD-------------------SL-----YRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 235 ~kkv~~g~-----~p~-------------------~l-----~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
.+.+.... .|. .+ ....+..+.++|.+||+ ||.+|||+.|+|.||||...
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 32221110 110 00 01235567888999999 99999999999999999743
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=316.24 Aligned_cols=246 Identities=26% Similarity=0.409 Sum_probs=202.1
Q ss_pred ceeeEeEEecccCceEEEEEEEcC-------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEY-------EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWV 93 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~-------tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfv 93 (745)
+| .+.+.||+|+||.||+|.+.. .+..||+|.++.. ......+.+.+|+.+++++ +||||+++++.+.
T Consensus 13 ~~-~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 13 RL-TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred He-eecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 45 888999999999999997643 2347899977632 2345677899999999999 7999999999876
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcc
Q 004564 94 DTANRNINFVTEMFTSGTLRQYRLKHK----------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDN 157 (745)
Q Consensus 94 d~~~~~iyLV~E~~~gGsL~~~l~k~~----------------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdN 157 (745)
. ...+++++||+.+|+|.+++.+.. .++...+..++.||+.||.|||++| |+||||||+|
T Consensus 89 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~N 164 (334)
T cd05100 89 Q--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARN 164 (334)
T ss_pred c--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccce
Confidence 5 568999999999999999987642 4778899999999999999999988 9999999999
Q ss_pred eeecCCCCcEEEcCcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCH
Q 004564 158 IFVNGNQGEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHP 231 (745)
Q Consensus 158 ILld~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~ 231 (745)
||++ .++.+||+|||++....... .....++..|||||++. ..++.++|||||||++|||++ |..||.. .+.
T Consensus 165 ill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~ 242 (334)
T cd05100 165 VLVT-EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPV 242 (334)
T ss_pred EEEc-CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-CCH
Confidence 9997 55899999999987654321 11123457899999886 568899999999999999998 8899977 456
Q ss_pred HHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 232 AQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 232 ~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
..+++.+..+..+. .....+.++.++|.+||+ +|.+||++.+++.+
T Consensus 243 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKEGHRMD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 77777776655443 234567899999999999 99999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.16 Aligned_cols=254 Identities=32% Similarity=0.463 Sum_probs=203.6
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~ 98 (745)
-+++| .+.+.||.|+||.||+|.+..++..||+|.+.... ......+.+..|+.+++.++||||++++++|... ..
T Consensus 8 ~~~~y-~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~ 83 (328)
T cd07856 8 ITNRY-VDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF--STPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LE 83 (328)
T ss_pred cccce-EEEEeecccCCeEEEEEEECCCCCEEEEEEecccc--cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CC
Confidence 46677 77799999999999999999999999999876432 2234456788999999999999999999988643 45
Q ss_pred eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 99 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
.+|+|+||+ +++|..++. ...+++..+..++.||+.||.|||+++ |+||||+|+|||++ ..+.+||+|||++...
T Consensus 84 ~~~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~-~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILIN-ENCDLKICDFGLARIQ 158 (328)
T ss_pred cEEEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeEC-CCCCEEeCcccccccc
Confidence 789999998 568888765 456899999999999999999999988 99999999999998 5689999999998754
Q ss_pred hccCCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH---------------cC
Q 004564 179 RKSHAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVV---------------SG 241 (745)
Q Consensus 179 ~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~---------------~g 241 (745)
... .....+++.|+|||.+.+ .++.++||||||+++|+|+||+.||..... ...+..+. .+
T Consensus 159 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 159 DPQ-MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH-VNQFSIITDLLGTPPDDVINTICSE 236 (328)
T ss_pred CCC-cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHhccch
Confidence 332 233468899999998754 588999999999999999999999976332 11111110 00
Q ss_pred -------------CCC-CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 242 -------------KKP-DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 242 -------------~~p-~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
..| .......++.++++|.+||+ +|.+|||++++|.||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293 (328)
T ss_pred hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence 000 01123457899999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.86 Aligned_cols=249 Identities=33% Similarity=0.440 Sum_probs=202.9
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.+.||.|++|.||+|....++..||+|.+.... ......+.+..|+.+++.++||||+++++++.+ ...+++|+
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 77 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVF 77 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEe
Confidence 56688999999999999999999999999987543 223445677889999999999999999998865 57899999
Q ss_pred eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC-
Q 004564 105 EMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~- 182 (745)
||+. ++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||+|+||+++ +++.+||+|||++.......
T Consensus 78 e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 78 EYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred cCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEc-CCCCEEEecCCcccccCCCcc
Confidence 9997 5899998887 58999999999999999999999998 99999999999998 56899999999987664332
Q ss_pred -CCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-------------------
Q 004564 183 -AAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS------------------- 240 (745)
Q Consensus 183 -~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~------------------- 240 (745)
.....++..|+|||.+.+ .++.++|||||||++|+|++|..||........+.+....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 223356788999998853 6888999999999999999999999774433332221110
Q ss_pred CCCCC-------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 241 GKKPD-------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 241 g~~p~-------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
...+. ......+..+.++|.+||. +|++||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00000 1111236789999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=300.36 Aligned_cols=241 Identities=22% Similarity=0.371 Sum_probs=199.9
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.+.||+|+||.||+|.+. .+..+|+|.++.... ....+..|+.+++.++||||+++++++.. ...+++++
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVCTE--RSPICLVF 78 (256)
T ss_pred EEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEEcc--CCceEEEE
Confidence 77899999999999999875 467899998763321 23468889999999999999999998755 56789999
Q ss_pred eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCC
Q 004564 105 EMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 183 (745)
Q Consensus 105 E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~ 183 (745)
||+.+++|.+++... ..++++.++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEc-CCCeEEECCCcceeecccCcc
Confidence 999999999998764 46899999999999999999999988 99999999999997 567999999999875533221
Q ss_pred C---cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHH
Q 004564 184 A---HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRF 258 (745)
Q Consensus 184 ~---~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~ 258 (745)
. ...++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .....+...+..+..+ ......+..+.+|
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 233 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRL-YKPRLASQSVYEL 233 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCCC-CCCCCCCHHHHHH
Confidence 1 223567899999887 568899999999999999998 9999976 4456666666655433 2244578899999
Q ss_pred HHHHhh-CccCCCCHHHHhcC
Q 004564 259 VEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 259 I~kcL~-dPskRpSa~ELL~h 278 (745)
+.+||+ +|.+|||+.++++.
T Consensus 234 ~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 234 MQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHcccChhhCCCHHHHHHh
Confidence 999999 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.89 Aligned_cols=227 Identities=19% Similarity=0.226 Sum_probs=188.3
Q ss_pred cCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEeccCCCCH
Q 004564 33 GASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTL 112 (745)
Q Consensus 33 GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~~gGsL 112 (745)
|.+++||+|.+..+++.||+|.++... ....|...+....||||+++++++.+ ...+++||||+.+|+|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCH
Confidence 899999999999999999999987432 12335555666789999999998865 5789999999999999
Q ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCCCcccCCCCc
Q 004564 113 RQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF 192 (745)
Q Consensus 113 ~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~~~~vGTp~Y 192 (745)
.+++.+...+++..+..|+.||+.||.|||+++ |+||||||+||+++ .++.++|+|||++....... ....++..|
T Consensus 73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~df~~~~~~~~~~-~~~~~~~~y 148 (237)
T cd05576 73 WSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLD-DRGHIQLTYFSRWSEVEDSC-DGEAVENMY 148 (237)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEecccchhcccccc-ccCCcCccc
Confidence 999988888999999999999999999999988 99999999999998 55799999999886654432 233567889
Q ss_pred CChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCC
Q 004564 193 MAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRL 270 (745)
Q Consensus 193 mAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRp 270 (745)
+|||.+. +.++.++|+||+|+++|+|++|..|+..... .+ .......++...++.++++|.+||+ +|++|+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~--~~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS--GI-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch--hc-----ccccccCCcccCCHHHHHHHHHHccCCHHHhc
Confidence 9999886 5688999999999999999999988764221 11 1111112344578899999999999 999999
Q ss_pred CH-----HHHhcCCCC
Q 004564 271 SA-----RELLNDPFL 281 (745)
Q Consensus 271 Sa-----~ELL~hPff 281 (745)
++ +++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 86 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=299.79 Aligned_cols=239 Identities=22% Similarity=0.380 Sum_probs=198.8
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
..| ++.+.||+|+||.||++. .++..||+|+++.. ...+.+.+|+.+++.++||||+++++.+.. ...
T Consensus 6 ~~~-~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~ 73 (254)
T cd05083 6 QKL-TLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD------VTAQAFLEETAVMTKLHHKNLVRLLGVILH---NGL 73 (254)
T ss_pred HHc-eeeeeeccCCCCceEecc--cCCCceEEEeecCc------chHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCc
Confidence 345 788999999999999984 57889999987632 234578899999999999999999998754 347
Q ss_pred EEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 101 NFVTEMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
+++|||+.+++|.+++.... .+++..+..++.||+.||.|||++| ++||||||+||+++ .++.+||+|||++...
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~-~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVS-EDGVAKVSDFGLARVG 150 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCcEEECCCccceec
Confidence 99999999999999987654 5899999999999999999999988 99999999999997 5689999999998654
Q ss_pred hccCCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHH
Q 004564 179 RKSHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVR 256 (745)
Q Consensus 179 ~~~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~ 256 (745)
... ......+..|+|||.+. +.++.++|+|||||++|+|++ |..||.. .....+...+..+..+. .....++.+.
T Consensus 151 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 227 (254)
T cd05083 151 SMG-VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK-MSLKEVKECVEKGYRME-PPEGCPADVY 227 (254)
T ss_pred ccc-CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhCCCCCC-CCCcCCHHHH
Confidence 322 22233567899999886 568899999999999999998 9999987 44556666666665443 3445788999
Q ss_pred HHHHHHhh-CccCCCCHHHHhc
Q 004564 257 RFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 257 d~I~kcL~-dPskRpSa~ELL~ 277 (745)
+++.+||+ +|..||++++++.
T Consensus 228 ~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 228 VLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 99999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=327.09 Aligned_cols=245 Identities=25% Similarity=0.375 Sum_probs=201.3
Q ss_pred eEeEEecccCceEEEEEEE-----cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceEeEEEEecCCC
Q 004564 25 RYNEILGKGASKTVYRAFD-----EYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTSWVDTANR 98 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d-----~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-HpNIVk~~~sfvd~~~~ 98 (745)
.+.++||+|+||.||+|.+ ..++..||+|+++... .....+.+.+|+.+|..+. ||||+++++++.. ..
T Consensus 40 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--~~ 114 (401)
T cd05107 40 VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLGACTK--GG 114 (401)
T ss_pred ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--CC
Confidence 5668899999999999984 3456789999987432 2344567889999999997 9999999998865 56
Q ss_pred eEEEEEeccCCCCHHHHHHHcC----------------------------------------------------------
Q 004564 99 NINFVTEMFTSGTLRQYRLKHK---------------------------------------------------------- 120 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~~---------------------------------------------------------- 120 (745)
.+++||||+.+|+|.+++.+.+
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 8999999999999999986532
Q ss_pred ----------------------------------------CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceee
Q 004564 121 ----------------------------------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFV 160 (745)
Q Consensus 121 ----------------------------------------~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILl 160 (745)
.+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl 272 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLI 272 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEE
Confidence 3566778899999999999999987 9999999999999
Q ss_pred cCCCCcEEEcCcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHH
Q 004564 161 NGNQGEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQI 234 (745)
Q Consensus 161 d~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i 234 (745)
+ ..+.+||+|||++....... .....+++.|||||.+. ..++.++|||||||++|||++ |..||......+.+
T Consensus 273 ~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 273 C-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred e-CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 8 56799999999997543211 12235788999999886 468899999999999999998 89999876666666
Q ss_pred HHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 235 YKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 235 ~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
...+..+..+. .+...+.++.+++.+||. +|.+||++.+|++.
T Consensus 352 ~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRGYRMA-KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 66666664432 344568899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=303.84 Aligned_cols=236 Identities=21% Similarity=0.333 Sum_probs=186.9
Q ss_pred EEecccCceEEEEEEEc------------CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEec
Q 004564 28 EILGKGASKTVYRAFDE------------YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT 95 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~------------~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~ 95 (745)
+.||+|+||.||+|... .....||+|.+... .......+..|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCVR- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 46899999999999742 22346888875432 23455678889999999999999999998765
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCC-------cE
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQG-------EV 167 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g-------~V 167 (745)
+...++||||+.+|+|..++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++. .+ .+
T Consensus 76 -~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~-~~~~~~~~~~~ 151 (262)
T cd05077 76 -DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAR-EGIDGECGPFI 151 (262)
T ss_pred -CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEec-CCccCCCCcee
Confidence 56779999999999999988764 56899999999999999999999988 999999999999963 33 38
Q ss_pred EEcCcchhhhhhccCCCcccCCCCcCChhhhh--hccCccccchhhhhHHHHHh-hcCCCCCCCCCHHHHHHHHHcCCCC
Q 004564 168 KIGDLGLAAILRKSHAAHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMV-TFEYPYSECTHPAQIYKKVVSGKKP 244 (745)
Q Consensus 168 KL~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGvILyELl-TG~~Pf~~~~~~~~i~kkv~~g~~p 244 (745)
||+|||++..... .....++..|+|||.+. +.++.++|||||||++|+|+ +|..||... ...+.. ....+..+
T Consensus 152 ~l~d~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~-~~~~~~~~ 227 (262)
T cd05077 152 KLSDPGIPITVLS--RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-TLAEKE-RFYEGQCM 227 (262)
T ss_pred EeCCCCCCccccC--cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-chhHHH-HHHhcCcc
Confidence 9999999865432 22346889999999885 45889999999999999998 588888763 233322 22222222
Q ss_pred CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 245 DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 245 ~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
.....+++++++|.+||+ +|.+||++.+||++
T Consensus 228 --~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 228 --LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 222346789999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=302.37 Aligned_cols=239 Identities=26% Similarity=0.401 Sum_probs=195.0
Q ss_pred EecccCceEEEEEEEcCCC------eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEE
Q 004564 29 ILGKGASKTVYRAFDEYEG------IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINF 102 (745)
Q Consensus 29 ~LG~GafgtVy~A~d~~tg------~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyL 102 (745)
.||+|+||.||+|.+.... ..+|+|.+.... .......+.+|+.+++.++||||+++++++.+ ....++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 76 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYI 76 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeEE
Confidence 5899999999999876544 789999875322 23456678899999999999999999998865 567999
Q ss_pred EEeccCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCC-----cEEEc
Q 004564 103 VTEMFTSGTLRQYRLKH-------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQG-----EVKIG 170 (745)
Q Consensus 103 V~E~~~gGsL~~~l~k~-------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g-----~VKL~ 170 (745)
||||+.+++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+||||+|||++. ++ .+||+
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~-~~~~~~~~~~l~ 153 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSE-KGYDADRVVKIG 153 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEec-CCCCCCcceEEC
Confidence 99999999999998753 34788999999999999999999988 999999999999974 34 79999
Q ss_pred CcchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 004564 171 DLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKP 244 (745)
Q Consensus 171 DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p 244 (745)
|||++....... .....++..|+|||.+. +.++.++|||||||++|+|+| |..||... +..++...+..+..+
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~~ 232 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL-NNQEVLQHVTAGGRL 232 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc-CHHHHHHHHhcCCcc
Confidence 999987653321 11224678899999886 568999999999999999998 99999764 445566666554433
Q ss_pred CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 245 DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 245 ~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
. .....+..+.++|.+||. +|.+||+++++++
T Consensus 233 ~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 233 Q-KPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred C-CcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2 334567899999999999 9999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=301.97 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=200.4
Q ss_pred CceeeEeEEecccCceEEEEEEEc----CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDE----YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA 96 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~----~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~ 96 (745)
.+++++.+.||+|+||.||+|... .++..||+|+++.... ....+.+..|+.+++.+.||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~ 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKPG 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence 345577899999999999999754 3588999998874431 145678999999999999999999999887655
Q ss_pred CCeEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 97 NRNINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 97 ~~~iyLV~E~~~gGsL~~~l~k~~-~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
....+++|||+.+++|.+++.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~ 156 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLA 156 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEcccccc
Confidence 678999999999999999987765 6999999999999999999999988 99999999999998 5589999999999
Q ss_pred hhhhccCCC-----cccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCC--------------HHHHH
Q 004564 176 AILRKSHAA-----HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTH--------------PAQIY 235 (745)
Q Consensus 176 ~~l~~~~~~-----~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~--------------~~~i~ 235 (745)
......... ...++..|+|||.+. ..++.++||||||+++|+|+||..|+..... ...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 876532211 123456799999876 5688999999999999999999999865321 11122
Q ss_pred HHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 236 KKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 236 kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
..+..+.. .......+.++.+++.+||. +|.+|||+.+++.
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 237 ELLKEGER-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHcCCc-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22222222 22234456889999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=300.24 Aligned_cols=247 Identities=23% Similarity=0.400 Sum_probs=203.7
Q ss_pred eEeEEecccCceEEEEEEEcC-CCeEEEEEEEeeccc------CCCHHHHHHHHHHHHHHHh-CCCCCcceEeEEEEecC
Q 004564 25 RYNEILGKGASKTVYRAFDEY-EGIEVAWNQVKLYDF------LQSPEDLERLYCEIHLLKT-LKHKNIMKFYTSWVDTA 96 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~-tg~~VAiK~ik~~~~------~~~~~~~e~l~~Ei~iLk~-L~HpNIVk~~~sfvd~~ 96 (745)
.+.+.||+|+||.||+|.+.. .+..+|+|.+..... ........++..|+.+++. ++||||+++++.+..
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-- 80 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE-- 80 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc--
Confidence 567889999999999999988 788999998875431 1234456778889998875 799999999998865
Q ss_pred CCeEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHhhh-CCCCEEeecCCCcceeecCCCCcEEEcC
Q 004564 97 NRNINFVTEMFTSGTLRQYRLK----HKRVNIRAVKLWCRQILRGLLYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGD 171 (745)
Q Consensus 97 ~~~iyLV~E~~~gGsL~~~l~k----~~~L~e~~i~~ia~QIL~gL~yLHs-~gp~IIHRDLKpdNILld~~~g~VKL~D 171 (745)
+..+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+ .+ ++|+||+|+|||++ .++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~-~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLG-EDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEEC-CCCcEEEec
Confidence 6789999999999999988643 3468999999999999999999996 55 99999999999997 568999999
Q ss_pred cchhhhhhcc-CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCccc
Q 004564 172 LGLAAILRKS-HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYR 249 (745)
Q Consensus 172 FGlA~~l~~~-~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~ 249 (745)
||++...... ......|+..|+|||.+. +.++.++|+||||+++|+|++|+.||.. .........+..+..+.....
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc-cCHHHHHHHHhhccCCcCCcc
Confidence 9999765443 223446899999999887 4588999999999999999999999976 445555555655554433344
Q ss_pred CCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 250 VKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 250 ~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
..++.+.++|.+||+ +|++||++.|+..
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 678999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=299.65 Aligned_cols=246 Identities=22% Similarity=0.317 Sum_probs=199.7
Q ss_pred eEeEEecccCceEEEEEEEc---CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCC----
Q 004564 25 RYNEILGKGASKTVYRAFDE---YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN---- 97 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~---~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~---- 97 (745)
++.++||+|+||+||+|.+. .++..||+|+++... ......+++.+|+.+|+.++||||+++++.++....
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 56788999999999999864 467899999886432 334567789999999999999999999998765322
Q ss_pred CeEEEEEeccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcC
Q 004564 98 RNINFVTEMFTSGTLRQYRLKH------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 171 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k~------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~D 171 (745)
...+++++|+.+|+|..++... ..++...+..++.||+.||+|||+++ |+||||||+||+++ .++.+||+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~-~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEc-CCCCEEECc
Confidence 2347889999999999886532 24789999999999999999999988 99999999999997 568999999
Q ss_pred cchhhhhhccC----CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCC
Q 004564 172 LGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPD 245 (745)
Q Consensus 172 FGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~ 245 (745)
||++....... .....+++.|++||.+. +.++.++||||||+++|+|++ |..||.. .+...++..+..+..+.
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~ 235 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNYLIKGNRLK 235 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHHHHcCCcCC
Confidence 99987654321 12234567899999886 468889999999999999999 8899976 45566777666654432
Q ss_pred CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 246 SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 246 ~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.....++.+.+++.+||+ +|++|||+.+++.
T Consensus 236 -~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 236 -QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 234567899999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=304.85 Aligned_cols=236 Identities=21% Similarity=0.276 Sum_probs=185.8
Q ss_pred EecccCceEEEEEEEcC------------------------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC
Q 004564 29 ILGKGASKTVYRAFDEY------------------------EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84 (745)
Q Consensus 29 ~LG~GafgtVy~A~d~~------------------------tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpN 84 (745)
.||+|+||.||+|.... ....||+|++... .......+.+|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS----HRDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH----HHHHHHHHHHHHHHHhcCCCCC
Confidence 58999999999996422 2245888876532 2344567888999999999999
Q ss_pred cceEeEEEEecCCCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCC
Q 004564 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGN 163 (745)
Q Consensus 85 IVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~ 163 (745)
|+++++++.. ....++||||+.+|+|..++.+ .+.+++..+..++.||+.||+|||+++ |+||||||+|||++..
T Consensus 78 iv~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~ 153 (274)
T cd05076 78 LAFVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARL 153 (274)
T ss_pred eeeEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEecc
Confidence 9999998876 5678999999999999998876 467899999999999999999999988 9999999999999632
Q ss_pred ------CCcEEEcCcchhhhhhccCCCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHh-hcCCCCCCCCCHHHH
Q 004564 164 ------QGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMV-TFEYPYSECTHPAQI 234 (745)
Q Consensus 164 ------~g~VKL~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELl-TG~~Pf~~~~~~~~i 234 (745)
.+.+||+|||++...... ....+++.|+|||.+.+ .++.++|||||||++|||+ +|..||.... +.+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT-PSEK 230 (274)
T ss_pred CcccCccceeeecCCccccccccc--cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC-hHHH
Confidence 234899999987543221 23357889999998863 5889999999999999995 6999997643 3333
Q ss_pred HHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 235 YKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 235 ~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
...+.... .+.....+.+.++|.+||+ +|.+|||+.++|++
T Consensus 231 ~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 ERFYEKKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHhcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22222111 1222346789999999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=305.45 Aligned_cols=250 Identities=18% Similarity=0.211 Sum_probs=186.8
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCC---CeEEEEEEEeecccCCCHH-H------HHHHHHHHHHHHhCCCCCcceEe
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYE---GIEVAWNQVKLYDFLQSPE-D------LERLYCEIHLLKTLKHKNIMKFY 89 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~t---g~~VAiK~ik~~~~~~~~~-~------~e~l~~Ei~iLk~L~HpNIVk~~ 89 (745)
..+| ++.++||+|+||+||+|.+..+ +..+|+|+..........+ . ......++..+..+.|+||++++
T Consensus 11 ~~~y-~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 11 GKEW-KIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCce-EEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 3566 8999999999999999998877 6677877654332111000 0 01122344456677999999999
Q ss_pred EEEEecCC--CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcE
Q 004564 90 TSWVDTAN--RNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEV 167 (745)
Q Consensus 90 ~sfvd~~~--~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~V 167 (745)
+.+..... ...+++++++. .++.+++......++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~-~~~~~ 165 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVD-GNNRG 165 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCcE
Confidence 87654322 23467788764 467777776666789999999999999999999988 99999999999997 55799
Q ss_pred EEcCcchhhhhhcc---------CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHH---
Q 004564 168 KIGDLGLAAILRKS---------HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQI--- 234 (745)
Q Consensus 168 KL~DFGlA~~l~~~---------~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i--- 234 (745)
||+|||+|+.+... ......||+.|+|||++. ..++.++|||||||++|||+||..||........+
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999999765321 112236999999999987 45899999999999999999999999876433322
Q ss_pred -----HHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 235 -----YKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 235 -----~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.+.+..+.. .....++.+.+++..|+. +|.+||++.+|++
T Consensus 246 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 246 AKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 223333322 123457889999999999 9999999999874
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.03 Aligned_cols=243 Identities=26% Similarity=0.426 Sum_probs=197.6
Q ss_pred eEeEEecccCceEEEEEEEcCCCe----EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGI----EVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~----~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
+..+.||+|+||.||+|.+..+|. .||+|.+... ........+.+|+.+++.++||||+++++.+.. ...
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~~~ 83 (303)
T cd05110 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET---TGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---PTI 83 (303)
T ss_pred eeccccccCCCccEEEEEEecCCCcceeeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---CCc
Confidence 566889999999999999887776 4687776532 234445578899999999999999999998754 346
Q ss_pred EEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 101 NFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~-~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
++++||+.+|+|.+++..+. .+++..+..|+.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~-~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVK-SPNHVKITDFGLARLLE 160 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeec-CCCceEEcccccccccc
Confidence 78999999999999987754 6899999999999999999999988 99999999999997 56799999999997654
Q ss_pred ccCC----CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCH
Q 004564 180 KSHA----AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDP 253 (745)
Q Consensus 180 ~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~ 253 (745)
.... ....++..|+|||.+. ..++.++|||||||++|||++ |..||.+. ....+...+..+..+. .....+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 238 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLP-QPPICTI 238 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHCCCCCC-CCCCCCH
Confidence 3221 1223577899999887 568899999999999999997 89999763 3455555555444332 3345678
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 254 el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
.+.+++.+||. +|.+||++.++++.
T Consensus 239 ~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 239 DVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999 99999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=288.02 Aligned_cols=247 Identities=29% Similarity=0.413 Sum_probs=202.9
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEecc
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMF 107 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~ 107 (745)
++||+|.||+||+|....+++.||+|.+++.+- ++.......+||-+|+.|+|.|||++++.. ..++.+-+|+|||
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelkhknivrl~dvl--hsdkkltlvfe~c 83 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVL--HSDKKLTLVFEFC 83 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhhhcceeehhhhh--ccCceeEEeHHHh
Confidence 679999999999999999999999999997762 333445678899999999999999999964 4478899999999
Q ss_pred CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC--CC
Q 004564 108 TSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AA 184 (745)
Q Consensus 108 ~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~--~~ 184 (745)
. .+|..|... ++.++.+.++.++.|+++||.|+|+++ +.||||||.|+||+ .+|.+||+|||+|+.+.-.. ..
T Consensus 84 d-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin-~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 84 D-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred h-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEec-cCCcEEecccchhhhcCCceEeee
Confidence 5 588888765 577999999999999999999999999 99999999999998 56899999999998876443 33
Q ss_pred cccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHc-CCC-----C----------C
Q 004564 185 HCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVS-GKK-----P----------D 245 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~-g~~-----p----------~ 245 (745)
..+-|..|.+|.++.+ .|+...|+||.|||+.|+.. |++.|.+..-..|+.+.+.. |.. | -
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 4468999999999875 59999999999999999997 66667775555555544321 111 1 0
Q ss_pred Ccc----------cCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 246 SLY----------RVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 246 ~l~----------~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
+.+ ...+..-++++.++|. +|.+|++|+++|+||||.
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~ 287 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFS 287 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccc
Confidence 111 1124457899999999 999999999999999996
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=310.63 Aligned_cols=255 Identities=29% Similarity=0.399 Sum_probs=200.4
Q ss_pred eEeEEecccCceEEEEEEEcCCCe----EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGI----EVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~----~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
.....||+|.||.||+|..+.++. ++|||.++-.+- .........+|+.+++.|+||||+.+...|+.. +..+
T Consensus 27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd--~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~v 103 (438)
T KOG0666|consen 27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD--GTGISMSACREIALLRELKHPNVISLVKVFLSH-DKKV 103 (438)
T ss_pred hccceecccccceeeEeeeccCCcccchhhHHHHHhccCC--CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-CceE
Confidence 455679999999999997655543 789998875431 122344578899999999999999999988754 7899
Q ss_pred EEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCC---CCcEEEcCc
Q 004564 101 NFVTEMFTSGTLRQYRLKH-----KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGN---QGEVKIGDL 172 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~-----~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~---~g~VKL~DF 172 (745)
++++||.+. +|.+.+.-+ +.++...+++++.|||.|+.|||++- |+||||||.||||.++ .|.|||+||
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999976 787776643 46899999999999999999999999 9999999999999754 389999999
Q ss_pred chhhhhhccCC-----CcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCC------C---HHHHHH
Q 004564 173 GLAAILRKSHA-----AHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECT------H---PAQIYK 236 (745)
Q Consensus 173 GlA~~l~~~~~-----~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~------~---~~~i~k 236 (745)
|+++.+..... ...+-|..|.|||++.+ .|+.++||||+|||+.||+|.++.|.+.. + ..++.+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 99999876432 23468999999999975 59999999999999999999988874311 1 122222
Q ss_pred HHH-cCCC-----------CC----------------------CcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCC
Q 004564 237 KVV-SGKK-----------PD----------------------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 237 kv~-~g~~-----------p~----------------------~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff 281 (745)
.+. -|.+ |. ...+..++...+++.++|. ||.+|+|++++|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 110 0110 10 0113357778999999999 99999999999999999
Q ss_pred Cccc
Q 004564 282 QIDD 285 (745)
Q Consensus 282 ~~~~ 285 (745)
..++
T Consensus 341 ~~d~ 344 (438)
T KOG0666|consen 341 TEDP 344 (438)
T ss_pred ccCC
Confidence 8764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=327.86 Aligned_cols=249 Identities=21% Similarity=0.365 Sum_probs=226.1
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEecc
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMF 107 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~ 107 (745)
..||-||||.|=++.-......+|+|++++.+ .....+.+.++.|-++|..++.|.||++|..|-+ .+.+||+||-|
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~h-IVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd--~kyvYmLmEaC 502 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKH-IVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD--SKYVYMLMEAC 502 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhh-ccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc--chhhhhhHHhh
Confidence 45999999999998766666669999998766 3456778889999999999999999999999866 78999999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc-CCCcc
Q 004564 108 TSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-HAAHC 186 (745)
Q Consensus 108 ~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~-~~~~~ 186 (745)
-||.|...+..++.+++...+.++.-++.|++|||++| ||+|||||+|.+++ +.|-+||.|||+|+.+..+ ...++
T Consensus 503 lGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd-~~Gy~KLVDFGFAKki~~g~KTwTF 579 (732)
T KOG0614|consen 503 LGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLD-NRGYLKLVDFGFAKKIGSGRKTWTF 579 (732)
T ss_pred cCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeec-cCCceEEeehhhHHHhccCCceeee
Confidence 99999999999999999999999999999999999999 99999999999998 6799999999999998765 45678
Q ss_pred cCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-
Q 004564 187 VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA- 264 (745)
Q Consensus 187 vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~- 264 (745)
+|||+|.|||++. ...+.++|.|||||++|||+||.+||++ .++-..|..+..|..--.+++.+...+.++|.++-.
T Consensus 580 cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~ 658 (732)
T KOG0614|consen 580 CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRD 658 (732)
T ss_pred cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhc
Confidence 9999999999764 6799999999999999999999999998 778899999999988777888899999999999888
Q ss_pred CccCCCC-----HHHHhcCCCCCc
Q 004564 265 TVSLRLS-----ARELLNDPFLQI 283 (745)
Q Consensus 265 dPskRpS-----a~ELL~hPff~~ 283 (745)
+|.+|+. +.++-+|.||..
T Consensus 659 ~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 659 NPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred CcHhhhccccCChHHHHhhhhhhc
Confidence 8999885 899999999964
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=335.44 Aligned_cols=256 Identities=27% Similarity=0.475 Sum_probs=217.3
Q ss_pred eCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEec
Q 004564 17 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDT 95 (745)
Q Consensus 17 ~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~ 95 (745)
-||+..+ .+.++||.|.+|.||++....++..+|+|+..... +.-+.+..|+++|+.+ .|||++.||++|...
T Consensus 15 pdp~d~~-ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 15 PDPADIF-EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred CCCCCcc-EEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-----cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 4788888 67799999999999999999999999999876432 3334567789999988 699999999998753
Q ss_pred C---CCeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEc
Q 004564 96 A---NRNINFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 170 (745)
Q Consensus 96 ~---~~~iyLV~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~ 170 (745)
. ++.+|||||||.|||.-++++.. .++.+..+..|++.+|.||..||.+. +||||||-.|||++ ..|.|||+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT-~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLT-ENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEe-ccCcEEEe
Confidence 2 56899999999999999987764 57899999999999999999999987 99999999999998 56899999
Q ss_pred Ccchhhhhhcc--CCCcccCCCCcCChhhhh------hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 004564 171 DLGLAAILRKS--HAAHCVGTPEFMAPEVYE------EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK 242 (745)
Q Consensus 171 DFGlA~~l~~~--~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~ 242 (745)
|||++..+... ...+++|||.|||||++. -.|+..+|+||||++..||.-|.+|+.+......++. +....
T Consensus 166 DFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~-IpRNP 244 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-IPRNP 244 (953)
T ss_pred eeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc-CCCCC
Confidence 99999887643 456778999999999985 2378899999999999999999999988665555554 33333
Q ss_pred CCCCc-ccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 243 KPDSL-YRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 243 ~p~~l-~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
+|... ++..+.++.+||..||. |-.+||+..++|+|||+.
T Consensus 245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 33322 45567899999999998 999999999999999998
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=338.62 Aligned_cols=244 Identities=24% Similarity=0.309 Sum_probs=207.8
Q ss_pred eeeEeEEecccCceEEEEEEEc-----CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCC
Q 004564 23 YGRYNEILGKGASKTVYRAFDE-----YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 23 Y~rl~e~LG~GafgtVy~A~d~-----~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~ 97 (745)
-.++.+.||+|+||+||+|... .....||||.++... +....+.|++|+.+|..|+|||||+|++.+.. +
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~--~ 561 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNIVRLLGVCRE--G 561 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc--C
Confidence 3467788999999999999542 345679999887443 45578899999999999999999999997754 7
Q ss_pred CeEEEEEeccCCCCHHHHHHHcC----------C----CCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCC
Q 004564 98 RNINFVTEMFTSGTLRQYRLKHK----------R----VNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGN 163 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k~~----------~----L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~ 163 (745)
+.++||+|||..|+|.+|+..+. . |+..++..++.||+.|++||-++. +|||||-..|+||. .
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVg-e 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVG-E 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceec-c
Confidence 89999999999999999988653 2 788999999999999999999988 99999999999996 5
Q ss_pred CCcEEEcCcchhhhhhccCCCcc----cCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHH
Q 004564 164 QGEVKIGDLGLAAILRKSHAAHC----VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKK 237 (745)
Q Consensus 164 ~g~VKL~DFGlA~~l~~~~~~~~----vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kk 237 (745)
+-.|||+|||+++..-....... .-..+|||||-+. +.|+.++|||||||+|||+++ |..||.+..+ ++..+.
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-~EVIe~ 717 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-QEVIEC 717 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-HHHHHH
Confidence 67999999999987655443332 2457999999665 889999999999999999998 8999999665 555667
Q ss_pred HHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHh
Q 004564 238 VVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELL 276 (745)
Q Consensus 238 v~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL 276 (745)
+..|.. -..+..+++++..++..||+ .|++||+++||-
T Consensus 718 i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 718 IRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 888877 55677889999999999999 999999999973
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=318.88 Aligned_cols=261 Identities=27% Similarity=0.423 Sum_probs=214.9
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCC---HHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS---PEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA 96 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~---~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~ 96 (745)
..|| .+..+||+|||+.||+|+|....+.||+|+-.+.+.... +...+...+|.+|.+.|+||.||++|++|--.
T Consensus 462 n~RY-LlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD- 539 (775)
T KOG1151|consen 462 NDRY-LLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD- 539 (775)
T ss_pred HHHH-HHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-
Confidence 4677 566899999999999999999999999998776553222 23456678899999999999999999998543
Q ss_pred CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeec-C-CCCcEEEcCcch
Q 004564 97 NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVN-G-NQGEVKIGDLGL 174 (745)
Q Consensus 97 ~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld-~-~~g~VKL~DFGl 174 (745)
...++-|+|||.|.+|.-|++.++.++++.++.|+.||+.||.||....|||||-||||.|||+- | .-|.|||+|||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 56889999999999999999999999999999999999999999999999999999999999983 2 236899999999
Q ss_pred hhhhhccCC---------CcccCCCCcCChhhhh-h----ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHH--H
Q 004564 175 AAILRKSHA---------AHCVGTPEFMAPEVYE-E----AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKK--V 238 (745)
Q Consensus 175 A~~l~~~~~---------~~~vGTp~YmAPEvl~-~----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kk--v 238 (745)
+.++..... ....||-+|++||.|- + ..+.++||||+|||+|.++.|+-||........|... +
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 999864322 2246999999999874 2 3678999999999999999999999765444444432 2
Q ss_pred HcC-CCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 239 VSG-KKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 239 ~~g-~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
+.. ....+.-.+.++++++||.+||+ .-..|..+.+|.+||+|.
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 211 11112234678999999999999 788999999999999996
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=331.26 Aligned_cols=239 Identities=25% Similarity=0.369 Sum_probs=205.8
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyLV 103 (745)
.+...||.|+|+.|-++.+..+++..++|++..... ...+|+.++... +||||+++++.+.+ +..+|+|
T Consensus 325 ~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~--------~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~~~v 394 (612)
T KOG0603|consen 325 EFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD--------DNQDEIPISLLVRDHPNIVKSHDVYED--GKEIYLV 394 (612)
T ss_pred ccccccCCCCccceeeeeccccccchhheecccccc--------ccccccchhhhhcCCCcceeecceecC--Cceeeee
Confidence 566779999999999999999999999999875421 233466555544 79999999997755 7899999
Q ss_pred EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCC
Q 004564 104 TEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 183 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~ 183 (745)
||++.|+.|.+-+.+.+.+. ..+..|++||+.++.|||++| ||||||||+|||+.+..|+++|+|||.+...... .
T Consensus 395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-~ 470 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-C 470 (612)
T ss_pred ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh-h
Confidence 99999999988777666555 788889999999999999998 9999999999999657789999999999887766 3
Q ss_pred CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHH
Q 004564 184 AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKC 262 (745)
Q Consensus 184 ~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kc 262 (745)
.+.+-|..|.|||++. ..|++++||||||++||+|++|+.||....+..+++..+..+... ...|..++++|.+|
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s----~~vS~~AKdLl~~L 546 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS----ECVSDEAKDLLQQL 546 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc----cccCHHHHHHHHHh
Confidence 3445789999999997 579999999999999999999999998766667888777655433 67899999999999
Q ss_pred hh-CccCCCCHHHHhcCCCC
Q 004564 263 LA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 263 L~-dPskRpSa~ELL~hPff 281 (745)
|+ +|.+|+++.+++.||||
T Consensus 547 L~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 547 LQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccCChhhCcChhhhccCcch
Confidence 99 99999999999999999
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=307.94 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=210.6
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHH-HhCCCCCcceEeEEEEecCCCeEEEEEec
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL-KTLKHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iL-k~L~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
..||.|+||+|++-.++.+|+..|+|.|+... .+.+..++..|.... ++=+.||||+||+..+. ++..|+.||+
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n---~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~--EGdcWiCMEL 144 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN---IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS--EGDCWICMEL 144 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeecc---chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc--CCceeeeHHH
Confidence 45999999999999999999999999998553 467778888888764 45579999999998776 5778999999
Q ss_pred cCCCCHHHHH-----HHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 107 FTSGTLRQYR-----LKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 107 ~~gGsL~~~l-----~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
|. .+|..+. .+...++++.+..++--.+.||.||-.. ..|||||+||+|||++ ..|.|||||||++..+..+
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILld-r~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLD-RHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEe-cCCCEeeecccchHhHHHH
Confidence 95 4776542 3456799999999999999999999764 3499999999999999 5689999999999888766
Q ss_pred CCCc-ccCCCCcCChhhhh---hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCccc----CCCH
Q 004564 182 HAAH-CVGTPEFMAPEVYE---EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYR----VKDP 253 (745)
Q Consensus 182 ~~~~-~vGTp~YmAPEvl~---~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~----~~s~ 253 (745)
...+ -.|-..|||||.+. ..|+-++|+||||++|||++||.+||.+..+.-+-...+..|..|.-... ..+.
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~ 301 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF 301 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence 5443 46889999999996 35999999999999999999999999887776666677888887754432 2588
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 254 el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
.+..||.-||. |-+.||...+|+++||++.-
T Consensus 302 ~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 302 SMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred HHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 99999999998 89999999999999999853
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=314.05 Aligned_cols=242 Identities=24% Similarity=0.376 Sum_probs=187.9
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEecc
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMF 107 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~ 107 (745)
.+||+|+||.||+|.-.. |..||||.+...... . ...|.+|+.+|.+++|||+|++++++.+..+ ..+||+||+
T Consensus 81 ~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~---~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LVYEym 154 (361)
T KOG1187|consen 81 NLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQ---G-EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLVYEYM 154 (361)
T ss_pred cceecCCCeEEEEEEECC-CCEEEEEEecCCCCc---c-hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEEEEcc
Confidence 579999999999997653 489999966533211 1 3449999999999999999999999987332 689999999
Q ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhC-CCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc-cCC
Q 004564 108 TSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSH-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-SHA 183 (745)
Q Consensus 108 ~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~-gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~-~~~ 183 (745)
..|+|.+.+.... .++|....+|+.++++||+|||.. .|+|||||||+.|||+| .+.+.||+|||+|..... ...
T Consensus 155 ~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~aKlsDFGLa~~~~~~~~~ 233 (361)
T KOG1187|consen 155 PNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNAKLSDFGLAKLGPEGDTS 233 (361)
T ss_pred CCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCEEccCccCcccCCccccc
Confidence 9999999988765 899999999999999999999984 45899999999999999 568999999999965543 222
Q ss_pred C-cc-cCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCC-----CHHHH-HHHHHcCCCCCCcc-----c
Q 004564 184 A-HC-VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECT-----HPAQI-YKKVVSGKKPDSLY-----R 249 (745)
Q Consensus 184 ~-~~-vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~-----~~~~i-~kkv~~g~~p~~l~-----~ 249 (745)
. .. .||..|+|||.+. +..+.++|||||||+|+||+||+.|..... +.... ...+..+.....+. .
T Consensus 234 ~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~ 313 (361)
T KOG1187|consen 234 VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEG 313 (361)
T ss_pred eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCC
Confidence 2 22 7999999999986 689999999999999999999998876432 11111 12233332221111 1
Q ss_pred CCC--HH---HHHHHHHHhh-CccCCCCHHHHh
Q 004564 250 VKD--PE---VRRFVEKCLA-TVSLRLSARELL 276 (745)
Q Consensus 250 ~~s--~e---l~d~I~kcL~-dPskRpSa~ELL 276 (745)
... .+ +..+...|++ +|..||++.|++
T Consensus 314 ~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 314 EYPDEKEVKKLAELALRCLRPDPKERPTMSQVV 346 (361)
T ss_pred CCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence 222 23 5566788998 899999999964
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.31 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=212.1
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
.+.+.-++||+||||.||.+....||+.+|.|.+.+... .....-.....|-.||.....+.||.+--.|.. +..++
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRi-Kkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT--kd~LC 261 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRI-KKRKGETMALNEKQILEKVSSPFIVSLAYAFET--KDALC 261 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHH-HHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC--CCceE
Confidence 344666889999999999999999999999997653321 122223345678999999999999998877744 78999
Q ss_pred EEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 102 FVTEMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
+|+.+|+||+|.=.+...+ .++++.++.|+.+|+.||+.||..+ ||+|||||+|||+| +.|+|+|+|+|+|..+.
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLD-d~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLD-DHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeec-cCCCeEeeccceEEecC
Confidence 9999999999977666665 8999999999999999999999988 99999999999998 77999999999998887
Q ss_pred ccCCCcc-cCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCC---CHHHHHHHHHcCCCCCCcccCCCHH
Q 004564 180 KSHAAHC-VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECT---HPAQIYKKVVSGKKPDSLYRVKDPE 254 (745)
Q Consensus 180 ~~~~~~~-vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~---~~~~i~kkv~~g~~p~~l~~~~s~e 254 (745)
....... +||..|||||++. +.|+..+|+|||||++|||+.|..||.... ..+++-+.+.+ .+..+....+++
T Consensus 339 ~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~kFS~e 416 (591)
T KOG0986|consen 339 EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSDKFSEE 416 (591)
T ss_pred CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcccccCHH
Confidence 6655444 8999999999997 569999999999999999999999995532 22334343432 355566788999
Q ss_pred HHHHHHHHhh-CccCCC-----CHHHHhcCCCCCc
Q 004564 255 VRRFVEKCLA-TVSLRL-----SARELLNDPFLQI 283 (745)
Q Consensus 255 l~d~I~kcL~-dPskRp-----Sa~ELL~hPff~~ 283 (745)
++++.+.+|+ +|++|+ +++++.+||||+.
T Consensus 417 akslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 417 AKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 9999999999 999987 6889999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=281.85 Aligned_cols=240 Identities=35% Similarity=0.548 Sum_probs=206.5
Q ss_pred CceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEeccCCCCHH
Q 004564 34 ASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLR 113 (745)
Q Consensus 34 afgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~~gGsL~ 113 (745)
+||.||+|.+..+|..+|+|++...... ...+.+.+|+.+++.++|+||+++++++.. ....++++|++.+++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHH
Confidence 6899999999999999999988744321 116789999999999999999999998866 57899999999999999
Q ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc-CCCcccCCCCc
Q 004564 114 QYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-HAAHCVGTPEF 192 (745)
Q Consensus 114 ~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~-~~~~~vGTp~Y 192 (745)
.++.....++...+..++.+++.+|.|||+++ |+|+||+|+||+++. .+.++|+|||.+...... ......+++.|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T smart00220 76 DLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDE-DGHVKLADFGLARQLDPGGLLTTFVGTPEY 152 (244)
T ss_pred HHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECC-CCcEEEccccceeeeccccccccccCCcCC
Confidence 99887777999999999999999999999988 999999999999984 589999999999776543 33445689999
Q ss_pred CChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccC-CCHHHHHHHHHHhh-CccCC
Q 004564 193 MAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRV-KDPEVRRFVEKCLA-TVSLR 269 (745)
Q Consensus 193 mAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~-~s~el~d~I~kcL~-dPskR 269 (745)
+|||.+. ..++.++||||||+++++|++|..||........+...+..+..+...... .+..+.+++.+||. +|++|
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 9999886 568889999999999999999999998766777777777665554333322 67899999999999 99999
Q ss_pred CCHHHHhcCCCC
Q 004564 270 LSARELLNDPFL 281 (745)
Q Consensus 270 pSa~ELL~hPff 281 (745)
|++.++++||||
T Consensus 233 p~~~~~~~~~~~ 244 (244)
T smart00220 233 LTAEEALQHPFF 244 (244)
T ss_pred cCHHHHhhCCCC
Confidence 999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.97 Aligned_cols=252 Identities=24% Similarity=0.394 Sum_probs=215.6
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyLV 103 (745)
-|..+||+|+||+|.+|..+.+.+.+|||++++.-..+ .++.+--..|-++|... +-|.+++++.+|.. -+.+|+|
T Consensus 352 nFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQ-dDDvectm~EKrvLAL~~kppFL~qlHScFQT--mDRLyFV 428 (683)
T KOG0696|consen 352 NFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQ-DDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDRLYFV 428 (683)
T ss_pred ceEEEeccCccceeeeecccCcchhhhhhhhccceeee-cCcccceehhhhheecCCCCchHHHHHHHhhh--hhheeeE
Confidence 56688999999999999999999999999988554333 34555556677777766 46788888888754 6789999
Q ss_pred EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh--hhcc
Q 004564 104 TEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI--LRKS 181 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~--l~~~ 181 (745)
|||++||+|-=.++.-+++.+..+..|+..|+-||-|||++| ||+||||.+|||++ ..|+|||+|||++.- ....
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd-~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEec-cCCceEeeecccccccccCCc
Confidence 999999999888888999999999999999999999999998 99999999999999 458999999999853 3344
Q ss_pred CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHH
Q 004564 182 HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVE 260 (745)
Q Consensus 182 ~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~ 260 (745)
...+++|||.|+|||++. +.|+.++|+||+||+||||+.|++||.+ .+..+++..+..-. ..+++..|.++.++..
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~ehn--vsyPKslSkEAv~ick 582 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEHN--VSYPKSLSKEAVAICK 582 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHcc--CcCcccccHHHHHHHH
Confidence 556789999999999987 8899999999999999999999999988 67788888887543 3466778999999999
Q ss_pred HHhh-CccCCCC-----HHHHhcCCCCCccc
Q 004564 261 KCLA-TVSLRLS-----ARELLNDPFLQIDD 285 (745)
Q Consensus 261 kcL~-dPskRpS-----a~ELL~hPff~~~~ 285 (745)
..|. .|.+|+. -.++-.||||+-.+
T Consensus 583 g~ltK~P~kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 583 GLLTKHPGKRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred HHhhcCCccccCCCCccccchhhCcchhhcc
Confidence 9998 8999974 57888999998654
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=338.10 Aligned_cols=243 Identities=22% Similarity=0.344 Sum_probs=202.5
Q ss_pred eeEeEEecccCceEEEEEEEcCC-----CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC
Q 004564 24 GRYNEILGKGASKTVYRAFDEYE-----GIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d~~t-----g~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~ 98 (745)
..+.+.||+|+||.||.|.-..- ...||+|.++. ..+......|.+|..+|+.++|||||++++..++ ..
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~---~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~~ 768 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR---LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--SG 768 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc---cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--CC
Confidence 46778899999999999965432 23488877653 3467888999999999999999999999998877 67
Q ss_pred eEEEEEeccCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcC
Q 004564 99 NINFVTEMFTSGTLRQYRLKH-------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 171 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~-------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~D 171 (745)
..++++|||.+|+|..|+++. ..++...+..++.||++|+.||+++. +|||||.+.|+||+.. ..|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~-r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDER-RVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeeccc-CcEEEcc
Confidence 889999999999999999876 35899999999999999999999988 9999999999999855 8999999
Q ss_pred cchhhhhhccCCCcc----cCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHH-HHHcCCCC
Q 004564 172 LGLAAILRKSHAAHC----VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYK-KVVSGKKP 244 (745)
Q Consensus 172 FGlA~~l~~~~~~~~----vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k-kv~~g~~p 244 (745)
||+|+.+........ .-...|||||.+. +.++.++|||||||+|||++| |..||....+ .++.. .+..|..+
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-~~v~~~~~~ggRL~ 924 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-FEVLLDVLEGGRLD 924 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-HHHHHHHHhCCccC
Confidence 999995543322221 2346899999887 789999999999999999999 8999998554 45555 44445333
Q ss_pred CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 245 DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 245 ~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.+..++..+.+++.+||+ +|.+||++..|++
T Consensus 925 --~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 --PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred --CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 345677788899999999 9999999999998
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=327.99 Aligned_cols=202 Identities=32% Similarity=0.440 Sum_probs=174.2
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC----CCeE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA----NRNI 100 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~----~~~i 100 (745)
-..+.||+||||.||++.++.+|+.||+|.++... .....++..+|+++|++|+|||||+++++=.... .+..
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 45588999999999999999999999999988654 4566788999999999999999999999643332 3456
Q ss_pred EEEEeccCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeec-CCCC--cEEEcCcch
Q 004564 101 NFVTEMFTSGTLRQYRLK---HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVN-GNQG--EVKIGDLGL 174 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k---~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld-~~~g--~VKL~DFGl 174 (745)
.++||||.||+|+.++.+ ..+|++.++..++..+..||.|||++| ||||||||.||++- |.+| ..||+|||.
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 799999999999999875 457999999999999999999999999 99999999999873 3334 369999999
Q ss_pred hhhhhcc-CCCcccCCCCcCChhhhh--hccCccccchhhhhHHHHHhhcCCCCCCCCCH
Q 004564 175 AAILRKS-HAAHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTHP 231 (745)
Q Consensus 175 A~~l~~~-~~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~ 231 (745)
|+-+... .....+||+.|.+||+++ +.|+..+|.|||||++|+++||..||-....+
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 9887654 455678999999999998 56899999999999999999999999654444
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.59 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=211.8
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC------CCCcceEeEEE
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK------HKNIMKFYTSW 92 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~------HpNIVk~~~sf 92 (745)
-++|| .+....|+|-|++|.+|.|...|..||||+|+. ++...+.=..|+.+|++|. .-++++|+..|
T Consensus 430 LD~RY-~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-----NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 430 LDSRY-EVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-----NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hccee-EEEeccccceeeeeeeccccCCCCeeEEEEeec-----chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 46788 566778999999999999999999999999983 3445556678999999994 34799999988
Q ss_pred EecCCCeEEEEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEE
Q 004564 93 VDTANRNINFVTEMFTSGTLRQYRLKHK---RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI 169 (745)
Q Consensus 93 vd~~~~~iyLV~E~~~gGsL~~~l~k~~---~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL 169 (745)
.. ..++|||+|.+ ..+|++.+++.+ .|..++|+.|+.|++.||..|-..| |+|.||||+|||||.....+||
T Consensus 504 ~h--knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 504 KH--KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred hh--cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeee
Confidence 65 78999999987 568999998865 5899999999999999999999998 9999999999999988889999
Q ss_pred cCcchhhhhhccCCCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHH--HcCCCCCC
Q 004564 170 GDLGLAAILRKSHAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKV--VSGKKPDS 246 (745)
Q Consensus 170 ~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv--~~g~~p~~ 246 (745)
||||.|........+.+.-+..|.|||++.+ .|+...|+||+||+||||.||+..|++.++.. +.+.. ..|+.|..
T Consensus 579 CDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~-MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 579 CDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ-MLRLFMELKGKFPNK 657 (752)
T ss_pred ccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH-HHHHHHHhcCCCcHH
Confidence 9999999888887777778899999999886 69999999999999999999999999865543 33322 22443321
Q ss_pred ccc----------------------------------C---------------C-------CHHHHHHHHHHhh-CccCC
Q 004564 247 LYR----------------------------------V---------------K-------DPEVRRFVEKCLA-TVSLR 269 (745)
Q Consensus 247 l~~----------------------------------~---------------~-------s~el~d~I~kcL~-dPskR 269 (745)
+.+ + + -.++++|+.+||. ||.+|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 100 0 0 1258899999999 99999
Q ss_pred CCHHHHhcCCCCCc
Q 004564 270 LSARELLNDPFLQI 283 (745)
Q Consensus 270 pSa~ELL~hPff~~ 283 (745)
+|..++|+||||+.
T Consensus 738 it~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 738 ITVNQALKHPFITE 751 (752)
T ss_pred CCHHHHhcCCcccC
Confidence 99999999999974
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=325.32 Aligned_cols=252 Identities=22% Similarity=0.280 Sum_probs=177.3
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCC----CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEe-
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYE----GIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVD- 94 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~t----g~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd- 94 (745)
...| .+.++||+|+||+||+|.+..+ +..||+|.+.... ..+....| .++...+.++..++..|..
T Consensus 131 ~~~y-~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 131 KDDF-VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred cCCe-EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 3455 7889999999999999999988 9999999875321 11111111 1222223333333322211
Q ss_pred ---cCCCeEEEEEeccCCCCHHHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHhhhCCCCEEee
Q 004564 95 ---TANRNINFVTEMFTSGTLRQYRLKHKR--------------------VNIRAVKLWCRQILRGLLYLHSHDPPVIHR 151 (745)
Q Consensus 95 ---~~~~~iyLV~E~~~gGsL~~~l~k~~~--------------------L~e~~i~~ia~QIL~gL~yLHs~gp~IIHR 151 (745)
.....+++|+||+.+++|.+++..... .....+..++.||+.||.|||+++ |+||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHR 279 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHR 279 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence 335689999999999999998765421 123457789999999999999988 9999
Q ss_pred cCCCcceeecCCCCcEEEcCcchhhhhhcc---CCCcccCCCCcCChhhhhh-----------------------ccCcc
Q 004564 152 DLKCDNIFVNGNQGEVKIGDLGLAAILRKS---HAAHCVGTPEFMAPEVYEE-----------------------AYNEL 205 (745)
Q Consensus 152 DLKpdNILld~~~g~VKL~DFGlA~~l~~~---~~~~~vGTp~YmAPEvl~~-----------------------~ys~k 205 (745)
||||+|||++...+.+||+|||+|+.+... .....++|+.|||||.+.. .++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 999999999866689999999999765432 2345679999999997631 13446
Q ss_pred ccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-------------CC------CcccCCCHHHHHHHHHHhh-C
Q 004564 206 VDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK-------------PD------SLYRVKDPEVRRFVEKCLA-T 265 (745)
Q Consensus 206 sDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~-------------p~------~l~~~~s~el~d~I~kcL~-d 265 (745)
+|||||||+||||+++..|+.. ...++.+.+..... .. ......+....+||.+||+ |
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 7999999999999998776543 23333332222111 00 0111123345689999999 9
Q ss_pred ccCCCCHHHHhcCCCCCcc
Q 004564 266 VSLRLSARELLNDPFLQID 284 (745)
Q Consensus 266 PskRpSa~ELL~hPff~~~ 284 (745)
|.+|||++++|+||||+..
T Consensus 438 P~kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 438 GRQRISAKAALAHPYFDRE 456 (566)
T ss_pred cccCCCHHHHhCCcCcCCC
Confidence 9999999999999999854
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=302.25 Aligned_cols=258 Identities=23% Similarity=0.360 Sum_probs=204.1
Q ss_pred CceEeCC-CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC--CCC----c
Q 004564 13 EFVEVDP-TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK--HKN----I 85 (745)
Q Consensus 13 ~~~e~dp-~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~--HpN----I 85 (745)
-|...|- ..|| .+..+||+|.||.|-.++|..++..||+|+++.- ....+...-||.+|.++. .|+ +
T Consensus 80 v~~~gD~l~~Ry-~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~DP~g~~rc 153 (415)
T KOG0671|consen 80 VYQVGDILTNRY-EIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-----DKYREAALIEIEVLQKINESDPNGKFRC 153 (415)
T ss_pred EEEeccccccce-ehhhhhcCCcccceEEEeecCCCceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence 3455555 7788 5668899999999999999999999999998732 456677788999999993 233 4
Q ss_pred ceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecC-
Q 004564 86 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG- 162 (745)
Q Consensus 86 Vk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~- 162 (745)
|.+.+.| + -.+++++|+|.+ |-++.+++..+. +++...++.+++||+.+++|||+.+ ++|-||||+|||+-.
T Consensus 154 v~m~~wF-d-yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss 228 (415)
T KOG0671|consen 154 VQMRDWF-D-YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSS 228 (415)
T ss_pred Eeeehhh-h-ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEecc
Confidence 5554533 3 368999999998 569999998764 6899999999999999999999988 999999999999831
Q ss_pred ------------------CCCcEEEcCcchhhhhhccCCCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCC
Q 004564 163 ------------------NQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEY 223 (745)
Q Consensus 163 ------------------~~g~VKL~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~ 223 (745)
+.-.|||+|||.|+.....+ ...+.|..|.|||++.+ +++..+||||+||||+||.||..
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence 12358999999998766555 45579999999999886 69999999999999999999999
Q ss_pred CCCCCCCHHHH--HHHHHcCCCCCCcc---------------------------------------cCCC---HHHHHHH
Q 004564 224 PYSECTHPAQI--YKKVVSGKKPDSLY---------------------------------------RVKD---PEVRRFV 259 (745)
Q Consensus 224 Pf~~~~~~~~i--~kkv~~g~~p~~l~---------------------------------------~~~s---~el~d~I 259 (745)
.|..-.+.+.+ ++.+. |..|..+. ...+ .++.++|
T Consensus 308 LFqtHen~EHLaMMerIl-Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl 386 (415)
T KOG0671|consen 308 LFQTHENLEHLAMMERIL-GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL 386 (415)
T ss_pred ecccCCcHHHHHHHHHhh-CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence 99776555433 33332 23221110 0112 2478999
Q ss_pred HHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 260 EKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 260 ~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
++||. ||++|+|+.|+|.||||..
T Consensus 387 ~~mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 387 RRMLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred HHHHccCccccccHHHHhcCHHhhc
Confidence 99999 9999999999999999973
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=308.46 Aligned_cols=248 Identities=27% Similarity=0.448 Sum_probs=206.6
Q ss_pred CCCceeeEe-------EEecccCceEEEEEEEc----CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcce
Q 004564 19 PTGRYGRYN-------EILGKGASKTVYRAFDE----YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87 (745)
Q Consensus 19 p~gRY~rl~-------e~LG~GafgtVy~A~d~----~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk 87 (745)
|++|-+++. ++||.|-||.||+|... .....||||.-|.. ..++..+.|..|.-+|++++|||||+
T Consensus 379 P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d---~t~d~tekflqEa~iMrnfdHphIik 455 (974)
T KOG4257|consen 379 PTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD---CTPDDTEKFLQEASIMRNFDHPHIIK 455 (974)
T ss_pred CCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC---CChhhHHHHHHHHHHHHhCCCcchhh
Confidence 666655554 56999999999999642 23446888877643 35667899999999999999999999
Q ss_pred EeEEEEecCCCeEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCc
Q 004564 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGE 166 (745)
Q Consensus 88 ~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~-~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~ 166 (745)
+++.+.+ ..+|+|||+++-|.|+.|++.++ .++...+..|++||+.+|.|||+.. +|||||-..||||.++ ..
T Consensus 456 LIGv~~e---~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp-~C 529 (974)
T KOG4257|consen 456 LIGVCVE---QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSP-QC 529 (974)
T ss_pred eeeeeec---cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCc-ce
Confidence 9998764 68999999999999999999765 6999999999999999999999987 9999999999999865 49
Q ss_pred EEEcCcchhhhhhccCCCcc---cCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcC
Q 004564 167 VKIGDLGLAAILRKSHAAHC---VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSG 241 (745)
Q Consensus 167 VKL~DFGlA~~l~~~~~~~~---vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g 241 (745)
|||+|||+++.+......+. .-..-|||||-++ +.++.++|||-|||||||++. |.-||.+-.+...|. ++.+|
T Consensus 530 VKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-~iEnG 608 (974)
T KOG4257|consen 530 VKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-HIENG 608 (974)
T ss_pred eeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-EecCC
Confidence 99999999998865433221 2346799999987 789999999999999999886 899999877655544 35566
Q ss_pred CCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 242 KKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 242 ~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.+++ .+..++|.+..++.+||+ +|++||.+.+|..
T Consensus 609 eRlP-~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 609 ERLP-CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred CCCC-CCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 6553 456788999999999999 9999999988763
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=295.64 Aligned_cols=263 Identities=24% Similarity=0.368 Sum_probs=207.4
Q ss_pred eCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEE---
Q 004564 17 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWV--- 93 (745)
Q Consensus 17 ~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfv--- 93 (745)
++-.+.|.++ .+||+|.||.||+|..+.+|+.||+|++-... ..+.......+|+++|..|+|+|++.++..+-
T Consensus 13 ~~~~~~yek~-~kigqGtfgeVFkAr~~n~~kkvalkkvlmen--eKeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 13 CDEVSKYEKL-AKIGQGTFGEVFKARSKNTGKKVALKKVLMEN--EKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred eecchHHHHH-HhcCCchHHHHHHHhhcCccchhHHHHHHHhc--cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 5667788666 56899999999999999999999998765432 11233456778999999999999998876432
Q ss_pred ---ecCCCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEE
Q 004564 94 ---DTANRNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI 169 (745)
Q Consensus 94 ---d~~~~~iyLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL 169 (745)
.....++|+|+.+|.. +|..++... .+++...++.++++++.||.|+|++. |+|||+|+.|+||+ .+|.+||
T Consensus 90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt-~dgilkl 165 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLIT-KDGILKL 165 (376)
T ss_pred CCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEc-CCceEEe
Confidence 1224569999999975 788887765 57999999999999999999999988 99999999999998 5689999
Q ss_pred cCcchhhhhhccC------CCcccCCCCcCChhhhh--hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHH--HHH
Q 004564 170 GDLGLAAILRKSH------AAHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYK--KVV 239 (745)
Q Consensus 170 ~DFGlA~~l~~~~------~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k--kv~ 239 (745)
+|||+++.+..+. .+..+-|..|.+||.+. ..|+++.|||..||||.||.|+.+-+.+.++..++.- .+.
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc 245 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC 245 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence 9999997764332 33445699999999886 4699999999999999999999999988665544421 111
Q ss_pred cCC---------------------CCCCc---------ccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcccc
Q 004564 240 SGK---------------------KPDSL---------YRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDDC 286 (745)
Q Consensus 240 ~g~---------------------~p~~l---------~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~~ 286 (745)
... .|... +-+.++++.++++++|. ||.+|+.++++|+|.||..+..
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 100 11000 11236788999999999 9999999999999999986654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=288.26 Aligned_cols=254 Identities=19% Similarity=0.331 Sum_probs=215.8
Q ss_pred eeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEE
Q 004564 24 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINF 102 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyL 102 (745)
.++..+||+|+|++|.++..+.|.+.+|+|++++.-+ +..++++-+..|-++..+. +||.+|-++.+|.. ...+++
T Consensus 252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~-nddedidwvqtek~vfe~asn~pflvglhscfqt--esrlff 328 (593)
T KOG0695|consen 252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESRLFF 328 (593)
T ss_pred ceeeeeecCcchhhhhheehcccceeeehhhHHHHhc-CCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cceEEE
Confidence 4788999999999999999999999999999986543 4556788888898888877 69999999998855 679999
Q ss_pred EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh-h-c
Q 004564 103 VTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-R-K 180 (745)
Q Consensus 103 V~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l-~-~ 180 (745)
|.||++||+|.-.++++++++++.++.|...|+.||.|||++| ||+||||.+|+|++ ..|++||+|+|+.+-- . .
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlld-aeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEc-cCCceeecccchhhcCCCCC
Confidence 9999999999888899999999999999999999999999998 99999999999999 4589999999998643 2 2
Q ss_pred cCCCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCC-------CCCHHHHHHHHHcCCCCCCcccCCC
Q 004564 181 SHAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSE-------CTHPAQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 181 ~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~-------~~~~~~i~kkv~~g~~p~~l~~~~s 252 (745)
....+++|||.|.|||++.+ .|+..+|+|+|||+|+||+.|+.||.- ......+++.+..... .+++..+
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--riprsls 483 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIPRSLS 483 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--cccceee
Confidence 34556789999999999985 699999999999999999999999942 2344556666665432 2445566
Q ss_pred HHHHHHHHHHhh-CccCCC------CHHHHhcCCCCCccc
Q 004564 253 PEVRRFVEKCLA-TVSLRL------SARELLNDPFLQIDD 285 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRp------Sa~ELL~hPff~~~~ 285 (745)
-.+..+++.-|. ||.+|+ ...++-.|+||+..+
T Consensus 484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id 523 (593)
T KOG0695|consen 484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID 523 (593)
T ss_pred hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence 777888888898 999986 478999999998544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=316.39 Aligned_cols=260 Identities=29% Similarity=0.490 Sum_probs=226.7
Q ss_pred eEeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEe
Q 004564 15 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVD 94 (745)
Q Consensus 15 ~e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd 94 (745)
..-+|...| .+...+|.|.||.||+|.|+.+++..|+|+|+++. .++..-+..||-+++.++|||||.+++++.-
T Consensus 9 srrnP~ddy-ellqrvgsgTygdvyKaRd~~s~elaavkvVkLep----~dd~~~iqqei~~~~dc~h~nivay~gsylr 83 (829)
T KOG0576|consen 9 SRRNPQDDY-ELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP----GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR 83 (829)
T ss_pred hhcCCccch-hheeeecCCcccchhhhcccccCchhhheeeeccC----CccccccccceeeeecCCCcChHHHHhhhhh
Confidence 334899999 45577999999999999999999999999999765 3556678889999999999999999999876
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcch
Q 004564 95 TANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 174 (745)
Q Consensus 95 ~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGl 174 (745)
...+|+.||||.+|+|.+.-.-.+++++.++..+++..+.||+|||+.| -+|||||-.|||++ +.|.|||+|||.
T Consensus 84 --~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanillt-d~gDvklaDfgv 158 (829)
T KOG0576|consen 84 --RDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLT-DEGDVKLADFGV 158 (829)
T ss_pred --hcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeec-ccCceeecccCc
Confidence 6789999999999999998778899999999999999999999999998 89999999999998 679999999999
Q ss_pred hhhhhcc--CCCcccCCCCcCChhhhh----hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcc
Q 004564 175 AAILRKS--HAAHCVGTPEFMAPEVYE----EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLY 248 (745)
Q Consensus 175 A~~l~~~--~~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~ 248 (745)
+..+... ....++|||.|||||+-. +.|+.++|||++|++..|+.-.++|-........++-.-.+|..|..+-
T Consensus 159 saqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 159 SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLK 238 (829)
T ss_pred hhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCccc
Confidence 9887653 455678999999999863 6799999999999999999999999877566666665556676665443
Q ss_pred --cCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 249 --RVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 249 --~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
...++.+.+|++.+|. +|++||+++.+|.|||....
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 2357789999999998 99999999999999999754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-33 Score=278.36 Aligned_cols=256 Identities=20% Similarity=0.370 Sum_probs=212.2
Q ss_pred eEeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceEeEEEE
Q 004564 15 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTSWV 93 (745)
Q Consensus 15 ~e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-HpNIVk~~~sfv 93 (745)
+.......| .+.+.+|+|.++.||.|+...+++.++||+++ +-..+.+.+|+.+|..|. ||||+++++...
T Consensus 32 i~wg~~ddY-eivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-------PVkkkKIkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 32 IDWGNQDDY-EIVRKVGRGKYSEVFEGINITNNEKCVIKILK-------PVKKKKIKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred eeccccchH-HHHHHHcCccHhhHhcccccCCCceEEEeeec-------hHHHHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence 333444456 55577999999999999999999999999987 445678999999999996 999999999988
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcc
Q 004564 94 DTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 173 (745)
Q Consensus 94 d~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFG 173 (745)
+...+...+|+||++..+..++. ..++.-.++.+++|||.||.|||+.| |+|||+||.|++|+.....++|+|+|
T Consensus 104 Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWG 178 (338)
T KOG0668|consen 104 DPESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
T ss_pred CccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecc
Confidence 88788899999999987766653 46888999999999999999999998 99999999999999888899999999
Q ss_pred hhhhhhccCCC-cccCCCCcCChhhhh--hccCccccchhhhhHHHHHhhcCCCC-CCCCCHHHHHHHHH--c-------
Q 004564 174 LAAILRKSHAA-HCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPY-SECTHPAQIYKKVV--S------- 240 (745)
Q Consensus 174 lA~~l~~~~~~-~~vGTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf-~~~~~~~~i~kkv~--~------- 240 (745)
+|.+....... ..+.+..|--||++- +.|+.+-|+|||||+|..|+..+-|| .+..+..|+.+... .
T Consensus 179 LAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 179 LAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred hHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHH
Confidence 99987665443 345788899999885 67999999999999999999998887 45567777765321 0
Q ss_pred ----------------CCC---------CCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 241 ----------------GKK---------PDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 241 ----------------g~~---------p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
|.. +..-....+|++.+|+.++|. |..+|+||+|++.||||..
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 000 111122347999999999999 9999999999999999974
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=292.53 Aligned_cols=254 Identities=30% Similarity=0.439 Sum_probs=199.3
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-----C---CCcceEeEE
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-----H---KNIMKFYTS 91 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-----H---pNIVk~~~s 91 (745)
+||| .+.++||.|-|+|||+|+|..+.+.||+|+++ ...-..+....||.+|++++ | ..||+|++.
T Consensus 77 ~gRY-~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK-----SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 77 GGRY-HVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK-----SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred CceE-EEEEeccccccceeEEEeeccCCeEEEEEEEe-----hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 5899 55578999999999999999999999999988 23455677888999999983 3 359999999
Q ss_pred EEec--CCCeEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCC---
Q 004564 92 WVDT--ANRNINFVTEMFTSGTLRQYRLK--HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQ--- 164 (745)
Q Consensus 92 fvd~--~~~~iyLV~E~~~gGsL~~~l~k--~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~--- 164 (745)
|..+ ++.+++||+|++ |-.|..++.+ .+.++...|+.|++|||.||.|||.. .+|||-||||+|||+....
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl~~~e~~~ 228 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLLCSTEIDP 228 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeeeeccccch
Confidence 9764 357899999998 6678887776 46799999999999999999999986 3599999999999992100
Q ss_pred --------------------------------------------------------------------------------
Q 004564 165 -------------------------------------------------------------------------------- 164 (745)
Q Consensus 165 -------------------------------------------------------------------------------- 164 (745)
T Consensus 229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~ 308 (590)
T KOG1290|consen 229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR 308 (590)
T ss_pred hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 004564 165 -------------------------------------------------------------------------------- 164 (745)
Q Consensus 165 -------------------------------------------------------------------------------- 164 (745)
T Consensus 309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~ 388 (590)
T KOG1290|consen 309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE 388 (590)
T ss_pred CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence
Q ss_pred --CcEEEcCcchhhhhhccCCCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCC---------CCHH
Q 004564 165 --GEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSEC---------THPA 232 (745)
Q Consensus 165 --g~VKL~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~---------~~~~ 232 (745)
-+|||+|||-|++... +.+.-+.|..|+|||++.+ .|+..+||||++|++|||+||.+.|..- ...+
T Consensus 389 ~di~vKIaDlGNACW~~k-hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA 467 (590)
T KOG1290|consen 389 CDIRVKIADLGNACWVHK-HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA 467 (590)
T ss_pred cceeEEEeeccchhhhhh-hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence 0268888888887654 3344578999999999875 6999999999999999999999988321 1233
Q ss_pred HHHHHH--------HcCCCCCCc------------------ccC----------CCHHHHHHHHHHhh-CccCCCCHHHH
Q 004564 233 QIYKKV--------VSGKKPDSL------------------YRV----------KDPEVRRFVEKCLA-TVSLRLSAREL 275 (745)
Q Consensus 233 ~i~kkv--------~~g~~p~~l------------------~~~----------~s~el~d~I~kcL~-dPskRpSa~EL 275 (745)
.|.+.+ ..|+....+ ..+ ...++.+|+.-||+ +|.+|+||.++
T Consensus 468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 333321 223221111 111 13468899999999 99999999999
Q ss_pred hcCCCCC
Q 004564 276 LNDPFLQ 282 (745)
Q Consensus 276 L~hPff~ 282 (745)
|+||||.
T Consensus 548 l~hPwLn 554 (590)
T KOG1290|consen 548 LKHPWLN 554 (590)
T ss_pred hcCcccc
Confidence 9999997
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-31 Score=301.92 Aligned_cols=259 Identities=21% Similarity=0.268 Sum_probs=186.2
Q ss_pred CCceeeEeEEecccCceEEEEEEEc----------------CCCeEEEEEEEeecccCCCHH----------HHHHHHHH
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDE----------------YEGIEVAWNQVKLYDFLQSPE----------DLERLYCE 73 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~----------------~tg~~VAiK~ik~~~~~~~~~----------~~e~l~~E 73 (745)
...| ++.++||+|+||+||+|.+. ..++.||+|.++........+ ..+....|
T Consensus 144 ~d~F-~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 144 SDDF-QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred ccCc-eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4456 77899999999999999752 345689999986432111011 11223447
Q ss_pred HHHHHhCCCCCc-----ceEeEEEEec------CCCeEEEEEeccCCCCHHHHHHHc-----------------------
Q 004564 74 IHLLKTLKHKNI-----MKFYTSWVDT------ANRNINFVTEMFTSGTLRQYRLKH----------------------- 119 (745)
Q Consensus 74 i~iLk~L~HpNI-----Vk~~~sfvd~------~~~~iyLV~E~~~gGsL~~~l~k~----------------------- 119 (745)
+.++..++|.++ ++++++|... .....++|+||+.+++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788876654 6676665431 135689999999999999887542
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCCC---cccCCCCcCCh
Q 004564 120 -KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA---HCVGTPEFMAP 195 (745)
Q Consensus 120 -~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~~---~~vGTp~YmAP 195 (745)
..+++..++.++.||+.+|.|||+++ |+||||||+|||++ .++.+||+|||++......... ...+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEEC-CCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12456788999999999999999988 99999999999998 4579999999999765432211 22358999999
Q ss_pred hhhhhc---------------------cC--ccccchhhhhHHHHHhhcCC-CCCCCC----------CHHHHHHHHHcC
Q 004564 196 EVYEEA---------------------YN--ELVDIYSFGMCILEMVTFEY-PYSECT----------HPAQIYKKVVSG 241 (745)
Q Consensus 196 Evl~~~---------------------ys--~ksDIWSLGvILyELlTG~~-Pf~~~~----------~~~~i~kkv~~g 241 (745)
|++... |+ .++||||+||++|+|++|.. ||.... .....++.+..+
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 987421 22 24799999999999999975 775421 111222233333
Q ss_pred CCCCCcccCCCHHHHHHHHHHhh-Cc---cCCCCHHHHhcCCCCC
Q 004564 242 KKPDSLYRVKDPEVRRFVEKCLA-TV---SLRLSARELLNDPFLQ 282 (745)
Q Consensus 242 ~~p~~l~~~~s~el~d~I~kcL~-dP---skRpSa~ELL~hPff~ 282 (745)
..........++..++|+.+||. +| .+|+|++|+|+||||.
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 33333455678999999999998 44 6899999999999995
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=296.77 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=201.3
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~ 98 (745)
|..+- ++.+.||+|-||.|.++.-. .+..||+|.++... +......|.+||++|.+|+||||+.+++.++. ++
T Consensus 536 PRs~L-~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a---~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~--De 608 (807)
T KOG1094|consen 536 PRSRL-RFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA---TKNARNDFLKEIKILSRLKHPNIVELLGVCVQ--DD 608 (807)
T ss_pred chhhe-ehhhhhcCcccceeEEEEec-CceEEEEeecCccc---chhHHHHHHHHHHHHhccCCCCeeEEEeeeec--CC
Confidence 44444 78899999999999999543 26899999887443 44556889999999999999999999998866 78
Q ss_pred eEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 99 NINFVTEMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
.+++||||+..|+|.+|+.++. .+..+...+++.||+.|++||.+.+ +|||||.+.|+|++++ +++||+|||+++
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e-~~iKiadfgmsR 685 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGE-FTIKIADFGMSR 685 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCc-ccEEecCccccc
Confidence 9999999999999999999984 3345566679999999999999998 9999999999999855 799999999998
Q ss_pred hhhccCCC----cccCCCCcCChhhh-hhccCccccchhhhhHHHHHhh--cCCCCCCCCCHHHHHHHHH---cCCCC--
Q 004564 177 ILRKSHAA----HCVGTPEFMAPEVY-EEAYNELVDIYSFGMCILEMVT--FEYPYSECTHPAQIYKKVV---SGKKP-- 244 (745)
Q Consensus 177 ~l~~~~~~----~~vGTp~YmAPEvl-~~~ys~ksDIWSLGvILyELlT--G~~Pf~~~~~~~~i~kkv~---~g~~p-- 244 (745)
-+-..... ..+-..+|||||.+ .+.++.++|+|+||++|||+++ .+.||+... .+++.+..- .+..+
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt-~e~vven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT-DEQVVENAGEFFRDQGRQV 764 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh-HHHHHHhhhhhcCCCCcce
Confidence 66443322 33566899999965 5899999999999999999886 589998744 455544332 22211
Q ss_pred -CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 245 -DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 245 -~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
...+..++..+.+++..||. +-.+||+.++|-.
T Consensus 765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 23355678889999999999 9999999999843
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=292.49 Aligned_cols=241 Identities=24% Similarity=0.364 Sum_probs=209.6
Q ss_pred eeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEE
Q 004564 24 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV 103 (745)
.....+||.|-||.||.|..+.-.-.||+|.++ .+...++.|.+|+.+|+.++|||+|++++.+ +....+|||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-----EDtMeveEFLkEAAvMKeikHpNLVqLLGVC--T~EpPFYIi 341 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC--THEPPFYII 341 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhh-----hcchhHHHHHHHHHHHHhhcCccHHHHhhhh--ccCCCeEEE
Confidence 345567999999999999999999999999887 2356788999999999999999999999965 557889999
Q ss_pred EeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc
Q 004564 104 TEMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~ 181 (745)
+|||..|+|.+|+++-. .++.-.+..++.||.+|++||..++ +|||||-..|+||. .+..||++|||+++.+...
T Consensus 342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVg-EnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccc-ccceEEeeccchhhhhcCC
Confidence 99999999999998754 4777888899999999999999988 99999999999996 5569999999999998776
Q ss_pred CCCcccC---CCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHH
Q 004564 182 HAAHCVG---TPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVR 256 (745)
Q Consensus 182 ~~~~~vG---Tp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~ 256 (745)
..+...| ..-|.|||-+. +.++.++|||+|||+|||++| |-.||.+ .+..++|..+..|.... -+..+.+.+.
T Consensus 419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgyRM~-~PeGCPpkVY 496 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGYRMD-GPEGCPPKVY 496 (1157)
T ss_pred ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhcccccc-CCCCCCHHHH
Confidence 6555444 46799999876 778999999999999999998 7899988 67899998887776543 3456889999
Q ss_pred HHHHHHhh-CccCCCCHHHHh
Q 004564 257 RFVEKCLA-TVSLRLSARELL 276 (745)
Q Consensus 257 d~I~kcL~-dPskRpSa~ELL 276 (745)
+++..||+ .|+.||++.|+-
T Consensus 497 eLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 497 ELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHHHhcCCcccCccHHHHH
Confidence 99999999 999999988763
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-33 Score=283.26 Aligned_cols=249 Identities=28% Similarity=0.446 Sum_probs=200.9
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC---CCeEEEEE
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA---NRNINFVT 104 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~---~~~iyLV~ 104 (745)
+-||.|+||.||.+.|..+|+.||+|.+ ....++-..-+++.+|+.+|..++|.|++..++...-.. -..+|+|+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~--pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKM--PNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhc--chHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 5699999999999999999999999965 344556667789999999999999999999888643211 13588999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC--
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-- 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~-- 182 (745)
|++.+ +|..++..-..++.+.++-+++|||+||+|||+.+ |.||||||.|+|||++ ..+||||||+|+......
T Consensus 137 ELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 137 ELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSN-CILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccC-ceEEecccccccccchhhhh
Confidence 99965 88888888889999999999999999999999988 9999999999999854 789999999998765443
Q ss_pred -CCcccCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHH----------------------
Q 004564 183 -AAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKK---------------------- 237 (745)
Q Consensus 183 -~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kk---------------------- 237 (745)
.+..+-|..|.|||++.+ .|+.++||||+|||+.||+..+..|......+++--.
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 334468999999999874 5999999999999999999999999775544443211
Q ss_pred H-HcCCCCCC---cccCCC-----HHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 238 V-VSGKKPDS---LYRVKD-----PEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 238 v-~~g~~p~~---l~~~~s-----~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
+ ..+.+++. +++..+ -+...++.++|. +|.+|.+.++++.|+++.
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 1 11223332 233333 356677788888 999999999999999885
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=281.10 Aligned_cols=253 Identities=31% Similarity=0.431 Sum_probs=206.0
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC---
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA--- 96 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~--- 96 (745)
..||.-+ ..+|.|+- .|..|+|..++++||+|.+... ..+.....+.++|..++..+.|+||++++.+|.-..
T Consensus 16 ~~Ry~nL-~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p--f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 16 PKRYVNL-KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP--FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeee-cccCCCCc-eEEecchhhccCceehhhhcCc--cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 3567444 66899999 8889999999999999988655 344566788999999999999999999999874311
Q ss_pred -CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 97 -NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 97 -~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
-..+|+|||+|. .+|.+.+. -.++-+.++.+++|++.|++|||+.| |+||||||+||+++ .++.+||.|||+|
T Consensus 92 ~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~-~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 92 EFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVN-SDCTLKILDFGLA 165 (369)
T ss_pred HHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceec-chhheeeccchhh
Confidence 246899999995 58888766 46888999999999999999999988 99999999999998 5689999999999
Q ss_pred hhhhcc-CCCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-C-----------
Q 004564 176 AILRKS-HAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-G----------- 241 (745)
Q Consensus 176 ~~l~~~-~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~-g----------- 241 (745)
...... ..+..+.|..|.|||++-+ .|.+.+||||+|||+.||++|...|.+.....+..+.+.. |
T Consensus 166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 887666 5566789999999998753 5999999999999999999999999875554444333211 0
Q ss_pred --------------------CCCCCcc-------cCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 242 --------------------KKPDSLY-------RVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 242 --------------------~~p~~l~-------~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
..|...+ +.....+++++.+||. +|.+|.+++++|+|||++
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0111111 1234568999999999 999999999999999997
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=302.43 Aligned_cols=248 Identities=21% Similarity=0.375 Sum_probs=208.6
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCC---eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecC
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEG---IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA 96 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg---~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~ 96 (745)
+-.|..+.++||.|.||.||+|..+.-| ..||||.+|.. -.+++...|..|+.||-+++||||+++-+. .+.
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G---ytekqrrdFL~EAsIMGQFdHPNIIrLEGV--VTk 701 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG---YTEKQRRDFLSEASIMGQFDHPNIIRLEGV--VTK 701 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC---ccHHHHhhhhhhhhhcccCCCCcEEEEEEE--Eec
Confidence 3457789999999999999999887665 57999988744 356778889999999999999999999994 466
Q ss_pred CCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 97 NRNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 97 ~~~iyLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
.+.+.||+|||+.|+|..|++++ +.+..-++..+++-|+.|++||-..+ +|||||...|||||.+ -..|++|||++
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsn-LvCKVsDFGLS 778 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSN-LVCKVSDFGLS 778 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccc-eEEEeccccce
Confidence 78999999999999999998876 56888899999999999999999988 9999999999999955 68999999999
Q ss_pred hhhhccCCCc---ccC--CCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCC-CCCc
Q 004564 176 AILRKSHAAH---CVG--TPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKK-PDSL 247 (745)
Q Consensus 176 ~~l~~~~~~~---~vG--Tp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~-p~~l 247 (745)
+.+....... ..| ..+|.|||.+. +.++.++||||+||+|||.++ |+.||-+..+.+ ..+.|..|.. |+++
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-VIkaIe~gyRLPpPm 857 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-VIKAIEQGYRLPPPM 857 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-HHHHHHhccCCCCCC
Confidence 9875443221 112 37899999887 889999999999999999665 999998866544 4556666654 4333
Q ss_pred ccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 248 YRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 248 ~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
.++..+.+|+..||+ +-..||.+.||+.+
T Consensus 858 --DCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 858 --DCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred --CCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 467889999999999 89999999999854
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=298.86 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=209.3
Q ss_pred eEeEEecccCceEEEEEEEcC---CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEE
Q 004564 25 RYNEILGKGASKTVYRAFDEY---EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~---tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iy 101 (745)
++.|+||+|.||.|++|..+. +...||+|.++..... .....|.+|+.+|.+|+|||+|++|+...+ ..+.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl~---qp~m 186 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVLD---QPAM 186 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeecc---chhh
Confidence 555889999999999996544 2357999998855432 278899999999999999999999998765 6789
Q ss_pred EEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 102 FVTEMFTSGTLRQYRLK--HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 102 LV~E~~~gGsL~~~l~k--~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
||||++..|+|.+.+.+ ...|....+..|+.||+.|+.||.+++ +|||||-..||||-. ...|||+||||.+.+.
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllas-prtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLAS-PRTVKICDFGLMRALG 263 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecc-cceeeeecccceeccC
Confidence 99999999999998877 345889999999999999999999988 999999999999964 4699999999998876
Q ss_pred ccCCCcc-----cCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCC
Q 004564 180 KSHAAHC-----VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 180 ~~~~~~~-----vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s 252 (745)
....... --...|+|||.++ +.++.++|+|+|||++|||+| |+-||.++ ...+|.+++..|.... -++.++
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~qIL~~iD~~erLp-RPk~cs 341 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQILKNIDAGERLP-RPKYCS 341 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-CHHHHHHhccccccCC-CCCCCh
Confidence 5433221 1345799999997 789999999999999999998 79999985 5788888888665432 345688
Q ss_pred HHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
..+.+++..||+ +|.+|||+..|..+-+++..
T Consensus 342 edIY~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 342 EDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred HHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 999999999999 99999999999876666543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=265.12 Aligned_cols=210 Identities=27% Similarity=0.448 Sum_probs=180.0
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEEEEec
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyLV~E~ 106 (745)
+.||+|++|.|-+..+..+|...|+|.++..- +....+++.+|+++.... ..|.+|.||+.++. ...+|+.||.
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tv---n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egdvwIcME~ 126 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATV---NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGDVWICMEL 126 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhc---ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cccEEEeHHH
Confidence 45899999999999999999999999887542 356677888899875544 79999999998876 5789999999
Q ss_pred cCCCCHHHH----HHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC
Q 004564 107 FTSGTLRQY----RLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 182 (745)
Q Consensus 107 ~~gGsL~~~----l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~ 182 (745)
|. .+|..+ +.+.+.+++..+-+++-.|+.||.|||++ ..+||||+||.|||+| ..|+|||||||++..+..+.
T Consensus 127 M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn-~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILIN-YDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred hh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEc-cCCcEEEcccccceeehhhh
Confidence 95 477665 34567899999999999999999999987 4599999999999998 66999999999999888776
Q ss_pred CCc-ccCCCCcCChhhhh-----hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC
Q 004564 183 AAH-CVGTPEFMAPEVYE-----EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPD 245 (745)
Q Consensus 183 ~~~-~vGTp~YmAPEvl~-----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~ 245 (745)
..+ ..|-..|||||.++ ..|+-++||||||++++||+++++||.....+-+..+.+.+...|.
T Consensus 204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~ 272 (282)
T KOG0984|consen 204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ 272 (282)
T ss_pred HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence 665 46889999999985 2588999999999999999999999988888888888888765553
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=299.75 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=209.7
Q ss_pred ceEeCCCCceeeEeEEecccCceEEEEEEEc----C---CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCc
Q 004564 14 FVEVDPTGRYGRYNEILGKGASKTVYRAFDE----Y---EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNI 85 (745)
Q Consensus 14 ~~e~dp~gRY~rl~e~LG~GafgtVy~A~d~----~---tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNI 85 (745)
-.|++..+. .+.+.||.|+||.|++|.-. . ....||+|..+... ...+.+.+..|+.+|+.+ +||||
T Consensus 290 ~~e~~~~~l--~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~~~~~~~~~~El~~m~~~g~H~ni 364 (609)
T KOG0200|consen 290 KWEIPRENL--KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA---SSSEKKDLMSELNVLKELGKHPNI 364 (609)
T ss_pred ceeechhhc--cccceeecccccceEeEEEeecccccccceEEEEEEeccccc---CcHHHHHHHHHHHHHHHhcCCcch
Confidence 556665555 45569999999999999532 1 25679999876443 337788999999999999 59999
Q ss_pred ceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHhhhCCCCEE
Q 004564 86 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK----------------RVNIRAVKLWCRQILRGLLYLHSHDPPVI 149 (745)
Q Consensus 86 Vk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~----------------~L~e~~i~~ia~QIL~gL~yLHs~gp~II 149 (745)
+.+++.+.. ...+++|+||+..|+|..|++..+ .++...+..++.||+.|++||++.. +|
T Consensus 365 v~llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~v 440 (609)
T KOG0200|consen 365 VNLLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CV 440 (609)
T ss_pred hhheeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--cc
Confidence 999998755 788999999999999999988766 3889999999999999999999987 99
Q ss_pred eecCCCcceeecCCCCcEEEcCcchhhhhhccCCCc---ccCC--CCcCChhhhh-hccCccccchhhhhHHHHHhh-cC
Q 004564 150 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH---CVGT--PEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FE 222 (745)
Q Consensus 150 HRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~~~---~vGT--p~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~ 222 (745)
||||-+.|||+. .+..+||+|||+|+......... ..|+ ..|||||.+. ..|+.++|||||||+||||+| |.
T Consensus 441 HRDLAaRNVLi~-~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~ 519 (609)
T KOG0200|consen 441 HRDLAARNVLIT-KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGG 519 (609)
T ss_pred chhhhhhhEEec-CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCC
Confidence 999999999997 44699999999998654432222 2232 3499999887 579999999999999999999 89
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 223 YPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 223 ~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.||.+......+++.+..|.+... +...++++.+++..||+ +|.+||+..++..
T Consensus 520 ~PYp~~~~~~~l~~~l~~G~r~~~-P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 520 TPYPGIPPTEELLEFLKEGNRMEQ-PEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCCCCCcHHHHHHHHhcCCCCCC-CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 999986667888888888887654 34558999999999999 9999999999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=320.10 Aligned_cols=237 Identities=20% Similarity=0.329 Sum_probs=178.7
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
...++||+|+||.||+|.+..++..||+|.++.... ....|+.+|++++|||||++++++.+ ....|+||
T Consensus 693 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~--~~~~~lv~ 762 (968)
T PLN00113 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRS--EKGAYLIH 762 (968)
T ss_pred CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEc--CCCCEEEE
Confidence 344679999999999999999999999998763221 11346889999999999999999866 56789999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhC-CCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCC
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSH-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 183 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~-gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~ 183 (745)
||+.+|+|.+++. .+++..+..++.||+.||+|||.+ .++|+||||||+||+++. .+..++. ||.+..... .
T Consensus 763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~-~~~~~~~-~~~~~~~~~--~ 835 (968)
T PLN00113 763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG-KDEPHLR-LSLPGLLCT--D 835 (968)
T ss_pred eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC-CCceEEE-ecccccccc--C
Confidence 9999999999985 488999999999999999999954 345999999999999984 4566664 555433321 2
Q ss_pred CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCC----HHHHHHHHHcCC------CCCC-----c
Q 004564 184 AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTH----PAQIYKKVVSGK------KPDS-----L 247 (745)
Q Consensus 184 ~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~----~~~i~kkv~~g~------~p~~-----l 247 (745)
....||+.|||||++. +.|+.++|||||||++|||+||+.||..... .....+...... .|.. .
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 2346899999999887 5699999999999999999999999854211 111111111100 0100 0
Q ss_pred ccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 248 YRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 248 ~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
......++.+++.+||+ +|.+|||+.|+++.
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00112256788999999 99999999999865
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=303.62 Aligned_cols=241 Identities=29% Similarity=0.414 Sum_probs=189.3
Q ss_pred eEeEEecccCceE-EEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEE
Q 004564 25 RYNEILGKGASKT-VYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINF 102 (745)
Q Consensus 25 rl~e~LG~Gafgt-Vy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyL 102 (745)
.-.+++|.|+-|+ ||+| ...|++||+|.+- .+..+...+||.+|+.- +|||||++|+ .+.+...+|+
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G--~ye~R~VAVKrll-------~e~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YI 580 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRG--VYEGREVAVKRLL-------EEFFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYI 580 (903)
T ss_pred ccHHHcccCCCCcEEEEE--eeCCceehHHHHh-------hHhHHHHHHHHHHHHhccCCCceEEEEe--eccCCceEEE
Confidence 3447799999986 5999 5668899999764 34556778899999988 5999999999 4566889999
Q ss_pred EEeccCCCCHHHHHHHcC-CC---CHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCC----CCcEEEcCcch
Q 004564 103 VTEMFTSGTLRQYRLKHK-RV---NIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGN----QGEVKIGDLGL 174 (745)
Q Consensus 103 V~E~~~gGsL~~~l~k~~-~L---~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~----~g~VKL~DFGl 174 (745)
..|+|.. +|.+++.... .+ ..-..+.++.|+++||++||+.+ ||||||||.||||... ...++|+|||+
T Consensus 581 alELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl 657 (903)
T KOG1027|consen 581 ALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGL 657 (903)
T ss_pred EehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccccc
Confidence 9999965 9999988741 11 11345778999999999999988 9999999999999753 24789999999
Q ss_pred hhhhhccC-----CCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhc-CCCCCCCCCHHHHHHHHHcCCCC-CC
Q 004564 175 AAILRKSH-----AAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKKP-DS 246 (745)
Q Consensus 175 A~~l~~~~-----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG-~~Pf~~~~~~~~i~kkv~~g~~p-~~ 246 (745)
++.+.... .....||-.|+|||++.+ ....++|||||||++|+.++| ..||... .+-...|..|... ..
T Consensus 658 sKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~---~~R~~NIl~~~~~L~~ 734 (903)
T KOG1027|consen 658 SKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS---LERQANILTGNYTLVH 734 (903)
T ss_pred ccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch---HHhhhhhhcCccceee
Confidence 98875432 334569999999999974 456689999999999999996 8999652 2222345555442 22
Q ss_pred cccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 247 LYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 247 l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
+....+.+++++|.+||. +|..||+|.++|.||||=
T Consensus 735 L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 735 LEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred eccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 222223389999999999 999999999999999994
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=282.93 Aligned_cols=240 Identities=28% Similarity=0.426 Sum_probs=188.0
Q ss_pred eeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC--CCCCcceEeEEEEecC--CCe
Q 004564 24 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL--KHKNIMKFYTSWVDTA--NRN 99 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L--~HpNIVk~~~sfvd~~--~~~ 99 (745)
..+.++||+|.||.||+| ..+++.||+|++. ....+.+..|-+|.+.. +|+||++|++.-.... ...
T Consensus 212 l~l~eli~~Grfg~V~Ka--qL~~~~VAVKifp-------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKA--QLDNRLVAVKIFP-------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred hhhHHHhhcCccceeehh--hccCceeEEEecC-------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 456689999999999999 4567999999886 45667788888887754 8999999998532211 347
Q ss_pred EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhh-------CCCCEEeecCCCcceeecCCCCcEEEcCc
Q 004564 100 INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS-------HDPPVIHRDLKCDNIFVNGNQGEVKIGDL 172 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs-------~gp~IIHRDLKpdNILld~~~g~VKL~DF 172 (745)
++||++|...|+|.+|++.+ .+++....+++..|++||+|||+ +.|+|+|||||..||||. ++++.-|+||
T Consensus 283 ywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccIaDF 360 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCIADF 360 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-cCCcEEeecc
Confidence 89999999999999997765 59999999999999999999998 347899999999999997 7799999999
Q ss_pred chhhhhhcc----CCCcccCCCCcCChhhhhhccCc-------cccchhhhhHHHHHhhcC------------CCCCC--
Q 004564 173 GLAAILRKS----HAAHCVGTPEFMAPEVYEEAYNE-------LVDIYSFGMCILEMVTFE------------YPYSE-- 227 (745)
Q Consensus 173 GlA~~l~~~----~~~~~vGTp~YmAPEvl~~~ys~-------ksDIWSLGvILyELlTG~------------~Pf~~-- 227 (745)
|+|.++... .....+||.+|||||++++..+. +.||||+|.+||||++.. .||..
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999877543 23346899999999999875443 489999999999999742 34421
Q ss_pred --CCCHHHHHHHHHcCCC-C---CCcccC-CCHHHHHHHHHHhh-CccCCCCHHH
Q 004564 228 --CTHPAQIYKKVVSGKK-P---DSLYRV-KDPEVRRFVEKCLA-TVSLRLSARE 274 (745)
Q Consensus 228 --~~~~~~i~kkv~~g~~-p---~~l~~~-~s~el~d~I~kcL~-dPskRpSa~E 274 (745)
-...+++...++..+. | ..+.+. .-..+++.++.||. ||.-|+||.=
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 1345566665655432 2 222222 22458999999999 9999999753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-29 Score=240.34 Aligned_cols=209 Identities=38% Similarity=0.595 Sum_probs=183.9
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEeccCC
Q 004564 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTS 109 (745)
Q Consensus 30 LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~~g 109 (745)
||.|++|.||++.+..++..+++|++...... ...+.+.+|+..++.++|++|+++++++.. ....++++|++.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS---SLLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccch---hHHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCC
Confidence 68999999999999888999999988744321 145789999999999999999999998765 4789999999999
Q ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccC--CCcc
Q 004564 110 GTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AAHC 186 (745)
Q Consensus 110 GsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~--~~~~ 186 (745)
++|.+++... ..++...+..++.+++.+|.+||+++ ++|+||+|.||+++...+.++|+|||.+....... ....
T Consensus 76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 9999998876 57999999999999999999999998 99999999999998426899999999997765543 3345
Q ss_pred cCCCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh
Q 004564 187 VGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA 264 (745)
Q Consensus 187 vGTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~ 264 (745)
.+...|++||.+.. .++.+.|+|+||+++++| ..+.+++.+||+
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHhh
Confidence 68899999999875 788999999999999999 678999999998
Q ss_pred -CccCCCCHHHHhcCC
Q 004564 265 -TVSLRLSARELLNDP 279 (745)
Q Consensus 265 -dPskRpSa~ELL~hP 279 (745)
+|.+||++.++++++
T Consensus 200 ~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 200 KDPEKRPSAKEILEHL 215 (215)
T ss_pred CCcccCcCHHHHhhCC
Confidence 999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=290.79 Aligned_cols=241 Identities=28% Similarity=0.445 Sum_probs=202.7
Q ss_pred eEeEEecccCceEEEEEEEcCCC----eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEG----IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg----~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
+.+++||.|+||+||+|...-.| .+||||++... ...+..+.+..|+-+|.+|+|||++++++.... ..+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~---t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~---s~~ 772 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF---TSPKASIELLDEALRMASLDHPNLLRLLGVCML---STL 772 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeecc---CCchhhHHHHHHHHHHhcCCCchHHHHhhhccc---chH
Confidence 55688999999999999765444 46888876532 345667789999999999999999999998764 348
Q ss_pred EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 101 NFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
.||++|+++|+|.+|++.+ .++-.+.+..|+.||++|+.|||.+. ++||||-..||||.. ...|||.|||+|..+.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVks-P~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKS-PNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecC-CCeEEEEecchhhccC
Confidence 8999999999999998876 47999999999999999999999988 999999999999984 4699999999998876
Q ss_pred ccCCCcc--c--CCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCH
Q 004564 180 KSHAAHC--V--GTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDP 253 (745)
Q Consensus 180 ~~~~~~~--v--GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~ 253 (745)
....... . -.+-|||-|.+. ..|+.++|||||||++||++| |..||.+ ...++|-+.+..|.+ ...+...+.
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiCti 927 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPICTI 927 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCccH
Confidence 5332211 1 346688888776 679999999999999999998 8999987 667888887777776 445667888
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHh
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELL 276 (745)
Q Consensus 254 el~d~I~kcL~-dPskRpSa~ELL 276 (745)
.+..++.+||. |+..||++++|.
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHH
Confidence 99999999999 999999999875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=271.59 Aligned_cols=246 Identities=30% Similarity=0.473 Sum_probs=189.9
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHh--CCCCCcceEeEEEEecC
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKT--LKHKNIMKFYTSWVDTA 96 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~--L~HpNIVk~~~sfvd~~ 96 (745)
.-.|-.++.+.||+|.||.||+| ...|+.||+|++.-. +-..+.+|.+|++. |+|+||+.|+.+-....
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG--~wrGe~VAVKiF~sr-------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRG--RWRGEDVAVKIFSSR-------DERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred hhhheeEEEEEecCccccceeec--cccCCceEEEEeccc-------chhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 44567789999999999999999 678999999998622 23457778888775 49999999998643221
Q ss_pred C--CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhh------CCCCEEeecCCCcceeecCCCCcEE
Q 004564 97 N--RNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS------HDPPVIHRDLKCDNIFVNGNQGEVK 168 (745)
Q Consensus 97 ~--~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs------~gp~IIHRDLKpdNILld~~~g~VK 168 (745)
+ -.+|||++|.+.|||.+|+.+ ..++.+.+.+++..++.||++||. ..|.|.|||||..||||. ++|..-
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-kn~~C~ 356 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCC 356 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc-cCCcEE
Confidence 1 258999999999999999887 679999999999999999999996 236799999999999997 668999
Q ss_pred EcCcchhhhhhcc------CCCcccCCCCcCChhhhhhccC-------ccccchhhhhHHHHHhhc----------CCCC
Q 004564 169 IGDLGLAAILRKS------HAAHCVGTPEFMAPEVYEEAYN-------ELVDIYSFGMCILEMVTF----------EYPY 225 (745)
Q Consensus 169 L~DFGlA~~l~~~------~~~~~vGTp~YmAPEvl~~~ys-------~ksDIWSLGvILyELlTG----------~~Pf 225 (745)
|+|||||...... .....+||.+|||||++++..+ ..+||||||.++||++-. +.||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 9999999765443 2334589999999999975432 358999999999999842 5888
Q ss_pred CCC----CCHHHHHHHHHc-CCCCCCcccCCC-H---HHHHHHHHHhh-CccCCCCHHHH
Q 004564 226 SEC----THPAQIYKKVVS-GKKPDSLYRVKD-P---EVRRFVEKCLA-TVSLRLSAREL 275 (745)
Q Consensus 226 ~~~----~~~~~i~kkv~~-g~~p~~l~~~~s-~---el~d~I~kcL~-dPskRpSa~EL 275 (745)
.+. .+.+++.+.|-- ...|....+..+ + .+.++++.||. +|+-|.||-.+
T Consensus 437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 553 344555544322 223433333333 3 35678899998 99999998554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=272.76 Aligned_cols=248 Identities=26% Similarity=0.415 Sum_probs=198.3
Q ss_pred eeeEeEEecccCceEEEEEEEcC---CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCC
Q 004564 23 YGRYNEILGKGASKTVYRAFDEY---EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 23 Y~rl~e~LG~GafgtVy~A~d~~---tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~ 98 (745)
+++...+||.|.|++||+|++.. ....||+|.+.... ...++..|+.+|..+ .+.||+++.+++- .++
T Consensus 37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~~r--nnd 108 (418)
T KOG1167|consen 37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGCFR--NND 108 (418)
T ss_pred hhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhhhc--cCC
Confidence 45777899999999999999988 78999999886442 345799999999999 5899999999874 478
Q ss_pred eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 99 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
.+.+|+||+....-.++.. .++...++.|++.++.||.++|.+| ||||||||.|+|.+...+.-.|+|||+|...
T Consensus 109 ~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred eeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHH
Confidence 9999999999998888765 4779999999999999999999999 9999999999999988899999999999721
Q ss_pred hc--------c--------------------------------------CCCcccCCCCcCChhhhh--hccCccccchh
Q 004564 179 RK--------S--------------------------------------HAAHCVGTPEFMAPEVYE--EAYNELVDIYS 210 (745)
Q Consensus 179 ~~--------~--------------------------------------~~~~~vGTp~YmAPEvl~--~~ys~ksDIWS 210 (745)
.. . ......|||.|.|||++. +.-+.++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 00 0 001125999999999987 45778999999
Q ss_pred hhhHHHHHhhcCCCCCCCCC----HHHHHH--------HH--HcCC----------------------------------
Q 004564 211 FGMCILEMVTFEYPYSECTH----PAQIYK--------KV--VSGK---------------------------------- 242 (745)
Q Consensus 211 LGvILyELlTG~~Pf~~~~~----~~~i~k--------kv--~~g~---------------------------------- 242 (745)
.|||++-++++.+||....+ ..++.- +. ..|.
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 99999999999999954332 222211 00 0111
Q ss_pred -CCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 243 -KPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 243 -~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
.+.......+..+.+|+.+||. +|.+|+||+++|+||||..
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 0011122335578999999999 9999999999999999983
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=241.45 Aligned_cols=212 Identities=34% Similarity=0.484 Sum_probs=182.8
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++.+.||.|++++||+|.+..++..+|+|.+...... ...+.+.+|+..++.++|+|++++++++.. ....++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~ 76 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLVM 76 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEEE
Confidence 5678899999999999999988999999988744321 367789999999999999999999998765 56889999
Q ss_pred eccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc--
Q 004564 105 EMFTSGTLRQYRLKHKR-VNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-- 181 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~-L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~-- 181 (745)
|++.+++|.+++..... +++..+..++.|++.+|.+||+++ ++|+||+|.||+++. .+.++|+|||++......
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~-~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGM-DGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcC-CCCEEEeeCceeeEecCccc
Confidence 99999999999988777 899999999999999999999987 999999999999984 489999999998776543
Q ss_pred -CCCcccCCCCcCChhhh-h-hccCccccchhhhhHHHHHhhcCCCCCC-CCCHHHHHHHHHcCCCC
Q 004564 182 -HAAHCVGTPEFMAPEVY-E-EAYNELVDIYSFGMCILEMVTFEYPYSE-CTHPAQIYKKVVSGKKP 244 (745)
Q Consensus 182 -~~~~~vGTp~YmAPEvl-~-~~ys~ksDIWSLGvILyELlTG~~Pf~~-~~~~~~i~kkv~~g~~p 244 (745)
......++..|++||++ . ..++.++|+|+||+++++|++|+.||.. ..+..++++.+..|..+
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 220 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL 220 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence 22344688899999998 3 4577799999999999999999999977 56666888888777643
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-29 Score=274.76 Aligned_cols=196 Identities=30% Similarity=0.430 Sum_probs=174.6
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCC----HHHHHHHHHHHHHHHhCC---CCCcceEeEEEEecCCCe
Q 004564 27 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS----PEDLERLYCEIHLLKTLK---HKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 27 ~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~----~~~~e~l~~Ei~iLk~L~---HpNIVk~~~sfvd~~~~~ 99 (745)
.+.||.|+||.|++|.++.+..+|++|.|.+...+.+ ...+-.+-.||.||..|+ |+||+|++++|.+ ++.
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd--dd~ 643 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED--DDY 643 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec--CCe
Confidence 4779999999999999999999999999987654432 122344778999999997 9999999999977 789
Q ss_pred EEEEEeccC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 100 INFVTEMFT-SGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 100 iyLV~E~~~-gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
+|++||-.. +.+|++|+..+..+++...+.|++||..|++.||++| |||||||-+|+.|+++ |.+||+|||.|...
T Consensus 644 yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~-g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 644 YYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSN-GFVKLIDFGSAAYT 720 (772)
T ss_pred eEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecC-CeEEEeeccchhhh
Confidence 999999754 5689999999999999999999999999999999999 9999999999999965 89999999999998
Q ss_pred hccCCCcccCCCCcCChhhhhhc-c-CccccchhhhhHHHHHhhcCCCCCC
Q 004564 179 RKSHAAHCVGTPEFMAPEVYEEA-Y-NELVDIYSFGMCILEMVTFEYPYSE 227 (745)
Q Consensus 179 ~~~~~~~~vGTp~YmAPEvl~~~-y-s~ksDIWSLGvILyELlTG~~Pf~~ 227 (745)
.......++||..|+|||++.+. | +..-|||+||++||.++..+.||..
T Consensus 721 ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 721 KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 88888899999999999999853 4 5678999999999999999999964
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=285.21 Aligned_cols=200 Identities=18% Similarity=0.191 Sum_probs=149.3
Q ss_pred HHhCCC-CCcceEeEEEEe----c-CCCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEE
Q 004564 77 LKTLKH-KNIMKFYTSWVD----T-ANRNINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVI 149 (745)
Q Consensus 77 Lk~L~H-pNIVk~~~sfvd----~-~~~~iyLV~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~II 149 (745)
.+.++| +||.+++++|.. . ....+++++|++ +++|.+++.. ...+++..++.|++||+.||.|||++| ||
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--Iv 102 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IV 102 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 345556 578888887611 1 134678888987 6699999875 356999999999999999999999998 99
Q ss_pred eecCCCcceeecC------------------CCCcEEEcCcchhhhhhcc------------------CCCcccCCCCcC
Q 004564 150 HRDLKCDNIFVNG------------------NQGEVKIGDLGLAAILRKS------------------HAAHCVGTPEFM 193 (745)
Q Consensus 150 HRDLKpdNILld~------------------~~g~VKL~DFGlA~~l~~~------------------~~~~~vGTp~Ym 193 (745)
||||||+||||+. ..+.+||+|||+++..... .....+||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999952 3456778888887542110 001135899999
Q ss_pred Chhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCC
Q 004564 194 APEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLS 271 (745)
Q Consensus 194 APEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpS 271 (745)
|||++. ..|+.++|||||||+||||++|..|+... ......+.....|... ....+...+++.+||+ +|.+||+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps 258 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPS 258 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcC
Confidence 999886 56999999999999999999998887542 2222233222333222 1235667899999999 9999999
Q ss_pred HHHHhcCCCCCc
Q 004564 272 ARELLNDPFLQI 283 (745)
Q Consensus 272 a~ELL~hPff~~ 283 (745)
+.|+|+||||..
T Consensus 259 ~~eil~h~~~~~ 270 (793)
T PLN00181 259 MSELLQSEFINE 270 (793)
T ss_pred hHHHhhchhhhh
Confidence 999999999964
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=226.09 Aligned_cols=160 Identities=27% Similarity=0.386 Sum_probs=129.6
Q ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCCCcccC
Q 004564 110 GTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVG 188 (745)
Q Consensus 110 GsL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~~~~vG 188 (745)
|+|.+++.++ +++++..++.|+.||+.||.|||+++ ||+|||++ .++.+|+ ||++...... ...|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~-~~~~~~~--fG~~~~~~~~---~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLT-WDGLLKL--DGSVAFKTPE---QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEc-Cccceee--ccceEeeccc---cCCC
Confidence 6899998874 56999999999999999999999975 99999997 5689999 9998765432 2268
Q ss_pred CCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC-----cccCCCH--HHHHHHH
Q 004564 189 TPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDS-----LYRVKDP--EVRRFVE 260 (745)
Q Consensus 189 Tp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~-----l~~~~s~--el~d~I~ 260 (745)
|+.|||||++. +.|+.++|||||||++|||+||+.||.........+..+..+..+.. .....+. .++++|.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 99999999987 56899999999999999999999999775555555555554433221 1111222 6999999
Q ss_pred HHhh-CccCCCCHHHHhcCCCCCc
Q 004564 261 KCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 261 kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
+||. +|.+||++.++++|+|+..
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHHH
Confidence 9999 9999999999999999853
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-24 Score=216.21 Aligned_cols=252 Identities=30% Similarity=0.391 Sum_probs=204.6
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC-CcceEeEEEEecCCCeEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHK-NIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~Hp-NIVk~~~sfvd~~~~~iyLV 103 (745)
.+.+.||.|+|+.||++.+. ..+++|.+...... .......+.+|+.++..+.|+ +|+++++.+.. ....+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~ 76 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR---KLVALKVLAKKLES-KSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYLV 76 (384)
T ss_pred eeEEeecCCCCeEEEEEEec---cEEEEEeechhhcc-chhHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEEEEE
Confidence 67788999999999999888 78899988755422 223577899999999999988 79999998843 5568999
Q ss_pred EeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhc
Q 004564 104 TEMFTSGTLRQYRLKHK---RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~~---~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~ 180 (745)
++++.++++.+++.... .+....+..++.|++.+|.|+|+.+ ++||||||+||+++.....++++|||++.....
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 99999999998777665 7999999999999999999999998 999999999999985543799999999975543
Q ss_pred cC--------CCcccCCCCcCChhhhhh----ccCccccchhhhhHHHHHhhcCCCCCCCCC---HHHHHHHHHcCCCC-
Q 004564 181 SH--------AAHCVGTPEFMAPEVYEE----AYNELVDIYSFGMCILEMVTFEYPYSECTH---PAQIYKKVVSGKKP- 244 (745)
Q Consensus 181 ~~--------~~~~vGTp~YmAPEvl~~----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~---~~~i~kkv~~g~~p- 244 (745)
.. .....||+.|+|||.+.. .+....|+||+|++++++++|..||..... ..+....+.....+
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 32 345579999999999874 688899999999999999999999876553 45666655554433
Q ss_pred CCcccCC------CHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcc
Q 004564 245 DSLYRVK------DPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 245 ~~l~~~~------s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~ 284 (745)
....... ...+.+++..++. +|..|.+..+...++|....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 1111111 2578999999999 89999999999988776543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=237.74 Aligned_cols=257 Identities=22% Similarity=0.322 Sum_probs=199.5
Q ss_pred eEeCCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEE
Q 004564 15 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWV 93 (745)
Q Consensus 15 ~e~dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfv 93 (745)
-.++-...| .+.+.||+|.||.+-+|.+..+...+++|.+..+ ......|.+|.+---.| .|.||+.-|+.-+
T Consensus 18 ~kv~l~d~y-~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF 91 (378)
T KOG1345|consen 18 KKVDLEDVY-TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-----QTTQADFVREFHYSFFLSPHQHIIDTYEVAF 91 (378)
T ss_pred cccchhhhh-hHHHHhcccceeeEEeeeccCCceEEEeeccCcc-----hhhHHHHHHHhccceeeccchhhhHHHHHHh
Confidence 345556667 7778999999999999999999999999988633 34567899998876666 4899999998755
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceee-cCCCCcEEEcCc
Q 004564 94 DTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFV-NGNQGEVKIGDL 172 (745)
Q Consensus 94 d~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILl-d~~~g~VKL~DF 172 (745)
.+. +.+++++||++.|+|..-+.. ..+.+..-+.++.|+++||.|+|+.+ +||||||.+|||| +.+.-+||||||
T Consensus 92 qt~-d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 92 QTS-DAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred hcC-ceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeec
Confidence 543 578899999999999887554 45889999999999999999999999 9999999999998 445568999999
Q ss_pred chhhhhhccCCCcccCCCCcCChhhhhh------ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHH---HHHHHcCCC
Q 004564 173 GLAAILRKSHAAHCVGTPEFMAPEVYEE------AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQI---YKKVVSGKK 243 (745)
Q Consensus 173 GlA~~l~~~~~~~~vGTp~YmAPEvl~~------~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i---~kkv~~g~~ 243 (745)
|+.+..+.... ..--+..|.|||+... ..++.+|+|.|||++|.++||.+||.......+- +.+...++-
T Consensus 168 G~t~k~g~tV~-~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 168 GLTRKVGTTVK-YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN 246 (378)
T ss_pred ccccccCceeh-hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC
Confidence 99865432211 1125678999998752 2567899999999999999999999753322222 333444433
Q ss_pred C--CCcccCCCHHHHHHHHHHhh-CccCC---CCHHHHhcCCCCC
Q 004564 244 P--DSLYRVKDPEVRRFVEKCLA-TVSLR---LSARELLNDPFLQ 282 (745)
Q Consensus 244 p--~~l~~~~s~el~d~I~kcL~-dPskR---pSa~ELL~hPff~ 282 (745)
| +...+..++.+..++++-|. ++.+| .+++...+..|..
T Consensus 247 ~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 247 PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 3 23445678889999999998 78888 6777777777753
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=231.29 Aligned_cols=245 Identities=23% Similarity=0.267 Sum_probs=202.0
Q ss_pred eeEeEEecccCceEEEEEEEcCC-----CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC
Q 004564 24 GRYNEILGKGASKTVYRAFDEYE-----GIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d~~t-----g~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~ 98 (745)
.++..++-+|.||.||+|+.... .+.|-+|.++.. .++-++..+..|.-+|..+.|||+..+.+..+.. ..
T Consensus 286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~---AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~-~~ 361 (563)
T KOG1024|consen 286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH---ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED-YA 361 (563)
T ss_pred eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc---ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec-cC
Confidence 37777899999999999955432 234555555422 3566788899999999999999999999987653 46
Q ss_pred eEEEEEeccCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEc
Q 004564 99 NINFVTEMFTSGTLRQYRLKH--------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 170 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~--------~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~ 170 (745)
..++++.++.-|+|..|+..- +.++..++..++.||..|++|||.++ |||.||-..|.+|+ +.-+|||+
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId-d~LqVklt 438 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID-DQLQVKLT 438 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh-hheeEEec
Confidence 678888999999999998821 24777888889999999999999999 99999999999998 66899999
Q ss_pred CcchhhhhhccCCCcc----cCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 004564 171 DLGLAAILRKSHAAHC----VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKP 244 (745)
Q Consensus 171 DFGlA~~l~~~~~~~~----vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p 244 (745)
|=.+++.+.+...... -....||+||.+. ..|+.++|+|||||+||||+| |+.||.+ .+|.+++..+..|.+.
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdGyRl 517 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDGYRL 517 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhcccee
Confidence 9999988765443221 2356799999886 679999999999999999998 8999998 6789999988888765
Q ss_pred CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 245 DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 245 ~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.. +-.++.++..++..||+ .|.+||+.+||..
T Consensus 518 aQ-P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 518 AQ-PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cC-CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 43 34578899999999999 9999999999863
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-25 Score=261.32 Aligned_cols=260 Identities=24% Similarity=0.391 Sum_probs=201.8
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeec--ccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLY--DFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~--~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~ 98 (745)
..|.....++|.|++|.|+.+........+++|..+.. ...........+..|+-+-..|.|||++.....+.+ ..
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~--~~ 394 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE--ID 394 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh--cc
Confidence 34777788899999999998888777777777765532 212222223337788888999999999887765544 33
Q ss_pred eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 99 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 99 ~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
.++-+|||+.+ +|..++.+.+.+....+..+++||+.||+|+|++| |.|||||++|+++. ..|.+||+|||.+...
T Consensus 395 ~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~-~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 395 GILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVT-ENGILKIIDFGAASVF 470 (601)
T ss_pred cchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEe-cCCceEEeecCcceee
Confidence 44445999999 99999998889999999999999999999999999 99999999999998 5689999999999776
Q ss_pred hccC------CCcccCCCCcCChhhhhh-ccCc-cccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHH-HcC-----CCC
Q 004564 179 RKSH------AAHCVGTPEFMAPEVYEE-AYNE-LVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKV-VSG-----KKP 244 (745)
Q Consensus 179 ~~~~------~~~~vGTp~YmAPEvl~~-~ys~-ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv-~~g-----~~p 244 (745)
.... ....+|+..|+|||++.+ .|++ .+||||.|++++.|++|++||.......+.+... ..+ ..|
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP 550 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence 4332 234579999999999974 5654 6999999999999999999996533322221111 111 123
Q ss_pred CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCcccc
Q 004564 245 DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDDC 286 (745)
Q Consensus 245 ~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~~ 286 (745)
..+....+...+.+|.++|+ +|.+|.|++++++++||+...+
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 34455567789999999999 9999999999999999986554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.6e-23 Score=224.08 Aligned_cols=173 Identities=21% Similarity=0.222 Sum_probs=131.9
Q ss_pred CCceeeEeEEecccCceEEEEEEEcC-CCeEEEEEEEeeccc-CCCHHHHHHHHHHHHHHHhCCCCCcce-EeEEEEecC
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEY-EGIEVAWNQVKLYDF-LQSPEDLERLYCEIHLLKTLKHKNIMK-FYTSWVDTA 96 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~-tg~~VAiK~ik~~~~-~~~~~~~e~l~~Ei~iLk~L~HpNIVk-~~~sfvd~~ 96 (745)
.++| .+.++||+|+||+||+|.+.. ++..||+|.+..... .......+.+.+|+++|+.|+|+||+. ++..
T Consensus 17 ~~~Y-~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----- 90 (365)
T PRK09188 17 SARF-VETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----- 90 (365)
T ss_pred cCCc-eEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence 4556 888999999999999998876 678889997652211 112345667999999999999999985 5541
Q ss_pred CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecC-CCcceeecCCCCcEEEcCcchh
Q 004564 97 NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDL-KCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 97 ~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDL-KpdNILld~~~g~VKL~DFGlA 175 (745)
...|+||||+.|++|... . ... ...|+.|++.+|.|||++| |+|||| ||+|||++ .++.+||+|||+|
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~-~~~~ikLiDFGlA 159 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMG-PDGEAAVIDFQLA 159 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEc-CCCCEEEEECccc
Confidence 357999999999999632 1 111 1468899999999999988 999999 99999997 5579999999999
Q ss_pred hhhhccC----------CCcccCCCCcCChhhhhh-------ccCccccch
Q 004564 176 AILRKSH----------AAHCVGTPEFMAPEVYEE-------AYNELVDIY 209 (745)
Q Consensus 176 ~~l~~~~----------~~~~vGTp~YmAPEvl~~-------~ys~ksDIW 209 (745)
..+.... .....+++.|+|||.+.. ..+...|-|
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 8553221 134468899999999862 134456777
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=211.88 Aligned_cols=248 Identities=22% Similarity=0.196 Sum_probs=184.1
Q ss_pred ceeeEeEEecccCceEEEEEEEcCCC-eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC----CCcceEeEEEEecC
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEG-IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH----KNIMKFYTSWVDTA 96 (745)
Q Consensus 22 RY~rl~e~LG~GafgtVy~A~d~~tg-~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~H----pNIVk~~~sfvd~~ 96 (745)
+| ++.+.||+|+||.||+|.+..++ ..+|+|......... ...+..|+.+|+.+.. +++.++++.+. ..
T Consensus 19 ~~-~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~----~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~ 92 (322)
T KOG1164|consen 19 RY-KLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK----PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-ST 92 (322)
T ss_pred ce-EEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC----CccchhHHHHHHHHhhhcCCCCCCEEEEecc-CC
Confidence 67 88899999999999999998875 789988776443111 1157789999999873 68999998764 23
Q ss_pred CCeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCC----CcEEEc
Q 004564 97 NRNINFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQ----GEVKIG 170 (745)
Q Consensus 97 ~~~iyLV~E~~~gGsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~----g~VKL~ 170 (745)
...-|+||+++ |-+|.+++... +.++...+..++.|++.+|++||+.| +|||||||+|+++.... ..+.|.
T Consensus 93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEE
Confidence 56788999987 77999987655 57999999999999999999999998 99999999999996432 469999
Q ss_pred Ccchhh--hhhcc---------C-CCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHH--H
Q 004564 171 DLGLAA--ILRKS---------H-AAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQI--Y 235 (745)
Q Consensus 171 DFGlA~--~l~~~---------~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i--~ 235 (745)
|||+++ ..... . ...+.||..|+++....+ ..+.+.|+||++.++.+|+.|..||......... +
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 999998 32111 1 223459999999998874 6889999999999999999999999765433222 2
Q ss_pred HHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 236 KKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 236 kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
+..........+......++.++...+-. +...+|....+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 250 EKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22211111111223334556666655555 66777777766544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.6e-23 Score=230.20 Aligned_cols=240 Identities=21% Similarity=0.301 Sum_probs=200.4
Q ss_pred EecccCceEEEEEE---EcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceEeEEEEecCCCeEEEEE
Q 004564 29 ILGKGASKTVYRAF---DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 29 ~LG~GafgtVy~A~---d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
++|+|+||.|+++. ....|.-+|+|+.++......... .-..|..++...+ ||.+++++..|.. +..+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeecc--ccchhHhh
Confidence 47999999999763 344577899998876554333332 5566888888886 9999999998865 67899999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCCC
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 184 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~~ 184 (745)
++..+|.|..-+.+...+.+..++.+...++.+++.+|+.+ |+|||+|++||+++ ..|++|+.|||+++..-.....
T Consensus 77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld-~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLL-LEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeec-ccCccccCCchhhhHhHhhhhc
Confidence 99999999998888888999999999999999999999998 99999999999998 5589999999999876544333
Q ss_pred cccCCCCcCChhhhhhccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh
Q 004564 185 HCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA 264 (745)
Q Consensus 185 ~~vGTp~YmAPEvl~~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~ 264 (745)
+||..|||||+++ ....++|.||||++++||+||..||.. ++.+.|.....+ ++...++.+++++..++.
T Consensus 154 --cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~~--~p~~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAELE--MPRELSAEARSLFRQLFK 223 (612)
T ss_pred --ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhccC--CchhhhHHHHHHHHHHHh
Confidence 8999999999998 777899999999999999999999976 445555443332 456678899999999998
Q ss_pred -CccCCCC-----HHHHhcCCCCCccc
Q 004564 265 -TVSLRLS-----ARELLNDPFLQIDD 285 (745)
Q Consensus 265 -dPskRpS-----a~ELL~hPff~~~~ 285 (745)
+|.+|.. +.++++|+||+..+
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred hCHHHHhccCcchhHHHhccchheeee
Confidence 8999874 58999999998654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.1e-21 Score=193.31 Aligned_cols=234 Identities=20% Similarity=0.283 Sum_probs=182.8
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC-CCcceEeEEEEecCC
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH-KNIMKFYTSWVDTAN 97 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~H-pNIVk~~~sfvd~~~ 97 (745)
-.|.| ++.+.||.|+||.+|.|.....|.+||||+-+... .--.+..|.++.+.|++ ..|+.++.++ +..
T Consensus 13 v~gky-~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a------~hpqL~yEskvY~iL~~g~GiP~i~~y~--~e~ 83 (341)
T KOG1163|consen 13 VGGKY-KLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA------KHPQLLYESKVYRILQGGVGIPHIRHYG--TEK 83 (341)
T ss_pred eccce-EEEEeecCCchhheeeeeeccCCceEEEEeecccC------CCcchhHHHHHHHHhccCCCCchhhhhc--ccc
Confidence 46788 88899999999999999999999999999654221 12247779999999974 6677776654 335
Q ss_pred CeEEEEEeccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeec--CCCCcEEEcCcch
Q 004564 98 RNINFVTEMFTSGTLRQYRL-KHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVN--GNQGEVKIGDLGL 174 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~-k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld--~~~g~VKL~DFGl 174 (745)
..-.+||+++ |-+|.++.. ..+.++.+++.-.+-|++.-++|+|.++ +|||||||+|+|.. .....+.|+|||+
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccc
Confidence 6778999998 668887654 4568999999999999999999999998 99999999999972 2334799999999
Q ss_pred hhhhhccC---------CCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCC--CHHHHHHHHHcCC
Q 004564 175 AAILRKSH---------AAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECT--HPAQIYKKVVSGK 242 (745)
Q Consensus 175 A~~l~~~~---------~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~--~~~~i~kkv~~g~ 242 (745)
|+...... .....||.+|++-...-+ .-+...|+-|+|.+|..+.-|..||.+.. +..|-|+++.+.+
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 98764322 223469999998775543 46678999999999999999999998754 3455666666543
Q ss_pred ---CCCCcccCCCHHHHHHHHHHhh
Q 004564 243 ---KPDSLYRVKDPEVRRFVEKCLA 264 (745)
Q Consensus 243 ---~p~~l~~~~s~el~d~I~kcL~ 264 (745)
.+..+.+..+.++.-.+.-|=.
T Consensus 241 ~s~~ie~LC~G~P~EF~myl~Y~R~ 265 (341)
T KOG1163|consen 241 MSTPIEVLCKGFPAEFAMYLNYCRG 265 (341)
T ss_pred cCCCHHHHhCCCcHHHHHHHHHHhh
Confidence 3455667778888888888865
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.4e-21 Score=223.78 Aligned_cols=214 Identities=27% Similarity=0.434 Sum_probs=165.3
Q ss_pred EeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEe
Q 004564 26 YNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTE 105 (745)
Q Consensus 26 l~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E 105 (745)
..++|..|+||.||++.++.+.+.+|+|+=+ .. -||+. |..+-+ +.++|
T Consensus 87 ~IklisngAygavylvrh~~trqrfa~kiNk-q~---------------lilRn-----ilt~a~--------npfvv-- 135 (1205)
T KOG0606|consen 87 TIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN---------------LILRN-----ILTFAG--------NPFVV-- 135 (1205)
T ss_pred eeEeeccCCCCceeeeeccccccchhhcccc-cc---------------hhhhc-----cccccC--------Cccee--
Confidence 3488999999999999999999999985322 11 11111 222221 12222
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc----
Q 004564 106 MFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS---- 181 (745)
Q Consensus 106 ~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~---- 181 (745)
|+....++.-++++.+. +.+++|||+.+ |+|||+||+|.+|+ .-|++|++|||++......
T Consensus 136 ----gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT-~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ----chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceee-ecccccccchhhhhhhhhhccch
Confidence 56666666666666554 66899999987 99999999999998 6699999999998653211
Q ss_pred -------------CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC--CCCC
Q 004564 182 -------------HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG--KKPD 245 (745)
Q Consensus 182 -------------~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g--~~p~ 245 (745)
.....+|||.|.|||++. +.|+..+|+|++|+|+||.+.|..||.+ ..+++++..+++- ..|.
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhhhhhhccccc
Confidence 112237999999999876 6799999999999999999999999988 7799999988773 3455
Q ss_pred CcccCCCHHHHHHHHHHhh-CccCCC---CHHHHhcCCCCCccccc
Q 004564 246 SLYRVKDPEVRRFVEKCLA-TVSLRL---SARELLNDPFLQIDDCE 287 (745)
Q Consensus 246 ~l~~~~s~el~d~I~kcL~-dPskRp---Sa~ELL~hPff~~~~~~ 287 (745)
. .....++++++|.++|+ +|..|. .+.++.+|+||+.-+-.
T Consensus 280 ~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 280 E-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred c-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 5 55678999999999999 888884 68899999999865543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-20 Score=188.56 Aligned_cols=143 Identities=20% Similarity=0.158 Sum_probs=112.2
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHH----------------------HHHHHHHHHHHHHhCCCCC
Q 004564 27 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPE----------------------DLERLYCEIHLLKTLKHKN 84 (745)
Q Consensus 27 ~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~----------------------~~e~l~~Ei~iLk~L~HpN 84 (745)
.+.||+|+||.||+|.+. +|+.||+|+++......... .......|+.+|+.|.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999987 89999999998543111000 0122345999999998887
Q ss_pred cceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHh-hhCCCCEEeecCCCcceeecCC
Q 004564 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYL-HSHDPPVIHRDLKCDNIFVNGN 163 (745)
Q Consensus 85 IVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yL-Hs~gp~IIHRDLKpdNILld~~ 163 (745)
+...+.... . ..++||||+.++++...+.+..++++..+..++.||+.+|.|| |+.| |+||||||+|||++
T Consensus 81 v~~p~~~~~---~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-- 152 (190)
T cd05147 81 IPCPEPILL---K-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-- 152 (190)
T ss_pred CCCCcEEEe---c-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE--
Confidence 754333221 1 2389999999988876655667899999999999999999999 6888 99999999999997
Q ss_pred CCcEEEcCcchhhhh
Q 004564 164 QGEVKIGDLGLAAIL 178 (745)
Q Consensus 164 ~g~VKL~DFGlA~~l 178 (745)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 378999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-20 Score=193.97 Aligned_cols=173 Identities=13% Similarity=0.090 Sum_probs=135.4
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHH------HHHHHHHHHhCCCCCcceEeEEEE
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLER------LYCEIHLLKTLKHKNIMKFYTSWV 93 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~------l~~Ei~iLk~L~HpNIVk~~~sfv 93 (745)
.+|| +..++||.|+||.||++.+ ++..+|+|++.... ...+...++ +.+|+..+.+|.||+|+...++++
T Consensus 30 ~~~y-~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~-~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 30 SYNI-KTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKV-KRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred hCce-EEEEEecCCCceEEEEEec--CCCcEEEEEechhc-CchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 6888 8889999999999999754 47789999886433 334444455 578999999999999999999877
Q ss_pred ecC------CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcE
Q 004564 94 DTA------NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEV 167 (745)
Q Consensus 94 d~~------~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~V 167 (745)
+.. ....+++|||++|.+|.++. .+++. .+.+|+.+|..||.+| ++||||||+||+++ ++| +
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~-~~g-i 173 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHG--MVSGDPHKGNFIVS-KNG-L 173 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcC--CccCCCChHHEEEe-CCC-E
Confidence 543 23578999999999998873 23333 4569999999999998 99999999999997 456 9
Q ss_pred EEcCcchhhhhhccCCCcccCCCCcCChh--hhhhccCccccchhhhhHHHHHh
Q 004564 168 KIGDLGLAAILRKSHAAHCVGTPEFMAPE--VYEEAYNELVDIYSFGMCILEMV 219 (745)
Q Consensus 168 KL~DFGlA~~l~~~~~~~~vGTp~YmAPE--vl~~~ys~ksDIWSLGvILyELl 219 (745)
+|+|||......... |-. +++..|+.++|+||||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~-----------a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRK-----------AKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchh-----------hHHHHHHHhHhcccccccceeEeehHHH
Confidence 999999875442211 112 23467889999999999988665
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.6e-20 Score=182.49 Aligned_cols=144 Identities=22% Similarity=0.185 Sum_probs=113.9
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCC--------------------CH--HHHHHHHHHHHHHHhCCCCC
Q 004564 27 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ--------------------SP--EDLERLYCEIHLLKTLKHKN 84 (745)
Q Consensus 27 ~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~--------------------~~--~~~e~l~~Ei~iLk~L~HpN 84 (745)
.+.||+|+||.||+|.+. +|+.||+|+++...... .. .....+..|+..+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999987 89999999988542110 00 01233468999999999998
Q ss_pred cceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhh-CCCCEEeecCCCcceeecCC
Q 004564 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS-HDPPVIHRDLKCDNIFVNGN 163 (745)
Q Consensus 85 IVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs-~gp~IIHRDLKpdNILld~~ 163 (745)
|......+.. ..|+||||+.|+++.........++...+..++.|++.+|.++|+ +| |+||||||+|||++
T Consensus 81 i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-- 152 (190)
T cd05145 81 VPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-- 152 (190)
T ss_pred CCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE--
Confidence 8554443332 238999999988665544455678899999999999999999999 88 99999999999997
Q ss_pred CCcEEEcCcchhhhhh
Q 004564 164 QGEVKIGDLGLAAILR 179 (745)
Q Consensus 164 ~g~VKL~DFGlA~~l~ 179 (745)
++.++|+|||++..+.
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 5799999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.9e-20 Score=192.29 Aligned_cols=208 Identities=19% Similarity=0.289 Sum_probs=167.9
Q ss_pred eeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeEEE
Q 004564 24 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINF 102 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~iyL 102 (745)
++++++||+|.||..+.|....++++||||.-. .+ ...-++.-|.+..+.| ..++|+..|-+. ..+.+-.|
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-rk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~NiL 101 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-RK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKYNIL 101 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEecc-cc-----CCcchHHHHHHHHHHHcCCCCCCceeeec--cccchhhh
Confidence 399999999999999999999999999999533 21 2334677899999988 479999988744 33566678
Q ss_pred EEeccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecC----CCCcEEEcCcchhhh
Q 004564 103 VTEMFTSGTLRQYRL-KHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG----NQGEVKIGDLGLAAI 177 (745)
Q Consensus 103 V~E~~~gGsL~~~l~-k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~----~~g~VKL~DFGlA~~ 177 (745)
|+|++ |-+|.++.. ..++++.+.+..++.|++.-++|+|++. +|+|||||+|+||.. +...|.|+|||+|+.
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 99988 668888655 4568999999999999999999999999 999999999999932 234689999999988
Q ss_pred hhccCC---------CcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCC--CCHHHHHHHHHcCC
Q 004564 178 LRKSHA---------AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSEC--THPAQIYKKVVSGK 242 (745)
Q Consensus 178 l~~~~~---------~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~--~~~~~i~kkv~~g~ 242 (745)
...... ....||.+||+-.... ..-+...|+-|||-+++..|-|..||.+. .+..+-|++|-..+
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 754322 2346999999987654 45788999999999999999999999874 35667777775433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=193.13 Aligned_cols=239 Identities=18% Similarity=0.164 Sum_probs=153.2
Q ss_pred CCCCce--eeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC----------CCc
Q 004564 18 DPTGRY--GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH----------KNI 85 (745)
Q Consensus 18 dp~gRY--~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~H----------pNI 85 (745)
.+++++ .+..+.||.|+++.||.+.|..||+++|+|+..... ......++.+.+|.-....+.+ -.+
T Consensus 6 ~~~~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~ 84 (288)
T PF14531_consen 6 ELGQRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRF 84 (288)
T ss_dssp SSS--EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B
T ss_pred cCCCCceEEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceE
Confidence 344444 345578999999999999999999999999988776 5556678888888765555432 112
Q ss_pred ceEeEEEE---------ecCCC------eEEEEEeccCCCCHHHHHH---HcCC----CCHHHHHHHHHHHHHHHHHhhh
Q 004564 86 MKFYTSWV---------DTANR------NINFVTEMFTSGTLRQYRL---KHKR----VNIRAVKLWCRQILRGLLYLHS 143 (745)
Q Consensus 86 Vk~~~sfv---------d~~~~------~iyLV~E~~~gGsL~~~l~---k~~~----L~e~~i~~ia~QIL~gL~yLHs 143 (745)
+.-++... ...+. +.+++|..+ .++|.+++. .... +...+...+..|+++.+++||+
T Consensus 85 l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~ 163 (288)
T PF14531_consen 85 LVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS 163 (288)
T ss_dssp ---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh
Confidence 22122111 11111 235667766 457877643 3322 3344455667999999999999
Q ss_pred CCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCCCcccCCCCcCChhhhhh---------ccCccccchhhhhH
Q 004564 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEE---------AYNELVDIYSFGMC 214 (745)
Q Consensus 144 ~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~---------~ys~ksDIWSLGvI 214 (745)
+| ++|+||+|+|+|++ .+|.++|+||+.....+..... ...+..|.|||+... .++.+.|.|+||++
T Consensus 164 ~G--lVHgdi~~~nfll~-~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 164 YG--LVHGDIKPENFLLD-QDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp TT--EEEST-SGGGEEE--TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred cc--eEecccceeeEEEc-CCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 99 99999999999998 5699999999887665543332 345688999998743 37889999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCC
Q 004564 215 ILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLR 269 (745)
Q Consensus 215 LyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskR 269 (745)
+|.|.++..||..... ...... .-......+..++.+|..+|+ +|.+|
T Consensus 240 ly~lWC~~lPf~~~~~-~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSP-EADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGG-GSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCc-cccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999999975321 111000 111222456789999999999 88877
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-20 Score=219.07 Aligned_cols=241 Identities=22% Similarity=0.259 Sum_probs=181.8
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
-+.+.||.+.|=+|.+|++. .|. |++|++-+.+..-+-....+...|++ .+.+++||.+.|-..- ..++..|||-
T Consensus 26 ~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~--~t~kAAylvR 100 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL--VTDKAAYLVR 100 (1431)
T ss_pred eeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH--HhhHHHHHHH
Confidence 67889999999999999765 344 88998876664445555555566777 6778999999987642 3467889999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh--hccC
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSH 182 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l--~~~~ 182 (745)
+|+.. +|.+.+.-+.-+..-+.+.|+.|||.||.-+|..| |+|+|||++||||+ ..+-+.|+||..-+.. ....
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiT-SWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILIT-SWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEe-eechhhhhcccccCCccCCCCC
Confidence 99876 78888777777888899999999999999999998 99999999999998 5678999999875332 1111
Q ss_pred CC-------cccCCCCcCChhhhhh-----------c-cCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCC
Q 004564 183 AA-------HCVGTPEFMAPEVYEE-----------A-YNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGK 242 (745)
Q Consensus 183 ~~-------~~vGTp~YmAPEvl~~-----------~-ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~ 242 (745)
.. +...-.+|.|||.|.. . ..++.||||+||+++||++ |++||. ..|++.--..+.
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~~ 252 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGNA 252 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccCc
Confidence 11 1124468999998742 1 4578999999999999998 678873 344443222111
Q ss_pred C-C-CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 243 K-P-DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 243 ~-p-~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
. | .-+.+..++.++.+|..|++ +|++|++|++.|+.
T Consensus 253 ~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1 1 11233456789999999999 99999999999975
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.3e-21 Score=200.61 Aligned_cols=263 Identities=35% Similarity=0.585 Sum_probs=193.3
Q ss_pred CCCceEeCCCCceeeEeEEeccc---CceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcce
Q 004564 11 CSEFVEVDPTGRYGRYNEILGKG---ASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87 (745)
Q Consensus 11 ~~~~~e~dp~gRY~rl~e~LG~G---afgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk 87 (745)
..+.++..|.+|+.+-++..|+. +.-.||+|.|...|.+|.|..+.......-...-+....=.+-|-+|.|-|||+
T Consensus 52 ~~eIleesp~~rw~krreqv~qrdvPgid~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvk 131 (458)
T KOG1266|consen 52 ESEILEESPCGRWGKRREQVGQRDVPGIDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVK 131 (458)
T ss_pred hhhhhccCchhhhhhhhhhccCCCCCchHHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHH
Confidence 45678899999998877777753 345689999999999999998764432222222233333345677778999999
Q ss_pred EeEEEEecC---CCeEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceee
Q 004564 88 FYTSWVDTA---NRNINFVTEMFTSGTLRQYRLKH----KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFV 160 (745)
Q Consensus 88 ~~~sfvd~~---~~~iyLV~E~~~gGsL~~~l~k~----~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILl 160 (745)
|+.+|-+.. ...+.|++||+..|+|.+++++. +.+..+.+++|+.||+.||.|||+..|+|+|++|.|+.|++
T Consensus 132 fH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi 211 (458)
T KOG1266|consen 132 FHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI 211 (458)
T ss_pred HHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee
Confidence 999997643 24688999999999999998864 46899999999999999999999999999999999999999
Q ss_pred cCCCCcEEEcCcchhhhhh------ccCCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCC---
Q 004564 161 NGNQGEVKIGDLGLAAILR------KSHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTH--- 230 (745)
Q Consensus 161 d~~~g~VKL~DFGlA~~l~------~~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~--- 230 (745)
. .+|-|||+--....... ........+-+.|.|||.-. ...+.++|||+||+|+++|..++.--.....
T Consensus 212 q-~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~ 290 (458)
T KOG1266|consen 212 Q-HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVE 290 (458)
T ss_pred c-CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceee
Confidence 8 66889985433221111 00111123678899998654 3466789999999999999998755332221
Q ss_pred HHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 231 PAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 231 ~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
.++-...++ ....+..-+++|.+||+ .|..||++.++|.||.+-
T Consensus 291 ~ee~ia~~i--------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 291 VEENIANVI--------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred hhhhhhhhe--------eeccCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 111111121 12234455899999999 999999999999999864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=177.12 Aligned_cols=136 Identities=18% Similarity=0.201 Sum_probs=107.0
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-----CCCCcceEeEEEEecCC-CeEE
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-----KHKNIMKFYTSWVDTAN-RNIN 101 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-----~HpNIVk~~~sfvd~~~-~~iy 101 (745)
++||+|+|+.||. ++.++.. +||++.... ....+.+.+|+.+|+.| +||||+++|+++....+ ..++
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~----~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG----DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred ceecCCCceEEEE--CCCCcCe-EEEEEeccc----cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 5799999999995 7777666 688886543 22446789999999999 57999999998876432 3434
Q ss_pred -EEEec--cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHH-HHhhhCCCCEEeecCCCcceeecC---CCCcEEEcCcch
Q 004564 102 -FVTEM--FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGL-LYLHSHDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGL 174 (745)
Q Consensus 102 -LV~E~--~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL-~yLHs~gp~IIHRDLKpdNILld~---~~g~VKL~DFGl 174 (745)
+|+|| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++ ||||||||+|||++. ..+.++|+||+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 5579999999664 56666 46788999888 8999998 999999999999963 224899999543
Q ss_pred h
Q 004564 175 A 175 (745)
Q Consensus 175 A 175 (745)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=177.08 Aligned_cols=184 Identities=16% Similarity=0.065 Sum_probs=138.2
Q ss_pred EeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceEeEEEEecCCCeEEEEE
Q 004564 26 YNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 26 l~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
....|++|+||+||.+.. .+.+++.+.+.........-....+.+|+++|++|. |++|++++++ ...+++|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvm 77 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDR 77 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEE
Confidence 457899999999998744 677787666654332222223346889999999995 5889999884 2469999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecC-CCcceeecCCCCcEEEcCcchhhhhhccCC
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDL-KCDNIFVNGNQGEVKIGDLGLAAILRKSHA 183 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDL-KpdNILld~~~g~VKL~DFGlA~~l~~~~~ 183 (745)
+|+.|.+|.+.... . ...++.|++.+|.++|++| |+|||| ||.|||++ .+|.++|+|||+|........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~-~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQ-EDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEc-CCCCEEEEECCCceecCCcch
Confidence 99999998654321 1 2357889999999999998 999999 79999997 568999999999974432210
Q ss_pred --------------C-cccCCCCcCChhhhh--hccC-ccccchhhhhHHHHHhhcCCCCCC
Q 004564 184 --------------A-HCVGTPEFMAPEVYE--EAYN-ELVDIYSFGMCILEMVTFEYPYSE 227 (745)
Q Consensus 184 --------------~-~~vGTp~YmAPEvl~--~~ys-~ksDIWSLGvILyELlTG~~Pf~~ 227 (745)
. ....++.|+.|+.-. ...+ ...+.++.|+-+|.++|+..|.-+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 012688999998543 2233 567899999999999999988744
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.8e-18 Score=182.77 Aligned_cols=188 Identities=26% Similarity=0.374 Sum_probs=141.2
Q ss_pred CCCCcceEeEEEEec-------------------------CCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHH
Q 004564 81 KHKNIMKFYTSWVDT-------------------------ANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQIL 135 (745)
Q Consensus 81 ~HpNIVk~~~sfvd~-------------------------~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL 135 (745)
+|||||+++++|.+. ...++|+||.-+. .+|++|+-.+. .+....+-++.|+|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-CchHHHHHHHHHHH
Confidence 699999999988752 3468999999885 49999977654 55566677899999
Q ss_pred HHHHHhhhCCCCEEeecCCCcceeecCCC---CcEEEcCcchhhhhh--------ccCCCcccCCCCcCChhhhhhc---
Q 004564 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQ---GEVKIGDLGLAAILR--------KSHAAHCVGTPEFMAPEVYEEA--- 201 (745)
Q Consensus 136 ~gL~yLHs~gp~IIHRDLKpdNILld~~~---g~VKL~DFGlA~~l~--------~~~~~~~vGTp~YmAPEvl~~~--- 201 (745)
+|+.|||.|| |.|||||.+||||.-++ ..+.|+|||.+-.-. .+......|...-||||+....
T Consensus 352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999999 99999999999994322 267899999863211 1122234588999999998632
Q ss_pred ----cCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHH
Q 004564 202 ----YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSAR 273 (745)
Q Consensus 202 ----ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ 273 (745)
.-.++|.|+.|.+.||+++...||.......--.+...+...| .++...++.+++++..+|+ +|++|+++.
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP-alp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP-ALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC-CCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 2358999999999999999999997632211111122222333 4666788999999999999 999999853
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.5e-18 Score=175.86 Aligned_cols=151 Identities=23% Similarity=0.175 Sum_probs=118.4
Q ss_pred CCceeeEeEEecccCceEEEEEE-EcCCCeEEEEEEEeecccCC------------------CHH--HHHHHHHHHHHHH
Q 004564 20 TGRYGRYNEILGKGASKTVYRAF-DEYEGIEVAWNQVKLYDFLQ------------------SPE--DLERLYCEIHLLK 78 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~-d~~tg~~VAiK~ik~~~~~~------------------~~~--~~e~l~~Ei~iLk 78 (745)
.|+.+++.+.||+|+||.||+|. +..+|..||+|+++...... ... ....+..|+.+++
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 56666899999999999999998 77899999999987543110 000 1234678999999
Q ss_pred hCCCC--CcceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCc
Q 004564 79 TLKHK--NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCD 156 (745)
Q Consensus 79 ~L~Hp--NIVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpd 156 (745)
.|.+. .+++++.. ...++||||+.+++|..+......+....+..++.||+.+|.+||++| +|+||||||+
T Consensus 106 ~L~~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~ 178 (237)
T smart00090 106 RLYEAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEY 178 (237)
T ss_pred HHHhcCCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChh
Confidence 99753 34455542 134899999999888776555566777788899999999999999975 4999999999
Q ss_pred ceeecCCCCcEEEcCcchhhhhh
Q 004564 157 NIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 157 NILld~~~g~VKL~DFGlA~~l~ 179 (745)
||+++ .+.++|+|||.+....
T Consensus 179 NIli~--~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH--DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE--CCCEEEEEChhhhccC
Confidence 99998 5799999999986543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.3e-18 Score=176.54 Aligned_cols=236 Identities=16% Similarity=0.279 Sum_probs=183.4
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEecc
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMF 107 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~ 107 (745)
-+|...-.|..|+|. ..|..++.|+++..+. +......|..|.-.|+-+.||||..+++.+.. ..++.+|..||
T Consensus 196 tkl~e~hsgelwrgr--wqgndivakil~vr~~--t~risrdfneefp~lrifshpnilpvlgacns--ppnlv~isq~m 269 (448)
T KOG0195|consen 196 TKLAESHSGELWRGR--WQGNDIVAKILNVREV--TARISRDFNEEFPALRIFSHPNILPVLGACNS--PPNLVIISQYM 269 (448)
T ss_pred hhhccCCCccccccc--ccCcchhhhhhhhhhc--chhhcchhhhhCcceeeecCCchhhhhhhccC--CCCceEeeeec
Confidence 346777889999994 4566677787776653 33445568889999999999999999998744 67899999999
Q ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEE--cCcchhhhhhccCC
Q 004564 108 TSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI--GDLGLAAILRKSHA 183 (745)
Q Consensus 108 ~gGsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL--~DFGlA~~l~~~~~ 183 (745)
+.|+|...+.... .++..+..+++..|++|+.|||+..|-|.---|....++|+ ++-+.+| +|--++-+ .
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid-edltarismad~kfsfq-----e 343 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID-EDLTARISMADTKFSFQ-----E 343 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec-chhhhheecccceeeee-----c
Confidence 9999999877654 36778889999999999999999876555556888999997 4344443 44333211 1
Q ss_pred CcccCCCCcCChhhhhhc----cCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHH
Q 004564 184 AHCVGTPEFMAPEVYEEA----YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259 (745)
Q Consensus 184 ~~~vGTp~YmAPEvl~~~----ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I 259 (745)
.....+|.||+||.+... .-.++|+|||++++|||.|.+.||.+..+.+--++...+|..+. ++...++.+..++
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~-ippgis~hm~klm 422 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVH-IPPGISRHMNKLM 422 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccccc-CCCCccHHHHHHH
Confidence 122468999999999743 33679999999999999999999999877777777777776653 4557889999999
Q ss_pred HHHhh-CccCCCCHHHHh
Q 004564 260 EKCLA-TVSLRLSARELL 276 (745)
Q Consensus 260 ~kcL~-dPskRpSa~ELL 276 (745)
.-|+. ||.+||..+.++
T Consensus 423 ~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 423 NICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHhcCCCCcCCCcceeh
Confidence 99999 999999876653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.5e-18 Score=190.11 Aligned_cols=174 Identities=28% Similarity=0.444 Sum_probs=140.5
Q ss_pred CeEEEEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcch
Q 004564 98 RNINFVTEMFTSGTLRQYRLKHK---RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 174 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k~~---~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGl 174 (745)
..+|+.|+++...+|.+|+.+.. ..+...++.|+.|+..|++| ++ .+|||+||.||++. .+.++||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~-~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFS-DDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccc-cchhhhhhhhhh
Confidence 36889999999999999998654 46778899999999999999 66 89999999999996 567999999999
Q ss_pred hhhhhccC--------CCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 004564 175 AAILRKSH--------AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKP 244 (745)
Q Consensus 175 A~~l~~~~--------~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~~g~~p 244 (745)
.+...... .+..+||..||+||.+. +.|+.++||||||+||+||++ ...++.. ...+..+..|..|
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r~g~ip 478 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIRDGIIP 478 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhhcCCCC
Confidence 97765433 22346999999999998 679999999999999999998 4444433 2233446667777
Q ss_pred CCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 245 DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 245 ~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
+.+ ....|+-..|+.++|. .|.+||++.+.-.|+|++
T Consensus 479 ~~~-~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 479 PEF-LQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred hHH-hhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 433 2456777899999998 899999888888887763
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.7e-17 Score=196.57 Aligned_cols=194 Identities=22% Similarity=0.248 Sum_probs=153.4
Q ss_pred CCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC---CCCcceEeEEEEec
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK---HKNIMKFYTSWVDT 95 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~---HpNIVk~~~sfvd~ 95 (745)
-.|..+.+.+.||+|+||+||+|.+.. |+.||+|+-+....- .|+--.+++.+|+ -+.|+.++..++.
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W-------EfYI~~q~~~RLk~~~~~~~~~~~~a~~~- 765 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW-------EFYICLQVMERLKPQMLPSIMHISSAHVF- 765 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce-------eeeehHHHHHhhchhhhcchHHHHHHHcc-
Confidence 455555888999999999999998877 999999976543311 1222223444444 3556666666554
Q ss_pred CCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecC------CCCcEEE
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG------NQGEVKI 169 (745)
Q Consensus 96 ~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~------~~g~VKL 169 (745)
.+.-++|+||...|||.+++...+.+++..+..++.|||+.++.||.++ |||+||||+|+||.. +.--++|
T Consensus 766 -~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 766 -QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred -CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEE
Confidence 4566889999999999999998889999999999999999999999998 999999999999931 2236899
Q ss_pred cCcchhhhhh---cc-CCCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCC
Q 004564 170 GDLGLAAILR---KS-HAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYP 224 (745)
Q Consensus 170 ~DFGlA~~l~---~~-~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~P 224 (745)
+|||-+..+. .. .....++|-.|-.+|+..+ .+++.+|.|.|+.+++-||.|++-
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999996553 22 3334568999999999985 699999999999999999999654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=159.52 Aligned_cols=138 Identities=22% Similarity=0.250 Sum_probs=111.2
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCC----HHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEE
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS----PEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~----~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV 103 (745)
+.||+|++|.||+|.. .|..|++|+......... .....++.+|+.++..+.|++|+.....+.+ ....+++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEE
Confidence 5699999999999976 678899997553221111 1123568889999999999988766665554 4567899
Q ss_pred EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 104 TEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
|||+.|++|.+++..... ....++.+|+.+|.++|+++ ++|||++|.|||++ .+.++|+|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 999999999998865432 77889999999999999988 99999999999997 57899999998754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.1e-18 Score=199.58 Aligned_cols=257 Identities=25% Similarity=0.334 Sum_probs=204.0
Q ss_pred CCCceeeEeEEecccCceEEEEEEEc-CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceEeEEEEecC
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDE-YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTSWVDTA 96 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~-~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-HpNIVk~~~sfvd~~ 96 (745)
|...| ++.+.||+|+|+.|-.+... .....+|.|.+.... .......++..|..+-+.+. |+|++.+++.+..
T Consensus 18 ~~~~~-~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~-- 92 (601)
T KOG0590|consen 18 PNSQY-KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS-- 92 (601)
T ss_pred ccccc-cccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCC--
Confidence 56667 67778999999999888653 334456666555443 44566777788999988887 9999999997644
Q ss_pred CCeEEEEEeccCCCCHHHHH-HHcC-CCCHHHHHHHHHHHHHHHHHhh-hCCCCEEeecCCCcceeecCCCC-cEEEcCc
Q 004564 97 NRNINFVTEMFTSGTLRQYR-LKHK-RVNIRAVKLWCRQILRGLLYLH-SHDPPVIHRDLKCDNIFVNGNQG-EVKIGDL 172 (745)
Q Consensus 97 ~~~iyLV~E~~~gGsL~~~l-~k~~-~L~e~~i~~ia~QIL~gL~yLH-s~gp~IIHRDLKpdNILld~~~g-~VKL~DF 172 (745)
....+++++|..|+++...+ .... ..+......++.|+..+|.|+| ..+ +.||||||+|.+++. .+ .+|++||
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~-s~~~l~~~df 169 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDE-SGSALKIADF 169 (601)
T ss_pred CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhcc-CCCcccCCCc
Confidence 67889999999999999887 4444 6778888899999999999999 777 999999999999984 46 9999999
Q ss_pred chhhhhhc-cCC----CcccC-CCCcCChhhhhh--ccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC--
Q 004564 173 GLAAILRK-SHA----AHCVG-TPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK-- 242 (745)
Q Consensus 173 GlA~~l~~-~~~----~~~vG-Tp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~-- 242 (745)
|+|+.+.. ... ...+| ++.|+|||.+.+ ...+..|+||.|+++.-|++|..||.........+.......
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~ 249 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR 249 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc
Confidence 99988766 221 22358 999999999875 467889999999999999999999976443333333333322
Q ss_pred CCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 243 KPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 243 ~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
.-...+...+....+++.++|. +|+.|.+.+++-.+||+..
T Consensus 250 ~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 250 FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 1244566678889999999997 9999999999999999985
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.4e-16 Score=156.31 Aligned_cols=134 Identities=22% Similarity=0.266 Sum_probs=105.1
Q ss_pred EecccCceEEEEEEEcCCCeEEEEEEEeecccCCC----HHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEE
Q 004564 29 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS----PEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 29 ~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~----~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
+||+|+||+||+|. .+|..|++|+......... .....++.+|+.+++.+.|+++....-.+.. ....++||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEE
Confidence 48999999999996 5678899997543221111 1234678899999999998865544333343 44568999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
||+.|++|.+++..... .++.||+.+|.+||+.+ ++|||++|.||+++ .+.++|+|||++..
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 99999999988655332 78999999999999988 99999999999997 57999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4e-16 Score=175.97 Aligned_cols=196 Identities=26% Similarity=0.385 Sum_probs=153.7
Q ss_pred HHhCCCCCcceEeEEEEecCCCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCC
Q 004564 77 LKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKC 155 (745)
Q Consensus 77 Lk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKp 155 (745)
|+.+.|.|+.+|++..++ ...+++|.+|+..|+|.+.+.. ..+++.-....+++.|+.||.|||... -..|+.|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~--~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD--GPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEec--CCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeecc
Confidence 467899999999999887 4789999999999999999887 457888999999999999999999864 239999999
Q ss_pred cceeecCCCCcEEEcCcchhhhhhc----cCCCcccCCCCcCChhhhhhc--------cCccccchhhhhHHHHHhhcCC
Q 004564 156 DNIFVNGNQGEVKIGDLGLAAILRK----SHAAHCVGTPEFMAPEVYEEA--------YNELVDIYSFGMCILEMVTFEY 223 (745)
Q Consensus 156 dNILld~~~g~VKL~DFGlA~~l~~----~~~~~~vGTp~YmAPEvl~~~--------ys~ksDIWSLGvILyELlTG~~ 223 (745)
.|.+++.. -.+||+|||+...... .......-..-|.|||++... .+.+.|||||||+++|+++...
T Consensus 78 ~nClvd~~-w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 78 SNCLVDSR-WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred ccceeeee-EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999955 5999999999877642 111111244679999998642 4567999999999999999999
Q ss_pred CCCCC---CCHHHHHHHHHc-CCC---CCCccc-CCCHHHHHHHHHHhh-CccCCCCHHHHh
Q 004564 224 PYSEC---THPAQIYKKVVS-GKK---PDSLYR-VKDPEVRRFVEKCLA-TVSLRLSARELL 276 (745)
Q Consensus 224 Pf~~~---~~~~~i~kkv~~-g~~---p~~l~~-~~s~el~d~I~kcL~-dPskRpSa~ELL 276 (745)
||... ..+.++...+.. +.. |..... ...+++..++..||. +|..||+++++-
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 99652 233556666666 332 221111 334578999999999 999999998875
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-15 Score=176.42 Aligned_cols=138 Identities=18% Similarity=0.177 Sum_probs=108.1
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccC----CCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL----QSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~----~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~i 100 (745)
...++||+|+||+||+|.... ..+++|........ ......+++.+|+.+++.++|++|+..+.++.+ ....
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~ 411 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--PEEK 411 (535)
T ss_pred CccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--CCCC
Confidence 557889999999999996543 34444433211111 111234678899999999999999887765554 4467
Q ss_pred EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhh
Q 004564 101 NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l 178 (745)
++||||+.+++|.+++. ....++.||+.+|.|||+++ |+||||||+|||++ ++.++|+|||++...
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~--~~~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR--DDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE--CCcEEEEeCcccccC
Confidence 89999999999999875 35678999999999999988 99999999999994 579999999998654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.6e-16 Score=157.09 Aligned_cols=144 Identities=22% Similarity=0.179 Sum_probs=109.9
Q ss_pred CCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCC--H----------------HHHHHHHHHHHHHHhCC
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS--P----------------EDLERLYCEIHLLKTLK 81 (745)
Q Consensus 20 ~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~--~----------------~~~e~l~~Ei~iLk~L~ 81 (745)
.|+.+.+.+.||+|+||.||+|... +|..||+|++........ . ........|+.++..+.
T Consensus 13 ~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 13 RGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred cCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 3444578899999999999999875 799999998775321000 0 01123677999999998
Q ss_pred CC--CcceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCccee
Q 004564 82 HK--NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIF 159 (745)
Q Consensus 82 Hp--NIVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNIL 159 (745)
|+ .+++.++ ....++||||+.|++|..+... .....++.+|+.++.++|+++ |+||||||+||+
T Consensus 92 ~~~i~v~~~~~------~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nil 157 (198)
T cd05144 92 EEGFPVPKPID------WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNIL 157 (198)
T ss_pred HcCCCCCceee------cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEE
Confidence 87 4555554 2345899999999998765321 345678999999999999988 999999999999
Q ss_pred ecCCCCcEEEcCcchhhhhh
Q 004564 160 VNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 160 ld~~~g~VKL~DFGlA~~l~ 179 (745)
++ .++.++|+|||++....
T Consensus 158 l~-~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 158 VD-DDEKIYIIDWPQMVSTD 176 (198)
T ss_pred Ec-CCCcEEEEECCccccCC
Confidence 98 46899999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.9e-15 Score=146.30 Aligned_cols=141 Identities=25% Similarity=0.202 Sum_probs=99.4
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHH--------------------HHHHHHHHHHHhCCCC--C
Q 004564 27 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDL--------------------ERLYCEIHLLKTLKHK--N 84 (745)
Q Consensus 27 ~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~--------------------e~l~~Ei~iLk~L~Hp--N 84 (745)
.+.||+|+||+||+|.+. +|..||+|+++........... .....|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 8999999988753211110000 0113566777776543 3
Q ss_pred cceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhh-CCCCEEeecCCCcceeecCC
Q 004564 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS-HDPPVIHRDLKCDNIFVNGN 163 (745)
Q Consensus 85 IVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs-~gp~IIHRDLKpdNILld~~ 163 (745)
+++.+.. ...++||||+.++.+........... ..+..++.|++.++.++|. ++ |+||||||+||+++
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-- 149 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-- 149 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE--
Confidence 5556552 23589999999854321111111111 6678899999999999999 87 99999999999998
Q ss_pred CCcEEEcCcchhhhhh
Q 004564 164 QGEVKIGDLGLAAILR 179 (745)
Q Consensus 164 ~g~VKL~DFGlA~~l~ 179 (745)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 6899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.5e-14 Score=146.64 Aligned_cols=141 Identities=15% Similarity=0.213 Sum_probs=106.5
Q ss_pred eEEec-ccCceEEEEEEEcCCCeEEEEEEEeecccC----C-----CHHHHHHHHHHHHHHHhCCCCCc--ceEeEEEEe
Q 004564 27 NEILG-KGASKTVYRAFDEYEGIEVAWNQVKLYDFL----Q-----SPEDLERLYCEIHLLKTLKHKNI--MKFYTSWVD 94 (745)
Q Consensus 27 ~e~LG-~GafgtVy~A~d~~tg~~VAiK~ik~~~~~----~-----~~~~~e~l~~Ei~iLk~L~HpNI--Vk~~~sfvd 94 (745)
..+|| .||.|+||++... +..+++|.+...... . ......++.+|+.++..|.|++| ++.+.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35688 8999999998654 788999988643211 1 11334678899999999998875 677765443
Q ss_pred cCCC--eEEEEEeccCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcC
Q 004564 95 TANR--NINFVTEMFTS-GTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 171 (745)
Q Consensus 95 ~~~~--~iyLV~E~~~g-GsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~D 171 (745)
.... ..++|||++.| .+|.+++.. ..+++.. +.||+.+|.+||++| |+||||||.|||++. ++.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~-~~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDP-DGKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcC-CCCEEEEE
Confidence 2221 23599999997 689888654 4566553 578999999999998 999999999999974 57999999
Q ss_pred cchhhh
Q 004564 172 LGLAAI 177 (745)
Q Consensus 172 FGlA~~ 177 (745)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998854
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.51 E-value=9.4e-14 Score=128.95 Aligned_cols=133 Identities=19% Similarity=0.099 Sum_probs=107.9
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC--CCcceEeEEEEecCCCeEEEEE
Q 004564 27 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH--KNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 27 ~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~H--pNIVk~~~sfvd~~~~~iyLV~ 104 (745)
.+.||.|.++.||++.+.. ..+++|.+..... ...+..|+.+++.|.| .++++++..... ....++++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~ 72 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLM 72 (155)
T ss_pred ceecccccccceEEEEecC--CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEE
Confidence 3679999999999998754 6899998753321 4578889999999976 589999886543 46789999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCC-CCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHD-PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g-p~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
||+.++.+..+ +......++.+++.+|.+||... ++++|+||+|+||+++. .+.++++|||.+..
T Consensus 73 e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-~~~~~l~Df~~~~~ 138 (155)
T cd05120 73 EWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-GKILGIIDWEYAGY 138 (155)
T ss_pred EecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC-CcEEEEEecccccC
Confidence 99998887654 55667778999999999999842 24999999999999984 68999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.8e-14 Score=159.58 Aligned_cols=247 Identities=21% Similarity=0.233 Sum_probs=196.7
Q ss_pred EeEEecc--cCceEEEEEEE--cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecCCCeE
Q 004564 26 YNEILGK--GASKTVYRAFD--EYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 26 l~e~LG~--GafgtVy~A~d--~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~~~~i 100 (745)
..+.+|. |.+|.||.+.. ..++..+|+|.-+... ..+....+=++|+...+.+ .|+|.++.+..|.. .+..
T Consensus 118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~--s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~~~l 193 (524)
T KOG0601|consen 118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF--SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--SGIL 193 (524)
T ss_pred cccccccCCCCCceeecccCCcccCCcccccccccCCC--CCccccccccchhhcccccCccccccccCccccc--CCcc
Confidence 3466899 99999999988 8889999988643322 2233334445566666666 49999999999876 6778
Q ss_pred EEEEeccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHH----HHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 101 NFVTEMFTSGTLRQYRLKHKR-VNIRAVKLWCRQILR----GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~~-L~e~~i~~ia~QIL~----gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
++-+|++. .+|..|...... ++...++..+.+.+. ||..+|+.+ ++|-|+||+||+...+....+++|||+.
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCccee
Confidence 88889885 788888776555 899999999999999 999999988 9999999999999866578999999998
Q ss_pred hhhhccCCC-------cccCCCCcCChhhhhhccCccccchhhhhHHHHHhhcCCCCCCC--CCHHHHHHHHHcCCCCCC
Q 004564 176 AILRKSHAA-------HCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSEC--THPAQIYKKVVSGKKPDS 246 (745)
Q Consensus 176 ~~l~~~~~~-------~~vGTp~YmAPEvl~~~ys~ksDIWSLGvILyELlTG~~Pf~~~--~~~~~i~kkv~~g~~p~~ 246 (745)
..+...... ...|...|++||+.++.++...|||++|.+..+-.++..+.... .... .+..+..|..
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~----~~r~~~ip~e 346 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS----QLRQGYIPLE 346 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc----ccccccCchh
Confidence 776543311 11477889999999999999999999999999999987666543 2222 2344556777
Q ss_pred cccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 247 LYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 247 l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
+....+..++..+..++. ++-.|++++.+++++++..
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 777778888888899998 8999999999999999973
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.9e-13 Score=161.81 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=199.8
Q ss_pred EeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEe
Q 004564 26 YNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTE 105 (745)
Q Consensus 26 l~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E 105 (745)
+.+-+-.|+++.++.+.-..+|...++|...+...+. ....+.+..+-.++-.-.+|-++.+.-.|. .....+++++
T Consensus 808 i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~-~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~--~rsP~~L~~~ 884 (1205)
T KOG0606|consen 808 ITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIR-TNDYESIRSKSNILITPRSPAVVRSFPSFP--CRSPLPLVGH 884 (1205)
T ss_pred ecccccCCCCcccccCCccccccccchhhhccchhhc-cccccccCCccCccccCCCCceecccCCCC--CCCCcchhhH
Confidence 3456889999999999877788777777665444322 223445555656655566788887766543 3678999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh------
Q 004564 106 MFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR------ 179 (745)
Q Consensus 106 ~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~------ 179 (745)
|..+++|...+.+-+..+.+..+.++..+..+++|||+.. ++|||++|+|+|+. ..|..+++|||+.....
T Consensus 885 ~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~-~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 885 YLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIA-YDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred HhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhc-ccCCcccCccccccccccccCcC
Confidence 9999999999888888999999999999999999999976 89999999999996 67899999998432110
Q ss_pred ------------------------c---cCCCcccCCCCcCChhhhhh-ccCccccchhhhhHHHHHhhcCCCCCCCCCH
Q 004564 180 ------------------------K---SHAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHP 231 (745)
Q Consensus 180 ------------------------~---~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~ 231 (745)
. ......+||+.|.|||...+ .....+|+|++|++++|.++|..||.. ..+
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na-~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA-ETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC-cch
Confidence 0 00112358999999998874 578899999999999999999999987 678
Q ss_pred HHHHHHHHcCCCCCC-cccCCCHHHHHHHHHHhh-CccCCCCHH---HHhcCCCCCccc
Q 004564 232 AQIYKKVVSGKKPDS-LYRVKDPEVRRFVEKCLA-TVSLRLSAR---ELLNDPFLQIDD 285 (745)
Q Consensus 232 ~~i~kkv~~g~~p~~-l~~~~s~el~d~I~kcL~-dPskRpSa~---ELL~hPff~~~~ 285 (745)
.++++.+..+..|-. -....++++++++..+|. +|.+|..+. ++-.||||+-.+
T Consensus 1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence 889988888776532 334568899999999999 999999888 999999998544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.4e-10 Score=117.82 Aligned_cols=142 Identities=19% Similarity=0.161 Sum_probs=104.6
Q ss_pred eEEecccCceEEEEEEEcC------CCeEEEEEEEeecc--cCC-------C---------HHHHHHH----HHHHHHHH
Q 004564 27 NEILGKGASKTVYRAFDEY------EGIEVAWNQVKLYD--FLQ-------S---------PEDLERL----YCEIHLLK 78 (745)
Q Consensus 27 ~e~LG~GafgtVy~A~d~~------tg~~VAiK~ik~~~--~~~-------~---------~~~~e~l----~~Ei~iLk 78 (745)
...||.|--+.||.|.... .+..+|+|+.+... +.. . ......+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998654 35799999987531 000 0 1112223 38999999
Q ss_pred hCC--CCCcceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHh-hhCCCCEEeecCCC
Q 004564 79 TLK--HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYL-HSHDPPVIHRDLKC 155 (745)
Q Consensus 79 ~L~--HpNIVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yL-Hs~gp~IIHRDLKp 155 (745)
+|. .-++++.+.. ..-++||||+.+..+..-..+...++.+.+..+..|++.+|..| |..| |||+||++
T Consensus 82 rl~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~ 153 (197)
T cd05146 82 RMQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSE 153 (197)
T ss_pred HHHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence 995 4678888863 24578999997754433333444566677788899999999999 8888 99999999
Q ss_pred cceeecCCCCcEEEcCcchhhhh
Q 004564 156 DNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 156 dNILld~~~g~VKL~DFGlA~~l 178 (745)
.||++. +|.+.|+|||.+...
T Consensus 154 ~NIL~~--~~~v~iIDF~qav~~ 174 (197)
T cd05146 154 YNMLWH--DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHEEEE--CCcEEEEECCCceeC
Confidence 999996 368999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=7e-11 Score=114.39 Aligned_cols=128 Identities=21% Similarity=0.098 Sum_probs=93.9
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCc-ceEeEEEEecCCCeEEEEEec
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNI-MKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNI-Vk~~~sfvd~~~~~iyLV~E~ 106 (745)
+.|+.|.++.||++... +..|++|+..... .....+..|+.+++.+.+.++ ++++.. +. ..-++|||+
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~--~~~~lv~e~ 72 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGT-----ELLINRENEAENSKLAAEAGIGPKLYYF--DP--ETGVLITEF 72 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCc-----ccccCHHHHHHHHHHHHHhCCCCceEEE--eC--CCCeEEEEe
Confidence 56899999999999754 7889999764221 112245779999999865554 456653 22 234789999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCC---CEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 107 FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDP---PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 107 ~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp---~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
+.|.++... . .....++.+++.+|..||+.+. .++|+|++|.||+++ ++.++|+|||.+.
T Consensus 73 i~G~~l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~ 135 (170)
T cd05151 73 IEGSELLTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAG 135 (170)
T ss_pred cCCCccccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE--CCeEEEEeccccc
Confidence 999887643 0 1123457899999999999762 259999999999998 4689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.17 E-value=2e-11 Score=140.67 Aligned_cols=141 Identities=20% Similarity=0.183 Sum_probs=92.2
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeeccc--------------------------CCCH----HHHHHHHHHHHH-
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF--------------------------LQSP----EDLERLYCEIHL- 76 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~--------------------------~~~~----~~~e~l~~Ei~i- 76 (745)
+.||.|++|.||+|....+|+.||+|+++..-. .... +..+.+..|+++
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 469999999999999988899999999874310 0000 112223334333
Q ss_pred -----HHhC----CCCCcceEeEEEEecCCCeEEEEEeccCCCCHHHH--HHHcC----CCCHHHHHHHHHHHHHHHHHh
Q 004564 77 -----LKTL----KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHK----RVNIRAVKLWCRQILRGLLYL 141 (745)
Q Consensus 77 -----Lk~L----~HpNIVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~--l~k~~----~L~e~~i~~ia~QIL~gL~yL 141 (745)
+.++ .+.+.+.+-..+.+- -..-++||||+.|+.+.++ +.+.+ .+.+..+..++.||+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~----- 278 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFR----- 278 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHh-----
Confidence 3333 233323222222221 2345799999999999874 33333 3556667777777764
Q ss_pred hhCCCCEEeecCCCcceeecCCCC----cEEEcCcchhhhhh
Q 004564 142 HSHDPPVIHRDLKCDNIFVNGNQG----EVKIGDLGLAAILR 179 (745)
Q Consensus 142 Hs~gp~IIHRDLKpdNILld~~~g----~VKL~DFGlA~~l~ 179 (745)
.| ++|+|+||.||+|+. +| .++++|||++..+.
T Consensus 279 --~G--ffHaDpHPGNIlv~~-~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 279 --DG--FFHADMHPGNIFVSY-DPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred --CC--eeeCCCChHHeEEec-CCCCCCeEEEEecceEEECC
Confidence 56 999999999999974 45 99999999986543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.17 E-value=1e-10 Score=132.43 Aligned_cols=141 Identities=21% Similarity=0.156 Sum_probs=93.6
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCH--------------------------HH----HH------HHH
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSP--------------------------ED----LE------RLY 71 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~--------------------------~~----~e------~l~ 71 (745)
+.||.|++|.||+|... +|+.||||+.+..-...-. .. .. .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 35999999999999864 7999999987632100000 00 00 134
Q ss_pred HHHHHHHhC----CC-CC--cceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHH-HHHHhh
Q 004564 72 CEIHLLKTL----KH-KN--IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILR-GLLYLH 142 (745)
Q Consensus 72 ~Ei~iLk~L----~H-pN--IVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~-~~L~e~~i~~ia~QIL~-gL~yLH 142 (745)
.|+..+..+ +| ++ |+++|..+ ...-++||||+.|++|.++.... ..++ ...++.+++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~----~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR----TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh----cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence 455555555 23 32 33444322 23458999999999998875432 2222 2345555555 467889
Q ss_pred hCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 143 s~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
..| ++|+|+||.||+++ .+|.++|+|||++..+.
T Consensus 275 ~~g--~~H~D~hPgNilv~-~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 RDG--FFHADLHPGNIFVL-KDGKIIALDFGIVGRLS 308 (437)
T ss_pred hCC--ceeCCCCcccEEEC-CCCcEEEEeCCCeeECC
Confidence 988 99999999999997 56899999999986553
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=4e-11 Score=136.13 Aligned_cols=249 Identities=19% Similarity=0.147 Sum_probs=177.2
Q ss_pred CCCceeeEeEEecccCceEEEEEEEc-CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceEeEEEEecC
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDE-YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTA 96 (745)
Q Consensus 19 p~gRY~rl~e~LG~GafgtVy~A~d~-~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L-~HpNIVk~~~sfvd~~ 96 (745)
+.+++. +...||.|.|+.|+..... .++..|++|.+...- ....+++ .-..|+-+...| .|.+++.++..|..
T Consensus 263 ~~~df~-~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~-- 337 (524)
T KOG0601|consen 263 KLTDFG-LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQ-- 337 (524)
T ss_pred ecCCcc-eeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhh-cchhhhhHhhHhhcccccCCCCCCccc--
Confidence 556663 4467999999999887533 678889888765322 2222222 224566666666 59999999999976
Q ss_pred CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 97 NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 97 ~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
.+..|+-.||+.++++.....-...+.+...+....|++.++.++|+.. ++|+|+||.||++..+++.-+++|||.++
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccccc
Confidence 5677788999999998876655556888999999999999999999977 99999999999997545788999999997
Q ss_pred hhhccCCCcccCCCCcC-Chhhhh--hccCccccchhhhhHHHHHhhcCC-CCCCCCCHHHHHHHHHcCCCCCCcccCCC
Q 004564 177 ILRKSHAAHCVGTPEFM-APEVYE--EAYNELVDIYSFGMCILEMVTFEY-PYSECTHPAQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 177 ~l~~~~~~~~vGTp~Ym-APEvl~--~~ys~ksDIWSLGvILyELlTG~~-Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s 252 (745)
.+..... .+...-.++ ..|++. ..+..++|++|||..+.+.+++.. +... .. ...+.+|..|.... ..
T Consensus 416 ~~~~~~~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-~~----~~~i~~~~~p~~~~--~~ 487 (524)
T KOG0601|consen 416 RLAFSSG-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-VQ----SLTIRSGDTPNLPG--LK 487 (524)
T ss_pred ccceecc-cccccccccccchhhccccccccccccccccccccccccCcccCccc-cc----ceeeecccccCCCc--hH
Confidence 6332221 223444455 255554 357789999999999999998753 3222 11 22344555553222 22
Q ss_pred HHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 253 ~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
.++..+.+.++. ++..|+.+.++..|+=|-
T Consensus 488 ~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 488 LQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 566777777777 888999999998887553
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.3e-10 Score=129.19 Aligned_cols=168 Identities=25% Similarity=0.262 Sum_probs=125.7
Q ss_pred EEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHc
Q 004564 40 RAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 119 (745)
Q Consensus 40 ~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~ 119 (745)
.|..+.++.+|.+...+... ....+.+.+-++.|+.|+||||++|++.++. ...+|+|+|-+. .|..++.+.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~----~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV~--Pl~~~lk~l 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSN----GEVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERVR--PLETVLKEL 101 (690)
T ss_pred ccceeccCCceEEEEEeCCC----chhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeeccc--cHHHHHHHh
Confidence 46667888999988777443 2445556777889999999999999999866 569999999986 577777764
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCC--CcccCCCCcCChhh
Q 004564 120 KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA--AHCVGTPEFMAPEV 197 (745)
Q Consensus 120 ~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~--~~~vGTp~YmAPEv 197 (745)
+ ...+..-++||+.||.|||..+ .++|++|.-+.|+|+ ..|..||++|-++........ ....---.|..|+.
T Consensus 102 ~---~~~v~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn-~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 102 G---KEEVCLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVN-ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEE 176 (690)
T ss_pred H---HHHHHHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEc-CCCcEEEeeeEEEeccccCCcccccchhhhcccChhh
Confidence 4 7778888999999999998542 499999999999998 669999999998754332211 11111223444544
Q ss_pred hhhccCccccchhhhhHHHHHhhc
Q 004564 198 YEEAYNELVDIYSFGMCILEMVTF 221 (745)
Q Consensus 198 l~~~ys~ksDIWSLGvILyELlTG 221 (745)
+... .-..|.|-|||++++++.|
T Consensus 177 ~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCcc-ccchhhhhHHHHHHHHhCc
Confidence 3211 1357999999999999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.7e-09 Score=107.12 Aligned_cols=145 Identities=20% Similarity=0.232 Sum_probs=105.7
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC--CCcceEeEEEEecC-CCeEEEEE
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH--KNIMKFYTSWVDTA-NRNINFVT 104 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~H--pNIVk~~~sfvd~~-~~~iyLV~ 104 (745)
+.||.|.++.||++... +|..+++|+....... .....+..|+.+++.+.+ .++++++.+..... ....++||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 56899999999999764 3678999976533211 134567889999999975 44677777543211 13568999
Q ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhC----------------------------------------
Q 004564 105 EMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSH---------------------------------------- 144 (745)
Q Consensus 105 E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~---------------------------------------- 144 (745)
||+.|.++...+.. ..++++....++.++++.|..||+.
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999988765432 4577777778888888888888852
Q ss_pred --------------CCCEEeecCCCcceeecCC-CCcEEEcCcchhhh
Q 004564 145 --------------DPPVIHRDLKCDNIFVNGN-QGEVKIGDLGLAAI 177 (745)
Q Consensus 145 --------------gp~IIHRDLKpdNILld~~-~g~VKL~DFGlA~~ 177 (745)
...++|+|++++||+++.+ .+.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1237999999999999853 45789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=5.2e-08 Score=97.55 Aligned_cols=145 Identities=21% Similarity=0.286 Sum_probs=105.2
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeeccc----CCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEE
Q 004564 27 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF----LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINF 102 (745)
Q Consensus 27 ~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~----~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyL 102 (745)
.++|-+|+-+.|+++ ...|+...||.--...+ +...-...+..+|+++|.++.--.|.----+|+|.. .-.+
T Consensus 12 l~likQGAEArv~~~--~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~--~~~i 87 (229)
T KOG3087|consen 12 LELIKQGAEARVPRG--SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY--GGQI 87 (229)
T ss_pred ceeeeccceeeEeee--ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC--CCeE
Confidence 477899999999999 45688878774322111 122234567888999999986444433222346643 4456
Q ss_pred EEeccCC-CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcE--EEcCcchhhh
Q 004564 103 VTEMFTS-GTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEV--KIGDLGLAAI 177 (745)
Q Consensus 103 V~E~~~g-GsL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~V--KL~DFGlA~~ 177 (745)
+|||+.| .++.+|+.... ....+....++++|=+.+.-||.++ |||+||..+||++..+++++ .|+|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence 8999976 47888888753 3444445789999999999999999 99999999999997665555 8999999854
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.79 E-value=8.1e-08 Score=108.00 Aligned_cols=213 Identities=18% Similarity=0.253 Sum_probs=151.3
Q ss_pred CceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEec--CCCeEEEEEeccCC-C
Q 004564 34 ASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT--ANRNINFVTEMFTS-G 110 (745)
Q Consensus 34 afgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~--~~~~iyLV~E~~~g-G 110 (745)
--.+.|+|+...+|..|++|.+.... .+.. .....-+++++++.|+|||+|.+.|... .+..+++|++|+++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r-~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDR-DQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccc-ccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 44678999999999999999883222 1111 1233456889999999999999988622 24678999999876 5
Q ss_pred CHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 111 TLRQYRL---------------KHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 111 sL~~~l~---------------k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
+|.++-. ...+.++..++.|+.||..||.++|+.| +..+-|.|.+|+++|+. +|+|...|+.
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~-RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKM-RIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcc-eEEEecccce
Confidence 6766422 1235788999999999999999999998 88999999999999764 8999888876
Q ss_pred hhhhccCCCcccCCCCcCChhhhhhccCccccchhhhhHHHHHhhcCCC-CCCCCCHHHH-HHHHHcCCCCCCcccCCCH
Q 004564 176 AILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYP-YSECTHPAQI-YKKVVSGKKPDSLYRVKDP 253 (745)
Q Consensus 176 ~~l~~~~~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGvILyELlTG~~P-f~~~~~~~~i-~kkv~~g~~p~~l~~~~s~ 253 (745)
..+.... . +.+++ ..+-|.=.||.+++.|.||..= +.. ....+. .+. +...++.
T Consensus 441 Dvl~~d~----------~--~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~-d~~~~s~~~~---------I~~~yS~ 496 (655)
T KOG3741|consen 441 DVLQEDP----------T--EPLES--QQQNDLRDLGLLLLALATGTENSNRT-DSTQSSHLTR---------ITTTYST 496 (655)
T ss_pred eeecCCC----------C--cchhH--HhhhhHHHHHHHHHHHhhcccccccc-cchHHHHHHH---------hhhhhhH
Confidence 5543322 0 12221 1346888999999999998432 222 122222 222 2345678
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcC
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 254 el~d~I~kcL~-dPskRpSa~ELL~h 278 (745)
+++++|.-+.. .+.. .++.+||.+
T Consensus 497 D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 497 DLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 88999988887 4544 778888754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.1e-07 Score=95.45 Aligned_cols=132 Identities=23% Similarity=0.347 Sum_probs=95.7
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHH-----HHHHHHHHHHHHHhCCC--CCcceEeEEEEecCCCeE
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPE-----DLERLYCEIHLLKTLKH--KNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~-----~~e~l~~Ei~iLk~L~H--pNIVk~~~sfvd~~~~~i 100 (745)
.+|++|+-+.+|.+. .-|.++.+|. ++.+.-..++ ..++-.+|++++..++- -+.+.+|+ ++ ...-
T Consensus 2 ~~i~~GAEa~i~~~~--~~g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d--vD--~~~~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTD--FLGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD--VD--PDNG 74 (204)
T ss_pred chhhCCcceeEEeee--ccCcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE--Ec--CCCC
Confidence 358899999999983 3455666664 4443222222 24556779999998864 45556666 55 3455
Q ss_pred EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 101 NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 101 yLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
.++|||+.|-.|++++... . ..+++.|=.-+.-||..| |||+||.+.||++.+ +.+.++|||++..
T Consensus 75 ~I~me~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~--~~i~~IDfGLg~~ 140 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSG--GRIYFIDFGLGEF 140 (204)
T ss_pred EEEEEEeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcC--eecCCCccceEEEeC--CcEEEEECCcccc
Confidence 6799999999999888766 2 345566666677799998 999999999999973 4599999999853
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.7e-07 Score=103.22 Aligned_cols=240 Identities=17% Similarity=0.207 Sum_probs=154.4
Q ss_pred CCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcce--------Ee
Q 004564 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK--------FY 89 (745)
Q Consensus 18 dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk--------~~ 89 (745)
++.|.-.....-||+|+-+.+|-. ..-+..|| |++..... ....+... .+.+.-.||-+-. +|
T Consensus 7 ~~~ge~i~~gr~LgqGgea~ly~l--~e~~d~VA-KIYh~Ppp----a~~aqk~a--~la~~p~~p~~~~rvaWPqa~L~ 77 (637)
T COG4248 7 DVYGEPIPPGRPLGQGGEADLYTL--GEVRDQVA-KIYHAPPP----AAQAQKVA--ELAATPDAPLLNYRVAWPQATLH 77 (637)
T ss_pred cccCcccCCCccccCCccceeeec--chhhchhh-eeecCCCc----hHHHHHHH--HhccCCCCcchhhhhcccHHHhh
Confidence 344444445566999999999966 22333444 65543331 11111111 2223335654332 23
Q ss_pred EEEEecCCCeEEEEEeccCCCC-HHHH------HHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecC
Q 004564 90 TSWVDTANRNINFVTEMFTSGT-LRQY------RLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG 162 (745)
Q Consensus 90 ~sfvd~~~~~iyLV~E~~~gGs-L~~~------l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~ 162 (745)
+- .....+-++|..+.+.. ...+ ++.....++..+.++++.|+.+...||.+| .+-+|++++||||.
T Consensus 78 G~---~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVs- 151 (637)
T COG4248 78 GG---RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVS- 151 (637)
T ss_pred CC---CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeee-
Confidence 21 11234788888887652 2222 112234678999999999999999999999 99999999999996
Q ss_pred CCCcEEEcCcchhhhhhccCC-CcccCCCCcCChhhhh-h-----ccCccccchhhhhHHHHHhhc-CCCCCCCC-----
Q 004564 163 NQGEVKIGDLGLAAILRKSHA-AHCVGTPEFMAPEVYE-E-----AYNELVDIYSFGMCILEMVTF-EYPYSECT----- 229 (745)
Q Consensus 163 ~~g~VKL~DFGlA~~l~~~~~-~~~vGTp~YmAPEvl~-~-----~ys~ksDIWSLGvILyELlTG-~~Pf~~~~----- 229 (745)
+++.|.|.|-..-.+-.+... ...+|.++|.+||+-. + .-+...|.|.||+++++++.| +.||++..
T Consensus 152 d~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a 231 (637)
T COG4248 152 DDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA 231 (637)
T ss_pred cCceEEEEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC
Confidence 778999988665443333222 2347999999999765 2 245679999999999999987 99997632
Q ss_pred -CHHHHHHHHHc-----------CCCCC---CcccCCCHHHHHHHHHHhhC---ccCCCCHHH
Q 004564 230 -HPAQIYKKVVS-----------GKKPD---SLYRVKDPEVRRFVEKCLAT---VSLRLSARE 274 (745)
Q Consensus 230 -~~~~i~kkv~~-----------g~~p~---~l~~~~s~el~d~I~kcL~d---PskRpSa~E 274 (745)
++.+ ..|.. |.+|. ..+....+.+..++.+|..+ +.-|||++.
T Consensus 232 p~p~E--~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 232 PNPLE--TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred CCcch--hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 2222 11222 22221 12345688999999999984 568999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.7e-07 Score=93.43 Aligned_cols=129 Identities=27% Similarity=0.227 Sum_probs=82.3
Q ss_pred EEEEEEEcCCCeEEEEEEEeeccc---------------C-------CCHHHHHHHHHHHHHHHhCCCC--CcceEeEEE
Q 004564 37 TVYRAFDEYEGIEVAWNQVKLYDF---------------L-------QSPEDLERLYCEIHLLKTLKHK--NIMKFYTSW 92 (745)
Q Consensus 37 tVy~A~d~~tg~~VAiK~ik~~~~---------------~-------~~~~~~e~l~~Ei~iLk~L~Hp--NIVk~~~sf 92 (745)
.||.|.+ ..|..+|+|+.+.... . ..........+|++.|+.|..- ++++.+..
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4899976 4677999998875310 0 0011245678899999999755 67888863
Q ss_pred EecCCCeEEEEEeccC--CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHH-hhhCCCCEEeecCCCcceeecCCCCcEEE
Q 004564 93 VDTANRNINFVTEMFT--SGTLRQYRLKHKRVNIRAVKLWCRQILRGLLY-LHSHDPPVIHRDLKCDNIFVNGNQGEVKI 169 (745)
Q Consensus 93 vd~~~~~iyLV~E~~~--gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~y-LHs~gp~IIHRDLKpdNILld~~~g~VKL 169 (745)
. + -++||||+. |..+..+... .++.+....++.+++..+.. +|..| |||+||.+.|||++. +.+.|
T Consensus 79 -~--~--~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~--~~~~i 147 (188)
T PF01163_consen 79 -N--R--NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDD--GKVYI 147 (188)
T ss_dssp -E--T--TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEET--TCEEE
T ss_pred -e--C--CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeec--ceEEE
Confidence 2 2 268999998 6555443222 12244556677888885555 57887 999999999999973 48999
Q ss_pred cCcchhhhh
Q 004564 170 GDLGLAAIL 178 (745)
Q Consensus 170 ~DFGlA~~l 178 (745)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.9e-08 Score=114.78 Aligned_cols=147 Identities=20% Similarity=0.251 Sum_probs=107.6
Q ss_pred HHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhccCCC-----------cccCCCCcCChhhhhh-c
Q 004564 134 ILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-----------HCVGTPEFMAPEVYEE-A 201 (745)
Q Consensus 134 IL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~~-----------~~vGTp~YmAPEvl~~-~ 201 (745)
+..||.|+|.+ +++||+.|.|++|.++ ..|.+||+.|+++......... .......|.|||.+.. .
T Consensus 108 v~dgl~flh~s-Ak~VH~ni~p~~i~~n-a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 108 VADGLAFLHRS-AKVVHGNIQPEAIVVN-ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred ccchhhhhccC-cceeecccchhheeec-cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 33899999987 6799999999999999 4589999999998655431111 1135678999998874 5
Q ss_pred cCccccchhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH-c-CCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhc
Q 004564 202 YNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVV-S-GKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 202 ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~kkv~-~-g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~ 277 (745)
.+.++|+||+|+.+|.+.. |+.-+..... ...+.... . +-.........++++++=+.++|. ++..||++..++.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCC-cchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 6789999999999999984 5555544222 22222211 1 111222334567899999999999 9999999999999
Q ss_pred CCCCCc
Q 004564 278 DPFLQI 283 (745)
Q Consensus 278 hPff~~ 283 (745)
.|||+-
T Consensus 265 ~~ff~D 270 (700)
T KOG2137|consen 265 IPFFSD 270 (700)
T ss_pred ccccCC
Confidence 999973
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.6e-06 Score=92.42 Aligned_cols=106 Identities=15% Similarity=0.128 Sum_probs=79.5
Q ss_pred HHHHHHHHHHhCCCCC--cceEeEEEEecC---CCeEEEEEeccCCC-CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHH
Q 004564 69 RLYCEIHLLKTLKHKN--IMKFYTSWVDTA---NRNINFVTEMFTSG-TLRQYRLK--HKRVNIRAVKLWCRQILRGLLY 140 (745)
Q Consensus 69 ~l~~Ei~iLk~L~HpN--IVk~~~sfvd~~---~~~iyLV~E~~~gG-sL~~~l~k--~~~L~e~~i~~ia~QIL~gL~y 140 (745)
.+.+|...+..|..-+ .++...+..... ...-++|||++.+. +|.+++.. ....+......++.+|...+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 3678888888774333 333333333221 23578999999875 89988754 3456677888999999999999
Q ss_pred hhhCCCCEEeecCCCcceeecC------CCCcEEEcCcchhh
Q 004564 141 LHSHDPPVIHRDLKCDNIFVNG------NQGEVKIGDLGLAA 176 (745)
Q Consensus 141 LHs~gp~IIHRDLKpdNILld~------~~g~VKL~DFGlA~ 176 (745)
||.+| |+|+||++.|||++. ..+.+.|+||+.+.
T Consensus 154 LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 154 MHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99999 999999999999973 24689999999874
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=7.6e-07 Score=94.13 Aligned_cols=140 Identities=22% Similarity=0.197 Sum_probs=100.2
Q ss_pred CceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeeccc-----C-----------CC--HHHHHHHHHHHHHHHhCCC
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF-----L-----------QS--PEDLERLYCEIHLLKTLKH 82 (745)
Q Consensus 21 gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~-----~-----------~~--~~~~e~l~~Ei~iLk~L~H 82 (745)
|....+...||-|--+.||.|.+. .|.++|+|.=+.... . .+ .-......+|..+|..|.-
T Consensus 90 ~~ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 90 GIVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred ChHHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 344577889999999999999887 788999996553210 0 00 0113346779999999965
Q ss_pred C--CcceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceee
Q 004564 83 K--NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFV 160 (745)
Q Consensus 83 p--NIVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILl 160 (745)
. .|++-++ .+.-.+||||+.|-.|.... ++.+....++..|+.-+.-+-..| |||+||.+-||+|
T Consensus 169 ~G~~VP~P~~------~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV 235 (304)
T COG0478 169 EGVKVPKPIA------WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILV 235 (304)
T ss_pred cCCCCCCccc------cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEE
Confidence 5 7888776 24567899999997775543 234444455555665555444666 9999999999999
Q ss_pred cCCCCcEEEcCcchh
Q 004564 161 NGNQGEVKIGDLGLA 175 (745)
Q Consensus 161 d~~~g~VKL~DFGlA 175 (745)
+ ++|.+.++||--+
T Consensus 236 ~-~dg~~~vIDwPQ~ 249 (304)
T COG0478 236 T-EDGDIVVIDWPQA 249 (304)
T ss_pred e-cCCCEEEEeCccc
Confidence 8 6689999999655
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.33 E-value=5.6e-06 Score=84.53 Aligned_cols=109 Identities=18% Similarity=0.162 Sum_probs=83.4
Q ss_pred HHHHHHHHHHHHhCCCC--CcceEeEEEEecC--CCeEEEEEeccCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHh
Q 004564 67 LERLYCEIHLLKTLKHK--NIMKFYTSWVDTA--NRNINFVTEMFTS-GTLRQYRLKHKRVNIRAVKLWCRQILRGLLYL 141 (745)
Q Consensus 67 ~e~l~~Ei~iLk~L~Hp--NIVk~~~sfvd~~--~~~iyLV~E~~~g-GsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yL 141 (745)
..+..+|...+..|..- .+++.+.+..... ....++|||++++ .+|.+++......+......++.++...+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 34677788887777433 3444555443322 2356899999987 48999988766688888899999999999999
Q ss_pred hhCCCCEEeecCCCcceeecCCC--CcEEEcCcchhhh
Q 004564 142 HSHDPPVIHRDLKCDNIFVNGNQ--GEVKIGDLGLAAI 177 (745)
Q Consensus 142 Hs~gp~IIHRDLKpdNILld~~~--g~VKL~DFGlA~~ 177 (745)
|.+| |+|+|+++.|||++..+ ..+.|+||+-+..
T Consensus 135 H~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 99999999999998443 2789999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=6.6e-08 Score=110.88 Aligned_cols=240 Identities=22% Similarity=0.246 Sum_probs=163.3
Q ss_pred CCCCceeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC-cceEeEEEEecC
Q 004564 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN-IMKFYTSWVDTA 96 (745)
Q Consensus 18 dp~gRY~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpN-IVk~~~sfvd~~ 96 (745)
|++.-| .+-.-+++|++++++++....+...+ .+.+... ....-++++|.+++||| .+..++.+ ..
T Consensus 239 Dk~kws-~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~ 305 (829)
T KOG0576|consen 239 DKTKWS-EFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDY--DG 305 (829)
T ss_pred CCccch-HHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCcccccccC--Cc
Confidence 444444 33344799999999999877666555 5555422 34566899999999999 66666544 33
Q ss_pred CCeEEEEEeccCCC-C-HHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcch
Q 004564 97 NRNINFVTEMFTSG-T-LRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 174 (745)
Q Consensus 97 ~~~iyLV~E~~~gG-s-L~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGl 174 (745)
+...++.++++.++ + ....-...-.+.+-++...++.-+++|+++|+.. =+||| ||+.. .+.+|.+||+.
T Consensus 306 E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s--~~~~~~~~~~v 377 (829)
T KOG0576|consen 306 EDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGS--EEEVKLLDFAV 377 (829)
T ss_pred ccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----ccccc--ccccccccccC
Confidence 56788999999887 2 1111111112334455566777788999999863 48998 87775 37899999999
Q ss_pred hhhhhcc-CCCcccCCCCcCChhhhh-hccCccccchhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC--c-c-
Q 004564 175 AAILRKS-HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDS--L-Y- 248 (745)
Q Consensus 175 A~~l~~~-~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~--l-~- 248 (745)
+..+... ......+|+.|+|||+.. +.+....|.|++|+-..+|.-|.+|-.. .+.... .-|..|.. + .
T Consensus 378 ~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~---~~g~~p~s~~L~~~ 452 (829)
T KOG0576|consen 378 PPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLP---MIGNGPNSPMLTDK 452 (829)
T ss_pred CcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--CccccC---CCCCCCCccccchh
Confidence 9877654 344567999999999765 6799999999999998899888887643 222111 11222210 0 0
Q ss_pred cCCCHHH-HHHHHHHhh-CccCCCCHHHHhcCCCCCc
Q 004564 249 RVKDPEV-RRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 249 ~~~s~el-~d~I~kcL~-dPskRpSa~ELL~hPff~~ 283 (745)
...++.. +++...|+. .|..|+.+..++.|.+|.-
T Consensus 453 ~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 453 SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 0111222 358888998 7999999999999998863
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.5e-05 Score=82.13 Aligned_cols=142 Identities=13% Similarity=0.124 Sum_probs=97.9
Q ss_pred cccCceEEEEEEEcCCCeEEEEEEEee--cccCCCHHHHHHHHHHHHHHHhCCCC--CcceEe--EEEEecCCCeEEEEE
Q 004564 31 GKGASKTVYRAFDEYEGIEVAWNQVKL--YDFLQSPEDLERLYCEIHLLKTLKHK--NIMKFY--TSWVDTANRNINFVT 104 (745)
Q Consensus 31 G~GafgtVy~A~d~~tg~~VAiK~ik~--~~~~~~~~~~e~l~~Ei~iLk~L~Hp--NIVk~~--~sfvd~~~~~iyLV~ 104 (745)
|+||.+.|++.. ..|..+-+|+-.. .....-+--...|.+|+..|..|..- .+++.. +.--......-+||+
T Consensus 27 ~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEE--eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 668999999874 3344677776531 11111133456789999999988532 244433 211112234567899
Q ss_pred eccCC-CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCc--EEEcCcchhhh
Q 004564 105 EMFTS-GTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGE--VKIGDLGLAAI 177 (745)
Q Consensus 105 E~~~g-GsL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~--VKL~DFGlA~~ 177 (745)
|-+.+ .+|.+++... .+.+......++.+|...+.-||..| +.|+|+.+.|||++.. |. |+++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~-g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCC-CCeeEEEEEhhccch
Confidence 96643 6888887653 34577778899999999999999998 9999999999999743 45 99999976543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.8e-06 Score=102.13 Aligned_cols=205 Identities=24% Similarity=0.360 Sum_probs=146.0
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceEeEEEEecCCC--eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhh
Q 004564 65 EDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR--NINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLH 142 (745)
Q Consensus 65 ~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~--~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLH 142 (745)
..+.....|+..+....|+|++.++.+-+..... .+.+..+++..-++...++.-..++...++.|..+++.||.|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 4455566677788888999999999876543222 23456789999999999998899999999999999999999999
Q ss_pred hCCCCEEeecCCCc---ceeecCCCCcEEEc--CcchhhhhhccCC-CcccCCCCcCChhhhhhc---cCccccchhhhh
Q 004564 143 SHDPPVIHRDLKCD---NIFVNGNQGEVKIG--DLGLAAILRKSHA-AHCVGTPEFMAPEVYEEA---YNELVDIYSFGM 213 (745)
Q Consensus 143 s~gp~IIHRDLKpd---NILld~~~g~VKL~--DFGlA~~l~~~~~-~~~vGTp~YmAPEvl~~~---ys~ksDIWSLGv 213 (745)
++. ..|.-|... +--+++ .+.+.++ ||+....+..... ....-+..+.|||.+... .....|+|.+|.
T Consensus 304 ~~~--l~~v~L~~s~~~~~~~~~-e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 304 SLS--LEHVVLSASSSKESTVDG-EGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred Hhc--cceeEEecccccccccCc-cceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 975 555555544 333332 2466666 8888766544322 223456678888887643 334479999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCC-HHHHHHHHHHhh-CccCCCCHHHHhcCCCCCccc
Q 004564 214 CILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD-PEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 214 ILyELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s-~el~d~I~kcL~-dPskRpSa~ELL~hPff~~~~ 285 (745)
.+..+..|..+-.....+. .+....+ ....+++.+|+. ++++|+++.+++.|||.+...
T Consensus 381 l~~~~~~~~~i~~~~~~~~-------------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAVPV-------------SLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred HHhhhhhcCcccccccchh-------------hhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 9999998765532211111 1111222 267899999998 899999999999999998543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.07 E-value=9.3e-05 Score=74.36 Aligned_cols=141 Identities=22% Similarity=0.249 Sum_probs=81.9
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC--CcceEeEEEEec-CCCeEEEEE
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHK--NIMKFYTSWVDT-ANRNINFVT 104 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~Hp--NIVk~~~sfvd~-~~~~iyLV~ 104 (745)
+.|+.|..+.||++.... ..+++|... .......+..|..+++.|... .+++++...... .....+++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~------~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD--GRYVLKFYR------PPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEESSSSEEEEEEETT--SEEEEEEES------SHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC--cEEEEEEeC------CCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 568999999999997654 488888754 124566788899999888533 356777633222 234579999
Q ss_pred eccCCCCHHH----------------HHHH---c----CCCCH------H---HHHHH------------HHHHHH-HHH
Q 004564 105 EMFTSGTLRQ----------------YRLK---H----KRVNI------R---AVKLW------------CRQILR-GLL 139 (745)
Q Consensus 105 E~~~gGsL~~----------------~l~k---~----~~L~e------~---~i~~i------------a~QIL~-gL~ 139 (745)
+++.|..+.. .+.+ . ..+.. . ....+ ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988776 1110 0 00000 0 00000 011111 233
Q ss_pred Hhhh-----CCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 140 YLHS-----HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 140 yLHs-----~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
.+++ ....++|+|+.|.|||++..++.|-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3332 223499999999999998555677899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.9e-06 Score=62.51 Aligned_cols=32 Identities=47% Similarity=0.585 Sum_probs=27.0
Q ss_pred eEEEEEEecCCC------CcccccccCcCCCCCHHHHH
Q 004564 376 IFLRLRIADKEG------RIRNIYFPFDVETDTALSVA 407 (745)
Q Consensus 376 i~L~LRi~d~~g------~~~~I~F~F~~~~DTa~sVA 407 (745)
|.|+||+.|+++ ..++|+|+|+++.|+|..||
T Consensus 1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA 38 (38)
T PF12202_consen 1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA 38 (38)
T ss_dssp EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence 679999999988 77899999999999999998
|
This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.98 E-value=6.6e-05 Score=78.01 Aligned_cols=135 Identities=12% Similarity=0.119 Sum_probs=79.3
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC--cceEeEEEEecCCCeEEEEEe
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN--IMKFYTSWVDTANRNINFVTE 105 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpN--IVk~~~sfvd~~~~~iyLV~E 105 (745)
..||+|..+.||+. .|..+++|...... ....+.+|.++++.+..-. +++.+.... ......+|||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~--~~~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF------DKETIKREFDASRKVFSLGIPTPHPFDLVE--DGGRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC------CHHHHHHHHHHHHHHHHcCCCCCceEEEEe--cCCeeeeeee
Confidence 56899999999984 24467777654211 2235688999999986443 466676443 3556788999
Q ss_pred ccCCCC-HHH-----------H-------HHH-cC----CCCHHH-HHHHHHH----------HHHH-HHHh--hhCCCC
Q 004564 106 MFTSGT-LRQ-----------Y-------RLK-HK----RVNIRA-VKLWCRQ----------ILRG-LLYL--HSHDPP 147 (745)
Q Consensus 106 ~~~gGs-L~~-----------~-------l~k-~~----~L~e~~-i~~ia~Q----------IL~g-L~yL--Hs~gp~ 147 (745)
++.|.+ +.. + +.+ |. ..+... ...+..+ +... ..+| +...+.
T Consensus 75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 999864 110 0 010 10 111110 1111000 0111 1111 223345
Q ss_pred EEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 148 IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
++|+|+.|.||+++ +++ +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~-~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITS-GKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEc-CCC-cEEEechhcC
Confidence 89999999999997 445 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00012 Score=75.90 Aligned_cols=78 Identities=17% Similarity=0.088 Sum_probs=51.3
Q ss_pred eEeEEecccCc-eEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceEeEEEEecCCCeEEE
Q 004564 25 RYNEILGKGAS-KTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTSWVDTANRNINF 102 (745)
Q Consensus 25 rl~e~LG~Gaf-gtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-HpNIVk~~~sfvd~~~~~iyL 102 (745)
|+.. |-.|.. +.||+.... +..+.+|+..... ...+.+|+++++.|. +--+++++.+... ....++
T Consensus 2 ~~~~-~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~l 69 (244)
T cd05150 2 RWER-VTEGQSGATVYRLDGK--NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWL 69 (244)
T ss_pred ccee-cCCCCCcCeEEEEcCC--CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEE
Confidence 4533 444444 899999543 4567777654211 335677999988884 4456678876543 356789
Q ss_pred EEeccCCCCHHH
Q 004564 103 VTEMFTSGTLRQ 114 (745)
Q Consensus 103 V~E~~~gGsL~~ 114 (745)
||+++.|.+|..
T Consensus 70 v~e~i~G~~l~~ 81 (244)
T cd05150 70 LTSAVPGVPAAA 81 (244)
T ss_pred EEEeeCCccHhH
Confidence 999999987764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.84 E-value=7.6e-05 Score=78.46 Aligned_cols=142 Identities=20% Similarity=0.158 Sum_probs=95.8
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccC------------------CCHHH--HHHHHHHHHHHHhCC--CCC
Q 004564 27 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL------------------QSPED--LERLYCEIHLLKTLK--HKN 84 (745)
Q Consensus 27 ~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~------------------~~~~~--~e~l~~Ei~iLk~L~--HpN 84 (745)
...|+.|--+.||+|.. ..+..||+|+.+..... .+... ..-..+|+.-|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34577888899999964 46889999998753210 00111 122456888888884 556
Q ss_pred cceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhh-CCCCEEeecCCCcceeecCC
Q 004564 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS-HDPPVIHRDLKCDNIFVNGN 163 (745)
Q Consensus 85 IVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs-~gp~IIHRDLKpdNILld~~ 163 (745)
+++=+.+. .-.+||||+....+.-=..+.-++..+....+..++++.+.-|-. .+ +||+||..-|||+.
T Consensus 132 vP~Pi~~~------~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-- 201 (268)
T COG1718 132 VPEPIAFR------NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-- 201 (268)
T ss_pred CCCceeec------CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE--
Confidence 66666632 346899998654211101112233444677778888888887766 55 99999999999997
Q ss_pred CCcEEEcCcchhhhhh
Q 004564 164 QGEVKIGDLGLAAILR 179 (745)
Q Consensus 164 ~g~VKL~DFGlA~~l~ 179 (745)
+|.+.|+|||-|....
T Consensus 202 ~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 DGEPYIIDVSQAVTID 217 (268)
T ss_pred CCeEEEEECccccccC
Confidence 5799999999886554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0001 Score=85.27 Aligned_cols=147 Identities=18% Similarity=0.173 Sum_probs=89.7
Q ss_pred ceeeEe-EEecccCceEEEEEEEcCCCeEEEEEEEeeccc--------------------------CCCHH----HHHH-
Q 004564 22 RYGRYN-EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF--------------------------LQSPE----DLER- 69 (745)
Q Consensus 22 RY~rl~-e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~--------------------------~~~~~----~~e~- 69 (745)
.|..|+ +-|+.++-|.||+|.-.. |+.||+|+.+..-. ..-.. ..++
T Consensus 124 ~F~eF~~~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l 202 (517)
T COG0661 124 LFSEFEPEPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRL 202 (517)
T ss_pred HHHHcCCCchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHH
Confidence 344555 569999999999998664 99999998764200 00011 1122
Q ss_pred -----HHHHHHHHHhCC-----CCC--cceEeEEEEecCCCeEEEEEeccCCCCHHHH--HHHcCCCCHHHHHHHHHHHH
Q 004564 70 -----LYCEIHLLKTLK-----HKN--IMKFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHKRVNIRAVKLWCRQIL 135 (745)
Q Consensus 70 -----l~~Ei~iLk~L~-----HpN--IVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~--l~k~~~L~e~~i~~ia~QIL 135 (745)
+..|...+.+++ .|+ |+++|-.+ + ..-.++|||+.|..+.++ +.. ..++.+.+..-..++.
T Consensus 203 ~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~--t--~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f 277 (517)
T COG0661 203 REELDYRREAANAERFRENFKDDPDVYVPKVYWEY--T--TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF 277 (517)
T ss_pred HHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhc--c--CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH
Confidence 333444444442 233 34444322 1 234689999999998887 333 4455444433322222
Q ss_pred HHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 136 ~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
--. +=..| ++|.|..|.||+|+ .+|++.+.|||+...+.
T Consensus 278 ~~q--~~~dg--ffHaDpHpGNi~v~-~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 278 LRQ--LLRDG--FFHADPHPGNILVR-SDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHH--HHhcC--ccccCCCccceEEe-cCCcEEEEcCcceecCC
Confidence 111 11245 99999999999998 45899999999986543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00067 Score=70.51 Aligned_cols=137 Identities=14% Similarity=0.143 Sum_probs=79.5
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHH---------HHHHHHHHHHHHhCCCCCcceEeEEEEec
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPED---------LERLYCEIHLLKTLKHKNIMKFYTSWVDT 95 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~---------~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~ 95 (745)
...+++-......|.+- ..+|..+.+|..+.... ..+.. ..++...+..++...--....+|-...-.
T Consensus 34 ~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~-r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk 110 (229)
T PF06176_consen 34 KIIKVFKNTKRNYVALI--EIDGKKYILKEPREENR-RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK 110 (229)
T ss_pred eEEEeecCCCccEEEEE--EECCcEEEEeccchhhh-hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence 33344444444444333 56678888886653221 11111 22223333333333333333433322211
Q ss_pred C---CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCc
Q 004564 96 A---NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 172 (745)
Q Consensus 96 ~---~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DF 172 (745)
. -...+++|||++|..|.++.. +++ .+...|..++.-||+.| +.|+|..|.|++++ + +.++++||
T Consensus 111 ~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~-~-~~i~iID~ 178 (229)
T PF06176_consen 111 IFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVS-N-NGIRIIDT 178 (229)
T ss_pred eccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEE-C-CcEEEEEC
Confidence 1 124568999999998876532 333 24456677789999998 99999999999997 3 46999999
Q ss_pred chhh
Q 004564 173 GLAA 176 (745)
Q Consensus 173 GlA~ 176 (745)
+...
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.48 E-value=2.6e-05 Score=96.69 Aligned_cols=213 Identities=15% Similarity=0.049 Sum_probs=146.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHhh
Q 004564 67 LERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----KRVNIRAVKLWCRQILRGLLYLH 142 (745)
Q Consensus 67 ~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~----~~L~e~~i~~ia~QIL~gL~yLH 142 (745)
.+.+..|...++.+.|+++...+.-.........|..++|+.+|.++..+.+. ..++...+....++.+....-+|
T Consensus 1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 34455667777788999999988765555566788999999999999987764 23555555555555567777766
Q ss_pred hC---CCCEEeecCCCcceeecCCCCcEEEcCcchhhhhhcc--CCCcccCCCCcCChhhhhh-ccCccccchhhhhHHH
Q 004564 143 SH---DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCIL 216 (745)
Q Consensus 143 s~---gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGvILy 216 (745)
+. |...+|++||+-|.+|.++ ..||++++|+.++..+. .....+++|.|++|++.+. .++.++|+|..|+-+|
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtn-y~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTN-YNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred hcccCCccchhhhhhhhccceecC-CcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 53 3347999999999999866 48999999999854432 3445578999999999986 5777799999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCCCCcccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 217 EMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 217 ELlTG~~Pf~~~~~~~~i~kkv~~g~~p~~l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
++..|..||-.. ...+.+.++.......+....+.+........|- +-..||.-...+.-+.+.
T Consensus 1432 ~rs~~n~~fi~f--lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1432 LRSDGNAYFIFF--LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHhcccHHHHHH--HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 999988887442 1112222333333333344433333333333333 556677777777766654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0005 Score=71.21 Aligned_cols=74 Identities=12% Similarity=0.008 Sum_probs=44.7
Q ss_pred EEecccCce-EEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC---CcceEeEEEEecC-CCeEEE
Q 004564 28 EILGKGASK-TVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHK---NIMKFYTSWVDTA-NRNINF 102 (745)
Q Consensus 28 e~LG~Gafg-tVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~Hp---NIVk~~~sfvd~~-~~~iyL 102 (745)
+.|+.|+.. .||+. +..+.+|+.+. ......+..|+.+|+.|... -+++.+....... ....++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~------~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSA------AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCc------cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 457777776 58876 23466664331 11244788899999988532 4555555322111 124578
Q ss_pred EEeccCCCCH
Q 004564 103 VTEMFTSGTL 112 (745)
Q Consensus 103 V~E~~~gGsL 112 (745)
+|+++.|.++
T Consensus 72 l~~~i~G~~l 81 (235)
T cd05155 72 VYRWLEGETA 81 (235)
T ss_pred EEEeecCCCC
Confidence 9999998776
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0021 Score=78.89 Aligned_cols=147 Identities=18% Similarity=0.296 Sum_probs=89.5
Q ss_pred EEecccCceEEEEEEEcCCC--eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCc--ceEeEEEEecC-CCeEE
Q 004564 28 EILGKGASKTVYRAFDEYEG--IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNI--MKFYTSWVDTA-NRNIN 101 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg--~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~-HpNI--Vk~~~sfvd~~-~~~iy 101 (745)
+.|+.|.+..+|+......+ ..+++|+...... ......+.+|+.+|+.|. |++| +++|..+.+.. ....|
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~---~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL---LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc---CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 66899999999998654332 4566665432221 112346778999999995 6665 77776543321 24678
Q ss_pred EEEeccCCCCHHH--------------------HHHH-cC------CC---------CHHHHHHHHHHH-----------
Q 004564 102 FVTEMFTSGTLRQ--------------------YRLK-HK------RV---------NIRAVKLWCRQI----------- 134 (745)
Q Consensus 102 LV~E~~~gGsL~~--------------------~l~k-~~------~L---------~e~~i~~ia~QI----------- 134 (745)
+||||+.|..+.+ .+.+ |. .+ ....+..|..|.
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 9999998864321 1110 10 01 123444443332
Q ss_pred ----HHHHHHhhhCCC---------CEEeecCCCcceeecCCCCc-EEEcCcchhhh
Q 004564 135 ----LRGLLYLHSHDP---------PVIHRDLKCDNIFVNGNQGE-VKIGDLGLAAI 177 (745)
Q Consensus 135 ----L~gL~yLHs~gp---------~IIHRDLKpdNILld~~~g~-VKL~DFGlA~~ 177 (745)
...+.+|..+-| .+||+|++++|||++..++. +-|.||.+++.
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 223566644322 39999999999999754444 47899999865
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00079 Score=67.75 Aligned_cols=130 Identities=22% Similarity=0.281 Sum_probs=88.7
Q ss_pred eEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcc-eEeEEEEecCCCeEEEE
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIM-KFYTSWVDTANRNINFV 103 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIV-k~~~sfvd~~~~~iyLV 103 (745)
+..+.|++|.+|.||++ ...|.++|+|+-+-. .-...+..|+++|..+.-.++. ++|.+ +..++.
T Consensus 25 ~v~~~L~KG~~s~Vyl~--~~~~~~~a~Kvrr~d------s~r~~l~kEakiLeil~g~~~~p~vy~y------g~~~i~ 90 (201)
T COG2112 25 RVEKELAKGTTSVVYLG--EWRGGEVALKVRRRD------SPRRNLEKEAKILEILAGEGVTPEVYFY------GEDFIR 90 (201)
T ss_pred hhhhhhhcccccEEEEe--eccCceEEEEEecCC------cchhhHHHHHHHHHHhhhcCCCceEEEe------chhhhh
Confidence 45567999999999999 567889999965522 3445688899999999876665 46653 233556
Q ss_pred EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCC-C-cceeecCCCCcEEEcCcchhhhhh
Q 004564 104 TEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLK-C-DNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 104 ~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLK-p-dNILld~~~g~VKL~DFGlA~~l~ 179 (745)
|||..|-.|....... +.+.+. .++..---|-..| |-|..|. | .||+++ ++.+.|+||..|+...
T Consensus 91 me~i~G~~L~~~~~~~---~rk~l~----~vlE~a~~LD~~G--I~H~El~~~~k~vlv~--~~~~~iIDFd~At~k~ 157 (201)
T COG2112 91 MEYIDGRPLGKLEIGG---DRKHLL----RVLEKAYKLDRLG--IEHGELSRPWKNVLVN--DRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhcCcchhhhhhcc---cHHHHH----HHHHHHHHHHHhc--cchhhhcCCceeEEec--CCcEEEEEccchhhcc
Confidence 9999998887764321 233333 3333333345555 8888876 3 366664 4589999999998543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0024 Score=69.11 Aligned_cols=77 Identities=10% Similarity=0.099 Sum_probs=53.1
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC---CCcceEeEEEEec-CCCeEEEE
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH---KNIMKFYTSWVDT-ANRNINFV 103 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~H---pNIVk~~~sfvd~-~~~~iyLV 103 (745)
+-||.|..+.||+..+. ++ .+.+|..+.. .....+..|...|+.|.- ..++++++.+.+. ..+..++|
T Consensus 20 ~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~------~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 20 ECISEQPYAALWALYDS-QG-NPMPLMARSF------STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eecCCccceeEEEEEcC-CC-CEEEEEeccc------ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 56999999999998432 23 4666764310 112467889999998853 4688888765432 23568999
Q ss_pred EeccCCCCH
Q 004564 104 TEMFTSGTL 112 (745)
Q Consensus 104 ~E~~~gGsL 112 (745)
||++.|+++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0028 Score=65.13 Aligned_cols=133 Identities=23% Similarity=0.344 Sum_probs=90.7
Q ss_pred CCceeeEeEEecccCc-eEEEEEEEcCCCeEEEEEEEeecccCCC----------H-------HHHHHHHHHHHHHHhC-
Q 004564 20 TGRYGRYNEILGKGAS-KTVYRAFDEYEGIEVAWNQVKLYDFLQS----------P-------EDLERLYCEIHLLKTL- 80 (745)
Q Consensus 20 ~gRY~rl~e~LG~Gaf-gtVy~A~d~~tg~~VAiK~ik~~~~~~~----------~-------~~~e~l~~Ei~iLk~L- 80 (745)
-+.-..+.+.||.|.- |.||++ ...|..+|+|+.+.-..... . ...+.|..|.+...+|
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv--~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk 112 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKV--EIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK 112 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEE--EECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence 3355588899999999 999999 56788999998443211111 0 2344678888776666
Q ss_pred --CCCCc--ceEeEEEEecC----------------CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHH
Q 004564 81 --KHKNI--MKFYTSWVDTA----------------NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLY 140 (745)
Q Consensus 81 --~HpNI--Vk~~~sfvd~~----------------~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~y 140 (745)
.+.++ |+.|++..-+. .....||.||..... .+... -+.+|++-|..
T Consensus 113 e~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~ 179 (207)
T PF13095_consen 113 EAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKI 179 (207)
T ss_pred hccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHH
Confidence 45566 89999764321 112346777766543 22333 35678888889
Q ss_pred hhhCCCCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 141 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 141 LHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
+|..| |+-+|+++.|.. +| ||+|||.+
T Consensus 180 ~~k~g--I~~~Dv~~~ny~-~G-----~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG--IVPRDVKPRNYR-GG-----KLVDFSSS 206 (207)
T ss_pred HHHCC--eeeccCcccccc-CC-----EEEecccC
Confidence 99988 999999999986 31 78999864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00084 Score=77.90 Aligned_cols=147 Identities=17% Similarity=0.155 Sum_probs=92.3
Q ss_pred eeeEe-EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCC----------------------------HHHHHHHHHH
Q 004564 23 YGRYN-EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS----------------------------PEDLERLYCE 73 (745)
Q Consensus 23 Y~rl~-e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~----------------------------~~~~e~l~~E 73 (745)
|..+. +-||.-+.|.||+|..+. |+.||+|+-+.. .... .+..+.+..|
T Consensus 161 f~~f~~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~E 238 (538)
T KOG1235|consen 161 FSEFDEEPIAAASLAQVHRARLKN-GEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQE 238 (538)
T ss_pred HHhcCcchhhhcchhheEEEEecC-CCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhh
Confidence 44555 569999999999998765 999999965431 1100 0112223333
Q ss_pred HH----------HHHhCCCCC------cceEeEEEEecCCCeEEEEEeccCCCCHHH--HHHHcCCCCHHHHHHHHHHHH
Q 004564 74 IH----------LLKTLKHKN------IMKFYTSWVDTANRNINFVTEMFTSGTLRQ--YRLKHKRVNIRAVKLWCRQIL 135 (745)
Q Consensus 74 i~----------iLk~L~HpN------IVk~~~sfvd~~~~~iyLV~E~~~gGsL~~--~l~k~~~L~e~~i~~ia~QIL 135 (745)
++ ..+.++|-+ |+++|-.+ -..-.|+|||+.|..+.+ ++.+++ ++...+...+.+..
T Consensus 239 LDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~ 313 (538)
T KOG1235|consen 239 LDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAY 313 (538)
T ss_pred cchHHHHHhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHH
Confidence 22 223334555 77777543 134578999999987754 455544 55554444444433
Q ss_pred HHHHHhhhCCCCEEeecCCCcceeecC---CCCcEEEcCcchhhhhhc
Q 004564 136 RGLLYLHSHDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 136 ~gL~yLHs~gp~IIHRDLKpdNILld~---~~g~VKL~DFGlA~~l~~ 180 (745)
.-+-+. +| ++|.|=.|.||++.. .++.+.|.|||+...+..
T Consensus 314 ~~qIf~--~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 314 LEQIFK--TG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHh--cC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 322222 34 999999999999983 467899999999866543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0031 Score=64.65 Aligned_cols=136 Identities=20% Similarity=0.298 Sum_probs=86.8
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccC------------CCHHHHHHHHHHHHHHHhCC------CCCcceEe
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL------------QSPEDLERLYCEIHLLKTLK------HKNIMKFY 89 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~------------~~~~~~e~l~~Ei~iLk~L~------HpNIVk~~ 89 (745)
..||+|+.-.||.- +.+ ....||+++..... ..........+|+.-...+. +..|.++|
T Consensus 7 ~~i~~G~~R~cy~H--P~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--CCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46999999999954 433 34567877644300 00122455666666666555 78899999
Q ss_pred EEEEecCCCeEEEEEeccCC------CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCC
Q 004564 90 TSWVDTANRNINFVTEMFTS------GTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGN 163 (745)
Q Consensus 90 ~sfvd~~~~~iyLV~E~~~g------GsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~ 163 (745)
+... ++..+-+|+|.+.. -||.+++ +++.++. .++..+.++ ..||-.+. |+.+||+|.||++...
T Consensus 84 G~ve--T~~G~Glv~e~I~d~dG~~s~TL~~~l-~~~~~~~-~~~~~L~~f---~~~l~~~~--Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 84 GFVE--TNLGLGLVVELIRDADGNISPTLEDYL-KEGGLTE-ELRQALDEF---KRYLLDHH--IVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEEe--cCCceEEEEEEEECCCCCcCccHHHHH-HcCCccH-HHHHHHHHH---HHHHHHcC--CeecCCCcccEEEEec
Confidence 9643 35567778887653 3688887 4455766 444444444 45666666 9999999999999432
Q ss_pred C--C-cEEEcC-cchh
Q 004564 164 Q--G-EVKIGD-LGLA 175 (745)
Q Consensus 164 ~--g-~VKL~D-FGlA 175 (745)
. . .+.|+| ||..
T Consensus 155 ~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 155 DSGEFRLVLIDGLGEK 170 (199)
T ss_pred CCCceEEEEEeCCCCc
Confidence 2 2 466766 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0026 Score=65.32 Aligned_cols=74 Identities=15% Similarity=0.136 Sum_probs=46.7
Q ss_pred EEecccCceEEEEEEEcC-CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC-CCcceEeEEEEecCCCeEEEEEe
Q 004564 28 EILGKGASKTVYRAFDEY-EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH-KNIMKFYTSWVDTANRNINFVTE 105 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~-tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~H-pNIVk~~~sfvd~~~~~iyLV~E 105 (745)
+.|..|-...+|++.... .+..|++|+..... ...-...+|+.+++.+.. .-.++++..+ . . .+|||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-----~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~--~--~~l~e 72 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-----ELIIDRERELRIHKLLSKHGLAPKLYATF--Q--N--GLIYE 72 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-----cceecHHHHHHHHHHHHhCCCCCeEEEEe--C--C--cEEEE
Confidence 567888889999985443 35678888654211 111123468888888843 3345666532 1 1 37999
Q ss_pred ccCCCCH
Q 004564 106 MFTSGTL 112 (745)
Q Consensus 106 ~~~gGsL 112 (745)
|+.|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0018 Score=65.69 Aligned_cols=101 Identities=23% Similarity=0.128 Sum_probs=78.3
Q ss_pred HHHHHHHhCCC-CCcceEeEEEEecCCCeEEEEEeccCCCCHHH---HHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCC-
Q 004564 72 CEIHLLKTLKH-KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ---YRLKHKRVNIRAVKLWCRQILRGLLYLHSHDP- 146 (745)
Q Consensus 72 ~Ei~iLk~L~H-pNIVk~~~sfvd~~~~~iyLV~E~~~gGsL~~---~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp- 146 (745)
.|.-+|+.|.+ +++++++|++ + -++++||...+++.. .+..-...++.....++.+++..+.+|+....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C----G--~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC----G--RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC----C--CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 48888999976 6999999976 2 255899998775532 11222357899999999999999999987311
Q ss_pred CEEeecCCCcceeecCCCCcEEEcCcchhhhhh
Q 004564 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 147 ~IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~ 179 (745)
.+.-.|++++|+-++ ++|++|++|...+....
T Consensus 82 ~~~lcDv~~~nfgv~-~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVN-DDGRLKLIDLDDVFVED 113 (188)
T ss_pred cEEEeecchHHeEEe-CCCcEEEEechhcchhH
Confidence 288899999999998 66899999999875543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.012 Score=66.49 Aligned_cols=80 Identities=26% Similarity=0.263 Sum_probs=56.5
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccC--CC-HHHHHHHHHHHHHHHhCC---CCCcceEeEEEEecCCCeEE
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL--QS-PEDLERLYCEIHLLKTLK---HKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~--~~-~~~~e~l~~Ei~iLk~L~---HpNIVk~~~sfvd~~~~~iy 101 (745)
+.||.|.+..||++.+...++.|++|+-...... .. +-..++...|...|+.+. -..++++|.+ + ...-+
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D--~~~~~ 107 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D--EELAV 107 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C--CCCCE
Confidence 5689999999999988654468999985422111 11 235678888988888873 3568888884 3 35578
Q ss_pred EEEeccCCCC
Q 004564 102 FVTEMFTSGT 111 (745)
Q Consensus 102 LV~E~~~gGs 111 (745)
+|||++.+..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998744
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.011 Score=62.97 Aligned_cols=139 Identities=17% Similarity=0.164 Sum_probs=79.0
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC--CcceEeEE----EEecCCCeEE
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHK--NIMKFYTS----WVDTANRNIN 101 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~Hp--NIVk~~~s----fvd~~~~~iy 101 (745)
+.|..|....+|+... .+..+++|+... ...+.+..|+.++..|.+. .+++.+.. ++....+..+
T Consensus 20 ~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 20 EGISAGIENTNYFVTT--DSGRYVLTLFEK-------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred ecccCccccceEEEEe--CCCcEEEEEcCC-------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 4577888889998843 345688887542 1234567788888888433 35555442 1112235678
Q ss_pred EEEeccCCCCHHH-----H------HHH-c---CCCC--------HHHHH------------HHHHHHHHHHHHhhh---
Q 004564 102 FVTEMFTSGTLRQ-----Y------RLK-H---KRVN--------IRAVK------------LWCRQILRGLLYLHS--- 143 (745)
Q Consensus 102 LV~E~~~gGsL~~-----~------l~k-~---~~L~--------e~~i~------------~ia~QIL~gL~yLHs--- 143 (745)
+|++++.|..+.. + +.+ | ..+. ..-.. .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999876421 0 000 0 0000 00000 011112233444432
Q ss_pred --CCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 144 --HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 144 --~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
....++|+|+.|.||++++ ++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~-~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDG-DELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeC-CceEEEeehhhhc
Confidence 1124999999999999984 4556899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.0086 Score=62.76 Aligned_cols=134 Identities=19% Similarity=0.202 Sum_probs=75.6
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCc-ceEeEEEEecCCCeEEEEEeccC
Q 004564 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNI-MKFYTSWVDTANRNINFVTEMFT 108 (745)
Q Consensus 30 LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNI-Vk~~~sfvd~~~~~iyLV~E~~~ 108 (745)
+..|-...+|+.. ..+..+++|+..... ....-....|..+++.+....+ ++++.. + . -++|+||+.
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~----~~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~--~--~~~v~e~i~ 71 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVC----KALGVDRQREYQILQALSALGLAPKPILV--N--E--HWLLVEWLE 71 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCccc----ccccCcHHHHHHHHHHHHhcCCCCceEEE--e--C--CEEEEEecc
Confidence 5678888999885 456778887543211 1110124678899998864333 455543 2 1 268999999
Q ss_pred CCCHHH--------------HHHH-cC------CCCH-HHHHHHHHHH---------HHHHHHhhhC------CCCEEee
Q 004564 109 SGTLRQ--------------YRLK-HK------RVNI-RAVKLWCRQI---------LRGLLYLHSH------DPPVIHR 151 (745)
Q Consensus 109 gGsL~~--------------~l~k-~~------~L~e-~~i~~ia~QI---------L~gL~yLHs~------gp~IIHR 151 (745)
|..+.. .+.+ |. +++. ..+..+..++ ...+..+-.. .+.++|+
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 876531 1111 10 1111 2222332222 1112222111 2348999
Q ss_pred cCCCcceeecCCCCcEEEcCcchhhh
Q 004564 152 DLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 152 DLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
|+.|.||++++ ++ +.|+||..|..
T Consensus 152 Dl~~~Nil~~~-~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 152 DVHAYNLVVTP-QG-LKLIDWEYASD 175 (256)
T ss_pred CCCcCcEEEeC-CC-CEEEeccccCc
Confidence 99999999984 34 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.0072 Score=69.31 Aligned_cols=162 Identities=20% Similarity=0.227 Sum_probs=101.9
Q ss_pred HHHHHHHHHHHhCCCCCcceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 004564 68 ERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147 (745)
Q Consensus 68 e~l~~Ei~iLk~L~HpNIVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~ 147 (745)
.++.....+++.+.|+|...++++-. +...+..+|+|+++ .+|.+++..+. +-... ++ .++
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r-~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s-------~~-------~~~-- 87 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSR-GKHERVIVVMEHYT-MSLEDILKTGN-LKDES-------LL-------AHG-- 87 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeec-CccceEEEEehhhc-cchHHHHHhcc-cchhh-------hc-------ccc--
Confidence 34566778999999999999998543 33456889999984 58999876655 22111 11 222
Q ss_pred EEeecCCCcceeecCCCCcEEEcCcchhhhhhccCCCcccCCCCcCChhhhhhccCccccchhhhhHHHHHhhcCCCCCC
Q 004564 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSE 227 (745)
Q Consensus 148 IIHRDLKpdNILld~~~g~VKL~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGvILyELlTG~~Pf~~ 227 (745)
+.|- +.++++| -++ ... ...+| +++||||+|.++.++.-|...+..
T Consensus 88 ~~~~-------------~~~~~td-~~~---t~~--~~~~~---------------pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 88 VLHL-------------NIIYITD-HFL---TKY--PSPIG---------------PKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred ccee-------------hhhhccc-ccc---ccC--CCCCC---------------cchhhhhHHHHHHHHHHhhHHHHH
Confidence 3332 2344444 111 100 11112 399999999999999999877765
Q ss_pred CCCHHHHHHHHHcCCCCCC---------cccCCCHHHHHHHHHHhh-CccCCCCHHHHhcCCCCC
Q 004564 228 CTHPAQIYKKVVSGKKPDS---------LYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 228 ~~~~~~i~kkv~~g~~p~~---------l~~~~s~el~d~I~kcL~-dPskRpSa~ELL~hPff~ 282 (745)
-...+++.....-+..+.. +....+....++..+|+- .|+.||...++++++-|.
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ 198 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFT 198 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHH
Confidence 4433333222211222211 122346667788889988 899999999999999885
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.013 Score=62.90 Aligned_cols=74 Identities=23% Similarity=0.182 Sum_probs=46.2
Q ss_pred EEecccCceEEEEEEEcC------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC-cceEeEEEEecCCCeE
Q 004564 28 EILGKGASKTVYRAFDEY------EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN-IMKFYTSWVDTANRNI 100 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~------tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpN-IVk~~~sfvd~~~~~i 100 (745)
+.|..|-...||+..... .+..+++|+..... ........|+.+++.+.... .++++.++. +
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~---~--- 72 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-----ELLIDRERELVVFARLSERNLGPKLYGIFP---N--- 72 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-----cceechHHHHHHHHHHHhCCCCCceEEEeC---C---
Confidence 456777788999886432 25788888754221 22234567888888885333 446666442 1
Q ss_pred EEEEeccCCCCH
Q 004564 101 NFVTEMFTSGTL 112 (745)
Q Consensus 101 yLV~E~~~gGsL 112 (745)
.+|++|+.|.++
T Consensus 73 ~~v~e~i~G~~l 84 (302)
T cd05156 73 GRIEEFIPSRTL 84 (302)
T ss_pred CchhheeCCCcC
Confidence 247899888765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.033 Score=62.10 Aligned_cols=87 Identities=17% Similarity=0.157 Sum_probs=58.1
Q ss_pred EecccCceEEEEEEEcCCCeEEEEEEEeecccC---CCHHHHHHHHHHHHHHHhCC--CC-CcceEeEEEEecCCCeEEE
Q 004564 29 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL---QSPEDLERLYCEIHLLKTLK--HK-NIMKFYTSWVDTANRNINF 102 (745)
Q Consensus 29 ~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~---~~~~~~e~l~~Ei~iLk~L~--Hp-NIVk~~~sfvd~~~~~iyL 102 (745)
.||-|....||++.+...+..|+||+-...-.. .-+-..+|..-|...|+.+. -| .++++|. ++ .....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D--~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FD--TEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Ec--ccccee
Confidence 379999999999998654478999986432211 11445677778888888773 23 5777887 34 456678
Q ss_pred EEeccCCC-CHHHHHHHc
Q 004564 103 VTEMFTSG-TLRQYRLKH 119 (745)
Q Consensus 103 V~E~~~gG-sL~~~l~k~ 119 (745)
|||++... .|+..+.++
T Consensus 78 vMEdL~~~~ilR~~Li~g 95 (370)
T TIGR01767 78 VMEDLSHHKIARKGLIEG 95 (370)
T ss_pred hHhhCccchHHHHHHHcC
Confidence 99998553 344554443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.039 Score=61.45 Aligned_cols=146 Identities=21% Similarity=0.206 Sum_probs=97.7
Q ss_pred eeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecc--------------------cCCCHHH-HH-HHHHHHHHHHhCC
Q 004564 24 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--------------------FLQSPED-LE-RLYCEIHLLKTLK 81 (745)
Q Consensus 24 ~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~--------------------~~~~~~~-~e-~l~~Ei~iLk~L~ 81 (745)
.-+..-|..|--+.||.|. ...|..+|||+++-.- ...++.. +. -..+|++-|++|.
T Consensus 146 ~~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~ 224 (520)
T KOG2270|consen 146 VEINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN 224 (520)
T ss_pred eecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence 3444558889999999986 4578889999987421 1111222 22 2456888899887
Q ss_pred CCCcceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeec
Q 004564 82 HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVN 161 (745)
Q Consensus 82 HpNIVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld 161 (745)
...|+----..+ +.-.|||+++.......=..+.-.++...+..+-.|++.-+.-|-+. .++||.||.--|+|+.
T Consensus 225 ~aGIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~-c~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 225 NAGIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQK-CRLVHADLSEFNLLYH 299 (520)
T ss_pred hcCCCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHH-hceeccchhhhhheEE
Confidence 666543222222 24578999986433222233445677777888888888877777543 2499999999999995
Q ss_pred CCCCcEEEcCcchhhh
Q 004564 162 GNQGEVKIGDLGLAAI 177 (745)
Q Consensus 162 ~~~g~VKL~DFGlA~~ 177 (745)
+|.+.|+|.+-+.-
T Consensus 300 --dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 --DGKLYIIDVSQSVE 313 (520)
T ss_pred --CCEEEEEEcccccc
Confidence 58999999987643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.11 Score=56.17 Aligned_cols=75 Identities=8% Similarity=-0.001 Sum_probs=42.8
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC--CCcceEeEE----EEecCCCeEE
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH--KNIMKFYTS----WVDTANRNIN 101 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~H--pNIVk~~~s----fvd~~~~~iy 101 (745)
+.|+.|....+|+.... +..+++|++. . ... +.+..|+.+++.|.. -.+++.+.. ++....+..+
T Consensus 28 ~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~---~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 28 KGIAEGIENSNFFLTTT--QGEYVLTLFE-R---LTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred chhccccccceEEEEeC--CCcEEEEEec-c---CCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 34677888899988543 3368888764 1 112 234446666666632 124444421 1111245678
Q ss_pred EEEeccCCCC
Q 004564 102 FVTEMFTSGT 111 (745)
Q Consensus 102 LV~E~~~gGs 111 (745)
+++++++|..
T Consensus 99 ~l~~~l~G~~ 108 (319)
T PRK05231 99 AIVTFLEGKW 108 (319)
T ss_pred EEEEecCCCC
Confidence 9999999874
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.0061 Score=66.60 Aligned_cols=136 Identities=21% Similarity=0.229 Sum_probs=91.6
Q ss_pred eeeEeEEecccCceEEEEEEEcCCCeEEEEEEEeecc-----cCCC-----------HHHHHH--HHHHHHHHHhCCC--
Q 004564 23 YGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-----FLQS-----------PEDLER--LYCEIHLLKTLKH-- 82 (745)
Q Consensus 23 Y~rl~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~-----~~~~-----------~~~~e~--l~~Ei~iLk~L~H-- 82 (745)
.+.++..||-|--+.||.+-+. .|.+.++|+-++.. .... --.+.+ ..+|...|+.|.-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3466788999999999999765 57788888654321 0001 111233 4578999999843
Q ss_pred CCcceEeEEEEecCCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecC
Q 004564 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG 162 (745)
Q Consensus 83 pNIVk~~~sfvd~~~~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~ 162 (745)
=-|++-++ ....++|||++.|-.|.+.. ...+..+ +...+..-+.-|-.+| +||+|+.--||+|.
T Consensus 172 fpVPkpiD------~~RH~Vvmelv~g~Pl~~v~---~v~d~~~---ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~- 236 (465)
T KOG2268|consen 172 FPVPKPID------HNRHCVVMELVDGYPLRQVR---HVEDPPT---LYDDLMGLIVRLANHG--LIHGDFNEFNIMVK- 236 (465)
T ss_pred CCCCCccc------ccceeeHHHhhcccceeeee---ecCChHH---HHHHHHHHHHHHHHcC--ceecccchheeEEe-
Confidence 23555555 34668899999998886542 1223333 3344444455567778 99999999999998
Q ss_pred CCCcEEEcCcch
Q 004564 163 NQGEVKIGDLGL 174 (745)
Q Consensus 163 ~~g~VKL~DFGl 174 (745)
+++.++++||--
T Consensus 237 dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 237 DDDKIVVIDFPQ 248 (465)
T ss_pred cCCCEEEeechH
Confidence 568999999954
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.05 Score=60.19 Aligned_cols=140 Identities=16% Similarity=0.159 Sum_probs=81.1
Q ss_pred eEeEEecccCceEEEEEEEcC----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCc-ceEeEEEEecCCCe
Q 004564 25 RYNEILGKGASKTVYRAFDEY----EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNI-MKFYTSWVDTANRN 99 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~----tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNI-Vk~~~sfvd~~~~~ 99 (745)
.+ +.|-.|-.-.+|++.... .+..|++|+.... ....+++ ..|+.+++.+..-++ +++++.+. +.
T Consensus 40 ~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~----t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~---~g- 109 (344)
T PLN02236 40 QV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEG----VELFFDR-DDEIRTFECMSRHGQGPRLLGRFP---NG- 109 (344)
T ss_pred EE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCC----CCeeech-HHHHHHHHHHHHcCCCCceEEEEC---Cc-
Confidence 44 345568888999985322 3467888865421 2233344 679999998854443 35666542 12
Q ss_pred EEEEEeccCCCCHHHH--------------HHH-cC--------CCCHHHHHHHHHHHHH-----------------HHH
Q 004564 100 INFVTEMFTSGTLRQY--------------RLK-HK--------RVNIRAVKLWCRQILR-----------------GLL 139 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~--------------l~k-~~--------~L~e~~i~~ia~QIL~-----------------gL~ 139 (745)
.|++|+.+.+|... +.+ |. ....+.+..|+.++.. .+.
T Consensus 110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~ 187 (344)
T PLN02236 110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN 187 (344)
T ss_pred --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence 47888877665311 111 10 1113444455433321 111
Q ss_pred H----hhh--CCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 140 Y----LHS--HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 140 y----LHs--~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
. +.. ....++|+||++.|||++..++.+.|+||..|.
T Consensus 188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 221 123489999999999998555789999998874
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.077 Score=56.91 Aligned_cols=31 Identities=19% Similarity=0.342 Sum_probs=25.1
Q ss_pred CCEEeecCCCcceeecCCCCc-EEEcCcchhhh
Q 004564 146 PPVIHRDLKCDNIFVNGNQGE-VKIGDLGLAAI 177 (745)
Q Consensus 146 p~IIHRDLKpdNILld~~~g~-VKL~DFGlA~~ 177 (745)
+.++|+|++|.|||++.+ +. +-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~-~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDED-ARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCC-CCEEEEECcHhccc
Confidence 348999999999999843 44 56999998854
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.0062 Score=70.68 Aligned_cols=69 Identities=25% Similarity=0.377 Sum_probs=58.0
Q ss_pred ceEEEEEEecCCC----CcccccccCcCCCCCHHHHHHHHHHccCCCcccHHHHHHHHHHHHHHhCCCCCCCC
Q 004564 375 GIFLRLRIADKEG----RIRNIYFPFDVETDTALSVATEMVAELDITDQDVTKIADMIDGEIASLVPEWRPGP 443 (745)
Q Consensus 375 ~i~L~LRi~d~~g----~~~~I~F~F~~~~DTa~sVA~EMV~~l~i~~~dv~~IA~~Id~~i~~l~p~w~~~~ 443 (745)
.+.|.+|+.|..+ ..+.|.|.|+++.|++.+||+|||+++.+++.|-..+|++|...+.++--.-....
T Consensus 318 ~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~~ 390 (632)
T KOG0584|consen 318 ALSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRNDRQ 390 (632)
T ss_pred cccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhccc
Confidence 3557777777652 33689999999999999999999999999999999999999999999876554444
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.057 Score=58.25 Aligned_cols=140 Identities=19% Similarity=0.165 Sum_probs=76.6
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC--CcceEeEE----EEecCCCeEE
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHK--NIMKFYTS----WVDTANRNIN 101 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~Hp--NIVk~~~s----fvd~~~~~iy 101 (745)
+.|+.|....+|++.. .+| .+++|+.... .. .+.+..|+.++..|... .+++++.. ++....+..+
T Consensus 28 ~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~---~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 28 KGIAEGVENSNYLLTT-DVG-RYILTLYEKR---VK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred cccCCccccceEEEEe-CCC-cEEEEEecCC---CC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 4577787789998753 233 5778865421 11 23455677777777422 24455442 1111245678
Q ss_pred EEEeccCCCCHH-----HH------HHH-c---CCC--------CHHHH-----H----------HHHHHHHHHHHHhhh
Q 004564 102 FVTEMFTSGTLR-----QY------RLK-H---KRV--------NIRAV-----K----------LWCRQILRGLLYLHS 143 (745)
Q Consensus 102 LV~E~~~gGsL~-----~~------l~k-~---~~L--------~e~~i-----~----------~ia~QIL~gL~yLHs 143 (745)
++++|++|..+. .+ +.+ | ..+ ..... . .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999885431 11 000 0 011 00100 0 001112234444432
Q ss_pred -----CCCCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 144 -----HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 144 -----~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
....++|+|+.+.||++++ ++.+.|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~-~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDG-DSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEEC-CceEEEeeccccc
Confidence 2245999999999999984 4556899999864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.2 Score=56.99 Aligned_cols=76 Identities=16% Similarity=0.097 Sum_probs=52.0
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCH---HHHHHHHHHHHHHHhCC---CCCcceEeEEEEecCCCeEE
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSP---EDLERLYCEIHLLKTLK---HKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~---~~~e~l~~Ei~iLk~L~---HpNIVk~~~sfvd~~~~~iy 101 (745)
+.||.|....||+..+. +..|++|+-......... -...+...|+..|+.+. -..++++|.+. ...-+
T Consensus 38 ~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d----ed~~v 111 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD----RTMAL 111 (418)
T ss_pred EEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC----CCCCE
Confidence 56899999999998763 456888875422221111 24566677788887764 25788899843 24567
Q ss_pred EEEeccCC
Q 004564 102 FVTEMFTS 109 (745)
Q Consensus 102 LV~E~~~g 109 (745)
++||++.+
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.11 Score=58.63 Aligned_cols=89 Identities=22% Similarity=0.231 Sum_probs=60.3
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeeccc-C-CCHHHHHHHHHHHHHHHhCC--CC-CcceEeEEEEecCCCeEEE
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF-L-QSPEDLERLYCEIHLLKTLK--HK-NIMKFYTSWVDTANRNINF 102 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~-~-~~~~~~e~l~~Ei~iLk~L~--Hp-NIVk~~~sfvd~~~~~iyL 102 (745)
+.||-|.-..||++.+...+..|+||+-...-. . .-+-..+|..-|...|+.+. -| .++++|. .+ .....+
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D--~e~~~~ 110 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FD--SVMNCC 110 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--EC--cHHhhH
Confidence 558999999999998854467899998642211 1 11345778888999888773 23 5778887 34 456678
Q ss_pred EEeccCCC-CHHHHHHHcC
Q 004564 103 VTEMFTSG-TLRQYRLKHK 120 (745)
Q Consensus 103 V~E~~~gG-sL~~~l~k~~ 120 (745)
|||+++.. .|++.+.++.
T Consensus 111 vMEdL~~~~ilR~~Li~G~ 129 (409)
T PRK12396 111 VMEDLSDHTILRTALINHE 129 (409)
T ss_pred HHHhCcccHHHHHHHHcCC
Confidence 99998643 3555555443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.89 E-value=0.23 Score=54.63 Aligned_cols=144 Identities=17% Similarity=0.206 Sum_probs=81.1
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC--CCcceEeEEEEecCCCeEEEEEe
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH--KNIMKFYTSWVDTANRNINFVTE 105 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~H--pNIVk~~~sfvd~~~~~iyLV~E 105 (745)
+.+-.|..-.+|...+. ++++++. . ...........+..+|+.+++.+.- .-+.+.++.+.+......++||+
T Consensus 31 ~~~~~G~sn~t~~~~~~--~~~~vlR-~--P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 31 EEISGGWSNDTFRLGDT--GQKYVLR-K--PPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred eeccCCcccceEEEecC--CceEEEe-c--CCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 33334444445555443 7777766 2 2122334556677788888888753 23344455443322347799999
Q ss_pred ccCCCCH---------H-HHHH--------H-cC-------------CCCHHHHHHHHHHH--------------HHHHH
Q 004564 106 MFTSGTL---------R-QYRL--------K-HK-------------RVNIRAVKLWCRQI--------------LRGLL 139 (745)
Q Consensus 106 ~~~gGsL---------~-~~l~--------k-~~-------------~L~e~~i~~ia~QI--------------L~gL~ 139 (745)
+..|..+ . ++.. . |. ......+..|..+. ..-..
T Consensus 106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 9998432 2 2222 0 00 01122333333333 22244
Q ss_pred HhhhCCC------CEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 140 YLHSHDP------PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 140 yLHs~gp------~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
||+.+-| .++|+|+++.||+++.. +-+=+.||+++..
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~-~~~gVlDwe~~~l 228 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPG-RPTGVLDWELATL 228 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCC-CeeEEEecccccc
Confidence 5555433 49999999999999854 4588999999864
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.16 Score=55.71 Aligned_cols=140 Identities=15% Similarity=0.169 Sum_probs=78.3
Q ss_pred eEeEEecccCceEEEEEEEcCC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCc-ceEeEEEEecCCCeE
Q 004564 25 RYNEILGKGASKTVYRAFDEYE---GIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNI-MKFYTSWVDTANRNI 100 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~t---g~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNI-Vk~~~sfvd~~~~~i 100 (745)
.+ +.|..|-.-.+|+...... +..|.+|+.-.. ....++ -.+|+.+++.+..-++ ++++.++ . .+
T Consensus 18 ~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~----t~~~Id-R~~E~~il~~l~~~gl~P~~l~~~--~-~G-- 86 (330)
T PLN02421 18 SV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPN----TDYVID-RERELQAIKYLSAAGFGAKLLGVF--G-NG-- 86 (330)
T ss_pred EE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCC----cCeEec-hHHHHHHHHHHHhcCCCCceeEEe--C-Cc--
Confidence 44 4455588888998854322 337887765421 112222 3568888888865444 4566544 2 12
Q ss_pred EEEEeccCCCCHHH--------------HHHH-cC-C------C-CHHHHHHHHHHHH----------------------
Q 004564 101 NFVTEMFTSGTLRQ--------------YRLK-HK-R------V-NIRAVKLWCRQIL---------------------- 135 (745)
Q Consensus 101 yLV~E~~~gGsL~~--------------~l~k-~~-~------L-~e~~i~~ia~QIL---------------------- 135 (745)
+|.+|+.+.+|.. .+.+ |. . . ....+..|..++-
T Consensus 87 -~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~ 165 (330)
T PLN02421 87 -MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELR 165 (330)
T ss_pred -EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHH
Confidence 4888887766421 1111 11 1 1 1233333433321
Q ss_pred ---HHHH-HhhhCC--CCEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 136 ---RGLL-YLHSHD--PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 136 ---~gL~-yLHs~g--p~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
..+. ++.+.+ .-+.|.||.+.|||++.+++.++++||..|.
T Consensus 166 ~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 166 DEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1111 121111 2379999999999997556789999999874
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.33 E-value=0.32 Score=52.58 Aligned_cols=29 Identities=10% Similarity=0.121 Sum_probs=25.1
Q ss_pred CEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 147 ~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
+++|+|+.++|||+++ ++.+.|+||..++
T Consensus 197 ~lcHgD~~~~Nvl~~~-~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDE-TRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcC-CCCEEEEEhhhcc
Confidence 4999999999999984 4688999998874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=92.84 E-value=0.67 Score=50.27 Aligned_cols=72 Identities=17% Similarity=0.088 Sum_probs=43.8
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC---CCCcceEeEEEEecCCCeEEEEE
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK---HKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~---HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
+.|+.|....+|+.. .++..+.+|+-. ......+..|..-|+.|. --.+++.+..... ...-+|||
T Consensus 23 ~~v~GG~i~~a~~~~--~~~~~~FvK~~~-------~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~--~~~~fLll 91 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD--TDGGSYFVKVNS-------ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY--DDDAFLLL 91 (288)
T ss_dssp EEE--SSSSEEEEEE--TTS-EEEEEEEE-------GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE---SSCCEEEE
T ss_pred EecCCCChhheEEEE--CCCccEEEEecC-------hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee--cCCceEEE
Confidence 568989999999985 678889888755 122346778888888883 3457788875543 34458999
Q ss_pred eccCCC
Q 004564 105 EMFTSG 110 (745)
Q Consensus 105 E~~~gG 110 (745)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.16 E-value=0.39 Score=54.35 Aligned_cols=59 Identities=19% Similarity=0.197 Sum_probs=40.2
Q ss_pred EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHH-hhhCCCCEEeecCCCcceeec
Q 004564 100 INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLY-LHSHDPPVIHRDLKCDNIFVN 161 (745)
Q Consensus 100 iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~y-LHs~gp~IIHRDLKpdNILld 161 (745)
..++-+|..|.++..++. .+..+++..+.++.-...+|-- |--.+ ++|.|+.|.||++-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~-~~~~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVK-WKSQPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhh-cccChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEE
Confidence 456667888888888854 4556666666666555555332 22334 99999999999994
|
|
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=91.22 E-value=0.83 Score=52.09 Aligned_cols=31 Identities=26% Similarity=0.299 Sum_probs=22.7
Q ss_pred CCEEeecCCCcceeecCCCC----cEEEcCcchhh
Q 004564 146 PPVIHRDLKCDNIFVNGNQG----EVKIGDLGLAA 176 (745)
Q Consensus 146 p~IIHRDLKpdNILld~~~g----~VKL~DFGlA~ 176 (745)
+-++|+||...|||.+.+++ -..|+||-.+.
T Consensus 268 ~VL~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh 302 (414)
T PF07914_consen 268 PVLVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVH 302 (414)
T ss_pred cceecCCccHHheeeecCCchhHHHHHHHHHHHhh
Confidence 34899999999999986433 23577776653
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=88.82 E-value=0.99 Score=50.61 Aligned_cols=103 Identities=17% Similarity=0.248 Sum_probs=66.7
Q ss_pred CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHhhhCCCCEEeecCCCcceeecCCCCcEEEcCcchhhh
Q 004564 98 RNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~gp~IIHRDLKpdNILld~~~g~VKL~DFGlA~~ 177 (745)
...|++|++. |+++.. -+....+++..++.+-+..|.-+... -+.-||||..+||||+ .|+|-|+||-+++.
T Consensus 299 ~y~yl~~kdh-gt~is~----ik~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId--~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDH-GTPISI----IKADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID--EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecC-Cceeee----eecccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee--cCceEEEEeeeeec
Confidence 4556677764 445432 22345677788888888777777665 4689999999999998 58999999999873
Q ss_pred hhccCCCcccCCCCcCChhhhhhccCccccchhh
Q 004564 178 LRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSF 211 (745)
Q Consensus 178 l~~~~~~~~vGTp~YmAPEvl~~~ys~ksDIWSL 211 (745)
..+.. .+--..+--|-+++|.-+..-+||-+
T Consensus 371 -~~~q~--~isy~rldhp~lF~G~dd~QFeIYrl 401 (488)
T COG5072 371 -SYSQG--IISYNRLDHPDLFNGVDDYQFEIYRL 401 (488)
T ss_pred -ccCCc--eeeccccCchhhhcCccceeeeHHHH
Confidence 21111 11112233455555555566677663
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=86.58 E-value=5.1 Score=42.64 Aligned_cols=75 Identities=19% Similarity=0.167 Sum_probs=50.1
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC---CCCcceEeEEEEecCCCeEEEEE
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK---HKNIMKFYTSWVDTANRNINFVT 104 (745)
Q Consensus 28 e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~---HpNIVk~~~sfvd~~~~~iyLV~ 104 (745)
+.+..|..-..|+..+ ...++.+|.- .......+..|+.-|..|. --++.+.+.+ +....+.|+|+
T Consensus 22 ~~v~gG~inea~~v~d--g~~~~FvK~n-------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~--G~~~~~sylVl 90 (286)
T COG3001 22 EEVSGGDINEAWRLRD--GTDPFFVKCN-------QREQLSMFTAEADGLELLARSNTITVPKVIAV--GASRDHSYLVL 90 (286)
T ss_pred cccCCccccceeEeec--CCcceEEEec-------chhhHHHHHHHHHHHHHHHhcCCccccceEEe--cCCCCeeEEEE
Confidence 3455566556666533 3445666642 3456677888988777774 3567788874 45578999999
Q ss_pred eccCCCCHH
Q 004564 105 EMFTSGTLR 113 (745)
Q Consensus 105 E~~~gGsL~ 113 (745)
||++.+.+.
T Consensus 91 e~L~~~~~d 99 (286)
T COG3001 91 EYLPTGPLD 99 (286)
T ss_pred eeccCCCCC
Confidence 999886553
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=86.53 E-value=1 Score=48.21 Aligned_cols=28 Identities=25% Similarity=0.381 Sum_probs=24.2
Q ss_pred CCEEeecCCCcceeecCCCCcEEEcCcchh
Q 004564 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 146 p~IIHRDLKpdNILld~~~g~VKL~DFGlA 175 (745)
.+++|+|+.+.||++++ +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECccc
Confidence 45999999999999984 57899999965
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=86.09 E-value=3 Score=47.12 Aligned_cols=76 Identities=13% Similarity=0.044 Sum_probs=44.4
Q ss_pred eEeEEecccCceEEEEEEEcCC-CeE-----EEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC-CcceEeEEEEecCC
Q 004564 25 RYNEILGKGASKTVYRAFDEYE-GIE-----VAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHK-NIMKFYTSWVDTAN 97 (745)
Q Consensus 25 rl~e~LG~GafgtVy~A~d~~t-g~~-----VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~Hp-NIVk~~~sfvd~~~ 97 (745)
.+ +.|..|-...+|++..... +.. |.+++. . ......++ -..|+.+++.|... --+++++.|.
T Consensus 54 ~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~---g-~~~~l~Id-R~~E~~i~~~Ls~~glgP~l~~~f~---- 123 (383)
T PTZ00384 54 EI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS---S-TYNSLVID-NDLQYNIAKLLGDNNFGPKIIGRFG---- 123 (383)
T ss_pred EE-EEeCCcccceEEEEEecCCCCCccccceEEEEec---c-CCCceEec-cHHHHHHHHHHHhCCCCCeEEEecC----
Confidence 44 4466688899999854322 122 333321 1 11112222 35689999999644 4556777552
Q ss_pred CeEEEEEeccCCCCH
Q 004564 98 RNINFVTEMFTSGTL 112 (745)
Q Consensus 98 ~~iyLV~E~~~gGsL 112 (745)
-++|.||+.|.+|
T Consensus 124 --~g~l~efIeGr~l 136 (383)
T PTZ00384 124 --DFTIQEWVEGNTM 136 (383)
T ss_pred --CEEEEEEeccccC
Confidence 2589999988775
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=83.44 E-value=0.28 Score=56.48 Aligned_cols=66 Identities=21% Similarity=0.455 Sum_probs=56.4
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceEeEEEEec
Q 004564 27 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT 95 (745)
Q Consensus 27 ~e~LG~GafgtVy~A~d~~tg~~VAiK~ik~~~~~~~~~~~e~l~~Ei~iLk~L~HpNIVk~~~sfvd~ 95 (745)
...+|.|+||+|+.+..+.++..+|||.|.+.. ......+..+|..-+..+.|++|++++..|...
T Consensus 54 ~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn---~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 54 GQCLGRGGFGVVFSAQNKADENKYAVKRITLKN---REESRSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred cccccccCccccCCccccccchhhHHHHhcccc---hhhhhhhhhccccchhhhcccchhhheeceecC
Confidence 456999999999999999888899999887654 455667788899999999999999999998653
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=83.37 E-value=1.3 Score=44.99 Aligned_cols=30 Identities=40% Similarity=0.586 Sum_probs=20.7
Q ss_pred CEEeecCCCcceeecCCCCcEEEcCcchhh
Q 004564 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 147 ~IIHRDLKpdNILld~~~g~VKL~DFGlA~ 176 (745)
.+.|.||.+.|||++..++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 389999999999995577899999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 745 | ||||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-69 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-28 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-28 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-28 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-27 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-26 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-25 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-24 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-23 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-23 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-23 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-23 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-21 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-21 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-21 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-20 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-20 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-20 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-20 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-20 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-20 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-20 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-19 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-19 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-19 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-19 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-19 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-18 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-18 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-18 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-17 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-17 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-17 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-16 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-16 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-16 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-16 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-16 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-16 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-16 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-16 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-16 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-16 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-16 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-16 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-16 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-16 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-16 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-16 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-15 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-15 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-15 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-15 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-14 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-10 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-09 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-08 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-06 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 7e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 8e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-04 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 7e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 8e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 8e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 8e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 8e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 8e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 8e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 8e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 8e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 8e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-04 |
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 440 bits (1134), Expect = e-151
Identities = 132/281 (46%), Positives = 185/281 (65%), Gaps = 5/281 (1%)
Query: 7 LEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPED 66
+E ++ V + GR+ +++ +G+G+ KTVY+ D +EVAW +++ + +
Sbjct: 11 IEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSE 68
Query: 67 LERLYCEIHLLKTLKHKNIMKFYTSWVDTA--NRNINFVTEMFTSGTLRQYRLKHKRVNI 124
+R E +LK L+H NI++FY SW T + I VTE+ TSGTL+ Y + K + I
Sbjct: 69 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI 128
Query: 125 RAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 184
+ ++ WCRQIL+GL +LH+ PP+IHRDLKCDNIF+ G G VKIGDLGLA + R S A
Sbjct: 129 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK 188
Query: 185 HCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP 244
+GTPEFMAPE+YEE Y+E VD+Y+FGMC+LEM T EYPYSEC + AQIY++V SG KP
Sbjct: 189 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 248
Query: 245 DSLYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQID 284
S +V PEV+ +E C+ R S ++LLN F Q +
Sbjct: 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 5e-61
Identities = 81/268 (30%), Positives = 122/268 (45%), Gaps = 25/268 (9%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+LGKG VY D + +A ++ + + L+ EI L K LKHKNI++
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPE----RDSRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQ-YRLKHKRVNIR--AVKLWCRQILRGLLYLHSH 144
+ S+ + I E G+L R K + + + +QIL GL YLH +
Sbjct: 84 YLGSFSENGFIKI--FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CVGTPEFMAPEV---YE 199
++HRD+K DN+ +N G +KI D G + L + GT ++MAPE+
Sbjct: 142 Q--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 200 EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK----PDSLYRVKDPEV 255
Y + DI+S G I+EM T + P+ E P KV K P+S+ E
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESM----SAEA 255
Query: 256 RRFVEKCLAT-VSLRLSARELLNDPFLQ 282
+ F+ KC R A +LL D FL+
Sbjct: 256 KAFILKCFEPDPDKRACANDLLVDEFLK 283
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 6e-57
Identities = 73/267 (27%), Positives = 118/267 (44%), Gaps = 18/267 (6%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+G G+ + + +G + W ++ + + + L E++LL+ LKH NI++
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIR----AVKLWCRQILRGLLYLHS 143
+Y +D N + V E G L K + V Q+ L H
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 144 HDPP---VIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAAHCVGTPEFMAPEVY 198
V+HRDLK N+F++G VK+GD GLA IL S A VGTP +M+PE
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 199 EE-AYNELVDIYSFGMCIL-EMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVR 256
+YNE DI+S G C+L E+ P++ + ++ K+ G K + E+
Sbjct: 189 NRMSYNEKSDIWSLG-CLLYELCALMPPFTAFSQK-ELAGKIREG-KFRRIPYRYSDELN 245
Query: 257 RFVEKCLAT-VSLRLSARELLNDPFLQ 282
+ + L R S E+L +P +
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLIL 272
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-56
Identities = 66/290 (22%), Positives = 124/290 (42%), Gaps = 17/290 (5%)
Query: 1 MNGLTHLEPDCSEFVEVDPTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLY 58
M+ H E +Y + +G+G+ +G + ++ +
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS 60
Query: 59 DFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 118
S ++ E E+ +L +KH NI+++ S+ + N ++ V + G L +
Sbjct: 61 R--MSSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLYIVMDYCEGGDLFKRINA 116
Query: 119 HKRVNI--RAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176
K V + W QI L ++H ++HRD+K NIF+ + G V++GD G+A
Sbjct: 117 QKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTVQLGDFGIAR 173
Query: 177 ILR--KSHAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQ 233
+L A C+GTP +++PE+ E YN DI++ G + E+ T ++ + E
Sbjct: 174 VLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF-EAGSMKN 232
Query: 234 IYKKVVSGKKPDSLYRVKDPEVRRFVEKCLATV-SLRLSARELLNDPFLQ 282
+ K++SG + ++R V + R S +L F+
Sbjct: 233 LVLKIISG-SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA 281
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 3e-56
Identities = 62/259 (23%), Positives = 107/259 (41%), Gaps = 16/259 (6%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIM 86
LG G+ V++ + +G A + + P+D R E+ + + +H +
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF--RGPKDRARKLAEVGSHEKVGQHPCCV 120
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHD 145
+ +W + + TE +L+Q+ + V + R L L +LHS
Sbjct: 121 RLEQAWEE--GGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG 177
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVYEEAYNE 204
++H D+K NIF+ G K+GD GL L + A G P +MAPE+ + +Y
Sbjct: 178 --LVHLDVKPANIFLGPR-GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGT 234
Query: 205 LVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA 264
D++S G+ ILE+ Q+ + + + L E+R + L
Sbjct: 235 AADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGL----SSELRSVLVMMLE 290
Query: 265 T-VSLRLSARELLNDPFLQ 282
LR +A LL P L+
Sbjct: 291 PDPKLRATAEALLALPVLR 309
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-55
Identities = 79/278 (28%), Positives = 129/278 (46%), Gaps = 15/278 (5%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+ +G+G VYRA +G+ VA +V+++D L + EI LLK L H N++K
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFD-LMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHKRVNI--RAVKLWCRQILRGLLYLHS 143
+Y S+++ + +N V E+ +G L + K ++ I R V + Q+ L ++HS
Sbjct: 97 YYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAAHCVGTPEFMAPEVYEE- 200
V+HRD+K N+F+ G VK+GDLGL + A VGTP +M+PE E
Sbjct: 155 RR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 211
Query: 201 AYNELVDIYSFGMCILEMVTFEYPY-SECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259
YN DI+S G + EM + P+ + + + KK+ P E+R+ V
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 271
Query: 260 EKCLATV-SLRLSARELLNDPFLQIDDCESNLRSLDYS 296
C+ R + + S+L +
Sbjct: 272 NMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHH 309
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-54
Identities = 63/274 (22%), Positives = 113/274 (41%), Gaps = 37/274 (13%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E++G G V++A +G +VK + E+ E+ L L H NI+
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKY--------NNEKAEREVKALAKLDHVNIVH 68
Query: 88 FYTSWVD--------------TANRNINFVTEMFTSGTLRQY--RLKHKRVNIRAVKLWC 131
+ W + + + E GTL Q+ + + ++++
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 132 RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-SHAAHCVGTP 190
QI +G+ Y+HS +I+RDLK NIF+ +VKIGD GL L+ GT
Sbjct: 129 EQITKGVDYIHSKK--LINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 191 EFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYR 249
+M+PE Y + VD+Y+ G+ + E++ E ++ + + G D
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGIISDIF-- 240
Query: 250 VKDPEVRRFVEKCLATV-SLRLSARELLNDPFLQ 282
D + + ++K L+ R + E+L +
Sbjct: 241 --DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 7e-53
Identities = 77/289 (26%), Positives = 122/289 (42%), Gaps = 44/289 (15%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+LG+GA V +A + + A +++ + E L + E+ LL +L H+ +++
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRH-----TEEKLSTILSEVMLLASLNHQYVVR 66
Query: 88 FYTSWVDTANRNIN-----------FVTEMFTSGTLRQYRLKHKR-VNIRAVKLWCRQIL 135
+Y +W++ N E +GTL RQIL
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH---------- 185
L Y+HS +IHRDLK NIF++ + VKIGD GLA + +S
Sbjct: 127 EALSYIHSQG--IIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 186 ------CVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKK 237
+GT ++A EV + YNE +D+YS G+ EM+ YP+S I KK
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKK 240
Query: 238 VVSGKK--PDSLYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQI 283
+ S P K ++ + + + R AR LLN +L +
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-52
Identities = 63/296 (21%), Positives = 108/296 (36%), Gaps = 30/296 (10%)
Query: 3 GLTHLEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ 62
G+ E E + + +G+G+ V+R D+ G + A +V+L F
Sbjct: 39 GVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV 98
Query: 63 SPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRV 122
E+ L I+ Y + + NI E+ G+L Q + +
Sbjct: 99 E---------ELVACAGLSSPRIVPLYGAVREGPWVNI--FMELLEGGSLGQLIKQMGCL 147
Query: 123 NIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 182
+ Q L GL YLH+ ++H D+K DN+ ++ + + D G A L+
Sbjct: 148 PEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205
Query: 183 AAHC-------VGTPEFMAPEV-YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQI 234
GT MAPEV + + VDI+S +L M+ +P+++
Sbjct: 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC 265
Query: 235 YKKVVSGK----KPDSLYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDD 285
K P S P + +++ L R SA EL + +
Sbjct: 266 LKIASEPPPIREIPPSC----APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-52
Identities = 65/294 (22%), Positives = 119/294 (40%), Gaps = 42/294 (14%)
Query: 21 GRY-GRYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
GRY + I LG+G V+ A ++ + A +++L + E++ E+ L
Sbjct: 1 GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKAL 57
Query: 78 KTLKHKNIMKFYTSWVDTANRNINF----------VTEMFTSGTLRQYRLKHKRVNIRAV 127
L+H I++++ +W++ ++ L+ + + R
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 128 KL---WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 184
+ QI + +LHS ++HRDLK NIF + VK+GD GL + +
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEE 174
Query: 185 H--------------CVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECT 229
VGT +M+PE +Y+ VDI+S G+ + E++ YP+S
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQM 231
Query: 230 HPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLATV-SLRLSARELLNDPFLQ 282
+ V + K P L+ K P V+ L+ R A ++ + +
Sbjct: 232 ERVRTLTDVRNLKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-51
Identities = 59/295 (20%), Positives = 118/295 (40%), Gaps = 31/295 (10%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN--I 85
+ +G G S V++ +E + A V L + + L+ EI L L+ + I
Sbjct: 15 KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 86 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHD 145
++ Y + ++ I V E + L + K K ++ K + + +L + +H H
Sbjct: 72 IRLYDYEIT--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 146 PPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILR----KSHAAHCVGTPEFMAPEV--- 197
++H DLK N V+G +K+ D G+A ++ VGT +M PE
Sbjct: 129 --IVHSDLKPANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 198 ---------YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLY 248
+ + D++S G + M + P+ + + ++
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243
Query: 249 RVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDM 302
+ + +++ ++ CL R+S ELL P++QI N + + E+ +
Sbjct: 244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYV 298
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-51
Identities = 77/249 (30%), Positives = 126/249 (50%), Gaps = 24/249 (9%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ-SPEDLERLYCEIHLLKTLKHKNIM 86
E +G G+ TV+RA E+ G +VA VK+ E + E+ ++K L+H NI+
Sbjct: 43 EKIGAGSFGTVHRA--EWHGSDVA---VKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQY---RLKHKRVNIRAVKLWCRQILRGLLYLHS 143
F + N +I VTE + G+L + ++++ R + +G+ YLH+
Sbjct: 98 LFMGAVTQPPNLSI--VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CVGTPEFMAPEVYE-E 200
+PP++HR+LK N+ V+ VK+ D GL+ + + + GTPE+MAPEV E
Sbjct: 156 RNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 201 AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK----PDSLYRVKDPEVR 256
NE D+YSFG+ + E+ T + P+ +PAQ+ V K P +L +P+V
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKCKRLEIPRNL----NPQVA 269
Query: 257 RFVEKCLAT 265
+E C
Sbjct: 270 AIIEGCWTN 278
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 4e-51
Identities = 62/292 (21%), Positives = 119/292 (40%), Gaps = 33/292 (11%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN--I 85
+ +G G S V++ +E + A V L + + L+ EI L L+ + I
Sbjct: 34 KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 86 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHD 145
++ Y + ++ I V E + L + K K ++ K + + +L + +H H
Sbjct: 91 IRLYDYEIT--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 146 PPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRK----SHAAHCVGTPEFMAPEVYEE 200
++H DLK N V+G +K+ D G+A ++ VGT +M PE ++
Sbjct: 148 --IVHSDLKPANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 201 A------------YNELVDIYSFGMCIL-EMVTFEYPYSECTHPAQIYKKVVSGKKPDSL 247
+ D++S G CIL M + P+ + + ++
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261
Query: 248 YRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRE 298
+ + +++ ++ CL R+S ELL P++QI N + + E
Sbjct: 262 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE 313
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 7e-51
Identities = 61/296 (20%), Positives = 120/296 (40%), Gaps = 33/296 (11%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN--I 85
+ +G G S V++ +E + A V L + + L+ EI L L+ + I
Sbjct: 62 KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 86 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHD 145
++ Y + ++ I V E + L + K K ++ K + + +L + +H H
Sbjct: 119 IRLYDYEIT--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 146 PPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILR----KSHAAHCVGTPEFMAPEVYEE 200
++H DLK N V+G +K+ D G+A ++ VG +M PE ++
Sbjct: 176 --IVHSDLKPANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 201 ------------AYNELVDIYSFGMCIL-EMVTFEYPYSECTHPAQIYKKVVSGKKPDSL 247
+ D++S G CIL M + P+ + + ++
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289
Query: 248 YRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDM 302
+ + +++ ++ CL R+S ELL P++QI N + + E+ +
Sbjct: 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYV 345
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-50
Identities = 71/305 (23%), Positives = 122/305 (40%), Gaps = 48/305 (15%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E++G+GA V +A ++ +VA +K ++S + + E+ L + H NI+K
Sbjct: 14 EVVGRGAFGVVCKA--KWRAKDVA---IKQ---IESESERKAFIVELRQLSRVNHPNIVK 65
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQY---RLKHKRVNIRAVKLWCRQILRGLLYLHSH 144
Y + ++ + V E G+L WC Q +G+ YLHS
Sbjct: 66 LYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 145 DP-PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYE-EAY 202
P +IHRDLK N+ + +KI D G A + ++H + G+ +MAPEV+E Y
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-QTHMTNNKGSAAWMAPEVFEGSNY 180
Query: 203 NELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK----PDSLYRVKDPEVRRF 258
+E D++S+G+ + E++T P+ E PA V +L +
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL----PKPIESL 236
Query: 259 VEKCLATVSLRLSARELLNDP-----FLQIDDCESNLRSLDYSRELDDMDPLIRQPHIDF 313
+ +C + DP +I + L R D ++ P
Sbjct: 237 MTRCWSK------------DPSQRPSMEEI---VKIMTHL--MRYFPGADEPLQYPCQHS 279
Query: 314 HHIDN 318
Sbjct: 280 LPPGE 284
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-49
Identities = 104/309 (33%), Positives = 150/309 (48%), Gaps = 48/309 (15%)
Query: 4 LTHLEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS 63
L L S DP +Y R+ +I G+GAS TVY A D G EVA ++ + LQ
Sbjct: 6 LEKLRSIVSV---GDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVA---IRQMN-LQQ 57
Query: 64 PEDLERLYCEIHLLKTLKHKNIMKFYTS-------WVDTANRNINFVTEMFTSGTLRQYR 116
E + EI +++ K+ NI+ + S WV V E G+L
Sbjct: 58 QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV---------VMEYLAGGSLTDV- 107
Query: 117 LKHKRVN---IRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 173
+ ++ I AV CR+ L+ L +LHS+ VIHRD+K DNI + G VK+ D G
Sbjct: 108 VTETCMDEGQIAAV---CRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFG 161
Query: 174 LAAIL--RKSHAAHCVGTPEFMAPEV-YEEAYNELVDIYSFGMCILEMVTFEYPYSECTH 230
A + +S + VGTP +MAPEV +AY VDI+S G+ +EM+ E PY +
Sbjct: 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-EN 220
Query: 231 PAQIYKKVVSGKKPDSLYRVKDPEV-----RRFVEKCLA-TVSLRLSARELLNDPFLQID 284
P + + + P +++PE R F+ +CL V R SA+ELL FL+I
Sbjct: 221 PLRALYLIATNGTP----ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276
Query: 285 DCESNLRSL 293
S+L L
Sbjct: 277 KPLSSLTPL 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-49
Identities = 69/248 (27%), Positives = 103/248 (41%), Gaps = 23/248 (9%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
EI+G G VYRA + G EVA + + +E + E L LKH NI+
Sbjct: 13 EIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDP- 146
+ N + V E G L + L KR+ + W QI RG+ YLH
Sbjct: 71 LRGVCLKEPNLCL--VMEFARGGPLNRV-LSGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 147 PVIHRDLKCDNIFVNGNQGE-------VKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYE 199
P+IHRDLK NI + +KI D GLA ++ G +MAPEV
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIR 187
Query: 200 -EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK----PDSLYRVKDPE 254
+++ D++S+G+ + E++T E P+ + V K P +
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGID-GLAVAYGVAMNKLALPIPSTC----PEP 242
Query: 255 VRRFVEKC 262
+ +E C
Sbjct: 243 FAKLMEDC 250
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-49
Identities = 92/309 (29%), Positives = 139/309 (44%), Gaps = 48/309 (15%)
Query: 4 LTHLEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS 63
L + DP Y +I G+G++ V A +++ G +VA VK+ D L+
Sbjct: 31 KAALRMVVDQ---GDPRLLLDSYVKI-GEGSTGIVCLAREKHSGRQVA---VKMMD-LRK 82
Query: 64 PEDLERLYCEIHLLKTLKHKNIMKFYTS-------WVDTANRNINFVTEMFTSGTLRQYR 116
+ E L+ E+ +++ +H N+++ Y S WV + E G L
Sbjct: 83 QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV---------LMEFLQGGALTDI- 132
Query: 117 LKHKRVN---IRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 173
+ R+N I V C +L+ L YLH+ VIHRD+K D+I + G VK+ D G
Sbjct: 133 VSQVRLNEEQIATV---CEAVLQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFG 186
Query: 174 LAAIL--RKSHAAHCVGTPEFMAPEV-YEEAYNELVDIYSFGMCILEMVTFEYPYSECTH 230
A + VGTP +MAPEV Y VDI+S G+ ++EMV E PY
Sbjct: 187 FCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DS 245
Query: 231 PAQIYKKVVSGKKPDSLYRVKDPEV-----RRFVEKCLA-TVSLRLSARELLNDPFLQID 284
P Q K++ P ++K+ R F+E+ L R +A+ELL+ PFL
Sbjct: 246 PVQAMKRLRDSPPP----KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301
Query: 285 DCESNLRSL 293
L L
Sbjct: 302 GLPECLVPL 310
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 5e-49
Identities = 61/256 (23%), Positives = 101/256 (39%), Gaps = 31/256 (12%)
Query: 26 YNEILGKGASKTVYRAFDEYEGIEVAWNQVKLY------DFLQSPEDLERLYCEIHLLKT 79
Y + +GKG V++ + VA +K + E + E+ ++
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVA---IKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 80 LKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWCRQILRGL 138
L H NI+K Y + V E G L K + I G+
Sbjct: 80 LNHPNIVKLYGL----MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 139 LYLHSHDPPVIHRDLKCDNIFVNGNQGE----VKIGDLGLAAILRKSHAAHCVGTPEFMA 194
Y+ + +PP++HRDL+ NIF+ K+ D GL+ S + +G ++MA
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-VSGLLGNFQWMA 194
Query: 195 PEVY---EEAYNELVDIYSFGMCILEMVTFEYPYSECTH-PAQIYKKVVSGKK----PDS 246
PE EE+Y E D YSF M + ++T E P+ E ++ + + P+
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254
Query: 247 LYRVKDPEVRRFVEKC 262
P +R +E C
Sbjct: 255 C----PPRLRNVIELC 266
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 9e-49
Identities = 79/274 (28%), Positives = 136/274 (49%), Gaps = 22/274 (8%)
Query: 16 EVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIH 75
+ DP + + +I GKG+ V++ D VA +K+ D ++ +++E + EI
Sbjct: 17 KADPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEIT 72
Query: 76 LLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQIL 135
+L + K+Y S++ + + + E G+ L+ ++ + R+IL
Sbjct: 73 VLSQCDSPYVTKYYGSYLK--DTKLWIIMEYLGGGSALDL-LEPGPLDETQIATILREIL 129
Query: 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC--VGTPEFM 193
+GL YLHS IHRD+K N+ ++ GEVK+ D G+A L + VGTP +M
Sbjct: 130 KGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 186
Query: 194 APEVYEEA-YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD 252
APEV +++ Y+ DI+S G+ +E+ E P+SE HP ++ + P ++
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKNNPP----TLEG 241
Query: 253 ---PEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282
++ FVE CL S R +A+ELL F+
Sbjct: 242 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-48
Identities = 55/281 (19%), Positives = 109/281 (38%), Gaps = 39/281 (13%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIM 86
E +G G +V++ +G A + K L D + E++ L +H +++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKK--PLAGSVDEQNALREVYAHAVLGQHSHVV 74
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIR----AVKLWCRQILRGLLYLH 142
+++++W + + ++ E G+L ++ R+ +K Q+ RGL Y+H
Sbjct: 75 RYFSAWAE--DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 143 SHDPPVIHRDLKCDNIFVNGN------------------QGEVKIGDLGLAAILRKSHAA 184
S ++H D+K NIF++ + KIGDLG +
Sbjct: 133 SMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV- 189
Query: 185 HCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK 242
G F+A EV +E + DI++ + ++ E + ++ G+
Sbjct: 190 -EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----GDQWHEIRQGR 244
Query: 243 KPDSLYRVKDPEVRRFVEKCLATV-SLRLSARELLNDPFLQ 282
P + +V E ++ + R SA L+ L
Sbjct: 245 LPR-IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 6e-48
Identities = 85/314 (27%), Positives = 138/314 (43%), Gaps = 35/314 (11%)
Query: 8 EPDCSEFV-EVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPED 66
+PD +E + DP + EI G G+ VY A D VA ++ QS E
Sbjct: 40 DPDVAELFFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSY-SGKQSNEK 97
Query: 67 LERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVN--- 123
+ + E+ L+ L+H N +++ ++ V E + K +
Sbjct: 98 WQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVE 155
Query: 124 IRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 183
I AV L+GL YLHSH+ +IHRD+K NI ++ G VK+GD G A+I+ +++
Sbjct: 156 IAAV---THGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANS 209
Query: 184 AHCVGTPEFMAPEV----YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVV 239
VGTP +MAPEV E Y+ VD++S G+ +E+ + P + +
Sbjct: 210 F--VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIA 266
Query: 240 SGKKPDSLYRVKDPEV----RRFVEKCLA-TVSLRLSARELLNDPFLQIDDCESNLRSL- 293
+ P ++ R FV+ CL R ++ LL F+ + + + L
Sbjct: 267 QNESP----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 322
Query: 294 ----DYSRELDDMD 303
D RELD++
Sbjct: 323 QRTKDAVRELDNLQ 336
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 9e-48
Identities = 85/298 (28%), Positives = 137/298 (45%), Gaps = 36/298 (12%)
Query: 14 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCE 73
++DP + E+ G GA VY+A ++ G A K+ + +S E+LE E
Sbjct: 12 RRDLDPNEVWEIVGEL-GDGAFGKVYKAKNKETGALAA---AKVIE-TKSEEELEDYIVE 66
Query: 74 IHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRV----NIRAVKL 129
I +L T H I+K ++ + + + E G + L+ R I+ V
Sbjct: 67 IEILATCDHPYIVKLLGAYY--HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVV-- 122
Query: 130 WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC--V 187
CRQ+L L +LHS +IHRDLK N+ + +G++++ D G++A K+ +
Sbjct: 123 -CRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFI 178
Query: 188 GTPEFMAPEV------YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG 241
GTP +MAPEV + Y+ DI+S G+ ++EM E P+ E +P ++ K+
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKS 237
Query: 242 KKPDSLYRVKDP-----EVRRFVEKCLA-TVSLRLSARELLNDPFLQIDDCESNLRSL 293
P + P E R F++ L R SA +LL PF+ LR L
Sbjct: 238 DPP----TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALREL 291
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-47
Identities = 77/291 (26%), Positives = 123/291 (42%), Gaps = 36/291 (12%)
Query: 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
Y I G GA+ V A+ + +VA +K + + ++ L EI +
Sbjct: 12 INRDDYELQEVI-GSGATAVVQAAYCAPKKEKVA---IKRINLEKCQTSMDELLKEIQAM 67
Query: 78 KTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ-YRLKHKRVNIRAVKLW------ 130
H NI+ +YTS+V + V ++ + G++ + + ++ L
Sbjct: 68 SQCHHPNIVSYYTSFVV--KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 131 -CRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC--- 186
R++L GL YLH + IHRD+K NI + G V+I D G++A L
Sbjct: 126 ILREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 187 ----VGTPEFMAPEVYEEA--YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS 240
VGTP +MAPEV E+ Y+ DI+SFG+ +E+ T PY + P ++ +
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK-YPPMKVLMLTLQ 241
Query: 241 GKKP------DSLYRVKD--PEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282
P +K R+ + CL R +A ELL F Q
Sbjct: 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-47
Identities = 40/246 (16%), Positives = 92/246 (37%), Gaps = 25/246 (10%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC-EIHLLKTLKHKNIM 86
L + S +++ ++G ++ VK+ R + E L+ H N++
Sbjct: 16 TKLNENHSGELWKG--RWQGNDIV---VKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHKRVNIRAVKLWCRQILRGLLYLHSH 144
+ + +T G+L + V+ + + RG+ +LH+
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYE----E 200
+P + L ++ ++ + +I + + + P ++APE + +
Sbjct: 131 EPLIPRHALNSRSVMIDED-MTARISMADVK---FSFQSPGRMYAPAWVAPEALQKKPED 186
Query: 201 AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK----PDSLYRVKDPEVR 256
D++SF + + E+VT E P+++ +I KV P + P V
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFADL-SNMEIGMKVALEGLRPTIPPGI----SPHVS 241
Query: 257 RFVEKC 262
+ ++ C
Sbjct: 242 KLMKIC 247
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-47
Identities = 57/257 (22%), Positives = 112/257 (43%), Gaps = 32/257 (12%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ-SPEDLERLYCEIHLLKTLKHKNIM 86
E++GKG VY + G EVA ++L D + + + L+ E+ + +H+N++
Sbjct: 39 ELIGKGRFGQVYHGR--WHG-EVA---IRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWCRQILRGLLYLHSHD 145
F + + + I +T + TL R +++ + ++I++G+ YLH+
Sbjct: 93 LFMGACMSPPHLAI--ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK- 149
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-------CVGTPEFMAPEV- 197
++H+DLK N+F + G+V I D GL +I A G +APE+
Sbjct: 150 -GILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 198 ---------YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLY 248
+ +++ D+++ G E+ E+P+ I ++ +G KP+
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPNLSQ 265
Query: 249 RVKDPEVRRFVEKCLAT 265
E+ + C A
Sbjct: 266 IGMGKEISDILLFCWAF 282
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 81/289 (28%), Positives = 140/289 (48%), Gaps = 33/289 (11%)
Query: 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
P + ++ G+G+ +VY+A + G VA +K +++ + EI ++
Sbjct: 26 QPEEVFDVLEKL-GEGSYGSVYKAIHKETGQIVA---IKQVPVESDLQEIIK---EISIM 78
Query: 78 KTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ-YRLKHKRVN---IRAVKLWCRQ 133
+ +++K+Y S+ N ++ V E +G++ RL++K + I + +
Sbjct: 79 QQCDSPHVVKYYGSYF--KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATI---LQS 133
Query: 134 ILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAAHCVGTPE 191
L+GL YLH IHRD+K NI +N +G K+ D G+A L + +GTP
Sbjct: 134 TLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPF 190
Query: 192 FMAPEV-YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRV 250
+MAPEV E YN + DI+S G+ +EM + PY++ HP + + + P
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD-IHPMRAIFMIPTNPPP----TF 245
Query: 251 KDPEV-----RRFVEKCLA-TVSLRLSARELLNDPFLQIDDCESNLRSL 293
+ PE+ FV++CL + R +A +LL PF++ S LR L
Sbjct: 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDL 294
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 7e-46
Identities = 78/299 (26%), Positives = 132/299 (44%), Gaps = 40/299 (13%)
Query: 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
DP G + + G G VY+ G A + + + ++ E + EI++L
Sbjct: 21 DPAGIFELVELV-GNGTYGQVYKGRHVKTGQLAAIKVMDV-----TGDEEEEIKQEINML 74
Query: 78 KTL-KHKNIMKFYTSWVDTANRNIN----FVTEMFTSGTLR--QYRLKHKRVN---IRAV 127
K H+NI +Y +++ ++ V E +G++ K + I +
Sbjct: 75 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134
Query: 128 KLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-- 185
CR+ILRGL +LH H VIHRD+K N+ + EVK+ D G++A L ++
Sbjct: 135 ---CREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 186 CVGTPEFMAPEV------YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVV 239
+GTP +MAPEV + Y+ D++S G+ +EM P + HP + +
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIP 247
Query: 240 SGKKPDSLYRVKD----PEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDDCESNLRSL 293
P R+K + + F+E CL S R + +L+ PF++ E +R
Sbjct: 248 RNPAP----RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQ 302
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-45
Identities = 71/248 (28%), Positives = 126/248 (50%), Gaps = 25/248 (10%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ-SPEDLERLYCEIHLLKTLKHKNIM 86
+ +G G+ TVY+ ++ G +VA VK+ + +P+ L+ E+ +L+ +H NI+
Sbjct: 30 QRIGSGSFGTVYKG--KWHG-DVA---VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWCRQILRGLLYLHSHD 145
F + I VT+ +L + + ++ + RQ RG+ YLH+
Sbjct: 84 LFM-GYSTAPQLAI--VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK- 139
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC----VGTPEFMAPEV--YE 199
+IHRDLK +NIF++ + VKIGD GLA + +H G+ +MAPEV +
Sbjct: 140 -SIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 200 EA--YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK---DPE 254
++ Y+ D+Y+FG+ + E++T + PYS + QI + V G L +V+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 255 VRRFVEKC 262
++R + +C
Sbjct: 258 MKRLMAEC 265
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-44
Identities = 68/290 (23%), Positives = 119/290 (41%), Gaps = 50/290 (17%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+ +GKG V+ ++ G +VA VK+ F + E EI+ ++H+NI+
Sbjct: 43 KQIGKGRYGEVWMG--KWRGEKVA---VKV--FFTTEEASWFRETEIYQTVLMRHENILG 95
Query: 88 FYTSWVDTANRNINF--VTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS-- 143
F + + +T+ +G+L Y LK ++ +++ + GL +LH+
Sbjct: 96 FIAADIKGTGSWTQLYLITDYHENGSLYDY-LKSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 144 ----HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA------HCVGTPEFM 193
P + HRDLK NI V N G I DLGLA VGT +M
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 194 APEVYEEA-------YNELVDIYSFGMCILEMVT----------FEYPYSECTHP----A 232
PEV +E+ + D+YSFG+ + E+ ++ PY +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 233 QIYKKVVSGKK----PDSLYRVK-DPEVRRFVEKCLATV-SLRLSARELL 276
+ + V K P+ + ++ + + +C A + RL+A +
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 8e-44
Identities = 72/291 (24%), Positives = 112/291 (38%), Gaps = 50/291 (17%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E +GKG V+R ++ G EVA VK+ F E EI+ L+H+NI+
Sbjct: 48 ESIGKGRFGEVWRG--KWRGEEVA---VKI--FSSREERSWFREAEIYQTVMLRHENILG 100
Query: 88 FYTSWVDTANRNINF--VTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS-- 143
F + V++ G+L Y L V + + GL +LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 144 ----HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA------HCVGTPEFM 193
P + HRDLK NI V N G I DLGLA + H VGT +M
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 194 APEVYEEA-------YNELVDIYSFGMCILEMVT----------FEYPYSECTHP----A 232
APEV +++ + DIY+ G+ E+ ++ PY +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 233 QIYKKVVSGKK----PDSLYRVK-DPEVRRFVEKCLATV-SLRLSARELLN 277
++ K V K P+ + + + + +C + RL+A +
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 73/290 (25%), Positives = 123/290 (42%), Gaps = 50/290 (17%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E +GKG V+R ++G VA VK+ F E E++ L+H+NI+
Sbjct: 14 ECVGKGRYGEVWRG--SWQGENVA---VKI--FSSRDEKSWFRETELYNTVMLRHENILG 66
Query: 88 FYTSWVDTANRNINF--VTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS-- 143
F S + + + + +T G+L Y L+ ++ + I GL +LH
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDY-LQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 144 ----HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA------HCVGTPEFM 193
P + HRDLK NI V N G+ I DLGLA + +S VGT +M
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 194 APEVYEEA-------YNELVDIYSFGMCILEMVT----------FEYPYSECT--HPA-- 232
APEV +E + VDI++FG+ + E+ ++ P+ + P+
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 233 QIYKKVVSGKK----PDSLYRVK-DPEVRRFVEKCLATV-SLRLSARELL 276
+ K V ++ P+ + + + +++C S RL+A +
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 4e-43
Identities = 60/306 (19%), Positives = 113/306 (36%), Gaps = 35/306 (11%)
Query: 18 DPTGRYGRYNEILGKGASK--TVYRAFDEYEGIEVAWNQVKLYDF-LQSPEDLERLYCEI 74
G Y I GKG TV A + G V V+ + S E + L E+
Sbjct: 22 PEGGCYELLTVI-GKGFEDLMTVNLARYKPTGEYVT---VRRINLEACSNEMVTFLQGEL 77
Query: 75 HLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVN------IRAVK 128
H+ K H NI+ + +++ A+ + VT G+ + + ++ I +
Sbjct: 78 HVSKLFNHPNIVPYRATFI--ADNELWVVTSFMAYGSAKDL-ICTHFMDGMNELAIAYI- 133
Query: 129 LWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---------R 179
+ +L+ L Y+H +HR +K +I ++ + G+V + L +
Sbjct: 134 --LQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVV 188
Query: 180 KSHAAHCVGTPEFMAPEVYEEA---YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYK 236
+ V +++PEV ++ Y+ DIYS G+ E+ P+ + Q+
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD-MPATQMLL 247
Query: 237 KVVSGKKPDSLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSLDYS 296
+ ++G P L P + + + LS + P D S+ +S
Sbjct: 248 EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS 307
Query: 297 RELDDM 302
Sbjct: 308 PHFHHF 313
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-43
Identities = 68/266 (25%), Positives = 112/266 (42%), Gaps = 18/266 (6%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIH-LLKTLKHKNIM 86
LG+GA V + G +A VK + ++ +RL ++ ++T+ +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMA---VKRIRATVNSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 87 KFYTSWVDTANRNINFVTE-MFTSGT--LRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS 143
FY + ++ E M TS +Q K + + + I++ L +LHS
Sbjct: 70 TFYGALFR--EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC-VGTPEFMAPEV----- 197
VIHRD+K N+ +N G+VK+ D G++ L A G +MAPE
Sbjct: 128 -KLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPEL 185
Query: 198 YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257
++ Y+ DI+S G+ ++E+ +PY P Q K+VV P E
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD 245
Query: 258 FVEKCLA-TVSLRLSARELLNDPFLQ 282
F +CL R + EL+ PF
Sbjct: 246 FTSQCLKKNSKERPTYPELMQHPFFT 271
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 58/265 (21%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIH-LLKTLKHKNIM 86
+G G V++ G +A VK + E+ +R+ ++ +LK+ I+
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIA---VKQMRRSGNKEENKRILMDLDVVLKSHDCPYIV 87
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDP 146
+ + +++ N ++ E+ + + + + R + I++ L YL
Sbjct: 88 QCFGTFIT--NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE-KH 144
Query: 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC-VGTPEFMAPEV------YE 199
VIHRD+K NI ++ +G++K+ D G++ L A G +MAPE +
Sbjct: 145 GVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 200 EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK-DPEVRRF 258
Y+ D++S G+ ++E+ T ++PY C ++ KV+ + P + + + F
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSF 263
Query: 259 VEKCLA-TVSLRLSARELLNDPFLQ 282
V+ CL R +LL F++
Sbjct: 264 VKDCLTKDHRKRPKYNKLLEHSFIK 288
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-42
Identities = 53/275 (19%), Positives = 88/275 (32%), Gaps = 31/275 (11%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+ LG+G V ++G A ++ +D E E + + H NI++
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRI----LCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 88 FYTSWVD--TANRNINFVTEMFTSGTLRQY----RLKHKRVNIRAVKLWCRQILRGLLYL 141
+ A + F GTL + K + + I RGL +
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-----------HAAHCVGTP 190
H+ HRDLK NI + G+ + DLG A T
Sbjct: 151 HA--KGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 191 EFMAPEVYE----EAYNELVDIYSFGMCIL-EMVTFEYPYSECTHPAQIYKKVVSGKKPD 245
+ APE++ +E D++S G C+L M+ E PY V +
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLG-CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 246 SLYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDP 279
+ + + + R LL+
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 70/304 (23%), Positives = 123/304 (40%), Gaps = 24/304 (7%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIH-LLKTLKHKNIM 86
+G+GA +V + + G +A VK ++ ++L ++ ++++ I+
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMA---VKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIV 84
Query: 87 KFYTSWVDTANRNINFVTE-MFTS---GTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLH 142
+FY + + E M TS Y + + + ++ L +L
Sbjct: 85 QFYGALFR--EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-AHCVGTPEFMAPEV---- 197
+ +IHRD+K NI ++ G +K+ D G++ L S A G +MAPE
Sbjct: 143 E-NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 198 -YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP---DSLYRVKDP 253
+ Y+ D++S G+ + E+ T +PY + +VV G P +S R P
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSP 260
Query: 254 EVRRFVEKCLA-TVSLRLSARELLNDPFLQ-IDDCESNLRSLDYSRELDDMDPLIRQPHI 311
FV CL S R +ELL PF+ ++ + + LD M P
Sbjct: 261 SFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACY-VCKILDQMPATPSSPMY 319
Query: 312 DFHH 315
HH
Sbjct: 320 VDHH 323
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 61/274 (22%), Positives = 111/274 (40%), Gaps = 30/274 (10%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+ILG+GA+ V+R + G A +K+++ + ++ E +LK L HKNI+K
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNI---RAVKLWCRQILRGLLYLHSH 144
+ +T R+ + E G+L + + R ++ G+ +L +
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 145 DPPVIHRDLKCDNIFVNGNQGE---VKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVYEE 200
++HR++K NI + K+ D G A L GT E++ P++YE
Sbjct: 132 G--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189
Query: 201 A---------YNELVDIYSFGMCIL-EMVT----FEYPYSECTHPAQIYKKVVSGKKPDS 246
A Y VD++S G T F P+ ++ K+++GK +
Sbjct: 190 AVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSGA 247
Query: 247 LYRVKDPE--VRRFVEKCLATVSLRLSARELLND 278
+ V+ E + + SL + LL
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-40
Identities = 58/286 (20%), Positives = 101/286 (35%), Gaps = 28/286 (9%)
Query: 16 EVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIH 75
EV + + A + E E+ L SP ++ +I
Sbjct: 54 EVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIR 113
Query: 76 LLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY---RLKHKRVNIRAVKLWCR 132
+ KN + I ++ L+ + R +
Sbjct: 114 RMDPFSTKNTVGQLQPSSPKVYLYI--QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH------- 185
QI + +LHS ++HRDLK NIF + VK+GD GL + +
Sbjct: 172 QIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 186 -------CVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKK 237
VGT +M+PE Y+ VDI+S G+ + E++ Y +S +I
Sbjct: 229 AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQMERVRIITD 285
Query: 238 VVSGKKPDSLYRVKDPEVRRFVEKCLATV-SLRLSARELLNDPFLQ 282
V + K P + K P+ V+ L+ + R A +++ + +
Sbjct: 286 VRNLKFPLLFTQ-KYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-40
Identities = 77/277 (27%), Positives = 124/277 (44%), Gaps = 27/277 (9%)
Query: 20 TGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEDLERLYCEIH 75
RY LGKG + D A K+ L P E++ EI
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFA---GKIVPKSLLLKPHQREKMSMEIS 67
Query: 76 LLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQIL 135
+ ++L H++++ F+ + D N + V E+ +L + + K + + + RQI+
Sbjct: 68 IHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 125
Query: 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH---CVGTPEF 192
G YLH + VIHRDLK N+F+N + EVKIGD GLA + C GTP +
Sbjct: 126 LGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLC-GTPNY 181
Query: 193 MAPEVYEE-AYNELVDIYSFGMCIL-EMVTFEYPYSECTHPAQIYKKVVSG--KKPDSLY 248
+APEV + ++ VD++S G CI+ ++ + P+ Y ++ P +
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKE-TYLRIKKNEYSIPKHI- 238
Query: 249 RVKDPEVRRFVEKCLATV-SLRLSARELLNDPFLQID 284
+P ++K L T + R + ELLND F
Sbjct: 239 ---NPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 77/277 (27%), Positives = 124/277 (44%), Gaps = 27/277 (9%)
Query: 20 TGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEDLERLYCEIH 75
RY LGKG + D A K+ L P E++ EI
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFA---GKIVPKSLLLKPHQREKMSMEIS 93
Query: 76 LLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQIL 135
+ ++L H++++ F+ + D N + V E+ +L + + K + + + RQI+
Sbjct: 94 IHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 151
Query: 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH---CVGTPEF 192
G YLH + VIHRDLK N+F+N + EVKIGD GLA + C GTP +
Sbjct: 152 LGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLC-GTPNY 207
Query: 193 MAPEVYEE-AYNELVDIYSFGMCIL-EMVTFEYPYSECTHPAQIYKKVVSG--KKPDSLY 248
+APEV + ++ VD++S G CI+ ++ + P+ Y ++ P +
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKE-TYLRIKKNEYSIPKHI- 264
Query: 249 RVKDPEVRRFVEKCLATV-SLRLSARELLNDPFLQID 284
+P ++K L T + R + ELLND F
Sbjct: 265 ---NPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-39
Identities = 63/278 (22%), Positives = 113/278 (40%), Gaps = 31/278 (11%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+ILG+GA+ V+R + G A +K+++ + ++ E +LK L HKNI+K
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNI---RAVKLWCRQILRGLLYLHSH 144
+ +T R+ + E G+L + + R ++ G+ +L +
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 145 DPPVIHRDLKCDNIFVNGNQGE---VKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVYEE 200
++HR++K NI + K+ D G A L GT E++ P++YE
Sbjct: 132 G--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189
Query: 201 A---------YNELVDIYSFGMCIL-EMVT----FEYPYSECTHPAQIYKKVVSGKKPDS 246
A Y VD++S G T F P+ ++ K+++GK +
Sbjct: 190 AVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSGA 247
Query: 247 LYRVKDPE--VRRFVEKCLATVSLRLSARELLNDPFLQ 282
+ V+ E + + SL + LL P L
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLT-PVLA 284
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 8e-39
Identities = 74/277 (26%), Positives = 107/277 (38%), Gaps = 19/277 (6%)
Query: 19 PTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHL 76
PT G + E LG G V R + G +VA +K SP++ ER EI +
Sbjct: 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVA---IKQCRQELSPKNRERWCLEIQI 65
Query: 77 LKTLKHKNIMKFY----TSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNI---RAVKL 129
+K L H N++ N E G LR+Y + + ++
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 130 WCRQILRGLLYLHSHDPPVIHRDLKCDNI--FVNGNQGEVKIGDLGLAAILRKSHAAH-C 186
I L YLH + +IHRDLK +NI + KI DLG A L +
Sbjct: 126 LLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 183
Query: 187 VGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPD 245
VGT +++APE+ E + Y VD +SFG E +T P+ P Q + KV
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243
Query: 246 SLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQ 282
+ +F L L + +LQ
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKL-ERWLQ 279
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-39
Identities = 68/298 (22%), Positives = 114/298 (38%), Gaps = 50/298 (16%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
LG G V++ + G+ +A KL P ++ E+ +L I+
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 95
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
FY ++ + I+ E G+L Q K R+ + + +++GL YL
Sbjct: 96 FYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE-KHK 152
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEV-YEEAYNELV 206
++HRD+K NI VN ++GE+K+ D G++ L S A VGT +M+PE Y+
Sbjct: 153 IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 211
Query: 207 DIYSFGMCILEMVTFEYPYSECTHPAQIY------------------------------- 235
DI+S G+ ++EM YP
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271
Query: 236 ----------KKVVSGKKPDSLYRVKDPEVRRFVEKCLATV-SLRLSARELLNDPFLQ 282
+V+ P V E + FV KCL + R ++L+ F++
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-38
Identities = 101/460 (21%), Positives = 179/460 (38%), Gaps = 77/460 (16%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+LGKG+ V D+ G E A + ++ D E L E+ LLK L H NIMK
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISK-RQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
Y + D V E++T G L + KR + RQ+L G+ Y+H +
Sbjct: 91 LYEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-- 146
Query: 148 VIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVYEEAYNE 204
++HRDLK +N+ + ++ ++I D GL+ S +GT ++APEV Y+E
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 206
Query: 205 LVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK---KPDSLYRVKDPEVRRFVEK 261
D++S G+ + +++ P++ I KKV GK + +V + + K
Sbjct: 207 KCDVWSTGVILYILLSGCPPFNGANE-YDILKKVEKGKYTFELPQWKKV-SESAKDLIRK 264
Query: 262 CLAT-VSLRLSARELLNDPFLQ-------------IDDCESNLRSLDYSREL-------- 299
L S+R+SAR+ L+ ++Q +D+ N+R +++L
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYM 324
Query: 300 -------DDMDPLIRQPHIDFHHIDNS---------FSNGCANGYGYDTPSEWGYSPVEV 343
D+ L FH +D + G V
Sbjct: 325 GSKLTSQDETKELTAI----FHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAV 380
Query: 344 ESNGIELFGYHDDDHSSDVD----ISIKGKRRDDGGIFLRLRIADKEGRIRNIYFPFDVE 399
E ++ D D + ++ ++ + + + R+ + FD +
Sbjct: 381 EHEVDQVLDAVDFDKNGYIEYSEFVT----------VAMDRKTLLSRERLERAFRMFDSD 430
Query: 400 TDTALSVATEMVAELDITDQDVTKIADMI-------DGEI 432
+S TE+ ++D D ++ DGE+
Sbjct: 431 NSGKISS-TELATIFGVSDVDSETWKSVLSEVDKNNDGEV 469
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 59/294 (20%), Positives = 107/294 (36%), Gaps = 40/294 (13%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIM 86
+L +G VY A D G E A ++ E + E+ +K L H NI+
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRL----LSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 87 KFYTSWVDTANRNIN-----FVTEMFTSGTLRQY---RLKHKRVNIRAVKLWCRQILRGL 138
+F ++ + + G L ++ ++ V Q R +
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 139 LYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--------------HAA 184
++H PP+IHRDLK +N+ ++ G +K+ D G A +
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 185 HCVGTPEFMAPEVYE----EAYNELVDIYSFGMCIL-EMVTFEYPYSECTHPAQIYKKVV 239
TP + PE+ + E DI++ G CIL + ++P+ + ++V
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-CILYLLCFRQHPFED-----GAKLRIV 262
Query: 240 SGKKPDSLYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRS 292
+GK + + + L RLS E+++ N +S
Sbjct: 263 NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 64/262 (24%), Positives = 110/262 (41%), Gaps = 43/262 (16%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC-EIHLLKTLKHKNIM 86
E+LGKG + + + + + ++ E+ +R + E+ +++ L+H N++
Sbjct: 16 EVLGKGCFGQAIKV--THRETGEV---MVMKELIRFDEETQRTFLKEVKVMRCLEHPNVL 70
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWCRQILRGLLYLHSHD 145
KF V ++ +NF+TE GTLR + + + + I G+ YLHS +
Sbjct: 71 KFIG--VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN 128
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH----------------CVGT 189
+IHRDL N V N V + D GLA ++ VG
Sbjct: 129 --IIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 190 PEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK----- 243
P +MAPE+ +Y+E VD++SFG+ + E++ + + V G
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245
Query: 244 ---PDSLYRV------KDPEVR 256
P S + + DPE R
Sbjct: 246 PNCPPSFFPITVRCCDLDPEKR 267
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 31/275 (11%)
Query: 21 GRY--GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEDLERLYCEIHL 76
+ G +LGKG+ VYRA + G+EVA +K+ D + ++R+ E+ +
Sbjct: 11 EDFKVGN---LLGKGSFAGVYRAESIHTGLEVA---IKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 77 LKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWCRQIL 135
LKH +I++ Y + D + + V EM +G + +Y + + K + + + QI+
Sbjct: 65 HCQLKHPSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII 122
Query: 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH---CVGTPEF 192
G+LYLHSH ++HRDL N+ + N +KI D GLA L+ H H C GTP +
Sbjct: 123 TGMLYLHSHG--ILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLC-GTPNY 178
Query: 193 MAPEVYE-EAYNELVDIYSFGMCIL-EMVTFEYPYSECTHPAQIYKKVVSG--KKPDSLY 248
++PE+ A+ D++S G C+ ++ P+ T KVV + P L
Sbjct: 179 ISPEIATRSAHGLESDVWSLG-CMFYTLLIGRPPFDTDTVKN-TLNKVVLADYEMPSFL- 235
Query: 249 RVKDPEVRRFVEKCLATV-SLRLSARELLNDPFLQ 282
E + + + L + RLS +L+ PF+
Sbjct: 236 ---SIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 59/255 (23%), Positives = 108/255 (42%), Gaps = 31/255 (12%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84
+ E+ +G V++A + VA VK++ +Q + + Y E++ L +KH+N
Sbjct: 27 QLLEVKARGRFGCVWKA--QLLNEYVA---VKIFP-IQDKQSWQNEY-EVYSLPGMKHEN 79
Query: 85 IMKFYTSWVDTANRNINF--VTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLH 142
I++F + + +++ +T G+L + LK V+ + + RGL YLH
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF-LKANVVSWNELCHIAETMARGLAYLH 138
Query: 143 S--------HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC----VGTP 190
H P + HRD+K N+ + N I D GLA +A VGT
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 191 EFMAPEVYEEA------YNELVDIYSFGMCILEMVTFEYPYSECTHPAQI--YKKVVSGK 242
+MAPEV E A +D+Y+ G+ + E+ + + +++
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257
Query: 243 KPDSLYRVKDPEVRR 257
+ + V + +R
Sbjct: 258 SLEDMQEVVVHKKKR 272
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-36
Identities = 76/295 (25%), Positives = 119/295 (40%), Gaps = 49/295 (16%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVK-------LYDFLQSPEDLERLYCEIHLLKTL 80
+ LG GA V AF+ +VA ++ + + + EI +LK L
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVA---IRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 81 KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLY 140
H I+K + + V E+ G L + +KR+ KL+ Q+L + Y
Sbjct: 198 NHPCIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 141 LHSHDPPVIHRDLKCDNIFV--NGNQGEVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEV 197
LH + +IHRDLK +N+ + +KI D G + IL ++ GTP ++APEV
Sbjct: 255 LHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312
Query: 198 ----YEEAYNELVDIYSFGMCILEMVTFEY-------PYSECTHPAQIYKKVVSGKKPDS 246
YN VD +S G IL + P+SE + ++ SGK
Sbjct: 313 LVSVGTAGYNRAVDCWSLG-VIL------FICLSGYPPFSEHRTQVSLKDQITSGK---- 361
Query: 247 LYRVKDP-------EVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSL 293
Y + V+K L R + E L P+LQ +D + + L
Sbjct: 362 -YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 415
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-36
Identities = 46/310 (14%), Positives = 88/310 (28%), Gaps = 51/310 (16%)
Query: 16 EVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF--LQSPEDLERLYCE 73
+ R + E L G V+ D + A +K++ S +LERL+
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA---LKVFTMGAENSRSELERLHEA 112
Query: 74 IHLLKTLKHKN------------------------IMKFYTSWVDTANRNINFVTEMFTS 109
L ++ + D A N + +
Sbjct: 113 TFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASV 172
Query: 110 ------GTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGN 163
TL + I A+ + Q++R L S ++H DN+F+ +
Sbjct: 173 DLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPD 230
Query: 164 QGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVY----EEAYNELVDIYSFGMCILEMV 219
G + +GD+ + P AP + + ++ + G+ I +
Sbjct: 231 -GRLMLGDVSALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
Query: 220 TFEYPYSECT-HPAQIYKKVVSGKKPDSLYRVKD-----PEVRRFVEKCLAT-VSLRLSA 272
P+ T +K+ V+ + + L RL
Sbjct: 288 CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP 347
Query: 273 RELLNDPFLQ 282
E + P
Sbjct: 348 LEAMETPEFL 357
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-36
Identities = 100/465 (21%), Positives = 182/465 (39%), Gaps = 90/465 (19%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+ LG GA V D+ +E A ++ S +L E+ +LK L H NIMK
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV--STSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
Y + D RN V E + G L + + N + +Q+L G+ YLH H+
Sbjct: 101 LYDFFED--KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN-- 156
Query: 148 VIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVYEEAYNE 204
++HRDLK +N+ + + +KI D GL+A+ +GT ++APEV + Y+E
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDE 216
Query: 205 LVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK---KPDSLYRVKDPEVRRFVEK 261
D++S G+ + ++ P+ T +I +KV GK V + +++
Sbjct: 217 KCDVWSIGVILFILLAGYPPFGGQTD-QEILRKVEKGKYTFDSPEWKNV-SEGAKDLIKQ 274
Query: 262 CLAT-VSLRLSARELLNDPFLQIDDCE--------------SNLRSLDYSREL------- 299
L R+SA++ L P+++ + N+R S++L
Sbjct: 275 MLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLY 334
Query: 300 --------DDMDPLIRQPHIDFHHIDNSFSNGCANGYGYDTPSE-------------WGY 338
++ L F HID NG G E +
Sbjct: 335 MASKLTSQEETKELTDI----FRHID-------KNGDGQLDRQELIDGYSKLSGEEVAVF 383
Query: 339 SPVEVESNGIELFGYHDDDHSSDVD----ISIKGKRRDDGGIFLRLRIADKEGRIRNIYF 394
++ES + G D D + +D ++ + + + + ++ + +
Sbjct: 384 DLPQIESEVDAILGAADFDRNGYIDYSEFVT----------VAMDRKSLLSKDKLESAFQ 433
Query: 395 PFDVETDTALSVATEMVAELDITDQDVTKIADMI-------DGEI 432
FD + + +SV E+ + + + +MI DG++
Sbjct: 434 KFDQDGNGKISV-DELASVFGLDHLESKTWKEMISGIDSNNDGDV 477
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-36
Identities = 71/300 (23%), Positives = 116/300 (38%), Gaps = 40/300 (13%)
Query: 6 HLEPDCSEFVEVDPTGRYGRYN----EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL 61
LE D + E G+ + ++LG GA T+ ++ +VA VK
Sbjct: 6 SLEQDDGD--EETSVVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVA---VKRIL-- 57
Query: 62 QSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--RLK 118
PE E+ LL+ +H N+++++ + D + E + TL++Y +
Sbjct: 58 --PECFSFADREVQLLRESDEHPNVIRYFCTEKD--RQFQYIAIE-LCAATLQEYVEQKD 112
Query: 119 HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGE----VKIGDLGL 174
+ + + L +Q GL +LHS + ++HRDLK NI ++ I D GL
Sbjct: 113 FAHLGLEPITL-LQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGL 169
Query: 175 AAILRK-----SHAAHCVGTPEFMAPEVYEEA----YNELVDIYSFGMCILEMVTFEYP- 224
L S + GT ++APE+ E VDI+S G +++
Sbjct: 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229
Query: 225 -YSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQ 282
A I S D R +EK +A R SA+ +L PF
Sbjct: 230 FGKSLQRQANILLGACSLDCLHPEKHE-DVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 77/295 (26%), Positives = 122/295 (41%), Gaps = 49/295 (16%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVK-------LYDFLQSPEDLERLYCEIHLLKTL 80
+ LG GA V AF+ +VA +K + + + EI +LK L
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVA---IKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 81 KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLY 140
H I+K + + V E+ G L + +KR+ KL+ Q+L + Y
Sbjct: 73 NHPCIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 141 LHSHDPPVIHRDLKCDNIFVNGNQGE--VKIGDLGLAAILRKSHAAH-CVGTPEFMAPEV 197
LH + +IHRDLK +N+ ++ + + +KI D G + IL ++ GTP ++APEV
Sbjct: 130 LHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
Query: 198 ----YEEAYNELVDIYSFGMCILEMVTFEY-------PYSECTHPAQIYKKVVSGKKPDS 246
YN VD +S G IL + P+SE + ++ SGK
Sbjct: 188 LVSVGTAGYNRAVDCWSLG-VIL------FICLSGYPPFSEHRTQVSLKDQITSGK---- 236
Query: 247 LYRVKDP-------EVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSL 293
Y + V+K L R + E L P+LQ +D + + L
Sbjct: 237 -YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 290
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-35
Identities = 105/472 (22%), Positives = 176/472 (37%), Gaps = 94/472 (19%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVA---------WNQVKLYDFLQSPEDLERLYCEIHLLK 78
LG GA V ++ E A D + E +Y EI LLK
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 79 TLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGL 138
+L H NI+K + + D + VTE + G L + + + + +QIL G+
Sbjct: 102 SLDHPNIIKLFDVFED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGI 159
Query: 139 LYLHSHDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAH-CVGTPEFMAP 195
YLH H+ ++HRD+K +NI N N +KI D GL++ K + +GT ++AP
Sbjct: 160 CYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
Query: 196 EVYEEAYNELVDIYSFGMCIL-EMVTFEYPYSECTHPAQIYKKVVSGK---KPDSLYRVK 251
EV ++ YNE D++S G I+ ++ P+ I KKV GK + +
Sbjct: 218 EVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGGQND-QDIIKKVEKGKYYFDFNDWKNI- 274
Query: 252 DPEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCE-------------SNLRSLDYSR 297
E + ++ L + R +A E LN +++ SN+R + S+
Sbjct: 275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQ 334
Query: 298 EL---------------DDMDPLIRQPHIDFHHIDNSFSNGCANGYGYDTPSE--WGYSP 340
+L ++ L F +D NG G E GY+
Sbjct: 335 KLAQAAILFIGSKLTTLEERKELTDI----FKKLD-------KNGDGQLDKKELIEGYNV 383
Query: 341 VEVESNGIELFGYHDDD-----HSSDVDISIKGKRRDDGGI--------FLRLRIADKEG 387
+ N + +++ D D +G I + +I E
Sbjct: 384 LRNFKNELGELKNVEEEVDNILKEVDFD--------KNGYIEYSEFISVCMDKQILFSEE 435
Query: 388 RIRNIYFPFDVETDTALSVATEMVAELDITDQDVTKIADMI-------DGEI 432
R+R + FD + ++ E+ +T D++ D I
Sbjct: 436 RLRRAFNLFDTDKSGKITK-EELANLFGLTSISEKTWNDVLGEADQNKDNMI 486
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-35
Identities = 45/301 (14%), Positives = 85/301 (28%), Gaps = 61/301 (20%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLE------------------- 68
+LG+ A D+ G V + F + P
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFE---VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135
Query: 69 --------RLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTS------GTLRQ 114
R L+K + K +++ D + F+ S L
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195
Query: 115 YRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 174
+ HK + A Q++R L LH + ++H L+ +I ++ G V +
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFLTGFEH 252
Query: 175 AAILRKSHAAHCVGTPEFMAPEV------------YEEAYNELVDIYSFGMCILEMVTFE 222
+R + F PE+ D ++ G+ I + +
Sbjct: 253 L--VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 223 YPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281
P ++ + + K VR +E L RL + + P
Sbjct: 311 LPITK-DAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEY 363
Query: 282 Q 282
+
Sbjct: 364 E 364
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 66/259 (25%), Positives = 117/259 (45%), Gaps = 19/259 (7%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEDLERLYCEIHLLKTLKHKNIMK 87
LGKG VY A ++ +A +K+ L+ +L E+ + L+H NI++
Sbjct: 17 LGKGKFGNVYLAREKQSKFILA---LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
Y + D + + E GT+ + K + + + + ++ L Y HS
Sbjct: 74 LYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-- 129
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEE-AYNELV 206
VIHRD+K +N+ + G+ GE+KI D G + S GT +++ PE+ E ++E V
Sbjct: 130 VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV 188
Query: 207 DIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG--KKPDSLYRVKDPEVRRFVEKCLA 264
D++S G+ E + + P+ E + YK++ PD + R + + L
Sbjct: 189 DLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFV----TEGARDLISRLLK 243
Query: 265 T-VSLRLSARELLNDPFLQ 282
S R RE+L P++
Sbjct: 244 HNPSQRPMLREVLEHPWIT 262
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-35
Identities = 72/269 (26%), Positives = 126/269 (46%), Gaps = 15/269 (5%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+LGKG+ V + D E A + +D + E+ LLK L H NIMK
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMK 85
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
+ D + + V E++T G L +K KR + +Q+ G+ Y+H H+
Sbjct: 86 LFEILED--SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 148 VIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVYEEAYNE 204
++HRDLK +NI + + ++KI D GL+ +++ +GT ++APEV Y+E
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 205 LVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK---KPDSLYRVKDPEVRRFVEK 261
D++S G+ + +++ P+ I K+V +GK + + + + K
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNE-YDILKRVETGKYAFDLPQWRTI-SDDAKDLIRK 259
Query: 262 CLAT-VSLRLSARELLNDPFLQIDDCESN 289
L SLR++A + L P++Q E+
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSETP 288
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 3e-34
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 37/221 (16%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E++G+G VY+ + VA VK++ F + ++ I+ + ++H NI +
Sbjct: 19 ELIGRGRYGAVYKG--SLDERPVA---VKVFSF-ANRQNFINE-KNIYRVPLMEHDNIAR 71
Query: 88 FYTSWV-DTANRNINF--VTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS- 143
F TA+ + + V E + +G+L +Y L + + + RGL YLH+
Sbjct: 72 FIVGDERVTADGRMEYLLVMEYYPNGSLXKY-LSLHTSDWVSSCRLAHSVTRGLAYLHTE 130
Query: 144 ------HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA----------HCV 187
+ P + HRDL N+ V + G I D GL+ L + V
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 188 GTPEFMAPEVYEEAYN--------ELVDIYSFGMCILEMVT 220
GT +MAPEV E A N + VD+Y+ G+ E+
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 59/276 (21%), Positives = 117/276 (42%), Gaps = 29/276 (10%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+G+G+ V A + I A ++ F++ + ++ EI ++K+L H NI++
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPK-YFVEDVDRFKQ---EIEIMKSLDHPNIIR 70
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
Y ++ D N +I V E+ T G L + + + + +L + Y H +
Sbjct: 71 LYETFED--NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN-- 126
Query: 148 VIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVYEEAYNE 204
V HRDLK +N F+ + +K+ D GLAA + VGTP +++P+V E Y
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGP 186
Query: 205 LVDIYSFGMCILEMVTFEYP--YSECTHPAQIYKKVVSGKKPDSLYRVKDP-------EV 255
D +S G ++ ++ YP + +++ K+ G + + +
Sbjct: 187 ECDEWSAG-VMMYVLLCGYPPFSAP--TDSEVMLKIREGT-----FTFPEKDWLNVSPQA 238
Query: 256 RRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNL 290
+ + L R+++ + L + + S
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 274
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 65/270 (24%), Positives = 117/270 (43%), Gaps = 29/270 (10%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
LG GA V+ + G+E +K + +S +E++ EI +LK+L H NI+K
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERV---IKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 88 FYTSWVDTANRNINFVTEMFTSGTL----RQYRLKHKRVNIRAVKLWCRQILRGLLYLHS 143
+ + D N+ V E G L + + K ++ V +Q++ L Y HS
Sbjct: 85 IFEVFED--YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142
Query: 144 HDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVYEE 200
V+H+DLK +NI F + + +KI D GLA + + + GT +MAPEV++
Sbjct: 143 QH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR 200
Query: 201 AYNELVDIYSFGMCILEMVTFEYP--YSECTHPAQIYKKVVSGK-----KPDSLYRVKDP 253
DI+S G ++ + ++ +K + + L P
Sbjct: 201 DVTFKCDIWSAG-VVMYFLLTGCLPFTGT--SLEEVQQKATYKEPNYAVECRPL----TP 253
Query: 254 EVRRFVEKCLAT-VSLRLSARELLNDPFLQ 282
+ +++ L R SA ++L+ + +
Sbjct: 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 1e-33
Identities = 48/313 (15%), Positives = 90/313 (28%), Gaps = 58/313 (18%)
Query: 15 VEVDPTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSP--EDLERL 70
VE + R +LG+ A D+ G V + F + P ++++
Sbjct: 69 VESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFE---VHVPYFTERPPSNAIKQM 125
Query: 71 YCEIHLLKTL----------------------KHKNIMKFYTSWVDTANRNIN--FVTEM 106
E+ L+ L K K +D + + F
Sbjct: 126 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 185
Query: 107 FTSG-------TLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIF 159
L + HK + A Q++R L LH + ++H L+ +I
Sbjct: 186 RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIV 243
Query: 160 VNGNQGEVKIGDLGLAAILRKSHAAHC---VGTPEFMAPEVY------EEAYNELVDIYS 210
++ G V + S + PE A + D ++
Sbjct: 244 LDQR-GGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302
Query: 211 FGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLR 269
G+ I + + P ++ + + K VR +E L R
Sbjct: 303 LGLAIYWIWCADLPNTD-DAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDR 355
Query: 270 LSARELLNDPFLQ 282
L + + P +
Sbjct: 356 LLPLQAMETPEYE 368
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 66/261 (25%), Positives = 119/261 (45%), Gaps = 23/261 (8%)
Query: 30 LGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEDLERLYCEIHLLKTLKHKNIMK 87
LGKG VY A ++ +A +K+ L+ +L EI + L+H NI++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMA---LKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
Y + D + I + E G L + KH R + + + ++ L Y H
Sbjct: 79 MYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK-- 134
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CVGTPEFMAPEVYE-EAYNE 204
VIHRD+K +N+ + G +GE+KI D G + S C GT +++ PE+ E + ++E
Sbjct: 135 VIHRDIKPENLLM-GYKGELKIADFGWSV-HAPSLRRRTMC-GTLDYLPPEMIEGKTHDE 191
Query: 205 LVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG--KKPDSLYRVKDPEVRRFVEKC 262
VD++ G+ E + P+ +H ++++V+ K P L + + K
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTE-THRRIVNVDLKFPPFL----SDGSKDLISKL 246
Query: 263 LAT-VSLRLSARELLNDPFLQ 282
L RL + ++ P+++
Sbjct: 247 LRYHPPQRLPLKGVMEHPWVK 267
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 29/269 (10%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-FLQSPEDLERLYCEIHLLKTLKHKNIM 86
+LGKG+ V + D E A VK+ + +D + E+ LLK L H NIM
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYA---VKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDP 146
K + D + + V E++T G L +K KR + +Q+ G+ Y+H H+
Sbjct: 85 KLFEILED--SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN- 141
Query: 147 PVIHRDLKCDNIFVNGNQGE--VKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVYEEAYN 203
++HRDLK +NI + + + +KI D GL+ +++ +GT ++APEV Y+
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYD 200
Query: 204 ELVDIYSFGMCILEMVTFEYP--YSECTHPAQIYKKVVSGKKPDSLYRVKDP-------E 254
E D++S G IL ++ P Y + + I K+V +GK Y P +
Sbjct: 201 EKCDVWSAG-VILYILLSGTPPFYGK--NEYDILKRVETGK-----YAFDLPQWRTISDD 252
Query: 255 VRRFVEKCLAT-VSLRLSARELLNDPFLQ 282
+ + K L SLR++A + L P++Q
Sbjct: 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQ 281
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 71/295 (24%), Positives = 134/295 (45%), Gaps = 25/295 (8%)
Query: 22 RYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ-SPEDLERLYCEIHLLK 78
G Y + +GKG V A G EVA +K+ D Q +P L++L+ E+ ++K
Sbjct: 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVA---IKIIDKTQLNPTSLQKLFREVRIMK 69
Query: 79 TLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGL 138
L H NI+K + V + + + E + G + Y + H R+ + + RQI+ +
Sbjct: 70 ILNHPNIVKLFE--VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV 127
Query: 139 LYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEV 197
Y H ++HRDLK +N+ ++ + +KI D G + G P + APE+
Sbjct: 128 QYCHQKR--IVHRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPEL 184
Query: 198 YE-EAYN-ELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD--- 252
++ + Y+ VD++S G+ + +V+ P+ ++ ++V+ GK YR+
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-ELRERVLRGK-----YRIPFYMS 238
Query: 253 PEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDMDPLI 306
+ +++ L R + +++ D ++ E L+ ELD D
Sbjct: 239 TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFV-EPELDISDQKR 292
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 63/294 (21%), Positives = 129/294 (43%), Gaps = 40/294 (13%)
Query: 22 RYGRYN--EILGKGASKTVYRAFDEYEGIEVA----------------------WNQVKL 57
+ +Y + +GKG+ V A++E + A +
Sbjct: 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 58 YDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRL 117
+Q +E++Y EI +LK L H N++K D ++ V E+ G + +
Sbjct: 71 GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-P 129
Query: 118 KHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177
K ++ + + + +++G+ YLH +IHRD+K N+ V + G +KI D G++
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGED-GHIKIADFGVSNE 186
Query: 178 LRKSHA--AHCVGTPEFMAPEV---YEEAYN-ELVDIYSFGMCILEMVTFEYPYSECTHP 231
+ S A ++ VGTP FMAPE + ++ + +D+++ G+ + V + P+ +
Sbjct: 187 FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246
Query: 232 AQIYKKVVSG--KKPDSLYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQ 282
++ K+ S + PD +++ + + L R+ E+ P++
Sbjct: 247 C-LHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 64/270 (23%), Positives = 119/270 (44%), Gaps = 17/270 (6%)
Query: 24 GRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK 81
++ + LG+GA V A + VA VK+ D ++ + E + EI + K L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 82 HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYL 141
H+N++KFY N E + G L + + + Q++ G++YL
Sbjct: 64 HENVVKFYGHR-REGNI-QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH----CVGTPEFMAPEV 197
H + HRD+K +N+ ++ +KI D GLA + R ++ GT ++APE+
Sbjct: 122 HGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 198 YE-EAYN-ELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEV 255
+ ++ E VD++S G+ + M+ E P+ + + Q Y K + ++ D
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 256 RRFVEKCLAT-VSLRLSARELLNDPFLQID 284
+ K L S R++ ++ D +
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKP 268
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 71/278 (25%), Positives = 127/278 (45%), Gaps = 40/278 (14%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-FLQSPEDLERLYCEIHLLKTLKHKNIM 86
E LGKGA V R + G+E A K+ + S D ++L E + + L+H NI+
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFA---AKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDP 146
+ + S + V ++ T G L + + + + +QIL + Y HS+
Sbjct: 69 RLHDSIQE--ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG- 125
Query: 147 PVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEV-YEEAY 202
++HR+LK +N+ + +G VK+ D GLA + S A H GTP +++PEV ++ Y
Sbjct: 126 -IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 203 NELVDIYSFGMCILEMVTFEY-------PYSECTHPAQIYKKVVSGKKPDSLYRVKDP-- 253
++ VDI++ G IL Y P+ + ++Y ++ +G Y P
Sbjct: 185 SKPVDIWACG-VIL------YILLVGYPPFWDEDQH-RLYAQIKAGA-----YDYPSPEW 231
Query: 254 -----EVRRFVEKCLAT-VSLRLSARELLNDPFLQIDD 285
E + ++ L R++A + L P++ +
Sbjct: 232 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 62/300 (20%), Positives = 112/300 (37%), Gaps = 39/300 (13%)
Query: 18 DPTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-----FLQSPEDLERL 70
D Y +LGKG TV+ + ++VA +K+ D
Sbjct: 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVA---IKVIPRNRVLGWSPLSDSVTC 81
Query: 71 YCEIHLLKTL----KHKNIMKFYTSWVDTANRNINFVTEMFTSGT-LRQYRLKHKRVNIR 125
E+ LL + H +++ W +T V E L Y + +
Sbjct: 82 PLEVALLWKVGAGGGHPGVIRLLD-WFET-QEGFMLVLERPLPAQDLFDYITEKGPLGEG 139
Query: 126 AVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH 185
+ + Q++ + + HS V+HRD+K +NI ++ +G K+ D G A+L
Sbjct: 140 PSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD 197
Query: 186 CVGTPEFMAPEVYE-EAYN-ELVDIYSFGMCIL-EMVTFEYPYSECTHPAQIYKKVVSGK 242
GT + PE Y+ ++S G+ +L +MV + P+ ++++ +
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGI-LLYDMVCGDIPFER-------DQEILEAE 249
Query: 243 KPDSLYRVKD---PEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRE 298
P+ + +CLA S R S E+L DP++Q + L
Sbjct: 250 -----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPA 304
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 27/275 (9%)
Query: 22 RYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEDLERLYCEIHLL 77
+ G Y + LG G V + G +VA VK+ + ++S + + ++ EI L
Sbjct: 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVA---VKILNRQKIRSLDVVGKIKREIQNL 65
Query: 78 KTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRG 137
K +H +I+K Y V + + V E + G L Y KH RV + +QIL
Sbjct: 66 KLFRHPHIIKLYQ--VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CVGTPEFMAP 195
+ Y H H V+HRDLK +N+ ++ + KI D GL+ ++ C G+P + AP
Sbjct: 124 VDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSC-GSPNYAAP 179
Query: 196 EVYE-EAYN-ELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD- 252
EV Y VDI+S G+ + ++ P+ + P ++KK+ G + + +
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-LFKKIRGGV-----FYIPEY 233
Query: 253 --PEVRRFVEKCLAT-VSLRLSARELLNDPFLQID 284
V + L R + +++ + + D
Sbjct: 234 LNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 71/291 (24%), Positives = 131/291 (45%), Gaps = 40/291 (13%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-FLQSPEDLERLYCEIHLLKTLKHKNIM 86
E LGKGA V R + G+E A K+ + S D ++L E + + L+H NI+
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFA---AKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDP 146
+ + S + V ++ T G L + + + + +QIL + Y HS+
Sbjct: 92 RLHDSIQE--ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG- 148
Query: 147 PVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEV-YEEAY 202
++HR+LK +N+ + +G VK+ D GLA + S A H GTP +++PEV ++ Y
Sbjct: 149 -IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 203 NELVDIYSFGMCILEMVTFEY-------PYSECTHPAQIYKKVVSGKKPDSLYRVKDP-- 253
++ VDI++ G IL Y P+ + ++Y ++ +G Y P
Sbjct: 208 SKPVDIWACG-VIL------YILLVGYPPFWDEDQH-RLYAQIKAGA-----YDYPSPEW 254
Query: 254 -----EVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRE 298
E + ++ L R++A + L P++ + ++ + +
Sbjct: 255 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVD 305
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 69/318 (21%), Positives = 129/318 (40%), Gaps = 17/318 (5%)
Query: 24 GRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK 81
++ + LG+GA V A + VA VK+ D ++ + E + EI + K L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 82 HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYL 141
H+N++KFY N E + G L + + + Q++ G++YL
Sbjct: 64 HENVVKFYGHR-REGNI-QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH----CVGTPEFMAPEV 197
H + HRD+K +N+ ++ +KI D GLA + R ++ GT ++APE+
Sbjct: 122 HGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 198 YE-EAYN-ELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEV 255
+ ++ E VD++S G+ + M+ E P+ + + Q Y K + ++ D
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 256 RRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDMDPLIRQPHIDFH 314
+ K L S R++ ++ D + + R S + + +
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNL 298
Query: 315 HIDNSFSNGCANGYGYDT 332
S G G+
Sbjct: 299 DFSPVNSASRTPGSGWSK 316
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 68/318 (21%), Positives = 111/318 (34%), Gaps = 77/318 (24%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD----FLQSPEDLERLYCEIHLLKTLKHK 83
+G+G+ V A + A +K+ + +P+D+ER+ E+ L+K L H
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRA---IKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNI------------------- 124
NI + Y + D + I V E+ G L +
Sbjct: 89 NIARLYEVYED--EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 125 ---------------------RAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNI-FVNG 162
+ + RQI L YLH+ + HRD+K +N F
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTN 204
Query: 163 NQGEVKIGDLGLAAILRKSHAAHC------VGTPEFMAPEV---YEEAYNELVDIYSFGM 213
E+K+ D GL+ K + GTP F+APEV E+Y D +S G
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG- 263
Query: 214 CIL-EMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDP-------EVRRFVEKCLAT 265
+L ++ P+ +V++ K ++P R + L
Sbjct: 264 VLLHLLLMGAVPFPGVNDA-DTISQVLNKK-----LCFENPNYNVLSPLARDLLSNLLNR 317
Query: 266 -VSLRLSARELLNDPFLQ 282
V R A L P++
Sbjct: 318 NVDERFDAMRALQHPWIS 335
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 60/292 (20%), Positives = 120/292 (41%), Gaps = 40/292 (13%)
Query: 24 GRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-----FLQSPEDLERLYCEIHL 76
+Y +LG G +VY + + VA +K + + R+ E+ L
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVA---IKHVEKDRISDWGELPNGTRVPMEVVL 99
Query: 77 LKTLKHK--NIMKFYTSWVDTANRNINFVTEMFT-SGTLRQYRLKHKRVNIRAVKLWCRQ 133
LK + +++ W + + + E L + + + + + Q
Sbjct: 100 LKKVSSGFSGVIRLLD-WFER-PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157
Query: 134 ILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFM 193
+L + + H+ V+HRD+K +NI ++ N+GE+K+ D G A+L+ + GT +
Sbjct: 158 VLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYS 215
Query: 194 APEVYE-EAYN-ELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK 251
PE Y+ ++S G+ + +MV + P+ ++++ G+ +
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------DEEIIRGQ-----VFFR 263
Query: 252 D---PEVRRFVEKCLAT-VSLRLSARELLNDPFLQ-----IDDCESNLRSLD 294
E + + CLA S R + E+ N P++Q + E +L SL
Sbjct: 264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLS 315
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-31
Identities = 62/294 (21%), Positives = 105/294 (35%), Gaps = 51/294 (17%)
Query: 27 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNI 85
+ILG G+S TV ++G VA VK + + EI LL H N+
Sbjct: 20 EKILGYGSSGTVVFQ-GSFQGRPVA---VKRML----IDFCDIALMEIKLLTESDDHPNV 71
Query: 86 MKFYTSWVDTANRNINFVTEMFTSGTL-------RQYRLKHKRVNIRAVKLWCRQILRGL 138
+++Y S +R + E + L K RQI G+
Sbjct: 72 IRYYCSETT--DRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 139 LYLHSHDPPVIHRDLKCDNIFVN------------GNQGEVKIGDLGLAAILR------K 180
+LHS +IHRDLK NI V+ + I D GL L +
Sbjct: 129 AHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 181 SHAAHCVGTPEFMAPEV--------YEEAYNELVDIYSFGMCILEMVTFEYP--YSECTH 230
++ + GT + APE+ + +DI+S G +++ + +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 231 PAQIYKKVVSGKKPDSLYRVK-DPEVRRFVEKCLAT-VSLRLSARELLNDPFLQ 282
+ I + + S + L+ E + + + R +A ++L P
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 68/314 (21%), Positives = 125/314 (39%), Gaps = 33/314 (10%)
Query: 22 RYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD---FLQSPEDLERLYCEIHL 76
G+Y ++LG+G+ V D A VK+ + P + EI L
Sbjct: 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRA---VKILKKKKLRRIPNGEANVKKEIQL 59
Query: 77 LKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWCRQIL 135
L+ L+HKN+++ + + + V E G + KR + + Q++
Sbjct: 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI 119
Query: 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-----CVGTP 190
GL YLHS ++H+D+K N+ + G +KI LG+A L A G+P
Sbjct: 120 DGLEYLHSQG--IVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQ-GSP 175
Query: 191 EFMAPEVY--EEAYN-ELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK--KPD 245
F PE+ + ++ VDI+S G+ + + T YP+ E + ++++ + G P
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSYAIPG 234
Query: 246 SLYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDMDP 304
P + ++ L + R S R++ + + + D D
Sbjct: 235 DC----GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK-KHPPAEAPVPIPPSPDTKDR 289
Query: 305 LIRQ---PHIDFHH 315
P+++ H
Sbjct: 290 WRSMTVVPYLEDLH 303
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 74/287 (25%), Positives = 119/287 (41%), Gaps = 33/287 (11%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSP-EDLERLYCEIHLLKTLKHKNIM 86
E++GKG V R + G + A V + F SP E L E + LKH +I+
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNI----RAVKLWCRQILRGLLYLH 142
+ ++ + + V E L +K + RQIL L Y H
Sbjct: 90 ELLETYSS--DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 143 SHDPPVIHRDLKCDNI-FVN-GNQGEVKIGDLGLAAILRKSHAAH--CVGTPEFMAPEV- 197
++ +IHRD+K + + N VK+G G+A L +S VGTP FMAPEV
Sbjct: 148 DNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 198 YEEAYNELVDIYSFGMCILEMVTFEYP--YSECTHPAQIYKKVVSGKKPDSLYRVKDP-- 253
E Y + VD++ G IL ++ Y ++++ ++ GK Y++
Sbjct: 206 KREPYGKPVDVWGCG-VILFILLSGCLPFYGT---KERLFEGIIKGK-----YKMNPRQW 256
Query: 254 -----EVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLD 294
+ V + L + R++ E LN P+L+ D + L
Sbjct: 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLP 303
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 47/305 (15%), Positives = 103/305 (33%), Gaps = 45/305 (14%)
Query: 30 LGKGASKTVYRA-----------FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLK 78
L +G + +++ + D + + E+ ++
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 79 TLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWC------- 131
+K++ + + + + E + ++ ++ ++
Sbjct: 99 DIKNEYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 132 -RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP 190
+ +L Y+H+ + HRD+K NI ++ N G VK+ D G + + GT
Sbjct: 157 IKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKN-GRVKLSDFGESEYMVDKKIKGSRGTY 214
Query: 191 EFMAPEVYE---EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG--KKPD 245
EFM PE + VDI+S G+C+ M P+S +++ + + + P
Sbjct: 215 EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPL 274
Query: 246 SLYRVKD---------------PEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESN 289
E F++ L + R+++ + L +L D +
Sbjct: 275 DRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA-DTNIED 333
Query: 290 LRSLD 294
LR
Sbjct: 334 LREFS 338
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-30
Identities = 78/352 (22%), Positives = 135/352 (38%), Gaps = 78/352 (22%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+++G G+ V++A EVA +V D E+ +++ +KH N++
Sbjct: 46 KVIGNGSFGVVFQAKLVESD-EVAIKKVLQ--------DKRFKNRELQIMRIVKHPNVVD 96
Query: 88 ----FYTSWVDTANRNINFVTEMFTSGTL----RQYRLKHKRVNIRAVKLWCRQILRGLL 139
FY++ +N V E + T+ R Y + + + +KL+ Q+LR L
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLE-YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 140 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFM------ 193
Y+HS + HRD+K N+ ++ G +K+ D G A IL E
Sbjct: 156 YIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG---------EPNVSYICS 204
Query: 194 ----APEVYEEA--YNELVDIYSFGMCIL-EMVTFE--YPYSECTH-------------P 231
APE+ A Y +DI+S G C++ E++ + +P
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTG-CVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263
Query: 232 AQI-------YKKVVSGKKPDSLYRV----KDPEVRRFVEKCLA-TVSLRLSARELLNDP 279
QI + +P +V P+ + + L T S RL+A E L P
Sbjct: 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323
Query: 280 FL----QIDDCESNLRSL----DYSRELDDMDPLIRQPHIDFHHIDNSFSNG 323
F + N R L ++++E + P + + H S G
Sbjct: 324 FFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLVPQHAEAELLSRG 375
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 80/315 (25%), Positives = 137/315 (43%), Gaps = 29/315 (9%)
Query: 22 RYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEDLERLYCEIHLL 77
G Y E LG+G+ V A +VA +K L+ + R+ EI L
Sbjct: 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVA---LKFISRQLLKKSDMHMRVEREISYL 63
Query: 78 KTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRG 137
K L+H +I+K Y T +I V E + G L Y ++ KR+ + + +QI+
Sbjct: 64 KLLRHPHIIKLYDVI-TT-PTDIVMVIE-YAGGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CVGTPEFMAP 195
+ Y H H ++HRDLK +N+ ++ N VKI D GL+ I+ + C G+P + AP
Sbjct: 121 IEYCHRHK--IVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNFLKTSC-GSPNYAAP 176
Query: 196 EVYE-EAYN-ELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK--KPDSLYRVK 251
EV + Y VD++S G+ + M+ P+ + P ++KKV S PD L
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-NLFKKVNSCVYVMPDFL---- 231
Query: 252 DPEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDMD---PLIR 307
P + + + + R++ +E+ DP+ ++ + + D L
Sbjct: 232 SPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGE 291
Query: 308 QPHIDFHHIDNSFSN 322
+I + +
Sbjct: 292 AMGFSEDYIVEALRS 306
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-29
Identities = 63/281 (22%), Positives = 116/281 (41%), Gaps = 24/281 (8%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E LG GA V+R + G A K D E + EI + L+H ++
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFA---AKFVM-TPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNI--RAVKLWCRQILRGLLYLHSHD 145
+ ++ D + + + E + G L + ++ + + + RQ+ +GL ++H ++
Sbjct: 219 LHDAFED--DNEMVMIYEFMSGGELFE-KVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 146 PPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVYE-EAY 202
+H DLK +NI F E+K+ D GL A L + GT EF APEV E +
Sbjct: 276 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 333
Query: 203 NELVDIYSFGMCILEMVTFEYP--YSECTHPAQIYKKVVSGK---KPDSLYRVKDPEVRR 257
D++S G + ++ E + + + V S + + + + +
Sbjct: 334 GYYTDMWSVG-VLSYILLSGLSPFGGE--NDDETLRNVKSCDWNMDDSAFSGISE-DGKD 389
Query: 258 FVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSR 297
F+ K L + R++ + L P+L + + SR
Sbjct: 390 FIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSR 430
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 66/291 (22%), Positives = 113/291 (38%), Gaps = 47/291 (16%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVA-----WNQVKLYDFLQSPEDLERLYCEIHLLKTLK- 81
EILG+G S V R + E A + + E E E+ +L+ +
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 82 HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYL 141
H NI++ ++ N V ++ G L Y + ++ + + R +L + L
Sbjct: 83 HPNIIQLKDTYET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICAL 140
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEV--- 197
H + ++HRDLK +NI ++ + +K+ D G + L GTP ++APE+
Sbjct: 141 HKLN--IVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 197
Query: 198 ----YEEAYNELVDIYSFGMCILEMVTFEY-------PYSECTHPAQIYKKVVSGKKPDS 246
Y + VD++S G I+ Y P+ + + ++SG
Sbjct: 198 SMNDNHPGYGKEVDMWSTG-VIM------YTLLAGSPPFWHRKQM-LMLRMIMSGN---- 245
Query: 247 LYRVKDP-------EVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESN 289
Y+ P V+ V + L R +A E L PF Q E
Sbjct: 246 -YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 69/280 (24%), Positives = 114/280 (40%), Gaps = 37/280 (13%)
Query: 22 RYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVK-------LYDFLQSPEDLERLYC 72
+Y+ LG GA V+ A D+ + EV VK L D L ++
Sbjct: 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVV---VKFIKKEKVLEDCWIEDPKLGKVTL 78
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGT-LRQYRLKHKRVNIRAVKLWC 131
EI +L ++H NI+K + V E SG L + +H R++
Sbjct: 79 EIAILSRVEHANIIKVLD--IFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF 136
Query: 132 RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-CVGTP 190
RQ++ + YL D +IHRD+K +NI + + +K+ D G AA L + + GT
Sbjct: 137 RQLVSAVGYLRLKD--IIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKLFYTFCGTI 193
Query: 191 EFMAPEVYE-EAYN-ELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLY 248
E+ APEV Y ++++S G+ + +V E P+ E ++ V
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE-------LEETVEAA-----I 241
Query: 249 RVKD---PEVRRFVEKCLAT-VSLRLSARELLNDPFLQID 284
E+ V L R + +L+ DP++
Sbjct: 242 HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-29
Identities = 61/279 (21%), Positives = 105/279 (37%), Gaps = 32/279 (11%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E LG GA V+R ++ G K + P D + EI ++ L H ++
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFV---AKFIN-TPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNI--RAVKLWCRQILRGLLYLHSHD 145
+ ++ D + + E + G L R+ + + V + RQ GL ++H H
Sbjct: 113 LHDAFED--KYEMVLILEFLSGGELFD-RIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 146 PPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVYE-EAY 202
++H D+K +NI VKI D GLA L T EF APE+ + E
Sbjct: 170 --IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 227
Query: 203 NELVDIYSFGMCILEMVTFEYP--YSECTHPAQIYKKVVSGKKPDSLYRVKDP------- 253
D+++ G + ++ E + + V + +
Sbjct: 228 GFYTDMWAIG-VLGYVLLSGLSPFAGE--DDLETLQNVKRCD-----WEFDEDAFSSVSP 279
Query: 254 EVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLR 291
E + F++ L RL+ + L P+L+ D R
Sbjct: 280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 318
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 67/284 (23%), Positives = 115/284 (40%), Gaps = 31/284 (10%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
LG+GA+ VYR + A +K+ + + EI +L L H NI+K
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYA---LKVLKKTVDKKIVRT---EIGVLLRLSHPNIIK 112
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
+ I+ V E+ T G L ++ + R +QIL + YLH +
Sbjct: 113 LKEIFET--PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG-- 168
Query: 148 VIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEV-YEEAYN 203
++HRDLK +N+ + +KI D GL+ I+ GTP + APE+ AY
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYG 228
Query: 204 ELVDIYSFG--MCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDP-------E 254
VD++S G IL + FE P+ + +++++++ + Y P
Sbjct: 229 PEVDMWSVGIITYIL-LCGFE-PFYDERGDQFMFRRILNCE-----YYFISPWWDEVSLN 281
Query: 255 VRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSR 297
+ V K + RL+ + L P++ +
Sbjct: 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKK 325
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-29
Identities = 78/303 (25%), Positives = 135/303 (44%), Gaps = 24/303 (7%)
Query: 16 EVDPTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEDLERLY 71
+ D + G Y + LG G V E G +VA VK+ + ++S + + ++
Sbjct: 8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVA---VKILNRQKIRSLDVVGKIR 64
Query: 72 CEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWC 131
EI LK +H +I+K Y V + +I V E + G L Y K+ R++ + +
Sbjct: 65 REIQNLKLFRHPHIIKLYQ--VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF 122
Query: 132 RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-CVGTP 190
+QIL G+ Y H H V+HRDLK +N+ ++ + KI D GL+ ++ G+P
Sbjct: 123 QQILSGVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSP 179
Query: 191 EFMAPEVYE-EAYN-ELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK--KPDS 246
+ APEV Y VDI+S G+ + ++ P+ + P ++KK+ G P
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-LFKKICDGIFYTPQY 238
Query: 247 LYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDMDPL 305
L +P V ++ L R + +++ + + D L D S +D
Sbjct: 239 L----NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ-DLPKYLFPEDPSYSSTMIDDE 293
Query: 306 IRQ 308
+
Sbjct: 294 ALK 296
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 65/270 (24%), Positives = 121/270 (44%), Gaps = 33/270 (12%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEDLERLYCEIHLLKTLKHKNI 85
E+LG GA V+ G A +K LE EI +LK +KH+NI
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFA---LKCIKKSPAFRDSSLEN---EIAVLKKIKHENI 68
Query: 86 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHD 145
+ ++ + V ++ + G L L+ + L +Q+L + YLH +
Sbjct: 69 VTLE-DIYESTT-HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 146 PPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAHCVGTPEFMAPEV-YEEAY 202
++HRDLK +N+ ++ + ++ I D GL+ + + + GTP ++APEV ++ Y
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPY 184
Query: 203 NELVDIYSFGMCILEMVTFEYP--YSECTHPAQIYKKVVSGKKPDSLYRVKDP------- 253
++ VD +S G I ++ YP Y E +++++K+ G Y + P
Sbjct: 185 SKAVDCWSIG-VITYILLCGYPPFYEE--TESKLFEKIKEGY-----YEFESPFWDDISE 236
Query: 254 EVRRFVEKCLAT-VSLRLSARELLNDPFLQ 282
+ F+ L + R + + L+ P++
Sbjct: 237 SAKDFICHLLEKDPNERYTCEKALSHPWID 266
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 58/296 (19%), Positives = 118/296 (39%), Gaps = 33/296 (11%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E LG+G V+R + K D + EI +L +H+NI+
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYM---AKFVK--VKGTDQVLVKKEISILNIARHRNILH 65
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNI--RAVKLWCRQILRGLLYLHSHD 145
+ S+ + + E + + + R+ + R + + Q+ L +LHSH+
Sbjct: 66 LHESFES--MEELVMIFEFISGLDIFE-RINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 146 PPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRKSHAAHC-VGTPEFMAPEVYE-EAY 202
+ H D++ +NI + +KI + G A L+ PE+ APEV++ +
Sbjct: 123 --IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 203 NELVDIYSFGMCILEMVTFEYP--YSECTHPAQIYKKVVSGKKPDSLYRVKDP------- 253
+ D++S G ++ ++ +E QI + +++ + Y +
Sbjct: 181 STATDMWSLG-TLVYVLLSGINPFLAE--TNQQIIENIMNAE-----YTFDEEAFKEISI 232
Query: 254 EVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDMDPLIRQ 308
E FV++ L R++A E L P+L+ + + + + LI++
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 63/303 (20%), Positives = 115/303 (37%), Gaps = 57/303 (18%)
Query: 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEDLERLYCEIHLLKT 79
Y ++LG+GA V + E A VK+ + + R E+ +L
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYA---VKIIEKQPGHIRSRVFR---EVEMLYQ 66
Query: 80 LK-HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGL 138
+ H+N+++ + + V E G++ + K + N + + + L
Sbjct: 67 CQGHRNVLELIEFFEE--EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASAL 124
Query: 139 LYLHSHDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAHC---------V 187
+LH+ + HRDLK +NI + NQ VKI D L + ++ +
Sbjct: 125 DFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 188 GTPEFMAPEV------YEEAYNELVDIYSFG--MCIL------------EMVTFEYPYSE 227
G+ E+MAPEV Y++ D++S G + IL ++ +
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 228 CTHPAQIYKKVVSGKKPDSLYRVKDP-------EVRRFVEKCLAT-VSLRLSARELLNDP 279
+++ + GK Y D + + K L RLSA ++L P
Sbjct: 243 PACQNMLFESIQEGK-----YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297
Query: 280 FLQ 282
++Q
Sbjct: 298 WVQ 300
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-28
Identities = 70/283 (24%), Positives = 124/283 (43%), Gaps = 41/283 (14%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-FLQSPEDLERLYCEIHLLKTLKHKNIM 86
E LGKGA V R G E A + + S D ++L E + + LKH NI+
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYA---AMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDP 146
+ + S + + + ++ T G L + + + + +QIL +L+ H
Sbjct: 74 RLHDSISE--EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG- 130
Query: 147 PVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAH--CVGTPEFMAPEV-YEEA 201
V+HR+LK +N+ + +G VK+ D GLA + A GTP +++PEV ++
Sbjct: 131 -VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 202 YNELVDIYSFGMCILEMVTFEY-------PYSECTHPAQIYKKVVSGKKPDSLYRVKDP- 253
Y + VD+++ G IL Y P+ + ++Y+++ +G Y P
Sbjct: 190 YGKPVDLWACG-VIL------YILLVGYPPFWDEDQ-HRLYQQIKAGA-----YDFPSPE 236
Query: 254 ------EVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESN 289
E + + K L S R++A E L P++ ++
Sbjct: 237 WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVAS 279
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 66/306 (21%), Positives = 116/306 (37%), Gaps = 39/306 (12%)
Query: 23 YGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK- 81
++ LG+G+ + + A VK+ + + ++ EI LK +
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFA---VKIIS-KRMEANTQK---EITALKLCEG 64
Query: 82 HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYL 141
H NI+K + + D + V E+ G L + K K + R+++ + ++
Sbjct: 65 HPNIVKLHEVFHD--QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 142 HSHDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAH--CVGTPEFMAPEV 197
H V+HRDLK +N+ F + N E+KI D G A + + T + APE+
Sbjct: 123 HDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180
Query: 198 YE-EAYNELVDIYSFGMCILEMVTFEYP--YSE-----CTHPAQIYKKVVSGKKPDSLYR 249
Y+E D++S G IL + S CT +I KK+ G +
Sbjct: 181 LNQNGYDESCDLWSLG-VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD-----FS 234
Query: 250 VKDP-------EVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDD 301
+ E + ++ L + RL L + +LQ S+ L L
Sbjct: 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS-NPLMTPDILGS 293
Query: 302 MDPLIR 307
+
Sbjct: 294 SGAAVH 299
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 61/295 (20%), Positives = 117/295 (39%), Gaps = 35/295 (11%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-----FLQSPEDLERLYCEIHLLKTLKH 82
E LG G V + ++ G+E A K + E + E+ +L+ + H
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYA---AKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLH 142
N++ + + + ++ + E+ + G L + + + ++ + +QIL G+ YLH
Sbjct: 75 HNVITLHDVYEN--RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 143 SHDPPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVY 198
+ + H DLK +NI + N +K+ D GLA + GTPEF+APE+
Sbjct: 133 TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 199 E-EAYNELVDIYSFGMCILEMVTFEYP--YSECTHPAQIYKKVVSGKKPDSLYRVKDP-- 253
E D++S G I ++ + + + S Y +
Sbjct: 191 NYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITSVS-----YDFDEEFF 242
Query: 254 -----EVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDM 302
+ F+ K L RL+ +E L P++ D + + + L++
Sbjct: 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENF 297
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 60/301 (19%), Positives = 116/301 (38%), Gaps = 38/301 (12%)
Query: 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL- 80
Y ++LG G + V F G + A +KL L + E+
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCA---LKL---LYDSPKARQ---EVDHHWQAS 79
Query: 81 KHKNIMKFYTSWVDTANRNINF--VTEMFTSGTL--RQYRLKHKRVNIRAVKLWCRQILR 136
+I+ + + + + E G L R + R R I
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139
Query: 137 GLLYLHSHDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAHCVGTPEFMA 194
+ +LHSH+ + HRD+K +N+ + + + +K+ D G A ++ TP ++A
Sbjct: 140 AIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVA 197
Query: 195 PEV-YEEAYNELVDIYSFGMCILEMVTFEYP--YSECTH--PAQIYKKVVSGKKPDSLYR 249
PEV E Y++ D++S G I+ ++ +P YS + +++ G+ Y
Sbjct: 198 PEVLGPEKYDKSCDMWSLG-VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ-----YG 251
Query: 250 VKDP-------EVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDD 301
+P + ++ + L T + RL+ + +N P++ L +R L +
Sbjct: 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ-TPLHTARVLQE 310
Query: 302 M 302
Sbjct: 311 D 311
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 73/280 (26%), Positives = 128/280 (45%), Gaps = 32/280 (11%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
EILG G V++ + G+++A K+ + +D E + EI ++ L H N+++
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLA---AKIIK-TRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNI--RAVKLWCRQILRGLLYLHSHD 145
Y ++ +I V E G L R+ + N+ L+ +QI G+ ++H
Sbjct: 151 LYDAFES--KNDIVLVMEYVDGGELFD-RIIDESYNLTELDTILFMKQICEGIRHMHQMY 207
Query: 146 PPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRKSHAAHC-VGTPEFMAPEVYE-EAY 202
++H DLK +NI VN + ++KI D GLA + GTPEF+APEV +
Sbjct: 208 --ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV 265
Query: 203 NELVDIYSFGMCILEMVTFEYP--YSECTHPAQIYKKVVSGKKPDSLYRVKDP------- 253
+ D++S G+ I M+ + + A+ +++ + + ++D
Sbjct: 266 SFPTDMWSVGV-IAYMLLSGLSPFLGD--NDAETLNNILACR-----WDLEDEEFQDISE 317
Query: 254 EVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRS 292
E + F+ K L S R+SA E L P+L S L +
Sbjct: 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSA 357
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 62/286 (21%), Positives = 120/286 (41%), Gaps = 52/286 (18%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-------FLQSPEDLERLYCEIHLLKTL 80
+++G+G S V R G E A VK+ + Q E E E H+L+ +
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFA---VKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 81 K-HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLL 139
H +I+ S+ + + V ++ G L Y + ++ + + R +L +
Sbjct: 157 AGHPHIITLIDSYES--SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 140 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEV- 197
+LH+++ ++HRDLK +NI ++ N ++++ D G + L GTP ++APE+
Sbjct: 215 FLHANN--IVHRDLKPENILLDDN-MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271
Query: 198 ------YEEAYNELVDIYSFGMCILEMVTFEY-------PYSECTHPAQIYKKVVSGKKP 244
Y + VD+++ G IL + P+ + + ++ G+
Sbjct: 272 KCSMDETHPGYGKEVDLWACG-VIL------FTLLAGSPPFWHRRQI-LMLRMIMEGQ-- 321
Query: 245 DSLYRVKDP-------EVRRFVEKCLAT-VSLRLSARELLNDPFLQ 282
Y+ P V+ + + L RL+A + L PF +
Sbjct: 322 ---YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-28
Identities = 73/345 (21%), Positives = 128/345 (37%), Gaps = 81/345 (23%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+++G G+ VY+A G VA +V D E+ +++ L H NI++
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLDHCNIVR 111
Query: 88 ----FYTSWVDTANRNINFVTEMFTSGTL----RQYRLKHKRVNIRAVKLWCRQILRGLL 139
FY+S +N V + + T+ R Y + + + VKL+ Q+ R L
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 140 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFM------ 193
Y+HS + HRD+K N+ ++ + +K+ D G A L + E
Sbjct: 171 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---------EPNVSYICS 219
Query: 194 ----APEVYEEA--YNELVDIYSFGMCIL-EMVTFE--YPYSECTHPAQIYK--KVV--- 239
APE+ A Y +D++S G C+L E++ + +P Q+ + KV+
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAG-CVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTP 276
Query: 240 -----------------SGKKPDSLYRV----KDPEVRRFVEKCLA-TVSLRLSARELLN 277
K +V PE + L T + RL+ E
Sbjct: 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336
Query: 278 DPFLQ----IDDCESNLRSL----DYSRELDDMDPLIRQPHIDFH 314
F + N R +++ + +P + I H
Sbjct: 337 HSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPH 381
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 77/299 (25%), Positives = 129/299 (43%), Gaps = 29/299 (9%)
Query: 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKL--YDFLQSPEDLERLYCEIHLLK 78
RY + + LG G TVY A D I+VA +K + E L+R E+H
Sbjct: 11 ERY-KIVDKLGGGGMSTVYLAEDTILNIKVA---IKAIFIPPREKEETLKRFEREVHNSS 66
Query: 79 TLKHKNIMKFYTSWVDT-ANRNINF-VTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILR 136
L H+NI+ D + + V E TL +Y H +++ + QIL
Sbjct: 67 QLSHQNIVSMI----DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILD 122
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS---HAAHCVGTPEFM 193
G+ + H ++HRD+K NI + + +KI D G+A L ++ H +GT ++
Sbjct: 123 GIKHAHDMR--IVHRDIKPQNILI-DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYF 179
Query: 194 APE-VYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD 252
+PE EA +E DIYS G+ + EM+ E P++ T I K + P+ V+
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET-AVSIAIKHIQDSVPNVTTDVRK 238
Query: 253 ---PEVRRFVEKCLA-TVSLR-LSARELLNDPFLQIDDCESNLRSLDYSRELDDMDPLI 306
+ + + + R + +E+ +D + R+ + ELD M +
Sbjct: 239 DIPQSLSNVILRATEKDKANRYKTIQEMKDD----LSSVLHENRANEDVYELDKMKTIA 293
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-27
Identities = 57/268 (21%), Positives = 100/268 (37%), Gaps = 35/268 (13%)
Query: 21 GRYGRYNEILGKGASKTVYRAFDEY-EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKT 79
G+Y + G +Y A D G V +K E E L
Sbjct: 80 GQY-EVKGCIAHGGLGWIYLALDRNVNGRPVV---LKGLVHSGDAEAQAMAMAERQFLAE 135
Query: 80 LKHKNIMKFYT--SWVDTANRNINF-VTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILR 136
+ H +I++ + D + + V E +L++ + +++ + + +IL
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILP 193
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPE 196
L YLHS +++ DLK +NI + Q +K+ DLG + R + + GTP F APE
Sbjct: 194 ALSYLHSI--GLVYNDLKPENIMLTEEQ--LKLIDLGAVS--RINSFGYLYGTPGFQAPE 247
Query: 197 VYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRV------ 250
+ DIY+ G + + + + + + K DS R+
Sbjct: 248 IVRTGPTVATDIYTVGRTLAALTLDLPTRNG-RYVDGLPEDDPVLKTYDSYGRLLRRAID 306
Query: 251 KDPEVRRFVEKCLATVSLRLSARELLND 278
DP +RF +A E+
Sbjct: 307 PDPR-QRFT-----------TAEEMSAQ 322
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 63/299 (21%), Positives = 117/299 (39%), Gaps = 39/299 (13%)
Query: 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL- 80
Y +++LG G + V + F++ + A +K +D + E+ L
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFA---LK------MLQDCPKARREVELHWRAS 112
Query: 81 KHKNIMKFYTSWVDTANRNINF--VTEMFTSGTL--RQYRLKHKRVNIRAVKLWCRQILR 136
+ +I++ + + V E G L R + R + I
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 137 GLLYLHSHDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAH-CVGTPEFM 193
+ YLHS + + HRD+K +N+ + + +K+ D G A ++ TP ++
Sbjct: 173 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 230
Query: 194 APEV-YEEAYNELVDIYSFGMCILEMVTFEYP--YSECTHPAQ--IYKKVVSGKKPDSLY 248
APEV E Y++ D++S G I+ ++ YP YS + ++ G+ Y
Sbjct: 231 APEVLGPEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-----Y 284
Query: 249 RVKDP-------EVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSREL 299
+P EV+ + L T + R++ E +N P++ L SR L
Sbjct: 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ-TPLHTSRVL 342
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 63/295 (21%), Positives = 120/295 (40%), Gaps = 35/295 (11%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAW-----NQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
E LG G V + ++ G+E A Q + E++ER E+ +L+ + H
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIER---EVSILRQVLH 74
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLH 142
NI+ + + + ++ + E+ + G L + + + ++ + +QIL G+ YLH
Sbjct: 75 PNIITLHDVYEN--RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 143 SHDPPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVY 198
+ + H DLK +NI + N +K+ D GLA + GTPEF+APE+
Sbjct: 133 TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 199 E-EAYNELVDIYSFGMCILEMVTFEYP--YSECTHPAQIYKKVVSGKKPDSLYRVKDP-- 253
E D++S G I ++ + + + + Y +
Sbjct: 191 NYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITAVS-----YDFDEEFF 242
Query: 254 -----EVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDM 302
+ F+ K L RL+ +E L P++ D + + + L++
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENF 297
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 75/292 (25%), Positives = 116/292 (39%), Gaps = 38/292 (13%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIH-LLKTLKHKNIM 86
E +G G+ R + +E A VK+ +S D EI LL+ +H NI+
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFA---VKI--IDKSKRDPTE---EIEILLRYGQHPNII 79
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDP 146
+ D + + VTE+ G L L+ K + R I + + YLH+
Sbjct: 80 TLKDVYDD--GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG- 136
Query: 147 PVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILRKSHAAH--CVGTPEFMAPEV-YEE 200
V+HRDLK NI +GN ++I D G A LR + T F+APEV +
Sbjct: 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ 195
Query: 201 AYNELVDIYSFGMCILEMVTFEYP--YSECT-HPAQIYKKVVSGKKPDSLYRVKDP---- 253
Y+ DI+S G +L + Y + P +I ++ SGK + +
Sbjct: 196 GYDAACDIWSLG-VLLYTMLTGYTPFANGPDDTPEEILARIGSGK-----FSLSGGYWNS 249
Query: 254 ---EVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESN--LRSLDYSREL 299
+ V K L RL+A +L P++ D L D +
Sbjct: 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLV 301
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 59/287 (20%), Positives = 119/287 (41%), Gaps = 19/287 (6%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQV--KLYDFLQSPEDLERLYCEIHLLKTLKHKNI 85
E LG G V + ++ G++ A + + + E + E+ +LK ++H N+
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 86 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHD 145
+ + + + ++ + E+ G L + + + + + +QIL G+ YLHS
Sbjct: 77 ITLHEVYEN--KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 146 PPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVYE-E 200
+ H DLK +NI + N + +KI D GLA + + GTPEF+APE+ E
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 201 AYNELVDIYSFGMCILEMVTFEYP--YSECTHPAQIYKKVVSGKK--PDSLYRVKDPEVR 256
D++S G I ++ + + V + D + +
Sbjct: 193 PLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 257 RFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDM 302
F+ + L R++ ++ L P+++ D + L + ++
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKF 296
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-27
Identities = 67/309 (21%), Positives = 130/309 (42%), Gaps = 25/309 (8%)
Query: 8 EPDCSEFVEVDPTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPE 65
P + +++ RY+ + +G G D+ VA VK + +
Sbjct: 4 APVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVA---VKYIE--RGAA 58
Query: 66 DLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIR 125
E + EI ++L+H NI++F V ++ + E + G L + R +
Sbjct: 59 IDENVQREIINHRSLRHPNIVRFKE--VILTPTHLAIIMEYASGGELYERICNAGRFSED 116
Query: 126 AVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQ-GEVKIGDLGLAAILRKSHAA 184
+ + +Q+L G+ Y HS + HRDLK +N ++G+ +KI D G +
Sbjct: 117 EARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174
Query: 185 H-CVGTPEFMAPEVYE-EAYN-ELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKK---- 237
VGTP ++APEV + Y+ ++ D++S G+ + M+ YP+ E + Y+K
Sbjct: 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQR 233
Query: 238 VVSGK--KPDSLYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLD 294
++S K PD + PE + + + R+S E+ + + + +
Sbjct: 234 ILSVKYSIPDDIR--ISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESN 291
Query: 295 YSRELDDMD 303
+ + +
Sbjct: 292 TGSQFQEPE 300
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 8e-27
Identities = 63/292 (21%), Positives = 119/292 (40%), Gaps = 46/292 (15%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVA-----WNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
E LG G V + + G E A ++ S E++ER E+++L+ ++H
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIER---EVNILREIRH 67
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLH 142
NI+ + + + ++ + E+ + G L + + + + + +QIL G+ YLH
Sbjct: 68 PNIITLHDIFEN--KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 143 SHDPPVIHRDLKCDNI-FVNGNQ--GEVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVY 198
S + H DLK +NI ++ N +K+ D G+A + + GTPEF+APE+
Sbjct: 126 SKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 199 E-EAYNELVDIYSFGMCILEMVTFEY-------PYSECTHPAQIYKKVVSGKKPDSLYRV 250
E D++S G I Y P+ T + + + Y
Sbjct: 184 NYEPLGLEADMWSIG-VIT------YILLSGASPFLGETK-QETLTNISAVN-----YDF 230
Query: 251 KDP-------EVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLD 294
+ + F+ + L R++ + L +++ N+R D
Sbjct: 231 DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK-AIRRRNVRGED 281
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 72/251 (28%), Positives = 111/251 (44%), Gaps = 30/251 (11%)
Query: 25 RYNEILGKGASKTVYRA----FDEYEGIEVAWNQVKLYDFLQ--SPEDLERLYCEIHLLK 78
++ + LGKG +V + G VA VK LQ + E L EI +LK
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVA---VKK---LQHSTEEHLRDFEREIEILK 66
Query: 79 TLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILR 136
+L+H NI+K+ RN+ + E G+LR Y L+ + I +KL + QI +
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY-LQKHKERIDHIKLLQYTSQICK 125
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP-EF--- 192
G+ YL + IHRDL NI V N+ VKIGD GL +L + V P E
Sbjct: 126 GMEYLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 193 -MAPEVYEEA-YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRV 250
APE E+ ++ D++SFG+ + E+ T Y E + + G ++
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDKQ--GQM 236
Query: 251 KDPEVRRFVEK 261
+ ++
Sbjct: 237 IVFHLIELLKN 247
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 50/295 (16%), Positives = 97/295 (32%), Gaps = 45/295 (15%)
Query: 28 EILGKGASKTVYRA-----FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
+LG+GA VY A D + +K+ +P + + LK
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFV---LKVQK-PANPWEFYIGTQLMERLKPSMQ 126
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRA-----VKLWCRQILRG 137
MKFY++ + V E+++ GTL +K + V + ++L
Sbjct: 127 HMFMKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM 184
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNG----------NQGEVKIGDLGLAAILRKSHA---- 183
+ +H + +IH D+K DN + + + DLG + ++
Sbjct: 185 IEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 184 -AHCVGTPEFMAPEV-YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG 241
A C T F E+ + +N +D + + M+ Y + + +
Sbjct: 243 TAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 242 KKPDSLYRVKDPEVRRFVEKCL-ATVSLRLSARELLNDPFLQIDD--CESNLRSL 293
F L L + +LL ++ + +R+L
Sbjct: 302 LP-------HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRAL 349
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 41/217 (18%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLE---------RLYCEIHLLK 78
E +G+G TV++A + VA +V+L D + R EI LLK
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRL--------DDDDEGVPSSALR---EICLLK 56
Query: 79 TLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRA--VKLWCRQILR 136
LKHKNI++ + V +++ + V E F L++Y ++ VK + Q+L+
Sbjct: 57 ELKHKNIVRLHD--VLHSDKKLTLVFE-FCDQDLKKY-FDSCNGDLDPEIVKSFLFQLLK 112
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFM--- 193
GL + HS + V+HRDLK N+ +N GE+K+ + GLA R + E +
Sbjct: 113 GLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLA---RAFGIPVRCYSAEVVTLW 166
Query: 194 --APEVY--EEAYNELVDIYSFGMCIL-EMVTFEYPY 225
P+V + Y+ +D++S G CI E+ P
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAG-CIFAELANAGRPL 202
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 34/222 (15%)
Query: 22 RYGRYNEILGKGASKTVYRA--FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKT 79
+ +G+G VY+A D + + A Q++ S EI LL+
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA------CREIALLRE 74
Query: 80 LKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRA----------VKL 129
LKH N++ ++ A+R + + + + L +K R + VK
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFD-YAEHDLWHI-IKFHRASKANKKPVQLPRGMVKS 132
Query: 130 WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGLA----AILRK-S 181
QIL G+ YLH++ V+HRDLK NI V G +G VKI D+G A + L+ +
Sbjct: 133 LLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190
Query: 182 HAAHCVGTPEFMAPEVY--EEAYNELVDIYSFGMCIL-EMVT 220
V T + APE+ Y + +DI++ G CI E++T
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG-CIFAELLT 231
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 72/251 (28%), Positives = 111/251 (44%), Gaps = 30/251 (11%)
Query: 25 RYNEILGKGASKTVYRA----FDEYEGIEVAWNQVKLYDFLQ--SPEDLERLYCEIHLLK 78
++ + LGKG +V + G VA VK LQ + E L EI +LK
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVA---VKK---LQHSTEEHLRDFEREIEILK 97
Query: 79 TLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILR 136
+L+H NI+K+ RN+ + E G+LR Y L+ + I +KL + QI +
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY-LQKHKERIDHIKLLQYTSQICK 156
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP-EF--- 192
G+ YL + IHRDL NI V N+ VKIGD GL +L + + V P E
Sbjct: 157 GMEYLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 213
Query: 193 -MAPEV-YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRV 250
APE E ++ D++SFG+ + E+ T Y E + + G ++
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDKQ--GQM 267
Query: 251 KDPEVRRFVEK 261
+ ++
Sbjct: 268 IVFHLIELLKN 278
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 67/274 (24%), Positives = 109/274 (39%), Gaps = 54/274 (19%)
Query: 25 RYNEILGKGASKTVYRA----FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL 80
+ LG+G V ++ G VA VK P+ EI +L+TL
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVA---VKALKADAGPQHRSGWKQEIDILRTL 90
Query: 81 KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLY 140
H++I+K+ D ++ V E G+LR Y L + + + L+ +QI G+ Y
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDY-LPRHSIGLAQLLLFAQQICEGMAY 149
Query: 141 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGT----PEF-MAP 195
LH+ IHRDL N+ + N VKIGD GLA + + H + V P F AP
Sbjct: 150 LHAQH--YIHRDLAARNVLL-DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206
Query: 196 EVYEEAYNELV-----DIYSFGMCILEMVTF---------------EYPYSECTHPAQIY 235
E E D++SFG+ + E++T + T ++
Sbjct: 207 ----ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV-LRLT 261
Query: 236 KKVVSGKK-------PDSLYRV------KDPEVR 256
+ + G++ P +Y + + R
Sbjct: 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFR 295
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 74/348 (21%), Positives = 116/348 (33%), Gaps = 80/348 (22%)
Query: 25 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
R+ + G+G TV ++ G+ VA +V +Q P R + L L H
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-----IQDPRFRNRELQIMQDLAVLHH 78
Query: 83 KNIMKFYTSWVDTANRN-----INFVTEMFTSGTL----RQYRLKHKRVNIRAVKLWCRQ 133
NI++ + + R+ +N V E + TL R Y + +K++ Q
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVME-YVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 134 ILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFM 193
++R + LH V HRD+K N+ VN G +K+ D G A L S E
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS---------EPN 188
Query: 194 ----------APEVYEEA--YNELVDIYSFGMCIL-EMVTFE--YPYSECTH-------- 230
APE+ Y VDI+S G CI EM+ E +
Sbjct: 189 VAYICSRYYRAPELIFGNQHYTTAVDIWSVG-CIFAEMMLGEPIFRGDNSAGQLHEIVRV 247
Query: 231 ----PAQIYKKVVSGKKPDSLYRVK---------------DPEVRRFVEKCLA-TVSLRL 270
++ +K+ LY K E + L R+
Sbjct: 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM 307
Query: 271 SARELLNDPFLQ----IDDCESNLRSLDYS------RELDDMDPLIRQ 308
E L P+ N + L E++ M +
Sbjct: 308 KPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKA 355
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 58/299 (19%), Positives = 111/299 (37%), Gaps = 45/299 (15%)
Query: 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-FLQSPEDLERLYCEIHLLKTL 80
Y ++ LG+G V + + G E A K + + + EI +L+
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYA---AKFLKKRRRGQDCRAEILHEIAVLELA 85
Query: 81 KH-KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNI---RAVKLWCRQILR 136
K ++ + + + I + E G + + + V +QIL
Sbjct: 86 KSCPRVINLHEVYEN--TSEIILILEYAAGGEI-FSLCLPELAEMVSENDVIRLIKQILE 142
Query: 137 GLLYLHSHDPPVIHRDLKCDNI-FVNGNQ-GEVKIGDLGLAAILRKSHAAH-CVGTPEFM 193
G+ YLH ++ ++H DLK NI + G++KI D G++ + + +GTPE++
Sbjct: 143 GVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYL 200
Query: 194 APEVYE-EAYNELVDIYSFGMCILEMVTFEY-------PYSECTHPAQIYKKVVSGKKPD 245
APE+ + D+++ G+ I Y P+ + + Y +
Sbjct: 201 APEILNYDPITTATDMWNIGI-IA------YMLLTHTSPFVGEDN-QETYLNISQVN--- 249
Query: 246 SLYRVKDP-------EVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYS 296
+ F++ L R +A L+ +LQ D E+ + S
Sbjct: 250 --VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETS 306
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 41/214 (19%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLE---------RLYCEIHLLK 78
LG+G VY+A D VA +++L + E R E+ LLK
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRL--------EHEEEGVPGTAIR---EVSLLK 88
Query: 79 TLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGL 138
L+H+NI++ + V N ++ + E + L++Y K+ V++R +K + Q++ G+
Sbjct: 89 ELQHRNIIELKS--VIHHNHRLHLIFE-YAENDLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 139 LYLHSHDPPVIHRDLKCDNIFVN----GNQGEVKIGDLGLAAILRKSHAAHCVGTPEFM- 193
+ HS +HRDLK N+ ++ +KIGD GLA R T E +
Sbjct: 146 NFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA---RAFGIPIRQFTHEIIT 200
Query: 194 ----APEVY--EEAYNELVDIYSFGMCIL-EMVT 220
PE+ Y+ VDI+S CI EM+
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIA-CIWAEMLM 233
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 72/293 (24%), Positives = 124/293 (42%), Gaps = 49/293 (16%)
Query: 6 HLEPDCSEFVEVDPT---GRYGRYNEILGKGASKTVYRA----FDEYEGIEVAWNQVKLY 58
+ + EVDPT R+ + LG+G V + G +VA VK
Sbjct: 2 DIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVA---VKSL 58
Query: 59 DFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 118
+ L EI +L+ L H+NI+K+ + I + E SG+L++Y K
Sbjct: 59 KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK 118
Query: 119 HK-RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177
+K ++N++ + QI +G+ YL S +HRDL N+ V ++ +VKIGD GL
Sbjct: 119 NKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLV-ESEHQVKIGDFGLTKA 175
Query: 178 LRKSHAAHCVGT----PEF-MAPE-VYEEAYNELVDIYSFGMCILEMVTF---------- 221
+ + V P F APE + + + D++SFG+ + E++T+
Sbjct: 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL 235
Query: 222 -----EYPYSECTHPAQIYKKVVSGKK-------PDSLYRV------KDPEVR 256
+ + T ++ + GK+ PD +Y++ P R
Sbjct: 236 FLKMIGPTHGQMTV-TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNR 287
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 67/212 (31%), Positives = 101/212 (47%), Gaps = 42/212 (19%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLE---------RLYCEIHLLK 78
E +G+G VY+A D +G VA +++L D E R EI LLK
Sbjct: 27 EKVGEGTYGVVYKAKDS-QGRIVALKRIRL--------DAEDEGIPSTAIR---EISLLK 74
Query: 79 TLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRA--VKLWCRQILR 136
L H NI+ V + R + V E F L++ L + ++ +K++ Q+LR
Sbjct: 75 ELHHPNIVSLID--VIHSERCLTLVFE-FMEKDLKKV-LDENKTGLQDSQIKIYLYQLLR 130
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFM--- 193
G+ + H H ++HRDLK N+ +N + G +K+ D GLA R T E +
Sbjct: 131 GVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLA---RAFGIPVRSYTHEVVTLW 184
Query: 194 --APEVY--EEAYNELVDIYSFGMCIL-EMVT 220
AP+V + Y+ VDI+S G CI EM+T
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIG-CIFAEMIT 215
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 64/251 (25%), Positives = 111/251 (44%), Gaps = 31/251 (12%)
Query: 25 RYNEILGKGASKTVYRA----FDEYEGIEVAWNQVKL--YDFLQSPEDLERLYCEIHLLK 78
+Y LGKG +V + G VA VK + D +R EI +LK
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVA---VKQLQHSGPDQQRDFQR---EIQILK 79
Query: 79 TLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRG 137
L I+K+ +++ V E SG LR + +H+ R++ + L+ QI +G
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP-EF---- 192
+ YL S +HRDL NI V ++ VKI D GLA +L + V P +
Sbjct: 140 MEYLGSRR--CVHRDLAARNILV-ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196
Query: 193 MAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKKPDSLYRV 250
APE + + ++ D++SFG+ + E+ T+ + S P+ + +++ ++
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS----PSAEFLRMMGCERDV----P 248
Query: 251 KDPEVRRFVEK 261
+ +E+
Sbjct: 249 ALSRLLELLEE 259
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 65/280 (23%), Positives = 119/280 (42%), Gaps = 48/280 (17%)
Query: 28 EILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHK 83
++LG GA TVY+ E I VA +K SP+ + + E +++ ++ +
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMASVDNP 77
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYL 141
++ + + + + +T++ G L Y ++ + NI + L WC QI +G+ YL
Sbjct: 78 HVCRLLG--ICLTST-VQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF----MAPEV 197
++HRDL N+ V Q VKI D GLA +L + + MA E
Sbjct: 134 EDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 198 YEEAYNELV---DIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDS 246
+ D++S+G+ + E++TF PY ++I + G++
Sbjct: 191 I--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPICTID 247
Query: 247 LYRV------KDPEVR-RFVEKCLATVSLRLSARELLNDP 279
+Y + D + R +F E L + ++ DP
Sbjct: 248 VYMIMRKCWMIDADSRPKFRE-------LIIEFSKMARDP 280
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC----EIHLLKTLKHK 83
+ LG+G TVY+ + VA +++L E E C E+ LLK LKH
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRL-------EHEEGAPCTAIREVSLLKDLKHA 60
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRA--VKLWCRQILRGLLYL 141
NI+ + + +++ V E + L+QY L I VKL+ Q+LRGL Y
Sbjct: 61 NIVTLHD--IIHTEKSLTLVFE-YLDKDLKQY-LDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-----HCVGTPEFMAPE 196
H V+HRDLK N+ +N +GE+K+ D GLA R + V T + P+
Sbjct: 117 HRQK--VLHRDLKPQNLLIN-ERGELKLADFGLA---RAKSIPTKTYDNEVVTLWYRPPD 170
Query: 197 VY--EEAYNELVDIYSFGMCIL-EMVT 220
+ Y+ +D++ G CI EM T
Sbjct: 171 ILLGSTDYSTQIDMWGVG-CIFYEMAT 196
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 77/316 (24%), Positives = 124/316 (39%), Gaps = 75/316 (23%)
Query: 25 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
RY + LG G + V+ A D VA +K P+ ++ EI +++ L H
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVA---IKKIVL-TDPQSVKHALREIKIIRRLDH 67
Query: 83 KNIMKFY-------TSWVDTANRNINF-----VTE-MFT--SGTLRQYRLKHKRVNIRAV 127
NI+K + + D V E M T + L Q L +
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA----- 122
Query: 128 KLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV 187
+L+ Q+LRGL Y+HS + V+HRDLK N+F+N +KIGD GLA I+ +
Sbjct: 123 RLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY----- 175
Query: 188 GTPEFM----------APEV--YEEAYNELVDIYSFGMCIL-EMVT----F--------- 221
+ +P + Y + +D+++ G CI EM+T F
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKTLFAGAHELEQM 234
Query: 222 -----------EYPYSECTHPAQIYKKVVSGKKPDSLYRV---KDPEVRRFVEKCLA-TV 266
E E +Y + + L ++ E F+E+ L +
Sbjct: 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294
Query: 267 SLRLSARELLNDPFLQ 282
RL+A E L+ P++
Sbjct: 295 MDRLTAEEALSHPYMS 310
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 79/313 (25%), Positives = 129/313 (41%), Gaps = 69/313 (22%)
Query: 25 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
+ +LG+GA V A + G VA +K + P R EI +LK KH
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVA---IKKIEPFDKPLFALRTLREIKILKHFKH 68
Query: 83 KNIMKFYTSWVDTANRNINF-----VTE-MFT--SGTLRQYRLKHKRVNIRAVKLWCRQI 134
+NI+ + + + NF + E M T + L + + + Q
Sbjct: 69 ENIITIFN--IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI-----QYFIYQT 121
Query: 135 LRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPE--F 192
LR + LH + VIHRDLK N+ +N N ++K+ D GLA I+ +S A + T +
Sbjct: 122 LRAVKVLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 193 M----------APEV--YEEAYNELVDIYSFGMCIL-EMVT-----------------FE 222
M APEV Y+ +D++S G CIL E+ F
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 223 Y---PYSE------CTHPAQIYKKVVSGKKPDSLYRV---KDPEVRRFVEKCLA-TVSLR 269
P+S+ + A+ Y K + L ++ +P+ +++ L + R
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297
Query: 270 LSARELLNDPFLQ 282
++A+E L P+LQ
Sbjct: 298 ITAKEALEHPYLQ 310
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-25
Identities = 60/250 (24%), Positives = 95/250 (38%), Gaps = 31/250 (12%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E +G+G V+ + VA VK P+ + E +LK H NI++
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVA---VKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLHSHD 145
V T + I V E+ G + L+ + +R L G+ YL S
Sbjct: 177 LIG--VCTQKQPIYIVMELVQGGDFLTF-LRTEGARLRVKTLLQMVGDAAAGMEYLESK- 232
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF----MAPEVYEEA 201
IHRDL N V +KI D G++ A G + APE
Sbjct: 233 -CCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 202 -YNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLYRV-- 250
Y+ D++SFG+ + E + PY ++ Q + V G + PD+++R+
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPYPNLSN-QQTREFVEKGGRLPCPELCPDAVFRLME 349
Query: 251 ----KDPEVR 256
+P R
Sbjct: 350 QCWAYEPGQR 359
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 74/257 (28%), Positives = 119/257 (46%), Gaps = 39/257 (15%)
Query: 25 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
Y +G GA +V A D+ G +VA KL QS +R Y E+ LLK ++H
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 83 KNIMKFYTSWVDTANRNIN------FVTE-MFT--SGTLRQYRLKHKRVNIRAVKLWCRQ 133
+N++ V T ++ V M T + + ++ ++ Q
Sbjct: 83 ENVIGLLD--VFTPASSLRNFYDFYLVMPFMQTDLQKIMGL-KFSEEK-----IQYLVYQ 134
Query: 134 ILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA--HCVGTPE 191
+L+GL Y+HS V+HRDLK N+ VN + E+KI D GLA R + A V T
Sbjct: 135 MLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLA---RHADAEMTGYVVTRW 188
Query: 192 FMAPEV--YEEAYNELVDIYSFGMCIL-EMVTFE--YPYSECTHPAQIYK--KVVSGKKP 244
+ APEV YN+ VDI+S G CI+ EM+T + + + Q+ + KV
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVG-CIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGT 245
Query: 245 DSLYRVKDPEVRRFVEK 261
+ + ++ D + +++
Sbjct: 246 EFVQKLNDKAAKSYIQS 262
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 8e-25
Identities = 70/216 (32%), Positives = 104/216 (48%), Gaps = 45/216 (20%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLE--------RLYCEIHLLKT 79
E LG G TVY+ ++ G+ VA +VKL D E R EI L+K
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKL--------DSEEGTPSTAIR---EISLMKE 59
Query: 80 LKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRA-------VKLWCR 132
LKH+NI++ Y V + V E F L++Y + + V VK +
Sbjct: 60 LKHENIVRLYD--VIHTENKLTLVFE-FMDNDLKKY-MDSRTVGNTPRGLELNLVKYFQW 115
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF 192
Q+L+GL + H + ++HRDLK N+ +N +G++K+GD GLA R + E
Sbjct: 116 QLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLA---RAFGIPVNTFSSEV 169
Query: 193 M-----APEVY--EEAYNELVDIYSFGMCIL-EMVT 220
+ AP+V Y+ +DI+S G CIL EM+T
Sbjct: 170 VTLWYRAPDVLMGSRTYSTSIDIWSCG-CILAEMIT 204
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 42/212 (19%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLE---------RLYCEIHLLK 78
E +G+G VY+A + Y A +++L + E R EI +LK
Sbjct: 8 EKIGEGTYGVVYKAQNNYGET-FALKKIRL--------EKEDEGIPSTTIR---EISILK 55
Query: 79 TLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRA--VKLWCRQILR 136
LKH NI+K Y V + + V E L++ L + + K + Q+L
Sbjct: 56 ELKHSNIVKLYD--VIHTKKRLVLVFE-HLDQDLKKL-LDVCEGGLESVTAKSFLLQLLN 111
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-----HCVGTPE 191
G+ Y H V+HRDLK N+ +N +GE+KI D GLA R H + T
Sbjct: 112 GIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLA---RAFGIPVRKYTHEIVTLW 165
Query: 192 FMAPEVY--EEAYNELVDIYSFGMCIL-EMVT 220
+ AP+V + Y+ +DI+S G CI EMV
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVG-CIFAEMVN 196
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 23/203 (11%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC----EIHLLKTLKHK 83
+G+G+ V++ + G VA + ED + EI +LK LKH
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLE------SEDDPVIKKIALREIRMLKQLKHP 62
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWCRQILRGLLYLH 142
N++ V R ++ V E + T+ + V VK Q L+ + + H
Sbjct: 63 NLVNLLE--VFRRKRRLHLVFE-YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA--HCVGTPEFMAPEVY-- 198
H+ IHRD+K +NI + +K+ D G A +L V T + +PE+
Sbjct: 120 KHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG 176
Query: 199 EEAYNELVDIYSFGMCIL-EMVT 220
+ Y VD+++ G C+ E+++
Sbjct: 177 DTQYGPPVDVWAIG-CVFAELLS 198
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 88/326 (26%), Positives = 141/326 (43%), Gaps = 55/326 (16%)
Query: 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKT 79
Y R + +G GA V A D G +VA KLY QS +R Y E+ LLK
Sbjct: 24 RAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKH 80
Query: 80 LKHKNIMKFYTSWVDTANRNIN------FVTE-MFTSGTLRQYRLKHKRVNIRAVKLWCR 132
++H+N++ V T + ++ V M T L + +KH+++ ++
Sbjct: 81 MRHENVIGLLD--VFTPDETLDDFTDFYLVMPFMGTD--LGKL-MKHEKLGEDRIQFLVY 135
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF 192
Q+L+GL Y+H+ +IHRDLK N+ VN + E+KI D GLA + V T +
Sbjct: 136 QMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLARQADSEMTGY-VVTRWY 191
Query: 193 MAPEV--YEEAYNELVDIYSFGMCIL-EMVTFE--YPYSECTHPAQIYKKVVSGKKPDSL 247
APEV Y + VDI+S G CI+ EM+T + + S+ + KV + +
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVG-CIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250
Query: 248 YRVKDPEVRRFV--------------------------EKCLA-TVSLRLSARELLNDPF 280
R++ E + ++ EK L R++A E L P+
Sbjct: 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310
Query: 281 LQI---DDCESNLRSLDYSRELDDMD 303
+ + E ++ D S + D
Sbjct: 311 FESLHDTEDEPQVQKYDDSFDDVDRT 336
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 78/252 (30%), Positives = 108/252 (42%), Gaps = 29/252 (11%)
Query: 25 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
RY + +G GA V A+D VA KL Q+ +R Y E+ L+K + H
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 83 KNIMKFYTSWVDTANRNIN------FVTE-MFT--SGTLRQYRLKHKRVNIRAVKLWCRQ 133
KNI+ V T +++ V E M ++ L H+R + Q
Sbjct: 84 KNIIGLLN--VFTPQKSLEEFQDVYIVMELMDANLCQVIQM-ELDHER-----MSYLLYQ 135
Query: 134 ILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-AHCVGTPEF 192
+L G+ +LHS +IHRDLK NI V + +KI D GLA S V T +
Sbjct: 136 MLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYY 192
Query: 193 MAPEV-YEEAYNELVDIYSFGMCIL-EMVTFEYPYSECTHPAQIYKKV-VSGKKPDSLYR 249
APEV Y E VDI+S G CI+ EM+ + H Q K + G +
Sbjct: 193 RAPEVILGMGYKENVDIWSVG-CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251
Query: 250 VKDPEVRRFVEK 261
P VR +VE
Sbjct: 252 KLQPTVRTYVEN 263
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-24
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLE----RLYCEIHLLKTLKHK 83
+ LG+G TVY+A D+ VA ++KL ++ + + R EI LL+ L H
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR---EIKLLQELSHP 72
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRA--VKLWCRQILRGLLYL 141
NI+ NI+ V + F L +K + + +K + L+GL YL
Sbjct: 73 NIIGLLD--AFGHKSNISLVFD-FMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-----HCVGTPEFMAPE 196
H H ++HRDLK +N+ ++ G +K+ D GLA + + H V T + APE
Sbjct: 129 HQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLA---KSFGSPNRAYTHQVVTRWYRAPE 182
Query: 197 VY--EEAYNELVDIYSFGMCIL-EMVT 220
+ Y VD+++ G CIL E++
Sbjct: 183 LLFGARMYGVGVDMWAVG-CILAELLL 208
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 78/340 (22%), Positives = 130/340 (38%), Gaps = 85/340 (25%)
Query: 25 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
RY + +G+GA V A+D + VA +K + +R EI +L +H
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVA---IKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 83 KNIMKFYTSWVDTANRNINF-----VTE-MFT--SGTLRQYRLKHKRVNIRAVKLWCRQI 134
+NI+ + A V + M T L+ L + + + QI
Sbjct: 85 ENIIGIND--IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-----CYFLYQI 137
Query: 135 LRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFM- 193
LRGL Y+HS + V+HRDLK N+ +N ++KI D GLA + H F+
Sbjct: 138 LRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDH-----DHTGFLT 189
Query: 194 ---------APEV--YEEAYNELVDIYSFGMCIL-EMVTFE--YPYSECTHPAQIYK--K 237
APE+ + Y + +DI+S G CIL EM++ +P Q+
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVG-CILAEMLSNRPIFPGKHYLD--QLNHILG 246
Query: 238 VVSGKKPDSLYRVKDPEVRRFV--------------------------EKCLA-TVSLRL 270
++ + L + + + R ++ +K L R+
Sbjct: 247 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 306
Query: 271 SARELLNDPFLQ----IDD---CESNLRSLDYSRELDDMD 303
+ L P+L+ D E+ + ELDD+
Sbjct: 307 EVEQALAHPYLEQYYDPSDEPIAEA---PFKFDMELDDLP 343
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 70/272 (25%), Positives = 111/272 (40%), Gaps = 22/272 (8%)
Query: 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKL--YDFLQSPEDLERLYCEIHLLK 78
RY EILG G V+ A D + +VA VK+ D + P R E
Sbjct: 12 DRY-ELGEILGFGGMSEVHLARDLRDHRDVA---VKVLRADLARDPSFYLRFRREAQNAA 67
Query: 79 TLKHKNIMKFY-TSWVDTANRNINF-VTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILR 136
L H I+ Y T +T + + V E TLR + + +
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-----HAAHCVGTPE 191
L + H + +IHRD+K NI + VK+ D G+A + S A +GT +
Sbjct: 128 ALNFSHQNG--IIHRDVKPANIMI-SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 192 FMAPE-VYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQI-YKKVVSGKKPDSLYR 249
+++PE ++ + D+YS G + E++T E P++ + P + Y+ V P S
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-PVSVAYQHVREDPIPPSARH 243
Query: 250 VK-DPEVRRFVEKCLA-TVSLR-LSARELLND 278
++ V K LA R +A E+ D
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 92/323 (28%), Positives = 138/323 (42%), Gaps = 56/323 (17%)
Query: 25 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
RY + +G GA +V AFD G+ VA KL QS +R Y E+ LLK +KH
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 83 KNIMKFYTSWVDTANRNIN------FVTE-MFTSGTLRQYRLKHKRVNIRAVKLWCRQIL 135
+N++ V T R++ VT M L +K +++ V+ QIL
Sbjct: 88 ENVIGLLD--VFTPARSLEEFNDVYLVTHLMGAD--LNNI-VKCQKLTDDHVQFLIYQIL 142
Query: 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAP 195
RGL Y+HS D +IHRDLK N+ VN + E+KI D GLA V T + AP
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLARHT-ADEMTGYVATRWYRAP 198
Query: 196 EV--YEEAYNELVDIYSFGMCIL-EMVTFE--YPYSECTHPAQIYKKVVSGKKPDSLYRV 250
E+ YN+ VDI+S G CI+ E++T +P ++ ++ ++V + L ++
Sbjct: 199 EIMLNWMHYNQTVDIWSVG-CIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 251 KDPEVRRFV--------------------------EKCLA-TVSLRLSARELLNDPFLQI 283
R ++ EK L R++A + L +
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 284 ---DDCESNLRSLDYSRELDDMD 303
D E D S E D+
Sbjct: 318 YHDPDDEPVADPYDQSLESRDLL 340
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 23/203 (11%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC----EIHLLKTLKHK 83
++G+G+ V + ++ G VA + S +D + + EI LLK L+H+
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLE-----SDDD-KMVKKIAMREIKLLKQLRHE 84
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWCRQILRGLLYLH 142
N++ V + V E F T+ L ++ + V+ + QI+ G+ + H
Sbjct: 85 NLVNLLE--VCKKKKRWYLVFE-FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA--HCVGTPEFMAPEVY-- 198
SH+ +IHRD+K +NI V+ G VK+ D G A L V T + APE+
Sbjct: 142 SHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVG 198
Query: 199 EEAYNELVDIYSFGMCIL-EMVT 220
+ Y + VD+++ G C++ EM
Sbjct: 199 DVKYGKAVDVWAIG-CLVTEMFM 220
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 64/275 (23%), Positives = 104/275 (37%), Gaps = 59/275 (21%)
Query: 25 RYN--EILGKGASKTVYRAFDEYEGIEVA-------WNQVKLYDFLQSPEDLERLYCEIH 75
Y + G+ V D EGI VA + + + L +R+ EI
Sbjct: 23 PYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 76 LLKTLKHKNIMKFY---TSWVDTANRNINFVTE-MFTSGTL------RQYRLKHKRVNIR 125
LL H NI+ + + A + VTE M T L ++ + +
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQH---- 135
Query: 126 AVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH 185
++ + IL GL LH V+HRDL NI + N ++ I D LA R+
Sbjct: 136 -IQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADN-NDITICDFNLA---RE----- 183
Query: 186 CVGTPEFM----------APEV--YEEAYNELVDIYSFGMCIL-EMVTFE--YPYSECTH 230
APE+ + + +LVD++S G C++ EM + + S +
Sbjct: 184 -DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAG-CVMAEMFNRKALFRGSTFYN 241
Query: 231 PAQIYK--KVVSGKKPDSLYRVKDPEVRRFVEKCL 263
Q+ K +VV K + + P R ++ L
Sbjct: 242 --QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSL 274
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 55/226 (24%), Positives = 102/226 (45%), Gaps = 25/226 (11%)
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRL-KHKRVNIRAVKLWC 131
E+ +++ L+H ++ + S+ D ++ V ++ G LR Y L ++ VKL+
Sbjct: 65 ELQIMQGLEHPFLVNLWYSFQD--EEDMFMVVDLLLGGDLR-YHLQQNVHFKEETVKLFI 121
Query: 132 RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CVGT 189
+++ L YL + +IHRD+K DNI ++ G V I D +AA+L + GT
Sbjct: 122 CELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQITTMA-GT 177
Query: 190 PEFMAPEVYEE----AYNELVDIYSFGMCILEMVTFEYPYSECTH--PAQIYKKVVSGKK 243
+MAPE++ Y+ VD +S G+ E++ PY + +I +
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237
Query: 244 --PDSLYRVKDPEVRRFVEKCL-ATVSLRL-SARELLNDPFLQ-ID 284
P + E+ ++K L R ++ N P++ I+
Sbjct: 238 TYPSAW----SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 67/208 (32%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 25 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
RY + +G GA V A+D VA KL Q+ +R Y E+ L+K + H
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 83 KNIMKFYTSWVDTANRNIN------FVTE-MFTSGTLRQYRLKHKRVNIRAVKLWCRQIL 135
KNI+ V T + + V E M + ++ ++ + Q+L
Sbjct: 121 KNIISLLN--VFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSYLLYQML 174
Query: 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-AHCVGTPEFMA 194
G+ +LHS +IHRDLK NI V + +KI D GLA S V T + A
Sbjct: 175 CGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 195 PEV-YEEAYNELVDIYSFGMCIL-EMVT 220
PEV Y E VDI+S G CI+ EMV
Sbjct: 232 PEVILGMGYKENVDIWSVG-CIMGEMVR 258
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 49/210 (23%), Positives = 92/210 (43%), Gaps = 26/210 (12%)
Query: 25 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK- 81
Y + LG+G V+ A + +V +K P +++ EI +L+ L+
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRG 89
Query: 82 HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYL 141
NI+ D +R V E + +Q ++ + ++ + +IL+ L Y
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYC 146
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA----HCVGTPEFMAPE- 196
HS ++HRD+K N+ ++ ++++ D GLA H V + F PE
Sbjct: 147 HSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLA---EFYHPGQEYNVRVASRYFKGPEL 201
Query: 197 -VYEEAYNELVDIYSFGMCIL-EMVTFEYP 224
V + Y+ +D++S G C+L M+ + P
Sbjct: 202 LVDYQMYDYSLDMWSLG-CMLASMIFRKEP 230
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 67/307 (21%), Positives = 124/307 (40%), Gaps = 59/307 (19%)
Query: 25 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK- 81
+Y + LGKGA V+++ D G VA K++D Q+ D +R + EI +L L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 82 HKNIMKFYTSWVDTANRNINFVTE-MFT--SGTLRQYRLKHKRVNIRAVKLWCRQILRGL 138
H+NI+ +R++ V + M T +R L+ + Q+++ +
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHK-----QYVVYQLIKVI 122
Query: 139 LYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-------------AILRKSHAAH 185
YLHS ++HRD+K NI +N VK+ D GL+ + + +
Sbjct: 123 KYLHSGG--LLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 186 CVGTPEFM----------APEV--YEEAYNELVDIYSFGMCIL-EMVT----FEYPYSEC 228
+ APE+ Y + +D++S G CIL E++ F P S
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG-CILGEILCGKPIF--PGSST 236
Query: 229 THPAQIYKKV-VSGK-KPDSLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDC 286
+ Q+ + + V + + ++ P + +E SL+ ++
Sbjct: 237 MN--QLERIIGVIDFPSNEDVESIQSPFAKTMIE------SLKEKVEIRQSNKRDIFTKW 288
Query: 287 ESNLRSL 293
++ L +
Sbjct: 289 KNLLLKI 295
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 71/311 (22%), Positives = 128/311 (41%), Gaps = 51/311 (16%)
Query: 28 EILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHK 83
++LG GA TVY+ E I VA +K SP+ + + E +++ ++ +
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMASVDNP 77
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYL 141
++ + + + + +T++ G L Y ++ + NI + L WC QI +G+ YL
Sbjct: 78 HVCRLLG--ICLTST-VQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF----MAPE- 196
++HRDL N+ V Q VKI D GLA +L + + MA E
Sbjct: 134 EDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 197 VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLY 248
+ Y D++S+G+ + E++TF PY ++I + G++ +Y
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPICTIDVY 249
Query: 249 RV------KDPEVR-RFVEKCLATVSLRLSARELLNDPFLQID-------DCESNLRSLD 294
+ D + R +F E L + ++ DP + S S
Sbjct: 250 MIMVKCWMIDADSRPKFRE-------LIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNF 302
Query: 295 YSRELDDMDPL 305
Y +D+ D
Sbjct: 303 YRALMDEEDMD 313
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 9e-23
Identities = 64/211 (30%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC----EIHLLKTLK-- 81
+G GA TVY+A D + G VA V++ L E+ LL+ L+
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVP---NGGGGGGGLPISTVREVALLRRLEAF 71
Query: 82 -HKNIMKFY---TSWVDTANRNINFVTEMFTSGTLRQY--RLKHKRVNIRAVKLWCRQIL 135
H N+++ + + V E LR Y + + +K RQ L
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 130
Query: 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA----HCVGTPE 191
RGL +LH++ ++HRDLK +NI V + G VK+ D GLA R V T
Sbjct: 131 RGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLA---RIYSYQMALTPVVVTLW 184
Query: 192 FMAPEV-YEEAYNELVDIYSFGMCIL-EMVT 220
+ APEV + Y VD++S G CI EM
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVG-CIFAEMFR 214
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-23
Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 45/231 (19%)
Query: 25 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
Y ++G+G+ VY A+D+ VA K+ + D +R+ EI +L LK
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILNRLKS 84
Query: 83 KNIMKFYTSWVDTANRNINF-----VTE-MFTSGTLRQYRLKHKRVNIRAVKLWCRQILR 136
I++ Y + + + F V E + L++ + +K +L
Sbjct: 85 DYIIRLYD--LIIPDDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEEHIKTILYNLLL 140
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--------------AILRKSH 182
G ++H +IHRDLK N +N + VK+ D GLA +
Sbjct: 141 GENFIHESG--IIHRDLKPANCLLNQD-CSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 183 AAHCVGTPEFM----------APEV--YEEAYNELVDIYSFGMCIL-EMVT 220
H + + APE+ +E Y + +DI+S G CI E++
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG-CIFAELLN 247
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 53/261 (20%), Positives = 108/261 (41%), Gaps = 41/261 (15%)
Query: 28 EILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHK 83
++LG G TV++ E I V +K+ + + + + + + +L H
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVC---IKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYL 141
+I++ + + + VT+ G+L + ++ R + L W QI +G+ YL
Sbjct: 76 HIVRLLG--LCPGSS-LQLVTQYLPLGSLLDH-VRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF----MAPEV 197
H ++HR+L N+ + +V++ D G+A +L + MA E
Sbjct: 132 EEHG--MVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 198 YEEAYNELV---DIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDS 246
+ + D++S+G+ + E++TF PY+ A++ + G++
Sbjct: 189 I--HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-LAEVPDLLEKGERLAQPQICTID 245
Query: 247 LYRV------KDPEVR-RFVE 260
+Y V D +R F E
Sbjct: 246 VYMVMVKCWMIDENIRPTFKE 266
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-22
Identities = 55/243 (22%), Positives = 90/243 (37%), Gaps = 50/243 (20%)
Query: 25 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
RY ++G G+ V A+D+ E VA K+ + D +R+ EI +L L H
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK--KILRVFEDLIDCKRILREIAILNRLNH 111
Query: 83 KNIMKFYTSWVDTANRNINF-----VTE-MFTSGTLRQYRLKHKRVNIRAVKLWCRQILR 136
+++K + F V E + ++ + +K +L
Sbjct: 112 DHVVKVLD--IVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-------------------AI 177
G+ Y+HS ++HRDLK N VN + VK+ D GLA
Sbjct: 168 GVKYVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 178 LRKSHAAHCVGTPEFM----------APEV--YEEAYNELVDIYSFGMCIL-EMVTFEYP 224
+ H + APE+ +E Y E +D++S G CI E++
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLNMIKE 283
Query: 225 YSE 227
Sbjct: 284 NVA 286
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 59/254 (23%), Positives = 106/254 (41%), Gaps = 43/254 (16%)
Query: 28 EILGKGASKTVYRAFDEYEG-IEVAWNQVK-LYDFLQSPEDLERLYCEIHLLKTLKHKNI 85
+ +G G V+ + +VA +K + + S ED E ++ L H +
Sbjct: 14 QEIGSGQFGLVHLG--YWLNKDKVA---IKTIREGAMSEEDFIE---EAEVMMKLSHPKL 65
Query: 86 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLHS 143
++ Y V I VTE G L Y L+ +R A L C + G+ YL
Sbjct: 66 VQLYG--VCLEQAPICLVTEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF----MAPEVYE 199
VIHRDL N V G +K+ D G+ + GT +F +PEV+
Sbjct: 123 AC--VIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVF- 177
Query: 200 EAYNELV---DIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLY 248
+++ D++SFG+ + E+ + + PY ++ +++ + + +G + +Y
Sbjct: 178 -SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTGFRLYKPRLASTHVY 235
Query: 249 RV------KDPEVR 256
++ + PE R
Sbjct: 236 QIMNHCWRERPEDR 249
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 63/251 (25%), Positives = 101/251 (40%), Gaps = 35/251 (13%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVK-LYDFLQSPEDLERLYCEIHLLKTLKHKNIM 86
LG G VY + + VA VK L + E+ E ++K +KH N++
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVA---VKTLKEDTMEVEEF---LKEAAVMKEIKHPNLV 72
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLHSH 144
+ V T +TE T G L Y + R + AV L QI + YL
Sbjct: 73 QLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF----MAPEVYEE 200
+ IHRDL N V N VK+ D GL+ ++ G +F APE
Sbjct: 131 N--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGA-KFPIKWTAPESLAY 186
Query: 201 A-YNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLYRV- 250
++ D+++FG+ + E+ T+ PY +Q+Y+ + + P+ +Y +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRMERPEGCPEKVYELM 245
Query: 251 -----KDPEVR 256
+P R
Sbjct: 246 RACWQWNPSDR 256
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 43/217 (19%)
Query: 28 EILGKGASKTVYRAFDEYEGIE-VAWNQVKLYDFLQSPEDLE---------RLYCEIHLL 77
+G+GA V++A D G VA +V++ R E+ +L
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRV--------QTGEEGMPLSTIR---EVAVL 65
Query: 78 KTLK---HKNIMKFY---TSWVDTANRNINFVTEMFTSGTLRQY--RLKHKRVNIRAVKL 129
+ L+ H N+++ + T + V E L Y ++ V +K
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 130 WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA----H 185
Q+LRGL +LHSH V+HRDLK NI V + G++K+ D GLA R
Sbjct: 125 MMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLA---RIYSFQMALTS 178
Query: 186 CVGTPEFMAPEV-YEEAYNELVDIYSFGMCIL-EMVT 220
V T + APEV + +Y VD++S G CI EM
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVG-CIFAEMFR 214
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 59/249 (23%), Positives = 101/249 (40%), Gaps = 31/249 (12%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
LG G VY + + VA +K + ++E E ++K +KH N+++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQ 280
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLHSHD 145
V T +TE T G L Y + R + AV L QI + YL +
Sbjct: 281 LLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP---EFMAPEVYEEA- 201
IHR+L N V N VK+ D GL+ ++ G ++ APE
Sbjct: 339 --FIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 202 YNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLYRV--- 250
++ D+++FG+ + E+ T+ PY +Q+Y+ + + P+ +Y +
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRMERPEGCPEKVYELMRA 454
Query: 251 ---KDPEVR 256
+P R
Sbjct: 455 CWQWNPSDR 463
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 5e-22
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 43/219 (19%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLE---------RLYCEIHLLK 78
+G+G V++A G +VA +V + + E R EI +L+
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLM--------ENEKEGFPITALR---EIKILQ 71
Query: 79 TLKHKNIMKFY------TSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRA--VKLW 130
LKH+N++ S + +I V + F L L + V +K
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFD-FCEHDLAGL-LSNVLVKFTLSEIKRV 129
Query: 131 CRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAA--- 184
+ +L GL Y+H + ++HRD+K N+ + G +K+ D GLA ++ + S
Sbjct: 130 MQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 185 HCVGTPEFMAPEVY--EEAYNELVDIYSFGMCIL-EMVT 220
+ V T + PE+ E Y +D++ G CI+ EM T
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAG-CIMAEMWT 224
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 57/314 (18%), Positives = 114/314 (36%), Gaps = 60/314 (19%)
Query: 9 PDCSEFVEVDPTGRYGRY---NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPE 65
P +++ Y +++LG G + V + F++ + A +K +
Sbjct: 2 PHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFA---LK------MLQ 52
Query: 66 DLERLYCEIHLLKTL-KHKNIMKFYTSWVDT--ANRNINFVTEMFTSGTL--RQYRLKHK 120
D + E+ L + +I++ + + + + V E G L R +
Sbjct: 53 DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 112
Query: 121 RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAIL 178
R + I + YLHS + + HRD+K +N+ + + +K+ D G A
Sbjct: 113 AFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA--- 167
Query: 179 RKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYP--YSECTHPAQ--I 234
E E Y++ D++S G I+ ++ YP YS +
Sbjct: 168 ----------------KETTGEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGM 210
Query: 235 YKKVVSGKKPDSLYRVKDP-------EVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDC 286
++ G+ Y +P EV+ + L T + R++ E +N P++
Sbjct: 211 KTRIRMGQ-----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265
Query: 287 ESN--LRSLDYSRE 298
L + +E
Sbjct: 266 VPQTPLHTSRVLKE 279
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 56/251 (22%), Positives = 103/251 (41%), Gaps = 41/251 (16%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+ +GKG V +Y G +VA VK +++ + E ++ L+H N+++
Sbjct: 27 QTIGKGEFGDVMLG--DYRGNKVA---VKC---IKNDATAQAFLAEASVMTQLRHSNLVQ 78
Query: 88 FYTSWVDTANR-NINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLHSH 144
V + + VTE G+L Y R + L + + + YL +
Sbjct: 79 LLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF----MAPEV-YE 199
+ +HRDL N+ V+ + K+ D GL +++ + G + APE E
Sbjct: 137 N--FVHRDLAARNVLVSED-NVAKVSDFGLT---KEASSTQDTG--KLPVKWTAPEALRE 188
Query: 200 EAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLYRV- 250
+ ++ D++SFG+ + E+ +F PY + +V G K P ++Y V
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKGYKMDAPDGCPPAVYEVM 247
Query: 251 -----KDPEVR 256
D +R
Sbjct: 248 KNCWHLDAAMR 258
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 9e-22
Identities = 66/254 (25%), Positives = 114/254 (44%), Gaps = 43/254 (16%)
Query: 28 EILGKGASKTVYRAFDEYEG-IEVAWNQVK-LYDFLQSPEDLERLYCEIHLLKTLKHKNI 85
+ LG G V +++G +VA VK + + S ++ + E + L H +
Sbjct: 14 KELGSGQFGVVKLG--KWKGQYDVA---VKMIKEGSMSEDEFFQ---EAQTMMKLSHPKL 65
Query: 86 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLHS 143
+KFY V + I VTE ++G L Y L+ + +L C + G+ +L S
Sbjct: 66 VKFYG--VCSKEYPIYIVTEYISNGCLLNY-LRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF----MAPEVYE 199
H IHRDL N V+ + VK+ D G+ + VGT +F APEV+
Sbjct: 123 HQ--FIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQYVSSVGT-KFPVKWSAPEVF- 177
Query: 200 EAYNELV---DIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLY 248
Y + D+++FG+ + E+ + + PY T+ +++ KV G + D++Y
Sbjct: 178 -HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-SEVVLKVSQGHRLYRPHLASDTIY 235
Query: 249 RV------KDPEVR 256
++ + PE R
Sbjct: 236 QIMYSCWHELPEKR 249
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 59/255 (23%), Positives = 105/255 (41%), Gaps = 37/255 (14%)
Query: 27 NEILGKGASKTVYRAF--DEYEGIEVAWNQVK-LYDFLQSPEDLERLYCEIHLLKTLKHK 83
++ LG G TV + + + VA VK L + P + L E ++++ L +
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVA---VKILKNEANDPALKDELLAEANVMQQLDNP 78
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS 143
I++ + A V EM G L +Y +++ V + + Q+ G+ YL
Sbjct: 79 YIVRMIG--ICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGT----P-EFMAPEVY 198
+ +HRDL N+ + Q KI D GL+ LR + T P ++ APE
Sbjct: 136 SN--FVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 199 EEAYNELV---DIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSL 247
Y + D++SFG+ + E ++ + PY ++ + G++ P +
Sbjct: 193 --NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEKGERMGCPAGCPREM 249
Query: 248 YRV------KDPEVR 256
Y + D E R
Sbjct: 250 YDLMNLCWTYDVENR 264
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 51/245 (20%), Positives = 88/245 (35%), Gaps = 72/245 (29%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+ LG G+ V FD G A +V +D E+ ++K L H NI+K
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKV--------LQDPRYKNRELDIMKVLDHVNIIK 64
Query: 88 ----FYTSWVDTANRN--------------------------------INFVTE-MFT-- 108
FYT+ + +N + E +
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 109 SGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVK 168
L+ + + + + + ++ Q+ R + ++HS + HRD+K N+ VN +K
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLK 182
Query: 169 IGDLGLAAILRKSHAAHCVGTPEFM----------APEVYEEA--YNELVDIYSFGMCIL 216
+ D G A L S E APE+ A Y +D++S G C+
Sbjct: 183 LCDFGSAKKLIPS---------EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG-CVF 232
Query: 217 -EMVT 220
E++
Sbjct: 233 GELIL 237
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 59/252 (23%), Positives = 109/252 (43%), Gaps = 39/252 (15%)
Query: 28 EILGKGASKTVYRAFDEYEG-IEVAWNQVK-LYDFLQSPEDLERLYCEIHLLKTLKHKNI 85
+ LG G V ++ G +VA +K + + S ++ E ++ L H+ +
Sbjct: 30 KELGTGQFGVVKYG--KWRGQYDVA---IKMIKEGSMSEDEFIE---EAKVMMNLSHEKL 81
Query: 86 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLHS 143
++ Y V T R I +TE +G L Y L+ R + +L C+ + + YL S
Sbjct: 82 VQLYG--VCTKQRPIFIITEYMANGCLLNY-LREMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF----MAPEVYE 199
+HRDL N VN G VK+ D GL+ + VG+ +F PEV
Sbjct: 139 KQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGS-KFPVRWSPPEVLM 194
Query: 200 EA-YNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLYRV 250
+ ++ DI++FG+ + E+ + + PY T+ ++ + + G + + +Y +
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQGLRLYRPHLASEKVYTI 253
Query: 251 ------KDPEVR 256
+ + R
Sbjct: 254 MYSCWHEKADER 265
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 60/244 (24%), Positives = 111/244 (45%), Gaps = 22/244 (9%)
Query: 29 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEDLERLYCEIHLLKTLKHKNIM 86
ILG+G+ TV A + E A +K+ + + + + E ++ L H +
Sbjct: 37 ILGEGSFSTVVLARELATSREYA---IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDP 146
K Y ++ D + + F +G L +Y K + + + +I+ L YLH
Sbjct: 94 KLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG- 150
Query: 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC----VGTPEFMAPEV-YEEA 201
+IHRDLK +NI +N ++I D G A +L VGT ++++PE+ E++
Sbjct: 151 -IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 208
Query: 202 YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK--PDSLYRVKDPEVRRFV 259
+ D+++ G I ++V P+ + I++K++ + P+ P+ R V
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKLEYDFPEKF----FPKARDLV 263
Query: 260 EKCL 263
EK L
Sbjct: 264 EKLL 267
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 59/259 (22%), Positives = 103/259 (39%), Gaps = 37/259 (14%)
Query: 25 RYNEILGKGASKTVYRAFDEYEG---IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK 81
+ ++GKG VY + I+ A +K + + +E E L++ L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCA---IKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 82 HKNIMKFYTSWVDTANRNINF-VTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGL 138
H N++ + + + G L Q+ ++ + N L + Q+ RG+
Sbjct: 81 HPNVLALIG--IMLPPEGLPHVLLPYMCHGDLLQF-IRSPQRNPTVKDLISFGLQVARGM 137
Query: 139 LYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAAHCVGTPEF----- 192
YL +HRDL N ++ + VK+ D GLA IL + + +
Sbjct: 138 EYLAEQK--FVHRDLAARNCMLDES-FTVKVADFGLARDILDREYYSVQQHRHARLPVKW 194
Query: 193 MAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK------- 243
A E + + D++SFG+ + E++T PY P + + G++
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLAQGRRLPQPEYC 253
Query: 244 PDSLYRV------KDPEVR 256
PDSLY+V DP VR
Sbjct: 254 PDSLYQVMQQCWEADPAVR 272
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 60/274 (21%), Positives = 109/274 (39%), Gaps = 38/274 (13%)
Query: 15 VEVDPTGRYGRYNEILGKGASKTVYRAF---DEYEGIEVAWNQVKLYDFLQSPEDLERLY 71
V + P+ +NE++G+G VY ++ + I A VK + + ++ +
Sbjct: 18 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSLNRITDIGEVSQFL 74
Query: 72 CEIHLLKTLKHKNIMKFYTSWVDTANRNINF-VTEMFTSGTLRQYRLKHKRVNIRAVKL- 129
E ++K H N++ + + V G LR + ++++ N L
Sbjct: 75 TEGIIMKDFSHPNVLSLLG--ICLRSEGSPLVVLPYMKHGDLRNF-IRNETHNPTVKDLI 131
Query: 130 -WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVG 188
+ Q+ +G+ YL S +HRDL N ++ VK+ D GLA +
Sbjct: 132 GFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEYYSVHN 188
Query: 189 TPEF------MAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVS 240
MA E + + + D++SFG+ + E++T PY + I ++
Sbjct: 189 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQ 247
Query: 241 GKK-------PDSLYRV------KDPEVR-RFVE 260
G++ PD LY V E+R F E
Sbjct: 248 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 281
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 62/261 (23%), Positives = 110/261 (42%), Gaps = 43/261 (16%)
Query: 28 EILGKGASKTVYRA---FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84
+G+G V++ E + VA +K S E+ E ++ H +
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPH 77
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLH 142
I+K V T N + + E+ T G LR + L+ ++ ++ L + Q+ L YL
Sbjct: 78 IVKLIG--VITENP-VWIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGT--P-EFMAPEVYE 199
S +HRD+ N+ V + VK+GD GL+ + S P ++MAP
Sbjct: 134 SKR--FVHRDIAARNVLV-SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP---- 186
Query: 200 EAYNELV-----DIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDS 246
E+ N D++ FG+C+ E++ P+ + + ++ +G++ P +
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNCPPT 245
Query: 247 LYRV------KDPEVR-RFVE 260
LY + DP R RF E
Sbjct: 246 LYSLMTKCWAYDPSRRPRFTE 266
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 66/312 (21%), Positives = 123/312 (39%), Gaps = 53/312 (16%)
Query: 25 RYNEILGKGASKTVYRA-----FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKT 79
+ LG+G+ VY + VA +K + S + E ++K
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVA---IKTVNEAASMRERIEFLNEASVMKE 84
Query: 80 LKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL---------- 129
++++ V + + + E+ T G L+ Y L+ R + +
Sbjct: 85 FNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSY-LRSLRPAMANNPVLAPPSLSKMI 141
Query: 130 -WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVG 188
+I G+ YL+++ +HRDL N V + VKIGD G+ + ++ G
Sbjct: 142 QMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGG 198
Query: 189 TPEF----MAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGK 242
M+PE + + + D++SFG+ + E+ T E PY ++ Q+ + V+ G
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVLRFVMEGG 257
Query: 243 K-------PDSLYRV------KDPEVR-RFVEKCLATVSLRLSARELLNDPFLQIDDCES 288
PD L+ + +P++R F+E + S +E + F ++ S
Sbjct: 258 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLE-------IISSIKEEMEPGFREVSFYYS 310
Query: 289 NLRSLDYSRELD 300
L ELD
Sbjct: 311 EENKLPEPEELD 322
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 59/268 (22%), Positives = 106/268 (39%), Gaps = 46/268 (17%)
Query: 25 RYNEILGKGASKTVYRAF---DEYEGIEVAWNQVK-LYDFLQSPEDLERLYCEIHLLKTL 80
+LGKG +V A ++ ++VA VK L + + D+E E +K
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVA---VKMLKADIIASSDIEEFLREAACMKEF 82
Query: 81 KHKNIMKFY----TSWVDTANRNINFVTEMFTSGTLRQY----RLKHKRVNIRAVKL--W 130
H ++ K S + G L + R+ N+ L +
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 131 CRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA--HCVG 188
I G+ YL S + IHRDL N + + V + D GL+ RK ++ + G
Sbjct: 143 MVDIACGMEYLSSRN--FIHRDLAARNCMLAED-MTVCVADFGLS---RKIYSGDYYRQG 196
Query: 189 TPEF-----MAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSG 241
+A E + + Y D+++FG+ + E++T + PY+ + A+IY ++ G
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-AEIYNYLIGG 255
Query: 242 KK-------PDSLYRV------KDPEVR 256
+ + +Y + DP+ R
Sbjct: 256 NRLKQPPECMEEVYDLMYQCWSADPKQR 283
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 47/278 (16%), Positives = 91/278 (32%), Gaps = 74/278 (26%)
Query: 25 RYNEILGKGASKTVYRA-------FDEYEGIEVAWNQVK---------LYDFLQSPEDLE 68
+NE LG+G +++ + + EV +K F +
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVL---LKVLDKAHRNYSESFFE------ 61
Query: 69 RLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVK 128
++ L HK+++ Y V V E G+L Y LK + I +
Sbjct: 62 ----AASMMSKLSHKHLVLNYG--VCVCGDENILVQEFVKFGSLDTY-LKKNKNCINILW 114
Query: 129 L--WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVN-------GNQGEVKIGDLGLAAILR 179
+Q+ + +L + +IH ++ NI + GN +K+ D G++ +
Sbjct: 115 KLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL 172
Query: 180 KSHAAHCVGTPEF-------MAPEV--YEEAYNELVDIYSFGMCILEMVTF-EYPYSECT 229
+ + PE + N D +SFG + E+ + + P S
Sbjct: 173 PK---------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223
Query: 230 HPAQIYKKVVSGK-----KPDSLYRV------KDPEVR 256
+ + K L + +P+ R
Sbjct: 224 S-QRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHR 260
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-20
Identities = 50/230 (21%), Positives = 97/230 (42%), Gaps = 22/230 (9%)
Query: 65 EDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNI 124
D + E ++ +++ + ++ D +R + V E G L + + V
Sbjct: 111 SDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYLYMVMEYMPGGDLVNL-MSNYDVPE 167
Query: 125 RAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 184
+ + + +++ L +HS IHRD+K DN+ ++ G +K+ D G + K
Sbjct: 168 KWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMV 224
Query: 185 HC---VGTPEFMAPEV-----YEEAYNELVDIYSFGMCILEMVTFEYP-YSECTHPAQIY 235
C VGTP++++PEV + Y D +S G+ + EM+ + P Y++ Y
Sbjct: 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTY 282
Query: 236 KKVVSGKKPDSLYRVKD--PEVRRFVEKCLATVSLRL---SARELLNDPF 280
K+++ K + D E + + L +RL E+ F
Sbjct: 283 SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 63/259 (24%), Positives = 108/259 (41%), Gaps = 39/259 (15%)
Query: 28 EILGKGASKTVYRAF---DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84
ILG+G VY + E I VA K L + E E ++K L H +
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS---EAVIMKNLDHPH 74
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLH 142
I+K + + E++ G L Y L+ + +++ + L + QI + + YL
Sbjct: 75 IVKLIG--IIEEEP-TWIIMELYPYGELGHY-LERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGT--P-EFMAPEVYE 199
S + +HRD+ NI V + VK+GD GL+ + T P ++M+PE
Sbjct: 131 SIN--CVHRDIAVRNILV-ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI- 186
Query: 200 EAYNELV---DIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLY 248
+ D++ F +C+ E+++F + P+ + + + G + P LY
Sbjct: 187 -NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRLPKPDLCPPVLY 244
Query: 249 RV------KDPEVR-RFVE 260
+ DP R RF E
Sbjct: 245 TLMTRCWDYDPSDRPRFTE 263
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 60/249 (24%), Positives = 102/249 (40%), Gaps = 33/249 (13%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
LG+G V+ VA +K E E ++K L+H+ +++
Sbjct: 190 VKLGQGCFGEVWMGTWNGT-TRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLHSHD 145
Y V + I VTE + G+L + +R +L QI G+ Y+ +
Sbjct: 244 LYA--VVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTP---EFMAPEVYEEA- 201
+HRDL+ NI V N K+ D GLA ++ + G ++ APE
Sbjct: 301 --YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 202 YNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLYRV--- 250
+ D++SFG+ + E+ T PY + ++ +V G + P+SL+ +
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERGYRMPCPPECPESLHDLMCQ 416
Query: 251 ---KDPEVR 256
K+PE R
Sbjct: 417 CWRKEPEER 425
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 59/256 (23%), Positives = 99/256 (38%), Gaps = 39/256 (15%)
Query: 28 EILGKGASKTVYRA---FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84
+I+G G S V + VA +K + E ++ H N
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVA---IKALKAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLH 142
I++ V T R VTE +G+L + L+ ++L R + G+ YL
Sbjct: 112 IIRLEG--VVTRGRLAMIVTEYMENGSLDTF-LRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAAHCVGTPEF----MAPEV 197
+HRDL N+ V+ N K+ D GL+ + AA+ + APE
Sbjct: 169 DLG--YVHRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 198 YEEAYNELV---DIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDS 246
A+ D++SFG+ + E++ + E PY T+ + V G + P +
Sbjct: 226 I--AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSVEEGYRLPAPMGCPHA 282
Query: 247 LYRV------KDPEVR 256
L+++ KD R
Sbjct: 283 LHQLMLDCWHKDRAQR 298
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 67/259 (25%), Positives = 105/259 (40%), Gaps = 43/259 (16%)
Query: 28 EILGKGASKTVYRAF---DEYEGIEVAWNQVKLY--DFLQSPEDLERLYCEIHLLKTLKH 82
E LG G+ V R + + VA VK D L PE ++ E++ + +L H
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVA---VKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLY 140
+N+++ Y V + VTE+ G+L L+ + + L + Q+ G+ Y
Sbjct: 81 RNLIRLYG--VVLTPP-MKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 141 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS----HAAHCVGTP-EFMAP 195
L S IHRDL N+ + VKIGD GL L ++ P + AP
Sbjct: 137 LESKR--FIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 196 EVYEEAYNELV---DIYSFGMCILEMVTF-EYPYSECTHPAQIYKKV-VSGKK------- 243
E D + FG+ + EM T+ + P+ +QI K+ G++
Sbjct: 194 ESL--KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-GSQILHKIDKEGERLPRPEDC 250
Query: 244 PDSLYRV------KDPEVR 256
P +Y V PE R
Sbjct: 251 PQDIYNVMVQCWAHKPEDR 269
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 4e-20
Identities = 57/260 (21%), Positives = 97/260 (37%), Gaps = 59/260 (22%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVK-------LYDFLQSPEDLERLYCEIHLLKTL 80
+ +GKG V +Y G +VA VK FL E ++ L
Sbjct: 199 QTIGKGEFGDVMLG--DYRGNKVA---VKCIKNDATAQAFLA----------EASVMTQL 243
Query: 81 KHKNIMKFYTSWVDTANR-NINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRG 137
+H N+++ V + + VTE G+L Y R + L + +
Sbjct: 244 RHSNLVQLLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF----M 193
+ YL ++ +HRDL N+ V+ + K+ D GL +++ + G +
Sbjct: 302 MEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLT---KEASSTQDTG--KLPVKWT 353
Query: 194 APEVYEEAYNELV---DIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK------ 243
APE + D++SFG+ + E+ +F PY + +V G K
Sbjct: 354 APEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKGYKMDAPDG 410
Query: 244 -PDSLYRV------KDPEVR 256
P ++Y V D R
Sbjct: 411 CPPAVYDVMKNCWHLDAATR 430
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 5e-20
Identities = 61/257 (23%), Positives = 110/257 (42%), Gaps = 35/257 (13%)
Query: 28 EILGKGASKTVYRAF---DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84
+G+G V++ E + VA +K S E+ E ++ H +
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLH 142
I+K V T N + + E+ T G LR + L+ ++ ++ L + Q+ L YL
Sbjct: 453 IVKLIG--VITEN-PVWIIMELCTLGELRSF-LQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGT--P-EFMAPE-VY 198
S +HRD+ N+ V + VK+GD GL+ + S P ++MAPE +
Sbjct: 509 SKR--FVHRDIAARNVLV-SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565
Query: 199 EEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLYRV 250
+ D++ FG+C+ E++ P+ + + ++ +G++ P +LY +
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCPPTLYSL 624
Query: 251 ------KDPEVR-RFVE 260
DP R RF E
Sbjct: 625 MTKCWAYDPSRRPRFTE 641
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 5e-20
Identities = 71/326 (21%), Positives = 120/326 (36%), Gaps = 64/326 (19%)
Query: 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVN 161
F+ ++ G L + +H + ++ + +I+ GL ++H+ V++RDLK NI ++
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD 326
Query: 162 GNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEV--YEEAYNELVDIYSFGMCILEMV 219
G V+I DLGLA K VGT +MAPEV AY+ D +S G + +++
Sbjct: 327 -EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 220 T----FEYPYSECTHPAQIYKKVVSGKK--PDSLYRVKDPEVRRFVEKCLA-TVSLRL-- 270
F ++ H +I + ++ PDS PE+R +E L V+ RL
Sbjct: 386 RGHSPFRQHKTKDKH--EIDRMTLTMAVELPDSF----SPELRSLLEGLLQRDVNRRLGC 439
Query: 271 ---SARELLNDPFLQIDDCESNLRSLD----YSRELD-----DMDPLIRQPHIDFHHIDN 318
A+E+ PF RSLD + ++ + D D
Sbjct: 440 LGRGAQEVKESPF---------FRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDE 490
Query: 319 SFSNGCA---------NGYGYDTPSEWG--------------YSPVEVESNGIELFGYHD 355
+ G + W +E H+
Sbjct: 491 EDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETDRLEARKKTKNKQLGHE 550
Query: 356 DDHSSDVDISIKGKRRDDGGIFLRLR 381
+D++ D + G G FL
Sbjct: 551 EDYALGKDCIMHGYMSKMGNPFLTQW 576
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 66/251 (26%), Positives = 109/251 (43%), Gaps = 37/251 (14%)
Query: 28 EILGKGASKTVYRAFDEYEG-IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIM 86
E LG G V+ Y G +VA +K Q + E +L+K L+H+ ++
Sbjct: 19 ERLGAGQFGEVWMG--YYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLHSH 144
+ Y V T I +TE +G+L + + + KL QI G+ ++
Sbjct: 72 RLYA--VVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF----MAPEVYEE 200
+ IHRDL+ NI V+ KI D GLA ++ + G +F APE
Sbjct: 129 N--YIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEYTAREGA-KFPIKWTAPEAINY 184
Query: 201 A-YNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLYRV- 250
+ D++SFG+ + E+VT PY T+P ++ + + G + P+ LY++
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGYRMVRPDNCPEELYQLM 243
Query: 251 -----KDPEVR 256
+ PE R
Sbjct: 244 RLCWKERPEDR 254
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 6e-20
Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 35/250 (14%)
Query: 28 EILGKGASKTVYRAFDEYEG-IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIM 86
LG+G V+ + G VA +K E E ++K L+H+ ++
Sbjct: 273 VKLGQGCFGEVWMG--TWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLHSH 144
+ Y V + I VTE + G+L + +R +L QI G+ Y+
Sbjct: 326 QLYA--VVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AAHCVGTP-EFMAPEVYEEA 201
+ +HRDL+ NI V N K+ D GLA ++ + A P ++ APE
Sbjct: 383 N--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 202 -YNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLYRV-- 250
+ D++SFG+ + E+ T PY + ++ +V G + P+SL+ +
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERGYRMPCPPECPESLHDLMC 498
Query: 251 ----KDPEVR 256
K+PE R
Sbjct: 499 QCWRKEPEER 508
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 57/253 (22%), Positives = 103/253 (40%), Gaps = 39/253 (15%)
Query: 30 LGKGASKTVYRAF--DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
LG G +V + + I+VA +K E++ R E ++ L + I++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMHQLDNPYIVR 74
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLHSHD 145
V A + V EM G L ++ L KR I + Q+ G+ YL +
Sbjct: 75 LIG--VCQAEA-LMLVMEMAGGGPLHKF-LVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGT----P-EFMAPEVYEE 200
+HRDL N+ + N+ KI D GL+ L + + + P ++ APE
Sbjct: 131 --FVHRDLAARNVLL-VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-- 185
Query: 201 AYNELV---DIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLYR 249
+ + D++S+G+ + E +++ + PY + ++ + GK+ P LY
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQGKRMECPPECPPELYA 244
Query: 250 V------KDPEVR 256
+ E R
Sbjct: 245 LMSDCWIYKWEDR 257
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 66 DLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIR 125
+E E +L+ + ++K S+ D N N+ V E G + + + R +
Sbjct: 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 126 AVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH 185
+ + QI+ YLHS D +I+RDLK +N+ ++ QG +++ D G A ++
Sbjct: 142 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTWTL 198
Query: 186 CVGTPEFMAPEV-YEEAYNELVDIYSFGMCILEMVTFEYP-YSECTHPAQIYKKVVSGKK 243
C GTPE +APE+ + YN+ VD ++ G+ I EM P +++ P QIY+K+VSGK
Sbjct: 199 C-GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSGKV 255
Query: 244 --PDSLYRVKDPEVRRFVEKCL 263
P +++ + L
Sbjct: 256 RFPSHF----SSDLKDLLRNLL 273
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 58/254 (22%), Positives = 103/254 (40%), Gaps = 35/254 (13%)
Query: 28 EILGKGASKTVYRA---FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84
+++G G V + I VA +K + + E ++ H N
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVA---IKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLH 142
I++ V T ++ + VTE +G+L + L+ ++L R I G+ YL
Sbjct: 108 IIRLEG--VVTKSKPVMIVTEYMENGSLDSF-LRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAAHCVGTPEF----MAPEV 197
+HRDL NI +N N K+ D GL + AA+ + +PE
Sbjct: 165 DMG--YVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 198 YEE-AYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLY 248
+ D++S+G+ + E++++ E PY E ++ + K V G + P +LY
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAALY 280
Query: 249 RV------KDPEVR 256
++ KD R
Sbjct: 281 QLMLDCWQKDRNNR 294
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 62/293 (21%), Positives = 119/293 (40%), Gaps = 45/293 (15%)
Query: 28 EILGKGASKTVYRAF---DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84
E++G+G VY ++ + I A VK + + ++ + E ++K H N
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 85 IMKFYTSWVDTANRNINF-VTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYL 141
++ + + V G LR + ++++ N L + Q+ +G+ +L
Sbjct: 152 VLSLLG--ICLRSEGSPLVVLPYMKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAAHCVGTPEF-----MAP 195
S +HRDL N ++ VK+ D GLA + K + T MA
Sbjct: 209 ASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 196 E-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDS 246
E + + + D++SFG+ + E++T PY + I ++ G++ PD
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQGRRLLQPEYCPDP 324
Query: 247 LYRV------KDPEVR-RFVEKCLATVSLRLSA--RELLNDPFLQIDDCESNL 290
LY V E+R F E + R+SA + + ++ ++ N+
Sbjct: 325 LYEVMLKCWHPKAEMRPSFSE-----LVSRISAIFSTFIGEHYVHVNATYVNV 372
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 61/269 (22%), Positives = 100/269 (37%), Gaps = 49/269 (18%)
Query: 25 RYNEILGKGASKTVYRAF-----DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKT 79
LG GA VY ++ ++VA VK + S +D E ++
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVA---VKTLPEVCSEQDELDFLMEALIISK 89
Query: 80 LKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL-------WCR 132
H+NI++ V + + E+ G L+ + + + + L R
Sbjct: 90 FNHQNIVRCIG--VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGE---VKIGDLGLAAILRKSHAAHC--V 187
I G YL + IHRD+ N + G KIGD G+A R + A
Sbjct: 148 DIACGCQYLEENH--FIHRDIAARNCLLT-CPGPGRVAKIGDFGMA---RDIYRASYYRK 201
Query: 188 GTPEF-----MAPEVYEEA-YNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVS 240
G M PE + E + D +SFG+ + E+ + PY ++ ++ + V S
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTS 260
Query: 241 GKK-------PDSLYRV------KDPEVR 256
G + P +YR+ PE R
Sbjct: 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 64/253 (25%), Positives = 109/253 (43%), Gaps = 41/253 (16%)
Query: 28 EILGKGASKTVYRAFDEYEG-IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIM 86
+ LG G V+ A Y +VA +K +E E +++KTL+H ++
Sbjct: 194 KKLGAGQFGEVWMA--TYNKHTKVAVKTMK-----PGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLHSH 144
K + V T I +TE G+L + + KL + QI G+ ++
Sbjct: 247 KLHA--VVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF----MAPEVYEE 200
+ IHRDL+ NI V+ + KI D GLA ++ + G +F APE
Sbjct: 304 N--YIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEYTAREGA-KFPIKWTAPEAI-- 357
Query: 201 AYNELV---DIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLYR 249
+ D++SFG+ ++E+VT+ PY ++P ++ + + G + P+ LY
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALERGYRMPRPENCPEELYN 416
Query: 250 V------KDPEVR 256
+ PE R
Sbjct: 417 IMMRCWKNRPEER 429
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 54/268 (20%), Positives = 91/268 (33%), Gaps = 21/268 (7%)
Query: 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKL--YDFLQSPEDLERLYCEIHLLK 78
G Y R ++G+G VY A D VA +KL P R+ E
Sbjct: 34 GPY-RLRRLVGRGGMGDVYEAEDTVRERIVA---LKLMSETLSSDPVFRTRMQREARTAG 89
Query: 79 TLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGL 138
L+ +++ + + + L + + RQI L
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYV--DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSAL 147
Query: 139 LYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH---AAHCVGTPEFMAP 195
H+ HRD+K +NI V+ + + D G+A+ + VGT +MAP
Sbjct: 148 DAAHAAG--ATHRDVKPENILVSAD-DFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAP 204
Query: 196 EVYE-EAYNELVDIYSFGMCIL-EMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK-D 252
E + DIY+ C+L E +T PY + + + S R
Sbjct: 205 ERFSESHATYRADIYALT-CVLYECLTGSPPYQGDQ-LSVMGAHINQAIPRPSTVRPGIP 262
Query: 253 PEVRRFVEKCLA-TVSLR-LSARELLND 278
+ + +A R ++ +L
Sbjct: 263 VAFDAVIARGMAKNPEDRYVTCGDLSAA 290
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-19
Identities = 71/333 (21%), Positives = 116/333 (34%), Gaps = 87/333 (26%)
Query: 24 GRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLY----DFLQSPEDLERLYCEIHLL 77
RY LG G TV+ A D VA +K+ + ++ ED EI LL
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVA---MKIVRGDKVYTEAAED------EIKLL 69
Query: 78 KTLK-----------HKNIMKFYTSWVDTANRNIN---FVTEMFTSGTLRQY--RLKHKR 121
+ + +I+K + N V E+ L + +H+
Sbjct: 70 QRVNDADNTKEDSMGANHILKLL-DHFNHKGPNGVHVVMVFEV-LGENLLALIKKYEHRG 127
Query: 122 VNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFV-----NGNQGEVKIGDLGLAA 176
+ + VK +Q+L GL Y+H +IH D+K +N+ + N ++KI DLG A
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 177 ILRKSHAAHCVGTPEFMAPEVYEEA-YNELVDIYSFGMCILEMVT---------FEYPYS 226
+ + + T E+ +PEV A + DI+S I E++T
Sbjct: 187 WYDEHYTNS-IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 227 ECTHPAQI---------------------------YKKVVSGKKPD------SLYRVKDP 253
+ H AQI + + K Y+
Sbjct: 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305
Query: 254 EVRRF---VEKCLA-TVSLRLSARELLNDPFLQ 282
E + + L R A L+N P+L+
Sbjct: 306 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 338
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 53/268 (19%), Positives = 99/268 (36%), Gaps = 47/268 (17%)
Query: 25 RYNEILGKGASKTVYRAF---DEYEGIEVAWNQVK-LYDFLQSPEDLERLYCEIHLLKTL 80
+ILG+G +V ++ ++VA VK + S ++E E +K
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVA---VKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 81 KHKNIMKFY---TSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL-------W 130
H N+++ + G L Y L + R+ + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTY-LLYSRLETGPKHIPLQTLLKF 152
Query: 131 CRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA--HCVG 188
I G+ YL + + +HRDL N + + V + D GL+ +K ++ + G
Sbjct: 153 MVDIALGMEYLSNRN--FLHRDLAARNCMLRDD-MTVCVADFGLS---KKIYSGDYYRQG 206
Query: 189 TPEF-----MAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSG 241
+A E + + Y D+++FG+ + E+ T PY ++Y ++ G
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ-NHEMYDYLLHG 265
Query: 242 KK-------PDSLYRV------KDPEVR 256
+ D LY + DP R
Sbjct: 266 HRLKQPEDCLDELYEIMYSCWRTDPLDR 293
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 58/255 (22%), Positives = 110/255 (43%), Gaps = 36/255 (14%)
Query: 28 EILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHK 83
+++G G VY+ + + VA +K + + E ++ H
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVA---IKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYL 141
NI++ V + + + +TE +G L ++ L+ K ++L R I G+ YL
Sbjct: 107 NIIRLEG--VISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGT----P-EFMAPE 196
+ + +HRDL NI VN N K+ D GL+ +L A + P + APE
Sbjct: 164 ANMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 197 VYEE-AYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSL 247
+ D++SFG+ + E++T+ E PY E ++ ++ K + G + P ++
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGFRLPTPMDCPSAI 279
Query: 248 YRV------KDPEVR 256
Y++ ++ R
Sbjct: 280 YQLMMQCWQQERARR 294
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-19
Identities = 38/165 (23%), Positives = 74/165 (44%), Gaps = 23/165 (13%)
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC---VGT 189
+++ + +H +HRD+K DNI ++ G +++ D G L + VGT
Sbjct: 183 EMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239
Query: 190 PEFMAPEV------YEEAYNELVDIYSFGMCILEMVTFEYP-YSECTHPAQIYKKVVSGK 242
P++++PE+ + Y D +S G+C+ EM+ E P Y+E + Y K+++ K
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHK 297
Query: 243 K----PDSLYRVKDPEVRRFVEKCLATVSLRL---SARELLNDPF 280
+ P + V + + + + + RL + PF
Sbjct: 298 ERFQFPTQVTDV-SENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 23/166 (13%)
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC---VGT 189
+I+ + +H +HRD+K DNI ++ G +++ D G LR VGT
Sbjct: 170 EIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTVRSLVAVGT 226
Query: 190 PEFMAPEV--------YEEAYNELVDIYSFGMCILEMVTFEYP-YSECTHPAQIYKKVVS 240
P++++PE+ +Y D ++ G+ EM + P Y++ A+ Y K+V
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD--STAETYGKIVH 284
Query: 241 GKKPDSLYRVKD---PEVRRFVEKCLATVSLRL---SARELLNDPF 280
K+ SL V + E R F+++ L RL A + PF
Sbjct: 285 YKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPF 330
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 61/269 (22%), Positives = 100/269 (37%), Gaps = 49/269 (18%)
Query: 25 RYNEILGKGASKTVYRAF-----DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKT 79
LG GA VY ++ ++VA VK + S +D E ++
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVA---VKTLPEVCSEQDELDFLMEALIISK 130
Query: 80 LKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL-------WCR 132
H+NI++ V + + E+ G L+ + + + + L R
Sbjct: 131 FNHQNIVRCIG--VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGE---VKIGDLGLAAILRKSHAAHC--V 187
I G YL + IHRD+ N + G KIGD G+A R + A
Sbjct: 189 DIACGCQYLEENH--FIHRDIAARNCLLT-CPGPGRVAKIGDFGMA---RDIYRAGYYRK 242
Query: 188 GTPEF-----MAPEVYEEA-YNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVS 240
G M PE + E + D +SFG+ + E+ + PY ++ ++ + V S
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTS 301
Query: 241 GKK-------PDSLYRV------KDPEVR 256
G + P +YR+ PE R
Sbjct: 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDR 330
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 54/252 (21%), Positives = 104/252 (41%), Gaps = 37/252 (14%)
Query: 30 LGKGASKTVYRAF--DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
LG G +V + + I+VA +K+ D E + E ++ L + I++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDP 146
V A + V EM G L ++ + + + + V Q+ G+ YL +
Sbjct: 401 LIG--VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN- 456
Query: 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGT----P-EFMAPEVYEEA 201
+HR+L N+ + N+ KI D GL+ L + + + P ++ APE
Sbjct: 457 -FVHRNLAARNVLL-VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--N 512
Query: 202 YNELV---DIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLYRV 250
+ + D++S+G+ + E +++ + PY + P ++ + GK+ P LY +
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQGKRMECPPECPPELYAL 571
Query: 251 ------KDPEVR 256
E R
Sbjct: 572 MSDCWIYKWEDR 583
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 2e-18
Identities = 54/202 (26%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 66 DLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIR 125
+E E +L + H I++ + ++ D + I + + G L K +R
Sbjct: 49 QVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNP 106
Query: 126 AVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH 185
K + ++ L YLHS D +I+RDLK +NI ++ G +KI D G A +
Sbjct: 107 VAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVTYTL 163
Query: 186 CVGTPEFMAPEV-YEEAYNELVDIYSFGMCILEMVTFEYP-YSECTHPAQIYKKVVSGKK 243
C GTP+++APEV + YN+ +D +SFG+ I EM+ P Y + + Y+K+++ +
Sbjct: 164 C-GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS--NTMKTYEKILNAEL 220
Query: 244 --PDSLYRVKDPEVRRFVEKCL 263
P + +V+ + + +
Sbjct: 221 RFPPFF----NEDVKDLLSRLI 238
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 21/183 (11%)
Query: 112 LRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 171
+ + + QI+ GL +LH + +I+RDLK +N+ ++ + G V+I D
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISD 332
Query: 172 LGLA--AILRKSHAAHCVGTPEFMAPEVY-EEAYNELVDIYSFGMCILEMVTFEYPY--- 225
LGLA ++ GTP FMAPE+ E Y+ VD ++ G+ + EM+ P+
Sbjct: 333 LGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392
Query: 226 SECTHPAQIYKKVVSGKK--PDSLYRVKDPEVRRFVEKCLA-TVSLRL-----SARELLN 277
E ++ ++V+ PD P + F E L RL S L
Sbjct: 393 GEKVENKELKQRVLEQAVTYPDKF----SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448
Query: 278 DPF 280
P
Sbjct: 449 HPL 451
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 63/274 (22%), Positives = 108/274 (39%), Gaps = 54/274 (19%)
Query: 25 RYNEILGKGASKTVYRA-----FDEYEGIEVAWNQVK-LYDFLQSPEDLERLYCEIHLLK 78
LG+GA V+ A + + VA VK L D + + E LL
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVA---VKALKD--PTLAARKDFQREAELLT 72
Query: 79 TLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--------- 129
L+H++I+KFY V + V E G L ++ L+ + +
Sbjct: 73 NLQHEHIVKFYG--VCGDGDPLIMVFEYMKHGDLNKF-LRAHGPDAMILVDGQPRQAKGE 129
Query: 130 --------WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181
QI G++YL S +HRDL N V N VKIGD G++ + +
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL-LVKIGDFGMSRDVYST 186
Query: 182 HAAHCVGTPEF----MAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIY 235
G M PE + + D++SFG+ + E+ T+ + P+ + ++ ++
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-TEVI 245
Query: 236 KKVVSGKK-------PDSLYRV------KDPEVR 256
+ + G+ P +Y V ++P+ R
Sbjct: 246 ECITQGRVLERPRVCPKEVYDVMLGCWQREPQQR 279
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 58/235 (24%), Positives = 108/235 (45%), Gaps = 25/235 (10%)
Query: 59 DFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 118
+ + + +++ E +L+ +H + ++ T +R + FV E G L + L
Sbjct: 41 EVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-QTHDR-LCFVMEYANGGEL-FFHLS 97
Query: 119 HKRV-NIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-A 176
+RV + + +I+ L YLHS D V++RD+K +N+ ++ G +KI D GL
Sbjct: 98 RERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDK-DGHIKITDFGLCKE 154
Query: 177 ILRKSHAAH--CVGTPEFMAPEVY-EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQ 233
+ C GTPE++APEV + Y VD + G+ + EM+ P+ H +
Sbjct: 155 GISDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ER 212
Query: 234 IYKKVVSGKK--PDSLYRVKDPEVRRFVEKCLA-TVSLRL-----SARELLNDPF 280
+++ ++ + P +L PE + + L RL A+E++ F
Sbjct: 213 LFELILMEEIRFPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 8e-18
Identities = 48/194 (24%), Positives = 81/194 (41%), Gaps = 22/194 (11%)
Query: 102 FVTEMFTSGTLRQ--YRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIF 159
V + G L+ Y + + +I GL LH +++RDLK +NI
Sbjct: 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENIL 318
Query: 160 VNGNQGEVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVY-EEAYNELVDIYSFGMCILE 217
++ + G ++I DLGLA + + VGT +MAPEV E Y D ++ G + E
Sbjct: 319 LD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYE 377
Query: 218 MVTFEYPY---SECTHPAQIYKKVVSGKK--PDSLYRVKDPEVRRFVEKCLA-TVSLRL- 270
M+ + P+ + ++ + V + + P+ R + L + RL
Sbjct: 378 MIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF----SPQARSLCSQLLCKDPAERLG 433
Query: 271 ----SARELLNDPF 280
SARE+ P
Sbjct: 434 CRGGSAREVKEHPL 447
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 60/278 (21%), Positives = 110/278 (39%), Gaps = 54/278 (19%)
Query: 25 RYNEILGKGASKTVYRA-----FDEYEGIEVAWNQVK-LYDFLQSPEDLERLYCEIHLLK 78
LG+GA V+ A E + + VA VK L + S + E LL
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVA---VKALKE--ASESARQDFQREAELLT 98
Query: 79 TLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--------- 129
L+H++I++F+ V T R + V E G L ++ L+ + + +
Sbjct: 99 MLQHQHIVRFFG--VCTEGRPLLMVFEYMRHGDLNRF-LRSHGPDAKLLAGGEDVAPGPL 155
Query: 130 -------WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 182
Q+ G++YL +HRDL N V VKIGD G++ + +
Sbjct: 156 GLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTD 212
Query: 183 AAHCVGTPEF----MAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYK 236
G M PE + + D++SFG+ + E+ T+ + P+ + ++ +
Sbjct: 213 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-TEAID 271
Query: 237 KVVSGKK-------PDSLYRV------KDPEVR-RFVE 260
+ G++ P +Y + ++P+ R +
Sbjct: 272 CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKD 309
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} Length = 98 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 2e-17
Identities = 25/91 (27%), Positives = 41/91 (45%), Gaps = 9/91 (9%)
Query: 357 DHSSDVDISIKGKRRDDG---GIFLRLRIAD---KEGRIRN---IYFPFDVETDTALSVA 407
D + + ++ DDG I L LRI D +G+ ++ I F FD+E D VA
Sbjct: 4 DPQEETGVRVELAEEDDGEKIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVA 63
Query: 408 TEMVAELDITDQDVTKIADMIDGEIASLVPE 438
EMV + + D +A I ++ + +
Sbjct: 64 QEMVESGYVCEGDHKTMAKAIKDRVSLIKRK 94
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 58/278 (20%), Positives = 104/278 (37%), Gaps = 52/278 (18%)
Query: 25 RYNEILGKGASKTVYRA-----FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKT 79
R+ E LG+ VY+ + VA +K E E L
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVA---IKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 80 LKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL---------- 129
L+H N++ V T ++ ++ + + G L ++ L + +
Sbjct: 69 LQHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEF-LVMRSPHSDVGSTDDDRTVKSAL 125
Query: 130 -------WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 182
QI G+ YL SH V+H+DL N+ V VKI DLGL + +
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDK-LNVKISDLGLFREVYAAD 182
Query: 183 AAHCVGTPEF----MAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYK 236
+G MAPE + ++ DI+S+G+ + E+ ++ PY ++ + +
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVVE 241
Query: 237 KVVSGKK-------PDSLYRV------KDPEVR-RFVE 260
+ + + P +Y + + P R RF +
Sbjct: 242 MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKD 279
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 65/278 (23%), Positives = 102/278 (36%), Gaps = 57/278 (20%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGIE-------VAWNQVKLYDFLQSPEDLERLYCEIHLL 77
+ + LG GA V A G+ VA VK+ + E L E+ +L
Sbjct: 26 SFGKTLGAGAFGKVVEA--TAYGLIKSDAAMTVA---VKMLKPSAHLTEREALMSELKVL 80
Query: 78 KTL-KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL------- 129
L H NI+ T +TE G L + L+ KR + K
Sbjct: 81 SYLGNHMNIVNLLG--ACTIGGPTLVITEYCCYGDLLNF-LRRKRDSFICSKTSPAIMED 137
Query: 130 ------------WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177
+ Q+ +G+ +L S + IHRDL NI + + KI D GLA
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILL-THGRITKICDFGLARD 194
Query: 178 LRKSHAAHCVGTPEF----MAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHP 231
++ G MAPE ++ Y D++S+G+ + E+ + PY
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 232 AQIYKKVVSGKK-------PDSLYRV------KDPEVR 256
++ YK + G + P +Y + DP R
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 60/279 (21%), Positives = 103/279 (36%), Gaps = 60/279 (21%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGIE-------VAWNQVKLYDFLQSPEDLERLYCEIHLL 77
+ + LG+GA V A + GI+ VA VK+ + + L E+ +L
Sbjct: 30 KLGKPLGRGAFGQVIEA--DAFGIDKTATCRTVA---VKMLKEGATHSEHRALMSELKIL 84
Query: 78 KTL-KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL------- 129
+ H N++ + + + E G L Y L+ KR K+
Sbjct: 85 IHIGHHLNVVNLLGA-CTKPGGPLMVIVEFCKFGNLSTY-LRSKRNEFVPYKVAPEDLYK 142
Query: 130 ----------WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179
+ Q+ +G+ +L S IHRDL NI ++ VKI D GLA R
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLA---R 196
Query: 180 KSHAAH--CVGTPEF-----MAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTH 230
+ MAPE +++ Y D++SFG+ + E+ + PY
Sbjct: 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 231 PAQIYKKVVSGKK-------PDSLYRV------KDPEVR 256
+ +++ G + +Y+ +P R
Sbjct: 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 295
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 35/144 (24%), Positives = 74/144 (51%), Gaps = 22/144 (15%)
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAAH--CVG 188
+I+ L +LH +I+RD+K +NI ++ + G V + D GL+ + ++ A+ C G
Sbjct: 167 EIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFC-G 222
Query: 189 TPEFMAPEV---YEEAYNELVDIYSFGMCILEMVT----FEYPYSECTHPAQIYKKVVSG 241
T E+MAP++ + +++ VD +S G+ + E++T F E A+I ++++
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF-TVDGEKNSQAEISRRILKS 281
Query: 242 KK--PDSLYRVKDPEVRRFVEKCL 263
+ P + + +++ L
Sbjct: 282 EPPYPQEM----SALAKDLIQRLL 301
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 61/233 (26%), Positives = 106/233 (45%), Gaps = 25/233 (10%)
Query: 61 LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK 120
+++ +D E ++L+ +KH I+ ++ T + + + E + G L +L+ +
Sbjct: 59 VRNAKDTAHTKAERNILEEVKHPFIVDLIYAF-QTGGK-LYLILEYLSGGEL-FMQLERE 115
Query: 121 RV-NIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AIL 178
+ + +I L +LH +I+RDLK +NI +N +QG VK+ D GL +
Sbjct: 116 GIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLN-HQGHVKLTDFGLCKESI 172
Query: 179 RKSHAAH--CVGTPEFMAPEV-YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIY 235
H C GT E+MAPE+ +N VD +S G + +M+T P++ +
Sbjct: 173 HDGTVTHTFC-GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-KKTI 230
Query: 236 KKVVSGKK--PDSLYRVKDPEVRRFVEKCLA-TVSLRL-----SARELLNDPF 280
K++ K P L E R ++K L + RL A E+ PF
Sbjct: 231 DKILKCKLNLPPYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 42/159 (26%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAAH--CVGT 189
+I L YLHS + +++RDLK +NI ++ +QG + + D GL + + C GT
Sbjct: 147 EIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFC-GT 202
Query: 190 PEFMAPEV-YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK--PDS 246
PE++APEV +++ Y+ VD + G + EM+ P+ A++Y +++ +
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYDNILNKPLQLKPN 261
Query: 247 LYRVKDPEVRRFVEKCLA-TVSLRL----SARELLNDPF 280
+ R +E L + RL E+ + F
Sbjct: 262 I----TNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 21/160 (13%)
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAAH--CVGT 189
++ L +LHS +I+RDLK +NI ++ +G +K+ D GL+ + A+ C GT
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFC-GT 189
Query: 190 PEFMAPEV-YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK--PDS 246
E+MAPEV + + D +SFG+ + EM+T P+ + ++ K P
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-KETMTMILKAKLGMPQF 248
Query: 247 LYRVKDPEVRRFVEKCLA-TVSLRL-----SARELLNDPF 280
L PE + + + RL E+ F
Sbjct: 249 L----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 59 DFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 118
+ + + +++ E +L+ +H + S+ T +R + FV E G L + L
Sbjct: 184 EVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-QTHDR-LCFVMEYANGGEL-FFHLS 240
Query: 119 HKRV-NIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-- 175
+RV + + + +I+ L YLHS V++RDLK +N+ ++ G +KI D GL
Sbjct: 241 RERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDK-DGHIKITDFGLCKE 298
Query: 176 AILRKSHAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQI 234
I + GTPE++APEV E+ Y VD + G+ + EM+ P+ H ++
Sbjct: 299 GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKL 357
Query: 235 YKKVVSGKK--PDSLYRVKDPEVRRFVEKCL 263
++ ++ + P +L PE + + L
Sbjct: 358 FELILMEEIRFPRTL----GPEAKSLLSGLL 384
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 17/156 (10%)
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAAH--CVGT 189
+I+ GL +LHS +++RDLK DNI ++ G +KI D G+ + + C GT
Sbjct: 126 EIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFC-GT 181
Query: 190 PEFMAPEVY-EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK--PDS 246
P+++APE+ + YN VD +SFG+ + EM+ + P+ +++ + P
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFHSIRMDNPFYPRW 240
Query: 247 LYRVKDPEVRRFVEKCLA-TVSLRL-SARELLNDPF 280
L + E + + K RL ++ P
Sbjct: 241 L----EKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 61/286 (21%), Positives = 111/286 (38%), Gaps = 69/286 (24%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGIE-------VAWNQVKLYDFLQSPEDLERLYCEIHLL 77
+ LG+G V +A ++ VA VK+ SP +L L E ++L
Sbjct: 26 VLGKTLGEGEFGKVVKA--TAFHLKGRAGYTTVA---VKMLKENASPSELRDLLSEFNVL 80
Query: 78 KTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL-------- 129
K + H +++K Y + + + + E G+LR + L+ R
Sbjct: 81 KQVNHPHVIKLYG--ACSQDGPLLLIVEYAKYGSLRGF-LRESRKVGPGYLGSGGSRNSS 137
Query: 130 -----------------WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 172
+ QI +G+ YL ++HRDL NI V ++KI D
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEG-RKMKISDF 194
Query: 173 GLAAILRKSHAAH--CVGTPEF-----MAPE-VYEEAYNELVDIYSFGMCILEMVTF-EY 223
GL+ R + + MA E +++ Y D++SFG+ + E+VT
Sbjct: 195 GLS---RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 224 PYSECTHPAQIYKKVVSGKK-------PDSLYRV------KDPEVR 256
PY +++ + +G + + +YR+ ++P+ R
Sbjct: 252 PYPGIPP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 31/250 (12%), Positives = 70/250 (28%), Gaps = 41/250 (16%)
Query: 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKL--YDFLQSPEDLERLYCEIHLLK 78
GRY R G ++A D +VA + + + L+ L
Sbjct: 31 GRY-RLLIFHGGVPPLQFWQALDTALDRQVA---LTFVDPQGVLPDDVLQETLSRTLRLS 86
Query: 79 TLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGL 138
+ + + V T + V E G+L++ + + + +
Sbjct: 87 RIDKPGVARVL-DVVHTRAGGL-VVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAA 142
Query: 139 LYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVY 198
H V + V+ + G+V + P+
Sbjct: 143 DAAHRAG--VALSIDHPSRVRVSID-GDVVLAYPATMP----------DANPQ------- 182
Query: 199 EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYK--KVVSGK--KPDSLYRVKDPE 254
DI G + ++ +P E + + + +G+ +P + R +
Sbjct: 183 -------DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235
Query: 255 VRRFVEKCLA 264
+ + +
Sbjct: 236 ISAVAARSVQ 245
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 62/292 (21%), Positives = 105/292 (35%), Gaps = 56/292 (19%)
Query: 5 THLEPDCSEFVEVDPTGRYGRYNEILGKGASKTVYRAF--DEYEGIEVAWNQVK-LYDFL 61
PD + + +D ++ +++G+G V +A + ++ A +K + ++
Sbjct: 10 GKNNPDPTIYPVLDWN--DIKFQDVIGEGNFGQVLKARIKKDGLRMDAA---IKRMKEYA 64
Query: 62 QSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK 120
S +D E+ +L L H NI+ + E G L + L+
Sbjct: 65 -SKDDHRDFAGELEVLCKLGHHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDF-LRKS 120
Query: 121 RVNIRAVKLW-----------------CRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGN 163
RV + RG+ YL IHRDL NI V N
Sbjct: 121 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 178
Query: 164 QGEVKIGDLGLAAILRKSHAAHCVGTPEF----MAPE-VYEEAYNELVDIYSFGMCILEM 218
KI D GL+ R MA E + Y D++S+G+ + E+
Sbjct: 179 Y-VAKIADFGLS---RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234
Query: 219 VTF-EYPYSECTHPAQIYKKVVSGKK-------PDSLYRV------KDPEVR 256
V+ PY T A++Y+K+ G + D +Y + + P R
Sbjct: 235 VSLGGTPYCGMTC-AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 285
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 30/114 (26%), Positives = 60/114 (52%), Gaps = 9/114 (7%)
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAAH--CVGT 189
+I+ L++LH +I+RDLK DN+ ++ +G K+ D G+ + C GT
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDH-EGHCKLADFGMCKEGICNGVTTATFC-GT 187
Query: 190 PEFMAPEVY-EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK 242
P+++APE+ E Y VD ++ G+ + EM+ P+ +++ +++ +
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAILNDE 240
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 39/160 (24%), Positives = 75/160 (46%), Gaps = 21/160 (13%)
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAAH--CVGT 189
+I GL +L S +I+RDLK DN+ ++ ++G +KI D G+ + C GT
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFC-GT 184
Query: 190 PEFMAPEVY-EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK--PDS 246
P+++APE+ + Y + VD ++FG+ + EM+ + P+ ++++ ++ P S
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEHNVAYPKS 243
Query: 247 LYRVKDPEVRRFVEKCLA-TVSLRL-----SARELLNDPF 280
+ E + + RL R++ F
Sbjct: 244 M----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 41/145 (28%), Positives = 65/145 (44%), Gaps = 18/145 (12%)
Query: 102 FVTEMFTSGTL-----RQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCD 156
FV E G L RQ +L + + + +I L YLH +I+RDLK D
Sbjct: 87 FVIEYVNGGDLMFHMQRQRKLPEEHA-----RFYSAEISLALNYLHERG--IIYRDLKLD 139
Query: 157 NIFVNGNQGEVKIGDLGLA-AILRKSHAAH--CVGTPEFMAPEV-YEEAYNELVDIYSFG 212
N+ ++ +G +K+ D G+ LR C GTP ++APE+ E Y VD ++ G
Sbjct: 140 NVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGEDYGFSVDWWALG 197
Query: 213 MCILEMVTFEYPYSECTHPAQIYKK 237
+ + EM+ P+ +
Sbjct: 198 VLMFEMMAGRSPFDIVGSSDNPDQN 222
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 9e-16
Identities = 69/277 (24%), Positives = 106/277 (38%), Gaps = 56/277 (20%)
Query: 25 RYNEILGKGASKTVYRA-------FDEYEGIEVAWNQVK-LYDFLQSPEDLERLYCEIHL 76
+ LG+GA V A E + VA VK L D + +DL L E+ +
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA---VKMLKDDA-TEKDLSDLVSEMEM 93
Query: 77 LKTL-KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL------ 129
+K + KHKNI+ T + + + E + G LR+Y L+ +R
Sbjct: 94 MKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREY-LRARRPPGMEYSYDINRVP 150
Query: 130 -----------WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178
Q+ RG+ YL S IHRDL N+ V +KI D GLA +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLV-TENNVMKIADFGLARDI 207
Query: 179 RKSHAAHCVGTPEF----MAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPA 232
MAPE +++ Y D++SFG+ + E+ T PY
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-E 266
Query: 233 QIYKKVVSGKK-------PDSLYRV------KDPEVR 256
+++K + G + + LY + P R
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 59/284 (20%), Positives = 96/284 (33%), Gaps = 65/284 (22%)
Query: 25 RYNEILGKGASKTVYRA-----FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKT 79
Y +G+GA V++A VA VK+ S + E L+
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVA---VKMLKEEASADMQADFQREAALMAE 106
Query: 80 LKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLW--------- 130
+ NI+K V + + + E G L ++ L+ +
Sbjct: 107 FDNPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEF-LRSMSPHTVCSLSHSDLSTRARV 163
Query: 131 ----------------CRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 174
RQ+ G+ YL +HRDL N V N VKI D GL
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKIADFGL 220
Query: 175 AAILRKSHAAHC--VGTPEF-----MAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPY 225
+ R ++A + M PE ++ Y D++++G+ + E+ ++ PY
Sbjct: 221 S---RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277
Query: 226 SECTHPAQIYKKVVSGKK-------PDSLYRV------KDPEVR 256
H ++ V G P LY + K P R
Sbjct: 278 YGMAH-EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 320
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 70/280 (25%), Positives = 107/280 (38%), Gaps = 62/280 (22%)
Query: 25 RYNEILGKGASKTVYRA-------FDEYEGIEVAWNQVK-LYDFLQSPEDLERLYCEIHL 76
+ LG+G V A E + VA VK L D + +DL L E+ +
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVA---VKMLKDDA-TEKDLSDLVSEMEM 139
Query: 77 LKTL-KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL------ 129
+K + KHKNI+ T + + + E + G LR+Y L+ +R
Sbjct: 140 MKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREY-LRARRPPGMEYSYDINRVP 196
Query: 130 -----------WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178
Q+ RG+ YL S IHRDL N+ V +KI D GLA
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLV-TENNVMKIADFGLA--- 250
Query: 179 RKSHAAH--CVGTPEF-----MAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECT 229
R + T MAPE +++ Y D++SFG+ + E+ T PY
Sbjct: 251 RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310
Query: 230 HPAQIYKKVVSGKK-------PDSLYRV------KDPEVR 256
+++K + G + + LY + P R
Sbjct: 311 V-EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 349
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 62/274 (22%), Positives = 107/274 (39%), Gaps = 53/274 (19%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGIE-------VAWNQVKLYDFLQSPEDLERLYCEIHLL 77
++ + LG GA V A G+ VA VK+ ++ E L E+ ++
Sbjct: 49 QFGKTLGAGAFGKVVEA--TAFGLGKEDAVLKVA---VKMLKSTAHADEKEALMSELKIM 103
Query: 78 KTL-KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL------- 129
L +H+NI+ T + +TE G L + L+ K +
Sbjct: 104 SHLGQHENIVNLLG--ACTHGGPVLVITEYCCYGDLLNF-LRRKSRVLETDPAFAIANST 160
Query: 130 --------WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181
+ Q+ +G+ +L S + IHRD+ N+ + N KIGD GLA +
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL-TNGHVAKIGDFGLARDIMND 217
Query: 182 HAAHCVGTPEF----MAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIY 235
G MAPE +++ Y D++S+G+ + E+ + PY ++ Y
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277
Query: 236 KKVVSGKK-------PDSLYRV------KDPEVR 256
K V G + P ++Y + +P R
Sbjct: 278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHR 311
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 2e-15
Identities = 38/144 (26%), Positives = 70/144 (48%), Gaps = 7/144 (4%)
Query: 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVN 161
FV E G L + + R + +I GL +L S +I+RDLK DN+ ++
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD 476
Query: 162 GNQGEVKIGDLGLA--AILRKSHAAHCVGTPEFMAPEVY-EEAYNELVDIYSFGMCILEM 218
+G +KI D G+ I GTP+++APE+ + Y + VD ++FG+ + EM
Sbjct: 477 S-EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 535
Query: 219 VTFEYPYSECTHPAQIYKKVVSGK 242
+ + P+ ++++ ++
Sbjct: 536 LAGQAPFEGEDED-ELFQSIMEHN 558
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 41/145 (28%), Positives = 65/145 (44%), Gaps = 18/145 (12%)
Query: 102 FVTEMFTSGTL-----RQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCD 156
FV E G L RQ +L + + + +I L YLH +I+RDLK D
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHA-----RFYSAEISLALNYLHERG--IIYRDLKLD 182
Query: 157 NIFVNGNQGEVKIGDLGLA-AILRKSHAAH--CVGTPEFMAPEV-YEEAYNELVDIYSFG 212
N+ ++ +G +K+ D G+ LR C GTP ++APE+ E Y VD ++ G
Sbjct: 183 NVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGEDYGFSVDWWALG 240
Query: 213 MCILEMVTFEYPYSECTHPAQIYKK 237
+ + EM+ P+ +
Sbjct: 241 VLMFEMMAGRSPFDIVGSSDNPDQN 265
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 65/283 (22%), Positives = 102/283 (36%), Gaps = 62/283 (21%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGIE-------VAWNQVKLYDFLQSPEDLERLYCEIHLL 77
+ ++LG GA V A GI VA VK+ + E L E+ ++
Sbjct: 48 EFGKVLGSGAFGKVMNA--TAYGISKTGVSIQVA---VKMLKEKADSSEREALMSELKMM 102
Query: 78 KTL-KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL------- 129
L H+NI+ T + I + E G L Y L+ KR ++
Sbjct: 103 TQLGSHENIVNLLG--ACTLSGPIYLIFEYCCYGDLLNY-LRSKREKFSEDEIEYENQKR 159
Query: 130 -----------------WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 172
+ Q+ +G+ +L +HRDL N+ V VKI D
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHG-KVVKICDF 216
Query: 173 GLAAILRKSHAAHCVGTPEF----MAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYS 226
GLA + G MAPE ++E Y D++S+G+ + E+ + PY
Sbjct: 217 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276
Query: 227 ECTHPAQIYKKVVSGKK-------PDSLYRV------KDPEVR 256
A YK + +G K + +Y + D R
Sbjct: 277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 319
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 34/218 (15%)
Query: 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAW----NQVKLYDFLQSPEDLERLYCEIH 75
RY + ++GKG+ V +A+D E VA N+ + Q+ E+
Sbjct: 53 MDRY-EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN--QA-------QIEVR 102
Query: 76 LLKTLKH------KNIMKFYTSWVDTANRN-INFVTEMFTSGTLRQYRLKHKR---VNIR 125
LL+ + I+ ++ RN + V EM S L L++ V++
Sbjct: 103 LLELMNKHDTEMKYYIVHLKRHFMF---RNHLCLVFEML-SYNLYDL-LRNTNFRGVSLN 157
Query: 126 AVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRKSHAA 184
+ + +Q+ LL+L + + +IH DLK +NI N + +KI D G + L +
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ 217
Query: 185 HCVGTPEFMAPEV-YEEAYNELVDIYSFGMCIL-EMVT 220
+ + + + +PEV Y+ +D++S G CIL EM T
Sbjct: 218 Y-IQSRFYRSPEVLLGMPYDLAIDMWSLG-CILVEMHT 253
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 66/276 (23%), Positives = 105/276 (38%), Gaps = 54/276 (19%)
Query: 25 RYNEILGKGASKTVYRA-------FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
+ LG+GA V A +VA VK+ + +DL L E+ ++
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVA---VKMLKSDATEKDLSDLISEMEMM 128
Query: 78 KTL-KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL------- 129
K + KHKNI+ T + + + E + G LR+Y L+ +R
Sbjct: 129 KMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREY-LQARRPPGLEYSYNPSHNPE 185
Query: 130 ----------WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179
Q+ RG+ YL S IHRDL N+ V + +KI D GLA +
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIH 242
Query: 180 KSHAAHCVGTPEF----MAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQ 233
MAPE +++ Y D++SFG+ + E+ T PY +
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EE 301
Query: 234 IYKKVVSGKK-------PDSLYRV------KDPEVR 256
++K + G + + LY + P R
Sbjct: 302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 337
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 16/95 (16%)
Query: 136 RGLLYLHSH-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAAHCV-GTPE 191
RGL YLH H DP +IHRD+K NI ++ E +GD GLA ++ + +H V GT
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTHVTTAVRGTIG 200
Query: 192 FMAPEVYEEAY------NELVDIYSFGMCILEMVT 220
+APE Y +E D++ +G+ +LE++T
Sbjct: 201 HIAPE-----YLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 35/215 (16%)
Query: 24 GRYN--EILGKGASKTVYRAFDEYEGIEVAW----NQVKLYDFLQSPEDLERLYCEIHLL 77
RY +++GKG+ V +A+D VA N+ + + Q+ EI +L
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHR--QA-------AEEIRIL 147
Query: 78 KTLKHK------NIMKFYTSWVDTANRN-INFVTEMFTSGTLRQY--RLKHKRVNIRAVK 128
+ L+ + N++ ++ RN I E+ S L + + K + ++ V+
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTF---RNHICMTFELL-SMNLYELIKKNKFQGFSLPLVR 203
Query: 129 LWCRQILRGLLYLHSHDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRKSHAAHCV 187
+ IL+ L LH + +IH DLK +NI + +K+ D G + + +
Sbjct: 204 KFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT-YI 260
Query: 188 GTPEFMAPEVY-EEAYNELVDIYSFGMCIL-EMVT 220
+ + APEV Y +D++S G CIL E++T
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLG-CILAELLT 294
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 33/89 (37%), Positives = 44/89 (49%), Gaps = 7/89 (7%)
Query: 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC----VGTPE 191
G+ +LH + IHRD+K NI ++ KI D GLA K VGT
Sbjct: 144 NGINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTA 200
Query: 192 FMAPEVYEEAYNELVDIYSFGMCILEMVT 220
+MAPE DIYSFG+ +LE++T
Sbjct: 201 YMAPEALRGEITPKSDIYSFGVVLLEIIT 229
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 73/378 (19%), Positives = 119/378 (31%), Gaps = 134/378 (35%)
Query: 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKT 79
GRY LG G TV+ ++D VA +K+ + E EI LLK+
Sbjct: 36 NGRY-HVIRKLGWGHFSTVWLSWDIQGKKFVA---MKVV--KSAEHYTETALDEIRLLKS 89
Query: 80 LKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLR---------------------QYRLK 118
+++ D + N V ++ + +
Sbjct: 90 VRN----------SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSN 139
Query: 119 HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFV------------------ 160
++ + + VK +Q+L+GL YLH+ +IH D+K +NI +
Sbjct: 140 YQGLPLPCVKKIIQQVLQGLDYLHTK-CRIIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198
Query: 161 ------------------------------NGNQGEVKIGDLGLAAILRKSHAAHCVGTP 190
N + +VKI DLG A + K + T
Sbjct: 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-TEDIQTR 257
Query: 191 EFMAPEVYEEA-YNELVDIYSFGMCILEMVTFEYP---------YSECTHPAQIYK---- 236
++ + EV + YN DI+S E+ T +Y + H A I +
Sbjct: 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK 317
Query: 237 ----------------------KVVSGKKPDSL-------YRVKDPEVR---RFVEKCLA 264
K ++ KP L Y E F+ L
Sbjct: 318 VPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLE 377
Query: 265 TV-SLRLSARELLNDPFL 281
+ R +A E L P+L
Sbjct: 378 LIPEKRATAAECLRHPWL 395
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 5e-13
Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 29 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKF 88
++G G VY+ +G +VA +K +S + +E EI L +H +++
Sbjct: 46 LIGHGVFGKVYKGVLR-DGAKVA---LKRRT-PESSQGIEEFETEIETLSFCRHPHLVSL 100
Query: 89 YTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLW------CRQILRGLLYLH 142
+ + + + +G L+++ L + W C RGL YLH
Sbjct: 101 IGFCDERNEMIL--IYKYMENGNLKRH-L-YGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAAHCV-GTPEFMAPEVY 198
+ +IHRD+K NI ++ N KI D G++ L ++H + V GT ++ PE +
Sbjct: 157 T--RAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYF 213
Query: 199 EEAY-NELVDIYSFGMCILEMVT 220
+ E D+YSFG+ + E++
Sbjct: 214 IKGRLTEKSDVYSFGVVLFEVLC 236
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 36/146 (24%), Positives = 61/146 (41%), Gaps = 22/146 (15%)
Query: 130 WCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGT 189
+ Q+ +G+ +L S IHRDL NI ++ VKI D GLA + K G
Sbjct: 198 YSFQVAKGMEFLASR--KCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGD 254
Query: 190 PEF----MAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKKVVSGKK 243
MAPE +++ Y D++SFG+ + E+ + PY + +++ G +
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 314
Query: 244 -------PDSLYRV------KDPEVR 256
+Y+ +P R
Sbjct: 315 MRAPDYTTPEMYQTMLDCWHGEPSQR 340
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 61/347 (17%), Positives = 106/347 (30%), Gaps = 104/347 (29%)
Query: 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAW----NQVKLYDFLQSPEDLERLYCEIH 75
+ +G G V A N K + E
Sbjct: 34 NNAF-LVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTR--SA-------KIEAD 83
Query: 76 LLKTLKH-----KNIMKFYTSWVDTANRN-INFVTEMFTSGTLRQYRLKHKRV--NIRAV 127
+LK +++ NI+K++ + + + E +L + ++ +I +
Sbjct: 84 ILKKIQNDDINNNNIVKYH-GKFM--YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDI 139
Query: 128 KLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQG---------------------- 165
KL+C +IL+ L YL + H DLK +NI ++
Sbjct: 140 KLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 166 --EVKIGDLGLAAILRKSHAAHCVGTPEFMAPEV-YEEAYNELVDIYSFGMCIL-EMVT- 220
+K+ D G A H + + T ++ APEV ++ D++SFG C+L E+ T
Sbjct: 198 STGIKLIDFGCATFKSDYHGSI-INTRQYRAPEVILNLGWDVSSDMWSFG-CVLAELYTG 255
Query: 221 --------------------------------------------FEYPYSECTHPAQIYK 236
+ + E K
Sbjct: 256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIK 315
Query: 237 KVVSGKKPDSLYRVKDPEVRRFVEKCLATV-SLRLSARELLNDPFLQ 282
V + +K F+ L +LR S ELL FL+
Sbjct: 316 HVKKCLPLYKI--IKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 37/202 (18%), Positives = 71/202 (35%), Gaps = 40/202 (19%)
Query: 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL 80
++ + +G G +Y AF + + A + VK+ ++ L+ E+ + +
Sbjct: 37 NQW-VLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKV-----EYQENGPLFSELKFYQRV 90
Query: 81 KHKNIMKFYTSWVDTANRNI----------------NF-VTEMFTSGT-LRQYRLKHKRV 122
K+ +K + I F V E G L++ ++
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTF 148
Query: 123 NIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVN-GNQGEVKIGDLGLA------ 175
V ++L L Y+H ++ +H D+K N+ + N +V + D GL+
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206
Query: 176 ----AILRKSHAAHCVGTPEFM 193
H GT EF
Sbjct: 207 GNHKQYQENPRKGH-NGTIEFT 227
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 49/235 (20%), Positives = 89/235 (37%), Gaps = 52/235 (22%)
Query: 20 TGRYGRYNEILGKGASKTVYRAFD-EYEGIEVAW----NQVKLYDFLQSPEDLERLYCEI 74
+ RY + LG+GA V D + G VA N + + + EI
Sbjct: 13 SARY-EIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCE--AARS-------EI 62
Query: 75 HLLKTLKHK------NIMKFYTSWVDTANRN-INFVTEMFTSGTLRQYRLKHKRV--NIR 125
+L+ L ++ W + + I V E+ + + ++ + +
Sbjct: 63 QVLEHLNTTDPNSTFRCVQML-EWFE--HHGHICIVFELL-GLSTYDFIKENGFLPFRLD 118
Query: 126 AVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQG------------------EV 167
++ QI + + +LHS+ + H DLK +NI + ++
Sbjct: 119 HIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 168 KIGDLGLAAILRKSHAAHCVGTPEFMAPEV-YEEAYNELVDIYSFGMCIL-EMVT 220
K+ D G A + H+ V T + APEV +++ D++S G CIL E
Sbjct: 177 KVVDFGSATYDDEHHSTL-VSTRHYRAPEVILALGWSQPCDVWSIG-CILIEYYL 229
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 50/235 (21%), Positives = 82/235 (34%), Gaps = 52/235 (22%)
Query: 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIE-VAW----NQVKLYDFLQSPEDLERLYCEI 74
RY LG+G V D G VA N K + + EI
Sbjct: 18 QERY-EIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYRE--AA-------RLEI 67
Query: 75 HLLKTLKHK------NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---KRVNIR 125
++LK +K K + W + ++ E+ ++ LK + +
Sbjct: 68 NVLKKIKEKDKENKFLCVLMS-DWFNFHG-HMCIAFELL-GKNTFEF-LKENNFQPYPLP 123
Query: 126 AVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQG------------------EV 167
V+ Q+ L +LH + + H DLK +NI ++ +
Sbjct: 124 HVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 168 KIGDLGLAAILRKSHAAHCVGTPEFMAPEV-YEEAYNELVDIYSFGMCIL-EMVT 220
++ D G A + H V T + PEV E + + D++S G CIL E
Sbjct: 182 RVADFGSATFDHEHHTTI-VATRHYRPPEVILELGWAQPCDVWSIG-CILFEYYR 234
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 52.6 bits (125), Expect = 2e-07
Identities = 51/330 (15%), Positives = 91/330 (27%), Gaps = 68/330 (20%)
Query: 13 EFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF----LQSPEDLE 68
F PT + R +I G+G V++ ++ VA + + + E
Sbjct: 12 PFSHCLPTEKLQRCEKI-GEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFE 68
Query: 69 RLYCEIHLLKTL---------KHKNIMKFYTSWV-------------------------- 93
+ EI + K L + + + +
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 94 --DTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHR 151
+ + V E G +++ K ++ K Q+ L HR
Sbjct: 129 PDFFKDDQLFIVLEFEFGGID-LEQMRTKLSSLATAKSILHQLTASLAVAE-ASLRFEHR 186
Query: 152 DLKCDNIFVN----------GNQGEVKIGDLGLAAIL------RKSHAAHCVGTPEFMAP 195
DL N+ + N I GL + R V M
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDE 246
Query: 196 EVYEEAYNELVDIYSFGMCILEMVTFEY-PYSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254
+++ + DIY EY PYS + K++ + + P
Sbjct: 247 DLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT--KCNTPA 304
Query: 255 VRRFVEKCLATVSLRL---SARELLNDPFL 281
+++ K L SA +LL L
Sbjct: 305 MKQIKRKIQEFHRTMLNFSSATDLLCQHSL 334
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 3e-07
Identities = 81/685 (11%), Positives = 168/685 (24%), Gaps = 230/685 (33%)
Query: 119 HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178
H + + IL S + C ++ D+ +IL
Sbjct: 6 HMDFETGEHQYQYKDIL-------SVFEDAFVDNFDCKDVQ-----------DM-PKSIL 46
Query: 179 RKSHAAHCVGTP-------------EFMAPEVYEEAYNELVDI-YSFGMCILEMVTFEYP 224
K H + + E+ ++ E++ I Y F ++ +
Sbjct: 47 SKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKF---LMSPIK---- 99
Query: 225 YSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPF---- 280
+E P+ + + + + D LY + V + + LR + EL
Sbjct: 100 -TEQRQPSMMTRMYIEQR--DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID 156
Query: 281 ---------LQIDDCESNLRS---------LDYSRELDDMDPLIRQPHIDFHHIDNSFSN 322
+ +D C S L+ L + + ID ++++
Sbjct: 157 GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL-LYQIDPNWTS 215
Query: 323 GCANGYGYDTPSEWGYSPVEVESNGIELFGYHDDDHSSDVDISIKGKRRDDGGIFLRLRI 382
+ + + L ++ V + +
Sbjct: 216 RSDHSSNIKLRIHSIQAELR------RLLKSKPYENCLLV--------LLN--------V 253
Query: 383 ADKEGRIRNIYFPFDVETDTALSVATEMVAELDITDQDVTKIADMIDGEIASLVPEWRPG 442
+ + + F++ L +T + + D + + +
Sbjct: 254 QNAK-----AWNAFNLSCKI-----------L-LTTRFKQ-VTDFLSAATTTHISLDHHS 295
Query: 443 PGIEETPRFANQGFCSNCASNRTS-------TGSLM------EYFSNPYGT--NLQLLQC 487
+ + R T + E + T N + + C
Sbjct: 296 MTLTPD---EVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC 352
Query: 488 CRNGCASMHGRFGEITFDVDESEHHVTDGAPNESSQSDCLHYQE---------------- 531
+ E + +V E P E + +
Sbjct: 353 DK------LTTIIESSLNVLE---------PAEYRK----MFDRLSVFPPSAHIPTILLS 393
Query: 532 -IWGQLESRELSSVDSGHSHSDEEYEKLDQSFATEDNKE-------------TKVESETA 577
IW + ++ V + + S + KE K+E+E A
Sbjct: 394 LIWFDVIKSDVMVVVN---------KLHKYSLVEKQPKESTISIPSIYLELKVKLENEYA 444
Query: 578 LNARNSTRHLVNSHSYSEIPSVDCD-----QSDN--------HEKEIQQE---------- 614
L+ +V+ Y+ + D D D H K I+
Sbjct: 445 LHRS-----IVDH--YNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVF 497
Query: 615 --LRWLKAKYMMELSELREQQLGVASNTSSYSNKENNTTNGRLSYPISSPTQRDRNGFHL 672
R+L+ K +R A N S Y + + +R
Sbjct: 498 LDFRFLEQK-------IRHD--STAWNASGSILNTLQQLKFYKPYICDNDPKYER----- 543
Query: 673 NLPMDKKHFSSNCSDRINKSCPSLD 697
L F + + S D
Sbjct: 544 -LVNAILDFLPKIEENLICS-KYTD 566
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 6e-07
Identities = 90/662 (13%), Positives = 172/662 (25%), Gaps = 210/662 (31%)
Query: 10 DCSEFVEV-DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLE 68
+ + D R L + V + +E I + + + P +
Sbjct: 50 EIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMT 109
Query: 69 RLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVK 128
R+Y ++ +R N ++F + RL+
Sbjct: 110 RMY---------------------IEQRDRLYN-DNQVFAKYNV--SRLQPY-------- 137
Query: 129 LWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVG 188
++ + LL L N+ ++G G G +A + S+ C
Sbjct: 138 ---LKLRQALLELRPA-----------KNVLIDGVLG---SGKTWVALDVCLSYKVQC-- 178
Query: 189 TPEFMAPEVYEEAYNELVDIY-SFGMC-----ILEMVTFEYPYSECTHPAQIYKKVVSGK 242
M +++ + + C +LEM+
Sbjct: 179 ---KMDFKIF----------WLNLKNCNSPETVLEMLQ---------------------- 203
Query: 243 KPDSLYRVKDPEVRRFVEKCLATVSLRLSARELLNDPFLQIDDCESNLRSL----DYSRE 298
L DP + + + +++ L+I ++ LR L Y
Sbjct: 204 ---KLLYQIDPN---WTSRSDHSSNIK-----------LRIHSIQAELRRLLKSKPYENC 246
Query: 299 LDDMDPLIRQPHI-DFHHIDNSFSNGC-----------ANGYGYDTPSE-------WGYS 339
L + ++ + + +F+ C + T + +
Sbjct: 247 LLVLL------NVQNAKAWN-AFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT 299
Query: 340 PVEVESNGIELFGYHDDDHSSDVDISIKGKRRDDGGIFLRL--RIAD--KEGRIRNIYFP 395
P EV+ L +D + R+ R IA+ ++G +
Sbjct: 300 PDEVK----SLL-------LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWK 348
Query: 396 FDVETDTALSVATEM-VAELD------------ITDQDVTKIADMIDGEIASLVPEWRPG 442
V D L+ E + L+ + I L W
Sbjct: 349 -HVNCD-KLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA-HI------PTILLSLIW--F 397
Query: 443 PGIEETPRFANQGFCSNCASNRTSTGSLMEYFSNPYGTNLQLLQCCRNGCASMHGRFGEI 502
I+ + S + L+L N ++H +
Sbjct: 398 DVIKSDVMVVVNKLHKYSLVEKQPKESTISI----PSIYLELKVKLENE-YALHRSI--V 450
Query: 503 TFDVDESEHHVTDGAPNESSQSDCLHYQEIWGQLESRELSSVDSGHSHSDEEYEK--LDQ 560
D P D Y I L +++ H + LD
Sbjct: 451 DHYNIPKTFDSDDLIPP---YLDQYFYSHI-----GHHLKNIE--HPERMTLFRMVFLDF 500
Query: 561 SFATEDNKETKVE-SETALNARNSTRHLVNS-HSYSE-IPSVDCDQSDNHEKEIQQELRW 617
F E K+ TA NA S + + Y I CD +E+ + L +
Sbjct: 501 RFL-----EQKIRHDSTAWNASGSILNTLQQLKFYKPYI----CDNDPKYERLVNAILDF 551
Query: 618 LK 619
L
Sbjct: 552 LP 553
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 6e-04
Identities = 33/226 (14%), Positives = 69/226 (30%), Gaps = 66/226 (29%)
Query: 36 KTVYRA---FDEYEGI-----EVAWNQVKLYD---FLQS-------PEDLERLYCEIHLL 77
+ ++ F I + W V D + + + I +
Sbjct: 372 RKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSI 431
Query: 78 ----------KTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-------- 119
+ H++I+ Y N F ++ L QY H
Sbjct: 432 YLELKVKLENEYALHRSIVDHY-------NIPKTFDSDDLIPPYLDQYFYSHIGHHLKNI 484
Query: 120 ---KRVNI-RAVKL---WCRQILRGLLYLHSHDPPVIH--RDLKC--DNIFVNGNQGEVK 168
+R+ + R V L + Q +R + +++ + LK I N + E
Sbjct: 485 EHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERL 544
Query: 169 IGDLGLAAILRKSHAAHCVGTPE-------FMAPE--VYEEAYNEL 205
+ + L K + + + MA + ++EEA+ ++
Sbjct: 545 VNAIL--DFLPK-IEENLICSKYTDLLRIALMAEDEAIFEEAHKQV 587
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 40/159 (25%), Positives = 64/159 (40%), Gaps = 16/159 (10%)
Query: 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL 80
RY R +G G+ +Y D G EVA +KL L E + K +
Sbjct: 9 NRY-RLGRKIGSGSFGDIYLGTDIAAGEEVA---IKLECVKTKHPQLHI---ESKIYKMM 61
Query: 81 KH-KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWCRQILRGL 138
+ I + + N+ V E+ +L ++ +++ V L Q++ +
Sbjct: 62 QGGVGIPTIRWCGAE-GDYNV-MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRI 118
Query: 139 LYLHSHDPPVIHRDLKCDNIFV--NGNQGEVKIGDLGLA 175
Y+HS + IHRD+K DN + V I D GLA
Sbjct: 119 EYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 39/152 (25%), Positives = 64/152 (42%), Gaps = 20/152 (13%)
Query: 55 VKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTS-WVDTANRNINF-VTEMFTSGTL 112
+K Y PE +++ + LK+ + K++ S D ++ F + + F S
Sbjct: 84 LKFYQRAAKPEQIQKW----IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ 139
Query: 113 RQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVN-GNQGEVKIGD 171
+ Y KR + + V +IL L Y+H H+ +H D+K N+ +N N +V + D
Sbjct: 140 KIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVD 197
Query: 172 LGLA----------AILRKSHAAHCVGTPEFM 193
GLA A H GT EF
Sbjct: 198 YGLAYRYCPEGVHKAYAADPKRCHD-GTIEFT 228
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 34/161 (21%), Positives = 61/161 (37%), Gaps = 18/161 (11%)
Query: 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL 80
+ R + +G G + + Y VA +KL L E K L
Sbjct: 9 PNF-RVGKKIGCGNFGELRLGKNLYTNEYVA---IKLEPMKSRAPQLHL---EYRFYKQL 61
Query: 81 KH-KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWCRQILRGL 138
I + Y + + V E+ +L L + +++ V + Q++ +
Sbjct: 62 GSGDGIPQVY--YFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRM 118
Query: 139 LYLHSHDPPVIHRDLKCDNIFV----NGNQGEVKIGDLGLA 175
Y+HS + +I+RD+K +N + N Q + I D LA
Sbjct: 119 EYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 18/72 (25%), Positives = 33/72 (45%), Gaps = 14/72 (19%)
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVN-GNQGEVKIGDLGLAAILRKS---------- 181
++L L +LH ++ +H ++ +NIFV+ +Q +V + G A S
Sbjct: 167 RLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGS 224
Query: 182 HAAHCVGTPEFM 193
+ H G EF+
Sbjct: 225 RSPH-EGDLEFI 235
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 33/166 (19%), Positives = 64/166 (38%), Gaps = 16/166 (9%)
Query: 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL 80
++ R +G G+ +Y + EVA +KL + L E + + L
Sbjct: 7 NKF-RLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLLY---ESKIYRIL 59
Query: 81 K-HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWCRQILRGL 138
+ I W V ++ +L ++++++ V + Q++ +
Sbjct: 60 QGGTGIPNVR--WFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRV 116
Query: 139 LYLHSHDPPVIHRDLKCDNIFV--NGNQGEVKIGDLGLAAILRKSH 182
++HS +HRD+K DN + +V I D GLA R +
Sbjct: 117 EFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 745 | ||||
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-77 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-51 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-41 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-41 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-40 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-39 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-38 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-37 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-36 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-34 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-34 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-14 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (633), Expect = 2e-77
Identities = 133/271 (49%), Positives = 180/271 (66%), Gaps = 5/271 (1%)
Query: 15 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEI 74
V + GR+ +++ +G+G+ KTVY+ D +EVAW +L D + + +R E
Sbjct: 2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAW--CELQDRKLTKSERQRFKEEA 59
Query: 75 HLLKTLKHKNIMKFYTSWVDTA--NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCR 132
+LK L+H NI++FY SW T + I VTE+ TSGTL+ Y + K + I+ ++ WCR
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR 119
Query: 133 QILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEF 192
QIL+GL +LH+ PP+IHRDLKCDNIF+ G G VKIGDLGLA + R S A +GTPEF
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEF 179
Query: 193 MAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD 252
MAPE+YEE Y+E VD+Y+FGMC+LEM T EYPYSEC + AQIY++V SG KP S +V
Sbjct: 180 MAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 253 PEVRRFVEKCLAT-VSLRLSARELLNDPFLQ 282
PEV+ +E C+ R S ++LLN F Q
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (510), Expect = 4e-59
Identities = 84/306 (27%), Positives = 136/306 (44%), Gaps = 21/306 (6%)
Query: 8 EPDCSE-FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPED 66
+PD +E F + DP + EI G G+ VY A D VA ++ QS E
Sbjct: 1 DPDVAELFFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSY-SGKQSNEK 58
Query: 67 LERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRA 126
+ + E+ L+ L+H N +++ ++ V E + K +
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVE 116
Query: 127 VKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC 186
+ L+GL YLHSH +IHRD+K NI ++ G VK+GD G A+I+ ++
Sbjct: 117 IAAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPAN--SF 171
Query: 187 VGTPEFMAPEVY----EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK 242
VGTP +MAPEV E Y+ VD++S G+ +E+ + P + +Y + +
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNE 230
Query: 243 KPDSLYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNL-----RSLDYS 296
P R FV+ CL R ++ LL F+ + + + R+ D
Sbjct: 231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAV 290
Query: 297 RELDDM 302
RELD++
Sbjct: 291 RELDNL 296
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 1e-56
Identities = 95/280 (33%), Positives = 139/280 (49%), Gaps = 15/280 (5%)
Query: 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
DP +Y R+ +I G+GAS TVY A D G EVA Q+ L Q E + EI ++
Sbjct: 17 DPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVM 71
Query: 78 KTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRG 137
+ K+ NI+ + S++ + V E G+L + ++ + CR+ L+
Sbjct: 72 RENKNPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQA 128
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAAHCVGTPEFMAP 195
L +LHS+ VIHRD+K DNI + + G VK+ D G A + +S + VGTP +MAP
Sbjct: 129 LEFLHSN--QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 196 E-VYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254
E V +AY VDI+S G+ +EM+ E PY +Y +G
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
Query: 255 VRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSL 293
R F+ +CL V R SA+ELL FL+I S+L L
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPL 285
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 7e-56
Identities = 78/280 (27%), Positives = 136/280 (48%), Gaps = 22/280 (7%)
Query: 16 EVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIH 75
+++P + LG GA VY+A ++ + A K+ D +S E+LE EI
Sbjct: 7 DLNPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAA---AKVID-TKSEEELEDYMVEID 61
Query: 76 LLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKR-VNIRAVKLWCRQI 134
+L + H NI+K ++ N+ + E G + L+ +R + +++ C+Q
Sbjct: 62 ILASCDHPNIVKLLDAFYY--ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 119
Query: 135 LRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAAHCVGTPEF 192
L L YLH + +IHRDLK NI + G++K+ D G++A ++ +GTP +
Sbjct: 120 LDALNYLHDNK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYW 176
Query: 193 MAPEVY------EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDS 246
MAPEV + Y+ D++S G+ ++EM E P+ E P ++ K+ + P
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN-PMRVLLKIAKSEPPTL 235
Query: 247 LYRVK-DPEVRRFVEKCLAT-VSLRLSARELLNDPFLQID 284
+ + F++KCL V R + +LL PF+ +D
Sbjct: 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-55
Identities = 73/265 (27%), Positives = 117/265 (44%), Gaps = 16/265 (6%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+G G+ + + +G + W ++ + + + L E++LL+ LKH NI++
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKR----VNIRAVKLWCRQILRGLLYLHS 143
+Y +D N + V E G L K + ++ V Q+ L H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 144 H---DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAAHCVGTPEFMAPEVY 198
V+HRDLK N+F++G VK+GD GLA IL S A VGTP +M+PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186
Query: 199 E-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257
+YNE DI+S G + E+ P+ ++ K+ GK YR E+
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREGKFRRIPYRY-SDELNE 244
Query: 258 FVEKCLAT-VSLRLSARELLNDPFL 281
+ + L R S E+L +P +
Sbjct: 245 IITRMLNLKDYHRPSVEEILENPLI 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 6e-54
Identities = 64/259 (24%), Positives = 114/259 (44%), Gaps = 15/259 (5%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
LGKG VY A ++ +A + L+ +L E+ + L+H NI++
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFK-AQLEKAGVEHQLRREVEIQSHLRHPNILR 70
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
Y + D + + E GT+ + K + + + + ++ L Y HS
Sbjct: 71 LYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK--R 126
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYE-EAYNELV 206
VIHRD+K +N+ + GE+KI D G + S GT +++ PE+ E ++E V
Sbjct: 127 VIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 185
Query: 207 DIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK--KPDSLYRVKDPEVRRFVEKCLA 264
D++S G+ E + + P+ E + YK++ + PD + R + + L
Sbjct: 186 DLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFV----TEGARDLISRLLK 240
Query: 265 T-VSLRLSARELLNDPFLQ 282
S R RE+L P++
Sbjct: 241 HNPSQRPMLREVLEHPWIT 259
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-53
Identities = 64/262 (24%), Positives = 115/262 (43%), Gaps = 15/262 (5%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+ LG+GA V A + VA VK+ D ++ + E + EI + K L H+N++K
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
FY E + G L + + + Q++ G++YLH
Sbjct: 68 FY--GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG-- 123
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH----CVGTPEFMAPEVY--EEA 201
+ HRD+K +N+ ++ +KI D GLA + R ++ GT ++APE+ E
Sbjct: 124 ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 202 YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEK 261
+ E VD++S G+ + M+ E P+ + + Q Y K + ++ D + K
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 262 CLAT-VSLRLSARELLNDPFLQ 282
L S R++ ++ D +
Sbjct: 243 ILVENPSARITIPDIKKDRWYN 264
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 2e-52
Identities = 70/309 (22%), Positives = 118/309 (38%), Gaps = 51/309 (16%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
LG G V++ + G+ +A KL P ++ E+ +L I+
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
FY ++ + I+ E G+L Q K R+ + + +++GL YL
Sbjct: 69 FYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHK 125
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYE-EAYNELV 206
++HRD+K NI VN GE+K+ D G++ L S A VGT +M+PE + Y+
Sbjct: 126 IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 207 DIYSFGMCILEMVTFEYPYSECTH------------------------------------ 230
DI+S G+ ++EM YP
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244
Query: 231 -----PAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQ-I 283
++ +V+ P V E + FV KCL + R ++L+ F++
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304
Query: 284 DDCESNLRS 292
D E +
Sbjct: 305 DAEEVDFAG 313
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 181 bits (459), Expect = 2e-51
Identities = 71/307 (23%), Positives = 126/307 (41%), Gaps = 18/307 (5%)
Query: 15 VEVDPTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC 72
VEV Y Y+ E LG GA V+R ++ G + P D +
Sbjct: 20 VEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT----PYPLDKYTVKN 75
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWC 131
EI ++ L H ++ + ++ D + + E + G L +++ V +
Sbjct: 76 EISIMNQLHHPKLINLHDAFED--KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 133
Query: 132 RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQ-GEVKIGDLGLAAILRKSHAAHC-VGT 189
RQ GL ++H H ++H D+K +NI + VKI D GLA L T
Sbjct: 134 RQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT 191
Query: 190 PEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYK-KVVSGKKPDSL 247
EF APE+ + E D+++ G+ +++ P++ + K + +
Sbjct: 192 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 251
Query: 248 YRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDMDPLI 306
+ PE + F++ L RL+ + L P+L+ D SNL S S + + I
Sbjct: 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD--HSNLTSRIPSSRYNKIRQKI 309
Query: 307 RQPHIDF 313
++ + D+
Sbjct: 310 KEKYADW 316
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 2e-49
Identities = 71/271 (26%), Positives = 125/271 (46%), Gaps = 25/271 (9%)
Query: 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLK 78
P G+ + +G G+ TVY+ +VA + + +P+ L+ E+ +L+
Sbjct: 6 PDGQI-TVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTA--PTPQQLQAFKNEVGVLR 59
Query: 79 TLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWCRQILRG 137
+H NI+ F + VT+ +L + + + + + RQ +G
Sbjct: 60 KTRHVNILLFMGYSTAP---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH----CVGTPEFM 193
+ YLH+ +IHRDLK +NIF++ + VKIGD GLA + + +H G+ +M
Sbjct: 117 MDYLHAK--SIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 194 APEVYE----EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYR 249
APEV Y+ D+Y+FG+ + E++T + PYS + QI V G L +
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233
Query: 250 VKD---PEVRRFVEKCLAT-VSLRLSARELL 276
V+ ++R + +CL R ++L
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (441), Expect = 5e-49
Identities = 69/305 (22%), Positives = 127/305 (41%), Gaps = 18/305 (5%)
Query: 15 VEVDPTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC 72
VE+ Y+ E LG GA V+R + G A V D E +
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT----PHESDKETVRK 72
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWC 131
EI + L+H ++ + ++ D + + + E + G L + +H +++ +
Sbjct: 73 EIQTMSVLRHPTLVNLHDAFED--DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 130
Query: 132 RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQ-GEVKIGDLGLAAILRKSHAAHC-VGT 189
RQ+ +GL ++H ++ +H DLK +NI + E+K+ D GL A L + GT
Sbjct: 131 RQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 188
Query: 190 PEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGK--KPDS 246
EF APEV E + D++S G+ +++ P+ + + + V S DS
Sbjct: 189 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDS 247
Query: 247 LYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDMDPL 305
+ + + F+ K L + R++ + L P+L + + SR D +
Sbjct: 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSI 307
Query: 306 IRQPH 310
+
Sbjct: 308 KTKYD 312
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 1e-47
Identities = 59/288 (20%), Positives = 111/288 (38%), Gaps = 14/288 (4%)
Query: 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
D Y + ++LG GA V A D+ VA +K + EI +L
Sbjct: 6 DIRDIY-DFRDVLGTGAFSEVILAEDKRTQKLVA---IKCIAKKALEGKEGSMENEIAVL 61
Query: 78 KTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRG 137
+KH NI+ + ++ + ++ + G L ++ R Q+L
Sbjct: 62 HKIKHPNIVALDDIYES--GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVN--GNQGEVKIGDLGLAAILRKSHAAHC-VGTPEFMA 194
+ YLH ++HRDLK +N+ ++ I D GL+ + GTP ++A
Sbjct: 120 VKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 177
Query: 195 PEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK-D 252
PEV + Y++ VD +S G+ ++ P+ + + + + + DS Y
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237
Query: 253 PEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSREL 299
+ F+ + R + + L P++ D S ++
Sbjct: 238 DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI 285
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 6e-47
Identities = 64/263 (24%), Positives = 121/263 (46%), Gaps = 19/263 (7%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+ILG+G+ TV A + E A ++ + + + E ++ L H +K
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
Y ++ D + + F +G L +Y K + + + +I+ L YLH
Sbjct: 73 LYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK--G 128
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----RKSHAAHCVGTPEFMAPEVY-EEAY 202
+IHRDLK +NI +N + ++I D G A +L +++ A VGT ++++PE+ E++
Sbjct: 129 IIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 203 NELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK--PDSLYRVKDPEVRRFVE 260
+ D+++ G I ++V P+ I++K++ + P+ P+ R VE
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKIIKLEYDFPEKF----FPKARDLVE 242
Query: 261 KCLAT-VSLRLSARELLNDPFLQ 282
K L + RL E+ L+
Sbjct: 243 KLLVLDATKRLGCEEMEGYGPLK 265
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 164 bits (415), Expect = 3e-46
Identities = 65/279 (23%), Positives = 116/279 (41%), Gaps = 25/279 (8%)
Query: 23 YGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKL-----YDFLQSPEDLERLYCEIH 75
Y Y EILG+G S V R + E A + + + + E E E+
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 76 LLKTLK-HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQI 134
+L+ + H NI++ ++ N V ++ G L Y + ++ + + R +
Sbjct: 62 ILRKVSGHPNIIQLKDTYET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119
Query: 135 LRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-HCVGTPEFM 193
L + LH + ++HRDLK +NI ++ + +K+ D G + L GTP ++
Sbjct: 120 LEVICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYL 176
Query: 194 APEVYE-------EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDS 246
APE+ E Y + VD++S G+ + ++ P+ + + ++SG
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFG 235
Query: 247 LYRVKD--PEVRRFVEKCLAT-VSLRLSARELLNDPFLQ 282
D V+ V + L R +A E L PF Q
Sbjct: 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-46
Identities = 59/269 (21%), Positives = 114/269 (42%), Gaps = 19/269 (7%)
Query: 23 YGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL 80
Y +Y E LG+G V+R + VK+ D + EI +L
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVLVKKEISILNIA 58
Query: 81 KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWCRQILRGLL 139
+H+NI+ + S+ + + E + + + +N R + + Q+ L
Sbjct: 59 RHRNILHLHESFES--MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 140 YLHSHDPPVIHRDLKCDNIFV-NGNQGEVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEV 197
+LHSH + H D++ +NI +KI + G A L+ PE+ APEV
Sbjct: 117 FLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 198 YE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK--PDSLYRVKDPE 254
++ + + D++S G + +++ P+ T QI + +++ + + ++ E
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-NQQIIENIMNAEYTFDEEAFKEISIE 233
Query: 255 VRRFVEKCLAT-VSLRLSARELLNDPFLQ 282
FV++ L R++A E L P+L+
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLK 262
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-45
Identities = 63/279 (22%), Positives = 123/279 (44%), Gaps = 15/279 (5%)
Query: 25 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVK--LYDFLQSPEDLERLYCEIHLLKTL 80
Y+ E LG G V + ++ G++ A +K + E + E+ +LK +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 81 KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLY 140
+H N++ + + + ++ + E+ G L + + + + + +QIL G+ Y
Sbjct: 71 QHPNVITLHEVYEN--KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 141 LHSHDPPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILRKSHAAHC-VGTPEFMAPE 196
LHS + H DLK +NI + N + +KI D GLA + + GTPEF+APE
Sbjct: 129 LHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 197 VYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYK-KVVSGKKPDSLYRVKDPE 254
+ E D++S G+ +++ P+ T + V+ + D +
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 255 VRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRS 292
+ F+ + L R++ ++ L P+++ D + L S
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSS 285
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-44
Identities = 57/268 (21%), Positives = 113/268 (42%), Gaps = 21/268 (7%)
Query: 24 GRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF--LQSPEDLERLYCEIHLLKT 79
+Y +LG G +VY + + VA V+ + R+ E+ LLK
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 80 LK--HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRG 137
+ +++ W + + + + L + + + + + Q+L
Sbjct: 64 VSSGFSGVIRLL-DWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEV 197
+ + H+ V+HRD+K +NI ++ N+GE+K+ D G A+L+ + GT + PE
Sbjct: 123 VRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEW 180
Query: 198 Y--EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEV 255
+ ++S G+ + +MV + P+ H +I + V ++ S E
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFE---HDEEIIRGQVFFRQRVS------SEC 231
Query: 256 RRFVEKCLAT-VSLRLSARELLNDPFLQ 282
+ + CLA S R + E+ N P++Q
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (397), Expect = 2e-43
Identities = 46/275 (16%), Positives = 96/275 (34%), Gaps = 17/275 (6%)
Query: 13 EFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYC 72
EF + + +++G G V + G + +K + +
Sbjct: 18 EFAKEIDISCV-KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLS 76
Query: 73 EIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWC 131
E ++ H N++ V T + + +TE +G+L + R + + +
Sbjct: 77 EASIMGQFDHPNVIHLE--GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 134
Query: 132 RQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH------ 185
R I G+ YL +HRDL NI VN N K+ D GL+ L +
Sbjct: 135 RGIAAGMKYLADM--NYVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSAL 191
Query: 186 -CVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK 243
+ APE + + D++S+G+ + E++++ + + +
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251
Query: 244 PDSLYRVKDPEVRRFVEKCLAT-VSLRLSARELLN 277
+ + + C + R +++N
Sbjct: 252 LPPPMDC-PSALHQLMLDCWQKDRNHRPKFGQIVN 285
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 6e-43
Identities = 54/254 (21%), Positives = 102/254 (40%), Gaps = 18/254 (7%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+ +GKG V +Y G +VA VK +++ + E ++ L+H N+++
Sbjct: 13 QTIGKGEFGDVMLG--DYRGNKVA---VKC---IKNDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKR--VNIRAVKLWCRQILRGLLYLHSHD 145
V+ + VTE G+L Y R + + + + + YL +
Sbjct: 65 LLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 122
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVY-EEAYNE 204
+HRDL N+ V+ + K+ D GL + ++ APE E+ ++
Sbjct: 123 -NFVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGK-LPVKWTAPEALREKKFST 179
Query: 205 LVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA 264
D++SFG+ + E+ +F + +V G K D+ P V ++ C
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-PPAVYEVMKNCWH 238
Query: 265 T-VSLRLSARELLN 277
++R S +L
Sbjct: 239 LDAAMRPSFLQLRE 252
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (390), Expect = 2e-42
Identities = 62/262 (23%), Positives = 120/262 (45%), Gaps = 17/262 (6%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
LG G+ V+ + G A +K + + + +E E +L + H I++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKK-EIVVRLKQVEHTNDERLMLSIVTHPFIIR 68
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
+ ++ D + I + + G L K +R K + ++ L YLHS
Sbjct: 69 MWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK--D 124
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYE-EAYNELV 206
+I+RDLK +NI ++ N G +KI D G A + C GTP+++APEV + YN+ +
Sbjct: 125 IIYRDLKPENILLDKN-GHIKITDFGFAKYVPDVTYTLC-GTPDYIAPEVVSTKPYNKSI 182
Query: 207 DIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLAT- 265
D +SFG+ I EM+ P+ + + Y+K+++ + + +V+ + + +
Sbjct: 183 DWWSFGILIYEMLAGYTPFYDSN-TMKTYEKILNAELR--FPPFFNEDVKDLLSRLITRD 239
Query: 266 -----VSLRLSARELLNDPFLQ 282
+L+ ++ N P+ +
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 152 bits (386), Expect = 2e-42
Identities = 66/270 (24%), Positives = 107/270 (39%), Gaps = 16/270 (5%)
Query: 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKT 79
+ RY EILG G V+ A D +VA ++ D + P R E
Sbjct: 6 SDRY-ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAA 63
Query: 80 LKHKNIMKFYTSWVD--TANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRG 137
L H I+ Y + A V E TLR + + +
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-----AAHCVGTPEF 192
L + H + +IHRD+K NI ++ VK+ D G+A + S A +GT ++
Sbjct: 124 LNFSHQN--GIIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 193 MAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK 251
++PE ++ + D+YS G + E++T E P++ + + Y+ V P S
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240
Query: 252 -DPEVRRFVEKCLAT-VSLRL-SARELLND 278
++ V K LA R +A E+ D
Sbjct: 241 LSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 6e-42
Identities = 54/289 (18%), Positives = 111/289 (38%), Gaps = 23/289 (7%)
Query: 4 LTHLEPDCSE---FVEVDPTGRYGRYNEILGKGASKTVYRAFD---EYEGIEVAWNQVKL 57
L+ L P+ + V + P+ +NE++G+G VY + + I A VK
Sbjct: 6 LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKS 62
Query: 58 YDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRL 117
+ + ++ + E ++K H N++ + + + V G LR +
Sbjct: 63 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKHGDLRNFIR 121
Query: 118 KHKR-VNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176
++ + + Q+ +G+ +HRDL N ++ VK+ D GLA
Sbjct: 122 NETHNPTVKDLIGFGLQVAKGM--KFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLAR 178
Query: 177 ILRKSHAA------HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECT 229
+ ++MA E + + + D++SFG+ + E++T P
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
Query: 230 HPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLAT-VSLRLSARELLN 277
+ I ++ G++ + + KC +R S EL++
Sbjct: 239 NTFDITVYLLQGRRLLQPEYC-PDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 6e-42
Identities = 56/303 (18%), Positives = 116/303 (38%), Gaps = 27/303 (8%)
Query: 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIH-LLKT 79
Y +++LG G + V + F++ + A ++ D + E+ +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRA 61
Query: 80 LKHKNIMKFYTSWVD--TANRNINFVTEMFTSGTLRQY--RLKHKRVNIRAVKLWCRQIL 135
+ +I++ + + + + V E G L + R + I
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121
Query: 136 RGLLYLHSHDPPVIHRDLKCDNIFVN--GNQGEVKIGDLGLAAILRKSHAAHCV-GTPEF 192
+ YLHS + + HRD+K +N+ +K+ D G A ++ TP +
Sbjct: 122 EAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 179
Query: 193 MAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPA---QIYKKVVSGKK--PDS 246
+APEV E Y++ D++S G+ + ++ P+ A + ++ G+ P+
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 247 LYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDMDPL 305
+ EV+ + L T + R++ E +N P++ + L SR L +
Sbjct: 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM-QSTKVPQTPLHTSRVLKEDKER 298
Query: 306 IRQ 308
Sbjct: 299 WED 301
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 8e-42
Identities = 61/286 (21%), Positives = 114/286 (39%), Gaps = 36/286 (12%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDL-ERLYCEIHLLKTLKHKNIM 86
+ LG+G TVY+A D+ VA ++KL ++ + + EI LL+ L H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDP 146
++ NI+ V + + + + +K + L+GL YLH H
Sbjct: 64 GLLDAFGH--KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CVGTPEFMAPEVY--EEAY 202
++HRDLK +N+ ++ N G +K+ D GLA + A+ V T + APE+ Y
Sbjct: 120 WILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 203 NELVDIYSFGMCILEMVTFEYPYSECTHPAQIYK-------------------------K 237
VD+++ G + E++ + Q+ + K
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 238 VVSGKKPDSLYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQ 282
G ++ ++ ++ R++A + L +
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-41
Identities = 66/303 (21%), Positives = 122/303 (40%), Gaps = 23/303 (7%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQ-VKLYDFLQSPEDLERLYCEIHLLKTLKHKNIM 86
++LG GA TVY+ EG +V +K SP+ + + E +++ ++ + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKR-VNIRAVKLWCRQILRGLLYLHSHD 145
+ + + +T++ G L Y +HK + + + WC QI +G+ YL
Sbjct: 75 RLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 130
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS----HAAHCVGTPEFMAPEVYE-E 200
++HRDL N+ V VKI D GLA +L HA ++MA E
Sbjct: 131 -RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 201 AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVE 260
Y D++S+G+ + E++TF + ++I + G++ +V +
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC-TIDVYMIMV 247
Query: 261 KCLAT-VSLRLSARELLNDPFLQIDDCESNLRSLDYSRELDDMDPLIRQPHIDFHHIDNS 319
KC R REL+ + D + L D + P + +
Sbjct: 248 KCWMIDADSRPKFRELIIEFSKMARDPQRYLVI--------QGDERMHLPSPTDSNFYRA 299
Query: 320 FSN 322
+
Sbjct: 300 LMD 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-41
Identities = 57/264 (21%), Positives = 113/264 (42%), Gaps = 18/264 (6%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
++LGKG V ++ G A ++ + + + +++ E +L+ +H +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
++ + + FV E G L + + + + + +I+ L YLHS
Sbjct: 70 LKYAFQT--HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--D 125
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAAHCVGTPEFMAPEVYE-EAYNE 204
V++RD+K +N+ ++ + G +KI D GL + GTPE++APEV E Y
Sbjct: 126 VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 205 LVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA 264
VD + G+ + EM+ P+ ++++ ++ + R PE + + L
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLK 241
Query: 265 T-VSLRLS-----ARELLNDPFLQ 282
RL A+E++ F
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-41
Identities = 53/270 (19%), Positives = 103/270 (38%), Gaps = 23/270 (8%)
Query: 27 NEILGKGASKTVYRAF--DEYEGIEVAWNQVK-LYDFLQSPEDLERLYCEIHLLKTLKHK 83
++ LG G TV + + + VA VK L + P + L E ++++ L +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVA---VKILKNEANDPALKDELLAEANVMQQLDNP 68
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS 143
I++ + V EM G L +Y +++ V + + Q+ G+ YL
Sbjct: 69 YIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-----CVGTPEFMAPEVY 198
+HRDL N+ + Q KI D GL+ LR + ++ APE
Sbjct: 126 S--NFVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 199 E-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257
++ D++SFG+ + E ++ +++ + G++ E+
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-PREMYD 241
Query: 258 FVEKCLAT-VSLRLSAREL---LNDPFLQI 283
+ C V R + L + + +
Sbjct: 242 LMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-41
Identities = 50/256 (19%), Positives = 98/256 (38%), Gaps = 18/256 (7%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+ +G G V+ + +VA +K + E E ++ L H +++
Sbjct: 11 QEIGSGQFGLVHLGYWL-NKDKVA---IKTIR--EGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDP 146
Y ++ I V E G L Y + + C + G+ YL
Sbjct: 65 LYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-- 120
Query: 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---RKSHAAHCVGTPEFMAPEVYEEA-Y 202
VIHRDL N V N +K+ D G+ + + + + ++ +PEV+ + Y
Sbjct: 121 CVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 203 NELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKC 262
+ D++SFG+ + E+ + E +++ + + +G + R+ V + + C
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLASTHVYQIMNHC 238
Query: 263 LAT-VSLRLSARELLN 277
R + LL
Sbjct: 239 WKERPEDRPAFSRLLR 254
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 6e-41
Identities = 55/260 (21%), Positives = 104/260 (40%), Gaps = 19/260 (7%)
Query: 28 EILGKGASKTVYRAFD---EYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84
+G+G V++ E + VA +K S E+ E ++ H +
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPH 69
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHS 143
I+K + + + E+ T G LR + +++ ++ L+ Q+ L YL S
Sbjct: 70 IVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS---HAAHCVGTPEFMAPEVYE- 199
+HRD+ N+ V+ VK+GD GL+ + S A+ ++MAPE
Sbjct: 127 K--RFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 200 EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259
+ D++ FG+C+ E++ + + ++ +G++ P + +
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC-PPTLYSLM 242
Query: 260 EKCLAT-VSLRLSARELLND 278
KC A S R EL
Sbjct: 243 TKCWAYDPSRRPRFTELKAQ 262
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 151 bits (382), Expect = 9e-41
Identities = 63/265 (23%), Positives = 111/265 (41%), Gaps = 15/265 (5%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQV--KLYDFLQSPEDLERLYCEIHLLKTLKHKNI 85
I+G+G VY G A + K Q + L+ T I
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 86 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHD 145
+ ++ ++F+ ++ G L + +H + ++ + +I+ GL ++H+
Sbjct: 70 VCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF 127
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYE--EAYN 203
V++RDLK NI ++ G V+I DLGLA K VGT +MAPEV + AY+
Sbjct: 128 --VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYD 184
Query: 204 ELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCL 263
D +S G + +++ P+ + + ++ L PE+R +E L
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244
Query: 264 AT-VSLRLS-----ARELLNDPFLQ 282
V+ RL A+E+ PF +
Sbjct: 245 QRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-40
Identities = 77/343 (22%), Positives = 127/343 (37%), Gaps = 53/343 (15%)
Query: 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL 77
D RY +G+GA V A+D + VA +K + +R EI +L
Sbjct: 5 DVGPRY-TNLSYIGEGAYGMVCSAYDNVNKVRVA---IKKISPFEHQTYCQRTLREIKIL 60
Query: 78 KTLKHKNIMKFYTSWVD-TANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILR 136
+H+NI+ T + + G LK + ++ + + QILR
Sbjct: 61 LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR 120
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC-----VGTPE 191
GL Y+HS V+HRDLK N+ +N ++KI D GLA + H V T
Sbjct: 121 GLKYIHSA--NVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 192 FMAPEVY--EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP----- 244
+ APE+ + Y + +DI+S G + EM++ + + Q+ + P
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 245 -----------------------DSLYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPF 280
+ L+ D + ++K L R+ + L P+
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297
Query: 281 LQ----IDDCESNLRSLDYSRELDDMDP-----LIRQPHIDFH 314
L+ D + ELDD+ LI + F
Sbjct: 298 LEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQ 340
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 5e-40
Identities = 60/261 (22%), Positives = 107/261 (40%), Gaps = 18/261 (6%)
Query: 28 EILGKGASKTVYRAF---DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84
E LG G+ V R + + VA +K D L PE ++ E++ + +L H+N
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP-DVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHS 143
+++ Y + + VTE+ G+L KH+ + + + Q+ G+ YL S
Sbjct: 73 LIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 144 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-----CVGTPEFMAPEVY 198
IHRDL N+ + VKIGD GL L ++ + + APE
Sbjct: 130 K--RFIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 199 E-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257
+ ++ D + FG+ + EM T+ + +QI K+ + ++
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN 246
Query: 258 FVEKCLAT-VSLRLSARELLN 277
+ +C A R + L +
Sbjct: 247 VMVQCWAHKPEDRPTFVALRD 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 7e-40
Identities = 62/261 (23%), Positives = 115/261 (44%), Gaps = 15/261 (5%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLL-KTLKHKNIM 86
++LGKG+ V+ A + A +K D + +D+E E +L +H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDP 146
+ ++ N+ FV E G L + + ++ + +I+ GL +LHS
Sbjct: 67 HMFCTFQT--KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG- 123
Query: 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH--CVGTPEFMAPEVYE-EAYN 203
+++RDLK DNI ++ + G +KI D G+ A GTP+++APE+ + YN
Sbjct: 124 -IVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 204 ELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCL 263
VD +SFG+ + EM+ + P+ +++ + R + E + + K
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLF 238
Query: 264 AT-VSLRLSAR-ELLNDPFLQ 282
RL R ++ P +
Sbjct: 239 VREPEKRLGVRGDIRQHPLFR 259
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 9e-40
Identities = 47/267 (17%), Positives = 98/267 (36%), Gaps = 23/267 (8%)
Query: 30 LGKGASKTVYRAFDEY--EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
LG G +V + + I+VA +K+ D E + E ++ L + I++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDP 146
+ V EM G L ++ + + + + V Q+ G+ YL
Sbjct: 74 LIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK-- 128
Query: 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-----CVGTPEFMAPEVYE-E 200
+HRDL N+ + KI D GL+ L + + ++ APE
Sbjct: 129 NFVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187
Query: 201 AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVE 260
++ D++S+G+ + E +++ + ++ + GK+ + PE+ +
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-PPELYALMS 246
Query: 261 KCLAT-VSLRLSAREL---LNDPFLQI 283
C R + + + +
Sbjct: 247 DCWIYKWEDRPDFLTVEQRMRACYYSL 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-39
Identities = 56/266 (21%), Positives = 102/266 (38%), Gaps = 23/266 (8%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84
+ E LG G V+ + +VA +K Q + E +L+K L+H+
Sbjct: 16 KLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQHQR 69
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLH 142
+++ Y I +TE +G+L + + + KL QI G+ ++
Sbjct: 70 LVRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC---VGTPEFMAP-EVY 198
IHRDL+ NI V+ + KI D GLA ++ + ++ AP +
Sbjct: 127 ER--NYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 199 EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRF 258
+ D++SFG+ + E+VT ++ + + G + E+ +
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-PEELYQL 242
Query: 259 VEKCLAT-VSLRLSAREL---LNDPF 280
+ C R + L L D F
Sbjct: 243 MRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 4e-39
Identities = 66/319 (20%), Positives = 119/319 (37%), Gaps = 50/319 (15%)
Query: 17 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHL 76
D +Y +G+G V++A G +VA +V + + + EI +
Sbjct: 6 CDEVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKI 62
Query: 77 LKTLKHKNIMKFYTSWVDTA------NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLW 130
L+ LKH+N++ A +I V + + + +K
Sbjct: 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV 122
Query: 131 CRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC---- 186
+ +L GL Y+H + ++HRD+K N+ + + G +K+ D GLA + +
Sbjct: 123 MQMLLNGLYYIHRN--KILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYT 179
Query: 187 --VGTPEFMAPEVY--EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYK------ 236
V T + PE+ E Y +D++ G + EM T T Q+
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239
Query: 237 -------------------KVVSGKKPDSLYRVK----DPEVRRFVEKCLAT-VSLRLSA 272
++V G+K R+K DP ++K L + R+ +
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299
Query: 273 RELLNDPFLQIDDCESNLR 291
+ LN F D S+L+
Sbjct: 300 DDALNHDFFWSDPMPSDLK 318
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 5e-39
Identities = 52/257 (20%), Positives = 96/257 (37%), Gaps = 18/257 (7%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+ LG G V +VA +K+ + + E ++ L H+ +++
Sbjct: 10 KELGTGQFGVVKYGKWR-GQYDVA---IKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWCRQILRGLLYLHSHDP 146
Y R I +TE +G L Y R R + + C+ + + YL S
Sbjct: 64 LYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK-- 119
Query: 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH---CVGTPEFMAPEVYE-EAY 202
+HRDL N VN G VK+ D GL+ + + PEV +
Sbjct: 120 QFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 203 NELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKC 262
+ DI++FG+ + E+ + E ++ + + G + + +V + C
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA-SEKVYTIMYSC 237
Query: 263 LAT-VSLRLSARELLND 278
R + + LL++
Sbjct: 238 WHEKADERPTFKILLSN 254
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (363), Expect = 2e-38
Identities = 65/265 (24%), Positives = 116/265 (43%), Gaps = 17/265 (6%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+ LG G+ V + G A + + + +E E +L+ + ++K
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPP 147
S+ D N N+ V E G + + + R + + + QI+ YLHS D
Sbjct: 106 LEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD-- 161
Query: 148 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVY-EEAYNELV 206
+I+RDLK +N+ ++ G +++ D G A ++ C GTPE +APE+ + YN+ V
Sbjct: 162 LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGRTWTLC-GTPEALAPEIILSKGYNKAV 219
Query: 207 DIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLAT- 265
D ++ G+ I EM P+ P QIY+K+VSGK +++ + L
Sbjct: 220 DWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVD 276
Query: 266 -----VSLRLSARELLNDPFLQIDD 285
+L+ ++ N + D
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFATTD 301
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-38
Identities = 61/315 (19%), Positives = 116/315 (36%), Gaps = 48/315 (15%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
+++G G+ VY+A G VA +V +D E+ +++ L H NI++
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVL--------QDKRFKNRELQIMRKLDHCNIVR 77
Query: 88 ----FYTSWVDTANRNINFVTEMFTSG---TLRQYRLKHKRVNIRAVKLWCRQILRGLLY 140
FY+S +N V + R Y + + + VKL+ Q+ R L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 141 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-CVGTPEFMAPEVY- 198
+HS + HRD+K N+ ++ + +K+ D G A L + + + + APE+
Sbjct: 138 IHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 199 -EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK------ 251
Y +D++S G + E++ + + + Q+ + + P +
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255
Query: 252 --------------------DPEVRRFVEKCLAT-VSLRLSARELLNDPFLQ-IDDCESN 289
PE + L + RL+ E F + D
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK 315
Query: 290 LRSLDYSRELDDMDP 304
L + + L +
Sbjct: 316 LPNGRDTPALFNFTT 330
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-38
Identities = 50/281 (17%), Positives = 108/281 (38%), Gaps = 26/281 (9%)
Query: 27 NEILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
+++G G VY+ + + VA +K + + E ++ H
Sbjct: 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVA---IKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRV-NIRAVKLWCRQILRGLLYL 141
NI++ + + +TE +G L ++ + ++ + R I G
Sbjct: 69 HNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG--MK 124
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-----CVGTPEFMAPE 196
+ + +HRDL NI VN N K+ D GL+ +L A + APE
Sbjct: 125 YLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 197 -VYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEV 255
+ + D++SFG+ + E++T+ ++ K + G + + +
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC-PSAI 242
Query: 256 RRFVEKCLAT-VSLRLSARELLN--DPFLQIDDCESNLRSL 293
+ + +C + R ++++ D ++ D +L++L
Sbjct: 243 YQLMMQCWQQERARRPKFADIVSILDKLIRAPD---SLKTL 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 5e-38
Identities = 73/287 (25%), Positives = 116/287 (40%), Gaps = 39/287 (13%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E +G+G VY+A ++ G VA +++L ++ EI LLK L H NI+K
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 65
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDP 146
+ V E + + + +K + Q+L+GL + HSH
Sbjct: 66 LLDVIHT--ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-- 121
Query: 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAAHCVGTPEFMAPEVY--EEAY 202
V+HRDLK N+ +N G +K+ D GLA H V T + APE+ + Y
Sbjct: 122 RVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 203 NELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK----------- 251
+ VDI+S G EMVT + + Q+++ + PD +
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 252 ---------------DPEVRRFVEKCLAT-VSLRLSARELLNDPFLQ 282
D + R + + L + R+SA+ L PF Q
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 7e-38
Identities = 82/320 (25%), Positives = 132/320 (41%), Gaps = 42/320 (13%)
Query: 25 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
Y + +G GA V A D G +VA ++ QS +R Y E+ LLK ++H
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--PFQSELFAKRAYRELRLLKHMRH 76
Query: 83 KNIMKFYTSWVDTANRNI--NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLY 140
+N++ + + +F M GT +KH+++ ++ Q+L+GL Y
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 141 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVY-- 198
+H+ HRDLK N+ VN + E+KI D GLA S V T + APEV
Sbjct: 137 IHAAGII--HRDLKPGNLAVNED-CELKILDFGLARQAD-SEMTGYVVTRWYRAPEVILN 192
Query: 199 EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKV-------------------- 238
Y + VDI+S G + EM+T + + H Q+ + +
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252
Query: 239 --------VSGKKPDSLYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQ-IDDCES 288
+ K S+ P +EK L R++A E L P+ + + D E
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 312
Query: 289 NLRSLDYSRELDDMDPLIRQ 308
+ Y DD+D + +
Sbjct: 313 EPQVQKYDDSFDDVDRTLDE 332
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 9e-38
Identities = 55/268 (20%), Positives = 98/268 (36%), Gaps = 24/268 (8%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVK-LYDFLQSPEDLERLYCEIHLLKTLKHK 83
R LG+G V+ VA +K L SPE + E ++K L+H+
Sbjct: 20 RLEVKLGQGCFGEVWMGTWN-GTTRVA---IKTLKPGTMSPEAFLQ---EAQVMKKLRHE 72
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYL 141
+++ Y I VTE + G+L + K + + + QI G+ Y+
Sbjct: 73 KLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 142 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS---HAAHCVGTPEFMAPEVY 198
+HRDL+ NI V N K+ D GLA ++ + ++ APE
Sbjct: 130 ERM--NYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 199 E-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257
+ D++SFG+ + E+ T ++ +V G + +
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC-PESLHD 245
Query: 258 FVEKCLAT-VSLRLSARELLN--DPFLQ 282
+ +C R + L + +
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-37
Identities = 63/286 (22%), Positives = 105/286 (36%), Gaps = 45/286 (15%)
Query: 28 EILGKGASKTVYRAFD-----EYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-K 81
++LG GA V A I+VA VK+ + E L E+ ++ L
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVA---VKMLKEKADSSEREALMSELKMMTQLGS 99
Query: 82 HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKR-------------------- 121
H+NI+ + + I + E G L Y +
Sbjct: 100 HENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 122 ---VNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178
+ + + Q+ +G+ +L +HRDL N+ V VKI D GLA +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHG-KVVKICDFGLARDI 214
Query: 179 RKSHAAH----CVGTPEFMAPE-VYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPA 232
++MAPE ++E Y D++S+G+ + E+ + PY A
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 233 QIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLAT-VSLRLSARELLN 277
YK + +G K D + E+ ++ C A R S L +
Sbjct: 275 NFYKLIQNGFKMDQPFYA-TEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 2e-37
Identities = 57/256 (22%), Positives = 98/256 (38%), Gaps = 18/256 (7%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
LG G VY + + VA +K + ++E E ++K +KH N+++
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 88 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKL--WCRQILRGLLYLHSHD 145
+TE T G L Y + R + AV L QI + YL
Sbjct: 78 LLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK- 134
Query: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA---AHCVGTPEFMAP-EVYEEA 201
IHRDL N V N VK+ D GL+ ++ A ++ AP +
Sbjct: 135 -NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 202 YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEK 261
++ D+++FG+ + E+ T+ +Q+Y+ + + + +V +
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC-PEKVYELMRA 251
Query: 262 CLAT-VSLRLSARELL 276
C S R S E+
Sbjct: 252 CWQWNPSDRPSFAEIH 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-37
Identities = 56/272 (20%), Positives = 101/272 (37%), Gaps = 27/272 (9%)
Query: 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHK 83
++ +++G+G V +A + +G+ + +K S +D E+ +L L H
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 84 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----------------KRVNIRAV 127
NI+ + E G L + K ++ + +
Sbjct: 72 NIINLL--GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 128 KLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC- 186
+ + RG+ YL IHRDL NI V N KI D GL+
Sbjct: 130 LHFAADVARGMDYLSQK--QFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMG 186
Query: 187 VGTPEFMAPE-VYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPD 245
+MA E + Y D++S+G+ + E+V+ A++Y+K+ G + +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246
Query: 246 SLYRVKDPEVRRFVEKCLAT-VSLRLSARELL 276
D EV + +C R S ++L
Sbjct: 247 KPLNC-DDEVYDLMRQCWREKPYERPSFAQIL 277
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (348), Expect = 4e-37
Identities = 67/291 (23%), Positives = 113/291 (38%), Gaps = 41/291 (14%)
Query: 25 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
+Y+ E +G+G VY+A + Y G A +++L + EI +LK LKH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEK--EDEGIPSTTIREISILKELKH 59
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLH 142
NI+K Y + + V E + + + K + Q+L G+ Y H
Sbjct: 60 SNIVKLYDVIHT--KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC--VGTPEFMAPEVY-- 198
V+HRDLK N+ +N GE+KI D GLA + + T + AP+V
Sbjct: 118 DR--RVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 199 EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYK---------------------- 236
+ Y+ +DI+S G EMV + + Q+ +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 237 ----KVVSGKKPDSLYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQ 282
V +S + D + K L + R++A++ L + +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 9e-37
Identities = 75/301 (24%), Positives = 124/301 (41%), Gaps = 39/301 (12%)
Query: 25 RYN--EILGKGASKTVYRAFD-EYEGIEVAWNQVKLYDFLQS-PEDLERLYCEIHLLKTL 80
+Y +G+GA V++A D + G VA +V++ + P R + L+T
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 81 KHKNIMKFYTSWVDTANRN---INFVTEMFTSGTLRQY-RLKHKRVNIRAVKLWCRQILR 136
+H N+++ + + + V E ++ V +K Q+LR
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 137 GLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC-VGTPEFMAP 195
GL +LHSH V+HRDLK NI V + G++K+ D GLA I A V T + AP
Sbjct: 128 GLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 196 EV-YEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYK------------------ 236
EV + +Y VD++S G EM + + + Q+ K
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 237 ------KVVSGKKPDSLYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQ-IDDCES 288
S + + D + + KCL + R+SA L+ P+ Q ++ C+
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 304
Query: 289 N 289
N
Sbjct: 305 N 305
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 137 bits (345), Expect = 3e-36
Identities = 57/295 (19%), Positives = 110/295 (37%), Gaps = 52/295 (17%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIM 86
LG+G V+ A + +V +K P +++ EI +L+ L+ NI+
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPNII 93
Query: 87 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDP 146
D +R V E + +Q ++ + ++ + +IL+ L Y HS
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSM-- 148
Query: 147 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR-KSHAAHCVGTPEFMAPEVYE--EAYN 203
++HRD+K N+ ++ ++++ D GLA V + F PE+ + Y+
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 204 ELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLY--------------- 248
+D++S G + M+ + P+ ++ + LY
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268
Query: 249 --------------------RVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQ 282
+ PE F++K L RL+ARE + P+
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 7e-36
Identities = 67/292 (22%), Positives = 114/292 (39%), Gaps = 41/292 (14%)
Query: 25 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
+Y E +G+G TV++A + VA +V+L D EI LLK LKH
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKH 60
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLH 142
KNI++ + ++ + V E + + + ++ VK + Q+L+GL + H
Sbjct: 61 KNIVRLHDVLHS--DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 143 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAAHCVGTPEFMAPEVY-- 198
S V+HRDLK N+ +N N GE+K+ + GLA + V T + P+V
Sbjct: 119 SR--NVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 199 EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG----------------- 241
+ Y+ +D++S G E+ P K++
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 242 ----------KKPDSLYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQ 282
++ + R ++ L R+SA E L P+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 9e-36
Identities = 58/273 (21%), Positives = 115/273 (42%), Gaps = 24/273 (8%)
Query: 28 EILGKGASKTVYRAFD---EYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKN 84
++LG GA V+ G A +K +Q + E E +L+ ++
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 85 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSH 144
+ T ++ + + G L + + +R V+++ +I+ L +LH
Sbjct: 90 FLVTLHYAFQT-ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 148
Query: 145 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---RKSHAAHCVGTPEFMAPEVY--- 198
+I+RD+K +NI ++ N G V + D GL+ A GT E+MAP++
Sbjct: 149 --GIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 199 EEAYNELVDIYSFGMCILEMVTFEYPY---SECTHPAQIYKKVVSGKKPDSLYRVKDPEV 255
+ +++ VD +S G+ + E++T P+ E A+I ++++ + P +
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALA 263
Query: 256 RRFVEKCLAT-VSLRLS-----ARELLNDPFLQ 282
+ +++ L RL A E+ F Q
Sbjct: 264 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (339), Expect = 9e-36
Identities = 52/282 (18%), Positives = 97/282 (34%), Gaps = 32/282 (11%)
Query: 24 GRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK 81
RY +G G+ +Y D G EVA +KL +L+ E + K ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVA---IKL---ECVKTKHPQLHIESKIYKMMQ 60
Query: 82 HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYL 141
+ W V E+ + ++ +++ V L Q++ + Y+
Sbjct: 61 GGVGIPTI-RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 142 HSHDPPVIHRDLKCDNIFV--NGNQGEVKIGDLGLAAILRKS---------HAAHCVGTP 190
HS + IHRD+K DN + V I D GLA R + + GT
Sbjct: 120 HSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 191 EFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK-----P 244
+ + + + D+ S G ++ P+ + K +K
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 245 DSLYRVKDPEVRRFVEKCLA-TVSLRLSA---RELLNDPFLQ 282
+ L + E ++ C + + R+L + F +
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 73/290 (25%), Positives = 116/290 (40%), Gaps = 50/290 (17%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMK 87
E +GKG V+R ++ G EVA VK++ E EI+ L+H+NI+
Sbjct: 9 ESIGKGRFGEVWRG--KWRGEEVA---VKIFS--SREERSWFREAEIYQTVMLRHENILG 61
Query: 88 FYTSWVDTANR--NINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS-- 143
F + + V++ G+L Y L V + + GL +LH
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 144 ----HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH------AAHCVGTPEFM 193
P + HRDLK NI V N G I DLGLA + H VGT +M
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 194 APEVYEEA-------YNELVDIYSFGMCILEMVT----------FEYPYSECTHPA---- 232
APEV +++ + DIY+ G+ E+ ++ PY +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 233 QIYKKVVSGK-KPDSLYRVKDPE----VRRFVEKCLAT-VSLRLSARELL 276
++ K V K +P+ R + E + + + +C + RL+A +
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 6e-34
Identities = 49/268 (18%), Positives = 102/268 (38%), Gaps = 24/268 (8%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQV--KLYDFLQSPEDLERLYCEIHLLKTLKHKNI 85
LG+G+ VY + + +V K + S + E ++K ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 86 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRV----------NIRAVKLWCRQIL 135
++ V + + + E+ T G L+ Y + ++ + +I
Sbjct: 86 VRLL--GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 136 RGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC----VGTPE 191
G+ YL+++ +HRDL N V + VKIGD G+ + ++ +
Sbjct: 144 DGMAYLNAN--KFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 192 FMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRV 250
+M+PE + + D++SFG+ + E+ T + Q+ + V+ G D
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 260
Query: 251 KDPEVRRFVEKCLAT-VSLRLSARELLN 277
+ + C +R S E+++
Sbjct: 261 -PDMLFELMRMCWQYNPKMRPSFLEIIS 287
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 6e-34
Identities = 56/306 (18%), Positives = 105/306 (34%), Gaps = 51/306 (16%)
Query: 13 EFVEVDPT------------GRYGRYNEILGKGASKTVYRA-----FDEYEGIEVAWNQV 55
+V +DPT R + + LG GA V A + VA V
Sbjct: 3 NYVYIDPTQLPYDHKWEFPRNRL-SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVA---V 58
Query: 56 KLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ 114
K+ + E L E+ +L L H NI+ + +TE G L
Sbjct: 59 KMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLN 116
Query: 115 YRLKHK------------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCD 156
+ + + +++ + + Q+ +G+ +L S + IHRDL
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAAR 174
Query: 157 NIFVNGNQGEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYEEAY-NELVDIYSF 211
NI + KI D GLA ++ + ++MAPE D++S+
Sbjct: 175 NILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233
Query: 212 GMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLAT-VSLRL 270
G+ + E+ + + K++ E+ ++ C R
Sbjct: 234 GIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP 293
Query: 271 SARELL 276
+ ++++
Sbjct: 294 TFKQIV 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 8e-34
Identities = 63/278 (22%), Positives = 113/278 (40%), Gaps = 33/278 (11%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVAWNQ----VKLYDFLQSPEDLERLYCEIHLLKTL-KH 82
+ LG+GA V A + VK+ + +DL L E+ ++K + KH
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 83 KNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY----------------RLKHKRVNIRA 126
KNI+ + + + + E + G LR+Y ++++ +
Sbjct: 79 KNIINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 127 VKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH- 185
+ Q+ RG+ YL S IHRDL N+ V + +KI D GLA +
Sbjct: 137 LVSCAYQVARGMEYLASK--KCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKK 193
Query: 186 ---CVGTPEFMAPE-VYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG 241
++MAPE +++ Y D++SFG+ + E+ T +++K + G
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 253
Query: 242 KKPDSLYRVKDPEVRRFVEKCLATV-SLRLSARELLND 278
+ D E+ + C V S R + ++L+ D
Sbjct: 254 HRMDKPSNC-TNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (325), Expect = 8e-34
Identities = 51/293 (17%), Positives = 92/293 (31%), Gaps = 45/293 (15%)
Query: 19 PTGRYGRYNEILGKGASKTVYRA-----FDEYEGIEVAWNQVKLYDFLQSPEDLERLYCE 73
P Y +G+GA V++A VA VK+ S + E
Sbjct: 11 PRNNI-EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVA---VKMLKEEASADMQADFQRE 66
Query: 74 IHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKR------------ 121
L+ + NI+K + + + E G L ++
Sbjct: 67 AALMAEFDNPNIVKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 122 ------------VNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI 169
++ RQ+ G+ YL +HRDL N V N VKI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGEN-MVVKI 181
Query: 170 GDLGLAAILRKSHAAH----CVGTPEFMAPE-VYEEAYNELVDIYSFGMCILEMVTFEYP 224
D GL+ + + +M PE ++ Y D++++G+ + E+ ++
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 225 YSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLAT-VSLRLSARELL 276
++ V G E+ + C + + R S +
Sbjct: 242 PYYGMAHEEVIYYVRDGNILACPENC-PLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 8e-34
Identities = 84/333 (25%), Positives = 129/333 (38%), Gaps = 49/333 (14%)
Query: 25 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH 82
RY +G GA +V AFD G+ VA ++ QS +R Y E+ LLK +KH
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKH 76
Query: 83 KNIMKFYTSWVD--TANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLY 140
+N++ + + + G +K +++ V+ QILRGL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 141 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVY-- 198
+HS D +IHRDLK N+ VN E+KI D GLA + T + APE+
Sbjct: 137 IHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMTGYVA-TRWYRAPEIMLN 192
Query: 199 EEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPD------------- 245
YN+ VDI+S G + E++T + H Q+ + P
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 246 ---------------SLYRVKDPEVRRFVEKCLAT-VSLRLSARELLNDPFLQ---IDDC 286
+++ +P +EK L R++A + L + D
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312
Query: 287 ESNLRSLDYSRE-----LDDMDPLIRQPHIDFH 314
E D S E +D+ L I F
Sbjct: 313 EPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 345
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 128 bits (323), Expect = 1e-33
Identities = 36/263 (13%), Positives = 87/263 (33%), Gaps = 29/263 (11%)
Query: 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL 80
Y + +G+G+ ++ + +VA +K L E K L
Sbjct: 5 VHY-KVGRRIGEGSFGVIFEGTNLLNNQQVA---IKFEPRRSDAPQLRD---EYRTYKLL 57
Query: 81 KHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLY 140
+ + N+ V ++ L ++ +++ V + +Q+L +
Sbjct: 58 AGCTGIPNVYYFGQEGLHNV-LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 141 LHSHDPPVIHRDLKCDNIFVN----GNQGEVKIGDLGLAAILRKS---------HAAHCV 187
+H +++RD+K DN + N + + D G+ R +
Sbjct: 117 IHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 188 GTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT--FEYPYSECTHPAQIYKKVVSGKKP 244
GT +M+ + + D+ + G + + + + Q Y+++ K+
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
Query: 245 DSLYRVKD---PEVRRFVEKCLA 264
L + E +++
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARN 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 7e-32
Identities = 55/281 (19%), Positives = 101/281 (35%), Gaps = 35/281 (12%)
Query: 25 RYNEILGKGASKTVYRAFD-----EYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKT 79
+ + LG+GA V A VA VK+ + + L E+ +L
Sbjct: 16 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVA---VKMLKEGATHSEHRALMSELKILIH 72
Query: 80 LKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKR----------------VN 123
+ H + + + E G L Y + +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 124 IRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-- 181
+ + + Q+ +G+ +L S IHRDL NI ++ VKI D GLA + K
Sbjct: 133 LEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPD 189
Query: 182 --HAAHCVGTPEFMA-PEVYEEAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQIYKK 237
++MA +++ Y D++SFG+ + E+ + PY + ++
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 238 VVSGKKPDSLYRVKDPEVRRFVEKCLAT-VSLRLSARELLN 277
+ G + + PE+ + + C S R + EL+
Sbjct: 250 LKEGTRMRAPDYT-TPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-30
Identities = 77/336 (22%), Positives = 130/336 (38%), Gaps = 59/336 (17%)
Query: 24 GRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK 81
RY + +G GA V A+D VA ++ Q+ +R Y E+ L+K +
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVN 74
Query: 82 HKNIMKFYTSWVDTA----NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRG 137
HKNI+ + +++ V E+ + + ++ + Q+L G
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCG 131
Query: 138 LLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHC-VGTPEFMAPE 196
+ +LHS IHRDLK NI V + +KI D GLA S V T + APE
Sbjct: 132 IKHLHSAGI--IHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 197 -VYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKV----------------- 238
+ Y E VDI+S G + EMV + + + Q K +
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 239 ---------------VSGKKPDSLY-------RVKDPEVRRFVEKCLAT-VSLRLSAREL 275
PDSL+ ++K + R + K L + R+S +
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 276 LNDPFLQIDDCESNLRSL---DYSRELDDMDPLIRQ 308
L P++ + + + + Y ++LD+ + I +
Sbjct: 309 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEE 344
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (253), Expect = 7e-24
Identities = 66/326 (20%), Positives = 111/326 (34%), Gaps = 73/326 (22%)
Query: 24 GRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK 81
RY LG G TV+ A D VA V+ E EI LL+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-----GDKVYTEAAEDEIKLLQRVN 67
Query: 82 H-----------KNIMKFYTSWVDTANRNINFVTEMFTSGT---LRQYRLKHKRVNIRAV 127
+I+K + ++ V G + +H+ + + V
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 128 KLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILRKSHA 183
K +Q+L GL Y+H +IH D+K +N+ + + + +A A H
Sbjct: 128 KQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 184 AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYS---------ECTHPAQ 233
+ + T E+ +PEV + DI+S I E++T ++ + + H AQ
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 234 IYK--------------------------KVVSGKKPDSLYRVK----------DPEVRR 257
I + + +S K L V E+
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 258 FVEKCLAT-VSLRLSARELLNDPFLQ 282
F+ L R A L+N P+L+
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWLK 332
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 69.4 bits (169), Expect = 3e-14
Identities = 33/210 (15%), Positives = 66/210 (31%), Gaps = 44/210 (20%)
Query: 28 EILGKGASKTVYRAFDEYEGIEVA--------------WNQVKLYDFLQSPEDLERLYCE 73
+++G+G V+ + E + E + D S + E
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 74 IHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQ 133
L+ L+ + K Y N + E+ + L + R+++
Sbjct: 65 FRALQKLQGLAVPKVYA-----WEGNA-VLMELIDAKELYRVRVENPD-------EVLDM 111
Query: 134 ILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFM 193
IL + + ++H DL N+ V+ + I D + + + E +
Sbjct: 112 ILEEVAKFYHR--GIVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEEGW------REIL 161
Query: 194 APEV------YEEAYNELVDIYSFGMCILE 217
+V + Y DI S IL+
Sbjct: 162 ERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 745 | |||
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.44 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.34 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.83 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.02 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.49 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.99 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=442.23 Aligned_cols=266 Identities=49% Similarity=0.910 Sum_probs=244.4
Q ss_pred EEECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 27599985246767745138659999998579929999997605557997799999999999993799983247689785
Q 004564 15 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVD 94 (745)
Q Consensus 15 ~e~dp~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd 94 (745)
+-..++|||+++.+.||+|+||+||+|.+..++..||+|.+.... ......+++.+|+++|++++|||||++|++|.+
T Consensus 2 ~g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 79 (270)
T d1t4ha_ 2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 79 (270)
T ss_dssp CEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCCCCCCEEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 884778877885169700828499999999999599999985122--798999999999999985799985069999840
Q ss_pred C--CCCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCC
Q ss_conf 5--89859999823689999999997488899999999999999987754099997940487763355199992897476
Q 004564 95 T--ANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 172 (745)
Q Consensus 95 ~--~~~~iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DF 172 (745)
. ....+|+||||+++|+|.+++.+...+++..++.|+.||+.||.|||+++++|+||||||+|||+++.++.+||+||
T Consensus 80 ~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 80 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred CCCCCCEEEEEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEEC
T ss_conf 33458889999957898948999751355469999999999999999999789979968767435116679998898005
Q ss_pred CHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 21565621677765688876880222100375332212366899986437899999997999999982999998666899
Q 004564 173 GLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 173 GlA~~l~~~~~~~~vGTp~YmAPEil~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p~~l~~~~s 252 (745)
|+|+..........+||+.|||||++.+.|+.++|||||||++|||+||+.||.+..+..++++.+..+..|..+....+
T Consensus 160 Gla~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (270)
T d1t4ha_ 160 GLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239 (270)
T ss_dssp TGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred CCCEECCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 76542368766775538130089884789998671100799999998788999876559999999973899865675578
Q ss_pred HHHHHHHHHHHH-CCCCCCCHHHHHCCCCCC
Q ss_conf 799999999862-806998999883498778
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLNDPFLQ 282 (745)
Q Consensus 253 ~el~~lI~kCL~-dPskRpSa~ELL~hPflq 282 (745)
++++++|.+||. +|.+|||+.|+|+||||+
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf 9999999997637975892999996775409
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=416.67 Aligned_cols=259 Identities=34% Similarity=0.521 Sum_probs=225.1
Q ss_pred EECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC
Q ss_conf 75999852467677451386599999985799299999976055579977999999999999937999832476897855
Q 004564 16 EVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT 95 (745)
Q Consensus 16 e~dp~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~ 95 (745)
..||..|| ++.+.||+|+||+||+|.+..+|+.||+|+++.... ...+.+.+|+.+|+.++||||++++++|.+
T Consensus 15 ~~dp~~~Y-~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~- 88 (293)
T d1yhwa1 15 VGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLV- 88 (293)
T ss_dssp SSCTTTTB-CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-
T ss_pred CCCCCCCC-EEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCC----HHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-
T ss_conf 99951053-887898128582999999989998999999843017----279999999999986799988058577988-
Q ss_pred CCCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHH
Q ss_conf 89859999823689999999997488899999999999999987754099997940487763355199992897476215
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 96 ~~~~iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA 175 (745)
...+|+||||+.+|+|.+++.+ +.+++..++.|++||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|
T Consensus 89 -~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~vkl~DFG~a 163 (293)
T d1yhwa1 89 -GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFC 163 (293)
T ss_dssp -TTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTC
T ss_pred -CCEEEEEEEECCCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEEC-CCCCEEECCCHHH
T ss_conf -9998999970379808988641-59999999999999999999999879--72267768886887-8996864251564
Q ss_pred HHHHCC--CCCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 656216--777656888768802221-00375332212366899986437899999997999999982999998666899
Q 004564 176 AILRKS--HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 176 ~~l~~~--~~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p~~l~~~~s 252 (745)
..+... .....+||+.|||||++. +.|+.++|||||||++|+|+||+.||.+......++..+..+..+...+...+
T Consensus 164 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s 243 (293)
T d1yhwa1 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243 (293)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSC
T ss_pred EEECCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 13213666444444477736826644799880120313729999980488998997999999999857999888855379
Q ss_pred HHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf 799999999862-806998999883498778632
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 253 ~el~~lI~kCL~-dPskRpSa~ELL~hPflq~~~ 285 (745)
+.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 244 ~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 9999999998669966890999996499657788
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=411.75 Aligned_cols=261 Identities=28% Similarity=0.428 Sum_probs=228.8
Q ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 52759998524676774513865999999857992999999760555799779999999999999379998324768978
Q 004564 14 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWV 93 (745)
Q Consensus 14 ~~e~dp~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fv 93 (745)
|...||..+| ...+.||+|+||+||+|.+..++..||+|+++... .......+.+.+|+.+|+.++|||||+++++|.
T Consensus 8 ~~~~dp~~~y-~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 85 (309)
T d1u5ra_ 8 FFKDDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (309)
T ss_dssp CCCSCHHHHE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCS-SCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCCCCCHHHC-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 5566907856-76279701888099999998999399999984444-358899999999999999778999823899999
Q ss_pred ECCCCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCC
Q ss_conf 55898599998236899999999974888999999999999999877540999979404877633551999928974762
Q 004564 94 DTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 173 (745)
Q Consensus 94 d~~~~~iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFG 173 (745)
+ ...+|+||||+.+|+|..++...+.+++..++.|++||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 86 ~--~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~~Kl~DFG 160 (309)
T d1u5ra_ 86 R--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFG 160 (309)
T ss_dssp E--TTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCT
T ss_pred E--CCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCCCEEEEC-CCCCEEEEECC
T ss_conf 8--9988999980699945789973799999999999999999999998689--76667884217987-99978984436
Q ss_pred HHHHHHCCCCCCCCCCCCCCCHHHHH----HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 15656216777656888768802221----00375332212366899986437899999997999999982999998666
Q 004564 174 LAAILRKSHAAHCVGTPEFMAPEVYE----EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYR 249 (745)
Q Consensus 174 lA~~l~~~~~~~~vGTp~YmAPEil~----~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p~~l~~ 249 (745)
+|..... ....+||+.|||||++. +.|+.++|||||||++|||++|..||.+. +..+....+..+..+.....
T Consensus 161 ~a~~~~~--~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~ 237 (309)
T d1u5ra_ 161 SASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSG 237 (309)
T ss_dssp TCBSSSS--BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCT
T ss_pred CCCCCCC--CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHHCCCCCCCCC
T ss_conf 5334677--87313476636889983467888672145455899999998788999997-99999999982899988878
Q ss_pred CCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf 899799999999862-80699899988349877863
Q 004564 250 VKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 250 ~~s~el~~lI~kCL~-dPskRpSa~ELL~hPflq~~ 284 (745)
.+++++++||.+||+ +|.+|||+.|+|+||||...
T Consensus 238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCC
T ss_conf 889999999999773796579189999719975378
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=409.23 Aligned_cols=260 Identities=29% Similarity=0.529 Sum_probs=224.5
Q ss_pred EEECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 27599985246767745138659999998579929999997605557997799999999999993799983247689785
Q 004564 15 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVD 94 (745)
Q Consensus 15 ~e~dp~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd 94 (745)
.+++|...| ++.+.||+|+||+||+|.+..++..||+|+++.. .....+.+.+|+.+|+.++||||++++++|.+
T Consensus 6 r~~~p~d~Y-~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 80 (288)
T d2jfla1 6 RDLNPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYY 80 (288)
T ss_dssp ESSCGGGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CCCCCCCCE-EEEEEEEECCCCEEEEEEECCCCEEEEEEEECCC----CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
T ss_conf 789910375-9847993077819999999999939999998728----99999999999999986799998849889800
Q ss_pred CCCCEEEEEEECCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCC
Q ss_conf 589859999823689999999997-4888999999999999999877540999979404877633551999928974762
Q 004564 95 TANRNINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 173 (745)
Q Consensus 95 ~~~~~iyLVtEy~~gGSL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFG 173 (745)
...+|+||||+.+|+|..++.+ .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 81 --~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFG 155 (288)
T d2jfla1 81 --ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFT-LDGDIKLADFG 155 (288)
T ss_dssp --TTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCT
T ss_pred --CCEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEEECCHHHEEEC-CCCCEEEEECH
T ss_conf --99589999627998188999862899999999999999999999999889--88714070031487-89998997161
Q ss_pred HHHHHHCC--CCCCCCCCCCCCCHHHHH------HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC-
Q ss_conf 15656216--777656888768802221------003753322123668999864378999999979999999829999-
Q 004564 174 LAAILRKS--HAAHCVGTPEFMAPEVYE------EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP- 244 (745)
Q Consensus 174 lA~~l~~~--~~~~~vGTp~YmAPEil~------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p- 244 (745)
+|...... .....+||+.|||||++. ..|+.++|||||||++|+|+||++||.+. +..++...+..+..+
T Consensus 156 ~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~-~~~~~~~~i~~~~~~~ 234 (288)
T d2jfla1 156 VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKSEPPT 234 (288)
T ss_dssp TCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS-CGGGHHHHHHHSCCCC
T ss_pred HHHCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHCCCCCC
T ss_conf 230357786410010256264799998320257888880665787899999982088999998-9999999997079987
Q ss_pred CCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf 98666899799999999862-806998999883498778632
Q 004564 245 DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 245 ~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~hPflq~~~ 285 (745)
...+...++++++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~ 276 (288)
T d2jfla1 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276 (288)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf 776566999999999997669966891999996292318898
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=409.20 Aligned_cols=257 Identities=27% Similarity=0.451 Sum_probs=220.0
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCE
Q ss_conf 98524676774513865999999857992999999760555799779999999999999379998324768978558985
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 20 ~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 99 (745)
..+| .+.+.||+|+||+||+|.+..+|..||+|.++... .....+++.+|+.+|+.++|||||+++++|.+ ...
T Consensus 5 ~d~y-~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~ 78 (322)
T d1s9ja_ 5 DDDF-EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGE 78 (322)
T ss_dssp GGGE-EEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--SSE
T ss_pred CCCC-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCE
T ss_conf 5688-89789712778099999998999699999987540---97899999999999986799999949999998--999
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEEECCCCCCEEECCCCCCEEECCCCHHHHH
Q ss_conf 99998236899999999974888999999999999999877540-99997940487763355199992897476215656
Q 004564 100 INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 100 iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs-~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~l 178 (745)
+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||+|...
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHH
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEC-CCCCEEEEECCCCCCC
T ss_conf 99999767998689987424999999999999999999999998599--97144577994687-8998999548776256
Q ss_pred HCCCCCCCCCCCCCCCHHHHHH-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHH------------------------
Q ss_conf 2167776568887688022210-037533221236689998643789999999799------------------------
Q 004564 179 RKSHAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQ------------------------ 233 (745)
Q Consensus 179 ~~~~~~~~vGTp~YmAPEil~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~------------------------ 233 (745)
........+||+.|||||++.+ .|+.++||||+||++|||+||+.||........
T Consensus 156 ~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 156 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp HHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred CCCCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCC
T ss_conf 78862111377141194687589989488899899999999988899899887899999988751775457742123332
Q ss_pred -----------------HHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf -----------------9999982999998666899799999999862-806998999883498778632
Q 004564 234 -----------------IYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 234 -----------------i~~ki~~g~~p~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~hPflq~~~ 285 (745)
....+.....|.......++++++||.+||. ||.+||||+|+|+||||+..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCCC
T ss_conf 2111122235413477887665026876676444899999999998689946790899996098647698
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=409.68 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=222.5
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCE
Q ss_conf 98524676774513865999999857992999999760555799779999999999999379998324768978558985
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 20 ~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 99 (745)
...| ++.+.||+|+||+||+|.+..+++.||+|+++... ..+..+++.+|+.+|+.++||||+++++++.+ ...
T Consensus 4 ~~dy-~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~ 77 (271)
T d1nvra_ 4 VEDW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNI 77 (271)
T ss_dssp TTEE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTE
T ss_pred CCCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH---CCHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCE
T ss_conf 7460-89989721748099999999999799999984566---41279999999999985799888469654046--743
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHHHHH
Q ss_conf 99998236899999999974888999999999999999877540999979404877633551999928974762156562
Q 004564 100 INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 100 iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~l~ 179 (745)
+|+||||+.+|+|.+++.+.+.+++..++.|++||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|....
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~-~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFR 154 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECE
T ss_pred EEEEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEEC-CCCCEEECCCHHHEEEC
T ss_conf 6798864589808999753799999999999999999999999759--83575468997887-89987983231422404
Q ss_pred CC----CCCCCCCCCCCCCHHHHHH-C-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCH
Q ss_conf 16----7776568887688022210-0-3753322123668999864378999999979999999829999986668997
Q 004564 180 KS----HAAHCVGTPEFMAPEVYEE-A-YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDP 253 (745)
Q Consensus 180 ~~----~~~~~vGTp~YmAPEil~~-~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p~~l~~~~s~ 253 (745)
.. .....+||+.|||||++.+ . ++.++||||+||++|+|+||++||.........+............+...++
T Consensus 155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 234 (271)
T d1nvra_ 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234 (271)
T ss_dssp ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCH
T ss_pred CCCCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCH
T ss_conf 68865311132557474287286189999971016173799999982997888898599999998638887886446999
Q ss_pred HHHHHHHHHHH-CCCCCCCHHHHHCCCCCCC
Q ss_conf 99999999862-8069989998834987786
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 254 el~~lI~kCL~-dPskRpSa~ELL~hPflq~ 283 (745)
++++||.+||+ +|.+|||++|+|+||||+.
T Consensus 235 ~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 235 APLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 9999999976799668909999961984585
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=408.91 Aligned_cols=253 Identities=24% Similarity=0.387 Sum_probs=225.6
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 85246767745138659999998579929999997605557997799999999999993799983247689785589859
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 100 (745)
.+| ++.+.||+|+||+||+|.++.+++.||+|++..... ......+.+.+|+.+|+.++||||+++++++.+ ...+
T Consensus 6 ~dy-~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~ 81 (263)
T d2j4za1 6 EDF-EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRV 81 (263)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred HHE-EEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC-CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEE
T ss_conf 376-998898517785899999989994999999816885-676899999999999985688888859999998--9998
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHHHHHC
Q ss_conf 99982368999999999748889999999999999998775409999794048776335519999289747621565621
Q 004564 101 NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 101 yLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~l~~ 180 (745)
|+||||+.+|+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|.....
T Consensus 82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCSCSCCCC
T ss_pred EEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEEEECCCCCEEC-CCCCEEECCCCEEEECCC
T ss_conf 999850479858988750489999999999999999999999889--46522023441466-899871155563354488
Q ss_pred CCCCCCCCCCCCCCHHHHHH-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHH
Q ss_conf 67776568887688022210-03753322123668999864378999999979999999829999986668997999999
Q 004564 181 SHAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259 (745)
Q Consensus 181 ~~~~~~vGTp~YmAPEil~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p~~l~~~~s~el~~lI 259 (745)
......+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+..+ ++...++++++||
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li 235 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEFT--FPDFVTEGARDLI 235 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCC--CCTTSCHHHHHHH
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHHHHHH
T ss_conf 852355788763499997589989314404675999998329999888-9999999999718999--9866899999999
Q ss_pred HHHHH-CCCCCCCHHHHHCCCCCCC
Q ss_conf 99862-8069989998834987786
Q 004564 260 EKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 260 ~kCL~-dPskRpSa~ELL~hPflq~ 283 (745)
.+||+ +|.+|||++|+|+||||+.
T Consensus 236 ~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 236 SRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 9976479768909999971907078
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=399.01 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=223.4
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCE
Q ss_conf 98524676774513865999999857992999999760555799779999999999999379998324768978558985
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 20 ~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 99 (745)
-.+| ++.+.||+|+||+||+|.+..+|..||+|++... .....+.+.+|+.+|+.++||||++++++|.+ .+.
T Consensus 25 l~~Y-~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~ 97 (350)
T d1koaa2 25 LDHY-DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNE 97 (350)
T ss_dssp GGTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTE
T ss_pred CCCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC----CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCE
T ss_conf 6575-8988984076819999998899989999998452----43169999999999986799799929999998--999
Q ss_pred EEEEEECCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECC-CCCCEEECCCCHHHH
Q ss_conf 9999823689999999997-48889999999999999998775409999794048776335519-999289747621565
Q 004564 100 INFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG-NQGEVKIGDLGLAAI 177 (745)
Q Consensus 100 iyLVtEy~~gGSL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~-~~g~VKL~DFGlA~~ 177 (745)
+|+||||+.+|+|.+++.+ .+.+++..++.|++||+.||.|||+++ |+||||||+|||++. ..+.+||+|||+|..
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CEEEEECHHHEEECCCCCCEEEEEECCHHEE
T ss_conf 99999857998899999762378999999999999999999997569--7600015467364168898699954521044
Q ss_pred HHCCC-CCCCCCCCCCCCHHHHHH-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCCCH
Q ss_conf 62167-776568887688022210-0375332212366899986437899999997999999982999--9986668997
Q 004564 178 LRKSH-AAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK--PDSLYRVKDP 253 (745)
Q Consensus 178 l~~~~-~~~~vGTp~YmAPEil~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~--p~~l~~~~s~ 253 (745)
+.... ....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+.. +.......++
T Consensus 176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 254 (350)
T d1koaa2 176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISE 254 (350)
T ss_dssp CCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred CCCCCCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHHCCCCCCCCCCCCCCH
T ss_conf 2565432000686242188997589987267655465999999859899899-799999999984788989422358999
Q ss_pred HHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf 99999999862-806998999883498778632
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 254 el~~lI~kCL~-dPskRpSa~ELL~hPflq~~~ 285 (745)
.+++||.+||. ||.+|||+.|+|+||||+...
T Consensus 255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf 999999997568966790899986291328898
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=401.22 Aligned_cols=254 Identities=28% Similarity=0.452 Sum_probs=224.3
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEE
Q ss_conf 52467677451386599999985799299999976055579977999999999999937999832476897855898599
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~iy 101 (745)
.| ++.+.||+|+||+||+|.++.+|+.||+|.++... .+....+.+.+|+.+|+.++||||++++++|.+.....+|
T Consensus 5 dy-~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 5 DY-EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTT--SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred HC-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
T ss_conf 37-99679830889199999999999799999987465--7979999999999999977899982489999917899899
Q ss_pred EEEECCCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCEEEECCCCCCEEECCCCCCEEECCCCH
Q ss_conf 99823689999999997----488899999999999999987754099---99794048776335519999289747621
Q 004564 102 FVTEMFTSGTLRQYRLK----HKRVNIRAVKLWCRQILRGLLYLHSHD---PPVIHRDLKCDNIFVNGNQGEVKIGDLGL 174 (745)
Q Consensus 102 LVtEy~~gGSL~~~l~k----~~~L~e~~i~~ia~QIL~gL~yLHs~g---~~IIHRDLKp~NILId~~~g~VKL~DFGl 174 (745)
+||||+++|+|.+++.+ ...+++..++.|+.||+.||.|||+++ .+|+||||||+|||++ .++.+||+|||+
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~-~~~~vkl~DFG~ 160 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGL 160 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC-TTSCEEECCHHH
T ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCC-CCCCEEEEECCC
T ss_conf 9995689993899998515457899999999999999999999997167788788586765425747-888579800100
Q ss_pred HHHHHCC--CCCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 5656216--777656888768802221-0037533221236689998643789999999799999998299999866689
Q 004564 175 AAILRKS--HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK 251 (745)
Q Consensus 175 A~~l~~~--~~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p~~l~~~~ 251 (745)
|..+... .....+||+.|||||++. ..|+.++|||||||++|||+||+.||.+ .+..++..++..+..+. ++..+
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~ 238 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFRR-IPYRY 238 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCC-CCTTS
T ss_pred EEECCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCC
T ss_conf 03224577755667788232799998399999389887527899998018899899-89999999997189988-97435
Q ss_pred CHHHHHHHHHHHH-CCCCCCCHHHHHCCCCC
Q ss_conf 9799999999862-80699899988349877
Q 004564 252 DPEVRRFVEKCLA-TVSLRLSARELLNDPFL 281 (745)
Q Consensus 252 s~el~~lI~kCL~-dPskRpSa~ELL~hPfl 281 (745)
++++++||.+||+ +|.+|||+.|+|+|||+
T Consensus 239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHHCCCC
T ss_conf 9999999999767995579189999729819
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=398.94 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=222.2
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 85246767745138659999998579929999997605557997799999999999993799983247689785589859
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 100 (745)
.+| ++.+.||+|+||+||+|.+..+|+.||+|+++.. .....+.+.+|+.+|+.++||||++++++|.+ +..+
T Consensus 29 d~Y-~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~ 101 (352)
T d1koba_ 29 DYY-DILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEM 101 (352)
T ss_dssp GTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEE
T ss_pred CCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC----CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCEE
T ss_conf 035-9989993177829999999899979999998872----64679999999999986799798919999998--9999
Q ss_pred EEEEECCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECC-CCCCEEECCCCHHHHH
Q ss_conf 99982368999999999748-889999999999999998775409999794048776335519-9992897476215656
Q 004564 101 NFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG-NQGEVKIGDLGLAAIL 178 (745)
Q Consensus 101 yLVtEy~~gGSL~~~l~k~~-~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~-~~g~VKL~DFGlA~~l 178 (745)
|+||||+.+|+|.+++.+.+ ++++..++.|++||+.||.|||++| |+||||||+|||++. ..+.+||+|||+|..+
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCCCCCCCCCCCEEEEEECCCCEEC
T ss_conf 9999828998088889863899899999999999999999999779--26513144553113467884899525630343
Q ss_pred HCCC-CCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCCCHH
Q ss_conf 2167-77656888768802221-00375332212366899986437899999997999999982999--99866689979
Q 004564 179 RKSH-AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK--PDSLYRVKDPE 254 (745)
Q Consensus 179 ~~~~-~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~--p~~l~~~~s~e 254 (745)
.... .....||+.|||||++. ..|+.++|||||||++|+|+||..||.+ .+..++...+..+.. +...+...+++
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 258 (352)
T d1koba_ 180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPE 258 (352)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred CCCCCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHHCCCCCCCCCCCCCCHH
T ss_conf 788720100476453489997479989763338989999999968899899-7999999999847889893002479999
Q ss_pred HHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf 9999999862-806998999883498778632
Q 004564 255 VRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 255 l~~lI~kCL~-dPskRpSa~ELL~hPflq~~~ 285 (745)
+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 259 ~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 99999997569966891899996097348882
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=400.03 Aligned_cols=256 Identities=21% Similarity=0.378 Sum_probs=224.1
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCE
Q ss_conf 98524676774513865999999857992999999760555799779999999999999379998324768978558985
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 20 ~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 99 (745)
..+| ++.+.||+|+||+||+|.++.+++.||+|++..... ......+.+|+.+|+.++||||++++++|.+ +..
T Consensus 8 ~d~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~ 81 (307)
T d1a06a_ 8 RDIY-DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL---EGKEGSMENEIAVLHKIKHPNIVALDDIYES--GGH 81 (307)
T ss_dssp GGTE-EEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEEC--SSE
T ss_pred CCCE-EEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHH---HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCE
T ss_conf 6666-998899406583999999999998999999815773---1289999999999986799899919899998--998
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECC--CCCCEEECCCCHHHH
Q ss_conf 999982368999999999748889999999999999998775409999794048776335519--999289747621565
Q 004564 100 INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGLAAI 177 (745)
Q Consensus 100 iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~--~~g~VKL~DFGlA~~ 177 (745)
+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||+.. .++.+||+|||+|..
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EEEEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCE--EEEEEECCCCEEECCCCCCCEEEEECCCEEEE
T ss_conf 8898852689848886530367887899999999999987524130--55687046300110468882499831543587
Q ss_pred HHCC-CCCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC--CCCCCCCCH
Q ss_conf 6216-777656888768802221-003753322123668999864378999999979999999829999--986668997
Q 004564 178 LRKS-HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP--DSLYRVKDP 253 (745)
Q Consensus 178 l~~~-~~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p--~~l~~~~s~ 253 (745)
.... .....+||+.|||||++. +.|+.++|||||||++|+|+||.+||.+ ....+++..+..+..+ .......++
T Consensus 160 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 238 (307)
T d1a06a_ 160 EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISD 238 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred CCCCCEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCCCCCCCCCCCCH
T ss_conf 2589704400328422591887379998078734515999999859799999-899999999861687778766667899
Q ss_pred HHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf 99999999862-80699899988349877863
Q 004564 254 EVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 254 el~~lI~kCL~-dPskRpSa~ELL~hPflq~~ 284 (745)
++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 239 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 99999999760897579189998629844799
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=398.43 Aligned_cols=254 Identities=23% Similarity=0.413 Sum_probs=225.4
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEE
Q ss_conf 52467677451386599999985799299999976055579977999999999999937999832476897855898599
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~iy 101 (745)
.| .+.++||+|+||.||+|+++.+++.||+|++++.... .....+++.+|+.+|+.++||||++++++|.+ ...+|
T Consensus 6 dy-~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~ 81 (337)
T d1o6la_ 6 DF-DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLC 81 (337)
T ss_dssp GE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEE
T ss_pred HC-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCCCC
T ss_conf 42-8988983176849999999899989999998156544-97999999999999986799988778764035--64211
Q ss_pred EEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHHHHHC-
Q ss_conf 9982368999999999748889999999999999998775409999794048776335519999289747621565621-
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK- 180 (745)
Q Consensus 102 LVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~l~~- 180 (745)
+||||+.+|+|..++.+.+.+++..++.+++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|+....
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~-~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCT
T ss_pred CCEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEEC-CCCCEEEEECCCCCCCCCC
T ss_conf 10003579860555532567759999999999965211343159--62246477784765-8998888205652003567
Q ss_pred -CCCCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHH
Q ss_conf -6777656888768802221-00375332212366899986437899999997999999982999998666899799999
Q 004564 181 -SHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRF 258 (745)
Q Consensus 181 -~~~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p~~l~~~~s~el~~l 258 (745)
......+||+.|||||++. ..|+.++||||+||++|||+||++||.+ .+..++++.+..+..+ ++...++++++|
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~dl 235 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIR--FPRTLSPEAKSL 235 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHH
T ss_pred CCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHHHHH
T ss_conf 8620551008899666650489888333102230678899878999999-6999999998528998--986689999999
Q ss_pred HHHHHH-CCCCCCC-----HHHHHCCCCCCCCC
Q ss_conf 999862-8069989-----99883498778632
Q 004564 259 VEKCLA-TVSLRLS-----ARELLNDPFLQIDD 285 (745)
Q Consensus 259 I~kCL~-dPskRpS-----a~ELL~hPflq~~~ 285 (745)
|.+||+ +|.+|++ ++++++||||+..+
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHHCCCCCHHHCCCCCCCHHHHHCCCCCCCCC
T ss_conf 986663893442256523499997291503699
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=397.60 Aligned_cols=264 Identities=22% Similarity=0.367 Sum_probs=227.7
Q ss_pred ECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 5999852467677451386599999985799299999976055579--97799999999999993799983247689785
Q 004564 17 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ--SPEDLERLYCEIHLLKTLKHKNIMKFYTSWVD 94 (745)
Q Consensus 17 ~dp~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~--s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd 94 (745)
.+...|| ++.+.||+|+||+||+|+++.+|+.||+|++++..... .....+.+.+|+.+|+.++|||||+++++|.+
T Consensus 6 ~~i~d~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 6 ENVDDYY-DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84 (293)
T ss_dssp SCGGGTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCCCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE
T ss_conf 8855677-982798117895999999999998999999875663213406899999999999986799899938899997
Q ss_pred CCCCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCC---CCEEECC
Q ss_conf 5898599998236899999999974888999999999999999877540999979404877633551999---9289747
Q 004564 95 TANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQ---GEVKIGD 171 (745)
Q Consensus 95 ~~~~~iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~---g~VKL~D 171 (745)
...+|+||||+.+|+|.+++...+.+++..++.|++||+.||.|||+++ |+||||||+|||++.++ ..+||+|
T Consensus 85 --~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 85 --KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp --SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred --CCEEEEEEECCCCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCEEEEECCCCCCCCEEECC
T ss_conf --9989999986778643100103564215578999999999987666254--221133301279825898666469643
Q ss_pred CCHHHHHHCC-CCCCCCCCCCCCCHHHHHH-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC--CCC
Q ss_conf 6215656216-7776568887688022210-03753322123668999864378999999979999999829999--986
Q 004564 172 LGLAAILRKS-HAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP--DSL 247 (745)
Q Consensus 172 FGlA~~l~~~-~~~~~vGTp~YmAPEil~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p--~~l 247 (745)
||+|...... ......||+.|+|||++.+ .|+.++||||+||++|+|+||+.||.+ .+..+.+..+..+... ...
T Consensus 161 fG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1jksa_ 161 FGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEY 239 (293)
T ss_dssp CTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHHH
T ss_pred HHHHHHCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHHCCCCCCCHH
T ss_conf 3442105777631224777743099998189999766522140999999708899889-999999999981688887010
Q ss_pred CCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCCC
Q ss_conf 66899799999999862-8069989998834987786321
Q 004564 248 YRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDDC 286 (745)
Q Consensus 248 ~~~~s~el~~lI~kCL~-dPskRpSa~ELL~hPflq~~~~ 286 (745)
+...++.+++||.+||. +|.+|||++|+|+||||+..+.
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCH
T ss_conf 4788999999999986389668919999961904188870
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=395.97 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=216.8
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCC--CCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCE
Q ss_conf 524676774513865999999857992999999760555--799779999999999999379998324768978558985
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF--LQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRN 99 (745)
Q Consensus 22 RY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~--~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 99 (745)
.| ++.++||+|+||+||+|++..+|+.||+|++..... ........+...++.+++.++||||++++++|.+ ...
T Consensus 5 dy-~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~~~ 81 (364)
T d1omwa3 5 DF-SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDK 81 (364)
T ss_dssp TE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--SSE
T ss_pred HC-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE--CCE
T ss_conf 68-510188428890999999999997999999845875426679999999999999850899858899999998--998
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHHHHH
Q ss_conf 99998236899999999974888999999999999999877540999979404877633551999928974762156562
Q 004564 100 INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 100 iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~l~ 179 (745)
+|+||||+.+|+|..++.+...+++..++.|++||+.||.|||+++ |+||||||+|||++ ..|.+||+|||+|+...
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~-~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-SSSCEEECCCTTCEECS
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCEEEEC-CCCCEEEEEECEEEECC
T ss_conf 8999991489838999873255327899999999999999999779--62204442216785-88967982201023337
Q ss_pred CCCCCCCCCCCCCCCHHHHH-H-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 16777656888768802221-0-037533221236689998643789999999--7999999982999998666899799
Q 004564 180 KSHAAHCVGTPEFMAPEVYE-E-AYNELVDIYSFGMCILEMVTFEYPYSECTH--PAQIYKKVVSGKKPDSLYRVKDPEV 255 (745)
Q Consensus 180 ~~~~~~~vGTp~YmAPEil~-~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~--~~~i~~ki~~g~~p~~l~~~~s~el 255 (745)
.......+||+.|||||++. + .|+.++|||||||++|||+||+.||..... ...+.+.+. ..+..++...++++
T Consensus 159 ~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 159 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMAVELPDSFSPEL 236 (364)
T ss_dssp SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS--SCCCCCCSSSCHHH
T ss_pred CCCCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC--CCCCCCCCCCCHHH
T ss_conf 8864331134554216876038999844104677899999985999888899899999998604--68887887789999
Q ss_pred HHHHHHHHH-CCCCCCC-----HHHHHCCCCCCCCC
Q ss_conf 999999862-8069989-----99883498778632
Q 004564 256 RRFVEKCLA-TVSLRLS-----ARELLNDPFLQIDD 285 (745)
Q Consensus 256 ~~lI~kCL~-dPskRpS-----a~ELL~hPflq~~~ 285 (745)
++||.+||. +|.+||| |+++|+||||+..+
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred HHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCCC
T ss_conf 999999856698880887435799997491023789
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=400.14 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=223.1
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEE
Q ss_conf 52467677451386599999985799299999976055579977999999999999937999832476897855898599
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~iy 101 (745)
.| ++.+.||+|+||+||+|.++.+++.||+|+++.... ......+.+.+|+.+|+.++||||++++++|.+ ...+|
T Consensus 9 dy-~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ 84 (288)
T d1uu3a_ 9 DF-KFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLY 84 (288)
T ss_dssp GE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEEE
T ss_pred CC-EEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCEEE
T ss_conf 77-898898508790999999989997999999865775-577789999999999987688886179999998--99889
Q ss_pred EEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHHHHHCC
Q ss_conf 99823689999999997488899999999999999987754099997940487763355199992897476215656216
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 102 LVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~l~~~ 181 (745)
+||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|..+...
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECC--
T ss_pred EEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCC--EECCCCCCCCCCCC-CCCEEEECCCCCCEECCCC
T ss_conf 99970489877776531599999999999999999997621650--88476774123668-8853886032102422567
Q ss_pred ----CCCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHH
Q ss_conf ----777656888768802221-003753322123668999864378999999979999999829999986668997999
Q 004564 182 ----HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVR 256 (745)
Q Consensus 182 ----~~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p~~l~~~~s~el~ 256 (745)
.....+||+.|||||++. ..|+.++|||||||++|+|+||+.||.. .+..+++.++..+... ++...+++++
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~ 238 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEYD--FPEKFFPKAR 238 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCC--CCTTCCHHHH
T ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHHH
T ss_conf 764333555677552584400268989666230456999998038899899-5999999999718999--9854799999
Q ss_pred HHHHHHHH-CCCCCCCHHH------HHCCCCCCCCC
Q ss_conf 99999862-8069989998------83498778632
Q 004564 257 RFVEKCLA-TVSLRLSARE------LLNDPFLQIDD 285 (745)
Q Consensus 257 ~lI~kCL~-dPskRpSa~E------LL~hPflq~~~ 285 (745)
+||.+||+ +|.+|||++| +++||||+..+
T Consensus 239 ~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp HHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHHHHHCCCCHHHCCCHHHHCCCHHHHCCCCCCCCC
T ss_conf 999998557976891978973778987697647899
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=395.04 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=224.3
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 85246767745138659999998579929999997605557997799999999999993799983247689785589859
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 100 (745)
.+| ++.+.||+|+||+||+|.++.+|+.||+|+++.... ......+.+.+|+.+|+.++||||++++++|.+ ...+
T Consensus 41 d~y-~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~ 116 (350)
T d1rdqe_ 41 DQF-DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNL 116 (350)
T ss_dssp GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CCE-EEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC-CCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCC--CCCC
T ss_conf 370-898896117680899999989998999999826774-588999999999999997487727403444432--2222
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHHHHHC
Q ss_conf 99982368999999999748889999999999999998775409999794048776335519999289747621565621
Q 004564 101 NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 101 yLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~l~~ 180 (745)
++||||+.+|+|..++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|+.+..
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~-~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSS
T ss_pred CCCCCCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHCCCC-CCCCEEEEECEEEEECCC
T ss_conf 322223346622666751589899999999999999899998599--86176799993607-789788610103332256
Q ss_pred CCCCCCCCCCCCCCHHHHHH-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHH
Q ss_conf 67776568887688022210-03753322123668999864378999999979999999829999986668997999999
Q 004564 181 SHAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFV 259 (745)
Q Consensus 181 ~~~~~~vGTp~YmAPEil~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p~~l~~~~s~el~~lI 259 (745)
. ....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+...++..+..+..+ .+...++++.+||
T Consensus 194 ~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li 269 (350)
T d1rdqe_ 194 R-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKVR--FPSHFSSDLKDLL 269 (350)
T ss_dssp C-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTCCHHHHHHH
T ss_pred C-CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHHHHHH
T ss_conf 6-6433676356788997179988533114500789999758899899-5999999998617988--9766899999999
Q ss_pred HHHHH-CCCCCC-----CHHHHHCCCCCCCCCC
Q ss_conf 99862-806998-----9998834987786321
Q 004564 260 EKCLA-TVSLRL-----SARELLNDPFLQIDDC 286 (745)
Q Consensus 260 ~kCL~-dPskRp-----Sa~ELL~hPflq~~~~ 286 (745)
.+||. ||.+|+ +++++|+||||+..+.
T Consensus 270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HHHHHHCHHHCCCCCCCCHHHHHCCCCCCCCCH
T ss_conf 998340998606553454999971905158998
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=392.79 Aligned_cols=254 Identities=25% Similarity=0.418 Sum_probs=224.4
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEE
Q ss_conf 52467677451386599999985799299999976055579977999999999999937999832476897855898599
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~iy 101 (745)
.| ++.+.||+|+||+||+|.++.+|+.||+|+++.... ......+.+.+|+.+|+.++||||+++++++.+ ...+|
T Consensus 5 dy-~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ 80 (316)
T d1fota_ 5 DF-QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIF 80 (316)
T ss_dssp GE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEE
T ss_pred HE-EEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC-CCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEE--CCEEE
T ss_conf 70-888897207680899999989997999999845775-488999999999999986369675330356852--88005
Q ss_pred EEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHHHHHCC
Q ss_conf 99823689999999997488899999999999999987754099997940487763355199992897476215656216
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 181 (745)
Q Consensus 102 LVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~l~~~ 181 (745)
+||||+.||+|..++.....+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|......
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~-~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSSC
T ss_pred EEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCC--EECCCCCCHHEEEC-CCCCEEEECCCCCEEECCC
T ss_conf 67650378632234322221110079999999987655412476--77055681050386-8998898317521671245
Q ss_pred CCCCCCCCCCCCCHHHHHH-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 7776568887688022210-037533221236689998643789999999799999998299999866689979999999
Q 004564 182 HAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVE 260 (745)
Q Consensus 182 ~~~~~vGTp~YmAPEil~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p~~l~~~~s~el~~lI~ 260 (745)
....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++.++..+..+ ++...+++++++|.
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~ 233 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAELR--FPPFFNEDVKDLLS 233 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHH
T ss_pred -CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHHHHHHH
T ss_conf -6434576343599998389998043046533368999759899999-6999999999708988--99778999999999
Q ss_pred HHHH-CCCCCC-----CHHHHHCCCCCCCCCC
Q ss_conf 9862-806998-----9998834987786321
Q 004564 261 KCLA-TVSLRL-----SARELLNDPFLQIDDC 286 (745)
Q Consensus 261 kCL~-dPskRp-----Sa~ELL~hPflq~~~~ 286 (745)
+||. +|.+|+ +++++|+||||+..+.
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred HHHHHCHHHCCCCCHHHHHHHHCCCCCCCCCH
T ss_conf 99544997666431021999981935146798
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=388.61 Aligned_cols=254 Identities=22% Similarity=0.345 Sum_probs=221.6
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC
Q ss_conf 99852467677451386599999985799299999976055579977999999999999937999832476897855898
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 19 p~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 98 (745)
--+|| ++.+.||+|+||+||+|+++.+++.||+|+++.. ......+.+|+.+|+.++||||++++++|.+ ..
T Consensus 3 ~~~rY-~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~ 74 (321)
T d1tkia_ 3 LYEKY-MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFES--ME 74 (321)
T ss_dssp CTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TT
T ss_pred CCCCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC-----CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CC
T ss_conf 70105-8878983177839999999899969999997578-----6659999999999985799798909899988--99
Q ss_pred EEEEEEECCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCC-CCCEEECCCCHHH
Q ss_conf 5999982368999999999748-8899999999999999987754099997940487763355199-9928974762156
Q 004564 99 NINFVTEMFTSGTLRQYRLKHK-RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGN-QGEVKIGDLGLAA 176 (745)
Q Consensus 99 ~iyLVtEy~~gGSL~~~l~k~~-~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~-~g~VKL~DFGlA~ 176 (745)
.+|+||||+.||+|.+++...+ .+++..++.|++||+.||.|||+++ |+||||||+|||++.+ ...+||+|||++.
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEECCCCCEEEEECCCCHHH
T ss_conf 889999538998088998753899999999999999999999998769--975135544434437885189976441110
Q ss_pred HHHCCC-CCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC--CCCCCCCC
Q ss_conf 562167-77656888768802221-003753322123668999864378999999979999999829999--98666899
Q 004564 177 ILRKSH-AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP--DSLYRVKD 252 (745)
Q Consensus 177 ~l~~~~-~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p--~~l~~~~s 252 (745)
...... ....++|+.|+|||++. ..|+.++||||+||++|+|+||..||.. .+..+++..+..+... ...+...+
T Consensus 153 ~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 231 (321)
T d1tkia_ 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEIS 231 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred CCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCC-CCHHHHHHHHHHCCCCCCHHHCCCCC
T ss_conf 03467753212233222340210487778401130279999999828999999-89999999998389998802236789
Q ss_pred HHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCC
Q ss_conf 799999999862-8069989998834987786
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 253 ~el~~lI~kCL~-dPskRpSa~ELL~hPflq~ 283 (745)
+++++||.+||. ||.+|||+.|+|+||||+.
T Consensus 232 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 99999999986699668909999963996566
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=379.49 Aligned_cols=257 Identities=25% Similarity=0.399 Sum_probs=224.0
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCC-----HHHHHHHHHHHHHHHHCC-CCCCCEEEEEEE
Q ss_conf 98524676774513865999999857992999999760555799-----779999999999999379-998324768978
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS-----PEDLERLYCEIHLLKTLK-HKNIMKFYTSWV 93 (745)
Q Consensus 20 ~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s-----~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~fv 93 (745)
..+| .+.+.||+|+||+||+|++..+++.||+|++++...... ....+++.+|+.+|+.++ ||||++++++|.
T Consensus 2 ~~~y-~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 2 YENY-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CCCC-EECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECC
T ss_conf 6638-885288417684999999999998999999962446411478889999999999999998507997479976214
Q ss_pred ECCCCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCC
Q ss_conf 55898599998236899999999974888999999999999999877540999979404877633551999928974762
Q 004564 94 DTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 173 (745)
Q Consensus 94 d~~~~~iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFG 173 (745)
+ ++.+|+||||+++|+|.+++..++.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 81 ~--~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG 155 (277)
T d1phka_ 81 T--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFG 155 (277)
T ss_dssp C--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCT
T ss_pred C--CCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEEC-CCCCEEECCCH
T ss_conf 6--7605999976898668999986599999999999999999999998759--94323462548986-89983871240
Q ss_pred HHHHHHCC-CCCCCCCCCCCCCHHHHHH-------CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--
Q ss_conf 15656216-7776568887688022210-------0375332212366899986437899999997999999982999--
Q 004564 174 LAAILRKS-HAAHCVGTPEFMAPEVYEE-------AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKK-- 243 (745)
Q Consensus 174 lA~~l~~~-~~~~~vGTp~YmAPEil~~-------~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~-- 243 (745)
++...... .....+||+.|+|||++.+ .|+.++||||+||++|+|+||+.||.+ .+...+...+..+..
T Consensus 156 ~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~~ 234 (277)
T d1phka_ 156 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQF 234 (277)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCC
T ss_pred HEEECCCCCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCC-CCHHHHHHHHHHCCCCC
T ss_conf 31672688721345246788898886053445678899233185656023103228889889-99999999998189888
Q ss_pred CCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCC
Q ss_conf 998666899799999999862-8069989998834987786
Q 004564 244 PDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 244 p~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~hPflq~ 283 (745)
+.......++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHH
T ss_conf 98543468999999999976589668919999973978797
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=385.18 Aligned_cols=254 Identities=24% Similarity=0.424 Sum_probs=220.3
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHH-HCCCCCCCEEEEEEEECCCCEE
Q ss_conf 524676774513865999999857992999999760555799779999999999999-3799983247689785589859
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLK-TLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 22 RY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk-~L~HpNIVkl~~~fvd~~~~~i 100 (745)
.| .+.+.||+|+||+||+|.++.+++.||+|++++.... .....+.+..|..++. .++||||++++++|.+ +..+
T Consensus 3 dy-~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~-~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~ 78 (320)
T d1xjda_ 3 DF-ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENL 78 (320)
T ss_dssp TE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred CE-EEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-CHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCCE
T ss_conf 71-8865894087828999999999989999998055533-848999999999999984799968789889704--9831
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHHHHHC
Q ss_conf 99982368999999999748889999999999999998775409999794048776335519999289747621565621
Q 004564 101 NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 101 yLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~l~~ 180 (745)
|+||||+.+|+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.....
T Consensus 79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~-~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENML 155 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCC
T ss_pred EEEEEECCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCCEEEC-CCCCEECCCCCHHHHCCC
T ss_conf 677750379808998640478999999999999999999998689--34034765404444-899630155530232356
Q ss_pred --CCCCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHH
Q ss_conf --6777656888768802221-0037533221236689998643789999999799999998299999866689979999
Q 004564 181 --SHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257 (745)
Q Consensus 181 --~~~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p~~l~~~~s~el~~ 257 (745)
......+||+.|+|||++. +.|+.++|||||||++|+|+||+.||.+ .+..+++.++..+..+ +++..++++++
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~d 232 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPF--YPRWLEKEAKD 232 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHH
T ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHHHH
T ss_conf 65334545787776899998279988323201122789898738899999-8999999999718998--97567999999
Q ss_pred HHHHHHH-CCCCCCCHH-HHHCCCCCCCCC
Q ss_conf 9999862-806998999-883498778632
Q 004564 258 FVEKCLA-TVSLRLSAR-ELLNDPFLQIDD 285 (745)
Q Consensus 258 lI~kCL~-dPskRpSa~-ELL~hPflq~~~ 285 (745)
||.+||. +|.+||++. ++++||||+..+
T Consensus 233 li~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 233 LLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HHHHHCCCCCCCCCCHHHHHHHCCHHCCCC
T ss_conf 999965448987838899998090131589
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.19 Aligned_cols=252 Identities=21% Similarity=0.348 Sum_probs=214.7
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCC--HHHHHHHHHHHHHHHHCC--CCCCCEEEEEEEE
Q ss_conf 998524676774513865999999857992999999760555799--779999999999999379--9983247689785
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS--PEDLERLYCEIHLLKTLK--HKNIMKFYTSWVD 94 (745)
Q Consensus 19 p~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s--~~~~e~l~~Ei~iLk~L~--HpNIVkl~~~fvd 94 (745)
..+|| ++.++||+|+||+||+|.+..++..||+|+++....... .....++.+|+.+|+.++ ||||++++++|.+
T Consensus 2 l~~~Y-~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 2 LESQY-QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp CTTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CCCEE-EEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE
T ss_conf 78837-99679840878399999999999799999985688443345567999999999999743589881279999830
Q ss_pred CCCCEEEEEEECCCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCC
Q ss_conf 589859999823689-9999999974888999999999999999877540999979404877633551999928974762
Q 004564 95 TANRNINFVTEMFTS-GTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 173 (745)
Q Consensus 95 ~~~~~iyLVtEy~~g-GSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFG 173 (745)
...+|+||||+.+ +++..++.+...+++..++.|+.||+.||.|||+++ |+||||||+|||++.+.+.+||+|||
T Consensus 81 --~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 81 --PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp --SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred --CCEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEEECCCCEEEECCCC
T ss_conf --99689999833686228999861589999999999999999999998779--75566761114774478848977546
Q ss_pred HHHHHHCCCCCCCCCCCCCCCHHHHHH-C-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 156562167776568887688022210-0-37533221236689998643789999999799999998299999866689
Q 004564 174 LAAILRKSHAAHCVGTPEFMAPEVYEE-A-YNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK 251 (745)
Q Consensus 174 lA~~l~~~~~~~~vGTp~YmAPEil~~-~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p~~l~~~~ 251 (745)
+|...........+||+.|+|||++.+ . ++.++||||+||++|+|+||+.||.. .. .+..+.. .+....
T Consensus 157 ~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~----~i~~~~~--~~~~~~ 227 (273)
T d1xwsa_ 157 SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DE----EIIRGQV--FFRQRV 227 (273)
T ss_dssp TCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HH----HHHHCCC--CCSSCC
T ss_pred CCEECCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCC---CH----HHHHCCC--CCCCCC
T ss_conf 53532444556656587747999984899788653325540345367568899887---36----7761544--778779
Q ss_pred CHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf 9799999999862-80699899988349877863
Q 004564 252 DPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 252 s~el~~lI~kCL~-dPskRpSa~ELL~hPflq~~ 284 (745)
++++++||.+||. +|.+|||++|+|+||||+..
T Consensus 228 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 9999999999760897589399998539866788
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.75 Aligned_cols=251 Identities=23% Similarity=0.345 Sum_probs=208.4
Q ss_pred EEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCC-HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEEEEC
Q ss_conf 774513865999999857992999999760555799-7799999999999993799983247689785589859999823
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS-PEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEM 106 (745)
Q Consensus 28 e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s-~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~iyLVtEy 106 (745)
++||+|+||+||+|.+..+|+.||+|+++....... ....+++.+|+.+|+.++|||||+++++|.+ +..+|+||||
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~~ivmE~ 81 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISLVFDF 81 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEEEEEC
T ss_pred EEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCCEEEHHHH
T ss_conf 38512728299999999999699999984202124567999999999999986799998689854225--8740220455
Q ss_pred CCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHHHHHCC--CCC
Q ss_conf 689999999997488899999999999999987754099997940487763355199992897476215656216--777
Q 004564 107 FTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAA 184 (745)
Q Consensus 107 ~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~l~~~--~~~ 184 (745)
+.++++..+......+++..++.|++||+.||.|||+++ |+||||||+|||++ ..+.+||+|||+|...... ...
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCCCC
T ss_pred HCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EECCCCCCCEEEEC-CCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 345077655412667789999999999999998863163--55035776258853-778411465761000578755433
Q ss_pred CCCCCCCCCCHHHHH--HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC--CCCCC---------------
Q ss_conf 656888768802221--00375332212366899986437899999997999999982--99999---------------
Q 004564 185 HCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS--GKKPD--------------- 245 (745)
Q Consensus 185 ~~vGTp~YmAPEil~--~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~--g~~p~--------------- 245 (745)
..+||+.|+|||++. ..|+.++|||||||++|||+||.+||.+..... ...++.. +..+.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred CEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHH-HHHHHHHHCCCCCHHHCCCHHCCCHHHHH
T ss_conf 02047333639997267788805643630428999985969999999999-99999985189972545210002134430
Q ss_pred ---------CCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf ---------8666899799999999862-80699899988349877863
Q 004564 246 ---------SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 246 ---------~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~hPflq~~ 284 (745)
......++++.+||.+||+ ||.+||||.|+|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 3478988678565689999999999763894569089999679965789
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.32 Aligned_cols=254 Identities=20% Similarity=0.323 Sum_probs=208.4
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHH-HCCCCCCCEEEEEEEE--CC
Q ss_conf 98524676774513865999999857992999999760555799779999999999999-3799983247689785--58
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLK-TLKHKNIMKFYTSWVD--TA 96 (745)
Q Consensus 20 ~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk-~L~HpNIVkl~~~fvd--~~ 96 (745)
.+.|..+.++||+|+||+||+|.+..+++.||+|+++.. ..+.+|+.++. .++||||++++++|.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC---------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC
T ss_conf 148798107965454869999998899989999998974---------77999999999866999978298999503468
Q ss_pred CCEEEEEEECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECC--CCCCEEECCC
Q ss_conf 98599998236899999999974--8889999999999999998775409999794048776335519--9992897476
Q 004564 97 NRNINFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG--NQGEVKIGDL 172 (745)
Q Consensus 97 ~~~iyLVtEy~~gGSL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~--~~g~VKL~DF 172 (745)
...+|+||||++||+|.+++.+. ..+++..++.|++||+.||.|||+++ |+||||||+|||++. +.+.+||+||
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 978999997789984999998627877579999999999999999999769--864441002201135555663113545
Q ss_pred CHHHHHHCC-CCCCCCCCCCCCCHHHHHH-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHCCC--CCC
Q ss_conf 215656216-7776568887688022210-03753322123668999864378999999979---9999998299--999
Q 004564 173 GLAAILRKS-HAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPA---QIYKKVVSGK--KPD 245 (745)
Q Consensus 173 GlA~~l~~~-~~~~~vGTp~YmAPEil~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~---~i~~ki~~g~--~p~ 245 (745)
|+|...... .....+||+.|||||++.+ .|+.++|||||||++|+|+||++||.+..... .+...+..+. .|.
T Consensus 159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~ 238 (335)
T d2ozaa1 159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238 (335)
T ss_dssp TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred CEEEECCCCCCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCCCCC
T ss_conf 51233368886432267756379277748988888888764516778865889988988778899999998538888898
Q ss_pred CCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf 8666899799999999862-80699899988349877863
Q 004564 246 SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 246 ~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~hPflq~~ 284 (745)
......++++++||.+||+ +|++|||+.|+|+||||+..
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHCC
T ss_conf 5434699999999999756996579099999709876178
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.97 Aligned_cols=248 Identities=24% Similarity=0.338 Sum_probs=210.1
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCC-----EEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEE
Q ss_conf 852467677451386599999985799-----299999976055579977999999999999937-99983247689785
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEG-----IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVD 94 (745)
Q Consensus 21 GRY~rl~e~LG~Gafg~Vy~A~d~~tg-----~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~fvd 94 (745)
.+| ++.++||+|+||+||+|.+...+ ..||+|.+.... .......+.+|+.+|+.+ +|||||+++++|.+
T Consensus 37 ~~~-~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 37 ENL-EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHE-EEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC---CHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 993-9701983078819999998578855420499999966335---878999999999999971589968687788862
Q ss_pred CCCCEEEEEEECCCCCCHHHHHHHCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCEEEE
Q ss_conf 58985999982368999999999748-----------------------8899999999999999987754099997940
Q 004564 95 TANRNINFVTEMFTSGTLRQYRLKHK-----------------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHR 151 (745)
Q Consensus 95 ~~~~~iyLVtEy~~gGSL~~~l~k~~-----------------------~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHR 151 (745)
...+|+||||+++|+|.+++.... .+++..++.|+.||+.||.|||+++ |+||
T Consensus 113 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHR 188 (325)
T d1rjba_ 113 --SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHR 188 (325)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred --CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEC
T ss_conf --995899997279995999998625777510221000012220012577899999999999999999997399--0505
Q ss_pred CCCCCCEEECCCCCCEEECCCCHHHHHHCCCC----CCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHH-CCCCC
Q ss_conf 48776335519999289747621565621677----7656888768802221-003753322123668999864-37899
Q 004564 152 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPY 225 (745)
Q Consensus 152 DLKp~NILId~~~g~VKL~DFGlA~~l~~~~~----~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf 225 (745)
||||+|||++ .++.+||+|||+|+....... ....||+.|||||++. +.|+.++|||||||++|||+| |..||
T Consensus 189 DlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 189 DLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCHHCCCCC-CCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCC
T ss_conf 2703214434-598289851422220457786156234357876578388727999963303000399999983899999
Q ss_pred CCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 999997999999982999998666899799999999862-80699899988349
Q 004564 226 SECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 226 ~~~~~~~~i~~ki~~g~~p~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~h 278 (745)
.+......+.+.+..+..+ ..+...++++++||.+||+ +|.+|||++||++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9989899999998569989-9887678999999999758896689399999999
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=373.24 Aligned_cols=257 Identities=21% Similarity=0.322 Sum_probs=217.5
Q ss_pred CCCCCCCE--EECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 98987752--7599985246767745138659999998579929999997605557997799999999999993799983
Q 004564 8 EPDCSEFV--EVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNI 85 (745)
Q Consensus 8 ep~~~~~~--e~dp~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNI 85 (745)
+|..+.|- |+++ .+| ++.+.||+|+||+||+|.+..++..||+|+++.. ....+++.+|+.+|+.++||||
T Consensus 3 ~p~~p~~~~wei~~-~~~-~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-----~~~~~~~~~E~~il~~l~HpnI 75 (287)
T d1opja_ 3 DPSSPNYDKWEMER-TDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNL 75 (287)
T ss_dssp CTTSTTCCTTBCCG-GGE-EEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-----CSCHHHHHHHHHHHHHCCCTTB
T ss_pred CCCCCCCCCCEECH-HHE-EEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC-----CCHHHHHHHHHHHHHHCCCCCE
T ss_conf 97989976517457-993-9865982088808999999999969999997776-----1039999999999986799988
Q ss_pred CEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCC
Q ss_conf 2476897855898599998236899999999974--88899999999999999987754099997940487763355199
Q 004564 86 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGN 163 (745)
Q Consensus 86 Vkl~~~fvd~~~~~iyLVtEy~~gGSL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~ 163 (745)
++++++|.+ ...+|+||||+.+|+|..++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++ .
T Consensus 76 v~~~~~~~~--~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~-~ 150 (287)
T d1opja_ 76 VQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-E 150 (287)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-G
T ss_pred ECCCCCEEE--CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEEC-C
T ss_conf 267752745--785478763146760677753035541579999999999999788898789--30576045768998-9
Q ss_pred CCCEEECCCCHHHHHHCCCCC---CCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 992897476215656216777---656888768802221-0037533221236689998643789999999799999998
Q 004564 164 QGEVKIGDLGLAAILRKSHAA---HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVV 239 (745)
Q Consensus 164 ~g~VKL~DFGlA~~l~~~~~~---~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~ 239 (745)
++.+||+|||+|+........ ...|++.|+|||++. +.|+.++|||||||++|||+||..||....+..++++.+.
T Consensus 151 ~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~ 230 (287)
T d1opja_ 151 NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 230 (287)
T ss_dssp GGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred CCCEEECCCCCEEECCCCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 99289832445465378872210355665466692787279998104302178999999867998877425999999985
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 2999998666899799999999862-8069989998834
Q 004564 240 SGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 240 ~g~~p~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~ 277 (745)
.+..+. .+...++.+++||.+||+ +|.+|||+.++++
T Consensus 231 ~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 231 KDYRME-RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp TTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCC-CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 588888-87433099999999975779768939999999
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.41 Aligned_cols=254 Identities=29% Similarity=0.436 Sum_probs=208.6
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEE
Q ss_conf 52467677451386599999985799299999976055579977999999999999937999832476897855898599
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~iy 101 (745)
+| ++.+.||+|+||+||+|.+..+++.||+|+++... ......+++.+|+.+|++++||||++++++|.+ ...+|
T Consensus 3 ~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~ 77 (298)
T d1gz8a_ 3 NF-QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLY 77 (298)
T ss_dssp TE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEE
T ss_pred CC-EECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCC--CCCEE
T ss_conf 97-76517723768099999999999799999980222--575899999999999986799838874453322--43203
Q ss_pred EEEECCCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHHHHH
Q ss_conf 99823689999999997--4888999999999999999877540999979404877633551999928974762156562
Q 004564 102 FVTEMFTSGTLRQYRLK--HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 102 LVtEy~~gGSL~~~l~k--~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~l~ 179 (745)
+||||+.++ +..++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|....
T Consensus 78 iv~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~-~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 78 LVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFG 153 (298)
T ss_dssp EEEECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTHHHHHC
T ss_pred EEEEECCCC-HHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EECCCCCCHHEEEC-CCCCCEECCCCCCEECC
T ss_conf 788623774-455544202568888999999999999999865288--99213571140113-46762103578613436
Q ss_pred CC--CCCCCCCCCCCCCHHHHHH--CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCCCCC--------
Q ss_conf 16--7776568887688022210--0375332212366899986437899999997999999982-999998--------
Q 004564 180 KS--HAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-GKKPDS-------- 246 (745)
Q Consensus 180 ~~--~~~~~vGTp~YmAPEil~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~-g~~p~~-------- 246 (745)
.. .....+||+.|+|||++.. .++.++||||+||++|+|++|+.||.+......++..... +.....
T Consensus 154 ~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp CCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CCCCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCC
T ss_conf 88641001036521541122136657774221033331342796687998988999999999983289833314442224
Q ss_pred -----------------CCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf -----------------666899799999999862-80699899988349877863
Q 004564 247 -----------------LYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 247 -----------------l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~hPflq~~ 284 (745)
.....++++++||.+||. +|.+|||++|+|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 21243454322220444166789999999999763995579189999678701469
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=368.36 Aligned_cols=249 Identities=18% Similarity=0.301 Sum_probs=211.9
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEECCCCE---EEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC
Q ss_conf 998524676774513865999999857992---99999976055579977999999999999937999832476897855
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGI---EVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT 95 (745)
Q Consensus 19 p~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~---~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~ 95 (745)
...+| ++.++||+|+||+||+|.+..++. .||+|.+.. .......+.+.+|+.+|++++|||||++++++.+
T Consensus 24 ~~~~~-~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~- 98 (299)
T d1jpaa_ 24 DISCV-KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS---GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK- 98 (299)
T ss_dssp CGGGE-EEEEEEEECSSSEEEEEEECC---CCEEEEEEECCS---SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred CHHHC-EEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECC---CCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE-
T ss_conf 80042-785698027882999999957997889999999784---4598999999999999985799888618999962-
Q ss_pred CCCEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCH
Q ss_conf 898599998236899999999974-8889999999999999998775409999794048776335519999289747621
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 174 (745)
Q Consensus 96 ~~~~iyLVtEy~~gGSL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGl 174 (745)
...+|+||||+.+|+|.+++... +.+++..+..|+.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+
T Consensus 99 -~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 99 -STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKVSDFGL 174 (299)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC--
T ss_pred -CCEEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEEC-CCCCEEECCCCC
T ss_conf -88779999722798530021045679999999999999999889885279--83576150448988-999199888443
Q ss_pred HHHHHCCCC-------CCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 565621677-------7656888768802221-003753322123668999864-3789999999799999998299999
Q 004564 175 AAILRKSHA-------AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPD 245 (745)
Q Consensus 175 A~~l~~~~~-------~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~~i~~ki~~g~~p~ 245 (745)
|+.+..... ....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ ....++...+..+..++
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~~ 253 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVINAIEQDYRLP 253 (299)
T ss_dssp ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC
T ss_pred CEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCCC
T ss_conf 15756777765365025666883003878883699786121445357899998679999999-99999999997378899
Q ss_pred CCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 8666899799999999862-80699899988349
Q 004564 246 SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 246 ~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~h 278 (745)
.+...++.+.++|.+||+ +|.+|||+.|+++.
T Consensus 254 -~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 254 -PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf -974226999999999758797689299999999
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.57 Aligned_cols=254 Identities=21% Similarity=0.315 Sum_probs=214.8
Q ss_pred CCEEEEE-EEECCCCCEEEEEEEEC--CCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
Q ss_conf 8524676-77451386599999985--79929999997605557997799999999999993799983247689785589
Q 004564 21 GRYGRYN-EILGKGASKTVYRAFDE--YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 21 GRY~rl~-e~LG~Gafg~Vy~A~d~--~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 97 (745)
.++..+. +.||+|+||+||+|... .+++.||+|+++... .+....+++.+|+.+|++++||||+++++++..
T Consensus 5 ~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~--- 79 (277)
T d1xbba_ 5 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEA--- 79 (277)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---
T ss_pred HHHCEECCCCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHH--CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC---
T ss_conf 253700187834587829999998169738599999988010--898999999999999986799898527777505---
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHHH
Q ss_conf 85999982368999999999748889999999999999998775409999794048776335519999289747621565
Q 004564 98 RNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 98 ~~iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~ 177 (745)
+..++||||+++|+|.+++.+...+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|..
T Consensus 80 ~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~-~~~~~kl~DFGla~~ 156 (277)
T d1xbba_ 80 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKA 156 (277)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEE
T ss_pred CCEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCHHHCCC-CCCCCCCCCHHHHHH
T ss_conf 977999974788968999752257899999999999999976687479--55677761131023-567512341345331
Q ss_pred HHCCC-----CCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 62167-----77656888768802221-003753322123668999864-378999999979999999829999986668
Q 004564 178 LRKSH-----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRV 250 (745)
Q Consensus 178 l~~~~-----~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~~i~~ki~~g~~p~~l~~~ 250 (745)
+.... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+..++...+..+..+. .+..
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~~-~p~~ 234 (277)
T d1xbba_ 157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERMG-CPAG 234 (277)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTT
T ss_pred CCCCCCCCCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCC
T ss_conf 343234432244567784203916653799984344303403132896589999999-89999999998289999-9865
Q ss_pred CCHHHHHHHHHHHH-CCCCCCCHHHH---HCCCCCCCC
Q ss_conf 99799999999862-80699899988---349877863
Q 004564 251 KDPEVRRFVEKCLA-TVSLRLSAREL---LNDPFLQID 284 (745)
Q Consensus 251 ~s~el~~lI~kCL~-dPskRpSa~EL---L~hPflq~~ 284 (745)
++++++++|.+||+ +|.+|||+.++ |+|+|++..
T Consensus 235 ~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHHCC
T ss_conf 67999999999758897689098999998528875047
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.19 Aligned_cols=261 Identities=22% Similarity=0.342 Sum_probs=213.0
Q ss_pred ECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 59998524676774513865999999857992999999760555799779999999999999379998324768978558
Q 004564 17 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA 96 (745)
Q Consensus 17 ~dp~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 96 (745)
+++-+|| ++.+.||+|+||+||+|++..+|+.||+|++..... ......++.+|+.+|+.++||||+++++++....
T Consensus 6 ~~~~~rY-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 6 CDEVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp SCBGGGE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CCCCCCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC--CHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC
T ss_conf 9762798-899997227482999999989997999999842224--6378999999999999835999660676540246
Q ss_pred ------CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEEC
Q ss_conf ------98599998236899999999974888999999999999999877540999979404877633551999928974
Q 004564 97 ------NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 170 (745)
Q Consensus 97 ------~~~iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~ 170 (745)
+..+|++|||+.++.+..+......+++..++.+++||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~-~~~~~kl~ 159 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLA 159 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEEC
T ss_pred CCCCCCCCEEEEEEECCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCC--EEECCCCCHHEEEC-CCCCEEEE
T ss_conf 5444457638999853578741012220344330899999999999998852299--88567672220366-89968763
Q ss_pred CCCHHHHHHC------CCCCCCCCCCCCCCHHHHH--HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC--
Q ss_conf 7621565621------6777656888768802221--00375332212366899986437899999997999999982--
Q 004564 171 DLGLAAILRK------SHAAHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-- 240 (745)
Q Consensus 171 DFGlA~~l~~------~~~~~~vGTp~YmAPEil~--~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~-- 240 (745)
|||++..... ......+||+.|+|||++. ..|+.++||||+||++|||+||+.||.+. +.......+..
T Consensus 160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~-~~~~~~~~i~~~~ 238 (318)
T d3blha1 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-TEQHQLALISQLC 238 (318)
T ss_dssp CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHH
T ss_pred ECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCC-CHHHHHHHHHHHC
T ss_conf 135002235544432113566024978742899707999891787006786466174487998998-9999999999841
Q ss_pred CCCCCCCC----------------------------CCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf 99999866----------------------------6899799999999862-80699899988349877863
Q 004564 241 GKKPDSLY----------------------------RVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 241 g~~p~~l~----------------------------~~~s~el~~lI~kCL~-dPskRpSa~ELL~hPflq~~ 284 (745)
+..+.... ...++.+.+||.+||. ||.+|+||+|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred CCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 8998255344320344433201334455503340444599899999999873896589099999749501569
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.49 Aligned_cols=251 Identities=22% Similarity=0.335 Sum_probs=202.9
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC----CC
Q ss_conf 52467677451386599999985799299999976055579977999999999999937999832476897855----89
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT----AN 97 (745)
Q Consensus 22 RY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~----~~ 97 (745)
+| +..++||+|+||+||+|.+..+++.||+|+++..... +.+|+.+|+.++||||++++++|... ..
T Consensus 21 ~Y-~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SY-TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred CC-EEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH--------HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
T ss_conf 76-7516982176839999999999979999998816068--------99999999866898987387899744765773
Q ss_pred CEEEEEEECCCCCCHHHH---HHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCH
Q ss_conf 859999823689999999---99748889999999999999998775409999794048776335519999289747621
Q 004564 98 RNINFVTEMFTSGTLRQY---RLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 174 (745)
Q Consensus 98 ~~iyLVtEy~~gGSL~~~---l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGl 174 (745)
..+|+||||+.++.+..+ ......+++..++.|++||+.||.|||++| |+||||||+|||++.+...+||+|||+
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEEECCCCCEEEECCCC
T ss_conf 189999841688607888863103689999999999999999999998668--764578860378735897116733660
Q ss_pred HHHHHCC-CCCCCCCCCCCCCHHHHH--HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CC--------
Q ss_conf 5656216-777656888768802221--00375332212366899986437899999997999999982-99--------
Q 004564 175 AAILRKS-HAAHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-GK-------- 242 (745)
Q Consensus 175 A~~l~~~-~~~~~vGTp~YmAPEil~--~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~-g~-------- 242 (745)
+...... .....+|++.|+|||++. ..|+.++||||+||++|||+||+.||........+...+.. |.
T Consensus 170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred HHHCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHH
T ss_conf 54404776532002555556827764046888210002465277855028799898799999999999748981776543
Q ss_pred ---------CC--------CCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCC
Q ss_conf ---------99--------98666899799999999862-8069989998834987786
Q 004564 243 ---------KP--------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 243 ---------~p--------~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~hPflq~ 283 (745)
.+ .......++++.+||.+||. ||.+||||.|+|+||||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 06210110355445674444315689999999999976589557929999966984524
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=365.49 Aligned_cols=257 Identities=24% Similarity=0.312 Sum_probs=216.2
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC--
Q ss_conf 985246767745138659999998579929999997605557997799999999999993799983247689785589--
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN-- 97 (745)
Q Consensus 20 ~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~-- 97 (745)
..|| ++.+.||+|+||+||+|.+..+++.||+|+++... .......+++.+|+.+|+.++||||+++++++.....
T Consensus 6 ~drY-~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 6 SDRY-ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-TTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CCEE-EEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHH-CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCC
T ss_conf 6206-98689960899299999999999899999985566-469899999999999998569998873114354326887
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHHH
Q ss_conf 85999982368999999999748889999999999999998775409999794048776335519999289747621565
Q 004564 98 RNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 98 ~~iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~ 177 (745)
..+|+||||+.|++|..++...+.+++..++.|++||+.||.|||+++ |+||||||+|||++ ..+.++|+|||.+..
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~-~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-TTSCEEECCCTTCEE
T ss_pred CEEEEEEECCCCCEEHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCC-CCCCCEEEHHHHHHH
T ss_conf 669999977889871011203589999999999999999999998579--52763467556657-543201003444322
Q ss_pred HHCC-----CCCCCCCCCCCCCHHHHHH-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCCC-CCCCC
Q ss_conf 6216-----7776568887688022210-0375332212366899986437899999997999999982-9999-98666
Q 004564 178 LRKS-----HAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-GKKP-DSLYR 249 (745)
Q Consensus 178 l~~~-----~~~~~vGTp~YmAPEil~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~-g~~p-~~l~~ 249 (745)
.... .....+||+.|||||++.+ .|+.++|||||||++|+|+||++||.+. +..++..++.. +..+ .....
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-SPVSVAYQHVREDPIPPSARHE 239 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHCCCCCGGGTSS
T ss_pred HCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCC-CHHHHHHHHHHCCCCCCCHHCC
T ss_conf 123544333346425762436999983999996632026528999997697998996-9999999998469999710034
Q ss_pred CCCHHHHHHHHHHHH-CCCCCC-CHHHHHCCCCCCC
Q ss_conf 899799999999862-806998-9998834987786
Q 004564 250 VKDPEVRRFVEKCLA-TVSLRL-SARELLNDPFLQI 283 (745)
Q Consensus 250 ~~s~el~~lI~kCL~-dPskRp-Sa~ELL~hPflq~ 283 (745)
..++.+++||.+||+ +|.+|| +++++ .|+|++.
T Consensus 240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r~ 274 (277)
T d1o6ya_ 240 GLSADLDAVVLKALAKNPENRYQTAAEM-RADLVRV 274 (277)
T ss_dssp SCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCHHHHHHH-HHHHHHH
T ss_conf 7899999999998667976777399999-9999997
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.31 Aligned_cols=259 Identities=29% Similarity=0.405 Sum_probs=213.3
Q ss_pred ECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 59998524676774513865999999857992999999760555799779999999999999379998324768978558
Q 004564 17 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA 96 (745)
Q Consensus 17 ~dp~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 96 (745)
.+...|| ++.+.||+|+||+||+|.+..+|+.||+|+++.. ..+....+++.+|+.+|+.++|||||+++++|....
T Consensus 14 ~~~~~~Y-~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~--~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 14 WEVRAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp ECCBSSE-EEEEEC------CEEEEEETTTCCEEEEEECSST--TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred EECCCCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH--HCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCC
T ss_conf 3447718-9988980177819999999999989999998522--259699999999999998668987547999863576
Q ss_pred ----CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCC
Q ss_conf ----9859999823689999999997488899999999999999987754099997940487763355199992897476
Q 004564 97 ----NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 172 (745)
Q Consensus 97 ----~~~iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DF 172 (745)
...+|+||||+ +.+|..+. ++..+++..++.+++||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~-~~~~~kl~Df 165 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDF 165 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCC
T ss_pred CCCCCCEEEEEEECC-CCCHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCHHHCC-CCCCCCCCCC
T ss_conf 555541599998405-52189998-7402269999999999999999987378--76456685111121-0012211343
Q ss_pred CHHHHHHCCCCCCCCCCCCCCCHHHHHH--CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCC------
Q ss_conf 2156562167776568887688022210--0375332212366899986437899999997999999982-999------
Q 004564 173 GLAAILRKSHAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-GKK------ 243 (745)
Q Consensus 173 GlA~~l~~~~~~~~vGTp~YmAPEil~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~-g~~------ 243 (745)
|+|...... ....+||+.|+|||++.+ .++.++||||+||++|+|++|++||.+......+...... +..
T Consensus 166 g~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 166 GLARQADSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp TTCEECCSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred CCEECCCCC-CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHH
T ss_conf 102206876-3102455333588998178789965010300389999997869988897689999998503788488886
Q ss_pred ---------------------CCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf ---------------------998666899799999999862-80699899988349877863
Q 004564 244 ---------------------PDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 244 ---------------------p~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~hPflq~~ 284 (745)
........++.+.+||.+||. +|.+||||.|+|+||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 530003443311578666556677556899999999999772995579299999639623758
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.76 Aligned_cols=248 Identities=27% Similarity=0.426 Sum_probs=211.7
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC
Q ss_conf 99852467677451386599999985799299999976055579977999999999999937999832476897855898
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 19 p~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 98 (745)
+.++| ++.+.||+|+||+||+|.. +..||+|+++... .+....+.+.+|+.+|+.++||||+++++++. ..
T Consensus 6 ~~~~~-~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~---~~ 76 (276)
T d1uwha_ 6 PDGQI-TVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---AP 76 (276)
T ss_dssp CTTCC-CCCSEEEECSSCEEEEEES---SSEEEEEECCCSS--CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SS
T ss_pred CCCCE-EEEEEEEECCCCEEEEEEE---CCEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE---CC
T ss_conf 54518-9988983078858999999---9989999997346--99899999999999998479987864567971---55
Q ss_pred EEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHHH
Q ss_conf 599998236899999999974-8889999999999999998775409999794048776335519999289747621565
Q 004564 99 NINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 99 ~iyLVtEy~~gGSL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~ 177 (745)
.+++||||+.+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|..
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~-~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATV 153 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTSSEEECCCCCSCC
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EECCCCCHHHEEEC-CCCCEEECCCCCEEE
T ss_conf 899999658998889998523578999999999999999988875099--95161478997981-899788750022133
Q ss_pred HHCC----CCCCCCCCCCCCCHHHHH----HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCC---
Q ss_conf 6216----777656888768802221----00375332212366899986437899999997999999982999998---
Q 004564 178 LRKS----HAAHCVGTPEFMAPEVYE----EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDS--- 246 (745)
Q Consensus 178 l~~~----~~~~~vGTp~YmAPEil~----~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p~~--- 246 (745)
.... ......||+.|||||++. +.|+.++|||||||++|||+||+.||.+......+...+..+..++.
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~ 233 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCHH
T ss_conf 35567763125665574317999995056899995315163599999999788998998969999999965888986000
Q ss_pred CCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 666899799999999862-80699899988349
Q 004564 247 LYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 247 l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~h 278 (745)
....+++.++++|.+||. +|.+|||+.+++++
T Consensus 234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 365554999999999758897689299999999
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.44 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=208.3
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC--
Q ss_conf 998524676774513865999999857992999999760555799779999999999999379998324768978558--
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA-- 96 (745)
Q Consensus 19 p~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~-- 96 (745)
-+.|| ++.+.||+|+||+||+|.+..+|+.||+|+++... .....+++.+|+.+|+.++||||+++++++....
T Consensus 6 i~~rY-~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 6 VGPRY-TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp CCTTE-EEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred CCCCE-EEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC---CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCC
T ss_conf 38985-99789940648099999999999499999980310---958999999999999976898988588899505645
Q ss_pred -CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHH
Q ss_conf -9859999823689999999997488899999999999999987754099997940487763355199992897476215
Q 004564 97 -NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 97 -~~~iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA 175 (745)
...+|++ +++.+|+|.+++.. ..+++..++.+++||+.||.|||+++ |+||||||+|||++ +.+.+||+|||+|
T Consensus 82 ~~~~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~-~~~~~kl~DfG~a 156 (345)
T d1pmea_ 82 QMKDVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLA 156 (345)
T ss_dssp TCCCEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTC
T ss_pred CCCEEEEE-EEECCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEEC-CCCCEEECCCCCE
T ss_conf 54149999-96259865664405-89999999999999999999999789--86777876437887-9997787545705
Q ss_pred HHHHCC-----CCCCCCCCCCCCCHHHHH--HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC----
Q ss_conf 656216-----777656888768802221--003753322123668999864378999999979999999829999----
Q 004564 176 AILRKS-----HAAHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP---- 244 (745)
Q Consensus 176 ~~l~~~-----~~~~~vGTp~YmAPEil~--~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p---- 244 (745)
...... .....+||+.|+|||++. ..|+.++||||+||++|+|+||..||............+.....+
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred EECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf 65047776410101102652000387860478887410100467013377669799788888999998765206997566
Q ss_pred ------------------------CCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf ------------------------98666899799999999862-80699899988349877863
Q 004564 245 ------------------------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 245 ------------------------~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~hPflq~~ 284 (745)
.......++++++||.+||. ||.+||||.|+|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 42343322220244677557787778378999999999999764895679089998619865558
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.08 Aligned_cols=261 Identities=27% Similarity=0.361 Sum_probs=206.2
Q ss_pred CCCCCEEEEEEEECCCCCEEEEEEEECCC-CEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC---CCCCCCEEEEEEE
Q ss_conf 99985246767745138659999998579-9299999976055579977999999999999937---9998324768978
Q 004564 18 DPTGRYGRYNEILGKGASKTVYRAFDEYE-GIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL---KHKNIMKFYTSWV 93 (745)
Q Consensus 18 dp~GRY~rl~e~LG~Gafg~Vy~A~d~~t-g~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L---~HpNIVkl~~~fv 93 (745)
..+.|| ++.+.||+|+||+||+|.+..+ ++.||+|+++..... ......+.+|+.+|+.| +||||++++++|.
T Consensus 4 ~~~~~Y-~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~ 80 (305)
T d1blxa_ 4 RADQQY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 80 (305)
T ss_dssp CGGGTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT--TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred CCCCCE-EEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCC--CHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEC
T ss_conf 875897-98889921558699999998889989999998023245--167999999999999874258988023663221
Q ss_pred EC---CCCEEEEEEECCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEE
Q ss_conf 55---89859999823689999999997-488899999999999999987754099997940487763355199992897
Q 004564 94 DT---ANRNINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI 169 (745)
Q Consensus 94 d~---~~~~iyLVtEy~~gGSL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL 169 (745)
.. ....+++++|++.++.+...... ...+++..++.+++||+.||.|||+++ |+||||||+|||++ ..+.+||
T Consensus 81 ~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~-~~~~~kl 157 (305)
T d1blxa_ 81 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKL 157 (305)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEE
T ss_pred CCCCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCEEEEC-CCCCEEE
T ss_conf 46666674699999740587144444303789998999999999999999997588--98357986278985-8997542
Q ss_pred CCCCHHHHHHCC-CCCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC--CCC--
Q ss_conf 476215656216-777656888768802221-00375332212366899986437899999997999999982--999--
Q 004564 170 GDLGLAAILRKS-HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS--GKK-- 243 (745)
Q Consensus 170 ~DFGlA~~l~~~-~~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~--g~~-- 243 (745)
+|||++...... .....+||+.|+|||++. ..|+.++||||+||++|||+||.+||.+. +..+...++.. +..
T Consensus 158 ~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 158 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS-SDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCG
T ss_pred CCHHHHHHHCCCCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCC-CHHHHHHHHHHHHCCCCH
T ss_conf 1000101100234577765485114831001798881110003289999998787998998-989999999984079961
Q ss_pred ---------------------CCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf ---------------------998666899799999999862-806998999883498778632
Q 004564 244 ---------------------PDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQIDD 285 (745)
Q Consensus 244 ---------------------p~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~hPflq~~~ 285 (745)
...+....++.+++||.+||+ ||.+||||.|+|+||||+..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCH
T ss_conf 1053211110333022345645440445899999999998748966791899996696340752
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=362.36 Aligned_cols=255 Identities=22% Similarity=0.364 Sum_probs=211.0
Q ss_pred ECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEEC
Q ss_conf 59998524676774513865999999857992999999760555799779999999999999379-99832476897855
Q 004564 17 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTSWVDT 95 (745)
Q Consensus 17 ~dp~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~fvd~ 95 (745)
..-..+| ++.++||+|+||+||+|.+..+++.||+|+++.. ..+++.+|+.+|+.+. ||||++++++|...
T Consensus 31 ~~~~d~y-~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 31 WGNQDDY-QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp CCCGGGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CCCCCCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH-------HHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
T ss_conf 8998671-8978983174819999998899979999998889-------9999999999998515799876799999816
Q ss_pred CCCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHH
Q ss_conf 89859999823689999999997488899999999999999987754099997940487763355199992897476215
Q 004564 96 ANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 96 ~~~~iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA 175 (745)
....+++||||+.+++|..+ .+.+++..++.+++||+.||.|||+++ |+||||||+|||++.+++.+||+|||+|
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a 177 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLA 177 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred CCCCEEEEEEECCCCCHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEECCCCCEEEECCCCCC
T ss_conf 87712688863179858997---468999999999999999998876433--4434564412377489983664156542
Q ss_pred HHHHCC-CCCCCCCCCCCCCHHHHHH--CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC--C---------
Q ss_conf 656216-7776568887688022210--0375332212366899986437899999997999999982--9---------
Q 004564 176 AILRKS-HAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS--G--------- 241 (745)
Q Consensus 176 ~~l~~~-~~~~~vGTp~YmAPEil~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~--g--------- 241 (745)
...... .....++|+.|+|||++.+ .|+.++||||+||++|+|++|..||............+.. +
T Consensus 178 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 178 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHH
T ss_conf 66468874443224864247610268888884523233545558760488999887601899999999878841555554
Q ss_pred --C----------------------CCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf --9----------------------9998666899799999999862-80699899988349877863
Q 004564 242 --K----------------------KPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 242 --~----------------------~p~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~hPflq~~ 284 (745)
. .+.......++++++||.+||. +|.+||||+|+|+||||+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred HCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 22544474300000333433112115521124489999999999866995689089999649355887
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=364.64 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=210.8
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 85246767745138659999998579929999997605557997799999999999993799983247689785589859
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 100 (745)
.|| ++.+.||+|+||+||+|.+. +++.||+|+++.... .....+++.+|+.+|+.++||||+++++.|.+ ....
T Consensus 2 ~~Y-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~ 75 (286)
T d1ob3a_ 2 EKY-HGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRL 75 (286)
T ss_dssp CSE-EEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCE
T ss_pred CCC-EECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC--CCCE
T ss_conf 996-34318722778189999968-999999999812326--85899999999999986799868766012046--7731
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHHHHHC
Q ss_conf 99982368999999999748889999999999999998775409999794048776335519999289747621565621
Q 004564 101 NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 101 yLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~l~~ 180 (745)
++++|++.++.+..+....+.+++..++.+++||+.||.|||+++ |+||||||+|||++ .++.+||+|||.|.....
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~-~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGI 152 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC
T ss_pred EEEEEEEHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHCCCC--EEECCCCCCEEEEC-CCCCEEECCCCCCEECCC
T ss_conf 589974004567899860477514456899999999999860574--88267877505686-899787323664301146
Q ss_pred CC--CCCCCCCCCCCCHHHHH--HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC--CCCC----------
Q ss_conf 67--77656888768802221--00375332212366899986437899999997999999982--9999----------
Q 004564 181 SH--AAHCVGTPEFMAPEVYE--EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS--GKKP---------- 244 (745)
Q Consensus 181 ~~--~~~~vGTp~YmAPEil~--~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~--g~~p---------- 244 (745)
.. ....++++.|+|||++. ..++.++||||+||++|||++|++||.+... .+...++.. +..+
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CCCCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCH-HHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 765410102431101378871788888410021117589999779799898898-9999999986389971104212333
Q ss_pred ---------------CCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCC
Q ss_conf ---------------98666899799999999862-8069989998834987786
Q 004564 245 ---------------DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 245 ---------------~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~hPflq~ 283 (745)
.......++.+++||.+||+ ||++|||+.|+|+||||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 2214333335676466651258999999999986689668909999856922074
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.90 Aligned_cols=247 Identities=21% Similarity=0.342 Sum_probs=210.6
Q ss_pred EEEEE-ECCCCCEEEEEEEECC--CCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEE
Q ss_conf 67677-4513865999999857--99299999976055579977999999999999937999832476897855898599
Q 004564 25 RYNEI-LGKGASKTVYRAFDEY--EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 25 rl~e~-LG~Gafg~Vy~A~d~~--tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~iy 101 (745)
.+.++ ||+|+||+||+|.+.. ++..||+|+++.. ......+++.+|+.+|++++||||+++++++.+ +.+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~~ 84 (285)
T d1u59a_ 11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALM 84 (285)
T ss_dssp EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEE
T ss_pred EECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHH---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC---CEEE
T ss_conf 8878487306080999999960897689999998820---397899999999999986799888068656036---8079
Q ss_pred EEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHHHHHC
Q ss_conf 998236899999999974-8889999999999999998775409999794048776335519999289747621565621
Q 004564 102 FVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 102 LVtEy~~gGSL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~l~~ 180 (745)
+||||+++|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.+..
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCEECTT
T ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEC-CCCCEEECCCHHHHCCCC
T ss_conf 999807899689975212569999999999999999878998688--10576764660454-688542033134211554
Q ss_pred CC-----CCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCH
Q ss_conf 67-----77656888768802221-003753322123668999864-378999999979999999829999986668997
Q 004564 181 SH-----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDP 253 (745)
Q Consensus 181 ~~-----~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~~i~~ki~~g~~p~~l~~~~s~ 253 (745)
.. .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+. +..++...+..+..+. .+..+++
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~-~~~~~~~~i~~~~~~~-~p~~~~~ 239 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRME-CPPECPP 239 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCCC-CCTTCCH
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCC-CHHHHHHHHHCCCCCC-CCCCCCH
T ss_conf 3432113562113743358688727999954123220178999993899999997-9999999998189999-9976789
Q ss_pred HHHHHHHHHHH-CCCCCCCHHHH---HCCCCCC
Q ss_conf 99999999862-80699899988---3498778
Q 004564 254 EVRRFVEKCLA-TVSLRLSAREL---LNDPFLQ 282 (745)
Q Consensus 254 el~~lI~kCL~-dPskRpSa~EL---L~hPflq 282 (745)
++.++|.+||+ +|.+|||+.++ |+|+|+.
T Consensus 240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 999999997577976890999999999999998
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.69 Aligned_cols=255 Identities=26% Similarity=0.371 Sum_probs=218.0
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 85246767745138659999998579929999997605557997799999999999993799983247689785589859
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 100 (745)
.|| ++.+.||+|+||+||+|.+..+++.||+|+++... .......++.+|+.+|+.++||||+++++.|.+ ...+
T Consensus 2 ~ry-~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~ 76 (292)
T d1unla_ 2 QKY-EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKL 76 (292)
T ss_dssp CSE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC--SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CCC-EEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCC--CCCE
T ss_conf 997-86269712868199999999999699999980321--786899999999999985675788821354444--4311
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHHHHHC
Q ss_conf 99982368999999999748889999999999999998775409999794048776335519999289747621565621
Q 004564 101 NFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 180 (745)
Q Consensus 101 yLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~l~~ 180 (745)
+++++++.+++|..++...+.+++..++.+++|++.||+|||+++ |+||||||+|||++ ..+.+||+|||.|.....
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~-~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGI 153 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCS
T ss_pred EEEEEECCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EEEECCCCCCCCCC-CCCCEEEEECCHHHCCCC
T ss_conf 588630233222112123565403678999999999987743399--86001467612113-378266520460110468
Q ss_pred CC--CCCCCCCCCCCCHHHHHH--CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC--CC------------
Q ss_conf 67--776568887688022210--0375332212366899986437899999997999999982--99------------
Q 004564 181 SH--AAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS--GK------------ 242 (745)
Q Consensus 181 ~~--~~~~vGTp~YmAPEil~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~--g~------------ 242 (745)
.. .....+++.|+|||++.+ .++.++||||+||++|||++|+.||....+..+...++.. +.
T Consensus 154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred CCCCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHC
T ss_conf 87510010344310146675069888804440265418899851899998899999999999861189973551344322
Q ss_pred -------------CCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCC
Q ss_conf -------------9998666899799999999862-8069989998834987786
Q 004564 243 -------------KPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQI 283 (745)
Q Consensus 243 -------------~p~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~hPflq~ 283 (745)
.........++.+++||.+||+ ||.+||||+|+|+||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 2113344454431043306568999999999986499668909999964953407
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.36 Aligned_cols=251 Identities=19% Similarity=0.316 Sum_probs=213.7
Q ss_pred EECCCCCEEEEEEEECCCCCEEEEEEEECCCC----EEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEE
Q ss_conf 75999852467677451386599999985799----29999997605557997799999999999993799983247689
Q 004564 16 EVDPTGRYGRYNEILGKGASKTVYRAFDEYEG----IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTS 91 (745)
Q Consensus 16 e~dp~GRY~rl~e~LG~Gafg~Vy~A~d~~tg----~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~ 91 (745)
|++|+. | .+.++||+|+||+||+|....++ ..||+|.++.. ........+.+|+.+|+.++||||++++++
T Consensus 3 ei~~~~-~-~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 3 EIHPSC-V-TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp BCCTTT-E-EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCHHH-E-EEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 578899-6-86159811779099999996899878799999998844---596899999999999985689878323677
Q ss_pred EEECCCCEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEEC
Q ss_conf 7855898599998236899999999974-888999999999999999877540999979404877633551999928974
Q 004564 92 WVDTANRNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 170 (745)
Q Consensus 92 fvd~~~~~iyLVtEy~~gGSL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~ 170 (745)
+.+ ...+++||||+.++++..++... +.+++..+..|+.||+.||.|||+++ |+||||||+||||+ .++.+||+
T Consensus 78 ~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~-~~~~~Kl~ 152 (283)
T d1mqba_ 78 ISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVS 152 (283)
T ss_dssp ECS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEEC
T ss_pred EEC--CCCEEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCC--CCCCCCCCCEEEEC-CCCEEEEC
T ss_conf 833--88038999721357402221023454208999999999998541212123--42576564427888-99849984
Q ss_pred CCCHHHHHHCCC-----CCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 762156562167-----77656888768802221-003753322123668999864378999999979999999829999
Q 004564 171 DLGLAAILRKSH-----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKP 244 (745)
Q Consensus 171 DFGlA~~l~~~~-----~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p 244 (745)
|||+|+.+.... .....||+.|||||++. +.|+.++|||||||++|||+|+..|+....+..+++..+..+..+
T Consensus 153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~ 232 (283)
T d1mqba_ 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232 (283)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred CCCHHHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf 55103003578765267426777734348888704999973556344898999996798865568999999998635789
Q ss_pred CCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 98666899799999999862-8069989998834
Q 004564 245 DSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 245 ~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~ 277 (745)
. .+...+..+.++|.+||. +|.+||++.++++
T Consensus 233 ~-~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 233 P-TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp C-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C-CCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9-85045799999999977679768939999999
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.50 Aligned_cols=250 Identities=22% Similarity=0.340 Sum_probs=211.2
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC
Q ss_conf 99852467677451386599999985799299999976055579977999999999999937999832476897855898
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98 (745)
Q Consensus 19 p~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 98 (745)
|..+| ++.+.||+|+||+||+|.+. ++..||+|+++... ...+.+.+|+.+|++++||||+++++++. ..
T Consensus 11 ~~~~~-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~---~~ 80 (272)
T d1qpca_ 11 PRETL-KLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVT---QE 80 (272)
T ss_dssp CGGGE-EEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC---SS
T ss_pred CHHHE-EEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCCC-----CCHHHHHHHHHHHHHCCCCCEEEEEEEEC---CC
T ss_conf 88993-88679810798289999999-99999999986476-----88899999999998679998857873104---59
Q ss_pred EEEEEEECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHH
Q ss_conf 599998236899999999974--888999999999999999877540999979404877633551999928974762156
Q 004564 99 NINFVTEMFTSGTLRQYRLKH--KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 99 ~iyLVtEy~~gGSL~~~l~k~--~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~ 176 (745)
.+|+||||+.+|+|.+++... .++++..+..|+.||+.||.|||+++ |+||||||+||||+ +++.+||+|||+|+
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLAR 157 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCE
T ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEEE-CCCCEEECCCCCEE
T ss_conf 7699999578982888875147898878899999999999999997489--54675642251562-02440423410147
Q ss_pred HHHCCC---CCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 562167---77656888768802221-00375332212366899986437899999997999999982999998666899
Q 004564 177 ILRKSH---AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKD 252 (745)
Q Consensus 177 ~l~~~~---~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p~~l~~~~s 252 (745)
.+.... .....||+.|||||++. +.|+.++|||||||++|||+||..|+.......++...+..+..+. .+...+
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~ 236 (272)
T d1qpca_ 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-RPDNCP 236 (272)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTCC
T ss_pred ECCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC-CCCCCH
T ss_conf 7358864420356774444582898379998245645257999999968988888889999999997068888-965571
Q ss_pred HHHHHHHHHHHH-CCCCCCCHHHHHC--CCCCC
Q ss_conf 799999999862-8069989998834--98778
Q 004564 253 PEVRRFVEKCLA-TVSLRLSARELLN--DPFLQ 282 (745)
Q Consensus 253 ~el~~lI~kCL~-dPskRpSa~ELL~--hPflq 282 (745)
+++.+||.+||+ +|.+|||+.++++ ++||.
T Consensus 237 ~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 999999999758897689399999998611321
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.78 Aligned_cols=248 Identities=20% Similarity=0.328 Sum_probs=210.0
Q ss_pred ECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 59998524676774513865999999857992999999760555799779999999999999379998324768978558
Q 004564 17 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA 96 (745)
Q Consensus 17 ~dp~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 96 (745)
+||+ .| .+.+.||+|+||+||+|.+. ++..||+|.++... ...+.+.+|+.+++.++||||+++++++..
T Consensus 2 idp~-~~-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-- 71 (263)
T d1sm2a_ 2 IDPS-EL-TFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-- 71 (263)
T ss_dssp BCCS-CE-EEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CCHH-HC-EEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCCC-----CCHHHHHHHHHHHHHCCCCCCCCCCCEECC--
T ss_conf 8969-95-88889820888299999988-99999999987886-----768999999999996689975653524315--
Q ss_pred CCEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHH
Q ss_conf 98599998236899999999974-88899999999999999987754099997940487763355199992897476215
Q 004564 97 NRNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 97 ~~~iyLVtEy~~gGSL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA 175 (745)
...+++||||+.+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 72 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla 148 (263)
T d1sm2a_ 72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMT 148 (263)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEEC-GGGCEEECSCC--
T ss_pred CCCEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EEECCCCHHHEEEC-CCCCEEECCCCHH
T ss_conf 99337999836999189975201347889999999999999877653164--31044315326666-8877686553210
Q ss_pred HHHHCCCC---CCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 65621677---7656888768802221-0037533221236689998643789999999799999998299999866689
Q 004564 176 AILRKSHA---AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVK 251 (745)
Q Consensus 176 ~~l~~~~~---~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p~~l~~~~ 251 (745)
+....... ....||+.|+|||++. +.|+.++|||||||++|||+|+..|+....+..++...+..+..+. .+...
T Consensus 149 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~ 227 (263)
T d1sm2a_ 149 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLA 227 (263)
T ss_dssp ----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC-CCTTS
T ss_pred EECCCCCCEEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC-CCCCC
T ss_conf 02368873350430017666785786079998403321059999999878988877899999999998068889-95436
Q ss_pred CHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 9799999999862-80699899988349
Q 004564 252 DPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 252 s~el~~lI~kCL~-dPskRpSa~ELL~h 278 (745)
++++.++|.+||+ +|.+|||+++++++
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 7999999999765797689199999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.23 Aligned_cols=257 Identities=21% Similarity=0.364 Sum_probs=216.1
Q ss_pred CCEEEEEEEECCCCCEEEEEEEE---CCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEECC
Q ss_conf 85246767745138659999998---579929999997605557997799999999999993799-98324768978558
Q 004564 21 GRYGRYNEILGKGASKTVYRAFD---EYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH-KNIMKFYTSWVDTA 96 (745)
Q Consensus 21 GRY~rl~e~LG~Gafg~Vy~A~d---~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~H-pNIVkl~~~fvd~~ 96 (745)
.+| ++.+.||+|+||+||+|++ ..+|+.||+|+++...........+++.+|+.+|++++| |||+++++.+.+
T Consensus 24 ~~y-~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-- 100 (322)
T d1vzoa_ 24 ENF-ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 100 (322)
T ss_dssp GGE-EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred HCE-EEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC--
T ss_conf 025-99989832878399999987658879489999983677210168999999999999864679839996200024--
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHH
Q ss_conf 98599998236899999999974888999999999999999877540999979404877633551999928974762156
Q 004564 97 NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 97 ~~~iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~ 176 (745)
...+++++||+.+|+|..++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|.
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSK 177 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEE
T ss_pred CCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHCCC--EEECCCCCCCEEEC-CCCCEEEEECCCHH
T ss_conf 8730012312341179999873045437888888999999998851499--89654773201246-99988874132022
Q ss_pred HHHC---CCCCCCCCCCCCCCHHHHHH---CCCCCCCCHHHHHHHHHHHHCCCCCCCC---CCHHHHHHHHHCCCCCCCC
Q ss_conf 5621---67776568887688022210---0375332212366899986437899999---9979999999829999986
Q 004564 177 ILRK---SHAAHCVGTPEFMAPEVYEE---AYNELVDIYSFGMCILEMVTFEYPYSEC---THPAQIYKKVVSGKKPDSL 247 (745)
Q Consensus 177 ~l~~---~~~~~~vGTp~YmAPEil~~---~ys~ksDIWSLGiiL~ELlTG~~Pf~~~---~~~~~i~~ki~~g~~p~~l 247 (745)
.... .......|++.|+|||++.+ .++.++|||||||+||+|+||+.||... .....+.+.......+ +
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~--~ 255 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--Y 255 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC--C
T ss_pred HHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCCC--C
T ss_conf 20344443221222333331068760577688713251777799999976899988887777999999833568998--8
Q ss_pred CCCCCHHHHHHHHHHHH-CCCCCC-----CHHHHHCCCCCCCCC
Q ss_conf 66899799999999862-806998-----999883498778632
Q 004564 248 YRVKDPEVRRFVEKCLA-TVSLRL-----SARELLNDPFLQIDD 285 (745)
Q Consensus 248 ~~~~s~el~~lI~kCL~-dPskRp-----Sa~ELL~hPflq~~~ 285 (745)
+...++++++||.+||. +|.+|+ +|+|+|+||||+..+
T Consensus 256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCC
T ss_conf 65479999999999744589881999745099997497234899
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.11 Aligned_cols=247 Identities=24% Similarity=0.408 Sum_probs=209.4
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCE----EEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 8524676774513865999999857992----999999760555799779999999999999379998324768978558
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGI----EVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTA 96 (745)
Q Consensus 21 GRY~rl~e~LG~Gafg~Vy~A~d~~tg~----~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 96 (745)
..| ++.++||+|+||+||+|.+..+|+ .||+|.++.. .+....+.+.+|+.+|+.++||||+++++++.+
T Consensus 9 ~dy-~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-- 82 (317)
T d1xkka_ 9 TEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-- 82 (317)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred HHC-EEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC--
T ss_conf 999-78319820899299999995899889899999996513---497999999999999986799888158999961--
Q ss_pred CCEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHH
Q ss_conf 98599998236899999999974-88899999999999999987754099997940487763355199992897476215
Q 004564 97 NRNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 175 (745)
Q Consensus 97 ~~~iyLVtEy~~gGSL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA 175 (745)
...++++|++.+|+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|
T Consensus 83 -~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~-~~~~~kl~DFGla 158 (317)
T d1xkka_ 83 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLA 158 (317)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCCSHH
T ss_pred -CCEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCHHHCCEEC-CCCCEEEECCCCC
T ss_conf -9836999842687401011133457999999999999999999998769--50476212031167-9987586025522
Q ss_pred HHHHCCCC----CCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 65621677----7656888768802221-003753322123668999864-37899999997999999982999998666
Q 004564 176 AILRKSHA----AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYR 249 (745)
Q Consensus 176 ~~l~~~~~----~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~~i~~ki~~g~~p~~l~~ 249 (745)
........ ....||+.|||||++. +.|+.++|||||||++|||+| |..||.+ .+..++...+..+..+. .+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~p~ 236 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPP 236 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCCCC-CCT
T ss_pred EECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCCC-CCC
T ss_conf 2335444532236510586446708874699983565440799999999779999999-99899999997599899-985
Q ss_pred CCCHHHHHHHHHHHH-CCCCCCCHHHHHCCC
Q ss_conf 899799999999862-806998999883498
Q 004564 250 VKDPEVRRFVEKCLA-TVSLRLSARELLNDP 279 (745)
Q Consensus 250 ~~s~el~~lI~kCL~-dPskRpSa~ELL~hP 279 (745)
.+++.+.++|.+||. +|.+|||+.+++.|.
T Consensus 237 ~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 5689999999984789934691999999999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.04 Aligned_cols=254 Identities=28% Similarity=0.398 Sum_probs=208.1
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC----C
Q ss_conf 852467677451386599999985799299999976055579977999999999999937999832476897855----8
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT----A 96 (745)
Q Consensus 21 GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~----~ 96 (745)
.|| ++.++||+|+||+||+|++..+|..||+|+++... .+.....++.+|+.+|+.++||||++++++|... .
T Consensus 17 ~~Y-~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 17 KRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp TTE-EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred CCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCC
T ss_conf 775-99889621758599999999999899999988233--697999999999999986489876489989702564345
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHH
Q ss_conf 98599998236899999999974888999999999999999877540999979404877633551999928974762156
Q 004564 97 NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 97 ~~~iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~ 176 (745)
...+|+||||+.++++. .+ ...+++..++.+++||+.||.|||++| |+||||||+|||++ .++.+|++|||++.
T Consensus 94 ~~~~~iv~Ey~~~~l~~-~~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~-~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQ-VI--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR 167 (355)
T ss_dssp CCEEEEEEECCSEEHHH-HH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC--
T ss_pred CCEEEEEEECCCHHHHH-HH--HCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCC-CCCCEEEECHHHHH
T ss_conf 76269998414467787-65--038999999999999999998865221--12456776321136-54431320102321
Q ss_pred HHHCCCC-CCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC--------------
Q ss_conf 5621677-7656888768802221-00375332212366899986437899999997999999982--------------
Q 004564 177 ILRKSHA-AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVS-------------- 240 (745)
Q Consensus 177 ~l~~~~~-~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~-------------- 240 (745)
....... ...++|+.|+|||++. ..++.++||||+||++|+|++|++||.+. +......++..
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~-~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR-DYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCC-CHHHHHHHHHHHCCCCCHHHHHHHH
T ss_conf 146665533221465555813314777787743335662578986598998889-7788999999720589879998765
Q ss_pred --------CCCCC-----------CC-------CCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf --------99999-----------86-------66899799999999862-80699899988349877863
Q 004564 241 --------GKKPD-----------SL-------YRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 241 --------g~~p~-----------~l-------~~~~s~el~~lI~kCL~-dPskRpSa~ELL~hPflq~~ 284 (745)
+..+. .. ....++.+++||.+||. +|++||||+|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 66777764175435666421264333543210133379999999999876994579089999669420878
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.18 Aligned_cols=256 Identities=29% Similarity=0.397 Sum_probs=209.8
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC---C
Q ss_conf 9852467677451386599999985799299999976055579977999999999999937999832476897855---8
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDT---A 96 (745)
Q Consensus 20 ~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~---~ 96 (745)
..|| ++.+.||+|+||+||+|++..+|+.||+|+++... .+....+++.+|+.+|+.++||||++++++|... .
T Consensus 17 ~~rY-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 17 PERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 93 (348)
T ss_dssp ETTE-EEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred CCCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCC
T ss_conf 9871-88889831788399999999999799999988200--28689999999999998668987425999996346456
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHH
Q ss_conf 98599998236899999999974888999999999999999877540999979404877633551999928974762156
Q 004564 97 NRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 97 ~~~iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~ 176 (745)
....+++++++.+|+|.+++. .+++++..++.+++||+.||.|||+++ |+||||||+|||++ .+|.+|++|||++.
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~-~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLAR 169 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCC----
T ss_pred CCCEEEEEEEECCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCC-CCCCCCCCCCCHHC
T ss_conf 686499999625886232002-245309999999999999999997388--76516677633455-43220013210001
Q ss_pred HHHCCCCCCCCCCCCCCCHHHHHH--CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC--CCC--------
Q ss_conf 562167776568887688022210--03753322123668999864378999999979999999829--999--------
Q 004564 177 ILRKSHAAHCVGTPEFMAPEVYEE--AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSG--KKP-------- 244 (745)
Q Consensus 177 ~l~~~~~~~~vGTp~YmAPEil~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g--~~p-------- 244 (745)
...... ....|++.|+|||++.+ .++.++||||+||++|+|++|.+||.+. +.......+... ..+
T Consensus 170 ~~~~~~-~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~-~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 170 HTDDEM-TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT-DHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp CCTGGG-SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred CCCCCC-CCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHHHCCCCCHHHHHHCC
T ss_conf 257544-44345435558355337756785512432058999997688997889-8899999999730799757732001
Q ss_pred ---------------C----CCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf ---------------9----8666899799999999862-80699899988349877863
Q 004564 245 ---------------D----SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLNDPFLQID 284 (745)
Q Consensus 245 ---------------~----~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~hPflq~~ 284 (745)
. ......++++++||.+||. ||.+||||.|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 024454443035578755566267899999999999775883459389998559954879
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.59 Aligned_cols=246 Identities=22% Similarity=0.366 Sum_probs=211.4
Q ss_pred CCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
Q ss_conf 99985246767745138659999998579929999997605557997799999999999993799983247689785589
Q 004564 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 18 dp~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 97 (745)
||+ .| .+.+.||+|+||+||+|... ++..||+|.++... ...+.+.+|+.+++.++||||+++++++.+ .
T Consensus 2 ~~~-~~-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-----~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~ 71 (258)
T d1k2pa_ 2 DPK-DL-TFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK--Q 71 (258)
T ss_dssp CCC-CC-CCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS-----SCHHHHHHHHHHHHTCCCTTBCCEEEEECC--S
T ss_pred CHH-HC-EEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCCC-----CCHHHHHHHHHHHHHCCCCCEEEEEEEEEE--C
T ss_conf 969-97-99689820788399999988-99899999987475-----778999999999996689860158899850--7
Q ss_pred CEEEEEEECCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHH
Q ss_conf 859999823689999999997-4888999999999999999877540999979404877633551999928974762156
Q 004564 98 RNINFVTEMFTSGTLRQYRLK-HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 98 ~~iyLVtEy~~gGSL~~~l~k-~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~ 176 (745)
..+++||||+.+|+|..++.. ...+++..++.|+.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.
T Consensus 72 ~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~-~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 72 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSR 148 (258)
T ss_dssp SSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEEC-TTCCEEECCCSSCC
T ss_pred CCEEEEEECCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCEEEEEC-CCCCEEECCCHHHE
T ss_conf 8169999704899388864102467768999999999999999875468--43466541358876-99847988614420
Q ss_pred HHHCCCC---CCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 5621677---7656888768802221-003753322123668999864-3789999999799999998299999866689
Q 004564 177 ILRKSHA---AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVK 251 (745)
Q Consensus 177 ~l~~~~~---~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~~i~~ki~~g~~p~~l~~~~ 251 (745)
....... ....||+.|+|||++. ..|+.++|||||||++|||+| |+.||.. .+..++..++..+..+. .+...
T Consensus 149 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~~-~p~~~ 226 (258)
T d1k2pa_ 149 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRLY-RPHLA 226 (258)
T ss_dssp BCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCCC-CCTTC
T ss_pred ECCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCC-CCHHHHHHHHHHCCCCC-CCCCC
T ss_conf 23578722524657887757807863799885210336432467397559999889-99999999998079789-96546
Q ss_pred CHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 9799999999862-80699899988349
Q 004564 252 DPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 252 s~el~~lI~kCL~-dPskRpSa~ELL~h 278 (745)
++++.+||.+||+ +|.+|||+.++|+|
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 5999999999766897689399999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.66 Aligned_cols=246 Identities=23% Similarity=0.378 Sum_probs=210.6
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCC---EEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
Q ss_conf 852467677451386599999985799---29999997605557997799999999999993799983247689785589
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEG---IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 21 GRY~rl~e~LG~Gafg~Vy~A~d~~tg---~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 97 (745)
.+| ++.+.||+|+||.||+|.+..++ ..||+|.++. .......+.+.+|+.+|+.++||||+++++++. .
T Consensus 7 ~~~-~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~ 79 (273)
T d1mp8a_ 7 ERI-ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN---CTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---E 79 (273)
T ss_dssp GGE-EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT---TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---S
T ss_pred HHE-EEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECC---CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE---C
T ss_conf 996-987799307882999999936996449999999365---668799999999999998689999856988995---3
Q ss_pred CEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHH
Q ss_conf 8599998236899999999974-888999999999999999877540999979404877633551999928974762156
Q 004564 98 RNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 98 ~~iyLVtEy~~gGSL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~ 176 (745)
..+|+||||+.+|+|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ ..+.+||+|||+|.
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~-~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSR 156 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC-----
T ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCC--EECCCCCHHHEEEC-CCCCEEECCCHHHE
T ss_conf 7479999840698077654224789999999999999987752302267--44141026553206-78967876503421
Q ss_pred HHHCC---CCCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 56216---777656888768802221-003753322123668999864-3789999999799999998299999866689
Q 004564 177 ILRKS---HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVK 251 (745)
Q Consensus 177 ~l~~~---~~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~~i~~ki~~g~~p~~l~~~~ 251 (745)
..... ......||+.|+|||++. +.|+.++|||||||++|||+| |.+||.. .+..+++..+..+..+. .+..+
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~ 234 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERLP-MPPNC 234 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCCC-CCTTC
T ss_pred ECCCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCC
T ss_conf 33677623305400583103266751699887452444247899998269999888-99999999998189998-98777
Q ss_pred CHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 9799999999862-80699899988349
Q 004564 252 DPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 252 s~el~~lI~kCL~-dPskRpSa~ELL~h 278 (745)
++.+.+||.+||. +|.+|||+.+++++
T Consensus 235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9999999999768797689299999999
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.72 Aligned_cols=247 Identities=24% Similarity=0.371 Sum_probs=211.5
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCEE--EEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEECCC
Q ss_conf 85246767745138659999998579929--9999976055579977999999999999937-99983247689785589
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIE--VAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 21 GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~--VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~ 97 (745)
..| ++.++||+|+||+||+|.+..++.. ||+|.++.. ...+..+.+.+|+.+|+.+ +||||+++++++.+ +
T Consensus 10 ~~~-~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~ 83 (309)
T d1fvra_ 10 NDI-KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--R 83 (309)
T ss_dssp GGC-EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--T
T ss_pred HHC-EEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC--C
T ss_conf 996-887798207882899999989996999999997823---3857999999999999862289988367888841--8
Q ss_pred CEEEEEEECCCCCCHHHHHHHC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEC
Q ss_conf 8599998236899999999974----------------888999999999999999877540999979404877633551
Q 004564 98 RNINFVTEMFTSGTLRQYRLKH----------------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVN 161 (745)
Q Consensus 98 ~~iyLVtEy~~gGSL~~~l~k~----------------~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId 161 (745)
..+|+||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG 161 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--CCCCCCCCCEEEEC
T ss_conf 7369999802898699998640355555123101234578999999999999999987663089--54555052048986
Q ss_pred CCCCCEEECCCCHHHHHHCCCCC-CCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCCHHHHHHHH
Q ss_conf 99992897476215656216777-656888768802221-00375332212366899986437-8999999979999999
Q 004564 162 GNQGEVKIGDLGLAAILRKSHAA-HCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFE-YPYSECTHPAQIYKKV 238 (745)
Q Consensus 162 ~~~g~VKL~DFGlA~~l~~~~~~-~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG~-~Pf~~~~~~~~i~~ki 238 (745)
..+.+||+|||+|......... ...||+.|+|||.+. +.|+.++|||||||++|||+||. +||.+ .+..+++..+
T Consensus 162 -~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-~~~~~~~~~i 239 (309)
T d1fvra_ 162 -ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKL 239 (309)
T ss_dssp -GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHG
T ss_pred -CCCCEEECCCCCCCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCC-CCHHHHHHHH
T ss_conf -88763874344322444223455301377555538752699996221531388999998368999999-9999999999
Q ss_pred HCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 82999998666899799999999862-80699899988349
Q 004564 239 VSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 239 ~~g~~p~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~h 278 (745)
..+..+. .+..+++++++||.+||+ +|++|||+.+++++
T Consensus 240 ~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 240 PQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GGTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHCCCCC-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 8268888-876678999999999767896689499999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.20 Aligned_cols=249 Identities=23% Similarity=0.357 Sum_probs=209.3
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECC-----CCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEE
Q ss_conf 8524676774513865999999857-----99299999976055579977999999999999937-99983247689785
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEY-----EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSWVD 94 (745)
Q Consensus 21 GRY~rl~e~LG~Gafg~Vy~A~d~~-----tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~fvd 94 (745)
.+| ++.+.||+|+||.||+|.+.. +++.||+|+++.. ......+.+..|..++.++ +|+||+.+++.+..
T Consensus 13 ~~y-~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 13 DRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp GGE-EEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHE-EEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCC---CCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECC
T ss_conf 997-984498416783999999867775557839999998600---1717899999999998861499849974115404
Q ss_pred CCCCEEEEEEECCCCCCHHHHHHHCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCE
Q ss_conf 58985999982368999999999748----------------88999999999999999877540999979404877633
Q 004564 95 TANRNINFVTEMFTSGTLRQYRLKHK----------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNI 158 (745)
Q Consensus 95 ~~~~~iyLVtEy~~gGSL~~~l~k~~----------------~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NI 158 (745)
.+..+++||||+++|+|.+++.... .+++..++.|+.||+.||.|||+++ |+||||||+||
T Consensus 89 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NI 165 (299)
T d1ywna1 89 -PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNI 165 (299)
T ss_dssp -TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred -CCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCE
T ss_conf -797579999845899299999853666665322202332146899999999999999999887379--71786773106
Q ss_pred EECCCCCCEEECCCCHHHHHHCC----CCCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCHH
Q ss_conf 55199992897476215656216----777656888768802221-0037533221236689998643-78999999979
Q 004564 159 FVNGNQGEVKIGDLGLAAILRKS----HAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTF-EYPYSECTHPA 232 (745)
Q Consensus 159 LId~~~g~VKL~DFGlA~~l~~~----~~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG-~~Pf~~~~~~~ 232 (745)
|++ .++.+||+|||+|+..... .....+||+.|||||++. +.|+.++|||||||++|||+|| .+||.......
T Consensus 166 Ll~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 166 LLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EEC-GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred EEC-CCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHH
T ss_conf 577-9982898457520011356652224751667210203686468899663221367899999868899998999899
Q ss_pred HHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 99999982999998666899799999999862-80699899988349
Q 004564 233 QIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 233 ~i~~ki~~g~~p~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~h 278 (745)
.+...+..+..+. .+...+++++++|.+||+ +|.+|||+.|+++|
T Consensus 245 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 245 EFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHCCCCCC-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9999996389888-886578999999999767796679199999999
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=345.62 Aligned_cols=248 Identities=21% Similarity=0.280 Sum_probs=212.5
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEEC-----CCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 99852467677451386599999985-----7992999999760555799779999999999999379998324768978
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDE-----YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWV 93 (745)
Q Consensus 19 p~GRY~rl~e~LG~Gafg~Vy~A~d~-----~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fv 93 (745)
|..+| .+.+.||+|+||+||+|... .++..||+|.++.. ......+++.+|+.+|+.++||||++++++|.
T Consensus 11 p~~~~-~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 11 PRNNI-EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp CGGGC-EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHHHC-EEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHH---CCHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
T ss_conf 98893-886798207883999999888765778829999998821---08579999999999999668997655246660
Q ss_pred ECCCCEEEEEEECCCCCCHHHHHHHCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCEE
Q ss_conf 558985999982368999999999748------------------------88999999999999999877540999979
Q 004564 94 DTANRNINFVTEMFTSGTLRQYRLKHK------------------------RVNIRAVKLWCRQILRGLLYLHSHDPPVI 149 (745)
Q Consensus 94 d~~~~~iyLVtEy~~gGSL~~~l~k~~------------------------~L~e~~i~~ia~QIL~gL~yLHs~g~~II 149 (745)
. ....++++||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+
T Consensus 87 ~--~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iv 162 (301)
T d1lufa_ 87 V--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FV 162 (301)
T ss_dssp S--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred C--CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC--EE
T ss_conf 5--9803899981589929999985275542100001110012103467889899999999999999855413578--68
Q ss_pred EECCCCCCEEECCCCCCEEECCCCHHHHHHCCC----CCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHCC-C
Q ss_conf 404877633551999928974762156562167----77656888768802221-00375332212366899986437-8
Q 004564 150 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFE-Y 223 (745)
Q Consensus 150 HRDLKp~NILId~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG~-~ 223 (745)
||||||+|||++ .++.+||+|||+|....... .....|++.|+|||++. ..|+.++|||||||++|||+||. +
T Consensus 163 HrDlKp~NILld-~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 163 HRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEEECCCCEEEC-CCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCC
T ss_conf 548840116898-9992898331442113677641115777767676798997268898056302523629999806899
Q ss_pred CCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 99999997999999982999998666899799999999862-8069989998834
Q 004564 224 PYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 224 Pf~~~~~~~~i~~ki~~g~~p~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~ 277 (745)
||.. .+..++...+..+..+. .+...++++.++|.+||+ +|++|||+.|+++
T Consensus 242 p~~~-~~~~e~~~~v~~~~~~~-~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 242 PYYG-MAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTTT-SCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC-CCHHHHHHHHHCCCCCC-CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9999-89999999997399788-87325299999999974889657939999999
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.74 Aligned_cols=249 Identities=20% Similarity=0.281 Sum_probs=211.6
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 85246767745138659999998579929999997605557997799999999999993799983247689785589859
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNI 100 (745)
Q Consensus 21 GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 100 (745)
.+| ++.+.||+|+||+||+|++..+ ..||+|+++... ...+.+.+|+.+|+.++||||+++|+++. .+.+
T Consensus 17 ~~~-~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~---~~~~ 86 (285)
T d1fmka3 17 ESL-RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVS---EEPI 86 (285)
T ss_dssp GGE-EEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC---SSSC
T ss_pred HHE-EEEEEEEECCCEEEEEEEECCC-CEEEEEEECCCC-----CCHHHHHHHHHHHHHCCCCCEEEEEEEEE---CCCE
T ss_conf 997-9846993079809999999999-999999988044-----88899999999998666678868999982---3975
Q ss_pred EEEEECCCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHHHH
Q ss_conf 999823689999999997--488899999999999999987754099997940487763355199992897476215656
Q 004564 101 NFVTEMFTSGTLRQYRLK--HKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 178 (745)
Q Consensus 101 yLVtEy~~gGSL~~~l~k--~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~l 178 (745)
++||||+.+|+|..++.. .+.+++..+..++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+|...
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~-~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLI 163 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCTTC--
T ss_pred EEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHH--EECCCCCCEEEEEC-CCCCEEECCCCHHHHC
T ss_conf 99999447994354200003553059999999999999999875411--43353123079998-9992998442555425
Q ss_pred HCCC---CCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHH
Q ss_conf 2167---77656888768802221-0037533221236689998643789999999799999998299999866689979
Q 004564 179 RKSH---AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPE 254 (745)
Q Consensus 179 ~~~~---~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p~~l~~~~s~e 254 (745)
.... .....||+.|+|||++. +.++.++||||||+++|||+||..||.......++...+..+..++ .+...+++
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~ 242 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPES 242 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTSCHH
T ss_pred CCCCCEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC-CCCCCCHH
T ss_conf 68873352454556654580898379989177413235899999868999998888999999998268999-98323799
Q ss_pred HHHHHHHHHH-CCCCCCCHHHHHC--CCCCCC
Q ss_conf 9999999862-8069989998834--987786
Q 004564 255 VRRFVEKCLA-TVSLRLSARELLN--DPFLQI 283 (745)
Q Consensus 255 l~~lI~kCL~-dPskRpSa~ELL~--hPflq~ 283 (745)
++++|.+||+ +|++||++++++. ++||..
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 99999997566975891999999987666238
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.25 Aligned_cols=254 Identities=20% Similarity=0.316 Sum_probs=214.3
Q ss_pred ECCCCCEEEEEEEECCCCCEEEEEEEECCCC---EEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 5999852467677451386599999985799---2999999760555799779999999999999379998324768978
Q 004564 17 VDPTGRYGRYNEILGKGASKTVYRAFDEYEG---IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWV 93 (745)
Q Consensus 17 ~dp~GRY~rl~e~LG~Gafg~Vy~A~d~~tg---~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fv 93 (745)
+.+......+.++||+|+||+||+|.+..++ ..||+|.++. ..+....+++.+|+.+|++++||||+++++++.
T Consensus 22 ~~~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~ 98 (311)
T d1r0pa_ 22 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 98 (311)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred ECHHHCEECCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECC---CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 68688155266698136880999999977998799999999884---369789999999999998678999867867898
Q ss_pred ECCCCEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCC
Q ss_conf 55898599998236899999999974-88899999999999999987754099997940487763355199992897476
Q 004564 94 DTANRNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 172 (745)
Q Consensus 94 d~~~~~iyLVtEy~~gGSL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DF 172 (745)
.. +..+++||||+.+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ ..+.+||+||
T Consensus 99 ~~-~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~-~~~~~kL~DF 174 (311)
T d1r0pa_ 99 RS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADF 174 (311)
T ss_dssp ET-TTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECSS
T ss_pred EC-CCCEEEEEEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCC--CCCCCCCHHHEEEC-CCCCEEEECC
T ss_conf 06-99438999874067414421013454048999999999887652003367--62577668757677-9998899106
Q ss_pred CHHHHHHCCC------CCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 2156562167------77656888768802221-0037533221236689998643789999999799999998299999
Q 004564 173 GLAAILRKSH------AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVVSGKKPD 245 (745)
Q Consensus 173 GlA~~l~~~~------~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~ki~~g~~p~ 245 (745)
|++....... .....||+.|+|||++. +.++.++||||||+++|||+||..||.......++...+..+..+.
T Consensus 175 G~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~ 254 (311)
T d1r0pa_ 175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 254 (311)
T ss_dssp GGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC
T ss_pred CCHHHCCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC
T ss_conf 52322556655531002565556455676887437999745746619999999978999988899999999998089889
Q ss_pred CCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 8666899799999999862-80699899988349
Q 004564 246 SLYRVKDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 246 ~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~h 278 (745)
.+...++.+.++|.+||+ +|.+||++.|++++
T Consensus 255 -~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 255 -QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf -964475999999999768897689399999999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.59 Aligned_cols=248 Identities=27% Similarity=0.402 Sum_probs=213.0
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEECCCC-------EEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEE
Q ss_conf 99852467677451386599999985799-------299999976055579977999999999999937-9998324768
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEG-------IEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYT 90 (745)
Q Consensus 19 p~GRY~rl~e~LG~Gafg~Vy~A~d~~tg-------~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~ 90 (745)
|..+| .+.+.||+|+||.||+|.+..++ ..||+|.++.. ........+.+|...+.++ +||||+++++
T Consensus 11 ~~~~~-~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 11 PRDRL-VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp CGGGE-EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CHHHE-EEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCC---CCHHHHHHHHHHHHHHHHHCCCCEEEECCC
T ss_conf 58996-97009851678289999985787555667549999998811---286889999999999998139996973465
Q ss_pred EEEECCCCEEEEEEECCCCCCHHHHHHHCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCC
Q ss_conf 978558985999982368999999999748----------------8899999999999999987754099997940487
Q 004564 91 SWVDTANRNINFVTEMFTSGTLRQYRLKHK----------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLK 154 (745)
Q Consensus 91 ~fvd~~~~~iyLVtEy~~gGSL~~~l~k~~----------------~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLK 154 (745)
+|.+ +..+++||||+.+|+|.+++.... .+++..++.|+.||+.||.|||+++ |+|||||
T Consensus 87 ~~~~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiK 162 (299)
T d1fgka_ 87 ACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLA 162 (299)
T ss_dssp EECS--SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred CCCC--CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEEEEC
T ss_conf 2201--88689999736999099999860677643222334574346799999999999999998766379--7863022
Q ss_pred CCCEEECCCCCCEEECCCCHHHHHHCCCC----CCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHH-CCCCCCCC
Q ss_conf 76335519999289747621565621677----7656888768802221-003753322123668999864-37899999
Q 004564 155 CDNIFVNGNQGEVKIGDLGLAAILRKSHA----AHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSEC 228 (745)
Q Consensus 155 p~NILId~~~g~VKL~DFGlA~~l~~~~~----~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~ 228 (745)
|+|||++ .++.+||+|||++........ ...++++.|+|||++. +.|+.++||||||+++|||+| |.+||.+
T Consensus 163 p~NiLl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~- 240 (299)
T d1fgka_ 163 ARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG- 240 (299)
T ss_dssp GGGEEEC-TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-
T ss_pred CCCEEEC-CCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_conf 1022454-78976762211101135555543146678884663266751798882555477588888740179898999-
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 997999999982999998666899799999999862-8069989998834
Q 004564 229 THPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 229 ~~~~~i~~ki~~g~~p~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~ 277 (745)
.+..+++..+..+..+. .+...++.+++||.+||+ +|++|||+.|+++
T Consensus 241 ~~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 241 VPVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CCHHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHCCCCCC-CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 99999999997288889-87435299999999976679767939999999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.62 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=207.6
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCC---CEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
Q ss_conf 85246767745138659999998579---929999997605557997799999999999993799983247689785589
Q 004564 21 GRYGRYNEILGKGASKTVYRAFDEYE---GIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 21 GRY~rl~e~LG~Gafg~Vy~A~d~~t---g~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 97 (745)
.+| ++.+.||+|+||.||+|..... ...||+|+++... ....+..+++.+|+.+|+.++||||+++|+++.+
T Consensus 8 ~d~-~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~-~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~--- 82 (273)
T d1u46a_ 8 KDL-RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV-LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--- 82 (273)
T ss_dssp GGE-EEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHE-EEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHH-CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE---
T ss_conf 891-99789803888399999998899907999999998355-5798999999999999986899998789877740---
Q ss_pred CEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHH
Q ss_conf 8599998236899999999974-888999999999999999877540999979404877633551999928974762156
Q 004564 98 RNINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 98 ~~iyLVtEy~~gGSL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~ 176 (745)
..+++||||+.+|+|.+++..+ +.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~-~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMR 159 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCE
T ss_pred CCHHEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEEEECHHHHCCC-CCCCEEECCCHHHH
T ss_conf 1001146542386125444212689999999999999999998752178--75205668881565-56543325611555
Q ss_pred HHHCCC-----CCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 562167-----77656888768802221-003753322123668999864-37899999997999999982999998666
Q 004564 177 ILRKSH-----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYR 249 (745)
Q Consensus 177 ~l~~~~-----~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~~i~~ki~~g~~p~~l~~ 249 (745)
...... .....|++.|+|||++. ..|+.++||||||+++|||+| |..||.+ .+..++...+.........+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~ 238 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPE 238 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCT
T ss_pred HCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHHCCCCCCCCC
T ss_conf 3035887526547632573107999983799994215661489999999689999999-699999999984799999854
Q ss_pred CCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 899799999999862-8069989998834
Q 004564 250 VKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 250 ~~s~el~~lI~kCL~-dPskRpSa~ELL~ 277 (745)
..++.++++|.+||. +|.+|||+.++++
T Consensus 239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 45399999999976889667929999999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.96 Aligned_cols=249 Identities=23% Similarity=0.354 Sum_probs=210.0
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEE-----CCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEE
Q ss_conf 9985246767745138659999998-----5799299999976055579977999999999999937-999832476897
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFD-----EYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTL-KHKNIMKFYTSW 92 (745)
Q Consensus 19 p~GRY~rl~e~LG~Gafg~Vy~A~d-----~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L-~HpNIVkl~~~f 92 (745)
|..+| .+.++||+|+||.||+|.. ..+++.||+|+++.. ........+.+|+.+++.+ +||||+++++++
T Consensus 21 ~~~~~-~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 21 PRNRL-SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp CGGGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHE-EEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEE
T ss_conf 78996-985498206882999999806644778869999998742---48779999999999987626999887899898
Q ss_pred EECCCCEEEEEEECCCCCCHHHHHHHCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCC
Q ss_conf 8558985999982368999999999748------------------8899999999999999987754099997940487
Q 004564 93 VDTANRNINFVTEMFTSGTLRQYRLKHK------------------RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLK 154 (745)
Q Consensus 93 vd~~~~~iyLVtEy~~gGSL~~~l~k~~------------------~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLK 154 (745)
.+ ...+++||||+.+|+|..++.+.. .+++..+..|+.||+.||.|||+++ |+|||||
T Consensus 97 ~~--~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLK 172 (311)
T d1t46a_ 97 TI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLA 172 (311)
T ss_dssp CS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred EE--CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCC
T ss_conf 31--9978999973799879999985356654444453322233458899999999999999999887579--2666241
Q ss_pred CCCEEECCCCCCEEECCCCHHHHHHCCC----CCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHH-CCCCCCCC
Q ss_conf 7633551999928974762156562167----77656888768802221-003753322123668999864-37899999
Q 004564 155 CDNIFVNGNQGEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSEC 228 (745)
Q Consensus 155 p~NILId~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~ 228 (745)
|+||+++ ..+.+||+|||++....... ....+||+.|+|||++. +.++.++||||||+++|||+| |.+||...
T Consensus 173 p~NIl~~-~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 173 ARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp GGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CCCCCCC-CCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
T ss_conf 0210000-257521023401023367886158620135968767788617999974001025899999985899887789
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 997999999982999998666899799999999862-8069989998834
Q 004564 229 THPAQIYKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 229 ~~~~~i~~ki~~g~~p~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~ 277 (745)
.....+.+.+..+..+. .+...++.+.+||.+||+ +|.+|||+.++++
T Consensus 252 ~~~~~~~~~i~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 252 PVDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CSSHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHCCCCCC-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 98999999986689889-85436599999999975779657929999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.74 Aligned_cols=241 Identities=21% Similarity=0.348 Sum_probs=208.6
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEE
Q ss_conf 52467677451386599999985799299999976055579977999999999999937999832476897855898599
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 22 RY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~iy 101 (745)
.| ++.+.||+|+||.||+|.. .|..||+|.++.. ...+.+.+|+.+|+.++||||+++++++.+. ...+|
T Consensus 8 ~~-~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~ 77 (262)
T d1byga_ 8 EL-KLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLY 77 (262)
T ss_dssp GE-EEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCE
T ss_pred HE-EEEEEEECCCCEEEEEEEE--CCEEEEEEEECCH------HHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CCCEE
T ss_conf 94-8857982079808999999--9909999998857------7799999999999867898985498788723-89289
Q ss_pred EEEECCCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEECCCCHHHHHH
Q ss_conf 9982368999999999748--88999999999999999877540999979404877633551999928974762156562
Q 004564 102 FVTEMFTSGTLRQYRLKHK--RVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179 (745)
Q Consensus 102 LVtEy~~gGSL~~~l~k~~--~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~l~ 179 (745)
+||||+.+|+|.+++.+.. .+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC-----
T ss_pred EEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCC--EECCCCCHHHHEEC-CCCCEEECCCCCCEECC
T ss_conf 9996369998999987457888899999999999985232113376--55366656760146-89977632456003447
Q ss_pred CCCCCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHH
Q ss_conf 16777656888768802221-003753322123668999864-3789999999799999998299999866689979999
Q 004564 180 KSHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVT-FEYPYSECTHPAQIYKKVVSGKKPDSLYRVKDPEVRR 257 (745)
Q Consensus 180 ~~~~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~~i~~ki~~g~~p~~l~~~~s~el~~ 257 (745)
... ....+++.|+|||++. +.|+.++|||||||++|||+| |++||.. .+..++...+..+..+.. +...++++++
T Consensus 155 ~~~-~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~~-~~~~~~~~~~ 231 (262)
T d1byga_ 155 STQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMDA-PDGCPPAVYE 231 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCCC-CTTCCHHHHH
T ss_pred CCC-CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCCCC-CCCCCHHHHH
T ss_conf 877-6556664677817872798885887775799999999789999999-999999999980899999-7657999999
Q ss_pred HHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 9999862-80699899988349
Q 004564 258 FVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 258 lI~kCL~-dPskRpSa~ELL~h 278 (745)
+|.+||. +|.+|||+.+++++
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9999756697689399999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.22 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=211.9
Q ss_pred EECCCCCEEEEEEEECCCCCEEEEEEEEC-----CCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEE
Q ss_conf 75999852467677451386599999985-----7992999999760555799779999999999999379998324768
Q 004564 16 EVDPTGRYGRYNEILGKGASKTVYRAFDE-----YEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYT 90 (745)
Q Consensus 16 e~dp~GRY~rl~e~LG~Gafg~Vy~A~d~-----~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~ 90 (745)
|+++ .+| .+.+.||+|+||+||+|.+. .++..||+|+++.. ........+.+|+.++++++||||+++++
T Consensus 16 ei~~-~~~-~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~---~~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 16 EVAR-EKI-TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp BCCG-GGE-EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred EECH-HHE-EEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 4268-991-883598207881899999878644778968999998701---28689999999999999769998841254
Q ss_pred EEEECCCCEEEEEEECCCCCCHHHHHHHC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEE
Q ss_conf 97855898599998236899999999974----------88899999999999999987754099997940487763355
Q 004564 91 SWVDTANRNINFVTEMFTSGTLRQYRLKH----------KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFV 160 (745)
Q Consensus 91 ~fvd~~~~~iyLVtEy~~gGSL~~~l~k~----------~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILI 160 (745)
.+.. ...+++||||+.+|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+
T Consensus 91 ~~~~--~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 91 VVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV 166 (308)
T ss_dssp EECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEE
T ss_pred EEEC--CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECEECCCCEEE
T ss_conf 7842--88106777604899889998750332113444688799999999999999999876479--6543286775403
Q ss_pred CCCCCCEEECCCCHHHHHHCCC----CCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCHHHH
Q ss_conf 1999928974762156562167----77656888768802221-0037533221236689998643-7899999997999
Q 004564 161 NGNQGEVKIGDLGLAAILRKSH----AAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTF-EYPYSECTHPAQI 234 (745)
Q Consensus 161 d~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG-~~Pf~~~~~~~~i 234 (745)
+ .++.+||+|||+|..+.... .....||+.|+|||.+. +.|+.++||||||+++|||+|| ..||.+ .+..++
T Consensus 167 d-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~~ 244 (308)
T d1p4oa_ 167 A-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQV 244 (308)
T ss_dssp C-TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHH
T ss_pred C-CCCEEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC-CCHHHH
T ss_conf 5-99649994245420235776303134023163237888873699883334443789999999689999999-899999
Q ss_pred HHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 999982999998666899799999999862-8069989998834
Q 004564 235 YKKVVSGKKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 235 ~~ki~~g~~p~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~ 277 (745)
+..+..+..+. .+...++.+.++|.+||+ +|.+|||+.++++
T Consensus 245 ~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 245 LRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHCCCCC-CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 99998088888-86335399999999975779658939999999
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=324.44 Aligned_cols=254 Identities=19% Similarity=0.237 Sum_probs=197.8
Q ss_pred CCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
Q ss_conf 99985246767745138659999998579929999997605557997799999999999993799983247689785589
Q 004564 18 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97 (745)
Q Consensus 18 dp~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 97 (745)
..++|| ++.+.||+|+||.||+|.+..+++.||+|+++.... .+++..|+.+++.++|+|++..+..+.. ..
T Consensus 4 ~vg~rY-~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~i~~~l~~~~~i~~~~~~~~-~~ 75 (299)
T d1ckia_ 4 RVGNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGA-EG 75 (299)
T ss_dssp EETTTE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT------SCCHHHHHHHHHHSTTSTTCCCEEEEEE-ET
T ss_pred EECCEE-EEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC------CHHHHHHHHHHHHCCCCCCCCEEEEEEE-CC
T ss_conf 188889-996898507880999999988998999999721005------8889999999997038996017999995-19
Q ss_pred CEEEEEEECCCCCCHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECC--CCCCEEECCCCH
Q ss_conf 85999982368999999999-748889999999999999998775409999794048776335519--999289747621
Q 004564 98 RNINFVTEMFTSGTLRQYRL-KHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGL 174 (745)
Q Consensus 98 ~~iyLVtEy~~gGSL~~~l~-k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~--~~g~VKL~DFGl 174 (745)
...++||||+ +++|...+. ..+.+++..+..++.|++.||.|||+++ |+||||||+|||++. ....+||+|||+
T Consensus 76 ~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~ 152 (299)
T d1ckia_ 76 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGL 152 (299)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred CEEEEEEEEC-CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCHHHCCCCCCCCCCEEEEECCCC
T ss_conf 8778999873-87133324430688768999999999999999999799--44266787660643357776156504675
Q ss_pred HHHHHCCC---------CCCCCCCCCCCCHHHHHH-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHCC-
Q ss_conf 56562167---------776568887688022210-037533221236689998643789999999799999--99829-
Q 004564 175 AAILRKSH---------AAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYK--KVVSG- 241 (745)
Q Consensus 175 A~~l~~~~---------~~~~vGTp~YmAPEil~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~~i~~--ki~~g- 241 (745)
|..+.... ....+||+.|||||++.+ .|++++|||||||++|||+||..||........... +....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH
T ss_pred CEECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCC
T ss_conf 13425544554100013577678735329999918998983218861778999984987665530577999999852356
Q ss_pred --CCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHH---HHCCCCCC
Q ss_conf --99998666899799999999862-8069989998---83498778
Q 004564 242 --KKPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARE---LLNDPFLQ 282 (745)
Q Consensus 242 --~~p~~l~~~~s~el~~lI~kCL~-dPskRpSa~E---LL~hPflq 282 (745)
..+..+...+++++.+||.+||. +|.+||++.+ +|+|+|.+
T Consensus 233 ~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 233 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 78983575347889999999998439955791999999999999997
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.52 Aligned_cols=247 Identities=26% Similarity=0.332 Sum_probs=190.1
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC--CE
Q ss_conf 5246767745138659999998579929999997605557997799999999999993799983247689785589--85
Q 004564 22 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN--RN 99 (745)
Q Consensus 22 RY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~--~~ 99 (745)
+| .+.+.||+|+||.||+|. .+|..||+|.++... ........|+..++.++||||+++++++.+... ..
T Consensus 4 ~~-~l~~~iG~G~fg~Vy~~~--~~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 4 TI-VLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GE-EEEEEEECCSSSEEEEEE--ETTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred EE-EEEEEEEECCCEEEEEEE--ECCEEEEEEEECCCC-----HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEE
T ss_conf 89-998898207881999999--999899999987200-----4679999999999627998683268899837986048
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC------CCCEEEECCCCCCEEECCCCCCEEECCCC
Q ss_conf 999982368999999999748889999999999999998775409------99979404877633551999928974762
Q 004564 100 INFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSH------DPPVIHRDLKCDNIFVNGNQGEVKIGDLG 173 (745)
Q Consensus 100 iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~------g~~IIHRDLKp~NILId~~~g~VKL~DFG 173 (745)
+|+||||+.+|+|..++.+. .+++..+..++.|++.||.|||+. .++|+||||||+||||+ .++.+||+|||
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~-~~~~~Kl~DFG 153 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLG 153 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC-TTSCEEECCCT
T ss_pred EEEEEECCCCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEEC-CCCCEEEEECC
T ss_conf 99999646698989998658-99989999999999999999887665204689866153173135786-88776887638
Q ss_pred HHHHHHCC------CCCCCCCCCCCCCHHHHHH-------CCCCCCCCHHHHHHHHHHHHCCCCCCCC------------
Q ss_conf 15656216------7776568887688022210-------0375332212366899986437899999------------
Q 004564 174 LAAILRKS------HAAHCVGTPEFMAPEVYEE-------AYNELVDIYSFGMCILEMVTFEYPYSEC------------ 228 (745)
Q Consensus 174 lA~~l~~~------~~~~~vGTp~YmAPEil~~-------~ys~ksDIWSLGiiL~ELlTG~~Pf~~~------------ 228 (745)
++...... .....+||+.|||||++.+ .++.++|||||||++|||+||..||...
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCC
T ss_conf 66234677762001355250354767822105654546777675012201599999996289988766311241012255
Q ss_pred --CCHHHHHHHHHCCCCCCCCCCC-----CCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf --9979999999829999986668-----99799999999862-80699899988349
Q 004564 229 --THPAQIYKKVVSGKKPDSLYRV-----KDPEVRRFVEKCLA-TVSLRLSARELLND 278 (745)
Q Consensus 229 --~~~~~i~~ki~~g~~p~~l~~~-----~s~el~~lI~kCL~-dPskRpSa~ELL~h 278 (745)
.....+...+..+...+.++.. ....+.+++.+||+ +|.+|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 6430999999875024688877655776899999999999760698589599999999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=319.18 Aligned_cols=246 Identities=16% Similarity=0.221 Sum_probs=201.0
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEECCCC
Q ss_conf 985246767745138659999998579929999997605557997799999999999993799-9832476897855898
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH-KNIMKFYTSWVDTANR 98 (745)
Q Consensus 20 ~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~H-pNIVkl~~~fvd~~~~ 98 (745)
++|| ++.+.||+|+||+||+|++..+++.||+|++.... ....+.+|++.++.+.| +||+.+++++.. ..
T Consensus 4 g~~Y-~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~ 74 (293)
T d1csna_ 4 GVHY-KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GL 74 (293)
T ss_dssp TTTE-EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT------TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TT
T ss_pred CCCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC------CCHHHHHHHHHHHHHCCCCCCCEEEEEEEC--CC
T ss_conf 9806-99799841788299999998899799999975025------829999999999996489998779999601--88
Q ss_pred EEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECC----CCCCEEECCCC
Q ss_conf 599998236899999999974-8889999999999999998775409999794048776335519----99928974762
Q 004564 99 NINFVTEMFTSGTLRQYRLKH-KRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNG----NQGEVKIGDLG 173 (745)
Q Consensus 99 ~iyLVtEy~~gGSL~~~l~k~-~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~----~~g~VKL~DFG 173 (745)
..++||||+ +++|..++... ..++...+..++.|++.||.|||++| |+||||||+|||++. ..+.+||+|||
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred CCEEEEEEC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCC--CEECCCCCCCEEECCCCCCCCCCEEECCCC
T ss_conf 117999964-88879999752031106899999999999999999779--662667713152347543447956872366
Q ss_pred HHHHHHCC---------CCCCCCCCCCCCCHHHHHH-CCCCCCCCHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHCC
Q ss_conf 15656216---------7776568887688022210-03753322123668999864378999999--979999999829
Q 004564 174 LAAILRKS---------HAAHCVGTPEFMAPEVYEE-AYNELVDIYSFGMCILEMVTFEYPYSECT--HPAQIYKKVVSG 241 (745)
Q Consensus 174 lA~~l~~~---------~~~~~vGTp~YmAPEil~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~--~~~~i~~ki~~g 241 (745)
+|+..... .....+||+.|||||++.+ .|++++||||||+++|||+||..||.... .....+.++...
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred EEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHC
T ss_conf 05771467665411102467627751026798964888886999898319999998698767885302199999999705
Q ss_pred C---CCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 9---9998666899799999999862-8069989998834
Q 004564 242 K---KPDSLYRVKDPEVRRFVEKCLA-TVSLRLSARELLN 277 (745)
Q Consensus 242 ~---~p~~l~~~~s~el~~lI~kCL~-dPskRpSa~ELL~ 277 (745)
. .+..+....++++.+++..|+. +|.+||+++.+.+
T Consensus 232 ~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf 6799958965799899999999984399300859999999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=320.93 Aligned_cols=254 Identities=26% Similarity=0.353 Sum_probs=196.5
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-----------CCCCCEE
Q ss_conf 98524676774513865999999857992999999760555799779999999999999379-----------9983247
Q 004564 20 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-----------HKNIMKF 88 (745)
Q Consensus 20 ~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~-----------HpNIVkl 88 (745)
+||| ++.++||+|+||+||+|++..+|+.||+|+++.. ....+.+.+|+.+|+.+. |+||+++
T Consensus 12 ~~rY-~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 12 DARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CCCE-EEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC-----CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEE
T ss_conf 7857-9989975077818999999999979999998343-----133689999999999840145555542276764789
Q ss_pred EEEEEECCCCEEEEEEECCCCCC-HHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEEECCCCCCEEECCCC
Q ss_conf 68978558985999982368999-999999--74888999999999999999877540-999979404877633551999
Q 004564 89 YTSWVDTANRNINFVTEMFTSGT-LRQYRL--KHKRVNIRAVKLWCRQILRGLLYLHS-HDPPVIHRDLKCDNIFVNGNQ 164 (745)
Q Consensus 89 ~~~fvd~~~~~iyLVtEy~~gGS-L~~~l~--k~~~L~e~~i~~ia~QIL~gL~yLHs-~g~~IIHRDLKp~NILId~~~ 164 (745)
++++........+++++++..+. ...+.. ....+++..++.+++||+.||.|||+ ++ |+||||||+|||++..+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~ 163 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVD 163 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEE
T ss_pred EEEEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEEECCC
T ss_conf 9876312565202343200035420000012234678689999999999999888764058--64656770570563057
Q ss_pred C-----CEEECCCCHHHHHHCCCCCCCCCCCCCCCHHHHH-HCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCH------H
Q ss_conf 9-----2897476215656216777656888768802221-00375332212366899986437899999997------9
Q 004564 165 G-----EVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYE-EAYNELVDIYSFGMCILEMVTFEYPYSECTHP------A 232 (745)
Q Consensus 165 g-----~VKL~DFGlA~~l~~~~~~~~vGTp~YmAPEil~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~------~ 232 (745)
. .+||+|||.+...... ....+||+.|+|||++. ..|+.++||||+||++++|++|+.||...... .
T Consensus 164 ~~~~~~~~kl~dfg~s~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 164 SPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TTTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CCCCCCEEEEEECCCCCCCCCC-CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHH
T ss_conf 6564430567531442123445-422366521057132146677764320123789999987889989875543210268
Q ss_pred HHHHHH-HCCCCC--------------------------------------CCCCCCCCHHHHHHHHHHHH-CCCCCCCH
Q ss_conf 999999-829999--------------------------------------98666899799999999862-80699899
Q 004564 233 QIYKKV-VSGKKP--------------------------------------DSLYRVKDPEVRRFVEKCLA-TVSLRLSA 272 (745)
Q Consensus 233 ~i~~ki-~~g~~p--------------------------------------~~l~~~~s~el~~lI~kCL~-dPskRpSa 272 (745)
.+...+ .-|..+ .......++++.+||.+||. ||.+||||
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCH
T ss_conf 99999998379987886245322000132012202432357764442100015674358999999999877994579089
Q ss_pred HHHHCCCCCC
Q ss_conf 9883498778
Q 004564 273 RELLNDPFLQ 282 (745)
Q Consensus 273 ~ELL~hPflq 282 (745)
+|+|+||||+
T Consensus 323 ~e~L~Hp~f~ 332 (362)
T d1q8ya_ 323 GGLVNHPWLK 332 (362)
T ss_dssp HHHHTCGGGT
T ss_pred HHHHCCCCCC
T ss_conf 9996693407
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.2e-23 Score=170.43 Aligned_cols=174 Identities=18% Similarity=0.174 Sum_probs=123.8
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCC----C----------CHHHHHHHHHHHHHHHHCCCCCCCEEEE
Q ss_conf 6767745138659999998579929999997605557----9----------9779999999999999379998324768
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL----Q----------SPEDLERLYCEIHLLKTLKHKNIMKFYT 90 (745)
Q Consensus 25 rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~----~----------s~~~~e~l~~Ei~iLk~L~HpNIVkl~~ 90 (745)
-+++.||+|+||+||+|.+. +|+.||+|+++..... . ..........|+..+..+.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred HHCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 22778024856599999979-99999999986044346665565630008889999997789999999816999144998
Q ss_pred EEEECCCCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEECCCCCCEEEC
Q ss_conf 97855898599998236899999999974888999999999999999877540999979404877633551999928974
Q 004564 91 SWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 170 (745)
Q Consensus 91 ~fvd~~~~~iyLVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~~IIHRDLKp~NILId~~~g~VKL~ 170 (745)
. . . .+++|||+.+..+. .++...+..++.|++.+|.|||+++ |+||||||+|||++ + +.++|+
T Consensus 82 ~--~--~--~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~-~-~~~~li 144 (191)
T d1zara2 82 W--E--G--NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EGIWII 144 (191)
T ss_dssp E--E--T--TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TEEEEC
T ss_pred E--C--C--CEEEEEEECCCCCC-------CHHHHHHHHHHHHHHHHHHHHHHCC--EEECCCCHHHEEEE-C-CCEEEE
T ss_conf 6--2--8--88999950456542-------0015789999999999999982688--89836890361142-8-989998
Q ss_pred CCCHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHH
Q ss_conf 7621565621677765688876880222100375332212366899
Q 004564 171 DLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCIL 216 (745)
Q Consensus 171 DFGlA~~l~~~~~~~~vGTp~YmAPEil~~~ys~ksDIWSLGiiL~ 216 (745)
|||+|..............-.-.-.+.+.+.|+..+|+||+.--++
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred ECCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf 7788430899870999987799999997578998446899999874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.44 E-value=2.1e-06 Score=57.16 Aligned_cols=139 Identities=15% Similarity=0.007 Sum_probs=88.0
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCCCEEEEE
Q ss_conf 676774513865999999857992999999760555799779999999999999379-9983247689785589859999
Q 004564 25 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTSWVDTANRNINFV 103 (745)
Q Consensus 25 rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~fvd~~~~~iyLV 103 (745)
+..+..+.++.+.||+. ...+..+.+|....... .....+.+|..++..+. +--+++++....+ .+..++|
T Consensus 17 ~~~~~~~G~s~~~v~rv--~~~~~~~vlk~~~~~~~----~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~lv 88 (263)
T d1j7la_ 17 RCVKDTEGMSPAKVYKL--VGENENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLL 88 (263)
T ss_dssp EEEECSCCCSSSEEEEE--ECSSCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEE
T ss_pred EEEECCCCCCCCCEEEE--EECCCEEEEEECCCCCC----CCHHHHHHHHHHHHHHHCCCCCCCEEEEEEC--CCCEEEE
T ss_conf 79976789987718999--90898699998488765----3255699999999987606998728999750--8964999
Q ss_pred EECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCC-------------------------------------
Q ss_conf 8236899999999974888999999999999999877540999-------------------------------------
Q 004564 104 TEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHDP------------------------------------- 146 (745)
Q Consensus 104 tEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g~------------------------------------- 146 (745)
|+++.|.++...... ......++.++...|..||+..+
T Consensus 89 ~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEECCCCCCCCCCCC-----CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 986043343543344-----026999999899999998556842143576446565557789987765555430332320
Q ss_pred --------------------CEEEECCCCCCEEECCCCCCEEECCCCHHHH
Q ss_conf --------------------9794048776335519999289747621565
Q 004564 147 --------------------PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 147 --------------------~IIHRDLKp~NILId~~~g~VKL~DFGlA~~ 177 (745)
.++|+|+.+.||+++ +++.+.|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~-~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCEE
T ss_pred CHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEEC-CCCEEEEEECHHCCC
T ss_conf 05799999999844986781789860047642364-996599960231441
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.34 E-value=3.4e-06 Score=55.76 Aligned_cols=81 Identities=19% Similarity=0.217 Sum_probs=53.7
Q ss_pred EEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCC---CHHHHHHHHHHHHHHHHCC-C--CCCCEEEEEEEECCCCEEE
Q ss_conf 77451386599999985799299999976055579---9779999999999999379-9--9832476897855898599
Q 004564 28 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ---SPEDLERLYCEIHLLKTLK-H--KNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 28 e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~---s~~~~e~l~~Ei~iLk~L~-H--pNIVkl~~~fvd~~~~~iy 101 (745)
+.||.|....||++.+...++.+.+|+-...-... -+....+...|+..|+.+. + ..++++|. .+. ...+
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~--~~~~ 107 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDT--EMAV 107 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EET--TTTE
T ss_pred EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEE--ECC--CCCE
T ss_conf 980798527689999579984899961771303467778887789999999999865057988552899--859--8877
Q ss_pred EEEECCCCCCH
Q ss_conf 99823689999
Q 004564 102 FVTEMFTSGTL 112 (745)
Q Consensus 102 LVtEy~~gGSL 112 (745)
+|||++.+..+
T Consensus 108 lvmE~L~~~~~ 118 (392)
T d2pula1 108 TVMEDLSHLKI 118 (392)
T ss_dssp EEECCCTTSEE
T ss_pred EEEECCCCCCC
T ss_conf 98713577653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.83 E-value=3.8e-05 Score=48.88 Aligned_cols=133 Identities=16% Similarity=0.025 Sum_probs=76.6
Q ss_pred EEEEEECCCC-CEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCC--CCCCEEEEEEEECCCCEEE
Q ss_conf 6767745138-659999998579929999997605557997799999999999993799--9832476897855898599
Q 004564 25 RYNEILGKGA-SKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH--KNIMKFYTSWVDTANRNIN 101 (745)
Q Consensus 25 rl~e~LG~Ga-fg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~H--pNIVkl~~~fvd~~~~~iy 101 (745)
++ +.+..|. .+.||+... ..+..+.+|..... ....+..|+..|+.|.. -.+++++.... ..+..+
T Consensus 14 ~~-~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-------~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~--~~~~~~ 82 (255)
T d1nd4a_ 14 DW-AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAAVLDVVT--EAGRDW 82 (255)
T ss_dssp EE-EECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCEE
T ss_pred CE-EECCCCCCCCEEEEEEE-CCCCEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCCCEEEECC--CCCCEE
T ss_conf 35-87678654775899993-89878999958966-------776899999999999865999886132224--566159
Q ss_pred EEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------------
Q ss_conf 99823689999999997488899999999999999987754099------------------------------------
Q 004564 102 FVTEMFTSGTLRQYRLKHKRVNIRAVKLWCRQILRGLLYLHSHD------------------------------------ 145 (745)
Q Consensus 102 LVtEy~~gGSL~~~l~k~~~L~e~~i~~ia~QIL~gL~yLHs~g------------------------------------ 145 (745)
+||++++|.++... ...... .+.++...|.-||+..
T Consensus 83 ~v~~~i~G~~~~~~-----~~~~~~---~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (255)
T d1nd4a_ 83 LLLGEVPGQDLLSS-----HLAPAE---KVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 154 (255)
T ss_dssp EEEECCSSEETTTS-----CCCHHH---HHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEEEECCCCCCC-----CCCHHH---HHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHH
T ss_conf 99874413554322-----126899---9999999999873688544887554124688999999875411011340112
Q ss_pred --------------------CCEEEECCCCCCEEECCCCCCEEECCCCHHHH
Q ss_conf --------------------99794048776335519999289747621565
Q 004564 146 --------------------PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 146 --------------------~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~ 177 (745)
+.++|+|+.+.||+++ .++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~-~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 155 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE-NGRFSGFIDCGRLGV 205 (255)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE-TTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHCCCCCCCEEEECCCCCCCEEEE-CCCEEEEEECHHCCC
T ss_conf 137999999998718765795678678887635773-796589998533265
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.02 E-value=0.0036 Score=35.88 Aligned_cols=75 Identities=17% Similarity=0.111 Sum_probs=46.8
Q ss_pred EEEEEECCCCCEEEEEEEECC-------CCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEECC
Q ss_conf 676774513865999999857-------992999999760555799779999999999999379-998324768978558
Q 004564 25 RYNEILGKGASKTVYRAFDEY-------EGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLK-HKNIMKFYTSWVDTA 96 (745)
Q Consensus 25 rl~e~LG~Gafg~Vy~A~d~~-------tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~-HpNIVkl~~~fvd~~ 96 (745)
++ +.|+.|-.-.+|++.... ....|.+++.- ... ... ...+|..+++.+. +.-.+++++.+
T Consensus 46 ~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g---~~~--~~i-dr~~E~~i~~~ls~~gl~Pkll~~~---- 114 (395)
T d1nw1a_ 46 RI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF---NPE--TES-HLVAESVIFTLLSERHLGPKLYGIF---- 114 (395)
T ss_dssp EE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC---SCC--CHH-HHHHHHHHHHHHHHTTSSSCEEEEE----
T ss_pred EE-EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC---CCC--HHH-HHHHHHHHHHHHHHCCCCCEEEEEC----
T ss_conf 99-991785334348999688775445789817999659---961--165-8999999999997579998089981----
Q ss_pred CCEEEEEEECCCCCCH
Q ss_conf 9859999823689999
Q 004564 97 NRNINFVTEMFTSGTL 112 (745)
Q Consensus 97 ~~~iyLVtEy~~gGSL 112 (745)
.+ .+|+||+.|.+|
T Consensus 115 ~~--g~I~efi~g~~l 128 (395)
T d1nw1a_ 115 SG--GRLEEYIPSRPL 128 (395)
T ss_dssp TT--EEEECCCCEEEC
T ss_pred CC--CEEEEEECCCCC
T ss_conf 89--569997345548
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.49 E-value=0.009 Score=33.23 Aligned_cols=136 Identities=13% Similarity=0.049 Sum_probs=71.1
Q ss_pred CCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCC-----EEEEEEEECCCCEEEEEEECC
Q ss_conf 386599999985799299999976055579977999999999999937999832-----476897855898599998236
Q 004564 33 GASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIM-----KFYTSWVDTANRNINFVTEMF 107 (745)
Q Consensus 33 Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~HpNIV-----kl~~~fvd~~~~~iyLVtEy~ 107 (745)
+.-..||++.. .+|..|++|+.+.. ....+.+..|+..|..|....|. ..-+.-........+.++++.
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~-----~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~ 106 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPE-----RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 106 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTT-----TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred CCCCEEEEEEC-CCCCEEEEEEECCC-----CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEEC
T ss_conf 61202699983-89997999984787-----7889999999999999985599878752068980566534799998652
Q ss_pred CCCCH-----HHHH---------HH---C------CCCCH----------------------HHHHHHHHHHHHHHHHHH
Q ss_conf 89999-----9999---------97---4------88899----------------------999999999999987754
Q 004564 108 TSGTL-----RQYR---------LK---H------KRVNI----------------------RAVKLWCRQILRGLLYLH 142 (745)
Q Consensus 108 ~gGSL-----~~~l---------~k---~------~~L~e----------------------~~i~~ia~QIL~gL~yLH 142 (745)
.|..+ ..+. .. . ..++. ......+.+++..+.-+-
T Consensus 107 ~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~ 186 (325)
T d1zyla1 107 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 186 (325)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHC
T ss_conf 77688999999999989999998863035786556778978876656899987476998898999999999999999845
Q ss_pred -H-CCCCEEEECCCCCCEEECCCCCCEEECCCCHHHH
Q ss_conf -0-9999794048776335519999289747621565
Q 004564 143 -S-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 177 (745)
Q Consensus 143 -s-~g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~~ 177 (745)
. ....+||+|+.++|||++ + + ..++||+-+..
T Consensus 187 ~~~~p~~liHgDlh~~NvL~~-~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 187 REDFTVLRLHGDCHAGNILWR-D-G-PMFVDLDDARN 220 (325)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-S-EEECCCTTCCE
T ss_pred CCCCCCEEECCCCCCCCEEEE-C-C-CEEEECHHCCC
T ss_conf 456871202478880428783-8-9-35886520146
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.99 E-value=0.028 Score=29.98 Aligned_cols=148 Identities=14% Similarity=0.075 Sum_probs=71.4
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCC-----CCCCEE-EEEE
Q ss_conf 9985246767745138659999998579929999997605557997799999999999993799-----983247-6897
Q 004564 19 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKH-----KNIMKF-YTSW 92 (745)
Q Consensus 19 p~GRY~rl~e~LG~Gafg~Vy~A~d~~tg~~VAiK~Ik~~~~~~s~~~~e~l~~Ei~iLk~L~H-----pNIVkl-~~~f 92 (745)
.-|....+ +.|..|--.+.|+.... +..+++|+.... ...+.+..|+.+|..|.. |..+.. -+.+
T Consensus 16 ~lg~~~~~-~~i~~G~~N~ny~v~t~--~g~yVLri~~~~------~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~ 86 (316)
T d2ppqa1 16 DVGSLTSY-KGIAEGVENSNFLLHTT--KDPLILTLYEKR------VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGEL 86 (316)
T ss_dssp CCCCEEEE-EEECC---EEEEEEEES--SCCEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCS
T ss_pred CCCCCEEE-ECCCCCCCCCEEEEEEC--CCCEEEEECCCC------CCHHHHHHHHHHHHHHHHCCCCCCCCCEECCCCC
T ss_conf 99985685-23788852673899978--972899980789------9988999999998754302555455641048976
Q ss_pred EECCCCEEEEEEECCCCCCH-----HHH------H---HHC-C--------------------------CCCHHHHHHHH
Q ss_conf 85589859999823689999-----999------9---974-8--------------------------88999999999
Q 004564 93 VDTANRNINFVTEMFTSGTL-----RQY------R---LKH-K--------------------------RVNIRAVKLWC 131 (745)
Q Consensus 93 vd~~~~~iyLVtEy~~gGSL-----~~~------l---~k~-~--------------------------~L~e~~i~~ia 131 (745)
+.........++.+..+... ... + ... . ..........+
T Consensus 87 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 166 (316)
T d2ppqa1 87 LGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEI 166 (316)
T ss_dssp CEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHH
T ss_pred CEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHH
T ss_conf 21341255024531146553332046788888998764544432024531011101200245677776531141279999
Q ss_pred HHHHHHHHHHHHC--CCCEEEECCCCCCEEECCCCCCEEECCCCHHH
Q ss_conf 9999998775409--99979404877633551999928974762156
Q 004564 132 RQILRGLLYLHSH--DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 176 (745)
Q Consensus 132 ~QIL~gL~yLHs~--g~~IIHRDLKp~NILId~~~g~VKL~DFGlA~ 176 (745)
..+...+...... ..++||+|+.++||++++ +...-+.||+.+.
T Consensus 167 ~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~-~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 167 RPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLG-DELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHCCCSSCEEEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCC-CCCEEEECCCCCC
T ss_conf 999876420485545450333786365640204-5412674222123
|